%%%%%y	w	lem	pos	chk
O	The	The	DT	B-NP
O	relationship	relationship	NN	I-NP
O	of	of	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	and	and	CC	O
O	isoelectric	isoelectric	JJ	B-NP
O	point	point	NN	I-NP
O	with	with	IN	B-PP
O	tumor	tumor	NN	B-NP
O	accumulation	accumulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	avidin	avidin	NN	B-NP
O	.	.	.	O

O	Radiolabeled	Radiolabele	VBN	B-NP
B-GGP	avidin	avidin	NN	I-NP
O	markedly	markedly	RB	B-ADVP
O	accumulated	accumulate	VBD	B-VP
O	in	in	IN	B-PP
O	intraperitoneal	intraperitoneal	JJ	B-NP
O	tumors	tumor	NNS	I-NP
O	and	and	CC	O
O	was	be	VBD	B-VP
O	cleared	clear	VBN	I-VP
O	rapidly	rapidly	RB	B-ADVP
O	from	from	IN	B-PP
O	circulation	circulation	NN	B-NP
O	when	when	WRB	B-ADVP
O	given	give	VBN	B-VP
O	intraperitoneally	intraperitoneally	RB	B-ADVP
O	.	.	.	O

O	This	This	DT	B-NP
O	study	study	NN	I-NP
O	investigated	investigate	VBD	B-VP
O	the	the	DT	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	tumor	tumor	NN	I-NP
O	localization	localization	NN	I-NP
O	of	of	IN	B-PP
B-GGP	avidin	avidin	NN	B-NP
O	.	.	.	O

O	METHODS	METHODS	NNS	B-NP
O	:	:	:	O
B-GGP	Avidin	Avidin	NN	B-NP
O	was	be	VBD	B-VP
O	deglycosylated	deglycosylate	VBN	I-VP
O	through	through	IN	B-PP
B-GGP	endoglycosydase	endoglycosydase	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	H	H	NN	I-NP
O	digestion	digestion	NN	I-NP
O	and	and	CC	O
O	/	/	SYM	B-NP
O	or	or	CC	O
O	neutralized	neutralize	VBN	B-VP
O	by	by	IN	B-PP
O	acetylation	acetylation	NN	B-NP
O	of	of	IN	B-PP
O	its	its	PRP$	B-NP
O	lysine	lysine	NN	I-NP
O	amino	amino	JJ	I-NP
O	acids	acid	NNS	I-NP
O	with	with	IN	B-PP
O	acetic	acetic	JJ	B-NP
O	acid	acid	NN	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	hydroxysuccinimide	hydroxysuccinimide	NN	I-NP
O	ester	ester	NN	I-NP
O	.	.	.	O

B-GGP	Avidin	Avidin	NNP	B-NP
O	and	and	CC	O
O	modified	modify	VBN	B-NP
B-GGP	avidins	avidin	NNS	I-NP
O	were	be	VBD	B-VP
O	analyzed	analyze	VBN	I-VP
O	using	use	VBG	B-VP
O	sodium	sodium	NN	B-NP
O	dodecylsulfate	dodecylsulfate	NN	I-NP
O	-	-	HYPH	B-NP
O	polyacrylamide	polyacrylamide	NN	I-NP
O	gel	gel	NN	I-NP
O	electrophoresis	electrophoresis	NN	I-NP
O	(	(	(	O
O	SDS	SDS	NN	B-NP
O	/	/	SYM	B-NP
O	PAGE	PAGE	NN	I-NP
O	)	)	)	O
O	and	and	CC	O
O	isoelectric	isoelectric	JJ	B-NP
O	focusing	focusing	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	tumor	tumor	NN	I-NP
O	model	model	NN	I-NP
O	was	be	VBD	B-VP
O	established	establish	VBN	I-VP
O	by	by	IN	B-PP
O	intraperitoneal	intraperitoneal	JJ	B-NP
O	injection	injection	NN	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	colon	colon	NN	I-NP
O	cancer	cancer	NN	I-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	LS180	LS180	NN	B-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	nude	nude	JJ	B-NP
O	mice	mouse	NNS	I-NP
O	.	.	.	O

B-GGP	Avidin	Avidin	NNP	B-NP
O	and	and	CC	O
O	modified	modify	VBN	B-NP
B-GGP	avidins	avidin	NNS	I-NP
O	were	be	VBD	B-VP
O	labeled	label	VBN	I-VP
O	with	with	IN	B-PP
O	111In	111In	NN	B-NP
O	using	use	VBG	B-VP
O	diethyleneamine	diethyleneamine	NN	B-NP
O	pentaacetic	pentaacetic	JJ	I-NP
O	acid	acid	NN	I-NP
O	-	-	HYPH	O
O	biotin	biotin	NN	B-NP
O	and	and	CC	O
O	were	be	VBD	B-VP
O	administered	administer	VBN	I-VP
O	intraperitoneally	intraperitoneally	RB	B-ADVP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	tumor	tumor	NN	I-NP
O	-	-	HYPH	O
O	bearing	bear	VBG	B-VP
O	mice	mouse	NNS	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	biodistribution	biodistribution	NN	I-NP
O	of	of	IN	B-PP
O	radioactivity	radioactivity	NN	B-NP
O	was	be	VBD	B-VP
O	examined	examine	VBN	I-VP
O	2	2	CD	B-NP
O	and	and	CC	I-NP
O	24	24	CD	I-NP
O	h	h	NN	I-NP
O	postinjection	postinjection	NN	I-NP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
O	Deglycosylated	Deglycosylate	VBN	B-NP
B-GGP	avidins	avidin	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	a	a	DT	B-NP
O	major	major	JJ	I-NP
O	band	band	NN	I-NP
O	of	of	IN	B-PP
O	smaller	small	JJR	B-NP
O	molecules	molecule	NNS	I-NP
O	on	on	IN	B-PP
O	SDS	SDS	NN	B-NP
O	/	/	SYM	I-NP
O	PAGE	PAGE	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	isoelectric	isoelectric	JJ	I-NP
O	point	point	NN	I-NP
O	of	of	IN	B-PP
O	neutralized	neutralized	JJ	B-NP
B-GGP	avidins	avidin	NNS	I-NP
O	was	be	VBD	B-VP
O	reduced	reduce	VBN	I-VP
O	to	to	TO	B-PP
O	less	less	JJR	B-NP
O	than	than	IN	B-PP
O	5	5	CD	B-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	that	that	DT	B-NP
O	of	of	IN	B-PP
O	unneutralized	unneutralized	JJ	B-NP
B-GGP	avidins	avidin	NNS	I-NP
O	was	be	VBD	B-VP
O	more	more	JJR	B-NP
O	than	than	IN	I-NP
O	9	9	CD	I-NP
O	.	.	.	I-NP
O	5	5	CD	I-NP
O	.	.	.	O

O	Biodistribution	Biodistribution	NN	B-NP
O	study	study	NN	I-NP
O	demonstrated	demonstrate	VBD	B-VP
O	that	that	IN	B-SBAR
O	liver	liver	NN	B-NP
O	uptake	uptake	NN	I-NP
O	was	be	VBD	B-VP
O	decreased	decrease	VBN	I-VP
O	by	by	IN	B-PP
O	deglycosylation	deglycosylation	NN	B-NP
O	and	and	CC	I-NP
O	kidney	kidney	NN	I-NP
O	accumulation	accumulation	NN	I-NP
O	was	be	VBD	B-VP
O	decreased	decrease	VBN	I-VP
O	by	by	IN	B-PP
O	neutralization	neutralization	NN	B-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	The	The	DT	B-NP
O	blood	blood	NN	I-NP
O	clearance	clearance	NN	I-NP
O	was	be	VBD	B-VP
O	remarkably	remarkably	RB	I-VP
O	slowed	slow	VBN	I-VP
O	by	by	IN	B-PP
O	combined	combine	VBN	B-NP
O	modification	modification	NN	I-NP
O	of	of	IN	B-PP
O	deglycosylation	deglycosylation	NN	B-NP
O	and	and	CC	I-NP
O	neutralization	neutralization	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	tumor	tumor	NN	I-NP
O	uptake	uptake	NN	I-NP
O	of	of	IN	B-PP
O	radioactivity	radioactivity	NN	B-NP
O	was	be	VBD	B-VP
O	reduced	reduce	VBN	I-VP
O	by	by	IN	B-PP
O	either	either	CC	O
O	deglycosylation	deglycosylation	NN	B-NP
O	or	or	CC	O
O	neutralization	neutralization	NN	B-NP
O	and	and	CC	O
O	was	be	VBD	B-VP
O	further	further	RBR	I-VP
O	decreased	decrease	VBN	I-VP
O	with	with	IN	B-PP
O	combined	combine	VBN	B-NP
O	modification	modification	NN	I-NP
O	.	.	.	O

O	CONCLUSION	CONCLUSION	NN	B-NP
O	:	:	:	O
O	Both	Both	CC	O
O	high	high	JJ	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	and	and	CC	O
O	positive	positive	JJ	B-NP
O	charge	charge	NN	I-NP
O	of	of	IN	B-PP
B-GGP	avidin	avidin	NN	B-NP
O	contributed	contribute	VBD	B-VP
O	to	to	TO	B-PP
O	its	its	PRP$	B-NP
O	accumulation	accumulation	NN	I-NP
O	in	in	IN	B-PP
O	tumor	tumor	NN	B-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	study	study	NN	I-NP
O	may	may	MD	B-VP
O	facilitate	facilitate	VB	I-VP
O	development	development	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	new	new	JJ	I-NP
O	vehicle	vehicle	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	delivery	delivery	NN	I-NP
O	of	of	IN	B-PP
O	therapeutic	therapeutic	JJ	B-NP
O	agents	agent	NNS	I-NP
O	to	to	TO	B-PP
O	intraperitoneal	intraperitoneal	JJ	B-NP
O	tumors	tumor	NNS	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	novel	novel	JJ	I-NP
O	aromatic	aromatic	JJ	I-NP
O	-	-	HYPH	I-NP
O	ring	ring	NN	I-NP
O	-	-	HYPH	O
O	hydroxylating	hydroxylate	VBG	B-VP
O	dioxygenase	dioxygenase	NN	B-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	diterpenoid	diterpenoid	NN	I-NP
O	-	-	HYPH	B-VP
O	degrading	degrade	VBG	B-NP
O	bacterium	bacterium	NN	I-NP
O	Pseudomonas	Pseudomonas	NNP	I-NP
O	abietaniphila	abietaniphila	NNP	I-NP
O	BKME	BKME	NNP	I-NP
O	-	-	:	O
O	9	9	CD	B-NP
O	.	.	.	O

O	Pseudomonas	Pseudomonas	NN	B-NP
O	abietaniphila	abietaniphila	NN	I-NP
O	BKME	BKME	NN	I-NP
O	-	-	HYPH	O
O	9	9	CD	B-NP
O	is	be	VBZ	B-VP
O	able	able	JJ	B-ADJP
O	to	to	TO	B-VP
O	degrade	degrade	VB	I-VP
O	dehydroabietic	dehydroabietic	JJ	B-NP
O	acid	acid	NN	I-NP
O	(	(	(	O
O	DhA	DhA	NN	B-NP
O	)	)	)	O
O	via	via	IN	B-PP
O	ring	ring	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	dioxygenase	dioxygenase	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	ditA1	ditA1	NN	I-NP
O	,	,	,	O
B-GGP	ditA2	ditA2	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	ditA3	ditA3	NN	B-NP
O	genes	gene	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	encode	encode	VBP	B-VP
O	the	the	DT	B-NP
O	alpha	alpha	NN	I-NP
O	and	and	CC	I-NP
O	beta	beta	NN	I-NP
O	subunits	subunit	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	oxygenase	oxygenase	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	ferredoxin	ferredoxin	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	diterpenoid	diterpenoid	JJ	I-NP
O	dioxygenase	dioxygenase	NN	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	,	,	,	O
O	were	be	VBD	B-VP
O	isolated	isolate	VBN	I-VP
O	and	and	CC	O
O	sequenced	sequence	VBN	B-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	ferredoxin	ferredoxin	NN	I-NP
O	gene	gene	NN	I-NP
O	is	be	VBZ	B-VP
O	9	9	CD	B-NP
O	.	.	.	O

O	2	2	CD	B-NP
O	kb	kb	NN	I-NP
O	upstream	upstream	RB	B-ADVP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	oxygenase	oxygenase	NN	I-NP
O	genes	gene	NNS	I-NP
O	and	and	CC	O
O	872	872	CD	B-NP
O	bp	bp	NN	I-NP
O	upstream	upstream	RB	B-ADVP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	putative	putative	JJ	I-NP
O	meta	meta	JJ	I-NP
O	ring	ring	NN	I-NP
O	cleavage	cleavage	NN	I-NP
O	dioxygenase	dioxygenase	NN	I-NP
O	gene	gene	NN	I-NP
O	,	,	,	O
B-GGP	ditC	ditC	NN	B-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	Tn5	Tn5	NN	I-NP
O	insertion	insertion	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	alpha	alpha	NN	I-NP
O	subunit	subunit	NN	I-NP
O	gene	gene	NN	I-NP
O	,	,	,	O
B-GGP	ditA1	ditA1	NN	B-NP
O	,	,	,	O
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	accumulation	accumulation	NN	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	mutant	mutant	JJ	I-NP
O	strain	strain	NN	I-NP
O	BKME	BKME	NN	I-NP
O	-	-	HYPH	O
O	941	941	CD	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	pathway	pathway	NN	I-NP
O	intermediate	intermediate	NN	I-NP
O	,	,	,	O
O	7	7	CD	B-NP
O	-	-	HYPH	I-NP
O	oxoDhA	oxoDhA	NN	I-NP
O	.	.	.	O

O	Disruption	Disruption	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	ferredoxin	ferredoxin	NN	I-NP
O	gene	gene	NN	I-NP
O	,	,	,	O
B-GGP	ditA3	ditA3	NN	B-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	wild	wild	JJ	B-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	BKME	BKME	NN	I-NP
O	-	-	HYPH	O
O	9	9	CD	B-NP
O	by	by	IN	B-PP
O	mutant	mutant	JJ	B-NP
O	-	-	HYPH	I-NP
O	allele	allele	NN	I-NP
O	exchange	exchange	NN	I-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	strain	strain	NN	I-NP
O	(	(	(	O
O	BKME	BKME	NN	B-NP
O	-	-	HYPH	B-NP
O	91	91	CD	I-NP
O	)	)	)	O
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	phenotype	phenotype	NN	I-NP
O	identical	identical	JJ	B-ADJP
O	to	to	TO	B-PP
O	that	that	DT	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mutant	mutant	JJ	I-NP
O	strain	strain	NN	I-NP
O	BKME	BKME	NN	I-NP
O	-	-	HYPH	B-NP
O	941	941	CD	I-NP
O	.	.	.	O

O	Sequence	Sequence	NN	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	putative	putative	JJ	I-NP
O	ferredoxin	ferredoxin	NN	I-NP
O	indicated	indicate	VBD	B-VP
O	that	that	IN	B-SBAR
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	likely	likely	JJ	B-ADJP
O	to	to	TO	B-VP
O	be	be	VB	I-VP
O	a	a	DT	B-NP
O	[	[	(	I-NP
O	4Fe	4Fe	NN	I-NP
O	-	-	HYPH	I-NP
O	4S	4S	NN	I-NP
O	]	]	)	O
O	-	-	HYPH	O
O	or	or	CC	O
O	[	[	(	B-NP
O	3Fe	3Fe	NN	I-NP
O	-	-	HYPH	I-NP
O	4S	4S	NN	I-NP
O	]	]	)	O
O	-	-	HYPH	B-NP
O	type	type	NN	I-NP
O	ferredoxin	ferredoxin	NN	I-NP
O	and	and	CC	B-NP
O	not	not	RB	I-NP
O	a	a	DT	B-NP
O	[	[	(	I-NP
O	2Fe	2Fe	NN	I-NP
O	-	-	HYPH	I-NP
O	2S	2S	NN	I-NP
O	]	]	)	O
O	-	-	HYPH	B-NP
O	type	type	NN	I-NP
O	ferredoxin	ferredoxin	NN	I-NP
O	,	,	,	O
O	as	as	IN	B-SBAR
O	found	find	VBN	B-VP
O	in	in	IN	B-PP
O	all	all	DT	B-NP
O	previously	previously	RB	I-NP
O	described	describe	VBN	I-NP
O	ring	ring	NN	I-NP
O	-	-	HYPH	O
O	hydroxylating	hydroxylate	VBG	B-VP
O	dioxygenases	dioxygenas	NNS	B-NP
O	.	.	.	O

O	Expression	Expression	NN	B-NP
O	in	in	IN	B-PP
O	Escherichia	Escherichia	FW	B-NP
O	coli	coli	FW	I-NP
O	of	of	IN	B-PP
B-GGP	ditA1A2A3	ditA1A2A3	NN	B-NP
O	,	,	,	O
O	encoding	encode	VBG	B-VP
O	the	the	DT	B-NP
O	diterpenoid	diterpenoid	JJ	I-NP
O	dioxygenase	dioxygenase	NN	I-NP
O	without	without	IN	B-PP
O	its	its	PRP$	B-NP
O	putative	putative	JJ	I-NP
O	reductase	reductase	NN	I-NP
O	component	component	NN	I-NP
O	,	,	,	O
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	functional	functional	JJ	I-NP
O	enzyme	enzyme	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	diterpenoid	diterpenoid	JJ	I-NP
O	dioxygenase	dioxygenase	NN	I-NP
O	attacks	attack	VBZ	B-VP
O	7	7	CD	B-NP
O	-	-	HYPH	I-NP
O	oxoDhA	oxoDhA	NN	I-NP
O	,	,	,	B-NP
O	and	and	CC	I-NP
O	not	not	RB	I-NP
O	DhA	DhA	NN	B-NP
O	,	,	,	O
O	at	at	IN	B-PP
O	C	C	NN	B-NP
O	-	-	HYPH	I-NP
O	11	11	CD	I-NP
O	and	and	CC	I-NP
O	C	C	NN	I-NP
O	-	-	HYPH	B-NP
O	12	12	CD	I-NP
O	,	,	,	O
O	producing	produce	VBG	B-VP
O	7	7	CD	B-NP
O	-	-	HYPH	I-NP
O	oxo	oxo	NN	I-NP
O	-	-	HYPH	I-NP
O	11	11	CD	I-NP
O	,	,	,	I-NP
O	12	12	CD	I-NP
O	-	-	HYPH	I-NP
O	dihydroxy	dihydroxy	NN	I-NP
O	-	-	HYPH	I-NP
O	8	8	CD	I-NP
O	,	,	,	I-NP
O	13	13	CD	I-NP
O	-	-	HYPH	I-NP
O	abietadien	abietadien	NN	I-NP
O	acid	acid	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	was	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	by	by	IN	B-PP
O	1H	1H	NN	B-NP
O	nuclear	nuclear	JJ	I-NP
O	magnetic	magnetic	JJ	I-NP
O	resonance	resonance	NN	I-NP
O	,	,	,	O
O	UV	UV	NN	B-NP
O	-	-	HYPH	B-NP
O	visible	visible	JJ	I-NP
O	light	light	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	high	high	JJ	B-NP
O	-	-	HYPH	I-NP
O	resolution	resolution	NN	I-NP
O	mass	mass	NN	I-NP
O	spectrometry	spectrometry	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	organization	organization	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	genes	gene	NNS	I-NP
O	encoding	encode	VBG	B-VP
O	the	the	DT	B-NP
O	various	various	JJ	I-NP
O	components	component	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	diterpenoid	diterpenoid	JJ	I-NP
O	dioxygenase	dioxygenase	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	phylogenetic	phylogenetic	JJ	I-NP
O	distinctiveness	distinctiveness	NN	I-NP
O	of	of	IN	B-PP
O	both	both	CC	O
O	the	the	DT	B-NP
O	alpha	alpha	NN	I-NP
O	subunit	subunit	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	ferredoxin	ferredoxin	NN	I-NP
O	component	component	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	unusual	unusual	JJ	I-NP
O	Fe	Fe	NN	I-NP
O	-	-	HYPH	B-NP
O	S	S	NN	I-NP
O	cluster	cluster	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	ferredoxin	ferredoxin	NN	I-NP
O	all	all	DT	B-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	enzyme	enzyme	NN	I-NP
O	belongs	belong	VBZ	B-VP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	new	new	JJ	I-NP
O	class	class	NN	I-NP
O	of	of	IN	B-PP
O	aromatic	aromatic	JJ	B-NP
O	ring	ring	NN	I-NP
O	-	-	HYPH	O
O	hydroxylating	hydroxylate	VBG	B-VP
O	dioxygenases	dioxygenas	NNS	B-NP
O	.	.	.	O

O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	I-NP
O	chromatin	chromatin	NN	I-NP
O	modification	modification	NN	I-NP
O	.	.	.	O

O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	I-NP
O	chromatin	chromatin	NN	I-NP
O	modification	modification	NN	I-NP
O	are	be	VBP	B-VP
O	two	two	CD	B-NP
O	global	global	JJ	I-NP
O	mechanisms	mechanism	NNS	I-NP
O	that	that	WDT	B-NP
O	regulate	regulate	VBP	B-VP
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	Recent	Recent	JJ	B-NP
O	studies	study	NNS	I-NP
O	provide	provide	VBP	B-VP
O	insight	insight	NN	B-NP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	of	of	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	silencing	silencing	NN	I-NP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	B-NP
O	CpG	CpG	NN	I-NP
O	binding	binding	NN	I-NP
O	protein	protein	NN	I-NP
O	,	,	,	O
B-GGP	MeCP2	MeCP2	NN	B-NP
O	.	.	.	O

B-GGP	MeCP2	MeCP2	NN	B-NP
O	is	be	VBZ	B-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	interact	interact	VB	I-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
B-GGP	Sin3	Sin3	NN	I-NP
O	/	/	SYM	B-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylase	deacetylase	NN	I-NP
O	co	co	AFX	O
O	-	-	HYPH	B-NP
O	repressor	repressor	NN	I-NP
O	complex	complex	NN	I-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
O	this	this	DT	B-NP
O	interaction	interaction	NN	I-NP
O	can	can	MD	B-VP
O	provide	provide	VB	I-VP
O	a	a	DT	B-NP
O	mechanistic	mechanistic	JJ	I-NP
O	explanation	explanation	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	long	long	JJ	I-NP
O	-	-	HYPH	I-NP
O	known	know	VBN	I-NP
O	relationship	relationship	NN	I-NP
O	between	between	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	I-NP
O	chromatin	chromatin	NN	I-NP
O	structure	structure	NN	I-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	several	several	JJ	B-NP
O	studies	study	NNS	I-NP
O	have	have	VBP	B-VP
O	shown	show	VBN	I-VP
O	that	that	IN	B-SBAR
O	inhibition	inhibition	NN	B-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	deacetylases	deacetylas	NNS	I-NP
O	by	by	IN	B-PP
O	specific	specific	JJ	B-NP
O	inhibitors	inhibitor	NNS	I-NP
O	can	can	MD	B-VP
O	reactivate	reactivate	VB	I-VP
O	endogenous	endogenous	JJ	B-NP
O	genes	gene	NNS	I-NP
O	or	or	CC	O
O	reporter	reporter	NN	B-NP
O	constructs	construct	NNS	I-NP
O	previously	previously	RB	B-VP
O	silenced	silence	VBN	I-VP
O	by	by	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	.	.	.	O

O	Taken	Take	VBN	B-VP
O	together	together	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	data	datum	NNS	I-NP
O	strongly	strongly	RB	B-VP
O	suggest	suggest	VBP	I-VP
O	that	that	IN	B-SBAR
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	can	can	MD	B-VP
O	pattern	pattern	VB	I-VP
O	chromatin	chromatin	NN	B-NP
O	modification	modification	NN	I-NP
O	.	.	.	O

O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	IV	IV	CD	B-NP
O	)	)	)	O
O	causes	cause	VBZ	B-VP
O	activation	activation	NN	B-NP
O	of	of	IN	B-PP
O	nuclear	nuclear	JJ	B-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	B-NP
O	kappa	kappa	NN	I-NP
O	B	B	NN	I-NP
O	,	,	,	O
O	DNA	DNA	NN	B-NP
O	strand	strand	NN	I-NP
O	breaks	break	NNS	I-NP
O	and	and	CC	O
O	dG	dG	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	via	via	IN	B-PP
O	free	free	JJ	B-NP
O	radical	radical	NN	I-NP
O	reactions	reaction	NNS	I-NP
O	.	.	.	O

O	Electrophoretic	Electrophoretic	JJ	B-NP
O	mobility	mobility	NN	I-NP
O	shift	shift	NN	I-NP
O	,	,	,	O
O	DNA	DNA	NN	B-NP
O	strand	strand	NN	I-NP
O	breakage	breakage	NN	I-NP
O	assays	assay	NNS	I-NP
O	and	and	CC	O
O	electron	electron	NN	B-NP
O	spin	spin	NN	I-NP
O	resonance	resonance	NN	I-NP
O	(	(	(	O
O	ESR	ESR	NN	B-NP
O	)	)	)	O
O	spin	spin	NN	B-NP
O	trapping	trapping	NN	I-NP
O	were	be	VBD	B-VP
O	used	use	VBN	I-VP
O	to	to	TO	B-VP
O	investigate	investigate	VB	I-VP
O	the	the	DT	B-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
O	nuclear	nuclear	JJ	B-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
O	(	(	(	O
O	NF	NF	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	kappa	kappa	NN	I-NP
O	B	B	NN	I-NP
O	,	,	,	O
O	DNA	DNA	NN	B-NP
O	strand	strand	NN	I-NP
O	breakage	breakage	NN	I-NP
O	and	and	CC	O
O	2	2	CD	B-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	deoxyguanosine	deoxyguanosine	NN	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	induced	induce	VBN	B-VP
O	by	by	IN	B-PP
O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	IV	IV	CD	B-NP
O	)	)	)	O
O	,	,	,	O
O	as	as	RB	B-ADVP
O	well	well	RB	I-ADVP
O	the	the	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	free	free	JJ	B-NP
O	radical	radical	NN	I-NP
O	reactions	reaction	NNS	I-NP
O	in	in	IN	B-PP
O	these	these	DT	B-NP
O	processes	process	NNS	I-NP
O	.	.	.	O

O	Incubation	Incubation	NN	B-NP
O	of	of	IN	B-PP
O	synthesized	synthesize	VBN	B-NP
O	Cr	Cr	NN	I-NP
O	(	(	(	O
O	IV	IV	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	glutathione	glutathione	NN	I-NP
O	complex	complex	NN	I-NP
O	with	with	IN	B-PP
O	cultured	culture	VBN	B-NP
O	Jurkat	Jurkat	NN	I-NP
O	cells	cell	NNS	I-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	activation	activation	NN	B-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	binding	binding	NN	I-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappa	kappa	NN	I-NP
O	B	B	NN	I-NP
O	.	.	.	O

O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	VI	VI	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	also	also	RB	B-ADVP
O	able	able	JJ	B-ADJP
O	to	to	TO	B-VP
O	induce	induce	VB	I-VP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappa	kappa	NN	I-NP
O	B	B	NN	I-NP
O	activation	activation	NN	I-NP
O	through	through	IN	B-PP
O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	V	V	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	IV	IV	CD	B-NP
O	)	)	)	O
O	intermediates	intermediate	NNS	B-NP
O	generated	generate	VBN	B-VP
O	during	during	IN	B-PP
O	the	the	DT	B-NP
O	reduction	reduction	NN	I-NP
O	of	of	IN	B-PP
O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	VI	VI	NN	B-NP
O	)	)	)	O
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	III	III	CD	B-NP
O	)	)	)	O
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	cause	cause	VB	I-VP
O	observable	observable	JJ	B-NP
O	NF	NF	NN	I-NP
O	-	-	HYPH	B-NP
O	kappa	kappa	NN	I-NP
O	B	B	NN	I-NP
O	activation	activation	NN	I-NP
O	due	due	IN	B-PP
O	to	to	TO	I-PP
O	its	its	PRP$	B-NP
O	inability	inability	NN	I-NP
O	to	to	TO	B-VP
O	cross	cross	VB	I-VP
O	cell	cell	NN	B-NP
O	membranes	membrane	NNS	I-NP
O	.	.	.	O

O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	IV	IV	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	O
O	induced	induce	VBN	B-NP
O	NF	NF	NN	I-NP
O	-	-	HYPH	B-NP
O	kappa	kappa	NN	I-NP
O	B	B	NN	I-NP
O	activation	activation	NN	I-NP
O	is	be	VBZ	B-VP
O	dose	dose	NN	B-NP
O	-	-	HYPH	B-PP
O	dependent	dependent	JJ	B-ADJP
O	.	.	.	O

B-GGP	Catalase	Catalase	NN	B-NP
O	inhibited	inhibit	VBD	B-VP
O	the	the	DT	B-NP
O	activation	activation	NN	I-NP
O	while	while	IN	B-SBAR
O	superoxide	superoxide	NN	B-NP
O	dismutase	dismutase	NN	I-NP
O	enhanced	enhance	VBD	B-VP
O	it	it	PRP	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	metal	metal	NN	I-NP
O	chelator	chelator	NN	I-NP
O	,	,	,	O
O	deferoxamine	deferoxamine	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	hydroxyl	hydroxyl	NN	B-NP
O	(	(	(	O
O	.	.	.	O
O	OH	OH	NN	O
O	)	)	)	O
O	radical	radical	JJ	B-NP
O	scavengers	scavenger	NNS	I-NP
O	,	,	,	O
O	sodium	sodium	NN	B-NP
O	formate	formate	NN	I-NP
O	and	and	CC	I-NP
O	aspirin	aspirin	NN	I-NP
O	,	,	,	O
O	also	also	RB	B-ADVP
O	inhibited	inhibit	VBD	B-VP
O	the	the	DT	B-NP
O	NF	NF	NN	I-NP
O	-	-	HYPH	B-NP
O	kappa	kappa	NN	I-NP
O	B	B	NN	I-NP
O	activation	activation	NN	I-NP
O	.	.	.	O

O	Electrophoretic	Electrophoretic	JJ	B-NP
O	assays	assay	NNS	I-NP
O	using	use	VBG	B-VP
O	lambda	lambda	SYM	B-NP
O	Hind	Hind	NN	B-NP
O	III	III	CD	I-NP
O	linear	linear	JJ	I-NP
O	DNA	DNA	NN	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	,	,	,	O
O	in	in	IN	B-PP
O	the	the	DT	I-PP
O	presence	presence	NN	I-PP
O	of	of	IN	I-PP
O	H2O2	H2O2	NN	B-NP
O	,	,	,	O
O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	IV	IV	CD	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	capable	capable	JJ	B-ADJP
O	of	of	IN	B-PP
O	causing	cause	VBG	B-VP
O	DNA	DNA	NN	B-NP
O	strand	strand	NN	I-NP
O	breaks	break	NNS	I-NP
O	.	.	.	O

O	Deferoxamine	Deferoxamine	NN	B-NP
O	,	,	,	O
O	sodium	sodium	NN	B-NP
O	formate	formate	NN	I-NP
O	and	and	CC	I-NP
O	aspirin	aspirin	NN	I-NP
O	inhibited	inhibit	VBD	B-VP
O	the	the	DT	B-NP
O	DNA	DNA	NN	I-NP
O	strand	strand	NN	I-NP
O	breaks	break	NNS	I-NP
O	.	.	.	O

O	HPLC	HPLC	NN	B-NP
O	measurements	measurement	NNS	I-NP
O	also	also	RB	B-ADVP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	.	.	.	O
O	OH	OH	NN	B-NP
O	radical	radical	NN	I-NP
O	generated	generate	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	Cr	Cr	NN	I-NP
O	(	(	(	O
O	IV	IV	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	reaction	reaction	NN	I-NP
O	with	with	IN	B-PP
O	H2O2	H2O2	NN	B-NP
O	was	be	VBD	B-VP
O	capable	capable	JJ	B-ADJP
O	of	of	IN	B-PP
O	causing	cause	VBG	B-VP
O	2	2	CD	B-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	deoxyguanosine	deoxyguanosine	NN	I-NP
O	(	(	(	O
O	dG	dG	NN	B-NP
O	)	)	)	O
O	hydroxylation	hydroxylation	NN	B-NP
O	to	to	TO	B-VP
O	generate	generate	VB	I-VP
O	8	8	CD	B-NP
O	-	-	HYPH	I-NP
O	hydroxyguanosine	hydroxyguanosine	NN	I-NP
O	(	(	(	O
O	8	8	CD	B-NP
O	-	-	HYPH	I-NP
O	OHdG	OHdG	NN	I-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	relative	relative	JJ	I-NP
O	magnitude	magnitude	NN	I-NP
O	of	of	IN	B-PP
O	8	8	CD	B-NP
O	-	-	HYPH	I-NP
O	OHdG	OHdG	NN	I-NP
O	formation	formation	NN	I-NP
O	correlated	correlate	VBD	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	generation	generation	NN	I-NP
O	of	of	IN	B-PP
O	.	.	.	O
O	OH	OH	NN	B-NP
O	radicals	radical	NNS	I-NP
O	.	.	.	O

O	ESR	ESR	NN	B-NP
O	spin	spin	NN	I-NP
O	trapping	trapping	NN	I-NP
O	measurements	measurement	NNS	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	reaction	reaction	NN	B-NP
O	of	of	IN	B-PP
O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	IV	IV	CD	B-NP
O	)	)	)	O
O	with	with	IN	B-PP
O	H2O2	H2O2	NN	B-NP
O	generated	generate	VBN	B-VP
O	.	.	.	O
O	OH	OH	NN	B-NP
O	radicals	radical	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	were	be	VBD	B-VP
O	inhibited	inhibit	VBN	I-VP
O	by	by	IN	B-PP
O	deferoxamine	deferoxamine	NN	B-NP
O	,	,	,	O
O	sodium	sodium	NN	B-NP
O	formate	formate	NN	I-NP
O	and	and	CC	I-NP
O	aspirin	aspirin	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	IV	IV	CD	B-NP
O	)	)	)	O
O	can	can	MD	B-VP
O	cause	cause	VB	I-VP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappa	kappa	NN	I-NP
O	B	B	NN	I-NP
O	activation	activation	NN	I-NP
O	,	,	,	O
O	DNA	DNA	NN	B-NP
O	strand	strand	NN	I-NP
O	breaks	break	NNS	I-NP
O	and	and	CC	O
O	dG	dG	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	through	through	IN	B-ADVP
O	.	.	.	O
O	OH	OH	``	O
O	radical	radical	JJ	B-NP
O	-	-	HYPH	I-NP
O	initiated	initiate	VBN	I-NP
O	reactions	reaction	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	reactive	reactive	JJ	I-NP
O	chromium	chromium	NN	I-NP
O	intermediate	intermediate	NN	I-NP
O	may	may	MD	B-VP
O	play	play	VB	I-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	of	of	IN	B-PP
O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	VI	VI	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	carcinogenesis	carcinogenesis	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	also	also	RB	B-ADVP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	Cr	Cr	NN	I-NP
O	(	(	(	O
O	IV	IV	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	glutathione	glutathione	NN	I-NP
O	complex	complex	NN	I-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	used	use	VBN	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	model	model	NN	I-NP
O	compound	compound	NN	I-NP
O	to	to	TO	B-VP
O	study	study	VB	I-VP
O	the	the	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	IV	IV	CD	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	Cr	Cr	NN	B-NP
O	(	(	(	O
O	VI	VI	NN	B-NP
O	)	)	)	O
O	carcinogenicity	carcinogenicity	NN	B-NP
O	.	.	.	O

O	Overhydroxylation	Overhydroxylation	NN	B-NP
O	of	of	IN	B-PP
O	lysyl	lysyl	NN	B-NP
O	residues	residue	NNS	I-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	initial	initial	JJ	I-NP
O	step	step	NN	I-NP
O	for	for	IN	B-PP
O	altered	altered	JJ	B-NP
O	collagen	collagen	NN	I-NP
O	cross	cross	AFX	O
O	-	-	HYPH	O
O	links	link	NNS	B-NP
O	and	and	CC	O
O	fibril	fibril	NN	B-NP
O	architecture	architecture	NN	I-NP
O	in	in	IN	B-PP
O	fibrotic	fibrotic	JJ	B-NP
O	skin	skin	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	fibrotic	fibrotic	JJ	B-NP
O	skin	skin	NN	I-NP
O	of	of	IN	B-PP
O	lipodermatosclerosis	lipodermatosclerosis	NN	B-NP
O	a	a	DT	B-NP
O	substantial	substantial	JJ	I-NP
O	increase	increase	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cross	cross	AFX	I-NP
O	-	-	HYPH	I-NP
O	link	link	NN	I-NP
O	hydroxylysylpyridinoline	hydroxylysylpyridinoline	NN	I-NP
O	is	be	VBZ	B-VP
O	observed	observe	VBN	I-VP
O	.	.	.	O

O	Hydroxylysylpyridinoline	Hydroxylysylpyridinoline	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	typical	typical	JJ	I-NP
O	cross	cross	AFX	I-NP
O	-	-	HYPH	I-NP
O	link	link	NN	I-NP
O	of	of	IN	B-PP
O	skeletal	skeletal	JJ	B-NP
O	tissue	tissue	NN	I-NP
O	and	and	CC	O
O	is	be	VBZ	B-VP
O	thought	think	VBN	I-VP
O	to	to	TO	I-VP
O	play	play	VB	I-VP
O	a	a	DT	B-NP
O	major	major	JJ	I-NP
O	part	part	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	hardening	hardening	NN	I-NP
O	of	of	IN	B-PP
O	sclerotic	sclerotic	JJ	B-NP
O	tissue	tissue	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	investigated	investigate	VBD	B-VP
O	whether	whether	IN	B-SBAR
O	the	the	DT	B-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
O	hydroxylysylpyridinoline	hydroxylysylpyridinoline	NN	B-NP
O	is	be	VBZ	B-VP
O	due	due	IN	B-PP
O	to	to	TO	I-PP
O	overhydroxylation	overhydroxylation	NN	B-NP
O	of	of	IN	B-PP
O	lysyl	lysyl	NN	B-NP
O	residues	residue	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	collagen	collagen	NN	I-NP
O	molecule	molecule	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	may	may	MD	B-VP
O	also	also	RB	I-VP
O	be	be	VB	I-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	an	an	DT	B-NP
O	increase	increase	NN	I-NP
O	of	of	IN	B-PP
O	glycosylated	glycosylate	VBN	B-NP
O	hydroxylysine	hydroxylysine	NN	I-NP
O	residues	residue	NNS	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	determined	determine	VBD	B-VP
O	whether	whether	IN	B-SBAR
O	the	the	DT	B-NP
O	collagen	collagen	NN	I-NP
O	fibrils	fibril	NNS	I-NP
O	in	in	IN	B-PP
O	lipodermatosclerosis	lipodermatosclerosis	NN	B-NP
O	showed	show	VBD	B-VP
O	a	a	DT	B-NP
O	decrease	decrease	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	diameter	diameter	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	tissue	tissue	NN	I-NP
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	after	after	IN	B-PP
O	fibrillogenesis	fibrillogenesis	NN	B-NP
O	of	of	IN	B-PP
O	pepsin	pepsin	NN	B-NP
O	-	-	HYPH	B-NP
O	solubilized	solubilize	VBN	I-NP
O	collagens	collagen	NNS	I-NP
O	.	.	.	O

O	Isolated	Isolate	VBN	B-VP
O	alpha	alpha	SYM	B-NP
O	-	-	HYPH	B-VP
O	chains	chain	NNS	B-NP
O	of	of	IN	B-PP
O	pepsin	pepsin	NN	B-NP
O	solubilized	solubilize	VBD	B-VP
O	collagen	collagen	NN	B-NP
O	I	I	PRP	B-NP
O	showed	show	VBD	B-VP
O	an	an	DT	B-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
O	lysyl	lysyl	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	(	(	(	O
O	hyl	hyl	NN	B-NP
O	/	/	SYM	O
O	(	(	(	O
O	hyl	hyl	NN	B-NP
O	+	+	SYM	B-NP
O	lys	ly	NNS	I-NP
O	)	)	)	O
O	)	)	)	O
O	as	as	IN	B-PP
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	normal	normal	JJ	B-NP
O	control	control	NN	I-NP
O	[	[	(	O
O	alpha1	alpha1	NN	B-NP
O	(	(	(	O
O	I	I	NN	B-NP
O	)	)	)	O
O	:	:	:	O
O	lipodermatosclerosis	lipodermatosclerosis	NN	B-NP
O	0	0	CD	I-NP
O	.	.	.	O
O	18	18	CD	B-NP
O	+	+	SYM	O
O	/	/	SYM	O
O	-	-	SYM	B-NP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	01	01	CD	I-NP
O	;	;	:	O
O	control	control	NN	B-NP
O	0	0	CD	I-NP
O	.	.	.	I-NP
O	12	12	CD	I-NP
O	+	+	SYM	O
O	/	/	SYM	O
O	-	-	SYM	B-NP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	01	01	CD	I-NP
O	;	;	:	O
O	alpha2	alpha2	NN	B-NP
O	(	(	(	O
O	I	I	NN	B-NP
O	)	)	)	O
O	:	:	:	O
O	lipodermatosclerosis	lipodermatosclerosis	NN	B-NP
O	0	0	CD	I-NP
O	.	.	.	O
O	36	36	CD	B-NP
O	+	+	SYM	O
O	/	/	SYM	O
O	-	-	SYM	B-NP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	02	02	CD	I-NP
O	;	;	:	O
O	control	control	NN	B-NP
O	0	0	CD	I-NP
O	.	.	.	O

O	25	25	CD	B-NP
O	+	+	SYM	O
O	/	/	SYM	B-NP
O	-	-	SYM	B-NP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	03	03	CD	I-NP
O	,	,	,	O
O	p	p	NN	B-NP
O	<	<	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	001	001	CD	I-NP
O	]	]	)	O
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	content	content	NN	I-NP
O	of	of	IN	B-PP
O	enzymatic	enzymatic	JJ	B-NP
O	glycosylated	glycosylate	VBN	I-NP
O	hydroxlysine	hydroxlysine	NN	I-NP
O	residues	residue	NNS	I-NP
O	increased	increase	VBD	B-VP
O	.	.	.	O

O	This	This	DT	B-NP
O	increase	increase	NN	I-NP
O	is	be	VBZ	B-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	decrease	decrease	NN	I-NP
O	of	of	IN	B-PP
O	fibril	fibril	NN	B-NP
O	diameter	diameter	NN	I-NP
O	of	of	IN	B-PP
O	both	both	CC	O
O	tissue	tissue	NN	B-NP
O	and	and	CC	O
O	fibrils	fibril	NNS	B-NP
O	formed	form	VBN	B-VP
O	in	in	FW	B-NP
O	vitro	vitro	FW	I-NP
O	of	of	IN	B-PP
O	pepsin	pepsin	NN	B-NP
O	-	-	HYPH	B-NP
O	solubilized	solubilize	VBN	I-NP
O	collagens	collagen	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	same	same	JJ	I-NP
O	pool	pool	NN	I-NP
O	of	of	IN	B-PP
O	collagens	collagen	NNS	B-NP
O	an	an	DT	B-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
B-GGP	collagen	collagen	NN	B-NP
I-GGP	III	III	CD	I-NP
O	content	content	NN	I-NP
O	was	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	as	as	IN	B-SBAR
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	controls	control	NNS	B-NP
O	(	(	(	O
O	lipodermatosclerosis	lipodermatosclerosis	NN	B-NP
O	14	14	CD	I-NP
O	.	.	.	O
O	5	5	CD	B-NP
O	%	%	NN	I-NP
O	+	+	SYM	B-NP
O	/	/	SYM	B-VP
O	-	-	SYM	B-NP
O	1	1	CD	I-NP
O	.	.	SYM	I-NP
O	6	6	CD	I-NP
O	,	,	,	O
O	control	control	NN	B-NP
O	10	10	CD	I-NP
O	.	.	.	O
O	3	3	CD	B-NP
O	%	%	NN	I-NP
O	+	+	SYM	B-NP
O	/	/	SYM	B-VP
O	-	-	SYM	B-NP
O	1	1	CD	I-NP
O	.	.	SYM	I-NP
O	6	6	CD	I-NP
O	,	,	,	O
O	p	p	NN	B-NP
O	<	<	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	001	001	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	results	result	NNS	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	overhydroxylation	overhydroxylation	NN	I-NP
O	of	of	IN	B-PP
O	lysyl	lysyl	NN	B-NP
O	residues	residue	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	generation	generation	NN	I-NP
O	of	of	IN	B-PP
O	hydroxylysylpyridinoline	hydroxylysylpyridinoline	NN	B-NP
O	,	,	,	O
O	is	be	VBZ	B-VP
O	not	not	RB	O
O	only	only	RB	B-ADJP
O	restricted	restricted	JJ	I-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	telopeptides	telopeptide	NNS	I-NP
O	but	but	CC	O
O	also	also	RB	B-ADVP
O	affects	affect	VBZ	B-VP
O	the	the	DT	B-NP
O	helical	helical	JJ	I-NP
O	part	part	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	molecule	molecule	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	process	process	NN	I-NP
O	is	be	VBZ	B-VP
O	further	further	RBR	B-ADJP
O	associated	associate	VBN	I-ADJP
O	with	with	IN	B-PP
O	an	an	DT	B-NP
O	increase	increase	NN	I-NP
O	of	of	IN	B-PP
O	glycosylated	glycosylate	VBN	B-NP
O	hydroxylysyl	hydroxylysyl	NN	I-NP
O	residues	residue	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	changes	change	NNS	I-NP
O	along	along	IN	B-PP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
B-GGP	collagen	collagen	NN	B-NP
I-GGP	III	III	CD	I-NP
O	content	content	NN	I-NP
O	seem	seem	VBP	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	responsible	responsible	JJ	B-ADJP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	observed	observe	VBN	I-NP
O	alteration	alteration	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	architecture	architecture	NN	I-NP
O	of	of	IN	B-PP
O	collagen	collagen	NN	B-NP
O	fibrils	fibril	NNS	I-NP
O	in	in	IN	B-PP
O	sclerotic	sclerotic	JJ	B-NP
O	skin	skin	NN	I-NP
O	.	.	.	O

O	ER	ER	NN	B-NP
O	/	/	SYM	I-NP
O	Golgi	Golgi	NN	I-NP
O	intermediates	intermediate	NNS	I-NP
O	acquire	acquire	VBP	B-VP
O	Golgi	Golgi	NNP	B-NP
O	enzymes	enzyme	NNS	I-NP
O	by	by	IN	B-PP
O	brefeldin	brefeldin	NN	B-NP
O	A	A	NN	I-NP
O	-	-	HYPH	B-NP
O	sensitive	sensitive	JJ	I-NP
O	retrograde	retrograde	JJ	I-NP
O	transport	transport	NN	I-NP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	.	.	.	O

O	Secretory	Secretory	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	exit	exit	VBP	B-VP
O	the	the	DT	B-NP
O	ER	ER	NN	I-NP
O	in	in	IN	B-PP
O	transport	transport	NN	B-NP
O	vesicles	vesicle	NNS	I-NP
O	that	that	WDT	B-NP
O	fuse	fuse	VBP	B-VP
O	to	to	TO	I-VP
O	form	form	VB	I-VP
O	vesicular	vesicular	JJ	B-NP
O	tubular	tubular	JJ	I-NP
O	clusters	cluster	NNS	I-NP
O	(	(	(	O
O	VTCs	VTC	NNS	B-NP
O	)	)	)	O
O	which	which	WDT	B-NP
O	move	move	VBP	B-VP
O	along	along	IN	B-PP
O	microtubule	microtubule	NN	B-NP
O	tracks	track	NNS	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	Golgi	Golgi	NNP	I-NP
O	apparatus	apparatus	NN	I-NP
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	the	the	DT	B-NP
O	well	well	RB	I-NP
O	-	-	HYPH	I-NP
O	characterized	characterize	VBN	B-VP
O	in	in	FW	B-NP
O	vitro	vitro	FW	I-NP
O	approach	approach	NN	I-NP
O	to	to	TO	B-VP
O	study	study	VB	I-VP
O	the	the	DT	B-NP
O	properties	property	NNS	I-NP
O	of	of	IN	B-PP
O	Golgi	Golgi	NNP	B-NP
O	membranes	membrane	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	determined	determine	VBD	B-VP
O	whether	whether	IN	B-SBAR
O	the	the	DT	B-NP
O	Golgi	Golgi	NNP	I-NP
O	enzyme	enzyme	NN	I-NP
B-GGP	NAGT	NAGT	NN	I-NP
I-GGP	I	I	CD	I-NP
O	is	be	VBZ	B-VP
O	transported	transport	VBN	I-VP
O	to	to	TO	B-PP
O	ER	ER	NN	B-NP
O	/	/	SYM	O
O	Golgi	Golgi	NN	B-NP
O	intermediates	intermediate	NNS	I-NP
O	.	.	.	O

O	Secretory	Secretory	JJ	B-NP
O	cargo	cargo	NN	I-NP
O	was	be	VBD	B-VP
O	arrested	arrest	VBN	I-VP
O	at	at	IN	B-PP
O	distinct	distinct	JJ	B-NP
O	steps	step	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	secretory	secretory	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	mutant	mutant	JJ	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	in	in	FW	B-NP
O	vitro	vitro	FW	I-NP
O	complementation	complementation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	defect	defect	NN	I-NP
O	was	be	VBD	B-VP
O	determined	determine	VBN	I-VP
O	.	.	.	O

O	Complementation	Complementation	NN	B-NP
O	yield	yield	NN	I-NP
O	increased	increase	VBD	B-VP
O	after	after	IN	B-PP
O	ER	ER	NN	B-NP
O	exit	exit	NN	I-NP
O	of	of	IN	B-PP
O	secretory	secretory	JJ	B-NP
O	cargo	cargo	NN	I-NP
O	and	and	CC	O
O	was	be	VBD	B-VP
O	optimal	optimal	JJ	B-ADJP
O	when	when	WRB	B-ADVP
O	transport	transport	NN	B-NP
O	was	be	VBD	B-VP
O	blocked	block	VBN	I-VP
O	at	at	IN	B-PP
O	an	an	DT	B-NP
O	ER	ER	NN	I-NP
O	/	/	SYM	B-NP
O	Golgi	Golgi	NN	I-NP
O	intermediate	intermediate	JJ	I-NP
O	step	step	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	rapid	rapid	JJ	I-NP
O	drop	drop	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	complementation	complementation	NN	I-NP
O	yield	yield	NN	I-NP
O	as	as	IN	B-PP
O	secretory	secretory	JJ	B-NP
O	cargo	cargo	NN	I-NP
O	progresses	progress	VBZ	B-VP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	stack	stack	NN	I-NP
O	suggests	suggest	VBZ	B-VP
O	that	that	IN	B-SBAR
O	Golgi	Golgi	NNP	B-NP
O	enzymes	enzyme	NNS	I-NP
O	are	be	VBP	B-VP
O	preferentially	preferentially	RB	I-VP
O	targeted	target	VBN	I-VP
O	to	to	TO	B-PP
O	ER	ER	NN	B-NP
O	/	/	SYM	O
O	Golgi	Golgi	NN	B-NP
O	intermediates	intermediate	NNS	I-NP
O	and	and	CC	O
O	not	not	RB	O
O	to	to	TO	B-PP
O	membranes	membrane	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Golgi	Golgi	NNP	I-NP
O	stack	stack	NN	I-NP
O	.	.	.	O

O	Two	Two	CD	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	for	for	IN	B-PP
O	in	in	FW	B-NP
O	vitro	vitro	FW	I-NP
O	complementation	complementation	NN	I-NP
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	distinguished	distinguish	VBN	I-VP
O	due	due	JJ	B-ADJP
O	to	to	TO	B-PP
O	their	their	PRP$	B-NP
O	different	different	JJ	I-NP
O	sensitivities	sensitivity	NNS	I-NP
O	to	to	TO	B-PP
O	brefeldin	brefeldin	NN	B-NP
O	A	A	NN	I-NP
O	(	(	(	O
O	BFA	BFA	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Transport	Transport	NN	B-NP
O	occurred	occur	VBD	B-VP
O	either	either	CC	O
O	by	by	IN	B-PP
O	direct	direct	JJ	B-NP
O	fusion	fusion	NN	I-NP
O	of	of	IN	B-PP
O	preexisting	preexist	VBG	B-VP
O	transport	transport	NN	B-NP
O	intermediates	intermediate	NNS	I-NP
O	with	with	IN	B-PP
O	ER	ER	NN	B-NP
O	/	/	SYM	B-NP
O	Golgi	Golgi	NN	I-NP
O	intermediates	intermediate	NNS	I-NP
O	,	,	,	O
O	or	or	CC	O
O	it	it	PRP	B-NP
O	occurred	occur	VBD	B-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	BFA	BFA	NN	I-NP
O	-	-	HYPH	O
O	sensitive	sensitive	JJ	B-ADJP
O	and	and	CC	O
O	most	most	RBS	B-ADVP
O	likely	likely	RB	I-ADVP
O	COP	COP	NN	B-NP
O	I	I	CD	I-NP
O	-	-	HYPH	B-NP
O	mediated	mediate	VBN	I-NP
O	step	step	NN	I-NP
O	.	.	.	O

O	Direct	Direct	JJ	B-NP
O	fusion	fusion	NN	I-NP
O	of	of	IN	B-PP
O	ER	ER	NN	B-NP
O	/	/	SYM	O
O	Golgi	Golgi	NN	B-NP
O	intermediates	intermediate	NNS	I-NP
O	with	with	IN	B-PP
O	cisternal	cisternal	JJ	B-NP
O	membranes	membrane	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Golgi	Golgi	NNP	I-NP
O	stack	stack	NN	I-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	observed	observe	VBN	I-VP
O	under	under	IN	B-PP
O	these	these	DT	B-NP
O	conditions	condition	NNS	I-NP
O	.	.	.	O

O	Immunofluorescent	Immunofluorescent	JJ	B-NP
O	studies	study	NNS	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	chromosomes	chromosome	NNS	I-NP
O	with	with	IN	B-PP
O	antibodies	antibody	NNS	B-NP
O	against	against	IN	B-PP
O	phosphorylated	phosphorylate	VBN	B-NP
B-GGP	H1	H1	NN	I-NP
I-GGP	histone	histone	NN	I-NP
O	.	.	.	O

O	One	One	CD	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	prominent	prominent	JJ	I-NP
O	cell	cell	NN	I-NP
O	cycle	cycle	NN	I-NP
O	-	-	HYPH	B-NP
O	related	relate	VBN	I-NP
O	modifications	modification	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	proteins	protein	NNS	I-NP
O	whose	whose	WP$	B-NP
O	function	function	NN	I-NP
O	remains	remain	VBZ	B-VP
O	unresolved	unresolved	JJ	B-ADJP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	of	of	IN	B-PP
O	linker	linker	NN	B-NP
B-GGP	histone	histone	NN	I-NP
I-GGP	H1	H1	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	work	work	NN	I-NP
O	we	we	PRP	B-NP
O	have	have	VBP	B-VP
O	used	use	VBN	I-VP
O	indirect	indirect	JJ	B-NP
O	immunofluorescence	immunofluorescence	NN	I-NP
O	on	on	IN	B-PP
O	human	human	JJ	B-NP
O	cells	cell	NNS	I-NP
O	with	with	IN	B-PP
O	antibodies	antibody	NNS	B-NP
O	that	that	WDT	B-NP
O	are	be	VBP	B-VP
O	specific	specific	JJ	B-ADJP
O	for	for	IN	B-PP
O	phosphorylated	phosphorylate	VBN	B-NP
B-GGP	histone	histone	NN	I-NP
I-GGP	H1	H1	NN	I-NP
O	to	to	TO	B-VP
O	examine	examine	VB	I-VP
O	the	the	DT	B-NP
O	cellular	cellular	JJ	I-NP
O	distribution	distribution	NN	I-NP
O	and	and	CC	I-NP
O	chromosome	chromosome	NN	I-NP
O	association	association	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	With	With	IN	B-PP
O	confocal	confocal	JJ	B-NP
O	microscopy	microscopy	NN	I-NP
O	on	on	IN	B-PP
O	whole	whole	JJ	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	strong	strong	JJ	B-NP
O	immunofluorescence	immunofluorescence	NN	I-NP
O	was	be	VBD	B-VP
O	seen	see	VBN	I-VP
O	in	in	IN	B-PP
O	association	association	NN	B-NP
O	with	with	IN	B-PP
O	mitotic	mitotic	JJ	B-NP
O	chromosomes	chromosome	NNS	I-NP
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	a	a	DT	B-NP
O	prominent	prominent	JJ	I-NP
O	punctate	punctate	NN	I-NP
O	pattern	pattern	NN	I-NP
O	of	of	IN	B-PP
O	labeling	label	VBG	B-VP
O	throughout	throughout	IN	B-PP
O	the	the	DT	B-NP
O	mitotic	mitotic	JJ	I-NP
O	cell	cell	NN	I-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	interphase	interphase	NN	B-NP
O	cells	cell	NNS	I-NP
O	showed	show	VBD	B-VP
O	very	very	RB	B-NP
O	little	little	JJ	I-NP
O	,	,	,	O
O	if	if	IN	B-SBAR
O	any	any	DT	B-NP
O	,	,	,	O
O	specific	specific	JJ	B-NP
O	fluorescence	fluorescence	NN	I-NP
O	.	.	.	O

O	Multiple	Multiple	JJ	B-NP
O	patterns	pattern	NNS	I-NP
O	of	of	IN	B-PP
O	fluorescence	fluorescence	NN	B-NP
O	distribution	distribution	NN	I-NP
O	were	be	VBD	B-VP
O	detected	detect	VBN	I-VP
O	with	with	IN	B-PP
O	metaphase	metaphase	NN	B-NP
O	chromosomes	chromosome	NNS	I-NP
O	,	,	,	O
O	ranging	range	VBG	B-VP
O	from	from	IN	B-PP
O	apparent	apparent	JJ	B-NP
O	tight	tight	JJ	I-NP
O	colocalization	colocalization	NN	I-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	DNA	DNA	NN	I-NP
O	to	to	TO	B-VP
O	expanded	expand	VBN	I-VP
O	"	"	''	O
O	puffy	puffy	JJ	B-NP
O	"	"	``	I-NP
O	mitotic	mitotic	JJ	I-NP
O	figures	figure	NNS	I-NP
O	to	to	TO	B-PP
O	an	an	DT	B-NP
O	amorphous	amorphous	JJ	I-NP
O	network	network	NN	I-NP
O	of	of	IN	B-PP
O	staining	staining	NN	B-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	was	be	VBD	B-VP
O	also	also	RB	I-VP
O	shown	show	VBN	I-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	ability	ability	NN	I-NP
O	to	to	TO	B-PP
O	label	label	NN	B-NP
O	chromosomes	chromosome	NNS	I-NP
O	could	could	MD	B-VP
O	vary	vary	VB	I-VP
O	drastically	drastically	RB	B-ADVP
O	with	with	IN	B-PP
O	different	different	JJ	B-NP
O	fixation	fixation	NN	I-NP
O	procedures	procedure	NNS	I-NP
O	,	,	,	O
O	adding	add	VBG	B-VP
O	further	further	JJ	B-NP
O	complications	complication	NNS	I-NP
O	to	to	TO	B-PP
O	interpretation	interpretation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	potentially	potentially	RB	I-NP
O	complex	complex	JJ	I-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	phosphorylated	phosphorylate	VBN	B-NP
B-GGP	histone	histone	NN	I-NP
I-GGP	H1	H1	NN	I-NP
O	in	in	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	condensation	condensation	NN	I-NP
O	or	or	CC	I-NP
O	decondensation	decondensation	NN	I-NP
O	.	.	.	O

O	Clinical	Clinical	JJ	B-NP
O	and	and	CC	I-NP
O	biochemical	biochemical	JJ	I-NP
O	characteristics	characteristic	NNS	I-NP
O	of	of	IN	B-PP
O	congenital	congenital	JJ	B-NP
O	disorder	disorder	NN	I-NP
O	of	of	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	type	type	NN	I-NP
O	Ic	Ic	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	recognized	recognize	VBN	I-NP
O	endoplasmic	endoplasmic	JJ	I-NP
O	reticulum	reticulum	NN	I-NP
O	defect	defect	NN	I-NP
O	in	in	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	glycan	glycan	NN	I-NP
O	synthesis	synthesis	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	report	report	VBP	B-VP
O	on	on	IN	B-PP
O	8	8	CD	B-NP
O	patients	patient	NNS	I-NP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	recently	recently	RB	I-NP
O	described	describe	VBN	I-NP
O	novel	novel	JJ	I-NP
O	subtype	subtype	NN	I-NP
O	of	of	IN	B-PP
O	congenital	congenital	JJ	B-NP
O	disorder	disorder	NN	I-NP
O	of	of	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	type	type	NN	I-NP
O	Ic	Ic	NN	I-NP
O	(	(	(	O
O	CDG	CDG	NN	B-NP
O	-	-	HYPH	B-NP
O	Ic	Ic	NN	I-NP
O	)	)	)	O
O	.	.	.	O

O	Their	Their	PRP$	B-NP
O	clinical	clinical	JJ	I-NP
O	presentation	presentation	NN	I-NP
O	was	be	VBD	B-VP
O	mainly	mainly	RB	B-ADJP
O	neurological	neurological	JJ	I-ADJP
O	with	with	IN	B-PP
O	developmental	developmental	JJ	B-NP
O	retardation	retardation	NN	I-NP
O	,	,	,	O
O	muscular	muscular	JJ	B-NP
O	hypotonia	hypotonia	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	epilepsy	epilepsy	NN	B-NP
O	.	.	.	O

O	Several	Several	JJ	B-NP
O	symptoms	symptom	NNS	I-NP
O	commonly	commonly	RB	B-VP
O	seen	see	VBN	I-VP
O	in	in	IN	B-PP
O	CDG	CDG	NN	B-NP
O	-	-	HYPH	I-NP
O	Ia	Ia	NN	I-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	inverted	inverted	JJ	B-NP
O	nipples	nipple	NNS	I-NP
O	,	,	,	O
O	abnormal	abnormal	JJ	B-NP
O	fat	fat	NN	I-NP
O	distribution	distribution	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	cerebellar	cerebellar	JJ	B-NP
O	hypoplasia	hypoplasia	NN	I-NP
O	were	be	VBD	B-VP
O	not	not	RB	I-VP
O	observed	observe	VBN	I-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	clinical	clinical	JJ	I-NP
O	course	course	NN	I-NP
O	is	be	VBZ	B-VP
O	milder	mild	JJR	B-ADJP
O	overall	overall	RB	B-ADVP
O	,	,	,	O
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	better	good	JJR	I-NP
O	neurological	neurological	JJ	I-NP
O	outcome	outcome	NN	I-NP
O	,	,	,	O
O	than	than	IN	B-PP
O	in	in	IN	B-PP
O	CDG	CDG	NN	B-NP
O	-	-	HYPH	B-NP
O	Ia	Ia	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	isoelectric	isoelectric	JJ	I-NP
O	focusing	focus	VBG	I-NP
O	pattern	pattern	NN	I-NP
O	of	of	IN	B-PP
O	serum	serum	NN	B-NP
B-GGP	transferrin	transferrin	NN	I-NP
O	in	in	IN	B-PP
O	CDG	CDG	NN	B-NP
O	-	-	HYPH	B-NP
O	Ia	Ia	NN	I-NP
O	and	and	CC	I-NP
O	CDG	CDG	NN	I-NP
O	-	-	HYPH	O
O	Ic	Ic	NN	B-NP
O	is	be	VBZ	B-VP
O	indistinguishable	indistinguishable	JJ	B-ADJP
O	.	.	.	O

O	Interestingly	Interestingly	RB	B-ADVP
O	,	,	,	O
B-GGP	beta	beta	SYM	O
I-GGP	-	-	HYPH	O
I-GGP	trace	trace	NN	B-NP
I-GGP	protein	protein	NN	I-NP
O	in	in	IN	B-PP
O	cerebrospinal	cerebrospinal	JJ	B-NP
O	fluid	fluid	NN	I-NP
O	derived	derive	VBN	B-VP
O	from	from	IN	B-PP
O	immunoblot	immunoblot	NN	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	brain	brain	NN	I-NP
O	showed	show	VBD	B-VP
O	a	a	DT	B-NP
O	less	less	RBR	I-NP
O	pronounced	pronounced	JJ	I-NP
O	hypoglycosylation	hypoglycosylation	NN	I-NP
O	pattern	pattern	NN	I-NP
O	in	in	IN	B-PP
O	CDG	CDG	NN	B-NP
O	-	-	HYPH	B-NP
O	Ic	Ic	NN	I-NP
O	patients	patient	NNS	I-NP
O	than	than	IN	B-PP
O	in	in	IN	B-PP
O	CDG	CDG	NN	B-NP
O	-	-	HYPH	O
O	Ia	Ia	NN	B-NP
O	patients	patient	NNS	I-NP
O	.	.	.	O

O	Analysis	Analysis	NN	B-NP
O	of	of	IN	B-PP
O	lipid	lipid	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	oligosaccharides	oligosaccharide	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	an	an	DT	B-NP
O	accumulation	accumulation	NN	I-NP
O	of	of	IN	B-PP
O	Man9GlcNAc2	Man9GlcNAc2	NN	B-NP
O	intermediates	intermediate	NNS	I-NP
O	due	due	JJ	B-ADJP
O	to	to	TO	B-PP
B-GGP	dolichol	dolichol	NN	B-NP
I-GGP	pyrophosphate	pyrophosphate	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	Man9GlcNAc2	Man9GlcNAc2	NN	I-NP
I-GGP	alpha	alpha	SYM	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
I-GGP	,	,	,	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	glucosyltransferase	glucosyltransferase	NN	I-NP
O	deficiency	deficiency	NN	I-NP
O	.	.	.	O

O	All	All	DT	B-NP
O	patients	patient	NNS	I-NP
O	were	be	VBD	B-VP
O	homozygous	homozygous	JJ	B-ADJP
O	for	for	IN	B-PP
O	an	an	DT	B-NP
O	A333V	A333V	NN	I-NP
O	mutation	mutation	NN	I-NP
O	.	.	.	O

O	Phosphorylation	Phosphorylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	RTP	RTP	NN	B-NP
O	,	,	,	O
O	an	an	DT	B-NP
O	ER	ER	NN	I-NP
O	stress	stress	NN	I-NP
O	-	-	HYPH	B-NP
O	responsive	responsive	JJ	I-NP
O	cytoplasmic	cytoplasmic	JJ	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

B-GGP	RTP	RTP	NN	B-NP
O	,	,	,	O
O	also	also	RB	B-ADVP
O	called	call	VBN	B-VP
B-GGP	Drg1	Drg1	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	Cap43	Cap43	NN	I-NP
O	/	/	SYM	I-NP
B-GGP	rit42	rit42	NN	I-NP
O	/	/	SYM	B-NP
B-GGP	TDD5	TDD5	NN	I-NP
O	/	/	SYM	I-NP
B-GGP	Ndr1	Ndr1	NN	I-NP
O	,	,	,	O
O	was	be	VBD	B-VP
O	originally	originally	RB	I-VP
O	identified	identify	VBN	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	homocysteine	homocysteine	NN	I-NP
O	-	-	HYPH	B-NP
O	responsive	responsive	JJ	I-NP
O	gene	gene	NN	I-NP
O	product	product	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	is	be	VBZ	B-VP
O	now	now	RB	I-VP
O	considered	consider	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	stress	stress	NN	B-NP
O	responses	response	NNS	I-NP
O	,	,	,	O
O	atherosclerosis	atherosclerosis	NN	B-NP
O	,	,	,	O
O	carcinogenesis	carcinogenesis	NN	B-NP
O	,	,	,	O
O	differentiation	differentiation	NN	B-NP
O	,	,	,	O
O	androgen	androgen	NN	B-NP
O	responses	response	NNS	I-NP
O	,	,	,	O
O	hypoxia	hypoxia	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	N	N	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	myc	myc	NN	I-NP
O	pathways	pathway	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	raised	raise	VBD	B-VP
O	an	an	DT	B-NP
O	antiserum	antiserum	NN	I-NP
O	against	against	IN	B-PP
O	a	a	DT	B-NP
O	recombinant	recombinant	JJ	I-NP
O	human	human	JJ	I-NP
B-GGP	RTP	RTP	NN	I-NP
O	.	.	.	O

O	Western	Western	NN	B-NP
O	blot	blot	NN	I-NP
O	analysis	analysis	NN	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	RTP	RTP	NN	B-NP
O	expression	expression	NN	I-NP
O	was	be	VBD	B-VP
O	induced	induce	VBN	I-VP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	umbilical	umbilical	JJ	I-NP
O	vein	vein	NN	I-NP
O	endothelial	endothelial	JJ	I-NP
O	cells	cell	NNS	I-NP
O	under	under	IN	B-PP
O	conditions	condition	NNS	B-NP
O	causing	cause	VBG	B-VP
O	endoplasmic	endoplasmic	JJ	B-NP
O	reticulum	reticulum	NN	I-NP
O	stress	stress	NN	I-NP
O	.	.	.	O

B-GGP	RTP	RTP	NN	B-NP
O	was	be	VBD	B-VP
O	partially	partially	RB	I-VP
O	phosphorylated	phosphorylate	VBN	I-VP
O	at	at	IN	B-PP
O	seven	seven	CD	B-NP
O	or	or	CC	I-NP
O	more	more	JJR	I-NP
O	sites	site	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	was	be	VBD	B-VP
O	reversible	reversible	JJ	B-ADJP
O	,	,	,	O
O	and	and	CC	O
O	was	be	VBD	B-VP
O	enhanced	enhance	VBN	I-VP
O	by	by	IN	B-PP
O	an	an	DT	B-NP
O	increased	increase	VBN	I-NP
O	level	level	NN	I-NP
O	of	of	IN	B-PP
O	intracellular	intracellular	JJ	B-NP
O	cAMP	cAMP	NN	I-NP
O	and	and	CC	O
O	inhibited	inhibit	VBN	B-VP
O	by	by	IN	B-PP
O	both	both	CC	O
O	a	a	DT	B-NP
O	protein	protein	NN	I-NP
O	kinase	kinase	NN	I-NP
O	A	A	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	and	and	CC	O
O	a	a	DT	B-NP
O	calmodulin	calmodulin	NN	I-NP
O	kinase	kinase	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	.	.	.	O

O	Protein	Protein	NN	B-NP
O	kinase	kinase	NN	I-NP
O	A	A	NN	I-NP
O	directly	directly	RB	B-ADVP
O	phosphorylated	phosphorylate	VBD	B-VP
O	recombinant	recombinant	JJ	B-NP
B-GGP	RTP	RTP	NN	I-NP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	.	.	.	O

O	The	The	DT	B-NP
O	phosphorylated	phosphorylated	JJ	I-NP
O	forms	form	NNS	I-NP
O	were	be	VBD	B-VP
O	abundant	abundant	JJ	B-ADJP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	early	early	JJ	I-NP
O	log	log	NN	I-NP
O	phase	phase	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	then	then	RB	B-VP
O	decreased	decrease	VBD	I-VP
O	with	with	IN	B-PP
O	increasing	increase	VBG	B-NP
O	cell	cell	NN	I-NP
O	density	density	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	demonstrated	demonstrate	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	RTP	RTP	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	phosphorylated	phosphorylate	VBN	I-NP
O	stress	stress	NN	I-NP
O	-	-	HYPH	I-NP
O	responsive	responsive	JJ	I-NP
O	protein	protein	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	related	relate	VBN	I-VP
O	to	to	TO	B-PP
O	cell	cell	NN	B-NP
O	growth	growth	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	method	method	NN	I-NP
O	for	for	IN	B-PP
O	determining	determine	VBG	B-VP
O	the	the	DT	B-NP
O	in	in	FW	I-NP
O	vivo	vivo	FW	I-NP
O	topology	topology	NN	I-NP
O	of	of	IN	B-PP
O	yeast	yeast	NN	B-NP
O	polytopic	polytopic	JJ	I-NP
O	membrane	membrane	NN	I-NP
O	proteins	protein	NNS	I-NP
O	demonstrates	demonstrate	VBZ	B-VP
O	that	that	IN	B-SBAR
B-GGP	Gap1p	Gap1p	NN	B-NP
O	fully	fully	RB	B-VP
O	integrates	integrate	VBZ	I-VP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	membrane	membrane	NN	I-NP
O	independently	independently	RB	B-ADVP
O	of	of	IN	B-PP
B-GGP	Shr3p	Shr3p	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	general	general	JJ	I-NP
O	amino	amino	NN	I-NP
O	acid	acid	NN	I-NP
O	permease	permease	NN	I-NP
O	(	(	(	O
B-GGP	Gap1p	Gap1p	NN	B-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	Saccharomyces	Saccharomyces	NNP	B-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	integral	integral	JJ	I-NP
O	membrane	membrane	NN	I-NP
O	protein	protein	NN	I-NP
O	that	that	WDT	B-NP
O	contains	contain	VBZ	B-VP
O	12	12	CD	B-NP
O	hydrophobic	hydrophobic	JJ	I-NP
O	regions	region	NNS	I-NP
O	predicted	predict	VBN	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	membrane	membrane	NN	B-NP
O	-	-	HYPH	O
O	spanning	span	VBG	B-VP
O	segments	segment	NNS	B-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	topological	topological	JJ	I-NP
O	reporter	reporter	NN	I-NP
O	construct	construct	NN	I-NP
O	,	,	,	O
O	encoding	encode	VBG	B-VP
O	an	an	DT	B-NP
O	internal	internal	JJ	I-NP
O	53	53	CD	I-NP
O	-	-	HYPH	I-NP
O	amino	amino	NN	I-NP
O	acid	acid	NN	I-NP
O	peptide	peptide	NN	I-NP
O	of	of	IN	B-PP
O	invertase	invertase	NN	B-NP
O	(	(	(	O
B-GGP	Suc2p	Suc2p	NN	B-NP
O	)	)	)	O
O	containing	contain	VBG	B-VP
O	three	three	CD	B-NP
O	Asp	Asp	NN	I-NP
O	-	-	HYPH	B-NP
O	X	X	SYM	I-NP
O	-	-	HYPH	I-NP
O	Ser	Ser	NN	I-NP
O	/	/	SYM	I-NP
O	Thr	Thr	NN	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	sites	site	NNS	I-NP
O	,	,	,	O
O	was	be	VBD	B-VP
O	inserted	insert	VBN	I-VP
O	in	in	IN	B-PP
O	-	-	HYPH	B-NP
O	frame	frame	NN	I-NP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	hydrophilic	hydrophilic	JJ	I-NP
O	NH	NH	NN	I-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	and	and	CC	I-NP
O	COOH	COOH	NN	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	domains	domain	NNS	I-NP
O	and	and	CC	O
O	each	each	DT	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	11	11	CD	I-NP
O	hydrophilic	hydrophilic	JJ	I-NP
O	loops	loop	NNS	I-NP
O	that	that	WDT	B-NP
O	separate	separate	VBP	B-VP
O	the	the	DT	B-NP
O	12	12	CD	I-NP
O	hydrophobic	hydrophobic	JJ	I-NP
O	segments	segment	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	Gap1p	Gap1p	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	resulting	result	VBG	I-NP
O	13	13	CD	I-NP
O	gene	gene	NN	I-NP
O	sandwich	sandwich	NN	I-NP
O	fusion	fusion	NN	I-NP
O	proteins	protein	NNS	I-NP
O	were	be	VBD	B-VP
O	expressed	express	VBN	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
B-GGP	gap1Delta	gap1Delta	NN	I-NP
O	null	null	JJ	I-NP
O	mutant	mutant	JJ	I-NP
O	strain	strain	NN	I-NP
O	;	;	:	O
O	9	9	CD	B-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	retain	retain	NN	I-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	transport	transport	NN	I-NP
O	activity	activity	NN	I-NP
O	and	and	CC	O
O	are	be	VBP	B-VP
O	folded	fold	VBN	I-VP
O	and	and	CC	O
O	correctly	correctly	RB	B-VP
O	targeted	target	VBN	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	plasma	plasma	NN	I-NP
O	membrane	membrane	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	state	state	NN	I-NP
O	of	of	IN	B-PP
O	each	each	DT	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	fusion	fusion	NN	I-NP
O	proteins	protein	NNS	I-NP
O	was	be	VBD	B-VP
O	monitored	monitor	VBN	I-VP
O	;	;	:	O
O	the	the	DT	B-NP
O	results	result	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	all	all	DT	B-NP
O	12	12	CD	I-NP
O	hydrophobic	hydrophobic	JJ	I-NP
O	segments	segment	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	Gap1p	Gap1p	NN	B-NP
O	span	span	NN	I-NP
O	the	the	DT	B-NP
O	membrane	membrane	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	NH	NH	NN	I-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	)	)	)	O
O	and	and	CC	O
O	COOH	COOH	NN	B-NP
O	termini	terminus	NNS	I-NP
O	are	be	VBP	B-VP
O	cytoplasmically	cytoplasmically	RB	I-VP
O	oriented	orient	VBN	I-VP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	were	be	VBD	B-VP
O	independently	independently	RB	I-VP
O	tested	test	VBN	I-VP
O	by	by	IN	B-PP
O	isolating	isolate	VBG	B-NP
O	sealed	seal	VBD	B-VP
O	right	right	JJ	B-NP
O	-	-	HYPH	I-NP
O	side	side	NN	I-NP
O	-	-	HYPH	B-VP
O	out	out	RP	B-PRT
O	microsomes	microsome	NNS	B-NP
O	from	from	IN	B-PP
O	sec12	sec12	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	strains	strain	NNS	I-NP
O	expressing	express	VBG	B-VP
O	six	six	CD	B-NP
O	different	different	JJ	I-NP
B-GGP	Gap1p	Gap1p	NN	I-NP
O	constructs	construct	NNS	I-NP
O	containing	contain	VBG	B-VP
O	functional	functional	JJ	B-NP
O	factor	factor	NN	I-NP
O	Xa	Xa	NN	I-NP
O	protease	protease	NN	I-NP
O	cleavage	cleavage	NN	I-NP
O	sites	site	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	pattern	pattern	NN	I-NP
O	of	of	IN	B-PP
O	factor	factor	NN	B-NP
O	Xa	Xa	NN	I-NP
O	protease	protease	NN	I-NP
O	cleavage	cleavage	NN	I-NP
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	consistent	consistent	JJ	B-ADJP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	12	12	CD	B-NP
O	membrane	membrane	NN	I-NP
O	-	-	HYPH	O
O	spanning	span	VBG	B-VP
O	domains	domain	NNS	B-NP
O	.	.	.	O

B-GGP	Gap1p	Gap1p	NN	B-NP
O	exhibited	exhibit	VBD	B-VP
O	the	the	DT	B-NP
O	same	same	JJ	I-NP
O	membrane	membrane	NN	I-NP
O	topology	topology	NN	I-NP
O	in	in	IN	B-PP
O	strains	strain	NNS	B-NP
O	lacking	lack	VBG	B-VP
B-GGP	Shr3p	Shr3p	NN	B-NP
O	;	;	:	O
O	therefore	therefore	RB	B-ADVP
O	,	,	,	O
B-GGP	Gap1p	Gap1p	NN	B-NP
O	fully	fully	RB	B-VP
O	integrates	integrate	VBZ	I-VP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	ER	ER	NN	I-NP
O	membrane	membrane	NN	I-NP
O	independently	independently	RB	B-ADVP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	permease	permease	NN	I-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	packaging	packaging	NN	I-NP
O	chaperone	chaperone	NN	I-NP
O	.	.	.	O

O	Exploring	Explore	VBG	B-VP
O	the	the	DT	B-NP
O	glycan	glycan	NN	I-NP
O	repertoire	repertoire	NN	I-NP
O	of	of	IN	B-PP
O	genetically	genetically	RB	B-NP
O	modified	modify	VBN	I-NP
O	mice	mouse	NNS	I-NP
O	by	by	IN	B-PP
O	isolation	isolation	NN	B-NP
O	and	and	CC	I-NP
O	profiling	profiling	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	major	major	JJ	I-NP
O	glycan	glycan	NN	I-NP
O	classes	class	NNS	I-NP
O	and	and	CC	O
O	nano	nano	AFX	B-NP
O	-	-	HYPH	I-NP
O	NMR	NMR	NN	I-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	glycan	glycan	NN	B-NP
O	mixtures	mixture	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	production	production	NN	I-NP
O	of	of	IN	B-PP
O	mice	mouse	NNS	B-NP
O	with	with	IN	B-PP
O	genetic	genetic	JJ	B-NP
O	alterations	alteration	NNS	I-NP
O	in	in	IN	B-PP
O	glycosyltransferases	glycosyltransferas	NNS	B-NP
O	has	have	VBZ	B-VP
O	highlighted	highlight	VBN	I-VP
O	the	the	DT	B-NP
O	need	need	NN	I-NP
O	to	to	TO	B-VP
O	isolate	isolate	VB	I-VP
O	and	and	CC	I-VP
O	study	study	VB	I-VP
O	complex	complex	JJ	B-NP
O	mixtures	mixture	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	major	major	JJ	I-NP
O	classes	class	NNS	I-NP
O	of	of	IN	B-PP
O	oligosaccharides	oligosaccharide	NNS	B-NP
O	(	(	(	O
O	glycans	glycan	NNS	B-NP
O	)	)	)	O
O	from	from	IN	B-PP
O	intact	intact	JJ	B-NP
O	tissues	tissue	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	have	have	VBP	B-VP
O	found	find	VBN	I-VP
O	that	that	IN	B-SBAR
O	nano	nano	AFX	B-NP
O	-	-	HYPH	I-NP
O	NMR	NMR	NN	I-NP
O	spectroscopy	spectroscopy	NN	I-NP
O	of	of	IN	B-PP
O	whole	whole	JJ	B-NP
O	mixtures	mixture	NNS	I-NP
O	of	of	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	and	and	CC	I-NP
O	O	O	NN	I-NP
O	-	-	HYPH	I-NP
O	glycans	glycan	NNS	B-NP
O	can	can	MD	B-VP
O	complement	complement	VB	I-VP
O	HPLC	HPLC	NN	B-NP
O	profiling	profiling	NN	I-NP
O	methods	method	NNS	I-NP
O	for	for	IN	B-PP
O	elucidating	elucidate	VBG	B-VP
O	structural	structural	JJ	B-NP
O	details	detail	NNS	I-NP
O	.	.	.	O

O	Working	Work	VBG	B-VP
O	toward	toward	IN	B-PP
O	obtaining	obtain	VBG	B-VP
O	such	such	JJ	B-NP
O	glycan	glycan	NN	I-NP
O	mixtures	mixture	NNS	I-NP
O	from	from	IN	B-PP
O	mouse	mouse	NN	B-NP
O	tissues	tissue	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	decided	decide	VBD	B-VP
O	to	to	TO	I-VP
O	develop	develop	VB	I-VP
O	an	an	DT	B-NP
O	approach	approach	NN	I-NP
O	to	to	TO	B-VP
O	isolate	isolate	VB	I-VP
O	not	not	RB	B-CONJP
O	only	only	RB	I-CONJP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	and	and	CC	I-NP
O	O	O	NN	I-NP
O	-	-	HYPH	I-NP
O	glycans	glycan	NNS	I-NP
O	,	,	,	O
O	but	but	CC	B-CONJP
O	also	also	RB	I-CONJP
O	to	to	TO	B-VP
O	separate	separate	VB	I-VP
O	out	out	RP	B-PRT
O	glycosphingolipids	glycosphingolipid	NNS	B-NP
O	,	,	,	O
O	glycosaminoglycans	glycosaminoglycan	NNS	B-NP
O	and	and	CC	O
O	glycosylphosphatidylinositol	glycosylphosphatidylinositol	NN	B-NP
O	anchors	anchor	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	describe	describe	VBP	B-VP
O	here	here	RB	B-ADVP
O	a	a	DT	B-NP
O	comprehensive	comprehensive	JJ	I-NP
O	Glycan	Glycan	NN	I-NP
O	Isolation	Isolation	NN	I-NP
O	Protocol	Protocol	NN	I-NP
O	that	that	WDT	B-NP
O	is	be	VBZ	B-VP
O	based	base	VBN	I-VP
O	primarily	primarily	RB	B-ADVP
O	upon	upon	IN	B-PP
O	the	the	DT	B-NP
O	physicochemical	physicochemical	JJ	I-NP
O	characteristics	characteristic	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	molecules	molecule	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	requires	require	VBZ	B-VP
O	only	only	RB	B-NP
O	commonly	commonly	RB	I-NP
O	available	available	JJ	I-NP
O	reagents	reagent	NNS	I-NP
O	and	and	CC	I-NP
O	equipment	equipment	NN	I-NP
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	radiolabeled	radiolabele	VBN	B-NP
O	internal	internal	JJ	I-NP
O	tracers	tracer	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	recovery	recovery	NN	B-NP
O	of	of	IN	B-PP
O	each	each	DT	B-NP
O	major	major	JJ	I-NP
O	class	class	NN	I-NP
O	of	of	IN	B-PP
O	glycans	glycan	NNS	B-NP
O	is	be	VBZ	B-VP
O	as	as	RB	B-ADJP
O	good	good	JJ	I-ADJP
O	or	or	CC	I-ADJP
O	better	good	JJR	I-ADJP
O	than	than	IN	B-PP
O	with	with	IN	B-PP
O	conventional	conventional	JJ	B-NP
O	approaches	approach	NNS	I-NP
O	for	for	IN	B-PP
O	isolating	isolate	VBG	B-VP
O	individual	individual	JJ	B-NP
O	classes	class	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	cross	cross	AFX	B-NP
O	-	-	HYPH	I-NP
O	contamination	contamination	NN	I-NP
O	is	be	VBZ	B-VP
O	minimal	minimal	JJ	B-ADJP
O	.	.	.	O

O	The	The	DT	B-NP
O	recovered	recover	VBN	I-NP
O	glycans	glycan	NNS	I-NP
O	are	be	VBP	B-VP
O	of	of	IN	B-PP
O	sufficient	sufficient	JJ	B-NP
O	purity	purity	NN	I-NP
O	to	to	TO	B-VP
O	provide	provide	VB	I-VP
O	a	a	DT	B-NP
O	"	"	``	I-NP
O	glycoprofile	glycoprofile	NN	I-NP
O	"	"	''	O
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	cell	cell	NN	I-NP
O	type	type	NN	I-NP
O	or	or	CC	I-NP
O	tissue	tissue	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	applied	apply	VBD	B-VP
O	this	this	DT	B-NP
O	approach	approach	NN	I-NP
O	to	to	TO	B-VP
O	compare	compare	VB	I-VP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	and	and	CC	I-NP
O	O	O	NN	I-NP
O	-	-	HYPH	I-NP
O	glycans	glycan	NNS	B-NP
O	from	from	IN	B-PP
O	wild	wild	JJ	B-NP
O	type	type	NN	I-NP
O	mouse	mouse	NN	I-NP
O	tissues	tissue	NNS	I-NP
O	with	with	IN	B-PP
O	those	those	DT	B-NP
O	from	from	IN	B-PP
O	mice	mouse	NNS	B-NP
O	genetically	genetically	RB	B-ADJP
O	deficient	deficient	JJ	I-ADJP
O	in	in	IN	B-PP
O	glycosyltransferases	glycosyltransferas	NNS	B-NP
O	.	.	.	O

O	N	N	NN	B-NP
O	-	-	HYPH	I-NP
O	and	and	CC	I-NP
O	O	O	NN	I-NP
O	-	-	HYPH	O
O	glycan	glycan	NN	B-NP
O	mixtures	mixture	NNS	I-NP
O	from	from	IN	B-PP
O	organs	organ	NNS	B-NP
O	of	of	IN	B-PP
O	mice	mouse	NNS	B-NP
O	deficient	deficient	JJ	B-ADJP
O	in	in	IN	B-PP
B-GGP	ST6Gal	ST6Gal	JJ	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	I	I	NN	I-NP
O	(	(	(	O
O	CMP	CMP	NN	B-NP
O	-	-	HYPH	B-NP
O	Sia	Sia	NN	I-NP
O	:	:	:	O
O	Galbeta1	Galbeta1	NN	B-NP
O	-	-	HYPH	O
O	4GlcNAc	4GlcNAc	NN	B-NP
O	alpha2	alpha2	NN	I-NP
O	-	-	HYPH	O
O	6	6	CD	B-NP
O	sialyltransferase	sialyltransferase	NN	I-NP
O	)	)	)	O
O	were	be	VBD	B-VP
O	studied	study	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	nano	nano	AFX	I-NP
O	-	-	HYPH	I-NP
O	NMR	NMR	NN	I-NP
O	spectroscopy	spectroscopy	NN	I-NP
O	approach	approach	NN	I-NP
O	,	,	,	O
O	showing	show	VBG	B-VP
O	no	no	DT	B-NP
O	detectable	detectable	JJ	I-NP
O	alpha2	alpha2	NN	I-NP
O	-	-	HYPH	B-NP
O	6	6	CD	I-NP
O	-	-	HYPH	I-NP
O	linked	link	VBN	I-NP
O	sialic	sialic	JJ	I-NP
O	acids	acid	NNS	I-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
B-GGP	ST6Gal	ST6Gal	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	I	I	PRP	B-NP
O	is	be	VBZ	B-VP
O	likely	likely	RB	B-ADJP
O	responsible	responsible	JJ	I-ADJP
O	for	for	IN	B-PP
O	generating	generate	VBG	B-VP
O	most	most	JJS	B-NP
O	or	or	CC	I-NP
O	all	all	DT	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	residues	residue	NNS	I-NP
O	in	in	IN	B-PP
O	normal	normal	JJ	B-NP
O	mice	mouse	NNS	I-NP
O	.	.	.	O

O	Similar	Similar	JJ	B-NP
O	studies	study	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	linkage	linkage	NN	I-NP
O	is	be	VBZ	B-VP
O	very	very	RB	B-ADJP
O	rare	rare	JJ	I-ADJP
O	in	in	IN	B-PP
O	ganglioside	ganglioside	NN	B-NP
O	glycans	glycan	NNS	I-NP
O	,	,	,	O
O	even	even	RB	B-ADVP
O	in	in	IN	B-PP
O	wild	wild	JJ	B-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	tissues	tissue	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	mice	mouse	NNS	B-NP
O	deficient	deficient	JJ	B-ADJP
O	in	in	IN	B-PP
B-GGP	GalNAcT	GalNAcT	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	8	8	CD	B-NP
O	(	(	(	O
B-GGP	UDP	UDP	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	GalNAc	GalNAc	NN	B-NP
I-GGP	:	:	:	O
I-GGP	polypeptide	polypeptide	NN	B-NP
I-GGP	O	O	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	Ser	Ser	NN	I-NP
I-GGP	/	/	SYM	B-NP
I-GGP	Thr	Thr	NN	I-NP
I-GGP	GalNAc	GalNAc	NN	I-NP
I-GGP	transferase	transferase	NN	I-NP
I-GGP	8	8	CD	I-NP
O	)	)	)	O
O	,	,	,	O
O	HPLC	HPLC	NN	B-NP
O	profiling	profiling	NN	I-NP
O	indicates	indicate	VBZ	B-VP
O	that	that	IN	B-SBAR
O	O	O	NN	B-NP
O	-	-	HYPH	B-NP
O	glycans	glycan	NNS	I-NP
O	persist	persist	VBP	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	thymus	thymus	NN	I-NP
O	in	in	IN	B-PP
O	large	large	JJ	B-NP
O	amounts	amount	NNS	I-NP
O	,	,	,	O
O	without	without	IN	B-PP
O	a	a	DT	B-NP
O	major	major	JJ	I-NP
O	change	change	NN	I-NP
O	in	in	IN	B-PP
O	overall	overall	JJ	B-NP
O	profile	profile	NN	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	other	other	JJ	B-NP
O	enzymes	enzyme	NNS	I-NP
O	can	can	MD	B-VP
O	synthesize	synthesize	VB	I-VP
O	the	the	DT	B-NP
O	GalNAc	GalNAc	NN	I-NP
O	-	-	HYPH	B-NP
O	O	O	NN	I-NP
O	-	-	HYPH	I-NP
O	Ser	Ser	NN	I-NP
O	/	/	SYM	I-NP
O	Thr	Thr	NN	I-NP
O	linkage	linkage	NN	I-NP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	tissue	tissue	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	demonstrate	demonstrate	VBP	B-VP
O	the	the	DT	B-NP
O	applicability	applicability	NN	I-NP
O	of	of	IN	B-PP
O	nano	nano	AFX	B-NP
O	-	-	HYPH	I-NP
O	NMR	NMR	NN	I-NP
O	spectroscopy	spectroscopy	NN	I-NP
O	to	to	TO	B-PP
O	complex	complex	JJ	B-NP
O	glycan	glycan	NN	I-NP
O	mixtures	mixture	NNS	I-NP
O	,	,	,	O
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	the	the	DT	B-NP
O	versatility	versatility	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Glycan	Glycan	NNP	I-NP
O	Isolation	Isolation	NNP	I-NP
O	Protocol	Protocol	NNP	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	makes	make	VBZ	B-VP
O	possible	possible	JJ	B-ADJP
O	the	the	DT	B-NP
O	concurrent	concurrent	JJ	I-NP
O	examination	examination	NN	I-NP
O	of	of	IN	B-PP
O	multiple	multiple	JJ	B-NP
O	glycan	glycan	NN	I-NP
O	classes	class	NNS	I-NP
O	from	from	IN	B-PP
O	intact	intact	JJ	B-NP
O	vertebrate	vertebrate	NN	I-NP
O	tissues	tissue	NNS	I-NP
O	.	.	.	O

O	Protein	Protein	NN	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	arginine	arginine	NN	I-NP
O	methylation	methylation	NN	I-NP
O	in	in	IN	B-PP
O	subcellular	subcellular	JJ	B-NP
O	fractions	fraction	NNS	I-NP
O	of	of	IN	B-PP
O	lymphoblastoid	lymphoblastoid	JJ	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Arginine	Arginine	NN	B-NP
O	methylation	methylation	NN	I-NP
O	in	in	IN	B-PP
O	RNA	RNA	NN	B-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	proteins	protein	NNS	B-NP
O	containing	contain	VBG	B-VP
O	arginine	arginine	NN	B-NP
O	-	-	HYPH	B-NP
O	and	and	CC	I-NP
O	glycine	glycine	NN	I-NP
O	-	-	HYPH	I-NP
O	rich	rich	JJ	I-NP
O	RGG	RGG	NN	I-NP
O	motifs	motif	NNS	I-NP
O	is	be	VBZ	B-VP
O	catalyzed	catalyze	VBN	I-VP
O	by	by	IN	B-PP
O	specific	specific	JJ	B-NP
O	protein	protein	NN	I-NP
O	arginine	arginine	NN	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	previously	previously	RB	B-ADVP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	lymphoblastoid	lymphoblastoid	JJ	B-NP
O	cells	cell	NNS	I-NP
O	grown	grow	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	indirect	indirect	JJ	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	,	,	,	O
O	adenosine	adenosine	NN	B-NP
O	dialdehyde	dialdehyde	NN	I-NP
O	(	(	(	O
O	AdOx	AdOx	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	accumulated	accumulate	VBD	B-VP
O	high	high	JJ	B-NP
O	level	level	NN	I-NP
O	of	of	IN	B-PP
O	hypomethylated	hypomethylate	VBN	B-NP
O	protein	protein	NN	I-NP
O	substrates	substrate	NNS	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	endogenous	endogenous	JJ	I-NP
O	protein	protein	NN	I-NP
O	methyltransferases	methyltransferas	NNS	I-NP
O	or	or	CC	O
O	recombinant	recombinant	JJ	B-NP
O	yeast	yeast	NN	I-NP
O	arginine	arginine	NN	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	[	[	(	O
O	Li	Li	NNP	B-NP
O	,	,	,	O
O	C	C	NNP	B-NP
O	.	.	.	O
O	et	et	FW	B-ADVP
O	al	al	FW	I-ADVP
O	.	.	.	O
O	(	(	(	O
O	1998	1998	CD	B-NP
O	)	)	)	O
O	Arch	Arch	NNP	B-NP
O	.	.	.	O

O	Biochem	Biochem	NNP	B-NP
O	.	.	.	O

O	Biophys	Biophy	NNS	B-NP
O	.	.	.	O

O	351	351	CD	B-NP
O	,	,	,	I-NP
O	53	53	CD	I-NP
O	-	-	HYPH	I-NP
O	59	59	CD	I-NP
O	]	]	)	O
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	we	we	PRP	B-NP
O	fractionated	fractionate	VBD	B-VP
O	the	the	DT	B-NP
O	lymphoblastoid	lymphoblastoid	JJ	I-NP
O	cells	cell	NNS	I-NP
O	to	to	TO	B-VP
O	locate	locate	VB	I-VP
O	the	the	DT	B-NP
O	methyltransferases	methyltransferas	NNS	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	substrates	substrate	NNS	I-NP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	.	.	.	O

O	Different	Different	JJ	B-NP
O	sets	set	NNS	I-NP
O	of	of	IN	B-PP
O	hypomethylated	hypomethylate	VBN	B-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	O
O	accepting	accept	VBG	B-VP
O	polypeptides	polypeptide	NNS	B-NP
O	with	with	IN	B-PP
O	wide	wide	JJ	B-NP
O	range	range	NN	I-NP
O	of	of	IN	B-PP
O	molecular	molecular	JJ	B-NP
O	masses	mass	NNS	I-NP
O	were	be	VBD	B-VP
O	present	present	JJ	B-ADJP
O	in	in	IN	B-PP
O	cytosolic	cytosolic	JJ	B-NP
O	,	,	,	I-NP
O	ribosomal	ribosomal	JJ	I-NP
O	,	,	,	O
O	and	and	CC	O
O	nucleus	nucleus	NN	B-NP
O	fractions	fraction	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	methylated	methylate	VBN	I-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	residues	residue	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	O
O	accepting	accept	VBG	B-VP
O	proteins	protein	NNS	B-NP
O	in	in	IN	B-PP
O	these	these	DT	B-NP
O	fractions	fraction	NNS	I-NP
O	were	be	VBD	B-VP
O	determined	determine	VBN	I-VP
O	.	.	.	O

O	In	In	IN	B-PP
O	all	all	DT	B-NP
O	three	three	CD	I-NP
O	fractions	fraction	NNS	I-NP
O	,	,	,	O
O	dimethylarginine	dimethylarginine	NN	B-NP
O	was	be	VBD	B-VP
O	the	the	DT	B-NP
O	most	most	RBS	I-NP
O	abundant	abundant	JJ	I-NP
O	methylated	methylate	VBN	I-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	protein	protein	NN	I-NP
O	-	-	HYPH	I-NP
O	arginine	arginine	NN	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	activities	activity	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	three	three	CD	I-NP
O	fractions	fraction	NNS	I-NP
O	were	be	VBD	B-VP
O	analyzed	analyze	VBN	I-VP
O	using	use	VBG	B-VP
O	recombinant	recombinant	JJ	B-NP
B-GGP	fibrillarin	fibrillarin	NN	I-NP
O	(	(	(	O
O	a	a	DT	B-NP
O	nucleolar	nucleolar	JJ	I-NP
O	RGG	RGG	NN	I-NP
O	protein	protein	NN	I-NP
O	)	)	)	O
O	as	as	IN	B-PP
O	the	the	DT	B-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	O
O	accepting	accept	VBG	B-VP
O	substrate	substrate	NN	B-NP
O	.	.	.	O

B-GGP	Fibrillarin	Fibrillarin	NN	B-NP
O	methylation	methylation	NN	I-NP
O	was	be	VBD	B-VP
O	strongest	strong	JJS	B-ADJP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cytosolic	cytosolic	JJ	I-NP
O	fraction	fraction	NN	I-NP
O	,	,	,	O
O	followed	follow	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	ribosomal	ribosomal	JJ	I-NP
O	and	and	CC	O
O	then	then	RB	O
O	the	the	DT	B-NP
O	nucleus	nucleus	NN	I-NP
O	fractions	fraction	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	demonstrated	demonstrate	VBD	B-VP
O	that	that	IN	B-SBAR
O	protein	protein	NN	B-NP
O	-	-	HYPH	B-NP
O	arginine	arginine	NN	I-NP
O	methyltransferases	methyltransferas	NNS	I-NP
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	their	their	PRP$	B-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	B-VP
O	accepting	accept	VBG	B-NP
O	substrates	substrate	NNS	I-NP
O	were	be	VBD	B-VP
O	widely	widely	RB	I-VP
O	distributed	distribute	VBN	I-VP
O	in	in	IN	B-PP
O	different	different	JJ	B-NP
O	subcellular	subcellular	JJ	I-NP
O	fractions	fraction	NNS	I-NP
O	of	of	IN	B-PP
O	lymphoblastoid	lymphoblastoid	JJ	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Dynamic	Dynamic	JJ	B-NP
O	associations	association	NNS	I-NP
O	of	of	IN	B-PP
O	heterochromatin	heterochromatin	NN	B-NP
O	protein	protein	NN	I-NP
O	1	1	CD	I-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	nuclear	nuclear	JJ	I-NP
O	envelope	envelope	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	study	study	VB	I-VP
O	the	the	DT	B-NP
O	dynamics	dynamic	NNS	I-NP
O	of	of	IN	B-PP
O	mammalian	mammalian	JJ	B-NP
O	HP1	HP1	NN	I-NP
O	proteins	protein	NNS	I-NP
O	we	we	PRP	B-NP
O	have	have	VBP	B-VP
O	microinjected	microinjecte	VBN	I-VP
O	recombinant	recombinant	JJ	B-NP
O	forms	form	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	mHP1alpha	mHP1alpha	NN	B-NP
O	,	,	,	O
B-GGP	M31	M31	NN	B-NP
O	and	and	CC	I-NP
B-GGP	M32	M32	NN	I-NP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	cytoplasm	cytoplasm	NN	I-NP
O	of	of	IN	B-PP
O	living	live	VBG	B-VP
O	cells	cell	NNS	B-NP
O	.	.	.	O

O	As	As	IN	B-SBAR
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	expected	expect	VBN	I-VP
O	from	from	IN	B-PP
O	previous	previous	JJ	B-NP
O	studies	study	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	three	three	CD	I-NP
O	fusion	fusion	NN	I-NP
O	proteins	protein	NNS	I-NP
O	were	be	VBD	B-VP
O	efficiently	efficiently	RB	I-VP
O	transported	transport	VBN	I-VP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	nucleus	nucleus	NN	I-NP
O	and	and	CC	O
O	targeted	target	VBN	B-VP
O	specific	specific	JJ	B-NP
O	chromatin	chromatin	NN	I-NP
O	areas	area	NNS	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	before	before	IN	B-PP
O	incorporation	incorporation	NN	B-NP
O	into	into	IN	B-PP
O	these	these	DT	B-NP
O	areas	area	NNS	I-NP
O	the	the	DT	B-NP
O	exogenous	exogenous	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	accumulated	accumulate	VBN	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	peripheral	peripheral	JJ	I-NP
O	zone	zone	NN	I-NP
O	and	and	CC	O
O	associated	associate	VBN	B-VP
O	closely	closely	RB	B-ADVP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	nuclear	nuclear	JJ	I-NP
O	envelope	envelope	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	transient	transient	JJ	I-NP
O	association	association	NN	I-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	occur	occur	VB	I-VP
O	when	when	WRB	B-ADVP
O	the	the	DT	B-NP
O	cells	cell	NNS	I-NP
O	were	be	VBD	B-VP
O	treated	treat	VBN	I-VP
O	with	with	IN	B-PP
O	deacetylase	deacetylase	NN	B-NP
O	inhibitors	inhibitor	NNS	I-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	an	an	DT	B-NP
O	acetylation	acetylation	NN	I-NP
O	-	-	HYPH	B-VP
O	inhibited	inhibit	VBN	B-NP
O	interaction	interaction	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	line	line	NN	B-NP
O	with	with	IN	B-PP
O	these	these	DT	B-NP
O	observations	observation	NNS	I-NP
O	,	,	,	O
O	recombinant	recombinant	JJ	B-NP
O	HP1	HP1	NN	I-NP
O	proteins	protein	NNS	I-NP
O	exhibited	exhibit	VBD	B-VP
O	saturable	saturable	JJ	B-NP
O	binding	binding	NN	I-NP
O	to	to	TO	B-PP
O	purified	purify	VBN	B-NP
O	nuclear	nuclear	JJ	I-NP
O	envelopes	envelope	NNS	I-NP
O	and	and	CC	O
O	stained	stain	VBD	B-VP
O	the	the	DT	B-NP
O	nuclei	nucleus	NNS	I-NP
O	of	of	IN	B-PP
O	detergent	detergent	NN	B-NP
O	-	-	HYPH	B-NP
O	permeabilized	permeabilize	VBN	I-NP
O	cells	cell	NNS	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	rim	rim	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	fashion	fashion	NN	I-NP
O	.	.	.	O

O	Competition	Competition	NN	B-NP
O	experiments	experiment	NNS	I-NP
O	with	with	IN	B-PP
O	various	various	JJ	B-NP
B-GGP	M31	M31	NN	I-NP
O	mutants	mutant	NNS	I-NP
O	allowed	allow	VBD	B-VP
O	mapping	mapping	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	nuclear	nuclear	JJ	I-NP
O	envelope	envelope	NN	I-NP
O	-	-	HYPH	B-PP
O	binding	bind	VBG	B-NP
O	site	site	NN	I-NP
O	within	within	IN	B-PP
O	an	an	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	region	region	NN	I-NP
O	that	that	WDT	B-NP
O	includes	include	VBZ	B-VP
O	the	the	DT	B-NP
O	chromodomain	chromodomain	NN	I-NP
O	.	.	.	O

O	A	A	DT	O
O	His	His	PRP$	O
O	(	(	(	O
O	6	6	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	B-VP
O	tagged	tag	VBN	B-NP
O	peptide	peptide	NN	I-NP
O	representing	represent	VBG	B-VP
O	this	this	DT	B-NP
O	region	region	NN	I-NP
O	inhibited	inhibit	VBD	B-VP
O	recruitment	recruitment	NN	B-NP
O	of	of	IN	B-PP
B-GGP	LAP2beta	LAP2beta	NN	B-NP
O	and	and	CC	I-NP
O	B	B	NN	I-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	lamins	lamin	NNS	I-NP
O	around	around	IN	B-PP
O	the	the	DT	B-NP
O	surfaces	surface	NNS	I-NP
O	of	of	IN	B-PP
O	condensed	condensed	JJ	B-NP
O	chromosomes	chromosome	NNS	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	involvement	involvement	NN	B-NP
O	of	of	IN	B-PP
O	HP1	HP1	NN	B-NP
O	proteins	protein	NNS	I-NP
O	in	in	IN	B-PP
O	nuclear	nuclear	JJ	B-NP
O	envelope	envelope	NN	I-NP
O	reassembly	reassembly	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	propeptide	propeptide	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	transforming	transform	VBG	I-NP
O	growth	growth	NN	I-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	O
O	beta	beta	SYM	B-NP
O	superfamily	superfamily	NN	I-NP
O	member	member	NN	I-NP
O	,	,	,	O
B-GGP	macrophage	macrophage	NN	B-NP
I-GGP	inhibitory	inhibitory	JJ	I-NP
I-GGP	cytokine	cytokine	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
B-GGP	MIC	MIC	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	)	)	)	O
O	,	,	,	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	multifunctional	multifunctional	JJ	I-NP
O	domain	domain	NN	I-NP
O	that	that	WDT	B-NP
O	can	can	MD	B-VP
O	facilitate	facilitate	VB	I-VP
O	protein	protein	NN	B-NP
O	folding	folding	NN	I-NP
O	and	and	CC	I-NP
O	secretion	secretion	NN	I-NP
O	.	.	.	O

B-GGP	Macrophage	Macrophage	JJ	B-NP
I-GGP	inhibitory	inhibitory	JJ	I-NP
I-GGP	cytokine	cytokine	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
B-GGP	MIC	MIC	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	divergent	divergent	JJ	I-NP
O	member	member	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	transforming	transform	VBG	I-NP
O	growth	growth	NN	I-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	O
O	beta	beta	SYM	B-NP
O	(	(	(	O
O	TGF	TGF	NN	B-NP
O	-	-	HYPH	O
O	beta	beta	SYM	O
O	)	)	)	O
O	superfamily	superfamily	NN	B-NP
O	.	.	.	O

O	While	While	IN	B-SBAR
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	synthesized	synthesize	VBN	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	pre	pre	AFX	I-NP
O	-	-	HYPH	I-NP
O	pro	pro	JJ	I-NP
O	form	form	NN	I-NP
O	,	,	,	O
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	unique	unique	JJ	B-ADJP
O	among	among	IN	B-PP
O	superfamily	superfamily	NN	B-NP
O	members	member	NNS	I-NP
O	because	because	IN	B-SBAR
O	it	it	PRP	B-NP
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	require	require	VB	I-VP
O	its	its	PRP$	B-NP
O	propeptide	propeptide	NN	I-NP
O	for	for	IN	B-PP
O	correct	correct	JJ	B-NP
O	folding	folding	NN	I-NP
O	or	or	CC	I-NP
O	secretion	secretion	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mature	mature	JJ	I-NP
O	peptide	peptide	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	investigate	investigate	VB	I-VP
O	factors	factor	NNS	B-NP
O	that	that	WDT	B-NP
O	enable	enable	VBP	B-VP
O	these	these	DT	B-NP
O	propeptide	propeptide	NN	I-NP
O	independent	independent	JJ	I-NP
O	events	event	NNS	I-NP
O	to	to	TO	B-VP
O	occur	occur	VB	I-VP
O	,	,	,	O
O	we	we	PRP	B-NP
O	constructed	construct	VBD	B-VP
B-GGP	MIC	MIC	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	/	/	SYM	I-NP
B-GGP	TGF	TGF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	beta1	beta1	NN	I-NP
O	chimeras	chimera	NNS	I-NP
O	,	,	,	O
O	both	both	CC	B-PP
O	with	with	IN	I-PP
O	and	and	CC	O
O	without	without	IN	B-PP
O	a	a	DT	B-NP
O	propeptide	propeptide	NN	I-NP
O	.	.	.	O

O	All	All	DT	B-NP
O	chimeras	chimera	NNS	I-NP
O	without	without	IN	B-PP
O	a	a	DT	B-NP
O	propeptide	propeptide	NN	I-NP
O	secreted	secrete	VBD	B-VP
O	less	less	RBR	B-ADVP
O	efficiently	efficiently	RB	I-ADVP
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	corresponding	correspond	VBG	I-NP
O	constructs	construct	NNS	I-NP
O	with	with	IN	B-PP
O	propeptide	propeptide	NN	B-NP
O	.	.	.	O

O	Folding	Folding	NN	B-NP
O	and	and	CC	I-NP
O	secretion	secretion	NN	I-NP
O	were	be	VBD	B-VP
O	most	most	RBS	I-VP
O	affected	affect	VBN	I-VP
O	after	after	IN	B-PP
O	replacement	replacement	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	predicted	predict	VBN	I-NP
O	major	major	JJ	I-NP
O	alpha	alpha	SYM	I-NP
O	-	-	HYPH	I-NP
O	helix	helix	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	mature	mature	JJ	I-NP
O	protein	protein	NN	I-NP
O	,	,	,	O
O	residues	residue	VBZ	B-VP
O	56	56	CD	B-NP
O	-	-	:	O
O	68	68	CD	B-NP
O	.	.	.	O

O	Exchanging	Exchange	VBG	B-VP
O	the	the	DT	B-NP
O	human	human	JJ	I-NP
O	propeptide	propeptide	NN	I-NP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	chimera	chimera	NN	I-NP
O	with	with	IN	B-PP
O	either	either	CC	O
O	the	the	DT	B-NP
O	murine	murine	JJ	I-NP
B-GGP	MIC	MIC	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	or	or	CC	I-NP
B-GGP	TGF	TGF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	beta1	beta1	NN	I-NP
O	propeptide	propeptide	NN	I-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	secretion	secretion	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	unprocessed	unprocessed	JJ	I-NP
O	,	,	,	I-NP
O	monomeric	monomeric	JJ	I-NP
O	chimera	chimera	NN	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	a	a	DT	B-NP
O	specific	specific	JJ	I-NP
O	interaction	interaction	NN	I-NP
O	between	between	IN	B-PP
O	the	the	DT	B-NP
O	human	human	JJ	I-NP
B-GGP	MIC	MIC	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	propeptide	propeptide	NN	I-NP
O	and	and	CC	O
O	mature	mature	JJ	B-NP
O	peptide	peptide	NN	I-NP
O	.	.	.	O

O	Propeptide	Propeptide	NN	B-NP
O	deletion	deletion	NN	I-NP
O	mutants	mutant	NNS	I-NP
O	enabled	enable	VBD	B-VP
O	identification	identification	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	region	region	NN	I-NP
O	between	between	IN	B-PP
O	residues	residue	NNS	B-NP
O	56	56	CD	B-NP
O	and	and	CC	I-NP
O	78	78	CD	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	important	important	JJ	B-ADJP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	interaction	interaction	NN	I-NP
O	between	between	IN	B-PP
O	the	the	DT	B-NP
O	propeptide	propeptide	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	mature	mature	JJ	I-NP
O	peptide	peptide	NN	I-NP
O	.	.	.	O

O	Cotransfection	Cotransfection	NN	B-NP
O	experiments	experiment	NNS	I-NP
O	demonstrated	demonstrate	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	propeptide	propeptide	NN	I-NP
O	must	must	MD	B-VP
O	be	be	VB	I-VP
O	in	in	IN	B-PP
O	cis	cis	NN	B-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	mature	mature	JJ	I-NP
O	peptide	peptide	NN	I-NP
O	for	for	IN	B-PP
O	this	this	DT	B-NP
O	phenomenon	phenomenon	NN	I-NP
O	to	to	TO	B-VP
O	occur	occur	VB	I-VP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	a	a	DT	B-NP
O	model	model	NN	I-NP
O	for	for	IN	B-PP
O	TGF	TGF	NN	B-NP
O	-	-	HYPH	O
O	beta	beta	SYM	B-NP
O	superfamily	superfamily	NN	I-NP
O	protein	protein	NN	I-NP
O	folding	folding	NN	I-NP
O	.	.	.	O

O	High	High	JJ	B-NP
O	frequency	frequency	NN	I-NP
O	of	of	IN	B-PP
O	promoter	promoter	NN	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	RASSF1A	RASSF1A	NN	B-NP
O	in	in	IN	B-PP
O	nasopharyngeal	nasopharyngeal	JJ	B-NP
O	carcinoma	carcinoma	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	have	have	VBP	B-VP
O	investigated	investigate	VBN	I-VP
O	the	the	DT	B-NP
O	genetic	genetic	JJ	I-NP
O	and	and	CC	I-NP
O	epigenetic	epigenetic	JJ	I-NP
O	changes	change	NNS	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	newly	newly	RB	I-NP
O	isolated	isolate	VBN	I-NP
O	tumor	tumor	NN	I-NP
O	suppressor	suppressor	NN	I-NP
O	gene	gene	NN	I-NP
O	on	on	IN	B-PP
O	3p21	3p21	NN	B-NP
O	.	.	.	O
O	3	3	CD	B-NP
O	,	,	,	O
B-GGP	RASSF1A	RASSF1A	NN	B-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	nasopharyngeal	nasopharyngeal	JJ	B-NP
O	carcinoma	carcinoma	NN	I-NP
O	(	(	(	O
O	NPC	NPC	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Four	Four	CD	B-NP
O	xenografts	xenograft	NNS	I-NP
O	,	,	,	O
O	four	four	CD	B-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	and	and	CC	O
O	21	21	CD	B-NP
O	primary	primary	JJ	I-NP
O	tumors	tumor	NNS	I-NP
O	were	be	VBD	B-VP
O	examined	examine	VBN	I-VP
O	.	.	.	O

O	Promoter	Promoter	NN	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	5	5	CD	I-NP
O	'	'	SYM	I-NP
O	CpG	CpG	NN	I-NP
O	island	island	NN	I-NP
O	of	of	IN	B-PP
B-GGP	RASSF1A	RASSF1A	NN	B-NP
O	was	be	VBD	B-VP
O	detected	detect	VBN	I-VP
O	in	in	IN	B-PP
O	4	4	CD	B-NP
O	of	of	IN	B-PP
O	4	4	CD	B-NP
O	(	(	(	O
O	100	100	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	xenografts	xenograft	NNS	B-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	3	3	CD	B-NP
O	of	of	IN	B-PP
O	4	4	CD	B-NP
O	(	(	(	O
O	75	75	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	cell	cell	NN	B-NP
O	lines	line	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	in	in	IN	B-PP
O	14	14	CD	B-NP
O	of	of	IN	B-PP
O	21	21	CD	B-NP
O	(	(	(	O
O	66	66	CD	B-NP
O	.	.	.	O
O	7	7	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	primary	primary	JJ	B-NP
O	tumors	tumor	NNS	I-NP
O	but	but	CC	B-PP
O	not	not	RB	B-PP
O	in	in	IN	I-PP
O	the	the	DT	B-NP
O	normal	normal	JJ	I-NP
O	nasopharyngeal	nasopharyngeal	JJ	I-NP
O	epithelia	epithelia	NN	I-NP
O	.	.	.	O

O	Mutations	Mutation	NNS	B-NP
O	were	be	VBD	B-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	2	2	CD	B-NP
O	of	of	IN	B-PP
O	21	21	CD	B-NP
O	(	(	(	O
O	9	9	CD	B-NP
O	.	.	SYM	I-NP
O	5	5	CD	I-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	primary	primary	JJ	B-NP
O	tumors	tumor	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	and	and	CC	O
O	xenografts	xenograft	NNS	B-NP
O	with	with	IN	B-PP
O	extensive	extensive	JJ	B-NP
O	methylation	methylation	NN	I-NP
O	,	,	,	O
O	no	no	DT	B-NP
B-GGP	RASSF1A	RASSF1A	NN	I-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	.	.	.	O

O	After	After	IN	B-PP
O	treatment	treatment	NN	B-NP
O	with	with	IN	B-PP
O	5	5	CD	B-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	aza	aza	SYM	I-NP
O	-	-	HYPH	I-NP
O	2	2	CD	I-NP
O	'	'	SYM	I-NP
O	deoxycytidine	deoxycytidine	NN	I-NP
O	,	,	,	I-NP
O	reexpression	reexpression	NN	I-NP
O	and	and	CC	I-NP
O	demethylation	demethylation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	RASSF1A	RASSF1A	NN	I-NP
O	gene	gene	NN	I-NP
O	were	be	VBD	B-VP
O	detected	detect	VBN	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	NPC	NPC	NN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	findings	finding	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	promoter	promoter	NN	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	may	may	MD	B-VP
O	participate	participate	VB	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	inactivation	inactivation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	RASSF1A	RASSF1A	NN	I-NP
O	gene	gene	NN	I-NP
O	in	in	IN	B-PP
O	NPC	NPC	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	high	high	JJ	I-NP
O	incidence	incidence	NN	I-NP
O	of	of	IN	B-PP
B-GGP	RASSF1A	RASSF1A	NN	B-NP
O	alterations	alteration	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	critical	critical	JJ	I-NP
O	target	target	NN	I-NP
O	gene	gene	NN	I-NP
O	on	on	IN	B-PP
O	chromosome	chromosome	NN	B-NP
O	3p21	3p21	NN	I-NP
O	.	.	.	O
O	3	3	CD	B-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	development	development	NN	I-NP
O	of	of	IN	B-PP
O	NPC	NPC	NN	B-NP
O	.	.	.	O

O	Cytosine	Cytosine	NN	B-NP
O	methylation	methylation	NN	I-NP
O	represses	repress	VBZ	B-VP
B-GGP	glutathione	glutathione	NN	B-NP
I-GGP	S	S	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	transferase	transferase	NN	B-NP
I-GGP	P1	P1	NN	I-NP
O	(	(	(	O
B-GGP	GSTP1	GSTP1	NN	B-NP
O	)	)	)	O
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	prostate	prostate	NN	I-NP
O	cancer	cancer	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Methylation	Methylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	glutathione	glutathione	NN	I-NP
I-GGP	S	S	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	transferase	transferase	NN	B-NP
I-GGP	P1	P1	NN	I-NP
O	(	(	(	O
B-GGP	GSTP1	GSTP1	NN	B-NP
O	)	)	)	O
O	gene	gene	NN	B-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	described	describe	VBN	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	highly	highly	RB	I-NP
O	specific	specific	JJ	I-NP
O	and	and	CC	I-NP
O	sensitive	sensitive	JJ	I-NP
O	biomarker	biomarker	NN	I-NP
O	for	for	IN	B-PP
O	prostate	prostate	NN	B-NP
O	cancer	cancer	NN	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	at	at	IN	B-PP
O	present	present	NN	B-NP
O	,	,	,	O
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	not	not	RB	I-VP
O	known	know	VBN	I-VP
O	whether	whether	IN	B-SBAR
O	methylation	methylation	NN	B-NP
O	represses	repress	VBZ	B-VP
B-GGP	GSTP1	GSTP1	NN	B-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	prostate	prostate	NN	I-NP
O	cancer	cancer	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	found	find	VBD	B-VP
O	the	the	DT	B-NP
B-GGP	GSTP1	GSTP1	NN	I-NP
O	gene	gene	NN	I-NP
O	promoter	promoter	NN	I-NP
O	to	to	TO	B-VP
O	be	be	VB	I-VP
O	completely	completely	RB	I-VP
O	methylated	methylate	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	LNCaP	LNCaP	NN	I-NP
O	prostate	prostate	NN	I-NP
O	cancer	cancer	NN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	,	,	,	O
O	where	where	WRB	B-ADVP
O	this	this	DT	B-NP
O	gene	gene	NN	I-NP
O	is	be	VBZ	B-VP
O	transcriptionally	transcriptionally	RB	B-ADJP
O	inactive	inactive	JJ	I-ADJP
O	.	.	.	O

O	In	In	IN	B-PP
O	contrast	contrast	NN	B-NP
O	,	,	,	O
O	Du145	Du145	NN	B-NP
O	and	and	CC	I-NP
O	PC3	PC3	NN	I-NP
O	prostate	prostate	NN	I-NP
O	cancer	cancer	NN	I-NP
O	cells	cell	NNS	I-NP
O	express	express	VBP	B-VP
O	the	the	DT	B-NP
B-GGP	GSTP1	GSTP1	NN	I-NP
O	gene	gene	NN	I-NP
O	and	and	CC	O
O	exhibit	exhibit	VBP	B-VP
O	methylated	methylate	VBN	I-VP
O	and	and	CC	I-VP
O	unmethylated	unmethylate	VBN	I-VP
B-GGP	GSTP1	GSTP1	NN	B-NP
O	alleles	allele	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	a	a	DT	B-NP
O	transient	transient	JJ	I-NP
O	transfection	transfection	NN	I-NP
O	assay	assay	NN	I-NP
O	using	use	VBG	B-VP
O	LNCaP	LNCaP	NN	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	methylation	methylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	GSTP1	GSTP1	NN	I-NP
O	promoter	promoter	NN	I-NP
O	-	-	HYPH	B-VP
O	driven	drive	VBN	B-NP
B-GGP	luciferase	luciferase	NN	I-NP
O	reporter	reporter	NN	I-NP
O	vector	vector	NN	I-NP
O	(	(	(	O
B-GGP	GSTP1	GSTP1	NN	B-NP
O	-	-	HYPH	B-NP
O	pGL3	pGL3	NN	I-NP
O	)	)	)	O
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	>	>	SYM	I-NP
O	20	20	CD	I-NP
O	-	-	HYPH	I-NP
O	fold	fold	JJ	I-NP
O	inhibition	inhibition	NN	I-NP
O	of	of	IN	B-PP
O	transcription	transcription	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	this	this	DT	B-NP
O	repression	repression	NN	I-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	relieved	relieve	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylase	deacetylase	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	,	,	,	O
O	trichostatin	trichostatin	NN	B-NP
O	A	A	NN	I-NP
O	(	(	(	O
O	TSA	TSA	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Treatment	Treatment	NN	B-NP
O	of	of	IN	B-PP
O	LNCaP	LNCaP	NN	B-NP
O	cells	cell	NNS	I-NP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	DNA	DNA	NN	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	,	,	,	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	Aza	Aza	NN	I-NP
O	-	-	HYPH	I-NP
O	2	2	CD	I-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	deoxycytidine	deoxycytidine	NN	I-NP
O	,	,	,	O
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	demethylation	demethylation	NN	B-NP
O	and	and	CC	O
O	activation	activation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	GSTP1	GSTP1	NN	I-NP
O	gene	gene	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	contrast	contrast	NN	B-NP
O	,	,	,	O
O	TSA	TSA	NN	B-NP
O	treatment	treatment	NN	I-NP
O	failed	fail	VBD	B-VP
O	to	to	TO	I-VP
O	demethylate	demethylate	VB	I-VP
O	or	or	CC	I-VP
O	activate	activate	VB	I-VP
O	the	the	DT	B-NP
B-GGP	GSTP1	GSTP1	NN	I-NP
O	gene	gene	NN	I-NP
O	.	.	.	O

O	Fully	Fully	RB	B-ADVP
O	methylated	methylate	VBN	B-VP
O	but	but	CC	O
O	not	not	RB	O
O	unmethylated	unmethylate	VBN	B-NP
B-GGP	GSTP1	GSTP1	NN	I-NP
O	promoter	promoter	NN	I-NP
O	fragment	fragment	NN	I-NP
O	was	be	VBD	B-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	bind	bind	VB	I-VP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	complex	complex	NN	I-NP
O	similar	similar	JJ	B-ADJP
O	to	to	TO	B-PP
O	methyl	methyl	NN	B-NP
O	cytosine	cytosine	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	protein	protein	NN	B-NP
O	complex	complex	NN	I-NP
O	1	1	CD	I-NP
O	that	that	WDT	B-NP
O	contains	contain	VBZ	B-VP
B-GGP	methyl	methyl	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	CpG	CpG	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	binding	bind	VBG	B-VP
I-GGP	domain	domain	NN	B-NP
I-GGP	2	2	CD	I-NP
I-GGP	protein	protein	NN	I-NP
O	(	(	(	O
B-GGP	MBD2	MBD2	NN	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	electrophoretic	electrophoretic	JJ	B-NP
O	mobility	mobility	NN	I-NP
O	shift	shift	NN	I-NP
O	assays	assay	NNS	I-NP
O	using	use	VBG	B-VP
O	LNCaP	LNCaP	NN	B-NP
O	cell	cell	NN	I-NP
O	nuclear	nuclear	JJ	I-NP
O	extracts	extract	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	cytosine	cytosine	NN	B-NP
O	methylation	methylation	NN	I-NP
O	can	can	MD	B-VP
O	repress	repress	VB	I-VP
B-GGP	GSTP1	GSTP1	NN	B-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	LNCaP	LNCaP	NN	B-NP
O	prostate	prostate	NN	I-NP
O	cancer	cancer	NN	I-NP
O	cells	cell	NNS	I-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	effect	effect	NN	I-NP
O	is	be	VBZ	B-VP
O	possibly	possibly	RB	I-VP
O	mediated	mediate	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	methyl	methyl	NN	I-NP
O	cytosine	cytosine	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	protein	protein	NN	B-NP
O	complex	complex	NN	I-NP
O	1	1	CD	I-NP
O	-	-	HYPH	I-NP
O	like	like	JJ	I-NP
O	complex	complex	NN	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	these	these	DT	B-NP
O	data	datum	NNS	I-NP
O	also	also	RB	B-ADVP
O	support	support	VBP	B-VP
O	the	the	DT	B-NP
O	notion	notion	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	dominance	dominance	NN	I-NP
O	of	of	IN	B-PP
O	methylation	methylation	NN	B-NP
O	over	over	IN	B-PP
O	TSA	TSA	NN	B-NP
O	-	-	HYPH	B-NP
O	sensitive	sensitive	JJ	I-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylation	deacetylation	NN	I-NP
O	in	in	IN	B-PP
O	silencing	silencing	JJ	B-NP
O	genes	gene	NNS	I-NP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	high	high	JJ	I-NP
O	CpG	CpG	NN	I-NP
O	density	density	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	promoter	promoter	NN	I-NP
O	region	region	NN	I-NP
O	.	.	.	O

O	Activation	Activation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	maternally	maternally	RB	I-NP
O	preset	preset	JJ	I-NP
O	program	program	NN	I-NP
O	of	of	IN	B-PP
O	apoptosis	apoptosis	NN	B-NP
O	by	by	IN	B-PP
O	microinjection	microinjection	NN	B-NP
O	of	of	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	I-NP
O	2	2	CD	I-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	deoxycytidine	deoxycytidine	NN	I-NP
O	and	and	CC	I-NP
O	5	5	CD	I-NP
O	-	-	HYPH	I-NP
O	methyl	methyl	NN	I-NP
O	-	-	SYM	I-NP
O	2	2	CD	I-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	deoxycytidine	deoxycytidine	NN	I-NP
O	-	-	HYPH	I-NP
O	5	5	CD	I-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	triphosphate	triphosphate	NN	I-NP
O	in	in	IN	B-PP
O	Xenopus	Xenopus	NNP	B-NP
O	laevis	laevis	NNP	I-NP
O	embryos	embryo	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	present	present	JJ	I-NP
O	study	study	NN	I-NP
O	examines	examine	VBZ	B-VP
O	the	the	DT	B-NP
O	effects	effect	NNS	I-NP
O	on	on	IN	B-PP
O	embryogenesis	embryogenesis	NN	B-NP
O	of	of	IN	B-PP
O	microinjecting	microinjecte	VBG	B-VP
O	Xenopus	Xenopus	NNP	B-NP
O	laevis	laevis	NNP	I-NP
O	fertilized	fertilize	VBD	B-VP
O	eggs	egg	NNS	B-NP
O	with	with	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	I-NP
O	2	2	CD	I-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	deoxycytidine	deoxycytidine	NN	I-NP
O	(	(	(	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	Aza	Aza	NN	I-NP
O	-	-	HYPH	B-NP
O	CdR	CdR	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	which	which	WDT	B-NP
O	induces	induce	VBZ	B-VP
O	hypomethylation	hypomethylation	NN	B-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	methyl	methyl	NN	I-NP
O	-	-	SYM	I-NP
O	2	2	CD	I-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	deoxycytidine	deoxycytidine	NN	I-NP
O	-	-	HYPH	I-NP
O	5	5	CD	I-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	triphosphate	triphosphate	NN	I-NP
O	(	(	(	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	B-NP
O	dCTP	dCTP	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	which	which	WDT	B-NP
O	induces	induce	VBZ	B-VP
O	hypermethylation	hypermethylation	NN	B-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	.	.	.	O

O	Embryos	Embryo	NNS	B-NP
O	injected	inject	VBN	B-VP
O	with	with	IN	B-PP
O	either	either	DT	B-NP
O	one	one	CD	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	analogs	analog	NNS	I-NP
O	cleaved	cleave	VBD	B-VP
O	normally	normally	RB	B-ADVP
O	until	until	IN	B-SBAR
O	the	the	DT	B-NP
O	mid	mid	JJ	I-NP
O	-	-	HYPH	I-NP
O	blastula	blastula	NN	I-NP
O	stage	stage	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
O	underwent	undergo	VBD	B-VP
O	massive	massive	JJ	B-NP
O	cell	cell	NN	I-NP
O	dissociation	dissociation	NN	I-NP
O	and	and	CC	O
O	stopped	stop	VBD	B-VP
O	development	development	NN	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	early	early	JJ	I-NP
O	gastrula	gastrula	NN	I-NP
O	stage	stage	NN	I-NP
O	.	.	.	O

O	Dissociated	Dissociate	VBN	B-NP
O	cells	cell	NNS	I-NP
O	that	that	WDT	B-NP
O	appeared	appear	VBD	B-VP
O	here	here	RB	B-ADVP
O	were	be	VBD	B-VP
O	positive	positive	JJ	B-ADJP
O	by	by	IN	B-PP
O	terminal	terminal	JJ	B-NP
O	deoxyribonucleotidyl	deoxyribonucleotidyl	NN	I-NP
O	transferase	transferase	NN	I-NP
O	-	-	HYPH	B-VP
O	mediated	mediate	VBN	B-NP
O	deoxyuridine	deoxyuridine	NN	I-NP
O	triphosphate	triphosphate	NN	I-NP
O	-	-	HYPH	B-NP
O	digoxigenin	digoxigenin	NN	I-NP
O	nick	nick	NN	I-NP
O	end	end	NN	I-NP
O	-	-	HYPH	B-NP
O	labeling	labeling	NN	I-NP
O	and	and	CC	O
O	contained	contain	VBD	B-VP
O	fragmented	fragmented	JJ	B-NP
O	nuclei	nucleus	NNS	I-NP
O	with	with	IN	B-PP
O	condensed	condensed	JJ	B-NP
O	chromatin	chromatin	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	DNA	DNA	NN	I-NP
O	from	from	IN	B-PP
O	these	these	DT	B-NP
O	cells	cell	NNS	I-NP
O	formed	form	VBD	B-VP
O	a	a	DT	B-NP
O	"	"	``	I-NP
O	ladder	ladder	NN	I-NP
O	"	"	''	O
O	on	on	IN	B-PP
O	electrophoresis	electrophoresis	NN	B-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	induction	induction	NN	I-NP
O	of	of	IN	B-PP
O	cell	cell	NN	B-NP
O	dissociation	dissociation	NN	I-NP
O	by	by	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	Aza	Aza	NN	I-NP
O	-	-	HYPH	I-NP
O	CdR	CdR	NN	I-NP
O	and	and	CC	I-NP
O	5	5	CD	I-NP
O	-	-	HYPH	I-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	B-NP
O	dCTP	dCTP	NN	I-NP
O	was	be	VBD	B-VP
O	postponed	postpone	VBN	I-VP
O	by	by	IN	B-PP
O	2	2	CD	B-NP
O	-	-	HYPH	I-NP
O	3	3	CD	I-NP
O	h	h	NN	I-NP
O	by	by	IN	B-PP
O	co	co	AFX	B-NP
O	-	-	HYPH	I-NP
O	injection	injection	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Bcl	Bcl	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	2	2	CD	B-NP
O	mRNA	mRNA	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	normal	normal	JJ	I-NP
O	metabolite	metabolite	NN	I-NP
O	(	(	(	O
O	CdR	CdR	NN	B-NP
O	and	and	CC	O
O	dCTP	dCTP	NN	B-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	)	)	)	O
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	a	a	DT	B-NP
O	specific	specific	JJ	I-NP
O	antibody	antibody	NN	I-NP
O	against	against	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	O
O	cytosine	cytosine	NN	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	confirmed	confirm	VBD	B-VP
O	that	that	IN	B-SBAR
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	Aza	Aza	NN	I-NP
O	-	-	HYPH	O
O	CdR	CdR	NN	B-NP
O	induces	induce	VBZ	B-VP
O	hypomethylation	hypomethylation	NN	B-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	O
O	dCTP	dCTP	NN	B-NP
O	induces	induce	VBZ	B-VP
O	hypermethylation	hypermethylation	NN	B-NP
O	in	in	IN	B-PP
O	X	X	NN	B-NP
O	.	.	.	O
O	laevis	laevis	NN	B-NP
O	embryos	embryo	NNS	I-NP
O	before	before	IN	B-PP
O	the	the	DT	B-NP
O	onset	onset	NN	I-NP
O	of	of	IN	B-PP
O	cell	cell	NN	B-NP
O	dissociation	dissociation	NN	I-NP
O	.	.	.	O

O	Incorporation	Incorporation	NN	B-NP
O	of	of	IN	B-PP
O	radioactive	radioactive	JJ	B-NP
O	precursors	precursor	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
O	synthesis	synthesis	NN	B-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	also	also	RB	B-ADVP
O	RNA	RNA	NN	B-NP
O	,	,	,	O
O	is	be	VBZ	B-VP
O	inhibited	inhibit	VBN	I-VP
O	significantly	significantly	RB	B-ADVP
O	in	in	IN	B-PP
O	both	both	CC	B-NP
O	5	5	CD	I-NP
O	-	-	HYPH	I-NP
O	Aza	Aza	NN	I-NP
O	-	-	HYPH	B-NP
O	CdR	CdR	NN	I-NP
O	-	-	HYPH	B-NP
O	injected	inject	VBN	B-VP
O	and	and	CC	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	B-NP
O	dCTP	dCTP	NN	I-NP
O	-	-	HYPH	B-NP
O	injected	inject	VBN	I-NP
O	embryos	embryo	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	Aza	Aza	NN	I-NP
O	-	-	HYPH	I-NP
O	CdR	CdR	NN	I-NP
O	and	and	CC	I-NP
O	5	5	CD	I-NP
O	-	-	HYPH	I-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	I-NP
O	dCTP	dCTP	NN	I-NP
O	are	be	VBP	B-VP
O	incorporated	incorporate	VBN	I-VP
O	into	into	IN	B-PP
O	DNA	DNA	NN	B-NP
O	and	and	CC	O
O	induce	induce	VB	B-VP
O	apoptosis	apoptosis	NN	B-NP
O	,	,	,	O
O	probably	probably	RB	B-ADVP
O	through	through	IN	B-PP
O	alteration	alteration	NN	B-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	coupled	couple	VBN	B-VP
O	with	with	IN	B-PP
O	inhibition	inhibition	NN	B-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	replication	replication	NN	I-NP
O	and	and	CC	O
O	/	/	SYM	B-NP
O	or	or	CC	O
O	transcription	transcription	NN	B-NP
O	.	.	.	O

O	Impairment	Impairment	NN	B-NP
O	of	of	IN	B-PP
O	erythrocyte	erythrocyte	NN	B-NP
O	viscoelasticity	viscoelasticity	NN	I-NP
O	is	be	VBZ	B-VP
O	correlated	correlate	VBN	I-VP
O	with	with	IN	B-PP
O	levels	level	NNS	B-NP
O	of	of	IN	B-PP
O	glycosylated	glycosylate	VBN	B-NP
O	haemoglobin	haemoglobin	NN	I-NP
O	in	in	IN	B-PP
O	diabetic	diabetic	JJ	B-NP
O	patients	patient	NNS	I-NP
O	.	.	.	O

O	Erythrocytes	Erythrocyte	NNS	B-NP
O	from	from	IN	B-PP
O	diabetic	diabetic	JJ	B-NP
O	patients	patient	NNS	I-NP
O	exhibit	exhibit	VBP	B-VP
O	impaired	impaired	JJ	B-NP
O	viscoelastic	viscoelastic	JJ	I-NP
O	properties	property	NNS	I-NP
O	when	when	WRB	B-ADVP
O	estimated	estimate	VBN	B-VP
O	by	by	IN	B-PP
O	various	various	JJ	B-NP
O	methods	method	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	determined	determine	VBD	B-VP
O	erythrocyte	erythrocyte	NN	B-NP
O	filterability	filterability	NN	I-NP
O	through	through	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	microm	microm	NN	I-NP
O	pores	pore	NNS	I-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	51	51	CD	B-NP
O	patients	patient	NNS	I-NP
O	with	with	IN	B-PP
O	non	non	AFX	B-NP
O	-	-	HYPH	I-NP
B-GGP	insulin	insulin	NN	I-NP
O	-	-	HYPH	I-NP
O	dependent	dependent	JJ	I-NP
O	diabetes	diabetes	NN	I-NP
O	mellitus	mellitus	NN	I-NP
O	,	,	,	O
O	18	18	CD	B-NP
O	healthy	healthy	JJ	I-NP
O	controls	control	NNS	I-NP
O	,	,	,	O
O	15	15	CD	B-NP
O	patients	patient	NNS	I-NP
O	with	with	IN	B-PP
O	homozygous	homozygous	JJ	B-NP
O	beta	beta	SYM	I-NP
O	-	-	HYPH	I-NP
O	thalassemia	thalassemia	NN	I-NP
O	and	and	CC	O
O	15	15	CD	B-NP
O	with	with	IN	B-PP
O	beta	beta	SYM	B-NP
O	-	-	HYPH	I-NP
O	thalassemia	thalassemia	NN	I-NP
O	traits	trait	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	filtration	filtration	NN	I-NP
O	measurements	measurement	NNS	I-NP
O	were	be	VBD	B-VP
O	made	make	VBN	I-VP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	Hemorheometer	Hemorheometer	NNP	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	uses	use	VBZ	B-VP
O	the	the	DT	B-NP
O	"	"	``	I-NP
O	initial	initial	JJ	I-NP
O	flow	flow	NN	I-NP
O	rate	rate	NN	I-NP
O	"	"	''	I-NP
O	principle	principle	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	determine	determine	VB	I-VP
O	the	the	DT	B-NP
O	Index	Index	NN	I-NP
O	of	of	IN	B-PP
O	Rigidity	Rigidity	NN	B-NP
O	(	(	(	O
O	IR	IR	NN	B-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	red	red	JJ	I-NP
O	blood	blood	NN	I-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	measured	measure	VBD	B-VP
O	the	the	DT	B-NP
O	passage	passage	NN	I-NP
O	time	time	NN	I-NP
O	of	of	IN	B-PP
O	white	white	JJ	B-NP
O	blood	blood	NN	I-NP
O	cell	cell	NN	I-NP
O	-	-	HYPH	B-NP
O	free	free	JJ	I-NP
O	erythrocyte	erythrocyte	NN	I-NP
O	suspensions	suspension	NNS	I-NP
O	,	,	,	O
O	8	8	CD	B-NP
O	%	%	NN	I-NP
O	per	per	IN	B-PP
O	volume	volume	NN	B-NP
O	,	,	,	O
O	through	through	IN	B-PP
O	the	the	DT	B-NP
O	filter	filter	NN	I-NP
O	.	.	.	O

O	Diabetic	Diabetic	JJ	B-NP
O	patients	patient	NNS	I-NP
O	had	have	VBD	B-VP
O	significantly	significantly	RB	I-VP
O	increased	increase	VBN	B-NP
O	IR	IR	NN	I-NP
O	in	in	IN	B-PP
O	comparison	comparison	NN	B-NP
O	to	to	TO	B-PP
O	healthy	healthy	JJ	B-NP
O	controls	control	NNS	I-NP
O	and	and	CC	B-PP
O	to	to	TO	B-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
O	beta	beta	SYM	B-NP
O	-	-	HYPH	B-NP
O	thalassemia	thalassemia	NN	I-NP
O	trait	trait	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
O	not	not	RB	O
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	level	level	NN	I-NP
O	found	find	VBN	B-VP
O	in	in	IN	B-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
O	homozygous	homozygous	JJ	B-NP
O	beta	beta	SYM	I-NP
O	-	-	HYPH	I-NP
O	thalassemia	thalassemia	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	diabetic	diabetic	JJ	B-NP
O	patients	patient	NNS	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	strong	strong	JJ	I-NP
O	correlation	correlation	NN	I-NP
O	between	between	IN	B-PP
O	IR	IR	NN	B-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	percentage	percentage	NN	I-NP
O	of	of	IN	B-PP
O	glycosylated	glycosylate	VBN	B-NP
O	haemoglobin	haemoglobin	NN	I-NP
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	(	(	(	O
O	r	r	NN	B-NP
O	=	=	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	737	737	CD	I-NP
O	,	,	,	O
O	P	P	NN	B-NP
O	<	<	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	0001	0001	CD	I-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
O	a	a	DT	B-NP
O	weaker	weak	JJR	I-NP
O	one	one	NN	I-NP
O	with	with	IN	B-PP
O	serum	serum	NN	B-NP
O	unconjugated	unconjugated	JJ	I-NP
O	bilirubin	bilirubin	NN	I-NP
O	(	(	(	O
O	r	r	NN	B-NP
O	=	=	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	363	363	CD	I-NP
O	,	,	,	O
O	P	P	NN	B-NP
O	=	=	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	0097	0097	CD	I-NP
O	)	)	)	O
O	and	and	CC	O
O	serum	serum	NN	B-NP
O	total	total	JJ	I-NP
O	lipids	lipid	NNS	I-NP
O	(	(	(	O
O	r	r	NN	B-NP
O	=	=	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	321	321	CD	I-NP
O	,	,	,	O
O	P	P	NN	B-NP
O	=	=	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	0286	0286	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	Patients	Patient	NNS	B-NP
O	with	with	IN	B-PP
O	severe	severe	JJ	B-NP
O	retinopathy	retinopathy	NN	I-NP
O	also	also	RB	B-ADVP
O	had	have	VBD	B-VP
O	significantly	significantly	RB	I-VP
O	increased	increase	VBN	I-VP
O	IR	IR	NN	B-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	comparison	comparison	NN	B-NP
O	to	to	TO	B-PP
O	those	those	DT	B-NP
O	with	with	IN	B-PP
O	or	or	CC	B-PP
O	without	without	IN	B-PP
O	mild	mild	JJ	B-NP
O	retinopathy	retinopathy	NN	I-NP
O	.	.	.	O

O	Anaemic	Anaemic	JJ	B-NP
O	diabetic	diabetic	JJ	I-NP
O	patients	patient	NNS	I-NP
O	,	,	,	O
O	especially	especially	RB	B-ADVP
O	those	those	DT	B-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	anaemia	anaemia	NN	I-NP
O	of	of	IN	B-PP
O	chronic	chronic	JJ	B-NP
O	disease	disease	NN	I-NP
O	,	,	,	O
O	also	also	RB	B-ADVP
O	had	have	VBD	B-VP
O	significantly	significantly	RB	I-VP
O	increased	increase	VBN	I-VP
O	IR	IR	NN	B-NP
O	in	in	IN	B-PP
O	comparison	comparison	NN	B-NP
O	to	to	TO	B-PP
O	non	non	AFX	B-NP
O	-	-	HYPH	I-NP
O	anaemic	anaemic	JJ	I-NP
O	diabetics	diabetic	NNS	I-NP
O	.	.	.	O

O	No	No	DT	B-NP
O	correlation	correlation	NN	I-NP
O	between	between	IN	B-PP
O	IR	IR	NN	B-NP
O	,	,	,	O
O	MCV	MCV	NN	B-NP
O	,	,	,	O
O	MCH	MCH	NN	B-NP
O	,	,	,	O
O	MCHC	MCHC	NN	B-NP
O	,	,	,	O
O	RDW	RDW	NN	B-NP
O	,	,	,	O
O	RBC	RBC	NN	B-NP
O	morphology	morphology	NN	I-NP
O	,	,	,	O
O	serum	serum	NN	B-NP
O	LDH	LDH	NN	I-NP
O	or	or	CC	O
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	erythrocyte	erythrocyte	NN	B-NP
O	inclusions	inclusion	NNS	I-NP
O	after	after	IN	B-PP
O	incubation	incubation	NN	B-NP
O	with	with	IN	B-PP
O	nitrous	nitrous	JJ	B-NP
O	sodium	sodium	NN	I-NP
O	solution	solution	NN	I-NP
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	findings	finding	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	glycosylation	glycosylation	NN	B-NP
O	of	of	IN	B-PP
O	skeletal	skeletal	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	probably	probably	RB	B-ADVP
O	contributes	contribute	VBZ	B-VP
O	significantly	significantly	RB	B-ADVP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	increased	increase	VBN	I-NP
O	membrane	membrane	NN	I-NP
O	rigidity	rigidity	NN	I-NP
O	of	of	IN	B-PP
O	diabetic	diabetic	JJ	B-NP
O	erythrocytes	erythrocyte	NNS	I-NP
O	.	.	.	O

O	Characterization	Characterization	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	secretable	secretable	JJ	I-NP
O	ectodomain	ectodomain	NN	I-NP
O	of	of	IN	B-PP
B-GGP	thyrotropin	thyrotropin	NN	B-NP
I-GGP	receptor	receptor	NN	I-NP
O	produced	produce	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	recombinant	recombinant	JJ	I-NP
O	baculovirus	baculovirus	NN	I-NP
O	system	system	NN	I-NP
O	.	.	.	O

B-GGP	Thyrotropin	Thyrotropin	NN	B-NP
I-GGP	receptor	receptor	NN	I-NP
O	(	(	(	O
B-GGP	TSHR	TSHR	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	member	member	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	hormone	hormone	NN	I-NP
O	receptor	receptor	NN	I-NP
O	family	family	NN	I-NP
O	and	and	CC	O
O	an	an	DT	B-NP
O	autoantigen	autoantigen	NN	I-NP
O	of	of	IN	B-PP
O	Graves	Graves	NN	B-NP
O	'	'	POS	B-NP
O	disease	disease	NN	I-NP
O	.	.	.	O

O	Various	Various	JJ	B-NP
O	attempts	attempt	NNS	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	made	make	VBN	I-VP
O	to	to	TO	B-VP
O	obtain	obtain	VB	I-VP
O	a	a	DT	B-NP
O	large	large	JJ	I-NP
O	amount	amount	NN	I-NP
O	of	of	IN	B-PP
O	soluble	soluble	JJ	B-NP
O	ectodomain	ectodomain	NN	I-NP
O	of	of	IN	B-PP
B-GGP	TSHR	TSHR	NN	B-NP
O	in	in	IN	B-PP
O	insect	insect	NN	B-NP
O	or	or	CC	O
O	mammalian	mammalian	JJ	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	but	but	CC	O
O	most	most	JJS	B-NP
O	of	of	IN	B-PP
O	them	them	PRP	B-NP
O	failed	fail	VBD	B-VP
O	to	to	TO	I-VP
O	secrete	secrete	VB	I-VP
O	the	the	DT	B-NP
O	overexpressed	overexpresse	VBN	I-NP
O	ectodomain	ectodomain	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	observed	observe	VBD	B-VP
O	that	that	IN	B-SBAR
O	about	about	RB	B-NP
O	one	one	CD	I-NP
O	-	-	HYPH	I-NP
O	third	third	JJ	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	ectodomain	ectodomain	NN	I-NP
O	protein	protein	NN	I-NP
O	(	(	(	O
B-GGP	sTSHR	sTSHR	NN	B-NP
O	-	-	HYPH	B-NP
O	gp	gp	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	in	in	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
O	signal	signal	NN	I-NP
O	peptide	peptide	NN	I-NP
O	of	of	IN	B-PP
B-GGP	TSHR	TSHR	NN	B-NP
O	was	be	VBD	B-VP
O	replaced	replace	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	baculovirus	baculovirus	NN	I-NP
O	-	-	HYPH	O
O	encoded	encode	VBN	B-VP
B-GGP	glycoprotein	glycoprotein	NN	B-NP
I-GGP	67	67	CD	I-NP
O	-	-	HYPH	I-NP
O	signal	signal	NN	I-NP
O	peptide	peptide	NN	I-NP
O	,	,	,	O
O	was	be	VBD	B-VP
O	secreted	secrete	VBN	I-VP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	culture	culture	NN	I-NP
O	medium	medium	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	remainder	remainder	NN	I-NP
O	stayed	stay	VBD	B-VP
O	within	within	IN	B-PP
O	cells	cell	NNS	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	recombinant	recombinant	JJ	I-NP
O	baculovirus	baculovirus	NN	I-NP
O	system	system	NN	I-NP
O	.	.	.	O

O	Microsequencing	Microsequence	VBG	B-VP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	purified	purify	VBN	I-NP
O	protein	protein	NN	I-NP
O	confirmed	confirm	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	baculovirus	baculovirus	NN	I-NP
O	signal	signal	NN	I-NP
O	peptide	peptide	NN	I-NP
O	was	be	VBD	B-VP
O	cleaved	cleave	VBN	I-VP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	expected	expected	JJ	I-NP
O	site	site	NN	I-NP
O	.	.	.	O

O	Carbohydrate	Carbohydrate	NN	B-NP
O	studies	study	NNS	I-NP
O	using	use	VBG	B-VP
O	several	several	JJ	B-NP
O	glycosidases	glycosidas	NNS	I-NP
O	and	and	CC	I-NP
O	lectins	lectin	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	secreted	secrete	VBN	I-NP
O	form	form	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	ectodomain	ectodomain	NN	I-NP
O	had	have	VBD	B-VP
O	biantennary	biantennary	JJ	B-NP
O	carbohydrate	carbohydrate	NN	I-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	the	the	DT	B-NP
O	non	non	AFX	I-NP
O	-	-	HYPH	I-NP
O	secreted	secrete	VBN	I-NP
O	form	form	NN	I-NP
O	had	have	VBD	B-VP
O	high	high	JJ	B-NP
O	-	-	HYPH	I-NP
O	mannose	mannose	NN	I-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	secreted	secrete	VBN	I-NP
O	form	form	NN	I-NP
O	of	of	IN	B-PP
B-GGP	sTSHR	sTSHR	NN	B-NP
O	-	-	HYPH	B-NP
O	gp	gp	NN	I-NP
O	exhibited	exhibit	VBD	B-VP
O	high	high	JJ	B-NP
O	-	-	HYPH	I-NP
O	affinity	affinity	NN	I-NP
O	ligand	ligand	NN	I-NP
O	binding	binding	NN	I-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	the	the	DT	B-NP
O	non	non	AFX	I-NP
O	-	-	HYPH	I-NP
O	secreted	secrete	VBN	I-NP
O	form	form	NN	I-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	show	show	VB	I-VP
O	any	any	DT	B-NP
O	significant	significant	JJ	I-NP
O	ligand	ligand	NN	I-NP
O	binding	binding	NN	I-NP
O	.	.	.	O

O	Regarding	Regard	VBG	B-VP
O	the	the	DT	B-NP
O	interactions	interaction	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	TSHR	TSHR	NN	B-NP
O	ectodomains	ectodomain	NNS	I-NP
O	with	with	IN	B-PP
O	anti	anti	AFX	B-NP
O	-	-	HYPH	I-NP
B-GGP	TSHR	TSHR	NN	I-NP
O	antibodies	antibody	NNS	I-NP
O	,	,	,	O
O	both	both	CC	O
O	the	the	DT	B-NP
O	secreted	secrete	VBN	I-NP
O	and	and	CC	I-NP
O	non	non	AFX	I-NP
O	-	-	HYPH	I-NP
O	secreted	secrete	VBN	I-NP
O	forms	form	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	sTSHR	sTSHR	NN	B-NP
O	-	-	HYPH	B-NP
O	gp	gp	NN	I-NP
O	,	,	,	O
O	almost	almost	RB	B-ADVP
O	completely	completely	RB	I-ADVP
O	neutralized	neutralize	VBD	B-VP
O	the	the	DT	B-NP
O	stimulatory	stimulatory	JJ	I-NP
O	and	and	CC	I-NP
O	inhibitory	inhibitory	JJ	I-NP
O	anti	anti	AFX	I-NP
O	-	-	HYPH	I-NP
B-GGP	TSHR	TSHR	NN	I-NP
O	antibody	antibody	NN	I-NP
O	activities	activity	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	conclusion	conclusion	NN	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	succeeded	succeed	VBD	B-VP
O	in	in	IN	B-PP
O	secreting	secrete	VBG	B-VP
O	the	the	DT	B-NP
O	ectodomain	ectodomain	NN	I-NP
O	of	of	IN	B-PP
B-GGP	TSHR	TSHR	NN	B-NP
O	into	into	IN	B-PP
O	culture	culture	NN	B-NP
O	medium	medium	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	was	be	VBD	B-VP
O	capable	capable	JJ	B-ADJP
O	of	of	IN	B-PP
O	binding	bind	VBG	B-VP
O	to	to	TO	B-PP
O	TSH	TSH	NN	B-NP
O	and	and	CC	O
O	neutralizing	neutralize	VBG	B-VP
O	anti	anti	AFX	B-NP
O	-	-	HYPH	I-NP
B-GGP	TSHR	TSHR	NN	I-NP
O	antibody	antibody	NN	I-NP
O	activities	activity	NNS	I-NP
O	.	.	.	O

O	C	C	NN	B-NP
O	.	.	.	O
O	elegans	elegan	VBZ	B-VP
B-GGP	EGL	EGL	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	9	9	CD	I-NP
O	and	and	CC	O
O	mammalian	mammalian	JJ	B-NP
O	homologs	homolog	NNS	I-NP
O	define	define	VBP	B-VP
O	a	a	DT	B-NP
O	family	family	NN	I-NP
O	of	of	IN	B-PP
O	dioxygenases	dioxygenas	NNS	B-NP
O	that	that	WDT	B-NP
O	regulate	regulate	VBP	B-VP
O	HIF	HIF	NN	B-NP
O	by	by	IN	B-PP
O	prolyl	prolyl	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	.	.	.	O

O	HIF	HIF	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	complex	complex	NN	I-NP
O	that	that	WDT	B-NP
O	plays	play	VBZ	B-VP
O	a	a	DT	B-NP
O	central	central	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	mammalian	mammalian	JJ	B-NP
O	oxygen	oxygen	NN	I-NP
O	homeostasis	homeostasis	NN	I-NP
O	.	.	.	O

O	Recent	Recent	JJ	B-NP
O	studies	study	NNS	I-NP
O	have	have	VBP	B-VP
O	defined	define	VBN	I-VP
O	posttranslational	posttranslational	JJ	B-NP
O	modification	modification	NN	I-NP
O	by	by	IN	B-PP
O	prolyl	prolyl	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	key	key	JJ	I-NP
O	regulatory	regulatory	JJ	I-NP
O	event	event	NN	I-NP
O	that	that	WDT	B-NP
O	targets	target	VBZ	B-VP
O	HIF	HIF	NN	B-NP
O	-	-	HYPH	O
O	alpha	alpha	SYM	O
O	subunits	subunit	NNS	B-NP
O	for	for	IN	B-PP
O	proteasomal	proteasomal	JJ	B-NP
O	destruction	destruction	NN	I-NP
O	via	via	IN	B-PP
O	the	the	DT	B-NP
B-GGP	von	von	NNP	I-NP
I-GGP	Hippel	Hippel	NNP	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	Lindau	Lindau	NNP	I-NP
O	ubiquitylation	ubiquitylation	NN	I-NP
O	complex	complex	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	define	define	VBP	B-VP
O	a	a	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	HIF	HIF	NN	I-NP
O	-	-	HYPH	I-NP
B-GGP	VHL	VHL	NN	I-NP
O	-	-	HYPH	I-NP
O	prolyl	prolyl	NN	I-NP
O	hydroxylase	hydroxylase	NN	I-NP
O	pathway	pathway	NN	I-NP
O	in	in	IN	B-PP
O	C	C	NN	B-NP
O	.	.	.	O
O	elegans	elegan	NNS	B-NP
O	,	,	,	O
O	and	and	CC	O
O	use	use	VBP	B-VP
O	a	a	DT	B-NP
O	genetic	genetic	JJ	I-NP
O	approach	approach	NN	I-NP
O	to	to	TO	B-VP
O	identify	identify	VB	I-VP
B-GGP	EGL	EGL	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	9	9	CD	I-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	dioxygenase	dioxygenase	NN	I-NP
O	that	that	WDT	B-NP
O	regulates	regulate	VBZ	B-VP
O	HIF	HIF	NN	B-NP
O	by	by	IN	B-PP
O	prolyl	prolyl	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	mammalian	mammalian	JJ	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	HIF	HIF	NN	I-NP
O	-	-	HYPH	B-NP
O	prolyl	prolyl	NN	I-NP
O	hydroxylases	hydroxylas	NNS	I-NP
O	are	be	VBP	B-VP
O	represented	represent	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	series	series	NN	I-NP
O	of	of	IN	B-PP
O	isoforms	isoform	NNS	B-NP
O	bearing	bear	VBG	B-VP
O	a	a	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	2	2	CD	I-NP
O	-	-	HYPH	I-NP
O	histidine	histidine	NN	I-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	-	-	HYPH	I-NP
O	carboxylate	carboxylate	NN	I-NP
O	iron	iron	NN	I-NP
O	coordination	coordination	NN	I-NP
O	motif	motif	NN	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	catalytic	catalytic	JJ	I-NP
O	site	site	NN	I-NP
O	.	.	.	O

O	Direct	Direct	JJ	B-NP
O	modulation	modulation	NN	I-NP
O	of	of	IN	B-PP
O	recombinant	recombinant	JJ	B-NP
O	enzyme	enzyme	NN	I-NP
O	activity	activity	NN	I-NP
O	by	by	IN	B-PP
O	graded	grade	VBN	B-NP
O	hypoxia	hypoxia	NN	I-NP
O	,	,	,	O
O	iron	iron	NN	B-NP
O	chelation	chelation	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	cobaltous	cobaltous	JJ	B-NP
O	ions	ion	NNS	I-NP
O	mirrors	mirror	NNS	I-NP
O	the	the	DT	B-NP
O	characteristics	characteristic	NNS	I-NP
O	of	of	IN	B-PP
O	HIF	HIF	NN	B-NP
O	induction	induction	NN	I-NP
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	,	,	,	O
O	fulfilling	fulfil	VBG	B-VP
O	requirements	requirement	NNS	B-NP
O	for	for	IN	B-PP
O	these	these	DT	B-NP
O	enzymes	enzyme	NNS	I-NP
O	being	be	VBG	B-VP
O	oxygen	oxygen	NN	B-NP
O	sensors	sensor	NNS	I-NP
O	that	that	WDT	B-NP
O	regulate	regulate	VBP	B-VP
O	HIF	HIF	NN	B-NP
O	.	.	.	O

O	Biochemical	Biochemical	JJ	B-NP
O	characterization	characterization	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	vanilloid	vanilloid	JJ	I-NP
I-GGP	receptor	receptor	NN	I-NP
I-GGP	1	1	CD	I-NP
O	expressed	express	VBN	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	dorsal	dorsal	JJ	I-NP
O	root	root	NN	I-NP
O	ganglia	ganglia	NNS	I-NP
O	derived	derive	VBD	B-VP
O	cell	cell	NN	B-NP
O	line	line	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	vanilloid	vanilloid	JJ	I-NP
O	receptor	receptor	NN	I-NP
B-GGP	VR1	VR1	NN	I-NP
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	ion	ion	NN	I-NP
O	channel	channel	NN	I-NP
O	predominantly	predominantly	RB	B-VP
O	expressed	express	VBN	I-VP
O	by	by	IN	B-PP
O	primary	primary	JJ	B-NP
O	sensory	sensory	JJ	I-NP
O	neurons	neuron	NNS	I-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	nociception	nociception	NN	B-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	we	we	PRP	B-NP
O	describe	describe	VBP	B-VP
O	its	its	PRP$	B-NP
O	biochemical	biochemical	JJ	I-NP
O	properties	property	NNS	I-NP
O	and	and	CC	O
O	assess	assess	VB	B-VP
O	the	the	DT	B-NP
O	subcellular	subcellular	JJ	I-NP
O	localization	localization	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	state	state	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	quaternary	quaternary	JJ	I-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
B-GGP	VR1	VR1	NN	B-NP
O	expressed	express	VBN	B-VP
O	in	in	IN	B-PP
O	HEK293	HEK293	NN	B-NP
O	cells	cell	NNS	I-NP
O	and	and	CC	B-PP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	DRG	DRG	NN	I-NP
O	-	-	HYPH	B-NP
O	derived	derive	VBN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	F	F	NN	I-NP
O	-	-	HYPH	O
O	11	11	CD	B-NP
O	(	(	(	O
O	N18TG2	N18TG2	NN	B-NP
O	mouse	mouse	NN	I-NP
O	neuroblastoma	neuroblastoma	NN	I-NP
O	x	x	SYM	B-VP
O	rat	rat	NN	B-NP
O	dorsal	dorsal	JJ	I-NP
O	root	root	NN	I-NP
O	ganglia	ganglia	NNS	I-NP
O	,	,	,	O
O	hybridoma	hybridoma	NN	B-NP
O	)	)	)	O
O	.	.	.	O

B-GGP	VR1	VR1	NN	B-NP
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	glycosylated	glycosylate	VBN	I-VP
O	in	in	IN	B-PP
O	both	both	DT	B-NP
O	cell	cell	NN	I-NP
O	types	type	NNS	I-NP
O	.	.	.	O

O	Of	Of	IN	B-PP
O	the	the	DT	B-NP
O	five	five	CD	I-NP
O	potential	potential	JJ	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	sites	site	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	predicted	predict	VBN	I-NP
O	transient	transient	JJ	I-NP
O	receptor	receptor	NN	I-NP
O	potential	potential	NN	I-NP
O	channel	channel	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	transmembrane	transmembrane	JJ	I-NP
O	folding	folding	NN	I-NP
O	proposes	propose	VBZ	B-VP
O	N604	N604	NN	B-NP
O	is	be	VBZ	B-VP
O	localized	localize	VBN	I-VP
O	extracellularly	extracellularly	RB	B-ADVP
O	.	.	.	O

O	We	We	PRP	B-NP
O	used	use	VBD	B-VP
O	site	site	NN	B-NP
O	-	-	HYPH	B-NP
O	directed	direct	VBN	I-NP
O	mutagenesis	mutagenesis	NN	I-NP
O	to	to	TO	B-VP
O	mutate	mutate	VB	I-VP
O	the	the	DT	B-NP
O	Asn	Asn	NN	I-NP
O	at	at	IN	B-PP
O	position	position	NN	B-NP
O	604	604	CD	I-NP
O	to	to	TO	B-PP
O	Thr	Thr	NNP	B-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	mutated	mutate	VBN	I-NP
B-GGP	VR1	VR1	NN	I-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	glycosylated	glycosylate	VBN	I-VP
O	,	,	,	O
O	confirming	confirm	VBG	B-VP
O	the	the	DT	B-NP
O	extracellular	extracellular	JJ	I-NP
O	location	location	NN	I-NP
O	of	of	IN	B-PP
O	N604	N604	NN	B-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	role	role	NN	I-NP
O	as	as	IN	B-PP
O	the	the	DT	B-NP
O	exclusive	exclusive	JJ	I-NP
O	site	site	NN	I-NP
O	of	of	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	VR1	VR1	NN	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

B-GGP	VR1	VR1	NN	B-NP
O	occured	occur	VBN	B-VP
O	in	in	IN	B-PP
O	high	high	JJ	B-NP
O	molecular	molecular	JJ	I-NP
O	mass	mass	NN	I-NP
O	complexes	complex	NNS	I-NP
O	as	as	IN	B-SBAR
O	assessed	assess	VBN	B-VP
O	by	by	IN	B-PP
O	blue	blue	JJ	B-NP
O	native	native	JJ	I-NP
O	PAGE	PAGE	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	limited	limit	VBN	B-NP
O	amounts	amount	NNS	I-NP
O	of	of	IN	B-PP
O	SDS	SDS	NN	B-NP
O	dimers	dimer	NNS	I-NP
O	,	,	,	O
O	trimers	trimer	NNS	B-NP
O	and	and	CC	I-NP
O	tetramers	tetramer	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	VR1	VR1	NN	B-NP
O	were	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	,	,	,	O
O	consistent	consistent	JJ	B-ADJP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	predicted	predict	VBN	I-NP
O	tetrameric	tetrameric	JJ	I-NP
O	quaternary	quaternary	JJ	I-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	receptor	receptor	NN	I-NP
O	.	.	.	O

O	Cross	Cross	NN	B-NP
O	-	-	HYPH	O
O	linking	link	VBG	B-VP
O	with	with	IN	B-PP
O	dimethyladipimidate	dimethyladipimidate	NN	B-NP
O	yielded	yield	VBD	B-VP
O	almost	almost	RB	B-NP
O	exclusively	exclusively	RB	I-NP
O	dimers	dimer	NNS	I-NP
O	.	.	.	O

O	Whereas	Whereas	IN	B-SBAR
B-GGP	VR1	VR1	NN	B-NP
O	localized	localize	VBD	B-VP
O	both	both	CC	B-PP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	plasma	plasma	NN	I-NP
O	membrane	membrane	NN	I-NP
O	and	and	CC	B-PP
O	to	to	TO	B-PP
O	intracellular	intracellular	JJ	B-NP
O	membranes	membrane	NNS	I-NP
O	in	in	IN	B-PP
O	HEK293	HEK293	NN	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	it	it	PRP	B-NP
O	localized	localize	VBD	B-VP
O	predominantly	predominantly	RB	B-ADVP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	plasma	plasma	NN	I-NP
O	membrane	membrane	NN	I-NP
O	in	in	IN	B-PP
O	F	F	NN	B-NP
O	-	-	HYPH	O
O	11	11	CD	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	confocal	confocal	JJ	B-NP
O	laserscanning	laserscanning	NN	I-NP
O	microscopy	microscopy	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	observed	observe	VBD	B-VP
O	an	an	DT	B-NP
O	enrichment	enrichment	NN	I-NP
O	of	of	IN	B-PP
O	anti	anti	AFX	B-NP
O	-	-	HYPH	I-NP
B-GGP	VR1	VR1	NN	I-NP
O	immunoreactivity	immunoreactivity	NN	I-NP
O	in	in	IN	B-PP
O	neurite	neurite	NN	B-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	structures	structure	NNS	I-NP
O	of	of	IN	B-PP
O	F	F	NN	B-NP
O	-	-	HYPH	O
O	11	11	CD	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	light	light	NN	I-NP
O	of	of	IN	B-PP
O	conflicting	conflict	VBG	B-VP
O	literature	literature	NN	B-NP
O	data	datum	NNS	I-NP
O	on	on	IN	B-PP
O	biochemical	biochemical	JJ	B-NP
O	characteristics	characteristic	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	VR1	VR1	NN	B-NP
O	,	,	,	O
O	our	our	PRP$	B-NP
O	data	datum	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	dorsal	dorsal	JJ	B-NP
O	root	root	NN	I-NP
O	ganglion	ganglion	NN	I-NP
O	-	-	HYPH	B-VP
O	derived	derive	VBN	B-NP
O	F	F	NN	I-NP
O	-	-	HYPH	O
O	11	11	CD	B-NP
O	cells	cell	NNS	I-NP
O	provide	provide	VBP	B-VP
O	a	a	DT	B-NP
O	powerful	powerful	JJ	I-NP
O	experimental	experimental	JJ	I-NP
O	system	system	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	study	study	NN	I-NP
O	of	of	IN	B-PP
B-GGP	VR1	VR1	NN	B-NP
O	biochemistry	biochemistry	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	methylosome	methylosome	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	20S	20S	NN	I-NP
O	complex	complex	NN	I-NP
O	containing	contain	VBG	B-VP
B-GGP	JBP1	JBP1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	pICln	pICln	NN	I-NP
O	,	,	,	O
O	produces	produce	VBZ	B-VP
O	dimethylarginine	dimethylarginine	NN	B-NP
O	-	-	HYPH	O
O	modified	modify	VBN	B-NP
O	Sm	Sm	NN	I-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	snRNPs	snRNP	NNS	B-NP
O	,	,	,	O
O	integral	integral	JJ	B-NP
O	components	component	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	pre	pre	AFX	I-NP
O	-	-	HYPH	I-NP
O	mRNA	mRNA	NN	I-NP
O	splicing	splicing	NN	I-NP
O	machinery	machinery	NN	I-NP
O	,	,	,	O
O	consist	consist	VBP	B-VP
O	of	of	IN	B-PP
O	seven	seven	CD	B-NP
O	Sm	Sm	NN	I-NP
O	proteins	protein	NNS	I-NP
O	which	which	WDT	B-NP
O	assemble	assemble	VBP	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	cytoplasm	cytoplasm	NN	I-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	ring	ring	NN	I-NP
O	structure	structure	NN	I-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	snRNAs	snRNA	NNS	I-NP
O	U1	U1	NN	I-NP
O	,	,	,	O
O	U2	U2	NN	B-NP
O	,	,	,	O
O	U4	U4	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	U5	U5	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	survival	survival	NN	I-NP
O	motor	motor	JJ	I-NP
O	neuron	neuron	NN	I-NP
O	(	(	(	O
O	SMN	SMN	NN	B-NP
O	)	)	)	O
O	protein	protein	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	spinal	spinal	JJ	I-NP
O	muscular	muscular	JJ	I-NP
O	atrophy	atrophy	NN	I-NP
O	disease	disease	NN	I-NP
O	gene	gene	NN	I-NP
O	product	product	NN	I-NP
O	,	,	,	O
O	is	be	VBZ	B-VP
O	crucial	crucial	JJ	B-ADJP
O	for	for	IN	B-PP
O	snRNP	snRNP	NN	B-NP
O	core	core	NN	I-NP
O	particle	particle	NN	I-NP
O	assembly	assembly	NN	I-NP
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	.	.	.	O

O	SMN	SMN	NN	B-NP
O	binds	bind	VBZ	B-VP
O	preferentially	preferentially	RB	B-ADVP
O	and	and	CC	I-ADVP
O	directly	directly	RB	B-ADVP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	symmetrical	symmetrical	JJ	I-NP
O	dimethylarginine	dimethylarginine	NN	I-NP
O	(	(	(	O
O	sDMA	sDMA	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	O
O	modified	modify	VBN	B-NP
O	arginine	arginine	NN	I-NP
O	-	-	HYPH	O
O	and	and	CC	O
O	glycine	glycine	NN	B-ADJP
O	-	-	HYPH	I-ADJP
O	rich	rich	JJ	I-ADJP
O	(	(	(	O
O	RG	RG	NN	B-NP
O	-	-	HYPH	O
O	rich	rich	JJ	O
O	)	)	)	O
O	domains	domain	NNS	B-NP
O	of	of	IN	B-PP
B-GGP	SmD1	SmD1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	SmD3	SmD3	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	unmodified	unmodified	JJ	I-NP
O	,	,	,	I-NP
O	but	but	CC	I-NP
O	not	not	RB	I-NP
O	the	the	DT	B-NP
O	sDMA	sDMA	NN	I-NP
O	-	-	HYPH	O
O	modified	modify	VBN	B-VP
O	,	,	,	O
O	RG	RG	NN	B-NP
O	domains	domain	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	SmD1	SmD1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	SmD3	SmD3	NN	I-NP
O	associate	associate	VBP	B-VP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	20S	20S	NN	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	complex	complex	NN	I-NP
O	,	,	,	O
O	termed	term	VBN	B-VP
O	the	the	DT	B-NP
O	methylosome	methylosome	NN	I-NP
O	,	,	,	O
O	that	that	WDT	B-NP
O	contains	contain	VBZ	B-VP
O	the	the	DT	B-NP
O	methyltransferase	methyltransferase	NN	I-NP
B-GGP	JBP1	JBP1	NN	I-NP
O	and	and	CC	O
O	a	a	DT	B-NP
B-GGP	JBP1	JBP1	NN	I-NP
O	-	-	HYPH	O
O	interacting	interact	VBG	B-VP
O	protein	protein	NN	B-NP
O	,	,	,	O
B-GGP	pICln	pICln	NN	B-NP
O	.	.	.	O

B-GGP	JBP1	JBP1	NN	B-NP
O	binds	bind	VBZ	B-VP
B-GGP	SmD1	SmD1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	SmD3	SmD3	NN	I-NP
O	via	via	IN	B-PP
O	their	their	PRP$	B-NP
O	RG	RG	NN	I-NP
O	domains	domain	NNS	I-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
B-GGP	pICln	pICln	NN	B-NP
O	binds	bind	VBZ	B-VP
O	the	the	DT	B-NP
O	Sm	Sm	NN	I-NP
O	domains	domain	NNS	I-NP
O	.	.	.	O

B-GGP	JBP1	JBP1	NN	B-NP
O	produces	produce	VBZ	B-VP
O	sDMAs	sDMA	NNS	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	RG	RG	NN	I-NP
O	domain	domain	NN	I-NP
O	-	-	HYPH	O
O	containing	contain	VBG	B-VP
O	Sm	Sm	NN	B-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	further	further	RB	B-ADVP
O	demonstrate	demonstrate	VBP	B-VP
O	the	the	DT	B-NP
O	existence	existence	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	6S	6S	NN	I-NP
O	complex	complex	NN	I-NP
O	that	that	WDT	B-NP
O	contains	contain	VBZ	B-VP
B-GGP	pICln	pICln	NN	B-NP
O	,	,	,	O
B-GGP	SmD1	SmD1	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	SmD3	SmD3	NN	B-NP
O	but	but	CC	B-NP
O	not	not	RB	I-NP
B-GGP	JBP1	JBP1	NN	B-NP
O	.	.	.	O

B-GGP	SmD3	SmD3	NN	B-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	methylosome	methylosome	NN	I-NP
O	,	,	,	O
O	but	but	CC	B-CONJP
O	not	not	RB	I-CONJP
O	that	that	DT	B-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	6S	6S	NN	I-NP
O	complex	complex	NN	I-NP
O	,	,	,	O
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	transferred	transfer	VBN	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	SMN	SMN	NN	I-NP
O	complex	complex	NN	I-NP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	.	.	.	O

O	Together	Together	RB	B-ADVP
O	with	with	IN	B-PP
O	previous	previous	JJ	B-NP
O	results	result	NNS	I-NP
O	,	,	,	O
O	these	these	DT	B-NP
O	data	datum	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	methylation	methylation	NN	B-NP
O	of	of	IN	B-PP
O	Sm	Sm	NN	B-NP
O	proteins	protein	NNS	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	methylosome	methylosome	NN	I-NP
O	directs	direct	VBZ	B-VP
O	Sm	Sm	NN	B-NP
O	proteins	protein	NNS	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	SMN	SMN	NN	I-NP
O	complex	complex	NN	I-NP
O	for	for	IN	B-PP
O	assembly	assembly	NN	B-NP
O	into	into	IN	B-PP
O	snRNP	snRNP	NN	B-NP
O	core	core	NN	I-NP
O	particles	particle	NNS	I-NP
O	and	and	CC	O
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	methylosome	methylosome	NN	I-NP
O	can	can	MD	B-VP
O	regulate	regulate	VB	I-VP
O	snRNP	snRNP	NN	B-NP
O	assembly	assembly	NN	I-NP
O	.	.	.	O

O	Methyl	Methyl	NN	B-NP
O	CpG	CpG	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	proteins	protein	NNS	B-NP
O	and	and	CC	O
O	transcriptional	transcriptional	JJ	B-NP
O	repression	repression	NN	I-NP
O	.	.	.	O

O	Since	Since	IN	B-PP
O	its	its	PRP$	B-NP
O	discovery	discovery	NN	I-NP
O	,	,	,	O
O	methylation	methylation	NN	B-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	in	in	IN	B-PP
O	mammalian	mammalian	JJ	B-NP
O	cells	cell	NNS	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	correlated	correlate	VBN	I-VP
O	with	with	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	repression	repression	NN	I-NP
O	and	and	CC	B-PP
O	with	with	IN	B-PP
O	specialized	specialize	VBN	B-NP
O	chromatin	chromatin	NN	I-NP
O	structures	structure	NNS	I-NP
O	.	.	.	O

O	Recently	Recently	RB	B-ADVP
O	,	,	,	O
O	considerable	considerable	JJ	B-NP
O	progress	progress	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	reported	report	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	identification	identification	NN	I-NP
O	of	of	IN	B-PP
O	protein	protein	NN	B-NP
O	factors	factor	NNS	I-NP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	highly	highly	RB	I-NP
O	conserved	conserve	VBN	I-NP
O	DNA	DNA	NN	I-NP
O	interaction	interaction	NN	I-NP
O	surface	surface	NN	I-NP
O	,	,	,	O
O	termed	term	VBN	B-VP
O	the	the	DT	B-NP
O	methyl	methyl	NN	I-NP
O	CpG	CpG	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	domain	domain	NN	B-NP
O	or	or	CC	I-NP
O	MBD	MBD	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	subset	subset	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	biochemically	biochemically	RB	I-VP
O	linked	link	VBN	I-VP
O	to	to	TO	B-PP
B-GGP	histone	histone	NN	B-NP
O	deacetylases	deacetylas	NNS	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	a	a	DT	B-NP
O	molecular	molecular	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	functional	functional	JJ	I-NP
O	properties	property	NNS	I-NP
O	of	of	IN	B-PP
O	methylated	methylate	VBN	B-NP
O	DNA	DNA	NN	I-NP
O	.	.	.	O

O	Despite	Despite	IN	B-PP
O	several	several	JJ	B-NP
O	obvious	obvious	JJ	I-NP
O	attractions	attraction	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	connection	connection	NN	I-NP
O	between	between	IN	B-PP
O	MBD	MBD	NN	B-NP
O	proteins	protein	NNS	I-NP
O	and	and	CC	O
B-GGP	histone	histone	NN	B-NP
O	deacetylases	deacetylas	NNS	I-NP
O	fails	fail	VBZ	B-VP
O	to	to	TO	I-VP
O	explain	explain	VB	I-VP
O	all	all	PDT	B-NP
O	the	the	DT	I-NP
O	existing	exist	VBG	I-NP
O	data	datum	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	fact	fact	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	biochemistry	biochemistry	NN	I-NP
O	and	and	CC	I-NP
O	DNA	DNA	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-NP
O	properties	property	NNS	I-NP
O	of	of	IN	B-PP
O	most	most	JJS	B-NP
O	MBD	MBD	NN	I-NP
O	family	family	NN	I-NP
O	members	member	NNS	I-NP
O	have	have	VBP	B-VP
O	not	not	RB	I-VP
O	been	be	VBN	I-VP
O	adequately	adequately	RB	I-VP
O	described	describe	VBN	I-VP
O	and	and	CC	O
O	considerable	considerable	JJ	B-NP
O	evidence	evidence	NN	I-NP
O	exists	exist	VBZ	B-VP
O	for	for	IN	B-PP
O	alternative	alternative	JJ	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	repression	repression	NN	I-NP
O	of	of	IN	B-PP
O	methylated	methylate	VBN	B-NP
O	loci	locus	NNS	I-NP
O	.	.	.	O

O	Null	Null	JJ	B-NP
O	mutations	mutation	NNS	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	generated	generate	VBN	I-VP
O	in	in	IN	B-PP
O	mice	mouse	NNS	B-NP
O	for	for	IN	B-PP
O	several	several	JJ	B-NP
O	MBD	MBD	NN	I-NP
O	family	family	NN	I-NP
O	members	member	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	phenotypes	phenotype	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mutant	mutant	JJ	I-NP
O	animals	animal	NNS	I-NP
O	raise	raise	VBP	B-VP
O	important	important	JJ	B-NP
O	questions	question	NNS	I-NP
O	regarding	regard	VBG	B-VP
O	the	the	DT	B-NP
O	functions	function	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	MBD	MBD	NN	I-NP
O	family	family	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	I	I	PRP	B-NP
O	review	review	VBP	B-VP
O	the	the	DT	B-NP
O	biochemistry	biochemistry	NN	I-NP
O	,	,	,	O
O	DNA	DNA	NN	B-NP
O	-	-	HYPH	B-VP
O	binding	bind	VBG	B-NP
O	properties	property	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	genetics	genetic	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	MBD	MBD	NN	I-NP
O	proteins	protein	NNS	I-NP
O	that	that	WDT	B-NP
O	are	be	VBP	B-VP
O	linked	link	VBN	I-VP
O	to	to	TO	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	repression	repression	NN	I-NP
O	,	,	,	O
O	namely	namely	RB	B-ADVP
O	,	,	,	O
B-GGP	MeCP2	MeCP2	NN	B-NP
O	,	,	,	O
B-GGP	MBD1	MBD1	NN	B-NP
O	,	,	,	O
B-GGP	MBD2	MBD2	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	MBD3	MBD3	NN	B-NP
O	.	.	.	O

O	Several	Several	JJ	B-NP
O	models	model	NNS	I-NP
O	to	to	TO	B-VP
O	account	account	VB	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	functional	functional	JJ	I-NP
O	properties	property	NNS	I-NP
O	of	of	IN	B-PP
O	methylated	methylate	VBN	B-NP
O	DNA	DNA	NN	I-NP
O	are	be	VBP	B-VP
O	presented	present	VBN	I-VP
O	.	.	.	O

O	Molecular	Molecular	JJ	B-NP
O	and	and	CC	I-NP
O	immunohistochemical	immunohistochemical	JJ	I-NP
O	study	study	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	inactivation	inactivation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	p16	p16	NN	I-NP
O	gene	gene	NN	I-NP
O	in	in	IN	B-PP
O	primary	primary	JJ	B-NP
O	hepatocellular	hepatocellular	JJ	I-NP
O	carcinoma	carcinoma	NN	I-NP
O	.	.	.	O

O	OBJECTIVE	OBJECTIVE	NN	B-NP
O	:	:	:	O
O	To	To	TO	B-VP
O	determine	determine	VB	I-VP
O	whether	whether	IN	B-SBAR
B-GGP	p16	p16	NN	B-NP
O	gene	gene	NN	I-NP
O	is	be	VBZ	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	genesis	genesis	NN	I-NP
O	of	of	IN	B-PP
O	primary	primary	JJ	B-NP
O	hepatocellular	hepatocellular	JJ	I-NP
O	carcinoma	carcinoma	NN	I-NP
O	(	(	(	O
O	HCC	HCC	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	METHODS	METHODS	NNS	B-NP
O	:	:	:	O
O	Twenty	Twenty	CD	B-NP
O	-	-	HYPH	I-NP
O	five	five	CD	I-NP
O	HCC	HCC	NN	I-NP
O	tumor	tumor	NN	I-NP
O	samples	sample	NNS	I-NP
O	with	with	IN	B-PP
O	corresponding	correspond	VBG	B-VP
O	non	non	AFX	B-NP
O	-	-	HYPH	I-NP
O	tumor	tumor	NN	I-NP
O	liver	liver	NN	I-NP
O	tissue	tissue	NN	I-NP
O	specimens	specimen	NNS	I-NP
O	were	be	VBD	B-VP
O	examined	examine	VBN	I-VP
O	for	for	IN	B-PP
B-GGP	p16	p16	NN	B-NP
O	gene	gene	NN	I-NP
O	alterations	alteration	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	identification	identification	NN	I-NP
O	of	of	IN	B-PP
O	deletion	deletion	NN	B-NP
O	of	of	IN	B-PP
O	exon	exon	NN	B-NP
O	1	1	CD	I-NP
O	and	and	CC	O
O	exon	exon	NN	B-NP
O	2	2	CD	I-NP
O	in	in	IN	B-PP
B-GGP	p16	p16	NN	B-NP
O	gene	gene	NN	I-NP
O	was	be	VBD	B-VP
O	performed	perform	VBN	I-VP
O	using	use	VBG	B-VP
O	comparative	comparative	JJ	B-NP
O	multiplex	multiplex	JJ	I-NP
O	polymerase	polymerase	NN	I-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	(	(	(	O
O	PCR	PCR	NN	B-NP
O	)	)	)	O
O	analysis	analysis	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	point	point	NN	I-NP
O	mutation	mutation	NN	I-NP
O	of	of	IN	B-PP
O	exon	exon	NN	B-NP
O	2	2	CD	I-NP
O	in	in	IN	B-PP
B-GGP	p16	p16	NN	B-NP
O	gene	gene	NN	I-NP
O	was	be	VBD	B-VP
O	investigated	investigate	VBN	I-VP
O	by	by	IN	B-PP
O	single	single	JJ	B-NP
O	strand	strand	NN	I-NP
O	conformational	conformational	JJ	I-NP
O	polymorphism	polymorphism	NN	I-NP
O	(	(	(	O
O	SSCP	SSCP	NN	B-NP
O	)	)	)	O
O	analysis	analysis	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	status	status	NN	I-NP
O	of	of	IN	B-PP
B-GGP	p16	p16	NN	B-NP
O	gene	gene	NN	I-NP
O	methylation	methylation	NN	I-NP
O	was	be	VBD	B-VP
O	screened	screen	VBN	I-VP
O	using	use	VBG	B-VP
O	a	a	DT	B-NP
O	PCR	PCR	NN	I-NP
O	based	based	JJ	I-NP
O	methylation	methylation	NN	I-NP
O	analysis	analysis	NN	I-NP
O	.	.	.	O

O	35	35	CD	B-NP
O	parafin	parafin	NN	I-NP
O	-	-	HYPH	B-NP
O	embedded	embed	VBN	I-NP
O	specimens	specimen	NNS	I-NP
O	of	of	IN	B-PP
O	HCC	HCC	NN	B-NP
O	with	with	IN	B-PP
O	corresponding	correspond	VBG	B-VP
O	non	non	AFX	B-NP
O	-	-	HYPH	I-NP
O	tumor	tumor	NN	B-NP
O	liver	liver	NN	I-NP
O	tissues	tissue	NNS	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	the	the	DT	B-NP
O	25	25	CD	I-NP
O	cases	case	NNS	I-NP
O	described	describe	VBN	B-VP
O	above	above	RB	B-ADVP
O	for	for	IN	B-PP
O	screening	screen	VBG	B-VP
B-GGP	p16	p16	NN	B-NP
O	gene	gene	NN	I-NP
O	alterations	alteration	NNS	I-NP
O	,	,	,	O
O	were	be	VBD	B-VP
O	investigated	investigate	VBN	I-VP
O	for	for	IN	B-PP
B-GGP	p16	p16	NN	B-NP
O	protein	protein	NN	I-NP
O	expression	expression	NN	I-NP
O	using	use	VBG	B-VP
O	immunohistochemical	immunohistochemical	JJ	B-NP
O	analysis	analysis	NN	I-NP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
O	Among	Among	IN	B-NP
O	25	25	CD	I-NP
O	cases	case	NNS	I-NP
O	,	,	,	O
O	2	2	CD	B-NP
O	homozygous	homozygous	JJ	I-NP
O	deletions	deletion	NNS	I-NP
O	and	and	CC	O
O	1	1	CD	B-NP
O	hemizygous	hemizygous	JJ	I-NP
O	deletion	deletion	NN	I-NP
O	were	be	VBD	B-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	HCC	HCC	NN	B-NP
O	samples	sample	NNS	I-NP
O	.	.	.	O

O	No	No	DT	B-NP
O	point	point	NN	I-NP
O	mutation	mutation	NN	I-NP
O	was	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	remaining	remain	VBG	I-NP
O	22	22	CD	I-NP
O	tumor	tumor	NN	I-NP
O	samples	sample	NNS	I-NP
O	without	without	IN	B-PP
B-GGP	p16	p16	NN	B-NP
O	gene	gene	NN	I-NP
O	deletions	deletion	NNS	I-NP
O	.	.	.	O

O	Hypermethylation	Hypermethylation	NN	B-NP
O	was	be	VBD	B-VP
O	detected	detect	VBN	I-VP
O	in	in	IN	B-PP
O	24	24	CD	B-NP
O	%	%	NN	I-NP
O	(	(	(	O
O	6	6	CD	B-NP
O	/	/	SYM	I-NP
O	25	25	CD	I-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	tumor	tumor	NN	B-NP
O	samples	sample	NNS	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	corresponding	correspond	VBG	I-NP
O	non	non	AFX	I-NP
O	-	-	HYPH	I-NP
O	tumor	tumor	NN	B-NP
O	liver	liver	NN	I-NP
O	tissue	tissue	NN	I-NP
O	specimens	specimen	NNS	I-NP
O	were	be	VBD	B-VP
O	always	always	RB	I-VP
O	unmethylated	unmethylate	VBN	I-VP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
B-GGP	p16	p16	NN	I-NP
O	locus	locus	NN	I-NP
O	.	.	.	O

O	Loss	Loss	NN	B-NP
O	of	of	IN	B-PP
B-GGP	p16	p16	NN	B-NP
O	protein	protein	NN	I-NP
O	expression	expression	NN	I-NP
O	occurred	occur	VBD	B-VP
O	in	in	IN	B-PP
O	16	16	CD	B-NP
O	of	of	IN	B-PP
O	35	35	CD	B-NP
O	(	(	(	O
O	45	45	CD	B-NP
O	.	.	.	O
O	7	7	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	tumor	tumor	NN	B-NP
O	samples	sample	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	all	all	PDT	B-NP
O	the	the	DT	I-NP
O	non	non	AFX	I-NP
O	-	-	HYPH	I-NP
O	tumor	tumor	NN	I-NP
O	liver	liver	NN	I-NP
O	tissue	tissue	NN	I-NP
O	specimens	specimen	NNS	I-NP
O	showed	show	VBD	B-VP
O	positive	positive	JJ	B-NP
B-GGP	p16	p16	NN	I-NP
O	staining	staining	NN	I-NP
O	.	.	.	O

O	For	For	IN	B-PP
O	the	the	DT	B-NP
O	25	25	CD	I-NP
O	cases	case	NNS	I-NP
O	examined	examine	VBN	B-VP
O	for	for	IN	B-PP
B-GGP	p16	p16	NN	B-NP
O	gene	gene	NN	I-NP
O	alterations	alteration	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	loss	loss	NN	I-NP
O	of	of	IN	B-PP
B-GGP	p16	p16	NN	B-NP
O	protein	protein	NN	I-NP
O	expression	expression	NN	I-NP
O	was	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	in	in	IN	B-PP
O	all	all	DT	B-NP
O	tumors	tumor	NNS	I-NP
O	with	with	IN	B-PP
B-GGP	p16	p16	NN	B-NP
O	gene	gene	NN	I-NP
O	alterations	alteration	NNS	I-NP
O	and	and	CC	O
O	also	also	RB	B-ADVP
O	in	in	IN	B-PP
O	3	3	CD	B-NP
O	tumors	tumor	NNS	I-NP
O	without	without	IN	B-PP
B-GGP	p16	p16	NN	B-NP
O	gene	gene	NN	I-NP
O	alterations	alteration	NNS	I-NP
O	.	.	.	O

O	CONCLUSION	CONCLUSION	NN	B-NP
O	:	:	:	O
O	Inactivation	Inactivation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	p16	p16	NN	I-NP
O	gene	gene	NN	I-NP
O	may	may	MD	B-VP
O	play	play	VB	I-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	genesis	genesis	NN	I-NP
O	of	of	IN	B-PP
O	primary	primary	JJ	B-NP
O	hepatocellular	hepatocellular	JJ	I-NP
O	carcinoma	carcinoma	NN	I-NP
O	.	.	.	O

O	[	[	(	O
O	Hypermethylation	Hypermethylation	NN	B-NP
O	of	of	IN	B-PP
O	DAP	DAP	NN	B-NP
O	-	-	HYPH	B-NP
O	kinase	kinase	NN	I-NP
O	gene	gene	NN	I-NP
O	CpG	CpG	NNP	I-NP
O	Island	Island	NNP	I-NP
O	in	in	IN	B-PP
O	malignant	malignant	JJ	B-NP
O	lymphoma	lymphoma	NN	I-NP
O	with	with	IN	B-PP
O	B	B	NN	B-NP
O	-	-	HYPH	B-NP
O	cell	cell	NN	I-NP
O	phenotype	phenotype	NN	I-NP
O	]	]	)	O

O	Death	Death	NN	B-NP
O	-	-	HYPH	B-PP
O	associated	associate	VBN	B-NP
O	protein	protein	NN	I-NP
O	-	-	HYPH	O
O	kinase	kinase	NN	B-NP
O	(	(	(	O
O	DAP	DAP	NN	B-NP
O	-	-	HYPH	B-NP
O	Kinase	Kinase	NN	I-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	pro	pro	AFX	I-NP
O	-	-	HYPH	I-NP
O	apoptotic	apoptotic	JJ	I-NP
O	serine	serine	NN	I-NP
O	/	/	SYM	B-VP
O	threonine	threonine	NN	B-NP
O	kinase	kinase	NN	I-NP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	death	death	NN	I-NP
O	domain	domain	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	apoptosis	apoptosis	NN	B-NP
O	induced	induce	VBN	B-VP
O	by	by	IN	B-PP
B-GGP	interferon	interferon	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	gamma	gamma	SYM	B-NP
O	,	,	,	O
B-GGP	tumor	tumor	NN	B-NP
I-GGP	necrosis	necrosis	NN	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	alpha	alpha	SYM	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	Fas	Fas	NN	B-NP
I-GGP	ligand	ligand	NN	I-NP
O	.	.	.	O

O	Epigenetic	Epigenetic	JJ	B-ADJP
O	down	down	RB	B-ADVP
O	-	-	HYPH	O
O	regulation	regulation	NN	B-NP
O	of	of	IN	B-PP
O	DAP	DAP	NN	B-NP
O	-	-	HYPH	B-NP
O	Kinase	Kinase	NN	I-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	by	by	IN	B-PP
O	hypermethylation	hypermethylation	NN	B-NP
O	of	of	IN	B-PP
O	its	its	PRP$	B-NP
O	promoter	promoter	NN	I-NP
O	region	region	NN	I-NP
O	was	be	VBD	B-VP
O	reported	report	VBN	I-VP
O	in	in	IN	B-PP
O	certain	certain	JJ	B-NP
O	kinds	kind	NNS	I-NP
O	of	of	IN	B-PP
O	malignancies	malignancy	NNS	B-NP
O	.	.	.	O

O	Previous	Previous	JJ	B-NP
O	patho	patho	AFX	I-NP
O	-	-	HYPH	I-NP
O	epidemiological	epidemiological	JJ	I-NP
O	studies	study	NNS	I-NP
O	indicated	indicate	VBD	B-VP
O	that	that	IN	B-SBAR
O	thyroid	thyroid	JJ	B-NP
O	lymphoma	lymphoma	NN	I-NP
O	(	(	(	O
O	TL	TL	NN	B-NP
O	)	)	)	O
O	evolves	evolve	VBZ	B-VP
O	among	among	IN	B-PP
O	active	active	JJ	B-NP
O	lymphoid	lymphoid	JJ	I-NP
O	cells	cell	NNS	I-NP
O	in	in	IN	B-PP
O	chronic	chronic	JJ	B-NP
O	lymphocytic	lymphocytic	JJ	I-NP
O	thyroiditis	thyroiditis	NN	I-NP
O	(	(	(	O
O	CLTH	CLTH	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	With	With	IN	B-PP
O	the	the	DT	B-NP
O	use	use	NN	I-NP
O	of	of	IN	B-PP
O	methylation	methylation	NN	B-NP
O	specific	specific	JJ	I-NP
O	polymerase	polymerase	NN	I-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	,	,	,	O
O	methylation	methylation	NN	B-NP
O	status	status	NN	I-NP
O	of	of	IN	B-PP
O	DAP	DAP	NN	B-NP
O	-	-	HYPH	B-NP
O	Kinase	Kinase	NN	I-NP
O	CpG	CpG	NN	I-NP
O	island	island	NN	I-NP
O	was	be	VBD	B-VP
O	examined	examine	VBN	I-VP
O	in	in	IN	B-PP
O	thyroid	thyroid	JJ	B-NP
O	lesions	lesion	NNS	I-NP
O	of	of	IN	B-PP
O	19	19	CD	B-NP
O	cases	case	NNS	I-NP
O	with	with	IN	B-PP
O	TL	TL	NN	B-NP
O	and	and	CC	O
O	9	9	CD	B-NP
O	with	with	IN	B-PP
O	CLTH	CLTH	NN	B-NP
O	.	.	.	O

O	Frequency	Frequency	NN	B-NP
O	of	of	IN	B-PP
O	methylation	methylation	NN	B-NP
O	was	be	VBD	B-VP
O	higher	high	JJR	B-ADJP
O	in	in	IN	B-PP
O	TL	TL	NN	B-NP
O	cases	case	NNS	I-NP
O	(	(	(	O
O	16	16	CD	B-NP
O	of	of	IN	B-PP
O	19	19	CD	B-NP
O	,	,	,	I-NP
O	84	84	CD	I-NP
O	.	.	.	O
O	2	2	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	than	than	IN	B-PP
O	in	in	IN	B-PP
O	CLTH	CLTH	NN	B-NP
O	cases	case	NNS	I-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	of	of	IN	B-PP
O	9	9	CD	B-NP
O	,	,	,	I-NP
O	22	22	CD	I-NP
O	.	.	.	O
O	2	2	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	(	(	(	O
O	p	p	NN	B-NP
O	<	<	SYM	B-ADJP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	01	01	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	DNA	DNA	NN	B-NP
O	extracted	extract	VBN	B-VP
O	from	from	IN	B-PP
O	peripheral	peripheral	JJ	B-NP
O	blood	blood	NN	I-NP
O	leukocytes	leukocyte	NNS	I-NP
O	from	from	IN	B-PP
O	TL	TL	NN	B-NP
O	and	and	CC	I-NP
O	CLTH	CLTH	NN	I-NP
O	cases	case	NNS	I-NP
O	never	never	RB	B-ADVP
O	showed	show	VBD	B-VP
O	methylation	methylation	NN	B-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	methylation	methylation	NN	I-NP
O	occurred	occur	VBD	B-VP
O	somatically	somatically	RB	B-ADVP
O	in	in	IN	B-PP
O	lesional	lesional	JJ	B-NP
O	lymphocytes	lymphocyte	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	thyroid	thyroid	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	also	also	RB	B-ADVP
O	examined	examine	VBD	B-VP
O	the	the	DT	B-NP
O	methylation	methylation	NN	I-NP
O	status	status	NN	I-NP
O	of	of	IN	B-PP
O	DAP	DAP	NN	B-NP
O	-	-	HYPH	B-NP
O	kinase	kinase	NN	I-NP
O	gene	gene	NN	I-NP
O	in	in	IN	B-PP
O	16	16	CD	B-NP
O	cases	case	NNS	I-NP
O	of	of	IN	B-PP
O	T	T	NN	B-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	malignancies	malignancy	NNS	I-NP
O	including	include	VBG	B-PP
O	eight	eight	CD	B-NP
O	adult	adult	JJ	I-NP
O	T	T	NN	I-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	leukemia	leukemia	NN	I-NP
O	/	/	SYM	B-NP
O	lymphoma	lymphoma	NN	I-NP
O	and	and	CC	O
O	24	24	CD	B-NP
O	NK	NK	NN	I-NP
O	/	/	SYM	B-NP
O	T	T	NN	I-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	,	,	,	O
O	34	34	CD	B-NP
O	B	B	NN	I-NP
O	-	-	HYPH	O
O	cell	cell	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	two	two	CD	B-NP
O	immunophenotypically	immunophenotypically	RB	I-NP
O	undetermined	undetermined	JJ	I-NP
O	lymphomas	lymphoma	NNS	I-NP
O	.	.	.	O

O	Frequency	Frequency	NN	B-NP
O	of	of	IN	B-PP
O	methylation	methylation	NN	B-NP
O	was	be	VBD	B-VP
O	higher	high	JJR	B-ADJP
O	in	in	IN	B-PP
O	B	B	NN	B-NP
O	-	-	HYPH	O
O	cell	cell	NN	B-NP
O	(	(	(	O
O	27	27	CD	B-NP
O	of	of	IN	B-PP
O	34	34	CD	B-NP
O	,	,	,	I-NP
O	79	79	CD	I-NP
O	.	.	.	O
O	4	4	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	than	than	IN	B-PP
O	in	in	IN	B-PP
O	T	T	NN	B-NP
O	-	-	HYPH	B-NP
O	cell	cell	NN	I-NP
O	malignancies	malignancy	NNS	I-NP
O	(	(	(	O
O	eight	eight	CD	B-NP
O	of	of	IN	B-PP
O	16	16	CD	B-NP
O	,	,	,	O
O	50	50	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	(	(	(	O
O	p	p	NN	B-NP
O	<	<	SYM	B-ADJP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	05	05	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	Fifteen	Fifteen	CD	B-NP
O	of	of	IN	B-PP
O	24	24	CD	B-NP
O	(	(	(	O
O	62	62	CD	B-NP
O	.	.	.	O
O	5	5	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	NK	NK	NN	B-NP
O	/	/	SYM	B-NP
O	T	T	NN	I-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	lymphomas	lymphoma	NNS	I-NP
O	showed	show	VBD	B-VP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	.	.	.	O

O	Hematopoietic	Hematopoietic	JJ	B-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	methylated	methylate	VBN	I-NP
O	gene	gene	NN	I-NP
O	were	be	VBD	B-VP
O	resistant	resistant	JJ	B-ADJP
O	to	to	TO	B-PP
O	apoptosis	apoptosis	NN	B-NP
O	.	.	.	O

O	Treatment	Treatment	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cells	cell	NNS	I-NP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	demethylating	demethylate	VBG	I-NP
O	agent	agent	NN	I-NP
O	restored	restore	VBD	B-VP
O	apoptotic	apoptotic	JJ	B-NP
O	cell	cell	NN	I-NP
O	death	death	NN	I-NP
O	in	in	IN	B-PP
O	one	one	CD	B-NP
O	B	B	NN	I-NP
O	-	-	HYPH	B-NP
O	cell	cell	NN	I-NP
O	lymphoma	lymphoma	NN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	with	with	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	results	result	NNS	I-NP
O	suggested	suggest	VBD	B-VP
O	that	that	IN	B-SBAR
O	suppression	suppression	NN	B-NP
O	of	of	IN	B-PP
O	DAP	DAP	NN	B-NP
O	-	-	HYPH	B-NP
O	Kinase	Kinase	NN	I-NP
O	expression	expression	NN	I-NP
O	by	by	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	might	might	MD	B-VP
O	play	play	VB	I-VP
O	a	a	DT	B-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	development	development	NN	I-NP
O	of	of	IN	B-PP
O	B	B	NN	B-NP
O	-	-	HYPH	B-NP
O	cell	cell	NN	I-NP
O	malignancies	malignancy	NNS	I-NP
O	.	.	.	O

O	Asparagine	Asparagine	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	HIF	HIF	NN	I-NP
O	transactivation	transactivation	NN	I-NP
O	domain	domain	NN	I-NP
O	a	a	DT	B-NP
O	hypoxic	hypoxic	JJ	I-NP
O	switch	switch	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	hypoxia	hypoxia	NN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	inducible	inducible	JJ	I-NP
I-GGP	factors	factor	NNS	I-NP
I-GGP	(	(	(	O
I-GGP	HIFs	HIF	NNS	B-NP
I-GGP	)	)	)	O
I-GGP	1alpha	1alpha	NN	B-NP
O	and	and	CC	I-NP
B-GGP	2alpha	2alpha	NN	I-NP
O	are	be	VBP	B-VP
O	key	key	JJ	B-NP
O	mammalian	mammalian	JJ	I-NP
O	transcription	transcription	NN	I-NP
O	factors	factor	NNS	I-NP
O	that	that	WDT	B-NP
O	exhibit	exhibit	VBP	B-VP
O	dramatic	dramatic	JJ	B-NP
O	increases	increase	NNS	I-NP
O	in	in	IN	B-PP
O	both	both	CC	O
O	protein	protein	NN	B-NP
O	stability	stability	NN	I-NP
O	and	and	CC	O
O	intrinsic	intrinsic	JJ	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	potency	potency	NN	I-NP
O	during	during	IN	B-PP
O	low	low	JJ	B-NP
O	-	-	HYPH	I-NP
O	oxygen	oxygen	NN	I-NP
O	stress	stress	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	increased	increase	VBN	I-NP
O	stability	stability	NN	I-NP
O	is	be	VBZ	B-VP
O	due	due	IN	B-PP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	absence	absence	NN	I-NP
O	of	of	IN	B-PP
O	proline	proline	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	in	in	IN	B-PP
O	normoxia	normoxia	NN	B-NP
O	promotes	promote	VBZ	B-VP
O	binding	binding	NN	B-NP
O	of	of	IN	B-PP
O	HIF	HIF	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
B-GGP	von	von	NNP	I-NP
I-GGP	Hippel	Hippel	NNP	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	Lindau	Lindau	NNP	I-NP
O	(	(	(	O
B-GGP	VHL	VHL	NN	B-NP
I-GGP	tumor	tumor	NN	I-NP
I-GGP	suppressor	suppressor	NN	I-NP
O	)	)	)	O
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	ligase	ligase	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	now	now	RB	B-ADVP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	hypoxic	hypoxic	JJ	B-NP
O	induction	induction	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	COOH	COOH	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	transactivation	transactivation	NN	I-NP
O	domain	domain	NN	I-NP
O	(	(	(	O
O	CAD	CAD	NN	B-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	HIF	HIF	NN	B-NP
O	occurs	occur	VBZ	B-VP
O	through	through	IN	B-PP
O	abrogation	abrogation	NN	B-NP
O	of	of	IN	B-PP
O	hydroxylation	hydroxylation	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	asparagine	asparagine	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	CAD	CAD	NN	I-NP
O	.	.	.	O

O	Inhibitors	Inhibitor	NNS	B-NP
O	of	of	IN	B-PP
O	Fe	Fe	NN	B-NP
O	(	(	(	O
O	II	II	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	and	and	CC	I-NP
O	2	2	CD	I-NP
O	-	-	HYPH	I-NP
O	oxoglutarate	oxoglutarate	JJ	I-NP
O	-	-	HYPH	I-NP
O	dependent	dependent	JJ	I-NP
O	dioxygenases	dioxygenas	NNS	I-NP
O	prevented	prevent	VBD	B-VP
O	hydroxylation	hydroxylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Asn	Asn	NN	I-NP
O	,	,	,	O
O	thus	thus	RB	B-ADVP
O	allowing	allow	VBG	B-VP
O	the	the	DT	B-NP
O	CAD	CAD	NN	I-NP
O	to	to	TO	B-VP
O	interact	interact	VB	I-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
B-GGP	p300	p300	NN	I-NP
O	transcription	transcription	NN	I-NP
O	coactivator	coactivator	NN	I-NP
O	.	.	.	O

O	Replacement	Replacement	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	Asn	Asn	NN	I-NP
O	by	by	IN	B-PP
O	Ala	Ala	NN	B-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	constitutive	constitutive	JJ	B-NP
B-GGP	p300	p300	NN	I-NP
O	interaction	interaction	NN	I-NP
O	and	and	CC	O
O	strong	strong	JJ	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	Full	Full	JJ	B-NP
O	induction	induction	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	and	and	CC	O
B-GGP	-	-	HYPH	B-NP
I-GGP	2alpha	2alpha	NN	I-NP
O	,	,	,	O
O	therefore	therefore	RB	B-ADVP
O	,	,	,	O
O	relies	rely	VBZ	B-VP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	abrogation	abrogation	NN	I-NP
O	of	of	IN	B-PP
O	both	both	CC	O
O	Pro	Pro	NN	B-NP
O	and	and	CC	O
O	Asn	Asn	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	during	during	IN	B-PP
O	normoxia	normoxia	NN	B-NP
O	occur	occur	VBP	B-VP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	degradation	degradation	NN	I-NP
O	and	and	CC	I-NP
O	COOH	COOH	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	transactivation	transactivation	NN	I-NP
O	domains	domain	NNS	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	Polymorphism	Polymorphism	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	N	N	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	acetyltransferase	acetyltransferase	NN	B-NP
I-GGP	2	2	CD	I-NP
O	gene	gene	NN	I-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	susceptibility	susceptibility	NN	I-NP
O	risk	risk	NN	I-NP
O	factor	factor	NN	I-NP
O	for	for	IN	B-PP
O	antituberculosis	antituberculosis	NN	B-NP
O	drug	drug	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	hepatitis	hepatitis	NN	I-NP
O	.	.	.	O

O	Antituberculosis	Antituberculosis	NN	B-NP
O	drug	drug	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	hepatitis	hepatitis	NN	I-NP
O	is	be	VBZ	B-VP
O	one	one	CD	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	most	most	RBS	I-NP
O	prevalent	prevalent	JJ	I-NP
O	drug	drug	NN	I-NP
O	-	-	HYPH	B-VP
O	induced	induce	VBN	B-NP
O	liver	liver	NN	I-NP
O	injuries	injury	NNS	I-NP
O	.	.	.	O

O	Isoniazid	Isoniazid	NN	B-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	major	major	JJ	I-NP
O	drug	drug	NN	I-NP
O	incriminated	incriminate	VBN	B-VP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	hepatotoxicity	hepatotoxicity	NN	I-NP
O	.	.	.	O

O	Isoniazid	Isoniazid	NN	B-NP
O	is	be	VBZ	B-VP
O	mainly	mainly	RB	I-VP
O	metabolized	metabolize	VBN	I-VP
O	to	to	TO	B-PP
O	hepatotoxic	hepatotoxic	JJ	B-NP
O	intermediates	intermediate	NNS	I-NP
O	by	by	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	O
O	acetyltransferase	acetyltransferase	NN	B-NP
O	(	(	(	O
O	NAT	NAT	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	association	association	NN	I-NP
O	of	of	IN	B-PP
O	polymorphic	polymorphic	JJ	B-NP
O	NAT	NAT	NN	I-NP
O	acetylator	acetylator	NN	I-NP
O	status	status	NN	I-NP
O	and	and	CC	O
O	antituberculosis	antituberculosis	NN	B-NP
O	drug	drug	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	hepatitis	hepatitis	NN	I-NP
O	is	be	VBZ	B-VP
O	debatable	debatable	JJ	B-ADJP
O	.	.	.	O

O	To	To	TO	B-VP
O	determine	determine	VB	I-VP
O	whether	whether	IN	B-SBAR
O	acetylator	acetylator	NN	B-NP
O	status	status	NN	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	risk	risk	NN	I-NP
O	factor	factor	NN	I-NP
O	for	for	IN	B-PP
O	antituberculosis	antituberculosis	NN	B-NP
O	drug	drug	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	hepatitis	hepatitis	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	genotyped	genotype	VBD	B-VP
B-GGP	NAT2	NAT2	NN	B-NP
O	in	in	IN	B-PP
O	224	224	CD	B-NP
O	incident	incident	JJ	I-NP
O	tuberculosis	tuberculosis	NN	I-NP
O	patients	patient	NNS	I-NP
O	who	who	WP	B-NP
O	received	receive	VBD	B-VP
O	antituberculosis	antituberculosis	NN	B-NP
O	treatment	treatment	NN	I-NP
O	.	.	.	O

O	Antituberculosis	Antituberculosis	NN	B-NP
O	drug	drug	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	hepatitis	hepatitis	NN	I-NP
O	was	be	VBD	B-VP
O	diagnosed	diagnose	VBN	I-VP
O	based	base	VBN	B-PP
O	on	on	IN	B-PP
O	a	a	DT	B-NP
O	positive	positive	JJ	I-NP
O	isoniazid	isoniazid	NN	I-NP
O	rechallenge	rechallenge	NN	I-NP
O	test	test	NN	I-NP
O	and	and	CC	I-NP
O	exclusion	exclusion	NN	I-NP
O	of	of	IN	B-PP
O	viral	viral	JJ	B-NP
O	hepatitis	hepatitis	NN	I-NP
O	.	.	.	O

O	Acetylator	Acetylator	NN	B-NP
O	status	status	NN	I-NP
O	was	be	VBD	B-VP
O	determined	determine	VBN	I-VP
O	by	by	IN	B-PP
O	genotyping	genotype	VBG	B-VP
B-GGP	NAT2	NAT2	NN	B-NP
O	in	in	IN	B-PP
O	patients	patient	NNS	B-NP
O	using	use	VBG	B-VP
O	a	a	DT	B-NP
O	polymerase	polymerase	NN	I-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	with	with	IN	B-PP
O	restriction	restriction	NN	B-NP
O	fragment	fragment	NN	I-NP
O	length	length	NN	I-NP
O	polymorphism	polymorphism	NN	I-NP
O	.	.	.	O

O	Univariate	Univariate	JJ	B-NP
O	analysis	analysis	NN	I-NP
O	and	and	CC	O
O	logistic	logistic	JJ	B-NP
O	regression	regression	NN	I-NP
O	analysis	analysis	NN	I-NP
O	were	be	VBD	B-VP
O	used	use	VBN	I-VP
O	to	to	TO	B-VP
O	evaluate	evaluate	VB	I-VP
O	the	the	DT	B-NP
O	risk	risk	NN	I-NP
O	factors	factor	NNS	I-NP
O	of	of	IN	B-PP
O	isoniazid	isoniazid	NN	B-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	hepatitis	hepatitis	NN	I-NP
O	.	.	.	O

O	Thirty	Thirty	CD	B-NP
O	-	-	HYPH	I-NP
O	three	three	CD	B-NP
O	patients	patient	NNS	I-NP
O	(	(	(	O
O	14	14	CD	B-NP
O	.	.	.	O
O	7	7	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	were	be	VBD	B-VP
O	diagnosed	diagnose	VBN	I-VP
O	with	with	IN	B-PP
O	antituberculosis	antituberculosis	NN	B-NP
O	drug	drug	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	hepatitis	hepatitis	NN	I-NP
O	.	.	.	O

O	Slow	Slow	JJ	B-NP
O	acetylators	acetylator	NNS	I-NP
O	had	have	VBD	B-VP
O	a	a	DT	B-NP
O	higher	high	JJR	I-NP
O	risk	risk	NN	I-NP
O	of	of	IN	B-PP
O	hepatotoxicity	hepatotoxicity	NN	B-NP
O	than	than	IN	B-PP
O	rapid	rapid	JJ	B-NP
O	acetylators	acetylator	NNS	I-NP
O	(	(	(	O
O	26	26	CD	B-NP
O	.	.	.	O
O	4	4	CD	B-NP
O	%	%	NN	I-NP
O	vs	v	NNS	I-NP
O	.	.	.	O
O	11	11	CD	B-NP
O	.	.	.	O
O	1	1	CD	B-NP
O	%	%	NN	I-NP
O	,	,	,	O
O	P	P	NN	B-NP
O	=	=	SYM	B-VP
O	.	.	.	O
O	013	013	''	O
O	)	)	)	O
O	.	.	.	O

O	Among	Among	IN	B-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
O	hepatotoxicity	hepatotoxicity	NN	B-NP
O	,	,	,	O
O	slow	slow	JJ	B-NP
O	acetylators	acetylator	NNS	I-NP
O	had	have	VBD	B-VP
O	significantly	significantly	RB	B-NP
O	higher	high	JJR	I-NP
O	serum	serum	NN	I-NP
O	aminotransferase	aminotransferase	NN	I-NP
O	levels	level	NNS	I-NP
O	than	than	IN	B-PP
O	rapid	rapid	JJ	B-NP
O	acetylators	acetylator	NNS	I-NP
O	.	.	.	O

O	Logistic	Logistic	JJ	B-NP
O	regression	regression	NN	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	slow	slow	JJ	B-NP
O	-	-	HYPH	I-NP
O	acetylator	acetylator	NN	I-NP
O	status	status	NN	I-NP
O	(	(	(	O
O	odds	odd	NNS	B-NP
O	ratio	ratio	NN	I-NP
O	[	[	(	O
O	OR	OR	NN	B-NP
O	]	]	)	O
O	,	,	,	O
O	3	3	CD	B-NP
O	.	.	.	I-NP
O	66	66	CD	I-NP
O	;	;	:	O
O	95	95	CD	B-NP
O	%	%	NN	I-NP
O	CI	CI	NN	I-NP
O	,	,	,	O
O	1	1	CD	B-NP
O	.	.	.	O
O	58	58	CD	B-NP
O	-	-	:	O
O	8	8	CD	B-NP
O	.	.	.	I-NP
O	49	49	CD	I-NP
O	;	;	:	O
O	P	P	NN	B-NP
O	=	=	JJ	I-NP
O	.	.	.	I-NP
O	003	003	CD	I-NP
O	)	)	)	O
O	and	and	CC	O
O	age	age	NN	B-NP
O	(	(	(	O
O	OR	OR	NN	B-NP
O	,	,	,	O
O	1	1	CD	B-NP
O	.	.	.	I-NP
O	09	09	CD	I-NP
O	;	;	:	O
O	95	95	CD	B-NP
O	%	%	NN	I-NP
O	CI	CI	NN	I-NP
O	,	,	,	O
O	1	1	CD	B-NP
O	.	.	.	O
O	04	04	CD	B-NP
O	-	-	HYPH	I-NP
O	1	1	CD	I-NP
O	.	.	.	I-NP
O	14	14	CD	I-NP
O	;	;	:	O
O	P	P	NN	B-NP
O	<	<	SYM	B-NP
O	.	.	.	I-NP
O	001	001	CD	I-NP
O	)	)	)	O
O	were	be	VBD	B-VP
O	the	the	DT	B-NP
O	only	only	JJ	I-NP
O	2	2	CD	I-NP
O	independent	independent	JJ	I-NP
O	risk	risk	NN	I-NP
O	factors	factor	NNS	I-NP
O	for	for	IN	B-PP
O	antituberculosis	antituberculosis	NN	B-NP
O	drug	drug	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	hepatitis	hepatitis	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	conclusion	conclusion	NN	B-NP
O	,	,	,	O
O	slow	slow	JJ	B-NP
O	-	-	HYPH	I-NP
O	acetylator	acetylator	NN	I-NP
O	status	status	NN	I-NP
O	of	of	IN	B-PP
B-GGP	NAT2	NAT2	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	significant	significant	JJ	I-NP
O	susceptibility	susceptibility	NN	I-NP
O	risk	risk	NN	I-NP
O	factor	factor	NN	I-NP
O	for	for	IN	B-PP
O	antituberculosis	antituberculosis	NN	B-NP
O	drug	drug	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	hepatitis	hepatitis	NN	I-NP
O	.	.	.	O

O	Additionally	Additionally	RB	B-ADVP
O	,	,	,	O
O	slow	slow	JJ	B-NP
O	acetylators	acetylator	NNS	I-NP
O	are	be	VBP	B-VP
O	prone	prone	JJ	B-ADJP
O	to	to	TO	B-VP
O	develop	develop	VB	I-VP
O	more	more	RBR	B-NP
O	severe	severe	JJ	I-NP
O	hepatotoxicity	hepatotoxicity	NN	I-NP
O	than	than	IN	B-PP
O	rapid	rapid	JJ	B-NP
O	acetylators	acetylator	NNS	I-NP
O	.	.	.	O

O	Regular	Regular	JJ	B-NP
O	monitoring	monitoring	NN	I-NP
O	of	of	IN	B-PP
O	serum	serum	NN	B-NP
O	aminotransferase	aminotransferase	NN	I-NP
O	levels	level	NNS	I-NP
O	is	be	VBZ	B-VP
O	mandatory	mandatory	JJ	B-ADJP
O	in	in	IN	B-PP
O	patients	patient	NNS	B-NP
O	receiving	receive	VBG	B-VP
O	antituberculosis	antituberculosis	NN	B-NP
O	treatment	treatment	NN	I-NP
O	,	,	,	O
O	especially	especially	RB	B-ADVP
O	in	in	IN	B-PP
O	slow	slow	JJ	B-NP
O	acetylators	acetylator	NNS	I-NP
O	.	.	.	O

O	Reversal	Reversal	NN	B-NP
O	of	of	IN	B-PP
O	tolerance	tolerance	NN	B-NP
O	induced	induce	VBN	B-VP
O	by	by	IN	B-PP
O	transplantation	transplantation	NN	B-NP
O	of	of	IN	B-PP
O	skin	skin	NN	B-NP
O	expressing	express	VBG	B-VP
O	the	the	DT	B-NP
O	immunodominant	immunodominant	JJ	I-NP
O	T	T	NN	I-NP
O	cell	cell	NN	I-NP
O	epitope	epitope	NN	I-NP
O	of	of	IN	B-PP
O	rat	rat	NN	B-NP
B-GGP	type	type	NN	I-NP
I-GGP	II	II	CD	I-NP
I-GGP	collagen	collagen	NN	I-NP
O	entitles	entitle	VBZ	B-VP
O	development	development	NN	B-NP
O	of	of	IN	B-PP
O	collagen	collagen	NN	B-NP
O	-	-	HYPH	O
O	induced	induce	VBN	B-NP
O	arthritis	arthritis	NN	I-NP
O	but	but	CC	B-NP
O	not	not	RB	I-NP
O	graft	graft	NN	B-NP
O	rejection	rejection	NN	I-NP
O	.	.	.	O

O	Collagen	Collagen	NN	B-NP
O	-	-	HYPH	B-PP
O	induced	induce	VBN	B-NP
O	arthritis	arthritis	NN	I-NP
O	(	(	(	O
O	CIA	CIA	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	induced	induce	VBN	I-VP
O	in	in	IN	B-PP
O	H	H	NN	B-NP
O	-	-	HYPH	B-NP
O	2	2	CD	I-NP
O	(	(	(	O
O	q	q	NN	B-NP
O	)	)	)	O
O	mice	mouse	NNS	B-NP
O	after	after	IN	B-PP
O	immunization	immunization	NN	B-NP
O	with	with	IN	B-PP
O	rat	rat	NN	B-NP
B-GGP	type	type	NN	I-NP
I-GGP	II	II	CD	I-NP
I-GGP	collagen	collagen	NN	I-NP
O	(	(	(	O
B-GGP	CII	CII	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	immunodominant	immunodominant	JJ	I-NP
O	T	T	NN	I-NP
O	cell	cell	NN	I-NP
O	epitope	epitope	NN	I-NP
O	on	on	IN	B-PP
O	heterologous	heterologous	JJ	B-NP
B-GGP	CII	CII	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	located	locate	VBN	I-VP
O	to	to	TO	B-PP
B-GGP	CII256	CII256	NN	B-NP
O	-	-	HYPH	B-NP
O	270	270	CD	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	have	have	VBP	B-VP
O	previously	previously	RB	I-VP
O	shown	show	VBN	I-VP
O	that	that	IN	B-SBAR
O	TSC	TSC	NN	B-NP
O	transgenic	transgenic	JJ	I-NP
O	mice	mouse	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	express	express	VBP	B-VP
O	the	the	DT	B-NP
O	heterologous	heterologous	JJ	I-NP
O	epitope	epitope	NN	I-NP
O	in	in	IN	B-PP
O	type	type	NN	B-NP
O	I	I	CD	I-NP
O	collagen	collagen	NN	I-NP
O	(	(	(	O
O	CI	CI	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	e	e	NN	B-NP
O	.	.	.	I-NP
O	g	g	NN	I-NP
O	.	.	.	O

O	in	in	IN	B-PP
O	skin	skin	NN	B-NP
O	,	,	,	O
O	are	be	VBP	B-VP
O	tolerized	tolerize	VBN	I-VP
O	against	against	IN	B-PP
O	rat	rat	NN	B-NP
B-GGP	CII	CII	NN	I-NP
O	and	and	CC	O
O	resistant	resistant	JJ	B-ADJP
O	to	to	TO	B-PP
O	CIA	CIA	NNP	B-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	we	we	PRP	B-NP
O	transplanted	transplant	VBD	B-VP
O	skin	skin	NN	B-NP
O	from	from	IN	B-PP
O	TSC	TSC	NN	B-NP
O	transgenic	transgenic	JJ	I-NP
O	mice	mouse	NNS	I-NP
O	onto	onto	IN	B-PP
O	non	non	AFX	B-NP
O	-	-	HYPH	I-NP
O	transgenic	transgenic	JJ	I-NP
O	CIA	CIA	NNP	I-NP
O	-	-	HYPH	I-NP
O	susceptible	susceptible	JJ	I-NP
O	littermates	littermate	NNS	I-NP
O	to	to	TO	B-VP
O	investigate	investigate	VB	I-VP
O	whether	whether	IN	B-SBAR
O	introduction	introduction	NN	B-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	epitope	epitope	NN	I-NP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	naive	naive	JJ	I-NP
O	immune	immune	JJ	I-NP
O	system	system	NN	I-NP
O	would	would	MD	B-VP
O	lead	lead	VB	I-VP
O	to	to	TO	B-PP
O	T	T	NN	B-NP
O	cell	cell	NN	I-NP
O	priming	priming	NN	I-NP
O	and	and	CC	O
O	graft	graft	NN	B-NP
O	rejection	rejection	NN	I-NP
O	or	or	CC	O
O	instead	instead	RB	B-ADVP
O	to	to	TO	B-PP
O	tolerance	tolerance	NN	B-NP
O	and	and	CC	I-NP
O	arthritis	arthritis	NN	I-NP
O	protection	protection	NN	I-NP
O	.	.	.	O

O	Interestingly	Interestingly	RB	B-ADVP
O	,	,	,	O
O	TSC	TSC	NN	B-NP
O	grafts	graft	NNS	I-NP
O	were	be	VBD	B-VP
O	accepted	accept	VBN	I-VP
O	and	and	CC	O
O	not	not	RB	B-NP
O	even	even	RB	I-NP
O	immunization	immunization	NN	I-NP
O	of	of	IN	B-PP
O	recipient	recipient	JJ	B-NP
O	mice	mouse	NNS	I-NP
O	with	with	IN	B-PP
B-GGP	CII	CII	NN	B-NP
O	in	in	IN	B-PP
O	adjuvant	adjuvant	JJ	B-NP
O	induced	induce	VBN	I-NP
O	graft	graft	NN	I-NP
O	rejection	rejection	NN	I-NP
O	.	.	.	O

O	Instead	Instead	RB	B-ADVP
O	,	,	,	O
O	TSC	TSC	NN	B-NP
O	skin	skin	NN	I-NP
O	recipients	recipient	NNS	I-NP
O	displayed	display	VBD	B-VP
O	a	a	DT	B-NP
O	reduced	reduce	VBN	I-NP
O	T	T	NN	I-NP
O	and	and	CC	I-NP
O	B	B	NN	I-NP
O	cell	cell	NN	I-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
B-GGP	CII	CII	NN	B-NP
O	and	and	CC	O
O	were	be	VBD	B-VP
O	also	also	RB	I-VP
O	protected	protect	VBN	I-VP
O	from	from	IN	B-PP
O	arthritis	arthritis	NN	B-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	additional	additional	JJ	B-NP
O	priming	priming	NN	I-NP
O	could	could	MD	B-VP
O	break	break	VB	I-VP
O	arthritis	arthritis	NN	B-NP
O	protection	protection	NN	I-NP
O	and	and	CC	O
O	was	be	VBD	B-VP
O	accompanied	accompany	VBN	I-VP
O	by	by	IN	B-PP
O	an	an	DT	B-NP
O	increased	increase	VBN	I-NP
O	T	T	NN	I-NP
O	cell	cell	NN	I-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	grafted	grafted	JJ	I-NP
O	epitope	epitope	NN	I-NP
O	.	.	.	O

O	Strikingly	Strikingly	RB	B-ADVP
O	,	,	,	O
O	despite	despite	IN	B-PP
O	the	the	DT	B-NP
O	regained	regain	VBN	I-NP
O	T	T	NN	I-NP
O	cell	cell	NN	I-NP
O	response	response	NN	I-NP
O	,	,	,	O
O	development	development	NN	B-NP
O	of	of	IN	B-PP
O	arthritis	arthritis	NN	B-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	accompanied	accompany	VBN	I-VP
O	by	by	IN	B-PP
O	graft	graft	NN	B-NP
O	rejection	rejection	NN	I-NP
O	,	,	,	O
O	showing	show	VBG	B-VP
O	that	that	IN	B-SBAR
O	these	these	DT	B-NP
O	immune	immune	JJ	I-NP
O	-	-	HYPH	I-NP
O	mediated	mediate	VBN	I-NP
O	inflammatory	inflammatory	JJ	I-NP
O	responses	response	NNS	I-NP
O	involve	involve	VBP	B-VP
O	different	different	JJ	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	.	.	.	O

O	Glucocorticoid	Glucocorticoid	NN	B-NP
O	regulation	regulation	NN	I-NP
O	and	and	CC	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	of	of	IN	B-PP
O	mouse	mouse	NN	B-NP
O	intestinal	intestinal	JJ	I-NP
B-GGP	type	type	NN	I-NP
I-GGP	IIb	IIb	NN	I-NP
I-GGP	Na	Na	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	P	P	NN	I-NP
I-GGP	(	(	(	O
I-GGP	i	i	NN	B-NP
I-GGP	)	)	)	O
I-GGP	cotransporter	cotransporter	NN	B-NP
O	during	during	IN	B-PP
O	ontogeny	ontogeny	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	sought	seek	VBD	B-VP
O	to	to	TO	I-VP
O	characterize	characterize	VB	I-VP
O	expression	expression	NN	B-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	apically	apically	RB	I-NP
O	expressed	express	VBN	I-NP
O	intestinal	intestinal	JJ	I-NP
O	Na	Na	NN	I-NP
O	-	-	HYPH	O
O	P	P	NN	B-NP
O	(	(	(	O
O	i	i	NN	B-NP
O	)	)	)	O
O	cotransporter	cotransporter	NN	B-NP
O	(	(	(	O
B-GGP	Na	Na	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	P	P	NN	B-NP
I-GGP	(	(	(	O
I-GGP	i	i	NN	B-NP
I-GGP	)	)	)	O
I-GGP	-	-	HYPH	B-NP
I-GGP	IIb	IIb	NN	I-NP
O	)	)	)	O
O	during	during	IN	B-PP
O	mouse	mouse	NN	B-NP
O	ontogeny	ontogeny	NN	I-NP
O	and	and	CC	O
O	to	to	TO	B-VP
O	assess	assess	VB	I-VP
O	the	the	DT	B-NP
O	effects	effect	NNS	I-NP
O	of	of	IN	B-PP
O	methylprednisolone	methylprednisolone	NN	B-NP
O	(	(	(	O
O	MP	MP	NN	B-NP
O	)	)	)	O
O	treatment	treatment	NN	B-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	control	control	NN	B-NP
O	mice	mouse	NNS	I-NP
O	,	,	,	O
O	Na	Na	NN	B-NP
O	-	-	HYPH	O
O	P	P	NN	B-NP
O	(	(	(	O
O	i	i	NN	B-NP
O	)	)	)	O
O	uptake	uptake	NN	B-NP
O	by	by	IN	B-PP
O	intestinal	intestinal	JJ	B-NP
O	brush	brush	NN	I-NP
O	-	-	HYPH	B-NP
O	border	border	NN	I-NP
O	membrane	membrane	NN	I-NP
O	vesicles	vesicle	NNS	I-NP
O	was	be	VBD	B-VP
O	highest	high	JJS	B-ADJP
O	at	at	IN	B-PP
O	14	14	CD	B-NP
O	days	day	NNS	I-NP
O	of	of	IN	B-PP
O	age	age	NN	B-NP
O	,	,	,	O
O	lower	low	JJR	B-ADJP
O	at	at	IN	B-PP
O	21	21	CD	B-NP
O	days	day	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	further	further	RBR	B-VP
O	reduced	reduce	VBN	I-VP
O	at	at	IN	B-PP
O	8	8	CD	B-NP
O	wk	wk	NN	I-NP
O	and	and	CC	O
O	8	8	CD	B-NP
O	-	-	HYPH	I-NP
O	9	9	CD	I-NP
O	mo	mo	NN	I-NP
O	of	of	IN	B-PP
O	age	age	NN	B-NP
O	.	.	.	O

B-GGP	Na	Na	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	P	P	NN	B-NP
I-GGP	(	(	(	O
I-GGP	i	i	NN	B-NP
I-GGP	)	)	)	O
I-GGP	-	-	HYPH	B-NP
I-GGP	IIb	IIb	NN	I-NP
O	mRNA	mRNA	NN	I-NP
O	and	and	CC	O
O	immunoreactive	immunoreactive	JJ	B-NP
O	protein	protein	NN	I-NP
O	levels	level	NNS	I-NP
O	in	in	IN	B-PP
O	14	14	CD	B-NP
O	-	-	HYPH	B-NP
O	day	day	NN	I-NP
O	-	-	HYPH	O
O	old	old	JJ	B-NP
O	animals	animal	NNS	I-NP
O	were	be	VBD	B-VP
O	markedly	markedly	RB	B-ADJP
O	higher	high	JJR	I-ADJP
O	than	than	IN	B-PP
O	in	in	IN	B-PP
O	older	old	JJR	B-NP
O	groups	group	NNS	I-NP
O	.	.	.	O

O	MP	MP	NN	B-NP
O	treatment	treatment	NN	I-NP
O	significantly	significantly	RB	B-ADVP
O	decreased	decrease	VBD	B-VP
O	Na	Na	NN	B-NP
O	-	-	HYPH	O
O	P	P	NN	B-NP
O	(	(	(	O
O	i	i	NN	B-NP
O	)	)	)	O
O	uptake	uptake	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Na	Na	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	P	P	NN	B-NP
I-GGP	(	(	(	O
I-GGP	i	i	NN	B-NP
I-GGP	)	)	)	O
I-GGP	-	-	HYPH	B-NP
I-GGP	IIb	IIb	NN	I-NP
O	mRNA	mRNA	NN	I-NP
O	and	and	CC	O
O	protein	protein	NN	B-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	14	14	CD	B-NP
O	-	-	HYPH	I-NP
O	day	day	NN	I-NP
O	-	-	HYPH	O
O	old	old	JJ	B-NP
O	mice	mouse	NNS	I-NP
O	.	.	.	O

O	Additionally	Additionally	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	size	size	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	was	be	VBD	B-VP
O	smaller	small	JJR	B-ADJP
O	in	in	IN	B-PP
O	14	14	CD	B-NP
O	-	-	HYPH	I-NP
O	day	day	NN	I-NP
O	-	-	HYPH	O
O	old	old	JJ	B-NP
O	mice	mouse	NNS	I-NP
O	.	.	.	O

O	Deglycosylation	Deglycosylation	NN	B-NP
O	of	of	IN	B-PP
O	protein	protein	NN	B-NP
O	from	from	IN	B-PP
O	14	14	CD	B-NP
O	-	-	HYPH	I-NP
O	day	day	NN	I-NP
O	-	-	HYPH	O
O	old	old	JJ	B-ADJP
O	and	and	CC	O
O	8	8	CD	B-NP
O	-	-	HYPH	I-NP
O	wk	wk	NN	I-NP
O	-	-	HYPH	I-NP
O	old	old	JJ	I-NP
O	animals	animal	NNS	I-NP
O	with	with	IN	B-PP
O	peptide	peptide	NN	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	glycosidase	glycosidase	NN	I-NP
O	reduced	reduce	VBD	B-VP
O	the	the	DT	B-NP
O	molecular	molecular	JJ	I-NP
O	weight	weight	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	predicted	predict	VBN	I-NP
O	size	size	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	conclude	conclude	VBP	B-VP
O	that	that	IN	B-SBAR
O	intestinal	intestinal	JJ	B-NP
O	Na	Na	NN	I-NP
O	-	-	HYPH	O
O	P	P	NN	B-NP
O	(	(	(	O
O	i	i	NN	B-NP
O	)	)	)	O
O	uptake	uptake	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Na	Na	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	P	P	NN	B-NP
I-GGP	(	(	(	O
I-GGP	i	i	NN	B-NP
I-GGP	)	)	)	O
I-GGP	-	-	HYPH	O
I-GGP	IIb	IIb	NN	B-NP
O	expression	expression	NN	I-NP
O	are	be	VBP	B-VP
O	highest	high	JJS	B-ADJP
O	at	at	IN	B-PP
O	14	14	CD	B-NP
O	days	day	NNS	I-NP
O	and	and	CC	O
O	decrease	decrease	VB	B-VP
O	with	with	IN	B-PP
O	age	age	NN	B-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	MP	MP	NN	B-NP
O	treatment	treatment	NN	I-NP
O	reduced	reduce	VBD	B-VP
O	intestinal	intestinal	JJ	B-NP
O	Na	Na	NN	I-NP
O	-	-	HYPH	O
O	P	P	NN	B-NP
O	(	(	(	O
O	i	i	NN	B-NP
O	)	)	)	O
O	uptake	uptake	NN	B-NP
O	approximately	approximately	RB	B-ADVP
O	threefold	threefold	RB	I-ADVP
O	in	in	IN	B-PP
O	14	14	CD	B-NP
O	-	-	HYPH	I-NP
O	day	day	NN	I-NP
O	-	-	HYPH	O
O	old	old	JJ	B-NP
O	mice	mouse	NNS	I-NP
O	and	and	CC	O
O	this	this	DT	B-NP
O	reduction	reduction	NN	I-NP
O	correlates	correlate	VBZ	B-VP
O	with	with	IN	B-PP
O	reduced	reduce	VBN	B-NP
B-GGP	Na	Na	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	P	P	NN	B-NP
I-GGP	(	(	(	O
I-GGP	i	i	NN	B-NP
I-GGP	)	)	)	O
I-GGP	-	-	HYPH	B-NP
I-GGP	IIb	IIb	NN	I-NP
O	mRNA	mRNA	NN	I-NP
O	and	and	CC	O
O	protein	protein	NN	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	also	also	RB	B-ADVP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	Na	Na	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	P	P	NN	B-NP
I-GGP	(	(	(	O
I-GGP	i	i	NN	B-NP
I-GGP	)	)	)	O
I-GGP	-	-	HYPH	B-NP
I-GGP	IIb	IIb	NN	I-NP
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	glycosylation	glycosylation	NN	B-NP
O	is	be	VBZ	B-VP
O	age	age	NN	B-NP
O	dependent	dependent	JJ	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	von	von	NNP	I-NP
I-GGP	Hippel	Hippel	NNP	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	Lindau	Lindau	NNP	I-NP
I-GGP	tumor	tumor	NN	I-NP
I-GGP	suppressor	suppressor	NN	I-NP
O	protein	protein	NN	I-NP
O	:	:	:	O
O	new	new	JJ	B-NP
O	insights	insight	NNS	I-NP
O	into	into	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	sensing	sensing	NN	I-NP
O	and	and	CC	I-NP
O	cancer	cancer	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	von	von	NNP	I-NP
I-GGP	Hippel	Hippel	NNP	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	Lindau	Lindau	NNP	I-NP
I-GGP	tumor	tumor	NN	I-NP
I-GGP	suppressor	suppressor	NN	I-NP
O	protein	protein	NN	I-NP
O	(	(	(	O
B-GGP	pVHL	pVHL	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	substrate	substrate	NN	I-NP
O	-	-	HYPH	B-NP
O	recognition	recognition	NN	I-NP
O	module	module	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	E3	E3	NN	I-NP
O	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	that	that	WDT	B-NP
O	targets	target	VBZ	B-VP
O	the	the	DT	B-NP
O	alpha	alpha	NN	I-NP
O	subunits	subunit	NNS	I-NP
O	of	of	IN	B-PP
O	hypoxia	hypoxia	NN	B-NP
O	-	-	HYPH	B-NP
O	inducible	inducible	JJ	I-NP
O	factor	factor	NN	I-NP
O	(	(	(	O
O	HIF	HIF	NN	B-NP
O	)	)	)	O
O	for	for	IN	B-PP
O	degradation	degradation	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	I-PP
O	presence	presence	NN	I-PP
O	of	of	IN	I-PP
O	oxygen	oxygen	NN	B-NP
O	.	.	.	O

O	Recognition	Recognition	NN	B-NP
O	of	of	IN	B-PP
O	HIF	HIF	NN	B-NP
O	by	by	IN	B-PP
B-GGP	pVHL	pVHL	NN	B-NP
O	is	be	VBZ	B-VP
O	linked	link	VBN	I-VP
O	to	to	TO	B-PP
O	enzymatic	enzymatic	JJ	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	of	of	IN	B-PP
O	conserved	conserve	VBN	B-NP
O	prolyl	prolyl	JJ	I-NP
O	residues	residue	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	HIF	HIF	NN	I-NP
O	alpha	alpha	NN	I-NP
O	subunits	subunit	NNS	I-NP
O	by	by	IN	B-PP
O	members	member	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	EGLN	EGLN	NN	I-NP
O	family	family	NN	I-NP
O	.	.	.	O

O	Dysregulation	Dysregulation	NN	B-NP
O	of	of	IN	B-PP
O	HIF	HIF	NN	B-NP
O	-	-	HYPH	I-NP
O	target	target	NN	I-NP
O	genes	gene	NNS	I-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
B-GGP	vascular	vascular	JJ	B-NP
I-GGP	endothelial	endothelial	JJ	I-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	and	and	CC	O
B-GGP	transforming	transform	VBG	B-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	alpha	alpha	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	implicated	implicate	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	pathogenesis	pathogenesis	NN	I-NP
O	of	of	IN	B-PP
O	renal	renal	JJ	B-NP
O	cell	cell	NN	I-NP
O	carcinomas	carcinoma	NNS	I-NP
O	and	and	CC	B-PP
O	of	of	IN	B-PP
O	hemangioblastomas	hemangioblastoma	NNS	B-NP
O	,	,	,	O
O	both	both	DT	B-NP
O	of	of	IN	B-PP
O	which	which	WDT	B-NP
O	frequently	frequently	RB	B-ADVP
O	lack	lack	VBP	B-VP
B-GGP	pVHL	pVHL	NN	B-NP
O	function	function	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	roles	role	NNS	I-NP
O	of	of	IN	B-PP
O	supernumerical	supernumerical	JJ	B-NP
O	X	X	NN	I-NP
O	chromosomes	chromosome	NNS	I-NP
O	and	and	CC	O
B-GGP	XIST	XIST	NN	B-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	testicular	testicular	JJ	B-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumors	tumor	NNS	I-NP
O	.	.	.	O

O	PURPOSE	PURPOSE	NN	B-NP
O	:	:	:	O
O	An	An	DT	B-NP
O	overabundance	overabundance	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	chromosomes	chromosome	NNS	I-NP
O	in	in	IN	B-PP
O	testicular	testicular	JJ	B-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumors	tumor	NNS	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	identification	identification	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	candidate	candidate	NN	I-NP
O	testicular	testicular	JJ	I-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumor	tumor	NN	I-NP
O	susceptibility	susceptibility	NN	I-NP
O	gene	gene	NN	I-NP
B-GGP	TGCT1	TGCT1	NN	I-NP
O	on	on	IN	B-PP
O	Xq27	Xq27	NN	B-NP
O	highlight	highlight	VBP	B-VP
O	the	the	DT	B-NP
O	potential	potential	JJ	I-NP
O	involvement	involvement	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	chromosomes	chromosome	NNS	I-NP
O	in	in	IN	B-PP
O	testicular	testicular	JJ	B-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumor	tumor	NN	I-NP
O	pathogenesis	pathogenesis	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	current	current	JJ	I-NP
O	study	study	NN	I-NP
O	was	be	VBD	B-VP
O	designed	design	VBN	I-VP
O	to	to	TO	B-VP
O	shed	shed	VB	I-VP
O	light	light	NN	B-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	question	question	NN	I-NP
O	whether	whether	IN	B-SBAR
O	the	the	DT	B-NP
O	multiple	multiple	JJ	I-NP
O	X	X	NN	I-NP
O	chromosomes	chromosome	NNS	I-NP
O	in	in	IN	B-PP
O	testicular	testicular	JJ	B-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumor	tumor	NN	I-NP
O	are	be	VBP	B-VP
O	active	active	JJ	B-ADJP
O	or	or	CC	I-ADJP
O	inactive	inactive	JJ	I-ADJP
O	through	through	IN	B-PP
O	a	a	DT	B-NP
O	complex	complex	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	chromosomal	chromosomal	JJ	I-NP
O	gain	gain	NN	I-NP
O	and	and	CC	O
B-GGP	XIST	XIST	NN	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	MATERIALS	MATERIALS	NNS	B-NP
O	AND	AND	CC	I-NP
O	METHODS	METHODS	NNS	I-NP
O	:	:	:	O
O	We	We	PRP	B-NP
O	analyzed	analyze	VBD	B-VP
O	4	4	CD	B-NP
O	testicular	testicular	JJ	I-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumor	tumor	NN	I-NP
O	derived	derive	VBN	B-VP
O	cell	cell	NN	B-NP
O	lines	line	NNS	I-NP
O	and	and	CC	O
O	20	20	CD	B-NP
O	primary	primary	JJ	I-NP
O	testicular	testicular	JJ	I-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumor	tumor	NN	I-NP
O	tissues	tissue	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	chromosomes	chromosome	NNS	I-NP
O	was	be	VBD	B-VP
O	determined	determine	VBN	I-VP
O	by	by	IN	B-PP
O	fluorescence	fluorescence	NN	B-NP
O	in	in	FW	B-NP
O	situ	situ	FW	I-NP
O	hybridization	hybridization	NN	I-NP
O	using	use	VBG	B-VP
O	the	the	DT	B-NP
O	X	X	NN	I-NP
O	chromosome	chromosome	NN	I-NP
O	specific	specific	JJ	I-NP
O	probe	probe	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	expression	expression	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	XIST	XIST	NN	B-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	3	3	CD	I-NP
O	X	X	SYM	B-NP
O	-	-	HYPH	I-NP
O	linked	link	VBN	I-NP
O	genes	gene	NNS	I-NP
B-GGP	androgen	androgen	NN	I-NP
I-GGP	receptor	receptor	NN	I-NP
O	(	(	(	O
B-GGP	AR	AR	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	fragile	fragile	JJ	B-NP
O	X	X	NN	I-NP
O	mental	mental	JJ	I-NP
O	retardation	retardation	NN	I-NP
O	(	(	(	O
B-GGP	FMR1	FMR1	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	Glypican	Glypican	JJ	B-NP
I-GGP	3	3	CD	I-NP
O	(	(	(	O
B-GGP	GPC3	GPC3	NN	B-NP
O	)	)	)	O
O	were	be	VBD	B-VP
O	studied	study	VBN	I-VP
O	by	by	IN	B-PP
B-GGP	reverse	reverse	JJ	B-NP
I-GGP	transcriptase	transcriptase	NN	I-NP
O	-	-	HYPH	I-NP
O	polymerase	polymerase	NN	I-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	.	.	.	O

O	Bisulfite	Bisulfite	NN	B-NP
O	genomic	genomic	JJ	I-NP
O	sequencing	sequencing	NN	I-NP
O	was	be	VBD	B-VP
O	used	use	VBN	I-VP
O	to	to	TO	B-VP
O	analyze	analyze	VB	I-VP
O	the	the	DT	B-NP
O	methylation	methylation	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	AR	AR	NN	I-NP
O	,	,	,	I-NP
B-GGP	FMR1	FMR1	NN	I-NP
O	and	and	CC	I-NP
B-GGP	GPC3	GPC3	NN	I-NP
O	genes	gene	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	relative	relative	JJ	I-NP
O	expression	expression	NN	I-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	2	2	CD	I-NP
O	X	X	SYM	I-NP
O	-	-	HYPH	I-NP
O	linked	link	VBN	B-VP
O	proto	proto	AFX	B-NP
O	-	-	HYPH	I-NP
O	oncogenes	oncogene	NNS	I-NP
B-GGP	ARAF1	ARAF1	NN	I-NP
O	and	and	CC	I-NP
B-GGP	ELK1	ELK1	NN	I-NP
O	were	be	VBD	B-VP
O	assayed	assay	VBN	I-VP
O	by	by	IN	B-PP
O	quantitative	quantitative	JJ	B-NP
B-GGP	reverse	reverse	JJ	I-NP
I-GGP	transcriptase	transcriptase	NN	I-NP
O	-	-	HYPH	I-NP
O	polymerase	polymerase	NN	I-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
B-GGP	XIST	XIST	NN	B-NP
O	expression	expression	NN	I-NP
O	was	be	VBD	B-VP
O	common	common	JJ	B-ADJP
O	in	in	IN	B-PP
O	seminomatous	seminomatous	JJ	B-NP
O	testicular	testicular	JJ	I-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumors	tumor	NNS	I-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	of	of	IN	B-PP
O	2	2	CD	B-NP
O	or	or	CC	I-NP
O	100	100	CD	I-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	seminoma	seminoma	NN	B-NP
O	derived	derive	VBN	I-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	and	and	CC	O
O	10	10	CD	B-NP
O	of	of	IN	B-PP
O	12	12	CD	B-NP
O	or	or	CC	I-NP
O	83	83	CD	I-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	seminomatous	seminomatous	JJ	B-NP
O	testicular	testicular	JJ	I-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumor	tumor	NN	I-NP
O	tissues	tissue	NNS	I-NP
O	)	)	)	O
O	but	but	CC	B-PP
O	not	not	RB	B-PP
O	in	in	IN	I-PP
O	nonseminomatous	nonseminomatous	JJ	B-NP
O	testicular	testicular	JJ	I-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumors	tumor	NNS	I-NP
O	(	(	(	O
O	0	0	CD	B-NP
O	of	of	IN	B-PP
O	2	2	CD	B-NP
O	or	or	CC	I-NP
O	0	0	CD	I-NP
O	%	%	NN	I-NP
O	nonseminoma	nonseminoma	NN	I-NP
O	derived	derive	VBN	B-VP
O	cell	cell	NN	B-NP
O	lines	line	NNS	I-NP
O	and	and	CC	O
O	2	2	CD	B-NP
O	of	of	IN	B-PP
O	8	8	CD	B-NP
O	or	or	CC	I-NP
O	25	25	CD	I-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	nonseminomatous	nonseminomatous	JJ	B-NP
O	testicular	testicular	JJ	I-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumor	tumor	NN	I-NP
O	tissues	tissue	NNS	I-NP
O	)	)	)	O
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	X	X	NN	B-NP
O	chromosomal	chromosomal	JJ	I-NP
O	gain	gain	NN	I-NP
O	was	be	VBD	B-VP
O	consistently	consistently	RB	I-VP
O	observed	observe	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	2	2	CD	I-NP
O	types	type	NNS	I-NP
O	of	of	IN	B-PP
O	tumors	tumor	NNS	B-NP
O	.	.	.	O

B-GGP	XIST	XIST	NN	B-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	testicular	testicular	JJ	B-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumors	tumor	NNS	I-NP
O	and	and	CC	O
O	normal	normal	JJ	B-NP
O	testicular	testicular	JJ	I-NP
O	parenchyma	parenchyma	NN	I-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	methylation	methylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	AR	AR	NN	I-NP
O	,	,	,	I-NP
B-GGP	FMR1	FMR1	NN	I-NP
O	or	or	CC	I-NP
B-GGP	GPC3	GPC3	NN	I-NP
O	genes	gene	NNS	I-NP
O	.	.	.	O

O	After	After	IN	B-PP
O	determining	determine	VBG	B-VP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	AR	AR	NN	B-NP
O	,	,	,	I-NP
B-GGP	FMR1	FMR1	NN	I-NP
O	and	and	CC	I-NP
B-GGP	GPC3	GPC3	NN	I-NP
O	in	in	IN	B-PP
O	testicular	testicular	JJ	B-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumor	tumor	NN	I-NP
O	samples	sample	NNS	I-NP
O	we	we	PRP	B-NP
O	concluded	conclude	VBD	B-VP
O	that	that	IN	B-SBAR
O	multiple	multiple	JJ	B-NP
O	X	X	NN	I-NP
O	chromosomes	chromosome	NNS	I-NP
O	in	in	IN	B-PP
O	testicular	testicular	JJ	B-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumors	tumor	NNS	I-NP
O	were	be	VBD	B-VP
O	predominantly	predominantly	RB	I-VP
O	hypomethylated	hypomethylate	VBN	I-VP
O	and	and	CC	O
O	active	active	JJ	B-ADJP
O	regardless	regardless	RB	B-ADVP
O	of	of	IN	B-PP
B-GGP	XIST	XIST	NN	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	biological	biological	JJ	I-NP
O	significance	significance	NN	I-NP
O	of	of	IN	B-PP
O	excess	excess	JJ	B-NP
O	active	active	JJ	I-NP
O	X	X	NN	I-NP
O	chromosomes	chromosome	NNS	I-NP
O	in	in	IN	B-PP
O	testicular	testicular	JJ	B-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumors	tumor	NNS	I-NP
O	was	be	VBD	B-VP
O	suggested	suggest	VBN	I-VP
O	by	by	IN	B-PP
O	enhanced	enhance	VBN	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	2	2	CD	I-NP
O	X	X	SYM	I-NP
O	-	-	HYPH	I-NP
O	linked	link	VBN	I-NP
O	oncogenes	oncogene	NNS	I-NP
B-GGP	ARAF1	ARAF1	NN	I-NP
O	and	and	CC	I-NP
B-GGP	ELK1	ELK1	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	testicular	testicular	JJ	I-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumor	tumor	NN	I-NP
O	derived	derive	VBN	B-VP
O	cell	cell	NN	B-NP
O	lines	line	NNS	I-NP
O	.	.	.	O

O	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	:	:	:	O
O	The	The	DT	B-NP
O	current	current	JJ	I-NP
O	data	datum	NNS	I-NP
O	may	may	MD	B-VP
O	suggest	suggest	VB	I-VP
O	the	the	DT	B-NP
O	potential	potential	JJ	I-NP
O	oncogenic	oncogenic	JJ	I-NP
O	implications	implication	NNS	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	chromosomal	chromosomal	JJ	I-NP
O	gain	gain	NN	I-NP
O	in	in	IN	B-PP
O	testicular	testicular	JJ	B-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	tumors	tumor	NNS	I-NP
O	.	.	.	O

O	Cloning	Cloning	NN	B-NP
O	and	and	CC	I-NP
O	sequence	sequence	NN	I-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	FSH	FSH	NN	B-NP
O	and	and	CC	I-NP
O	LH	LH	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	giant	giant	JJ	I-NP
O	panda	panda	NN	I-NP
O	(	(	(	O
O	Ailuropoda	Ailuropoda	NN	B-NP
O	melanoleuca	melanoleuca	NN	I-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	giant	giant	JJ	I-NP
O	panda	panda	NN	I-NP
O	(	(	(	O
O	Ailuropoda	Ailuropoda	NN	B-NP
O	melanoleuca	melanoleuca	NN	I-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	endangered	endanger	VBN	I-NP
O	species	specie	NNS	I-NP
O	and	and	CC	O
O	indigenous	indigenous	JJ	B-ADJP
O	to	to	TO	B-PP
O	China	China	NNP	B-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	proposed	propose	VBN	I-VP
O	that	that	IN	B-SBAR
O	it	it	PRP	B-NP
O	has	have	VBZ	B-VP
O	a	a	DT	B-NP
O	highly	highly	RB	I-NP
O	specialized	specialize	VBN	I-NP
O	reproductive	reproductive	JJ	I-NP
O	pattern	pattern	NN	I-NP
O	with	with	IN	B-PP
O	low	low	JJ	B-NP
O	fecundity	fecundity	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
O	little	little	JJ	B-NP
O	is	be	VBZ	B-VP
O	known	know	VBN	I-VP
O	about	about	IN	B-PP
O	its	its	PRP$	B-NP
O	basic	basic	JJ	I-NP
O	reproductive	reproductive	JJ	I-NP
O	biology	biology	NN	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	molecular	molecular	JJ	I-NP
O	level	level	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	report	report	NN	I-NP
O	the	the	DT	B-NP
O	genes	gene	NNS	I-NP
O	encoding	encode	VBG	B-VP
B-GGP	gonadotropin	gonadotropin	NN	B-NP
I-GGP	subunits	subunit	NNS	I-NP
I-GGP	alpha	alpha	NN	I-NP
O	,	,	,	O
B-GGP	follicle	follicle	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	stimulating	stimulate	VBG	B-VP
I-GGP	hormone	hormone	NN	B-NP
I-GGP	(	(	(	O
I-GGP	FSH	FSH	NN	B-NP
I-GGP	)	)	)	O
I-GGP	beta	beta	NN	B-NP
O	and	and	CC	O
B-GGP	luteinizing	luteinize	VBG	B-VP
I-GGP	hormone	hormone	NN	B-NP
I-GGP	(	(	(	O
I-GGP	LH	LH	NN	B-NP
I-GGP	)	)	)	O
I-GGP	beta	beta	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	giant	giant	JJ	I-NP
O	panda	panda	NN	I-NP
O	were	be	VBD	B-VP
O	amplified	amplify	VBN	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	time	time	NN	I-NP
O	by	by	IN	B-PP
O	RT	RT	NN	B-NP
O	-	-	HYPH	B-NP
O	PCR	PCR	NN	I-NP
O	from	from	IN	B-PP
O	pituitary	pituitary	JJ	B-NP
O	total	total	JJ	I-NP
O	RNA	RNA	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	were	be	VBD	B-VP
O	cloned	clone	VBN	I-VP
O	,	,	,	O
O	sequenced	sequence	VBN	B-VP
O	and	and	CC	I-VP
O	analyzed	analyze	VBN	I-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	open	open	JJ	I-NP
O	reading	reading	NN	I-NP
O	region	region	NN	I-NP
O	(	(	(	O
O	ORF	ORF	NN	B-NP
O	)	)	)	O
O	of	of	IN	B-PP
B-GGP	gonadotropin	gonadotropin	NN	B-NP
I-GGP	subunits	subunit	NNS	I-NP
I-GGP	alpha	alpha	NN	I-NP
O	,	,	,	O
B-GGP	FSH	FSH	NN	B-NP
I-GGP	beta	beta	NN	I-NP
O	and	and	CC	O
B-GGP	LH	LH	NN	B-NP
I-GGP	beta	beta	NN	I-NP
O	are	be	VBP	B-VP
O	363	363	CD	B-NP
O	,	,	,	I-NP
O	390	390	CD	I-NP
O	and	and	CC	I-NP
O	426	426	CD	I-NP
O	bp	bp	NN	I-NP
O	long	long	RB	B-ADVP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	They	They	PRP	B-NP
O	displayed	display	VBD	B-VP
O	a	a	DT	B-NP
O	reasonably	reasonably	RB	I-NP
O	high	high	JJ	I-NP
O	degree	degree	NN	I-NP
O	(	(	(	O
O	74	74	CD	B-NP
O	-	-	HYPH	I-NP
O	94	94	CD	I-NP
O	,	,	,	I-NP
O	85	85	CD	I-NP
O	-	-	HYPH	I-NP
O	93	93	CD	I-NP
O	,	,	,	I-NP
O	75	75	CD	I-NP
O	-	-	HYPH	I-NP
O	91	91	CD	I-NP
O	%	%	NN	I-NP
O	,	,	,	O
O	for	for	IN	B-PP
O	alpha	alpha	NN	B-NP
O	,	,	,	O
B-GGP	FSH	FSH	NN	B-NP
I-GGP	beta	beta	NN	I-NP
O	and	and	CC	O
B-GGP	LH	LH	NN	B-NP
I-GGP	beta	beta	NN	I-NP
O	subunits	subunit	NNS	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	)	)	)	O
O	of	of	IN	B-PP
O	identity	identity	NN	B-NP
O	when	when	WRB	B-ADVP
O	deduced	deduce	VBN	B-VP
O	amino	amino	JJ	B-NP
O	acids	acid	NNS	I-NP
O	were	be	VBD	B-VP
O	compared	compare	VBN	I-VP
O	with	with	IN	B-PP
O	homologous	homologous	JJ	B-NP
O	sequences	sequence	NNS	I-NP
O	from	from	IN	B-PP
O	partial	partial	JJ	B-NP
O	available	available	JJ	I-NP
O	mammals	mammal	NNS	I-NP
O	including	include	VBG	B-PP
O	human	human	JJ	B-NP
O	,	,	,	I-NP
O	cattle	cattle	NNS	I-NP
O	,	,	,	O
O	sheep	sheep	NN	B-NP
O	,	,	,	O
O	pig	pig	NN	B-NP
O	,	,	,	O
O	rat	rat	NN	B-NP
O	,	,	,	O
O	mouse	mouse	NN	B-NP
O	.	.	.	O

O	Three	Three	CD	B-NP
O	distinct	distinct	JJ	I-NP
O	differences	difference	NNS	I-NP
O	were	be	VBD	B-VP
O	found	find	VBN	I-VP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	site	site	NN	I-NP
O	of	of	IN	B-PP
O	59	59	CD	B-NP
O	aa	aa	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	alpha	alpha	NN	I-NP
O	subunit	subunit	NN	I-NP
O	and	and	CC	O
O	55	55	CD	B-NP
O	aa	aa	NN	I-NP
O	,	,	,	O
O	68	68	CD	B-NP
O	aa	aa	NN	I-NP
O	of	of	IN	B-PP
B-GGP	FSH	FSH	NN	B-NP
I-GGP	beta	beta	NN	I-NP
O	subunit	subunit	NN	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	results	result	NNS	I-NP
O	provide	provide	VBP	B-VP
O	an	an	DT	B-NP
O	insight	insight	NN	I-NP
O	into	into	IN	B-PP
O	understanding	understand	VBG	B-VP
O	the	the	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	of	of	IN	B-PP
O	reproduction	reproduction	NN	B-NP
O	regulation	regulation	NN	I-NP
O	and	and	CC	O
O	genetic	genetic	JJ	B-NP
O	characteristics	characteristic	NNS	I-NP
O	of	of	IN	B-PP
O	giant	giant	JJ	B-NP
O	panda	panda	NN	I-NP
O	which	which	WDT	B-NP
O	will	will	MD	B-VP
O	make	make	VB	I-VP
O	an	an	DT	B-NP
O	actual	actual	JJ	I-NP
O	contribution	contribution	NN	I-NP
O	to	to	TO	B-PP
O	its	its	PRP$	B-NP
O	conservation	conservation	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	they	they	PRP	B-NP
O	lay	lie	VBD	B-VP
O	a	a	DT	B-NP
O	foundation	foundation	NN	I-NP
O	for	for	IN	B-PP
O	a	a	DT	B-NP
O	further	further	JJ	I-NP
O	study	study	NN	I-NP
O	towards	towards	IN	B-PP
O	producing	produce	VBG	B-VP
O	recombinant	recombinant	JJ	B-NP
O	panda	panda	NN	I-NP
O	FSH	FSH	NN	I-NP
O	and	and	CC	I-NP
O	LH	LH	NN	I-NP
O	which	which	WDT	B-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	used	use	VBN	I-VP
O	in	in	IN	B-PP
O	artificial	artificial	JJ	B-NP
O	breeding	breeding	NN	I-NP
O	aimed	aim	VBN	B-VP
O	to	to	TO	I-VP
O	increase	increase	VB	I-VP
O	its	its	PRP$	B-NP
O	captive	captive	JJ	I-NP
O	reproductive	reproductive	JJ	I-NP
O	efficiency	efficiency	NN	I-NP
O	.	.	.	O

O	Erasure	Erasure	NN	B-NP
O	of	of	IN	B-PP
O	methylation	methylation	NN	B-NP
O	imprinting	imprinting	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Igf2r	Igf2r	NN	B-NP
O	during	during	IN	B-PP
O	mouse	mouse	NN	B-NP
O	primordial	primordial	JJ	I-NP
O	germ	germ	NN	I-NP
O	-	-	HYPH	B-NP
O	cell	cell	NN	I-NP
O	development	development	NN	I-NP
O	.	.	.	O

O	During	During	IN	B-PP
O	germ	germ	NN	B-NP
O	cell	cell	NN	I-NP
O	differentiation	differentiation	NN	I-NP
O	in	in	IN	B-PP
O	mice	mouse	NNS	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	genome	genome	NN	I-NP
O	undergoes	undergo	VBZ	B-VP
O	specific	specific	JJ	B-NP
O	epigenetic	epigenetic	JJ	I-NP
O	modifications	modification	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	include	include	VBP	B-VP
O	demethylation	demethylation	NN	B-NP
O	of	of	IN	B-PP
O	imprinted	imprinted	JJ	B-NP
O	genes	gene	NNS	I-NP
O	and	and	CC	O
O	subsequent	subsequent	JJ	B-NP
O	establishment	establishment	NN	I-NP
O	of	of	IN	B-PP
O	parental	parental	JJ	B-NP
O	allele	allele	NN	I-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	methylation	methylation	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	mouse	mouse	NN	I-NP
B-GGP	Igf2r	Igf2r	NN	I-NP
O	gene	gene	NN	I-NP
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	imprinted	imprinted	JJ	I-NP
O	gene	gene	NN	I-NP
O	that	that	WDT	B-NP
O	shows	show	VBZ	B-VP
O	maternal	maternal	JJ	B-NP
O	-	-	HYPH	I-NP
O	specific	specific	JJ	I-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	Maternal	Maternal	JJ	B-NP
O	-	-	HYPH	I-NP
O	specific	specific	JJ	I-NP
O	methylation	methylation	NN	I-NP
O	of	of	IN	B-PP
O	differentially	differentially	RB	B-NP
O	methylated	methylate	VBN	I-NP
O	region	region	NN	I-NP
O	2	2	CD	I-NP
O	(	(	(	O
O	DMR2	DMR2	NN	B-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	gene	gene	NN	I-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	necessary	necessary	JJ	B-ADJP
O	for	for	IN	B-PP
O	its	its	PRP$	B-NP
O	maternal	maternal	JJ	I-NP
O	-	-	HYPH	I-NP
O	specific	specific	JJ	I-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	Before	Before	IN	B-PP
O	the	the	DT	B-NP
O	allele	allele	NN	I-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	methylation	methylation	NN	I-NP
O	is	be	VBZ	B-VP
O	established	establish	VBN	I-VP
O	,	,	,	O
O	DMR2	DMR2	NN	B-NP
O	is	be	VBZ	B-VP
O	demethylated	demethylate	VBN	I-VP
O	in	in	IN	B-PP
O	both	both	CC	B-NP
O	male	male	JJ	I-NP
O	and	and	CC	I-NP
O	female	female	JJ	I-NP
O	primordial	primordial	JJ	I-NP
O	germ	germ	NN	I-NP
O	cells	cell	NNS	I-NP
O	(	(	(	O
O	PGCs	PGC	NNS	B-NP
O	)	)	)	O
O	by	by	IN	B-PP
O	13	13	CD	B-NP
O	.	.	.	O
O	5	5	CD	B-NP
O	days	day	NNS	I-NP
O	post	post	IN	B-PP
O	coitum	coitum	NN	B-NP
O	(	(	(	O
O	dpc	dpc	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	demethylation	demethylation	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	region	region	NN	I-NP
O	occurs	occur	VBZ	B-VP
O	earlier	earlier	RBR	B-ADVP
O	in	in	IN	B-PP
O	PGC	PGC	NN	B-NP
O	development	development	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	timing	timing	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	demethylation	demethylation	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	,	,	,	O
O	however	however	RB	B-ADVP
O	,	,	,	O
O	unknown	unknown	JJ	B-ADJP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	attempted	attempt	VBD	B-VP
O	to	to	TO	I-VP
O	determine	determine	VB	I-VP
O	the	the	DT	B-NP
O	timing	timing	NN	I-NP
O	of	of	IN	B-PP
O	methylation	methylation	NN	B-NP
O	erasure	erasure	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Igf2r	Igf2r	NN	B-NP
O	DMR2	DMR2	NN	I-NP
O	in	in	IN	B-PP
O	developing	develop	VBG	B-NP
O	PGCs	PGC	NNS	I-NP
O	,	,	,	O
O	using	use	VBG	B-VP
O	transgenic	transgenic	JJ	B-NP
O	mice	mouse	NNS	I-NP
O	expressing	express	VBG	B-VP
B-GGP	green	green	JJ	B-NP
I-GGP	fluorescent	fluorescent	JJ	I-NP
I-GGP	protein	protein	NN	I-NP
O	specifically	specifically	RB	B-ADVP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	germ	germ	NN	I-NP
O	line	line	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	purified	purify	VBD	B-VP
O	migrating	migrate	VBG	B-VP
O	PGCs	PGC	NNS	B-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	transgenic	transgenic	JJ	I-NP
O	mice	mouse	NNS	I-NP
O	and	and	CC	O
O	examined	examine	VBD	B-VP
O	the	the	DT	B-NP
O	methylation	methylation	NN	I-NP
O	status	status	NN	I-NP
O	of	of	IN	B-PP
O	DMR2	DMR2	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	some	some	DT	B-NP
O	CpG	CpG	NN	I-NP
O	sites	site	NNS	I-NP
O	within	within	IN	B-PP
O	DMR2	DMR2	NN	B-NP
O	start	start	NN	I-NP
O	demethylation	demethylation	NN	I-NP
O	at	at	IN	B-PP
O	9	9	CD	B-NP
O	.	.	.	O
O	5	5	CD	B-NP
O	dpc	dpc	NN	I-NP
O	in	in	IN	B-PP
O	some	some	DT	B-NP
O	migrating	migrating	JJ	I-NP
O	PGCs	PGC	NNS	I-NP
O	,	,	,	O
O	before	before	IN	B-PP
O	the	the	DT	B-NP
O	cells	cell	NNS	I-NP
O	colonize	colonize	VBP	B-VP
O	genital	genital	JJ	B-NP
O	ridges	ridge	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	progression	progression	NN	I-NP
O	of	of	IN	B-PP
O	demethylation	demethylation	NN	B-NP
O	is	be	VBZ	B-VP
O	rapid	rapid	JJ	B-ADJP
O	after	after	IN	B-PP
O	colonization	colonization	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	genital	genital	JJ	I-NP
O	ridges	ridge	NNS	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	examine	examine	VB	I-VP
O	whether	whether	IN	B-SBAR
O	the	the	DT	B-NP
O	gonadal	gonadal	JJ	I-NP
O	environment	environment	NN	I-NP
O	is	be	VBZ	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	demethylation	demethylation	NN	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	analyzed	analyze	VBD	B-VP
O	the	the	DT	B-NP
O	methylation	methylation	NN	I-NP
O	of	of	IN	B-PP
O	DMR2	DMR2	NN	B-NP
O	after	after	IN	B-PP
O	culturing	culture	VBG	B-VP
O	migrating	migrate	VBG	B-NP
O	PGCs	PGC	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	absence	absence	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	gonadal	gonadal	JJ	I-NP
O	environment	environment	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	culture	culture	NN	I-NP
O	experiments	experiment	NNS	I-NP
O	support	support	VBP	B-VP
O	the	the	DT	B-NP
O	idea	idea	NN	I-NP
O	that	that	IN	B-SBAR
O	a	a	DT	B-NP
O	gonadal	gonadal	JJ	I-NP
O	environment	environment	NN	I-NP
O	is	be	VBZ	B-VP
O	not	not	RB	I-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	demethylation	demethylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	region	region	NN	I-NP
O	in	in	IN	B-PP
O	at	at	IN	B-ADVP
O	least	least	JJS	I-ADVP
O	a	a	DT	B-NP
O	fraction	fraction	NN	I-NP
O	of	of	IN	B-PP
O	PGCs	PGC	NNS	B-NP
O	.	.	.	O

O	Inhibition	Inhibition	NN	B-NP
O	of	of	IN	B-PP
O	complex	complex	JJ	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	increases	increase	VBZ	B-VP
O	the	the	DT	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PrPsc	PrPsc	NN	B-NP
O	.	.	.	O

O	N	N	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-VP
O	glycans	glycan	NNS	B-NP
O	with	with	IN	B-PP
O	complex	complex	JJ	B-NP
O	structure	structure	NN	I-NP
O	have	have	VBP	B-VP
O	a	a	DT	B-NP
O	major	major	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	biological	biological	JJ	I-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	wide	wide	JJ	I-NP
O	variety	variety	NN	I-NP
O	of	of	IN	B-PP
O	cell	cell	NN	B-NP
O	surface	surface	NN	I-NP
O	and	and	CC	O
O	secreted	secrete	VBN	B-NP
O	glycoproteins	glycoprotein	NNS	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	geldanamycin	geldanamycin	NN	B-NP
O	,	,	,	O
O	an	an	DT	B-NP
O	inhibitor	inhibitor	NN	I-NP
O	of	of	IN	B-PP
O	Hsp90	Hsp90	NN	B-NP
O	,	,	,	O
O	interferes	interfere	VBZ	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	complex	complex	JJ	B-NP
O	glycosylated	glycosylate	VBN	I-NP
O	mammalian	mammalian	JJ	I-NP
B-GGP	prion	prion	NN	I-NP
I-GGP	protein	protein	NN	I-NP
O	(	(	(	O
B-GGP	PrPC	PrPC	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Similarly	Similarly	RB	B-ADVP
O	to	to	TO	B-PP
O	inhibitors	inhibitor	NNS	B-NP
O	of	of	IN	B-PP
O	alpha	alpha	SYM	B-NP
O	-	-	HYPH	B-VP
O	mannosidases	mannosidas	NNS	B-NP
O	,	,	,	O
O	geldanamycin	geldanamycin	NN	B-NP
O	stabilized	stabilize	VBD	B-VP
O	a	a	DT	B-NP
O	high	high	JJ	I-NP
O	mannose	mannose	NN	I-NP
B-GGP	PrPC	PrPC	NN	I-NP
O	glycoform	glycoform	NN	I-NP
O	and	and	CC	O
O	prevented	prevent	VBD	B-VP
O	the	the	DT	B-NP
O	subsequent	subsequent	JJ	I-NP
O	processing	processing	NN	I-NP
O	into	into	IN	B-PP
O	complex	complex	JJ	B-NP
O	structures	structure	NNS	I-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	a	a	DT	B-NP
B-GGP	PrP	PrP	NN	I-NP
O	/	/	SYM	O
B-GGP	Grp94	Grp94	NN	B-NP
O	complex	complex	NN	I-NP
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	isolated	isolate	VBN	I-VP
O	from	from	IN	B-PP
O	geldanamycin	geldanamycin	NN	B-NP
O	-	-	HYPH	B-NP
O	treated	treat	VBN	I-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
B-GGP	Grp94	Grp94	NN	B-NP
O	might	might	MD	B-VP
O	play	play	VB	I-VP
O	a	a	DT	B-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	processing	processing	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PrPC	PrPC	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	endoplasmic	endoplasmic	JJ	I-NP
O	reticulum	reticulum	NN	I-NP
O	.	.	.	O

O	Inhibition	Inhibition	NN	B-NP
O	of	of	IN	B-PP
O	complex	complex	JJ	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	interfere	interfere	VB	I-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	glycosylphosphatidylinositol	glycosylphosphatidylinositol	NN	I-NP
O	(	(	(	O
O	GPI	GPI	NN	B-NP
O	)	)	)	O
O	anchor	anchor	NN	B-NP
O	attachment	attachment	NN	I-NP
O	and	and	CC	O
O	cellular	cellular	JJ	B-NP
O	trafficking	trafficking	NN	I-NP
O	of	of	IN	B-PP
O	high	high	JJ	B-NP
O	mannose	mannose	NN	I-NP
B-GGP	PrPC	PrPC	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	outer	outer	JJ	I-NP
O	leaflet	leaflet	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	plasma	plasma	NN	I-NP
O	membrane	membrane	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	scrapie	scrapie	NN	B-NP
O	-	-	HYPH	B-NP
O	infected	infect	VBN	I-NP
O	neuroblastoma	neuroblastoma	NN	I-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	however	however	RB	B-ADVP
O	,	,	,	O
O	high	high	JJ	B-NP
O	mannose	mannose	NN	I-NP
B-GGP	PrPC	PrPC	NN	I-NP
O	glycoforms	glycoform	NNS	I-NP
O	were	be	VBD	B-VP
O	preferred	prefer	VBN	I-VP
O	substrates	substrate	NNS	B-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PrP	PrP	NN	B-NP
O	-	-	HYPH	O
O	scrapie	scrapie	NN	B-NP
O	(	(	(	O
B-GGP	PrPSc	PrPSc	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	study	study	NN	I-NP
O	reveals	reveal	VBZ	B-VP
O	that	that	IN	B-SBAR
O	complex	complex	JJ	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	is	be	VBZ	B-VP
O	dispensable	dispensable	JJ	B-ADJP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	cellular	cellular	JJ	I-NP
O	trafficking	trafficking	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PrPC	PrPC	NN	B-NP
O	,	,	,	O
O	but	but	CC	O
O	modulates	modulate	VBZ	B-VP
O	the	the	DT	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PrPSc	PrPSc	NN	B-NP
O	.	.	.	O

O	Chromatin	Chromatin	NN	B-NP
O	-	-	HYPH	I-NP
O	dependent	dependent	JJ	I-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	MMTV	MMTV	NN	I-NP
O	promoter	promoter	NN	I-NP
O	by	by	IN	B-PP
O	cAMP	cAMP	NN	B-NP
O	signaling	signaling	NN	I-NP
O	is	be	VBZ	B-VP
O	mediated	mediate	VBN	I-VP
O	through	through	IN	B-PP
O	distinct	distinct	JJ	B-NP
O	pathways	pathway	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	nucleoprotein	nucleoprotein	NN	I-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mouse	mouse	NN	I-NP
O	mammary	mammary	JJ	I-NP
O	tumor	tumor	NN	I-NP
O	virus	virus	NN	I-NP
O	(	(	(	O
O	MMTV	MMTV	NN	B-NP
O	)	)	)	O
O	promoter	promoter	NN	B-NP
O	defines	define	VBZ	B-VP
O	its	its	PRP$	B-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
O	cAMP	cAMP	NN	B-NP
O	signaling	signaling	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	stably	stably	RB	I-NP
O	replicating	replicate	VBG	I-NP
O	MMTV	MMTV	NN	I-NP
O	template	template	NN	I-NP
O	in	in	IN	B-PP
O	highly	highly	RB	B-NP
O	organized	organize	VBN	I-NP
O	chromatin	chromatin	NN	I-NP
O	is	be	VBZ	B-VP
O	repressed	repress	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	cAMP	cAMP	NN	B-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	a	a	DT	B-NP
O	transiently	transiently	RB	I-NP
O	transfected	transfecte	VBN	I-NP
O	template	template	NN	I-NP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	disorganized	disorganized	JJ	I-NP
O	structure	structure	NN	I-NP
O	is	be	VBZ	B-VP
O	activated	activate	VBN	I-VP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	investigate	investigate	VBP	B-VP
O	the	the	DT	B-NP
O	nature	nature	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cAMP	cAMP	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	signal	signal	NN	I-NP
O	(	(	(	I-NP
O	s	s	NNS	I-NP
O	)	)	)	O
O	by	by	IN	B-PP
O	which	which	WDT	B-NP
O	these	these	DT	B-NP
O	opposing	oppose	VBG	I-NP
O	responses	response	NNS	I-NP
O	occur	occur	VBP	B-VP
O	to	to	TO	I-VP
O	gain	gain	VB	I-VP
O	insight	insight	NN	B-NP
O	into	into	IN	B-PP
O	their	their	PRP$	B-NP
O	mechanism	mechanism	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	changes	change	NNS	I-NP
O	observed	observe	VBN	B-VP
O	at	at	IN	B-PP
O	both	both	DT	B-NP
O	templates	template	NNS	I-NP
O	are	be	VBP	B-VP
O	mediated	mediate	VBN	I-VP
O	through	through	IN	B-PP
O	cAMP	cAMP	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	protein	protein	NN	I-NP
O	kinase	kinase	NN	I-NP
O	A	A	NN	I-NP
O	(	(	(	O
O	PKA	PKA	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	MMTV	MMTV	NN	I-NP
O	promoter	promoter	NN	I-NP
O	lacks	lack	VBZ	B-VP
O	a	a	DT	B-NP
O	consensus	consensus	NN	I-NP
O	cAMP	cAMP	NN	I-NP
O	response	response	NN	I-NP
O	element	element	NN	I-NP
O	(	(	(	O
O	CRE	CRE	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	neither	neither	DT	B-NP
O	template	template	NN	I-NP
O	requires	require	VBZ	B-VP
O	cAMP	cAMP	NN	B-NP
O	response	response	NN	I-NP
O	element	element	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	protein	protein	NN	B-NP
O	(	(	(	O
O	CREB	CREB	NN	B-NP
O	)	)	)	O
O	to	to	TO	B-VP
O	elicit	elicit	VB	I-VP
O	a	a	DT	B-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
O	cAMP	cAMP	NN	B-NP
O	signaling	signaling	NN	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	responses	response	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	templates	template	NNS	I-NP
O	differ	differ	VBP	B-VP
O	mechanistically	mechanistically	RB	B-ADVP
O	in	in	IN	B-PP
O	that	that	IN	B-NP
O	the	the	DT	B-NP
O	CREB	CREB	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	protein	protein	NN	B-NP
B-GGP	p300	p300	NN	I-NP
O	potentiates	potentiate	VBZ	B-VP
O	activation	activation	NN	B-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	transient	transient	JJ	I-NP
O	template	template	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	manner	manner	NN	I-NP
O	dependent	dependent	JJ	B-ADJP
O	on	on	IN	B-PP
O	its	its	PRP$	B-NP
O	Cys	Cys	NN	I-NP
O	/	/	SYM	I-NP
O	His	His	NN	I-NP
O	-	-	HYPH	I-NP
O	rich	rich	JJ	I-NP
O	region	region	NN	I-NP
O	3	3	CD	I-NP
O	,	,	,	O
O	but	but	CC	O
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	appear	appear	VB	I-VP
O	to	to	TO	I-VP
O	affect	affect	VB	I-VP
O	the	the	DT	B-NP
O	repression	repression	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	replicating	replicate	VBG	I-NP
O	chromatin	chromatin	NN	I-NP
O	template	template	NN	I-NP
O	.	.	.	O

O	Chromatin	Chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	assays	assay	NNS	I-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	cAMP	cAMP	NN	B-NP
O	treatment	treatment	NN	I-NP
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
O	acetylation	acetylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	in	in	IN	B-PP
O	multiple	multiple	JJ	B-NP
O	modifications	modification	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	at	at	IN	B-PP
O	specific	specific	JJ	B-NP
O	nucleosomes	nucleosome	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	promoter	promoter	NN	I-NP
O	region	region	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	stable	stable	JJ	I-NP
O	MMTV	MMTV	NN	I-NP
O	template	template	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	findings	finding	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	novel	novel	JJ	B-NP
O	CREB	CREB	NN	I-NP
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	,	,	,	I-NP
O	chromatin	chromatin	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	pathways	pathway	NNS	I-NP
O	for	for	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	regulation	regulation	NN	I-NP
O	by	by	IN	B-PP
O	cAMP	cAMP	NN	B-NP
O	.	.	.	O

O	Identification	Identification	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ZPC	ZPC	NN	I-NP
O	oligosaccharide	oligosaccharide	NN	I-NP
O	ligand	ligand	NN	I-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	sperm	sperm	NN	B-NP
O	binding	binding	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	glycan	glycan	NN	I-NP
O	structures	structure	NNS	I-NP
O	of	of	IN	B-PP
O	Xenopus	Xenopus	NNP	B-NP
O	laevis	laevis	NNP	I-NP
O	vitelline	vitelline	NN	I-NP
O	envelope	envelope	NN	I-NP
O	glycoproteins	glycoprotein	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	Xenopus	Xenopus	NNP	I-NP
O	laevis	laevis	NN	I-NP
O	egg	egg	NN	I-NP
O	vitelline	vitelline	NN	I-NP
O	envelope	envelope	NN	I-NP
O	is	be	VBZ	B-VP
O	composed	compose	VBN	I-VP
O	of	of	IN	B-PP
O	five	five	CD	B-NP
O	glycoproteins	glycoprotein	NNS	I-NP
O	(	(	(	O
B-GGP	ZPA	ZPA	NN	B-NP
O	,	,	,	O
B-GGP	ZPB	ZPB	NN	B-NP
O	,	,	,	O
B-GGP	ZPC	ZPC	NN	B-NP
O	,	,	,	O
B-GGP	ZPD	ZPD	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	ZPX	ZPX	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	As	As	IN	B-SBAR
O	shown	show	VBN	B-VP
O	previously	previously	RB	B-ADVP
O	,	,	,	O
B-GGP	ZPC	ZPC	NN	B-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	primary	primary	JJ	I-NP
O	ligand	ligand	NN	I-NP
O	for	for	IN	B-PP
O	sperm	sperm	NN	B-NP
O	binding	binding	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	egg	egg	NN	I-NP
O	envelope	envelope	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	this	this	DT	B-NP
O	binding	binding	NN	I-NP
O	involves	involve	VBZ	B-VP
O	the	the	DT	B-NP
O	oligosaccharide	oligosaccharide	NN	I-NP
O	moieties	moiety	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	(	(	(	O
O	Biol	Biol	NN	B-NP
O	.	.	.	O

O	Reprod	Reprod	NNP	B-NP
O	.	.	NN	I-NP
O	,	,	,	O
O	62	62	CD	B-NP
O	:	:	:	O
O	766	766	CD	B-NP
O	-	-	HYPH	I-NP
O	774	774	CD	I-NP
O	,	,	,	I-NP
O	2000	2000	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	To	To	TO	B-VP
O	understand	understand	VB	I-VP
O	the	the	DT	B-NP
O	molecular	molecular	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	of	of	IN	B-PP
O	sperm	sperm	NN	B-NP
O	-	-	HYPH	B-NP
O	egg	egg	NN	I-NP
O	envelope	envelope	NN	I-NP
O	binding	binding	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	characterized	characterize	VBD	B-VP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	glycans	glycan	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	vitelline	vitelline	NN	I-NP
O	envelope	envelope	NN	I-NP
O	(	(	(	O
O	VE	VE	NN	B-NP
O	)	)	)	O
O	glycoproteins	glycoprotein	NNS	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	glycans	glycan	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	VE	VE	NN	I-NP
O	were	be	VBD	B-VP
O	composed	compose	VBN	I-VP
O	predominantly	predominantly	RB	B-ADVP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	heterogeneous	heterogeneous	JJ	I-NP
O	mixture	mixture	NN	I-NP
O	of	of	IN	B-PP
O	high	high	JJ	B-NP
O	-	-	HYPH	I-NP
O	mannose	mannose	NN	I-NP
O	(	(	(	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	9	9	CD	I-NP
O	)	)	)	O
O	and	and	CC	O
O	neutral	neutral	JJ	B-NP
O	,	,	,	I-NP
O	complex	complex	JJ	I-NP
O	oligosaccharides	oligosaccharide	NNS	I-NP
O	primarily	primarily	RB	B-VP
O	derived	derive	VBN	I-VP
O	from	from	IN	B-PP
B-GGP	ZPC	ZPC	NN	B-NP
O	(	(	(	O
O	the	the	DT	B-NP
O	dominant	dominant	JJ	I-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	)	)	)	O
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
B-GGP	ZPA	ZPA	NN	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	glycans	glycan	NNS	I-NP
O	were	be	VBD	B-VP
O	composed	compose	VBN	I-VP
O	of	of	IN	B-PP
O	acidic	acidic	JJ	B-NP
O	-	-	HYPH	I-NP
O	complex	complex	JJ	I-NP
O	and	and	CC	I-NP
O	high	high	JJ	I-NP
O	-	-	HYPH	I-NP
O	mannose	mannose	NN	I-NP
O	oligosaccharides	oligosaccharide	NNS	I-NP
O	,	,	,	O
B-GGP	ZPX	ZPX	NN	B-NP
O	had	have	VBD	B-VP
O	only	only	RB	B-NP
O	high	high	JJ	I-NP
O	-	-	HYPH	I-NP
O	mannose	mannose	NN	I-NP
O	oligosaccharides	oligosaccharide	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	ZPB	ZPB	NN	B-NP
O	lacked	lack	VBD	B-VP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	oligosaccharides	oligosaccharide	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	consensus	consensus	NN	I-NP
O	sequence	sequence	NN	I-NP
O	for	for	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	evolutionarily	evolutionarily	RB	I-NP
O	conserved	conserve	VBN	I-NP
O	residue	residue	NN	I-NP
O	N113	N113	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ZPC	ZPC	NN	I-NP
O	protein	protein	NN	I-NP
O	sequence	sequence	NN	I-NP
O	was	be	VBD	B-VP
O	glycosylated	glycosylate	VBN	I-VP
O	solely	solely	RB	B-ADVP
O	with	with	IN	B-PP
O	high	high	JJ	B-NP
O	-	-	HYPH	I-NP
O	mannose	mannose	NN	I-NP
O	oligosaccharides	oligosaccharide	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	of	of	IN	B-PP
O	importance	importance	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	three	three	CD	I-NP
O	-	-	HYPH	I-NP
O	dimensional	dimensional	JJ	I-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ZPC	ZPC	NN	I-NP
O	glycoproteins	glycoprotein	NNS	I-NP
O	.	.	.	O

O	One	One	CD	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	complex	complex	JJ	I-NP
O	oligosaccharides	oligosaccharide	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	ZPC	ZPC	NN	B-NP
O	possessed	possess	VBD	B-VP
O	terminal	terminal	JJ	B-NP
O	beta	beta	SYM	I-NP
O	-	-	HYPH	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetyl	acetyl	NN	I-NP
O	-	-	HYPH	I-NP
O	glucosamine	glucosamine	NN	I-NP
O	residues	residue	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	same	same	JJ	I-NP
B-GGP	ZPC	ZPC	NN	I-NP
O	oligosaccharide	oligosaccharide	NN	I-NP
O	species	specie	NNS	I-NP
O	isolated	isolate	VBN	B-VP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	activated	activate	VBN	I-NP
O	egg	egg	NN	I-NP
O	envelopes	envelope	NNS	I-NP
O	lacked	lack	VBD	B-VP
O	terminal	terminal	JJ	B-ADJP
O	beta	beta	SYM	O
O	-	-	HYPH	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetyl	acetyl	NN	I-NP
O	-	-	HYPH	I-NP
O	glucosamine	glucosamine	NN	I-NP
O	residues	residue	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	previously	previously	RB	B-ADVP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	cortical	cortical	JJ	I-NP
O	granules	granule	NNS	I-NP
O	contain	contain	VBP	B-VP
O	beta	beta	SYM	B-NP
O	-	-	HYPH	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetyl	acetyl	NN	I-NP
O	-	-	HYPH	O
O	glucosaminidase	glucosaminidase	NN	B-NP
O	(	(	(	O
O	J	J	NN	B-NP
O	.	.	.	O

O	Exp	Exp	NN	B-NP
O	.	.	.	O

O	Zool	Zool	NN	B-NP
O	.	.	NN	I-NP
O	,	,	,	O
O	235	235	CD	B-NP
O	:	:	:	O
O	335	335	CD	B-NP
O	-	-	HYPH	I-NP
O	340	340	CD	I-NP
O	,	,	,	I-NP
O	1985	1985	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	We	We	PRP	B-NP
O	propose	propose	VBP	B-VP
O	that	that	IN	B-SBAR
O	an	an	DT	B-NP
O	alteration	alteration	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	oligosaccharide	oligosaccharide	NN	I-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
B-GGP	ZPC	ZPC	NN	B-NP
O	by	by	IN	B-PP
O	glucosaminidase	glucosaminidase	NN	B-NP
O	released	release	VBN	B-VP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	cortical	cortical	JJ	I-NP
O	granule	granule	NN	I-NP
O	reaction	reaction	NN	I-NP
O	is	be	VBZ	B-VP
O	responsible	responsible	JJ	B-ADJP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	loss	loss	NN	I-NP
O	of	of	IN	B-PP
O	sperm	sperm	NN	B-NP
O	binding	binding	NN	I-NP
O	ligand	ligand	NN	I-NP
O	activity	activity	NN	I-NP
O	at	at	IN	B-PP
O	fertilization	fertilization	NN	B-NP
O	.	.	.	O

B-GGP	Set2	Set2	NN	B-NP
O	-	-	HYPH	B-PP
O	catalyzed	catalyze	VBN	B-NP
O	methylation	methylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	represses	repress	VBZ	B-VP
O	basal	basal	JJ	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	GAL4	GAL4	NN	B-NP
O	in	in	IN	B-PP
O	Saccharomyces	Saccharomyces	NNP	B-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	.	.	.	O

O	Recent	Recent	JJ	B-NP
O	work	work	NN	I-NP
O	has	have	VBZ	B-VP
O	shown	show	VBN	I-VP
O	that	that	IN	B-SBAR
B-GGP	histone	histone	NN	B-NP
O	methylation	methylation	NN	I-NP
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	regulator	regulator	NN	I-NP
O	of	of	IN	B-PP
O	transcription	transcription	NN	B-NP
O	.	.	.	O

O	While	While	IN	B-SBAR
O	much	much	JJ	B-NP
O	is	be	VBZ	B-VP
O	known	know	VBN	I-VP
O	about	about	IN	B-PP
O	the	the	DT	B-NP
O	roles	role	NNS	I-NP
O	of	of	IN	B-PP
O	histone	histone	NN	B-NP
O	methyltransferases	methyltransferas	NNS	I-NP
O	(	(	(	O
O	HMTs	HMT	NNS	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	establishment	establishment	NN	I-NP
O	of	of	IN	B-PP
O	heterochromatin	heterochromatin	NN	B-NP
O	,	,	,	O
O	little	little	JJ	B-NP
O	is	be	VBZ	B-VP
O	known	know	VBN	I-VP
O	of	of	IN	B-PP
O	their	their	PRP$	B-NP
O	roles	role	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	actively	actively	RB	B-NP
O	transcribed	transcribe	VBN	I-NP
O	genes	gene	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	describe	describe	VBP	B-VP
O	an	an	DT	B-NP
O	in	in	FW	I-NP
O	vivo	vivo	FW	I-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Saccharomyces	Saccharomyces	NNP	I-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	HMT	HMT	NNP	I-NP
O	,	,	,	O
B-GGP	Set2	Set2	NNP	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	identified	identify	VBD	B-VP
B-GGP	SET2	SET2	NN	B-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	gene	gene	NN	I-NP
O	necessary	necessary	JJ	B-ADJP
O	for	for	IN	B-PP
O	repression	repression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	GAL4	GAL4	NN	B-NP
O	basal	basal	JJ	I-NP
O	expression	expression	NN	I-NP
O	and	and	CC	O
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	evolutionarily	evolutionarily	RB	I-NP
O	conserved	conserve	VBN	I-NP
O	SACI	SACI	NN	I-NP
O	,	,	,	O
O	SACII	SACII	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	SET	SET	NN	B-NP
O	domains	domain	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	Set2	Set2	NN	B-NP
O	are	be	VBP	B-VP
O	necessary	necessary	JJ	B-ADJP
O	for	for	IN	B-PP
O	this	this	DT	B-NP
O	repression	repression	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	confirm	confirm	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	Set2	Set2	NN	B-NP
O	catalyzes	catalyze	VBZ	B-VP
O	methylation	methylation	NN	B-NP
O	of	of	IN	B-PP
O	lysine	lysine	NN	B-NP
O	36	36	CD	I-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	tail	tail	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	.	.	.	O

O	Conversion	Conversion	NN	B-NP
O	of	of	IN	B-PP
O	lysine	lysine	NN	B-NP
O	36	36	CD	I-NP
O	to	to	TO	B-PP
O	an	an	DT	B-NP
O	unmethylatable	unmethylatable	JJ	I-NP
O	arginine	arginine	NN	I-NP
O	causes	cause	VBZ	B-VP
O	a	a	DT	B-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	repression	repression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	GAL4	GAL4	NN	B-NP
O	transcription	transcription	NN	I-NP
O	,	,	,	O
O	as	as	IN	B-SBAR
O	does	do	VBZ	O
O	a	a	DT	B-NP
O	Delta	Delta	NNP	I-NP
B-GGP	set2	set2	NN	I-NP
O	mutation	mutation	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	further	further	RB	B-ADVP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	lysine	lysine	NN	B-NP
O	36	36	CD	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	at	at	IN	B-PP
B-GGP	GAL4	GAL4	NN	B-NP
O	is	be	VBZ	B-VP
O	methylated	methylate	VBN	I-VP
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	methylation	methylation	NN	I-NP
O	is	be	VBZ	B-VP
O	dependent	dependent	JJ	B-ADJP
O	upon	upon	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
B-GGP	SET2	SET2	NN	B-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	possible	possible	JJ	I-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	carbohydrate	carbohydrate	NN	B-NP
O	moieties	moiety	NNS	I-NP
O	in	in	IN	B-PP
B-GGP	prostaglandin	prostaglandin	NN	B-NP
I-GGP	D2	D2	NN	I-NP
O	and	and	CC	O
O	prostaglandin	prostaglandin	NN	B-NP
O	E2	E2	NN	I-NP
O	receptor	receptor	NN	I-NP
O	proteins	protein	NNS	I-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	porcine	porcine	JJ	I-NP
O	temporal	temporal	JJ	I-NP
O	cortex	cortex	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	binding	binding	NN	I-NP
O	activities	activity	NNS	I-NP
O	of	of	IN	B-PP
O	prostaglandins	prostaglandin	NNS	B-NP
O	(	(	(	O
O	PGs	PG	NNS	B-NP
O	)	)	)	O
O	D2	D2	NN	B-NP
O	and	and	CC	I-NP
O	E2	E2	NN	I-NP
O	were	be	VBD	B-VP
O	measured	measure	VBN	I-VP
O	after	after	IN	B-PP
O	deglycosylation	deglycosylation	NN	B-NP
O	of	of	IN	B-PP
O	P2	P2	NN	B-NP
O	membranes	membrane	NNS	I-NP
O	prepared	prepare	VBN	B-VP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	porcine	porcine	JJ	I-NP
O	temporal	temporal	JJ	I-NP
O	cortex	cortex	NN	I-NP
O	in	in	IN	B-SBAR
O	order	order	NN	O
O	to	to	TO	B-VP
O	investigate	investigate	VB	I-VP
O	the	the	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	carbohydrate	carbohydrate	NN	B-NP
O	moieties	moiety	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	receptor	receptor	NN	I-NP
O	binding	binding	NN	I-NP
O	.	.	.	O

O	PGD2	PGD2	NN	B-NP
O	and	and	CC	I-NP
O	PGE2	PGE2	NN	I-NP
O	binding	binding	NN	I-NP
O	activities	activity	NNS	I-NP
O	were	be	VBD	B-VP
O	significantly	significantly	RB	I-VP
O	decreased	decrease	VBN	I-VP
O	by	by	IN	B-PP
O	pretreatment	pretreatment	NN	B-NP
O	with	with	IN	B-PP
O	various	various	JJ	B-NP
O	exoglycosidases	exoglycosidas	NNS	I-NP
O	,	,	,	O
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	neuraminidase	neuraminidase	NN	B-NP
O	for	for	IN	B-PP
O	PGE2	PGE2	NN	B-NP
O	binding	binding	NN	I-NP
O	,	,	,	O
O	alpha	alpha	SYM	O
O	-	-	HYPH	O
O	mannosidase	mannosidase	NN	B-NP
O	and	and	CC	O
O	beta	beta	SYM	O
O	-	-	HYPH	O
O	galactosidase	galactosidase	NN	B-NP
O	for	for	IN	B-PP
O	PGD2	PGD2	NN	B-NP
O	binding	binding	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	beta	beta	SYM	B-NP
O	-	-	HYPH	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	O
O	acetylhexosaminidase	acetylhexosaminidase	NN	B-NP
O	for	for	IN	B-PP
O	both	both	DT	B-NP
O	.	.	.	O

O	Further	Further	RB	B-ADVP
O	,	,	,	O
O	peptide	peptide	NN	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	glycohydrolase	glycohydrolase	NN	I-NP
O	F	F	NN	I-NP
O	and	and	CC	O
B-GGP	endo	endo	AFX	O
I-GGP	-	-	HYPH	O
I-GGP	alpha	alpha	SYM	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	N	N	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	acetylgalactosaminidase	acetylgalactosaminidase	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	are	be	VBP	B-VP
O	specific	specific	JJ	B-ADJP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	cleavage	cleavage	NN	I-NP
O	of	of	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	glycan	glycan	NN	I-NP
O	and	and	CC	I-NP
O	O	O	NN	I-NP
O	-	-	HYPH	B-NP
O	glycan	glycan	NN	I-NP
O	linkages	linkage	NNS	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	,	,	,	O
O	in	in	IN	B-PP
O	glycoproteins	glycoprotein	NNS	B-NP
O	were	be	VBD	B-VP
O	used	use	VBN	I-VP
O	.	.	.	O

O	Pretreatment	Pretreatment	NN	B-NP
O	with	with	IN	B-PP
O	either	either	DT	B-NP
O	of	of	IN	B-PP
O	them	them	PRP	B-NP
O	also	also	RB	B-ADVP
O	reduced	reduce	VBD	B-VP
O	both	both	CC	O
O	PGD2	PGD2	NN	B-NP
O	and	and	CC	O
O	PGE2	PGE2	NN	B-NP
O	binding	binding	NN	I-NP
O	activities	activity	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	reduction	reduction	NN	I-NP
O	was	be	VBD	B-VP
O	dependent	dependent	JJ	B-ADJP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	pretreatment	pretreatment	NN	I-NP
O	time	time	NN	I-NP
O	and	and	CC	O
O	enzyme	enzyme	NN	B-NP
O	concentration	concentration	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	time	time	NN	I-NP
O	courses	course	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	reduction	reduction	NN	I-NP
O	were	be	VBD	B-VP
O	typically	typically	RB	I-VP
O	characterized	characterize	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	marked	marked	JJ	I-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	nonspecific	nonspecific	JJ	I-NP
O	bindings	binding	NNS	I-NP
O	.	.	.	O

O	Scatchard	Scatchard	NN	B-NP
O	plot	plot	NN	I-NP
O	analysis	analysis	NN	I-NP
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	reduction	reduction	NN	I-NP
O	was	be	VBD	B-VP
O	caused	cause	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	affinity	affinity	NN	I-NP
O	rather	rather	RB	B-PP
O	than	than	IN	I-PP
O	one	one	CD	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	maximal	maximal	JJ	I-NP
O	binding	binding	NN	I-NP
O	capacity	capacity	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	specificity	specificity	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	binding	bind	VBG	I-NP
O	sites	site	NNS	I-NP
O	thereby	thereby	RB	B-ADVP
O	shifted	shift	VBD	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	more	more	RBR	B-ADJP
O	nonspecific	nonspecific	JJ	I-ADJP
O	without	without	IN	B-PP
O	affecting	affect	VBG	B-VP
O	the	the	DT	B-NP
O	order	order	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	relative	relative	JJ	I-NP
O	affinities	affinity	NNS	I-NP
O	among	among	IN	B-PP
O	PGs	PG	NNS	B-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	binding	bind	VBG	I-NP
O	sites	site	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	carbohydrate	carbohydrate	NN	I-NP
O	moieties	moiety	NNS	I-NP
O	on	on	IN	B-PP
O	PG	PG	NN	B-NP
O	receptor	receptor	NN	I-NP
O	proteins	protein	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	brain	brain	NN	I-NP
O	are	be	VBP	B-VP
O	essential	essential	JJ	B-ADJP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	their	their	PRP$	B-NP
O	binding	binding	NN	I-NP
O	activities	activity	NNS	I-NP
O	.	.	.	O

O	Sequence	Sequence	NN	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	membrane	membrane	NN	I-NP
O	protein	protein	NN	I-NP
O	gene	gene	NN	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	coronavirus	coronavirus	NN	I-NP
O	OC43	OC43	NN	I-NP
O	and	and	CC	I-NP
O	evidence	evidence	NN	I-NP
O	for	for	IN	B-PP
O	O	O	NN	B-NP
O	-	-	HYPH	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	gene	gene	NN	I-NP
O	encoding	encode	VBG	B-VP
O	the	the	DT	B-NP
O	membrane	membrane	NN	I-NP
O	(	(	(	O
B-GGP	M	M	NN	B-NP
O	)	)	)	O
O	protein	protein	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	OC43	OC43	NN	I-NP
O	strain	strain	NN	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	coronavirus	coronavirus	NN	I-NP
O	(	(	(	O
O	HCV	HCV	NN	B-NP
O	-	-	HYPH	B-NP
O	OC43	OC43	NN	I-NP
O	)	)	)	O
O	was	be	VBD	B-VP
O	amplified	amplify	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	reverse	reverse	JJ	I-NP
O	transcription	transcription	NN	I-NP
O	-	-	HYPH	B-NP
O	polymerase	polymerase	NN	I-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	of	of	IN	B-PP
O	viral	viral	JJ	B-NP
O	RNA	RNA	NN	I-NP
O	with	with	IN	B-PP
O	HCV	HCV	NN	B-NP
O	-	-	HYPH	B-NP
O	OC43	OC43	NN	I-NP
O	-	-	HYPH	B-NP
O	and	and	CC	I-NP
O	bovine	bovine	JJ	I-NP
O	coronavirus	coronavirus	NN	I-NP
O	(	(	(	O
O	BCV	BCV	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	primers	primer	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	nucleotide	nucleotide	NN	I-NP
O	sequence	sequence	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cloned	clone	VBN	I-NP
O	1	1	CD	I-NP
O	.	.	.	I-NP
O	5	5	CD	I-NP
O	kb	kb	NN	I-NP
O	fragment	fragment	NN	I-NP
O	revealed	reveal	VBD	B-VP
O	an	an	DT	B-NP
O	open	open	JJ	I-NP
O	reading	reading	NN	I-NP
O	frame	frame	NN	I-NP
O	(	(	(	O
O	ORF	ORF	NN	B-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	690	690	CD	B-NP
O	nucleotides	nucleotide	NNS	I-NP
O	which	which	WDT	B-NP
O	was	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	as	as	IN	B-PP
O	the	the	DT	B-NP
B-GGP	M	M	NN	I-NP
O	protein	protein	NN	I-NP
O	gene	gene	NN	I-NP
O	from	from	IN	B-PP
O	its	its	PRP$	B-NP
O	homology	homology	NN	I-NP
O	to	to	TO	B-PP
O	BCV	BCV	NN	B-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	ORF	ORF	NN	I-NP
O	encodes	encode	VBZ	B-VP
O	a	a	DT	B-NP
O	protein	protein	NN	I-NP
O	of	of	IN	B-PP
O	230	230	CD	B-NP
O	amino	amino	NN	I-NP
O	acids	acid	NNS	I-NP
O	with	with	IN	B-PP
O	an	an	DT	B-NP
O	M	M	NN	I-NP
O	(	(	(	O
O	r	r	NN	B-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	26416	26416	CD	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	gene	gene	NN	I-NP
O	is	be	VBZ	B-VP
O	preceded	precede	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	motif	motif	NN	I-NP
O	UCCAAAC	UCCAAAC	NN	I-NP
O	,	,	,	O
O	analogous	analogous	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	consensus	consensus	NN	I-NP
O	coronavirus	coronavirus	NN	I-NP
O	transcription	transcription	NN	I-NP
O	initiation	initiation	NN	I-NP
O	sequence	sequence	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	M	M	NN	I-NP
O	protein	protein	NN	I-NP
O	of	of	IN	B-PP
O	HCV	HCV	NN	B-NP
O	-	-	HYPH	B-NP
O	OC43	OC43	NN	I-NP
O	shows	show	VBZ	B-VP
O	features	feature	NNS	B-NP
O	typical	typical	JJ	B-ADJP
O	of	of	IN	B-PP
O	all	all	DT	B-NP
O	coronavirus	coronavirus	NN	I-NP
B-GGP	M	M	NN	I-NP
O	proteins	protein	NNS	I-NP
O	studied	study	VBN	B-VP
O	:	:	:	O
O	a	a	DT	B-NP
O	hydrophilic	hydrophilic	JJ	I-NP
O	,	,	,	I-NP
O	presumably	presumably	RB	I-NP
O	external	external	JJ	I-NP
O	N	N	NN	I-NP
O	terminus	terminus	NN	I-NP
O	including	include	VBG	B-PP
O	about	about	IN	B-NP
O	10	10	CD	I-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	a	a	DT	B-NP
O	potential	potential	JJ	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	followed	follow	VBN	B-VP
O	by	by	IN	B-PP
O	three	three	CD	B-NP
O	major	major	JJ	I-NP
O	hydrophobic	hydrophobic	JJ	I-NP
O	transmembrane	transmembrane	NN	I-NP
O	domains	domain	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	sequence	sequence	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	M	M	NN	I-NP
O	protein	protein	NN	I-NP
O	of	of	IN	B-PP
O	HCV	HCV	NN	B-NP
O	-	-	HYPH	B-NP
O	OC43	OC43	NN	I-NP
O	has	have	VBZ	B-VP
O	94	94	CD	B-NP
O	%	%	NN	I-NP
O	identity	identity	NN	I-NP
O	with	with	IN	B-PP
O	that	that	DT	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Mebus	Mebus	NNP	I-NP
O	strain	strain	NN	I-NP
O	of	of	IN	B-PP
O	BCV	BCV	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	also	also	RB	B-VP
O	contains	contain	VBZ	I-VP
O	six	six	CD	B-NP
O	potential	potential	JJ	I-NP
O	O	O	NN	I-NP
O	-	-	HYPH	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	sites	site	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	exposed	expose	VBN	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	domain	domain	NN	I-NP
O	.	.	.	O

O	Indeed	Indeed	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	M	M	NN	I-NP
O	protein	protein	NN	I-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	inhibited	inhibit	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	tunicamycin	tunicamycin	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	indicative	indicative	JJ	B-ADJP
O	of	of	IN	B-PP
O	O	O	NN	B-NP
O	-	-	HYPH	O
O	glycosylation	glycosylation	NN	B-NP
O	,	,	,	O
O	as	as	IN	B-SBAR
O	previously	previously	RB	B-ADVP
O	reported	report	VBN	B-VP
O	for	for	IN	B-PP
O	BCV	BCV	NN	B-NP
O	and	and	CC	O
O	murine	murine	JJ	B-NP
O	hepatitis	hepatitis	NN	I-NP
O	virus	virus	NN	I-NP
O	.	.	.	O

O	Virions	Virion	NNS	B-NP
O	released	release	VBN	B-VP
O	from	from	IN	B-PP
O	tunicamycin	tunicamycin	NN	B-NP
O	-	-	HYPH	B-NP
O	treated	treat	VBN	I-NP
O	cells	cell	NNS	I-NP
O	contained	contain	VBD	B-VP
O	the	the	DT	B-NP
B-GGP	M	M	NN	I-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	but	but	CC	O
O	were	be	VBD	B-VP
O	devoid	devoid	JJ	B-ADJP
O	of	of	IN	B-PP
O	both	both	CC	O
B-GGP	peplomer	peplomer	NN	B-NP
O	(	(	(	O
B-GGP	S	S	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	haemagglutinin	haemagglutinin	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	esterase	esterase	NN	B-NP
O	(	(	(	O
B-GGP	HE	HE	NN	B-NP
O	)	)	)	O
O	proteins	protein	NNS	B-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
O	inhibition	inhibition	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	S	S	NN	I-NP
O	and	and	CC	I-NP
B-GGP	HE	HE	NN	I-NP
O	structural	structural	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	prevented	prevent	VBD	B-VP
O	their	their	PRP$	B-NP
O	incorporation	incorporation	NN	I-NP
O	into	into	IN	B-PP
O	progeny	progeny	NN	B-NP
O	virions	virion	NNS	I-NP
O	,	,	,	O
O	an	an	DT	B-NP
O	indication	indication	NN	I-NP
O	that	that	IN	B-SBAR
O	they	they	PRP	B-NP
O	are	be	VBP	B-VP
O	dispensable	dispensable	JJ	B-ADJP
O	for	for	IN	B-PP
O	virion	virion	NN	B-NP
O	morphogenesis	morphogenesis	NN	I-NP
O	,	,	,	O
O	unlike	unlike	IN	B-PP
O	the	the	DT	B-NP
B-GGP	M	M	NN	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	Production	Production	NN	B-NP
O	and	and	CC	I-NP
O	secretion	secretion	NN	I-NP
O	of	of	IN	B-PP
O	high	high	JJ	B-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	recombinant	recombinant	JJ	B-NP
O	human	human	JJ	I-NP
B-GGP	acetylcholinesterase	acetylcholinesterase	NN	I-NP
O	in	in	IN	B-PP
O	cultured	culture	VBN	B-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	:	:	:	O
O	microheterogeneity	microheterogeneity	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	catalytic	catalytic	JJ	I-NP
O	subunit	subunit	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	allow	allow	VB	I-VP
O	for	for	IN	B-PP
O	structural	structural	JJ	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	human	human	JJ	I-NP
B-GGP	acetylcholinesterase	acetylcholinesterase	NN	I-NP
O	(	(	(	O
B-GGP	hAChE	hAChE	NN	B-NP
O	)	)	)	O
O	subunit	subunit	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	series	series	NN	I-NP
O	of	of	IN	B-PP
O	eukaryotic	eukaryotic	JJ	B-NP
O	vectors	vector	NNS	I-NP
O	was	be	VBD	B-VP
O	designed	design	VBN	I-VP
O	for	for	IN	B-PP
O	efficient	efficient	JJ	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	Several	Several	JJ	B-NP
O	eukaryotic	eukaryotic	JJ	I-NP
O	multicistronic	multicistronic	JJ	I-NP
O	expression	expression	NN	I-NP
O	vectors	vector	NNS	I-NP
O	were	be	VBD	B-VP
O	tested	test	VBN	I-VP
O	in	in	IN	B-PP
O	various	various	JJ	B-NP
O	mammalian	mammalian	JJ	I-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	.	.	.	O

O	All	All	DT	B-NP
O	expression	expression	NN	I-NP
O	vectors	vector	NNS	I-NP
O	contained	contain	VBD	B-VP
O	the	the	DT	B-NP
O	selectable	selectable	JJ	I-NP
O	neo	neo	NN	I-NP
O	gene	gene	NN	I-NP
O	under	under	IN	B-PP
O	control	control	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	weak	weak	JJ	I-NP
O	promoter	promoter	NN	I-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	the	the	DT	B-NP
B-GGP	hAChE	hAChE	NN	I-NP
O	cDNA	cDNA	NN	I-NP
O	was	be	VBD	B-VP
O	under	under	IN	B-PP
O	control	control	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cytomegalovirus	cytomegalovirus	NN	I-NP
O	(	(	(	O
O	CMV	CMV	NN	B-NP
O	)	)	)	O
O	immediate	immediate	JJ	B-ADJP
O	-	-	HYPH	O
O	early	early	JJ	B-NP
O	or	or	CC	I-NP
O	Rous	Rous	JJ	I-NP
O	sarcoma	sarcoma	NN	I-NP
O	virus	virus	NN	I-NP
O	long	long	JJ	I-NP
O	terminal	terminal	JJ	I-NP
O	repeat	repeat	NN	I-NP
O	(	(	(	O
O	RSV	RSV	NN	B-NP
O	LTR	LTR	NN	I-NP
O	)	)	)	O
O	or	or	CC	O
O	simian	simian	JJ	B-NP
O	virus	virus	NN	I-NP
O	40	40	CD	I-NP
O	(	(	(	O
O	SV40	SV40	NN	B-NP
O	)	)	)	O
O	early	early	JJ	B-NP
O	promoters	promoter	NNS	I-NP
O	.	.	.	O

O	Optimal	Optimal	JJ	B-NP
O	production	production	NN	I-NP
O	and	and	CC	I-NP
O	secretion	secretion	NN	I-NP
O	of	of	IN	B-PP
O	recombinant	recombinant	JJ	B-NP
B-GGP	hAChE	hAChE	NN	I-NP
O	(	(	(	O
B-GGP	rehAChE	rehAChE	NN	B-NP
O	)	)	)	O
O	was	be	VBD	B-VP
O	achieved	achieve	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	embryonal	embryonal	JJ	I-NP
O	kidney	kidney	NN	I-NP
O	293	293	CD	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	transfected	transfecte	VBN	B-VP
O	either	either	CC	B-PP
O	with	with	IN	I-PP
O	the	the	DT	B-NP
O	RSV	RSV	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	hAChE	hAChE	NN	I-NP
O	or	or	CC	B-PP
O	with	with	IN	B-PP
O	CMV	CMV	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	hAChE	hAChE	NN	I-NP
O	expression	expression	NN	I-NP
O	vectors	vector	NNS	I-NP
O	.	.	.	O

O	Clones	Clone	NNS	B-NP
O	expressing	express	VBG	B-VP
O	and	and	CC	I-VP
O	secreting	secrete	VBG	I-VP
O	as	as	RB	B-NP
O	much	much	JJ	I-NP
O	as	as	IN	I-NP
O	5	5	CD	I-NP
O	-	-	HYPH	I-NP
O	25	25	CD	I-NP
O	pg	pg	NN	I-NP
O	of	of	IN	B-PP
O	enzyme	enzyme	NN	B-NP
O	per	per	IN	B-PP
O	cell	cell	NN	B-NP
O	per	per	IN	B-PP
O	24	24	CD	B-NP
O	h	h	NN	I-NP
O	were	be	VBD	B-VP
O	obtained	obtain	VBN	I-VP
O	without	without	IN	B-PP
O	resorting	resorte	VBG	B-VP
O	to	to	TO	B-PP
O	coamplification	coamplification	NN	B-NP
O	techniques	technique	NNS	I-NP
O	or	or	CC	O
O	continuous	continuous	JJ	B-NP
O	maintenance	maintenance	NN	I-NP
O	of	of	IN	B-PP
O	cells	cell	NNS	B-NP
O	under	under	IN	B-PP
O	selective	selective	JJ	B-NP
O	pressure	pressure	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	purified	purify	VBN	I-NP
O	(	(	(	O
O	specific	specific	JJ	B-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
O	6000	6000	CD	B-NP
O	units	unit	NNS	I-NP
O	per	per	IN	B-PP
O	mg	mg	NN	B-NP
O	protein	protein	NN	I-NP
O	)	)	)	O
O	homodimer	homodimer	NN	B-NP
O	and	and	CC	I-NP
O	tetramer	tetramer	NN	I-NP
O	enzyme	enzyme	NN	I-NP
O	molecules	molecule	NNS	I-NP
O	displayed	display	VBD	B-VP
O	typical	typical	JJ	B-NP
B-GGP	AChE	AChE	NN	I-NP
O	biochemical	biochemical	JJ	I-NP
O	properties	property	NNS	I-NP
O	:	:	:	O
O	a	a	DT	B-NP
O	Km	Km	NN	I-NP
O	value	value	NN	I-NP
O	of	of	IN	B-PP
O	120	120	CD	B-NP
O	microM	microM	NN	I-NP
O	for	for	IN	B-PP
O	acetylthiocholine	acetylthiocholine	NN	B-NP
O	;	;	:	O
O	a	a	DT	B-NP
O	kcat	kcat	NN	I-NP
O	value	value	NN	I-NP
O	of	of	IN	B-PP
O	3	3	CD	B-NP
O	.	.	.	O
O	9	9	CD	B-NP
O	x	x	CC	I-NP
O	10	10	CD	I-NP
O	(	(	(	O
O	5	5	CD	B-NP
O	)	)	)	O
O	/	/	SYM	B-NP
O	min	min	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	selective	selective	JJ	B-ADJP
O	by	by	IN	B-PP
B-GGP	AChE	AChE	NN	B-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	inhibitors	inhibitor	NNS	I-NP
O	.	.	.	O

O	Catalytic	Catalytic	JJ	B-NP
O	subunit	subunit	NN	I-NP
O	dimers	dimer	NNS	I-NP
O	(	(	(	O
O	130	130	CD	B-NP
O	kDa	kDa	NN	I-NP
O	)	)	)	O
O	exhibit	exhibit	VBP	B-VP
O	differential	differential	JJ	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	upon	upon	IN	B-PP
O	reduction	reduction	NN	B-NP
O	resolve	resolve	VBP	B-VP
O	into	into	IN	B-PP
O	67	67	CD	B-NP
O	-	-	HYPH	B-NP
O	and	and	CC	I-NP
O	70	70	CD	I-NP
O	-	-	HYPH	I-NP
O	kDa	kDa	NN	I-NP
O	monomeric	monomeric	JJ	I-NP
O	subunits	subunit	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	two	two	CD	I-NP
O	forms	form	NNS	I-NP
O	appear	appear	VBP	B-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	single	single	JJ	I-NP
O	discrete	discrete	JJ	I-NP
O	62	62	CD	I-NP
O	-	-	HYPH	I-NP
O	kDa	kDa	NN	I-NP
O	band	band	NN	I-NP
O	following	follow	VBG	B-PP
O	deglycosylation	deglycosylation	NN	B-NP
O	by	by	IN	B-PP
B-GGP	N	N	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	glycanase	glycanase	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	O
O	terminal	terminal	JJ	B-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	sequence	sequence	NN	I-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	purified	purify	VBN	I-NP
O	mature	mature	JJ	I-NP
O	enzyme	enzyme	NN	I-NP
O	suggests	suggest	VBZ	B-VP
O	the	the	DT	B-NP
O	existence	existence	NN	I-NP
O	of	of	IN	B-PP
O	two	two	CD	B-NP
O	alternative	alternative	JJ	I-NP
O	cleavage	cleavage	NN	I-NP
O	sites	site	NNS	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	removal	removal	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	signal	signal	NN	I-NP
O	peptide	peptide	NN	I-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
O	'	'	``	I-NP
O	mature	mature	JJ	I-NP
O	'	'	''	I-NP
O	position	position	NN	I-NP
O	1	1	CD	I-NP
O	is	be	VBZ	B-VP
O	either	either	CC	O
O	Ala31	Ala31	NN	B-NP
O	or	or	CC	I-NP
O	Gly33	Gly33	NN	I-NP
O	.	.	.	O

O	Both	Both	DT	B-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	positions	position	NNS	I-NP
O	conform	conform	VBP	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	consensus	consensus	NN	I-NP
O	signal	signal	NN	I-NP
O	peptide	peptide	NN	I-NP
O	recognition	recognition	NN	I-NP
O	sequences	sequence	NNS	I-NP
O	and	and	CC	O
O	demonstrate	demonstrate	VBP	B-VP
O	bidirected	bidirecte	VBN	B-NP
O	processing	processing	NN	I-NP
O	of	of	IN	B-PP
O	signal	signal	NN	B-NP
O	peptides	peptide	NNS	I-NP
O	on	on	IN	B-PP
O	a	a	DT	B-NP
O	native	native	JJ	I-NP
O	molecule	molecule	NN	I-NP
O	.	.	.	O

O	Evaluation	Evaluation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	CD44	CD44	NN	B-NP
O	variant	variant	NN	I-NP
O	6	6	CD	B-NP
O	expression	expression	NN	I-NP
O	and	and	CC	O
O	clinicopathological	clinicopathological	JJ	B-NP
O	factors	factor	NNS	I-NP
O	in	in	IN	B-PP
O	pulmonary	pulmonary	JJ	B-NP
O	metastases	metastasis	NNS	I-NP
O	from	from	IN	B-PP
O	colon	colon	NN	B-NP
O	carcinoma	carcinoma	NN	I-NP
O	.	.	.	O

O	Although	Although	IN	B-SBAR
O	relatively	relatively	RB	B-NP
O	little	little	JJ	I-NP
O	is	be	VBZ	B-VP
O	known	know	VBN	I-VP
O	about	about	IN	B-PP
O	the	the	DT	B-NP
O	molecular	molecular	JJ	I-NP
O	mechanisms	mechanism	NNS	I-NP
O	underlying	underlie	VBG	B-VP
O	tumor	tumor	NN	B-NP
O	progression	progression	NN	I-NP
O	,	,	,	O
O	recently	recently	RB	B-ADVP
B-GGP	CD44	CD44	NN	B-NP
O	glycoproteins	glycoprotein	NNS	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
B-GGP	c	c	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	Met	Met	NN	I-NP
O	receptor	receptor	NN	I-NP
O	tyrosine	tyrosine	NN	I-NP
O	kinase	kinase	NN	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	identified	identify	VBN	I-VP
O	as	as	IN	B-PP
O	potentially	potentially	RB	B-NP
O	important	important	JJ	I-NP
O	components	component	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	metastatic	metastatic	JJ	I-NP
O	cascade	cascade	NN	I-NP
O	.	.	.	O

B-GGP	CD44	CD44	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	family	family	NN	I-NP
O	of	of	IN	B-PP
O	transmembrane	transmembrane	NN	B-NP
O	receptors	receptor	NNS	I-NP
O	generated	generate	VBN	B-VP
O	from	from	IN	B-PP
O	a	a	DT	B-NP
O	single	single	JJ	I-NP
O	gene	gene	NN	I-NP
O	by	by	IN	B-PP
O	alternative	alternative	JJ	B-NP
O	splicing	splicing	NN	I-NP
O	and	and	CC	O
O	differential	differential	JJ	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	.	.	.	O

O	Important	Important	JJ	B-NP
O	biological	biological	JJ	I-NP
O	processes	process	NNS	I-NP
O	involving	involve	VBG	B-VP
B-GGP	CD44	CD44	NN	B-NP
O	glycoproteins	glycoprotein	NNS	I-NP
O	include	include	VBP	B-VP
O	cell	cell	NN	B-NP
O	adhesion	adhesion	NN	I-NP
O	,	,	,	O
O	lymphocyte	lymphocyte	NN	B-NP
O	homing	homing	NN	I-NP
O	,	,	,	O
O	hematopoiesis	hematopoiesis	NN	B-NP
O	,	,	,	O
O	tumor	tumor	NN	B-NP
O	progression	progression	NN	I-NP
O	and	and	CC	I-NP
O	metastasis	metastasis	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	precise	precise	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	via	via	IN	B-PP
O	which	which	WDT	B-NP
B-GGP	CD44	CD44	NN	B-NP
O	promotes	promote	VBZ	B-VP
O	tumorigenesis	tumorigenesis	NN	B-NP
O	have	have	VBP	B-VP
O	not	not	RB	I-VP
O	yet	yet	RB	I-VP
O	been	be	VBN	I-VP
O	elucidated	elucidate	VBN	I-VP
O	.	.	.	O

O	We	We	PRP	B-NP
O	evaluated	evaluate	VBD	B-VP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	adhesion	adhesion	NN	B-NP
O	molecule	molecule	NN	I-NP
B-GGP	CD44	CD44	NN	I-NP
O	variant	variant	NN	I-NP
O	6	6	CD	I-NP
O	in	in	IN	B-PP
O	pulmonary	pulmonary	JJ	B-NP
O	metastases	metastasis	NNS	I-NP
O	from	from	IN	B-PP
O	colorectal	colorectal	JJ	B-NP
O	carcinomas	carcinoma	NNS	I-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	correlation	correlation	NN	I-NP
O	with	with	IN	B-PP
O	clinicopathological	clinicopathological	JJ	B-NP
O	parameters	parameter	NNS	I-NP
O	.	.	.	O

O	Twenty	Twenty	CD	B-NP
O	patients	patient	NNS	I-NP
O	were	be	VBD	B-VP
O	randomly	randomly	RB	I-VP
O	selected	select	VBN	I-VP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	patients	patient	NNS	I-NP
O	who	who	WP	B-NP
O	had	have	VBD	B-VP
O	undergone	undergo	VBN	I-VP
O	a	a	DT	B-NP
O	resection	resection	NN	I-NP
O	of	of	IN	B-PP
O	pulmonary	pulmonary	JJ	B-NP
O	metastasis	metastasis	NN	I-NP
O	from	from	IN	B-PP
O	colorectal	colorectal	JJ	B-NP
O	cancer	cancer	NN	I-NP
O	.	.	.	O

O	Formalin	Formalin	NN	B-NP
O	-	-	HYPH	O
O	fixed	fix	VBN	B-VP
O	,	,	,	O
O	paraffin	paraffin	NN	B-NP
O	-	-	HYPH	B-VP
O	embedded	embed	VBN	B-NP
O	archival	archival	JJ	I-NP
O	specimens	specimen	NNS	I-NP
O	of	of	IN	B-PP
O	tumor	tumor	NN	B-NP
O	tissues	tissue	NNS	I-NP
O	and	and	CC	O
O	adjacent	adjacent	JJ	B-NP
O	normal	normal	JJ	I-NP
O	mucosa	mucosa	NN	I-NP
O	from	from	IN	B-PP
O	these	these	DT	B-NP
O	patients	patient	NNS	I-NP
O	were	be	VBD	B-VP
O	the	the	DT	B-NP
O	subjects	subject	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	study	study	NN	I-NP
O	.	.	.	O

O	Immunoreactivity	Immunoreactivity	NN	B-NP
O	for	for	IN	B-PP
B-GGP	CD44	CD44	NN	B-NP
O	was	be	VBD	B-VP
O	quantified	quantify	VBN	I-VP
O	.	.	.	O

O	Specimens	Specimen	NNS	B-NP
O	were	be	VBD	B-VP
O	considered	consider	VBN	I-VP
O	positive	positive	JJ	B-ADJP
O	if	if	IN	B-SBAR
O	almost	almost	RB	B-NP
O	25	25	CD	I-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	neoplastic	neoplastic	JJ	I-NP
O	cells	cell	NNS	I-NP
O	were	be	VBD	B-VP
O	stained	stain	VBN	I-VP
O	.	.	.	O

B-GGP	CD44	CD44	NN	B-NP
O	v6	v6	NN	I-NP
O	expression	expression	NN	I-NP
O	was	be	VBD	B-VP
O	related	relate	VBN	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	interval	interval	NN	I-NP
O	between	between	IN	B-PP
O	colon	colon	NN	B-NP
O	resection	resection	NN	I-NP
O	and	and	CC	I-NP
O	metastases	metastasis	NNS	I-NP
O	diagnosis	diagnosis	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	pulmonary	pulmonary	JJ	B-NP
O	metastases	metastasis	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	survival	survival	NN	I-NP
O	after	after	IN	B-PP
O	lung	lung	NN	B-NP
O	resection	resection	NN	I-NP
O	.	.	.	O

O	No	No	DT	B-NP
O	statistical	statistical	JJ	I-NP
O	correlation	correlation	NN	I-NP
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	between	between	IN	B-PP
B-GGP	CD44	CD44	NN	B-NP
O	v6	v6	NN	I-NP
O	positivity	positivity	NN	I-NP
O	and	and	CC	I-NP
O	disease	disease	NN	I-NP
O	-	-	HYPH	B-NP
O	free	free	JJ	I-NP
O	interval	interval	NN	I-NP
O	after	after	IN	B-PP
O	colon	colon	NN	B-NP
O	resection	resection	NN	I-NP
O	,	,	,	O
O	number	number	NN	B-NP
O	of	of	IN	B-PP
O	metastases	metastasis	NNS	B-NP
O	or	or	CC	O
O	2	2	CD	B-NP
O	-	-	HYPH	I-NP
O	year	year	NN	I-NP
O	survival	survival	NN	I-NP
O	after	after	IN	B-PP
O	lung	lung	NN	B-NP
O	resection	resection	NN	I-NP
O	.	.	.	O

O	Probably	Probably	RB	B-NP
B-GGP	CD44	CD44	NN	I-NP
O	v6	v6	NN	I-NP
O	is	be	VBZ	B-VP
O	necessary	necessary	JJ	B-ADJP
O	and	and	CC	I-ADJP
O	sufficient	sufficient	JJ	I-ADJP
O	to	to	TO	B-VP
O	confer	confer	VB	I-VP
O	metastatic	metastatic	JJ	B-NP
O	potential	potential	NN	I-NP
O	to	to	TO	B-PP
O	carcinoma	carcinoma	NN	B-NP
O	cells	cell	NNS	I-NP
O	increasing	increase	VBG	B-VP
O	the	the	DT	B-NP
O	migration	migration	NN	I-NP
O	capacity	capacity	NN	I-NP
O	and	and	CC	O
O	participating	participate	VBG	B-VP
O	in	in	IN	B-PP
O	invasion	invasion	NN	B-NP
O	via	via	IN	B-PP
O	changes	change	NNS	B-NP
O	in	in	IN	B-PP
O	adhesion	adhesion	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	extracellular	extracellular	JJ	I-NP
O	ligands	ligand	NNS	I-NP
O	,	,	,	O
O	but	but	CC	O
O	is	be	VBZ	B-VP
O	not	not	RB	O
O	necessary	necessary	JJ	B-ADJP
O	to	to	TO	B-VP
O	modify	modify	VB	I-VP
O	the	the	DT	B-NP
O	clinical	clinical	JJ	I-NP
O	history	history	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	metastases	metastasis	NNS	I-NP
O	.	.	.	O

O	Therefore	Therefore	RB	B-ADVP
O	the	the	DT	B-NP
O	evaluation	evaluation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	CD44	CD44	NN	B-NP
O	v6	v6	NN	I-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	lung	lung	NN	B-NP
O	metastases	metastasis	NNS	I-NP
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	influence	influence	VB	I-VP
O	the	the	DT	B-NP
O	therapeutic	therapeutic	JJ	I-NP
O	scheme	scheme	NN	I-NP
O	.	.	.	O

O	Promoter	Promoter	NN	B-NP
O	-	-	HYPH	B-PP
O	restricted	restrict	VBN	B-NP
B-GGP	H3	H3	NN	I-NP
O	Lys	Ly	VBZ	B-VP
O	4	4	CD	B-NP
O	di	di	AFX	I-NP
O	-	-	HYPH	I-NP
O	methylation	methylation	NN	I-NP
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	epigenetic	epigenetic	JJ	I-NP
O	mark	mark	NN	I-NP
O	for	for	IN	B-PP
O	monoallelic	monoallelic	JJ	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	Methylation	Methylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	tails	tail	NNS	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	implicated	implicate	VBN	I-VP
O	in	in	IN	B-PP
O	long	long	JJ	B-NP
O	-	-	HYPH	I-NP
O	term	term	NN	I-NP
O	epigenetic	epigenetic	JJ	I-NP
O	memory	memory	NN	I-NP
O	.	.	.	O

O	Methylated	Methylate	VBN	B-NP
B-GGP	H3	H3	NN	I-NP
O	Lys	Lys	NN	I-NP
O	4	4	CD	I-NP
O	(	(	(	O
O	K4	K4	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	generally	generally	RB	I-NP
O	conserved	conserve	VBN	I-NP
O	mark	mark	NN	I-NP
O	for	for	IN	B-PP
O	euchromatic	euchromatic	JJ	B-NP
O	,	,	,	I-NP
O	transcriptionally	transcriptionally	RB	I-NP
O	active	active	JJ	I-NP
O	regions	region	NNS	I-NP
O	,	,	,	O
O	although	although	IN	B-SBAR
O	the	the	DT	B-NP
O	effect	effect	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	modification	modification	NN	I-NP
O	is	be	VBZ	B-VP
O	likely	likely	RB	B-ADJP
O	also	also	RB	B-ADVP
O	to	to	TO	B-VP
O	depend	depend	VB	I-VP
O	on	on	IN	B-PP
O	its	its	PRP$	B-NP
O	distribution	distribution	NN	I-NP
O	both	both	DT	B-ADVP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	euchromatic	euchromatic	JJ	I-NP
O	region	region	NN	I-NP
O	and	and	CC	O
O	more	more	RBR	B-ADVP
O	specifically	specifically	RB	I-ADVP
O	within	within	IN	B-PP
O	a	a	DT	B-NP
O	given	give	VBN	I-NP
O	gene	gene	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	we	we	PRP	B-NP
O	describe	describe	VBP	B-VP
O	a	a	DT	B-NP
O	profile	profile	NN	I-NP
O	of	of	IN	B-PP
B-GGP	H3K4	H3K4	NN	B-NP
O	di	di	AFX	B-NP
O	-	-	HYPH	I-NP
O	methylation	methylation	NN	I-NP
O	that	that	WDT	B-NP
O	is	be	VBZ	B-VP
O	specific	specific	JJ	B-ADJP
O	for	for	IN	B-PP
O	monoallelically	monoallelically	RB	B-NP
O	expressed	express	VBN	I-NP
O	genes	gene	NNS	I-NP
O	.	.	.	O

O	Both	Both	CC	O
O	X	X	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	genes	gene	NNS	I-NP
O	subject	subject	JJ	B-ADJP
O	to	to	TO	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	O
O	inactivation	inactivation	NN	B-NP
O	and	and	CC	O
O	autosomal	autosomal	JJ	B-NP
O	imprinted	imprinted	JJ	I-NP
O	genes	gene	NNS	I-NP
O	have	have	VBP	B-VP
O	di	di	AFX	B-NP
O	-	-	HYPH	B-NP
O	methylated	methylate	VBN	I-NP
B-GGP	H3K4	H3K4	NN	I-NP
O	restricted	restrict	VBN	B-VP
O	to	to	TO	B-PP
O	their	their	PRP$	B-NP
O	promoter	promoter	NN	I-NP
O	regions	region	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	contrast	contrast	NN	B-NP
O	,	,	,	O
O	high	high	JJ	B-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	H3K4	H3K4	NN	B-NP
O	di	di	AFX	O
O	-	-	HYPH	O
O	methylation	methylation	NN	B-NP
O	are	be	VBP	B-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	both	both	CC	O
O	promoters	promoter	NNS	B-NP
O	and	and	CC	O
O	exonic	exonic	JJ	B-NP
O	parts	part	NNS	I-NP
O	of	of	IN	B-PP
O	autosomal	autosomal	JJ	B-NP
O	genes	gene	NNS	I-NP
O	and	and	CC	B-PP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	genes	gene	NNS	I-NP
O	that	that	WDT	B-NP
O	escape	escape	VBP	B-VP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	inactivation	inactivation	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	pattern	pattern	NN	I-NP
O	of	of	IN	B-PP
O	promoter	promoter	NN	B-NP
O	restricted	restricted	JJ	I-NP
B-GGP	H3	H3	NN	I-NP
O	Lys	Ly	VBZ	B-VP
O	4	4	CD	B-NP
O	di	di	AFX	I-NP
O	-	-	HYPH	I-NP
O	methylation	methylation	NN	I-NP
O	,	,	,	O
O	already	already	RB	B-ADJP
O	present	present	JJ	I-ADJP
O	in	in	IN	B-PP
O	totipotent	totipotent	JJ	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	is	be	VBZ	B-VP
O	causally	causally	RB	B-ADJP
O	related	relate	VBN	I-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	long	long	JJ	I-NP
O	-	-	HYPH	I-NP
O	term	term	NN	I-NP
O	programming	programming	NN	I-NP
O	of	of	IN	B-PP
O	allelic	allelic	JJ	B-NP
O	expression	expression	NN	I-NP
O	and	and	CC	O
O	provides	provide	VBZ	B-VP
O	an	an	DT	B-NP
O	epigenetic	epigenetic	JJ	I-NP
O	mark	mark	NN	I-NP
O	for	for	IN	B-PP
O	monoallelically	monoallelically	RB	B-NP
O	expressed	express	VBN	I-NP
O	genes	gene	NNS	I-NP
O	.	.	.	O

O	Inhibition	Inhibition	NN	B-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	deacetylase	deacetylase	NN	I-NP
O	increases	increase	VBZ	B-VP
O	cytotoxicity	cytotoxicity	NN	B-NP
O	to	to	TO	B-PP
O	anticancer	anticancer	JJ	B-NP
O	drugs	drug	NNS	I-NP
O	targeting	target	VBG	B-VP
O	DNA	DNA	NN	B-NP
O	.	.	.	O

O	Several	Several	JJ	B-NP
O	anticancer	anticancer	JJ	I-NP
O	drugs	drug	NNS	I-NP
O	target	target	NN	I-NP
O	DNA	DNA	NN	I-NP
O	or	or	CC	O
O	enzymes	enzyme	NNS	B-NP
O	acting	act	VBG	B-VP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	DNA	DNA	NN	I-NP
O	.	.	.	O

O	Because	Because	IN	B-SBAR
O	chromatin	chromatin	NN	B-NP
O	DNA	DNA	NN	I-NP
O	is	be	VBZ	B-VP
O	tightly	tightly	RB	B-ADJP
O	compacted	compacted	JJ	I-ADJP
O	,	,	,	O
O	accessibility	accessibility	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	drug	drug	NN	I-NP
O	target	target	NN	I-NP
O	may	may	MD	B-VP
O	reduce	reduce	VB	I-VP
O	the	the	DT	B-NP
O	efficiency	efficiency	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	anticancer	anticancer	JJ	I-NP
O	drugs	drug	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	thus	thus	RB	B-ADVP
O	treated	treat	VBD	B-VP
O	four	four	CD	B-NP
O	human	human	JJ	I-NP
O	cancer	cancer	NN	I-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	and	and	CC	O
O	two	two	CD	B-NP
O	normal	normal	JJ	I-NP
O	epithelial	epithelial	JJ	I-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	with	with	IN	B-PP
O	either	either	CC	O
O	trichostatin	trichostatin	NN	B-NP
O	A	A	NN	I-NP
O	(	(	(	O
O	TSA	TSA	NN	B-NP
O	)	)	)	O
O	or	or	CC	O
O	SAHA	SAHA	NN	B-NP
O	,	,	,	O
O	two	two	CD	B-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylase	deacetylase	NN	I-NP
O	inhibitors	inhibitor	NNS	I-NP
O	,	,	,	O
O	before	before	IN	B-PP
O	exposing	expose	VBG	B-VP
O	the	the	DT	B-NP
O	cells	cell	NNS	I-NP
O	to	to	TO	B-PP
O	VP	VP	NN	B-NP
O	-	-	HYPH	O
O	16	16	CD	B-NP
O	,	,	,	O
O	ellipticine	ellipticine	NN	B-NP
O	,	,	,	O
O	camptothecin	camptothecin	NN	B-NP
O	,	,	,	O
O	doxorubicin	doxorubicin	NN	B-NP
O	,	,	,	O
O	cisplatin	cisplatin	NN	B-NP
O	,	,	,	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	fluorouracil	fluorouracil	NN	I-NP
O	,	,	,	O
O	or	or	CC	O
O	cyclophosmamide	cyclophosmamide	NN	B-NP
O	.	.	.	O

O	Pretreatment	Pretreatment	NN	B-NP
O	with	with	IN	B-PP
O	TSA	TSA	NN	B-NP
O	or	or	CC	I-NP
O	SAHA	SAHA	NN	I-NP
O	increased	increase	VBD	B-VP
O	the	the	DT	B-NP
O	killing	killing	NN	I-NP
O	efficiency	efficiency	NN	I-NP
O	of	of	IN	B-PP
O	VP	VP	NN	B-NP
O	-	-	HYPH	O
O	16	16	CD	B-NP
O	,	,	,	O
O	ellipticine	ellipticine	NN	B-NP
O	,	,	,	O
O	doxorubicin	doxorubicin	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	cisplatin	cisplatin	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	magnitude	magnitude	NN	I-NP
O	of	of	IN	B-PP
O	sensitization	sensitization	NN	B-NP
O	is	be	VBZ	B-VP
O	cell	cell	NN	B-NP
O	type	type	NN	I-NP
O	specific	specific	JJ	B-ADJP
O	and	and	CC	O
O	is	be	VBZ	B-VP
O	>	>	SYM	B-NP
O	10	10	CD	I-NP
O	-	-	HYPH	B-VP
O	fold	fold	RB	B-ADVP
O	for	for	IN	B-PP
O	VP	VP	NN	B-NP
O	-	-	HYPH	O
O	16	16	CD	B-NP
O	in	in	IN	B-PP
O	D54	D54	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	brain	brain	NN	I-NP
O	tumor	tumor	NN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	intrinsically	intrinsically	RB	B-ADJP
O	resistant	resistant	JJ	I-ADJP
O	to	to	TO	B-PP
O	topoisomerase	topoisomerase	NN	B-NP
O	II	II	CD	I-NP
O	inhibitors	inhibitor	NNS	I-NP
O	.	.	.	O

O	Topoisomerase	Topoisomerase	NN	B-NP
O	II	II	CD	I-NP
O	levels	level	NNS	I-NP
O	and	and	CC	I-NP
O	activity	activity	NN	I-NP
O	were	be	VBD	B-VP
O	not	not	RB	I-VP
O	affected	affect	VBN	I-VP
O	by	by	IN	B-PP
O	this	this	DT	B-NP
O	treatment	treatment	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
B-GGP	p53	p53	NN	B-NP
O	,	,	,	O
B-GGP	p21	p21	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	Gadd45	Gadd45	NN	B-NP
O	protein	protein	NN	I-NP
O	levels	level	NNS	I-NP
O	were	be	VBD	B-VP
O	markedly	markedly	RB	I-VP
O	induced	induce	VBN	I-VP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	pretreatment	pretreatment	NN	B-NP
O	with	with	IN	B-PP
O	TSA	TSA	NN	B-NP
O	also	also	RB	B-ADVP
O	increased	increase	VBD	B-VP
O	VP	VP	NN	B-NP
O	-	-	HYPH	B-NP
O	16	16	CD	I-NP
O	-	-	HYPH	I-NP
O	induced	induce	VBN	I-NP
O	apoptosis	apoptosis	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
B-GGP	p53	p53	NN	I-NP
O	-	-	HYPH	O
O	dependent	dependent	JJ	B-NP
O	and	and	CC	I-NP
O	-	-	HYPH	I-NP
O	independent	independent	JJ	I-NP
O	manner	manner	NN	I-NP
O	.	.	.	O

O	Treating	Treat	VBG	B-VP
O	the	the	DT	B-NP
O	cells	cell	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	reverse	reverse	NN	I-NP
O	order	order	NN	I-NP
O	(	(	(	O
O	anticancer	anticancer	JJ	B-NP
O	drug	drug	NN	I-NP
O	first	first	RB	B-ADVP
O	,	,	,	O
O	followed	follow	VBN	B-VP
O	by	by	IN	B-PP
O	TSA	TSA	NN	B-NP
O	or	or	CC	O
O	SAHA	SAHA	NN	B-NP
O	)	)	)	O
O	had	have	VBD	B-VP
O	no	no	DT	B-NP
O	more	more	RBR	I-NP
O	cytotoxic	cytotoxic	JJ	I-NP
O	effect	effect	NN	I-NP
O	than	than	IN	B-PP
O	the	the	DT	B-NP
O	drug	drug	NN	I-NP
O	alone	alone	RB	B-ADVP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	loosening	loosen	VBG	B-VP
O	-	-	HYPH	O
O	up	up	RP	B-PRT
O	the	the	DT	B-NP
O	chromatin	chromatin	NN	I-NP
O	structure	structure	NN	I-NP
O	by	by	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	can	can	MD	B-VP
O	increase	increase	VB	I-VP
O	the	the	DT	B-NP
O	efficiency	efficiency	NN	I-NP
O	of	of	IN	B-PP
O	several	several	JJ	B-NP
O	anticancer	anticancer	JJ	I-NP
O	drugs	drug	NNS	I-NP
O	targeting	target	VBG	B-VP
O	DNA	DNA	NN	B-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	advantageous	advantageous	JJ	B-ADJP
O	for	for	IN	B-PP
O	treating	treat	VBG	B-VP
O	tumors	tumor	NNS	B-NP
O	intrinsically	intrinsically	RB	B-ADJP
O	resistant	resistant	JJ	I-ADJP
O	to	to	TO	B-PP
O	these	these	DT	B-NP
O	drugs	drug	NNS	I-NP
O	.	.	.	O

O	Epigenetic	Epigenetic	JJ	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	telomere	telomere	NN	B-NP
O	length	length	NN	I-NP
O	in	in	IN	B-PP
O	mammalian	mammalian	JJ	B-NP
O	cells	cell	NNS	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
B-GGP	Suv39h1	Suv39h1	NN	I-NP
O	and	and	CC	I-NP
B-GGP	Suv39h2	Suv39h2	NN	I-NP
B-GGP	histone	histone	NN	I-NP
O	methyltransferases	methyltransferas	NNS	I-NP
O	.	.	.	O

O	Telomeres	Telomere	NNPS	B-NP
O	are	be	VBP	B-VP
O	capping	cap	VBG	I-VP
O	structures	structure	NNS	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	ends	end	NNS	I-NP
O	of	of	IN	B-PP
O	eukaryotic	eukaryotic	JJ	B-NP
O	chromosomes	chromosome	NNS	I-NP
O	composed	compose	VBN	B-VP
O	of	of	IN	B-PP
O	TTAGGG	TTAGGG	NN	B-NP
O	repeats	repeat	NNS	I-NP
O	bound	bind	VBD	B-VP
O	to	to	TO	B-PP
O	an	an	DT	B-NP
O	array	array	NN	I-NP
O	of	of	IN	B-PP
O	specialized	specialize	VBN	B-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	Telomeres	Telomere	NNPS	B-NP
O	are	be	VBP	B-VP
O	heterochromatic	heterochromatic	JJ	B-NP
O	regions	region	NNS	I-NP
O	.	.	.	O

O	Yeast	Yeast	NN	B-NP
O	and	and	CC	I-NP
O	flies	fly	NNS	I-NP
O	with	with	IN	B-PP
O	defects	defect	NNS	B-NP
O	in	in	IN	B-PP
O	activities	activity	NNS	B-NP
O	that	that	WDT	B-NP
O	modify	modify	VBP	B-VP
O	the	the	DT	B-NP
O	state	state	NN	I-NP
O	of	of	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	also	also	RB	B-ADVP
O	have	have	VBP	B-VP
O	abnormal	abnormal	JJ	B-NP
O	telomere	telomere	NN	I-NP
O	function	function	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
O	the	the	DT	B-NP
O	putative	putative	JJ	I-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	-	-	HYPH	O
O	modifying	modify	VBG	B-VP
O	activities	activity	NNS	B-NP
O	in	in	IN	B-PP
O	regulating	regulate	VBG	B-VP
O	telomeres	telomere	NNS	B-NP
O	in	in	IN	B-PP
O	mammals	mammal	NNS	B-NP
O	is	be	VBZ	B-VP
O	unknown	unknown	JJ	B-ADJP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	we	we	PRP	B-NP
O	report	report	VBP	B-VP
O	on	on	IN	B-PP
O	telomere	telomere	NN	B-NP
O	length	length	NN	I-NP
O	and	and	CC	I-NP
O	function	function	NN	I-NP
O	in	in	IN	B-PP
O	mice	mouse	NNS	B-NP
O	null	null	JJ	B-ADJP
O	with	with	IN	B-PP
O	respect	respect	NN	B-NP
O	to	to	TO	B-PP
O	both	both	CC	O
O	the	the	DT	B-NP
B-GGP	histone	histone	NN	I-NP
O	methyltransferases	methyltransferas	NNS	I-NP
O	(	(	(	O
O	HMTases	HMTas	NNS	B-NP
O	)	)	)	O
B-GGP	Suv39h1	Suv39h1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Suv39h2	Suv39h2	NN	I-NP
O	(	(	(	O
O	called	call	VBN	B-VP
O	SUV39DN	SUV39DN	NN	B-NP
O	mice	mouse	NNS	I-NP
O	)	)	)	O
O	.	.	.	O

B-GGP	Suv39h1	Suv39h1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Suv39h2	Suv39h2	NN	I-NP
O	govern	govern	NN	I-NP
O	methylation	methylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	Lys9	Lys9	NN	I-NP
O	(	(	(	O
B-GGP	H3	H3	NN	B-NP
O	-	-	HYPH	B-NP
O	Lys9	Lys9	NN	I-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	heterochromatic	heterochromatic	JJ	B-NP
O	regions	region	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	primary	primary	JJ	B-NP
O	cells	cell	NNS	I-NP
O	derived	derive	VBN	B-VP
O	from	from	IN	B-PP
O	SUV39DN	SUV39DN	NN	B-NP
O	mice	mouse	NNS	I-NP
O	have	have	VBP	B-VP
O	abnormally	abnormally	RB	B-NP
O	long	long	JJ	I-NP
O	telomeres	telomere	NNS	I-NP
O	relative	relative	JJ	B-ADVP
O	to	to	TO	B-PP
O	wild	wild	JJ	B-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	controls	control	NNS	I-NP
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	chromatin	chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	(	(	(	O
O	ChIP	ChIP	NN	B-NP
O	)	)	)	O
O	analysis	analysis	NN	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
O	telomeres	telomere	NNS	B-NP
O	were	be	VBD	B-VP
O	enriched	enrich	VBN	I-VP
O	in	in	IN	B-PP
O	di	di	AFX	B-NP
O	-	-	HYPH	I-NP
O	and	and	CC	I-NP
O	trimethylated	trimethylate	VBN	I-NP
B-GGP	H3	H3	NN	I-NP
O	-	-	HYPH	B-NP
O	Lys9	Lys9	NN	I-NP
O	but	but	CC	O
O	that	that	IN	B-SBAR
O	telomeres	telomere	NNS	B-NP
O	of	of	IN	B-PP
O	SUV39DN	SUV39DN	NN	B-NP
O	cells	cell	NNS	I-NP
O	had	have	VBD	B-VP
O	less	less	RBR	I-VP
O	dimethylated	dimethylate	VBN	I-VP
O	and	and	CC	I-VP
O	trimethylated	trimethylate	VBN	B-NP
B-GGP	H3	H3	NN	I-NP
O	-	-	HYPH	O
O	Lys9	Lys9	NN	B-NP
O	but	but	CC	O
O	more	more	RBR	B-NP
O	monomethylated	monomethylate	VBN	I-NP
B-GGP	H3	H3	NN	I-NP
O	-	-	HYPH	B-NP
O	Lys9	Lys9	NN	I-NP
O	.	.	.	O

O	Concomitant	Concomitant	JJ	B-ADJP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
B-GGP	H3	H3	NN	B-NP
O	-	-	HYPH	B-NP
O	Lys9	Lys9	NN	I-NP
O	methylation	methylation	NN	I-NP
O	,	,	,	O
O	telomeres	telomere	VBZ	B-VP
O	in	in	IN	B-PP
O	SUV39DN	SUV39DN	NN	B-NP
O	cells	cell	NNS	I-NP
O	had	have	VBD	B-VP
O	reduced	reduce	VBN	I-VP
O	binding	binding	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	chromobox	chromobox	NN	I-NP
O	proteins	protein	NNS	I-NP
B-GGP	Cbx1	Cbx1	NN	I-NP
O	,	,	,	I-NP
B-GGP	Cbx3	Cbx3	NN	I-NP
O	and	and	CC	I-NP
B-GGP	Cbx5	Cbx5	NN	I-NP
O	,	,	,	O
O	homologs	homolog	NNS	B-NP
O	of	of	IN	B-PP
O	Drosophila	Drosophila	FW	B-NP
O	melanogaster	melanogaster	FW	I-NP
B-GGP	heterochromatin	heterochromatin	NN	I-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
B-GGP	HP1	HP1	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	These	These	DT	B-NP
O	findings	finding	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	substantial	substantial	JJ	B-NP
O	changes	change	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	state	state	NN	I-NP
O	of	of	IN	B-PP
O	telomeric	telomeric	JJ	B-NP
O	heterochromatin	heterochromatin	NN	I-NP
O	in	in	IN	B-PP
O	SUV39DN	SUV39DN	NN	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	are	be	VBP	B-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	abnormal	abnormal	JJ	B-NP
O	telomere	telomere	NN	I-NP
O	elongation	elongation	NN	I-NP
O	.	.	.	O

O	Taken	Take	VBN	B-VP
O	together	together	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	results	result	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	epigenetic	epigenetic	JJ	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	telomere	telomere	NN	B-NP
O	length	length	NN	I-NP
O	in	in	IN	B-PP
O	mammals	mammal	NNS	B-NP
O	by	by	IN	B-PP
B-GGP	Suv39h1	Suv39h1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Suv39h2	Suv39h2	NN	I-NP
O	.	.	.	O

O	Role	Role	NN	B-NP
O	of	of	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	organic	organic	JJ	I-NP
O	anion	anion	NN	I-NP
O	transporter	transporter	NN	I-NP
B-GGP	OAT1	OAT1	NN	I-NP
O	.	.	.	O

O	Organic	Organic	JJ	B-NP
O	anion	anion	NN	I-NP
O	transporters	transporter	NNS	I-NP
O	(	(	(	O
O	OAT	OAT	NN	B-NP
O	)	)	)	O
O	play	play	VBP	B-VP
O	essential	essential	JJ	B-NP
O	roles	role	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	body	body	NN	I-NP
O	disposition	disposition	NN	I-NP
O	of	of	IN	B-PP
O	clinically	clinically	RB	B-NP
O	important	important	JJ	I-NP
O	anionic	anionic	JJ	I-NP
O	drugs	drug	NNS	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	antiviral	antiviral	JJ	B-NP
O	drugs	drug	NNS	I-NP
O	,	,	,	O
O	antitumor	antitumor	JJ	B-NP
O	drugs	drug	NNS	I-NP
O	,	,	,	O
O	antibiotics	antibiotic	NNS	B-NP
O	,	,	,	O
O	antihypertensives	antihypertensive	NNS	B-NP
O	,	,	,	O
O	and	and	CC	O
O	anti	anti	AFX	B-NP
O	-	-	HYPH	I-NP
O	inflammatories	inflammatory	NNS	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	reported	report	VBD	B-VP
O	previously	previously	RB	B-ADVP
O	(	(	(	O
O	Kuze	Kuze	NNP	B-NP
O	,	,	,	O
O	K	K	NNP	B-NP
O	.	.	NNP	I-NP
O	,	,	,	O
O	Graves	Graves	NN	B-NP
O	,	,	,	O
O	P	P	NN	B-NP
O	.	.	.	O
O	,	,	,	O
O	Leahy	Leahy	NNP	B-NP
O	,	,	,	O
O	A	A	NNP	B-NP
O	.	.	.	O
O	,	,	,	O
O	Wilson	Wilson	NNP	B-NP
O	,	,	,	O
O	P	P	NNP	B-NP
O	.	.	.	O
O	,	,	,	O
O	Stuhlmann	Stuhlmann	NNP	B-NP
O	,	,	,	O
O	H	H	NNP	B-NP
O	.	.	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	You	You	PRP	B-NP
O	,	,	,	O
O	G	G	NN	B-NP
O	.	.	.	O

O	(	(	(	O
O	1999	1999	CD	B-NP
O	)	)	)	O
O	J	J	NNP	B-NP
O	.	.	.	O

O	Biol	Biol	NN	B-NP
O	.	.	.	O

O	Chem	Chem	NNP	B-NP
O	.	.	.	O

O	274	274	CD	B-NP
O	,	,	,	I-NP
O	1519	1519	CD	I-NP
O	-	-	HYPH	I-NP
O	1524	1524	CD	I-NP
O	)	)	)	O
O	that	that	IN	B-SBAR
O	tunicamycin	tunicamycin	NN	B-NP
O	,	,	,	O
O	an	an	DT	B-NP
O	inhibitor	inhibitor	NN	I-NP
O	of	of	IN	B-PP
O	asparagine	asparagine	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	,	,	,	O
O	significantly	significantly	RB	B-ADVP
O	inhibited	inhibit	VBD	B-VP
O	organic	organic	JJ	B-NP
O	anion	anion	NN	I-NP
O	transport	transport	NN	I-NP
O	in	in	IN	B-PP
O	COS	COS	NN	B-NP
O	-	-	HYPH	B-NP
O	7	7	CD	I-NP
O	cells	cell	NNS	I-NP
O	expressing	express	VBG	B-VP
O	a	a	DT	B-NP
O	mouse	mouse	NN	I-NP
O	organic	organic	JJ	I-NP
O	anion	anion	NN	I-NP
O	transporter	transporter	NN	I-NP
O	(	(	(	O
B-GGP	mOAT1	mOAT1	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	in	in	IN	B-PP
B-GGP	mOAT1	mOAT1	NN	B-NP
O	function	function	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	investigated	investigate	VBD	B-VP
O	the	the	DT	B-NP
O	effect	effect	NN	I-NP
O	of	of	IN	B-PP
O	disrupting	disrupt	VBG	B-VP
O	putative	putative	JJ	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	sites	site	NNS	I-NP
O	in	in	IN	B-PP
B-GGP	mOAT1	mOAT1	NN	B-NP
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	its	its	PRP$	B-NP
O	human	human	JJ	I-NP
O	counterpart	counterpart	NN	I-NP
O	,	,	,	O
B-GGP	hOAT1	hOAT1	NN	B-NP
O	,	,	,	O
O	by	by	IN	B-PP
O	mutating	mutate	VBG	B-VP
O	asparagine	asparagine	NN	B-NP
O	to	to	TO	B-PP
O	glutamine	glutamine	NN	B-NP
O	and	and	CC	O
O	assessing	assess	VBG	B-VP
O	mutant	mutant	JJ	B-NP
O	transporters	transporter	NNS	I-NP
O	in	in	IN	B-PP
O	HeLa	HeLa	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	putative	putative	JJ	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	Asp	Asp	NN	I-NP
O	-	-	HYPH	O
O	39	39	CD	B-NP
O	in	in	IN	B-PP
B-GGP	mOAT1	mOAT1	NN	B-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	glycosylated	glycosylate	VBN	I-VP
O	but	but	CC	O
O	the	the	DT	B-NP
O	corresponding	correspond	VBG	I-NP
O	site	site	NN	I-NP
O	(	(	(	O
O	Asp	Asp	NN	B-NP
O	-	-	HYPH	B-NP
O	39	39	CD	I-NP
O	)	)	)	O
O	in	in	IN	B-PP
B-GGP	hOAT1	hOAT1	NN	B-NP
O	was	be	VBD	B-VP
O	glycosylated	glycosylate	VBN	I-VP
O	.	.	.	O

O	Disrupting	Disrupt	VBG	B-NP
O	Asp	Asp	NN	I-NP
O	-	-	HYPH	O
O	39	39	CD	B-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	complete	complete	JJ	I-NP
O	loss	loss	NN	I-NP
O	of	of	IN	B-PP
O	transport	transport	NN	B-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	both	both	CC	O
B-GGP	mOAT1	mOAT1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	hOAT1	hOAT1	NN	I-NP
O	without	without	IN	B-PP
O	affecting	affect	VBG	B-VP
O	their	their	PRP$	B-NP
O	cell	cell	NN	I-NP
O	surface	surface	NN	I-NP
O	expression	expression	NN	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	loss	loss	NN	I-NP
O	of	of	IN	B-PP
O	function	function	NN	B-NP
O	is	be	VBZ	B-VP
O	not	not	RB	O
O	because	because	IN	B-PP
O	of	of	IN	I-PP
O	deglycosylation	deglycosylation	NN	B-NP
O	of	of	IN	B-PP
O	Asp	Asp	NN	B-NP
O	-	-	HYPH	O
O	39	39	CD	B-NP
O	per	per	FW	I-NP
O	se	se	FW	I-NP
O	but	but	CC	O
O	rather	rather	RB	B-VP
O	is	be	VBZ	I-VP
O	likely	likely	JJ	B-ADJP
O	because	because	IN	B-PP
O	of	of	IN	I-PP
O	the	the	DT	B-NP
O	change	change	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	important	important	JJ	I-NP
O	amino	amino	NN	I-NP
O	acid	acid	NN	I-NP
O	critically	critically	RB	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	substrate	substrate	NN	I-NP
O	binding	binding	NN	I-NP
O	.	.	.	O

O	Single	Single	JJ	B-NP
O	replacement	replacement	NN	I-NP
O	of	of	IN	B-PP
O	asparagines	asparagine	NNS	B-NP
O	at	at	IN	B-PP
O	other	other	JJ	B-NP
O	sites	site	NNS	I-NP
O	had	have	VBD	B-VP
O	no	no	DT	B-NP
O	effect	effect	NN	I-NP
O	on	on	IN	B-PP
O	transport	transport	NN	B-NP
O	activity	activity	NN	I-NP
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
O	glycosylation	glycosylation	NN	B-NP
O	at	at	IN	B-PP
O	individual	individual	JJ	B-NP
O	sites	site	NNS	I-NP
O	is	be	VBZ	B-VP
O	not	not	RB	O
O	essential	essential	JJ	B-ADJP
O	for	for	IN	B-PP
O	OAT	OAT	NN	B-NP
O	function	function	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	contrast	contrast	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	simultaneous	simultaneous	JJ	I-NP
O	replacement	replacement	NN	I-NP
O	of	of	IN	B-PP
O	all	all	DT	B-NP
O	asparagines	asparagine	NNS	I-NP
O	in	in	IN	B-PP
O	both	both	CC	O
B-GGP	mOAT1	mOAT1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	hOAT1	hOAT1	NN	I-NP
O	impaired	impair	VBD	B-VP
O	the	the	DT	B-NP
O	trafficking	trafficking	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	transporters	transporter	NNS	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	plasma	plasma	NN	I-NP
O	membrane	membrane	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	summary	summary	NN	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	provided	provide	VBD	B-VP
O	the	the	DT	B-NP
O	evidence	evidence	NN	I-NP
O	that	that	IN	B-SBAR
O	1	1	LS	B-LST
O	)	)	)	O
O	Asp	Asp	NN	B-NP
O	-	-	HYPH	O
O	39	39	CD	B-NP
O	is	be	VBZ	B-VP
O	crucially	crucially	RB	I-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	substrate	substrate	NN	B-NP
O	recognition	recognition	NN	I-NP
O	of	of	IN	B-PP
B-GGP	OAT1	OAT1	NN	B-NP
O	,	,	,	O
O	2	2	LS	B-LST
O	)	)	)	O
O	glycosylation	glycosylation	NN	B-NP
O	at	at	IN	B-PP
O	individual	individual	JJ	B-NP
O	sites	site	NNS	I-NP
O	is	be	VBZ	B-VP
O	not	not	RB	I-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
B-GGP	OAT1	OAT1	NN	B-NP
O	function	function	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	3	3	LS	B-LST
O	)	)	)	O
O	glycosylation	glycosylation	NN	B-NP
O	plays	play	VBZ	B-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	targeting	targeting	NN	I-NP
O	of	of	IN	B-PP
B-GGP	OAT1	OAT1	NN	B-NP
O	onto	onto	IN	B-PP
O	the	the	DT	B-NP
O	plasma	plasma	NN	I-NP
O	membrane	membrane	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	study	study	NN	I-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	molecular	molecular	JJ	I-NP
O	identification	identification	NN	I-NP
O	and	and	CC	I-NP
O	characterization	characterization	NN	I-NP
O	of	of	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	OAT1	OAT1	NN	B-NP
O	and	and	CC	O
O	may	may	MD	B-VP
O	provide	provide	VB	I-VP
O	important	important	JJ	B-NP
O	insights	insight	NNS	I-NP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	structure	structure	NN	I-NP
O	-	-	HYPH	B-NP
O	function	function	NN	I-NP
O	relationships	relationship	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	organic	organic	JJ	I-NP
O	anion	anion	NN	I-NP
O	transporter	transporter	NN	I-NP
O	family	family	NN	I-NP
O	.	.	.	O

O	Cytochrome	Cytochrome	NN	B-NP
O	P450	P450	NN	I-NP
O	isoenzymes	isoenzyme	NNS	I-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	rat	rat	NN	B-NP
O	liver	liver	NN	I-NP
O	microsomal	microsomal	JJ	I-NP
O	metabolism	metabolism	NN	I-NP
O	of	of	IN	B-PP
O	californine	californine	NN	B-NP
O	and	and	CC	I-NP
O	protopine	protopine	NN	I-NP
O	.	.	.	O

O	Studies	Study	NNS	B-NP
O	are	be	VBP	B-VP
O	described	describe	VBN	I-VP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	cytochrome	cytochrome	NN	I-NP
O	P450	P450	NN	I-NP
O	(	(	(	O
O	CYP	CYP	NN	B-NP
O	)	)	)	O
O	isoenzyme	isoenzyme	NN	B-NP
O	dependence	dependence	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	main	main	JJ	I-NP
O	metabolic	metabolic	JJ	I-NP
O	steps	step	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Eschscholtzia	Eschscholtzia	NNP	I-NP
O	californica	californica	NN	I-NP
O	alkaloids	alkaloid	NNS	I-NP
O	californine	californine	NN	I-NP
O	and	and	CC	I-NP
O	protopine	protopine	NN	I-NP
O	using	use	VBG	B-VP
O	rat	rat	NN	B-NP
O	liver	liver	NN	I-NP
O	microsomes	microsome	NNS	I-NP
O	.	.	.	O

O	Preparations	Preparation	NNS	B-NP
O	of	of	IN	B-PP
O	E	E	NN	B-NP
O	.	.	.	O
O	californica	californica	NN	B-NP
O	are	be	VBP	B-VP
O	in	in	IN	B-PP
O	use	use	NN	B-NP
O	as	as	IN	B-PP
O	phytopharmaceuticals	phytopharmaceutical	NNS	B-NP
O	and	and	CC	B-PP
O	as	as	IN	B-PP
O	herbal	herbal	JJ	B-NP
O	drugs	drug	NNS	I-NP
O	of	of	IN	B-PP
O	abuse	abuse	NN	B-NP
O	.	.	.	O

O	CYP	CYP	NN	B-NP
O	isoenzyme	isoenzyme	NN	I-NP
O	dependences	dependence	NNS	I-NP
O	were	be	VBD	B-VP
O	studied	study	VBN	I-VP
O	using	use	VBG	B-VP
O	specific	specific	JJ	B-NP
O	chemical	chemical	JJ	I-NP
O	inhibitors	inhibitor	NNS	I-NP
O	for	for	IN	B-PP
B-GGP	CYP1A2	CYP1A2	NN	B-NP
O	,	,	,	O
B-GGP	CYP2D1	CYP2D1	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	CYP3A2	CYP3A2	NN	B-NP
O	(	(	(	O
O	alpha	alpha	SYM	O
O	-	-	HYPH	O
O	naphthoflavone	naphthoflavone	NN	B-NP
O	,	,	,	O
O	quinine	quinine	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	ketoconazole	ketoconazole	NN	B-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	)	)	)	O
O	.	.	.	O

B-GGP	CYP2C11	CYP2C11	NN	B-NP
O	was	be	VBD	B-VP
O	inhibited	inhibit	VBN	I-VP
O	by	by	IN	B-PP
O	specific	specific	JJ	B-NP
O	antibodies	antibody	NNS	I-NP
O	for	for	IN	B-PP
O	lack	lack	NN	B-NP
O	of	of	IN	B-PP
O	specific	specific	JJ	B-NP
O	chemical	chemical	JJ	I-NP
O	inhibitors	inhibitor	NNS	I-NP
O	.	.	.	O

O	Californine	Californine	NN	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	demethylation	demethylation	NN	I-NP
O	was	be	VBD	B-VP
O	mainly	mainly	RB	I-VP
O	catalyzed	catalyze	VBN	I-VP
O	by	by	IN	B-PP
B-GGP	CYP3A2	CYP3A2	NN	B-NP
O	and	and	CC	B-PP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	minor	minor	JJ	I-NP
O	extent	extent	NN	I-NP
O	by	by	IN	B-PP
B-GGP	CYP1A2	CYP1A2	NN	B-NP
O	and	and	CC	I-NP
B-GGP	CYP2D1	CYP2D1	NN	I-NP
O	,	,	,	B-PP
O	but	but	CC	I-PP
O	not	not	RB	B-PP
O	by	by	IN	I-PP
B-GGP	CYP2C11	CYP2C11	NN	B-NP
O	.	.	.	O

B-GGP	CYP2D1	CYP2D1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	CYP2C11	CYP2C11	NN	I-NP
O	were	be	VBD	B-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	mainly	mainly	RB	I-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	demethylenation	demethylenation	NN	B-NP
O	of	of	IN	B-PP
O	both	both	CC	B-NP
O	,	,	,	I-NP
O	californine	californine	NN	I-NP
O	and	and	CC	I-NP
O	protopine	protopine	NN	I-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
B-GGP	CYP1A2	CYP1A2	NN	B-NP
O	and	and	CC	I-NP
B-GGP	CYP3A2	CYP3A2	NN	I-NP
O	showed	show	VBD	B-VP
O	only	only	RB	B-NP
O	minor	minor	JJ	I-NP
O	contribution	contribution	NN	I-NP
O	.	.	.	O

O	Kinetic	Kinetic	JJ	B-NP
O	parameters	parameter	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	reactions	reaction	NNS	I-NP
O	were	be	VBD	B-VP
O	established	establish	VBN	I-VP
O	.	.	.	O

O	K	K	NN	B-NP
O	(	(	(	O
O	m	m	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	V	V	NN	B-NP
O	(	(	(	O
O	max	max	NN	B-NP
O	)	)	)	O
O	values	value	NNS	B-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	californine	californine	NN	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	demethylation	demethylation	NN	I-NP
O	were	be	VBD	B-VP
O	4	4	CD	B-NP
O	.	.	SYM	I-NP
O	5	5	CD	I-NP
O	+	+	SYM	O
O	/	/	SYM	O
O	-	-	SYM	B-NP
O	4	4	CD	B-NP
O	.	.	SYM	I-NP
O	7	7	CD	I-NP
O	microM	microM	NN	I-NP
O	and	and	CC	O
O	22	22	CD	B-NP
O	.	.	.	I-NP
O	9	9	CD	I-NP
O	+	+	SYM	O
O	/	/	SYM	O
O	-	-	SYM	B-NP
O	13	13	CD	B-NP
O	.	.	SYM	I-NP
O	7	7	CD	I-NP
O	min	min	NN	I-NP
O	/	/	SYM	O
O	mg	mg	NN	B-NP
O	protein	protein	NN	I-NP
O	(	(	(	O
O	high	high	JJ	B-NP
O	affinity	affinity	NN	I-NP
O	)	)	)	O
O	and	and	CC	O
O	161	161	CD	B-NP
O	.	.	.	I-NP
O	3	3	CD	I-NP
O	+	+	SYM	B-NP
O	/	/	SYM	B-VP
O	-	-	SYM	B-NP
O	16	16	CD	B-NP
O	.	.	SYM	I-NP
O	7	7	CD	I-NP
O	microM	microM	NN	I-NP
O	and	and	CC	O
O	311	311	CD	B-NP
O	.	.	.	I-NP
O	8	8	CD	I-NP
O	+	+	SYM	O
O	/	/	SYM	O
O	-	-	SYM	B-NP
O	39	39	CD	B-NP
O	.	.	.	I-NP
O	4	4	CD	I-NP
O	min	min	NN	I-NP
O	/	/	SYM	O
O	mg	mg	NN	B-NP
O	protein	protein	NN	I-NP
O	(	(	(	O
O	low	low	JJ	B-NP
O	affinity	affinity	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	Californine	Californine	NN	B-NP
O	demethylenation	demethylenation	NN	I-NP
O	and	and	CC	O
O	protopine	protopine	NN	B-NP
O	demethylenation	demethylenation	NN	I-NP
O	showed	show	VBD	B-VP
O	substrate	substrate	NN	B-NP
O	inhibition	inhibition	NN	I-NP
O	and	and	CC	O
O	K	K	NN	B-NP
O	(	(	(	O
O	m	m	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	V	V	NN	B-NP
O	(	(	(	O
O	max	max	NN	B-NP
O	)	)	)	O
O	values	value	NNS	B-NP
O	were	be	VBD	B-VP
O	5	5	CD	B-NP
O	.	.	SYM	I-NP
O	0	0	CD	I-NP
O	+	+	SYM	O
O	/	/	SYM	O
O	-	-	SYM	B-NP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	5	5	CD	I-NP
O	and	and	CC	I-NP
O	7	7	CD	I-NP
O	.	.	.	O
O	1	1	CD	B-NP
O	+	+	SYM	O
O	/	/	SYM	O
O	-	-	SYM	B-NP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	6	6	CD	I-NP
O	microM	microM	NN	I-NP
O	and	and	CC	I-NP
O	83	83	CD	I-NP
O	.	.	.	I-NP
O	3	3	CD	I-NP
O	+	+	SYM	B-NP
O	/	/	SYM	B-NP
O	-	-	SYM	B-VP
O	2	2	CD	B-NP
O	.	.	.	O
O	6	6	CD	B-NP
O	and	and	CC	I-NP
O	160	160	CD	I-NP
O	.	.	.	I-NP
O	7	7	CD	I-NP
O	+	+	SYM	O
O	/	/	SYM	B-NP
O	-	-	SYM	B-NP
O	4	4	CD	B-NP
O	.	.	SYM	I-NP
O	0	0	CD	I-NP
O	min	min	NN	I-NP
O	/	/	SYM	B-NP
O	mg	mg	NN	I-NP
O	protein	protein	NN	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	Expression	Expression	NN	B-NP
O	and	and	CC	I-NP
O	methylation	methylation	NN	I-NP
O	status	status	NN	I-NP
O	of	of	IN	B-PP
B-GGP	14	14	CD	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	sigma	sigma	SYM	I-NP
O	gene	gene	NN	I-NP
O	can	can	MD	B-VP
O	characterize	characterize	VB	I-VP
O	the	the	DT	B-NP
O	different	different	JJ	I-NP
O	histological	histological	JJ	I-NP
O	features	feature	NNS	I-NP
O	of	of	IN	B-PP
O	ovarian	ovarian	JJ	B-NP
O	cancer	cancer	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	hypothesize	hypothesize	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	14	14	CD	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	sigma	sigma	SYM	I-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	regulation	regulation	NN	I-NP
O	by	by	IN	B-PP
O	methylation	methylation	NN	B-NP
O	can	can	MD	B-VP
O	characterize	characterize	VB	I-VP
O	histological	histological	JJ	B-NP
O	types	type	NNS	I-NP
O	of	of	IN	B-PP
O	primary	primary	JJ	B-NP
O	human	human	JJ	I-NP
O	epithelial	epithelial	JJ	I-NP
O	ovarian	ovarian	JJ	I-NP
O	cancer	cancer	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	test	test	VB	I-VP
O	this	this	DT	B-NP
O	hypothesis	hypothesis	NN	I-NP
O	,	,	,	O
O	ovarian	ovarian	JJ	B-NP
O	cancer	cancer	NN	I-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	and	and	CC	O
O	54	54	CD	B-NP
O	ovarian	ovarian	JJ	I-NP
O	cancer	cancer	NN	I-NP
O	tissue	tissue	NN	I-NP
O	samples	sample	NNS	I-NP
O	were	be	VBD	B-VP
O	analyzed	analyze	VBN	I-VP
O	for	for	IN	B-PP
O	expression	expression	NN	B-NP
O	and	and	CC	O
O	methylation	methylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	14	14	CD	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	sigma	sigma	SYM	I-NP
O	gene	gene	NN	I-NP
O	using	use	VBG	B-VP
O	methylation	methylation	NN	B-NP
O	specific	specific	JJ	I-NP
O	PCR	PCR	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	of	of	IN	B-PP
O	our	our	PRP$	B-NP
O	experiments	experiment	NNS	I-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	14	14	CD	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	sigma	sigma	SYM	I-NP
O	gene	gene	NN	I-NP
O	was	be	VBD	B-VP
O	methylated	methylate	VBN	I-VP
O	and	and	CC	O
O	inactivated	inactivate	VBN	B-VP
O	in	in	IN	B-PP
O	ES	ES	NN	B-NP
O	-	-	HYPH	B-NP
O	2	2	CD	I-NP
O	ovarian	ovarian	JJ	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	was	be	VBD	B-VP
O	derived	derive	VBN	I-VP
O	from	from	IN	B-PP
O	clear	clear	JJ	B-NP
O	cell	cell	NN	I-NP
O	adenocarcinoma	adenocarcinoma	NN	I-NP
O	.	.	.	O

O	Treatment	Treatment	NN	B-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	with	with	IN	B-PP
O	demethylating	demethylate	VBG	B-VP
O	agent	agent	NN	B-NP
O	5	5	CD	I-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	I-NP
O	2	2	CD	I-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	deoxycytidine	deoxycytidine	NN	I-NP
O	restored	restore	VBD	B-VP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	14	14	CD	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	sigma	sigma	SYM	I-NP
O	gene	gene	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	human	human	JJ	B-NP
O	ovarian	ovarian	JJ	I-NP
O	cancer	cancer	NN	I-NP
O	tissues	tissue	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	14	14	CD	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	sigma	sigma	SYM	I-NP
O	protein	protein	NN	I-NP
O	was	be	VBD	B-VP
O	inactivated	inactivate	VBN	I-VP
O	in	in	IN	B-PP
O	most	most	JJS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	ovarian	ovarian	JJ	I-NP
O	clear	clear	JJ	I-NP
O	cell	cell	NN	I-NP
O	carcinoma	carcinoma	NN	I-NP
O	tissues	tissue	NNS	I-NP
O	.	.	.	O

O	Interestingly	Interestingly	RB	B-ADVP
O	,	,	,	O
B-GGP	14	14	CD	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	sigma	sigma	SYM	I-NP
O	protein	protein	NN	I-NP
O	expression	expression	NN	I-NP
O	was	be	VBD	B-VP
O	positive	positive	JJ	B-ADJP
O	in	in	IN	B-PP
O	significantly	significantly	RB	B-NP
O	higher	high	JJR	I-NP
O	percentages	percentage	NNS	I-NP
O	of	of	IN	B-PP
O	serous	serous	JJ	B-NP
O	(	(	(	O
O	89	89	CD	B-NP
O	.	.	.	O
O	5	5	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	endometrioid	endometrioid	JJ	B-ADJP
O	(	(	(	O
O	90	90	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
O	mucinous	mucinous	JJ	B-ADJP
O	(	(	(	O
O	81	81	CD	B-NP
O	.	.	.	O
O	8	8	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	I-NP
O	ovarian	ovarian	JJ	I-NP
O	adenocarcinoma	adenocarcinoma	NN	I-NP
O	tissues	tissue	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	ovarian	ovarian	JJ	I-NP
O	clear	clear	JJ	I-NP
O	cell	cell	NN	I-NP
O	carcinoma	carcinoma	NN	I-NP
O	samples	sample	NNS	I-NP
O	with	with	IN	B-PP
O	inactivated	inactivate	VBN	B-NP
B-GGP	14	14	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	sigma	sigma	SYM	I-NP
O	protein	protein	NN	I-NP
O	were	be	VBD	B-VP
O	highly	highly	RB	I-VP
O	methylated	methylate	VBN	I-VP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	inactivation	inactivation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	14	14	CD	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	sigma	sigma	NN	I-NP
O	gene	gene	NN	I-NP
O	is	be	VBZ	B-VP
O	through	through	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	direct	direct	JJ	B-NP
O	DNA	DNA	NN	I-NP
O	sequencing	sequencing	NN	I-NP
O	,	,	,	O
B-GGP	14	14	CD	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	sigma	sigma	SYM	I-NP
O	gene	gene	NN	I-NP
O	methylation	methylation	NN	I-NP
O	on	on	IN	B-PP
O	all	all	PDT	B-NP
O	the	the	DT	I-NP
O	17	17	CD	I-NP
O	CpG	CpG	NN	I-NP
O	sites	site	NNS	I-NP
O	was	be	VBD	B-VP
O	significantly	significantly	RB	B-ADJP
O	higher	high	JJR	I-ADJP
O	in	in	IN	B-PP
O	ovarian	ovarian	JJ	B-NP
O	clear	clear	JJ	I-NP
O	cell	cell	NN	I-NP
O	carcinoma	carcinoma	NN	I-NP
O	as	as	IN	B-SBAR
O	compared	compare	VBN	B-VP
O	to	to	TO	B-PP
O	other	other	JJ	B-NP
O	histological	histological	JJ	I-NP
O	types	type	NNS	I-NP
O	of	of	IN	B-PP
O	ovarian	ovarian	JJ	B-NP
O	cancer	cancer	NN	I-NP
O	(	(	(	O
O	serous	serous	JJ	B-ADJP
O	,	,	,	O
O	endometrioid	endometrioid	JJ	B-ADJP
O	,	,	,	O
O	and	and	CC	O
O	mucinous	mucinous	JJ	B-ADJP
O	)	)	)	O
O	.	.	.	O

O	This	This	DT	B-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	report	report	NN	I-NP
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
B-GGP	14	14	CD	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	3	3	CD	I-NP
I-GGP	sigma	sigma	SYM	I-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	and	and	CC	O
O	methylation	methylation	NN	B-NP
O	status	status	NN	I-NP
O	can	can	MD	B-VP
O	characterize	characterize	VB	I-VP
O	histological	histological	JJ	B-NP
O	features	feature	NNS	I-NP
O	of	of	IN	B-PP
O	different	different	JJ	B-NP
O	types	type	NNS	I-NP
O	of	of	IN	B-PP
O	ovarian	ovarian	JJ	B-NP
O	cancer	cancer	NN	I-NP
O	.	.	.	O

O	Thrombophilic	Thrombophilic	JJ	B-NP
O	dysfibrinogen	dysfibrinogen	NN	I-NP
O	Tokyo	Tokyo	NNP	I-NP
O	V	V	NNP	I-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	substitution	substitution	NN	I-NP
O	of	of	IN	B-PP
O	gammaAla327Thr	gammaAla327Thr	NN	B-NP
O	:	:	:	O
O	formation	formation	NN	B-NP
O	of	of	IN	B-PP
O	fragile	fragile	NN	B-NP
O	but	but	CC	I-NP
O	fibrinolysis	fibrinolysis	NN	I-NP
O	-	-	HYPH	I-NP
O	resistant	resistant	JJ	I-NP
O	fibrin	fibrin	NN	I-NP
O	clots	clot	NNS	I-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	relevance	relevance	NN	I-NP
O	to	to	TO	B-PP
O	arterial	arterial	JJ	B-NP
O	thromboembolism	thromboembolism	NN	I-NP
O	.	.	.	O

O	Thrombophilic	Thrombophilic	JJ	B-NP
O	dysfibrinogen	dysfibrinogen	NN	I-NP
O	Tokyo	Tokyo	NNP	I-NP
O	V	V	NNP	I-NP
O	was	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	43	43	CD	I-NP
O	-	-	HYPH	I-NP
O	year	year	NN	I-NP
O	-	-	HYPH	O
O	old	old	JJ	B-NP
O	man	man	NN	I-NP
O	with	with	IN	B-PP
O	recurrent	recurrent	JJ	B-NP
O	thromboembolism	thromboembolism	NN	I-NP
O	.	.	.	O

O	Based	Base	VBN	B-PP
O	on	on	IN	B-PP
O	analyses	analysis	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	patient	patient	NN	I-NP
O	fibrinogen	fibrinogen	NN	I-NP
O	genes	gene	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	sequence	sequence	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	aberrant	aberrant	JJ	I-NP
O	fibrinogen	fibrinogen	NN	I-NP
O	peptide	peptide	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	deglycosylation	deglycosylation	NN	B-NP
O	experiments	experiment	NNS	I-NP
O	,	,	,	O
O	fibrinogen	fibrinogen	NN	B-NP
O	Tokyo	Tokyo	NNP	I-NP
O	V	V	NNP	I-NP
O	was	be	VBD	B-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	have	have	VB	I-VP
O	an	an	DT	B-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	substitution	substitution	NN	I-NP
O	of	of	IN	B-PP
O	gamma	gamma	NN	B-NP
O	Ala327Thr	Ala327Thr	NN	I-NP
O	and	and	CC	O
O	possibly	possibly	RB	B-NP
O	extra	extra	JJ	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	at	at	IN	B-PP
O	gamma	gamma	NN	B-NP
O	Asn325	Asn325	NN	I-NP
O	because	because	IN	B-SBAR
O	the	the	DT	B-NP
O	mutation	mutation	NN	I-NP
O	confers	confer	VBZ	B-VP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	consensus	consensus	NN	I-NP
O	sequence	sequence	NN	I-NP
O	Asn	Asn	NN	I-NP
O	-	-	HYPH	O
O	X	X	SYM	O
O	-	-	HYPH	O
O	Thr	Thr	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	mutation	mutation	NN	I-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	impaired	impair	VBN	B-NP
O	function	function	NN	I-NP
O	and	and	CC	I-NP
O	hypofibrinogenemia	hypofibrinogenemia	NN	I-NP
O	(	(	(	O
O	hypodysfibrinogen	hypodysfibrinogen	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Polymerization	Polymerization	NN	B-NP
O	of	of	IN	B-PP
O	fibrin	fibrin	NN	B-NP
O	monomers	monomer	NNS	I-NP
O	derived	derive	VBN	B-VP
O	from	from	IN	B-PP
O	patient	patient	NN	B-NP
O	fibrinogen	fibrinogen	NN	I-NP
O	was	be	VBD	B-VP
O	severely	severely	RB	B-ADJP
O	impaired	impaired	JJ	I-ADJP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	partial	partial	JJ	I-NP
O	correction	correction	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	calcium	calcium	NN	B-NP
O	,	,	,	O
O	resulting	result	VBG	B-VP
O	in	in	IN	B-PP
O	very	very	RB	B-NP
O	low	low	JJ	I-NP
O	clottability	clottability	NN	I-NP
O	.	.	.	O

O	Additionally	Additionally	RB	B-ADVP
O	,	,	,	O
O	a	a	DT	B-NP
O	large	large	JJ	I-NP
O	amount	amount	NN	I-NP
O	of	of	IN	B-PP
O	soluble	soluble	JJ	B-NP
O	cross	cross	AFX	O
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	fibrin	fibrin	NN	I-NP
O	was	be	VBD	B-VP
O	formed	form	VBN	I-VP
O	upon	upon	IN	B-PP
O	thrombin	thrombin	NN	B-NP
O	treatment	treatment	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	factor	factor	NN	B-NP
O	XIII	XIII	NN	I-NP
O	and	and	CC	I-NP
O	calcium	calcium	NN	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	Tokyo	Tokyo	NNP	B-NP
O	V	V	NN	I-NP
O	-	-	HYPH	B-VP
O	derived	derive	VBN	B-NP
O	fibrin	fibrin	NN	I-NP
O	was	be	VBD	B-VP
O	resistant	resistant	JJ	B-ADJP
O	to	to	TO	B-PP
O	degradation	degradation	NN	B-NP
O	by	by	IN	B-PP
B-GGP	tissue	tissue	NN	B-NP
I-GGP	plasminogen	plasminogen	NN	I-NP
I-GGP	activator	activator	NN	I-NP
O	(	(	(	O
B-GGP	tPA	tPA	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	O
O	catalyzed	catalyze	VBN	B-NP
B-GGP	plasmin	plasmin	NN	I-NP
O	digestion	digestion	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
O	Tokyo	Tokyo	NNP	B-NP
O	V	V	NNP	I-NP
O	fibrin	fibrin	NN	I-NP
O	appeared	appear	VBD	B-VP
O	severely	severely	RB	I-VP
O	perturbed	perturb	VBN	I-VP
O	,	,	,	O
O	since	since	IN	B-SBAR
O	there	there	EX	B-NP
O	are	be	VBP	B-VP
O	large	large	JJ	B-NP
O	pores	pore	NNS	I-NP
O	inside	inside	IN	B-PP
O	the	the	DT	B-NP
O	tangled	tangle	VBN	I-NP
O	fibrin	fibrin	NN	I-NP
O	networks	network	NNS	I-NP
O	and	and	CC	I-NP
O	fiber	fiber	NN	I-NP
O	ends	end	VBZ	B-VP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	boundaries	boundary	NNS	I-NP
O	.	.	.	O

O	Taken	Take	VBN	B-VP
O	together	together	RB	B-ADVP
O	,	,	,	O
O	these	these	DT	B-NP
O	data	datum	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	Tokyo	Tokyo	NNP	B-NP
O	V	V	NNP	I-NP
O	fibrin	fibrin	NN	I-NP
O	clots	clot	NNS	I-NP
O	are	be	VBP	B-VP
O	fragile	fragile	JJ	B-ADJP
O	,	,	,	O
O	so	so	IN	B-SBAR
O	that	that	IN	I-SBAR
O	fibrinolysis	fibrinolysis	NN	B-NP
O	-	-	HYPH	O
O	resistant	resistant	JJ	B-NP
O	insoluble	insoluble	JJ	I-NP
O	fibrin	fibrin	NN	I-NP
O	and	and	CC	O
O	soluble	soluble	JJ	B-NP
O	fibrin	fibrin	NN	I-NP
O	polymers	polymer	NNS	I-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	released	release	VBN	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	circulation	circulation	NN	I-NP
O	,	,	,	O
O	partly	partly	RB	B-VP
O	accounting	account	VBG	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	recurrent	recurrent	JJ	I-NP
O	embolic	embolic	JJ	I-NP
O	episodes	episode	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	patient	patient	NN	I-NP
O	.	.	.	O

O	Tracking	Track	VBG	B-VP
O	global	global	JJ	B-NP
O	patterns	pattern	NNS	I-NP
O	of	of	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	variation	variation	NN	I-NP
O	in	in	IN	B-PP
O	highly	highly	RB	B-NP
O	variable	variable	JJ	I-NP
O	viral	viral	JJ	I-NP
O	glycoproteins	glycoprotein	NNS	I-NP
O	:	:	:	O
O	HIV	HIV	NN	B-NP
O	,	,	,	O
O	SIV	SIV	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	HCV	HCV	NN	B-NP
O	envelopes	envelope	NNS	I-NP
O	and	and	CC	O
O	influenza	influenza	NN	B-NP
B-GGP	hemagglutinin	hemagglutinin	NN	I-NP
O	.	.	.	O

O	Human	Human	JJ	B-NP
O	and	and	CC	I-NP
O	simian	simian	JJ	I-NP
O	immunodeficiency	immunodeficiency	NN	I-NP
O	viruses	virus	NNS	I-NP
O	(	(	(	O
O	HIV	HIV	NN	B-NP
O	and	and	CC	O
O	SIV	SIV	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	influenza	influenza	NN	B-NP
O	virus	virus	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	hepatitis	hepatitis	NN	B-NP
O	C	C	NN	I-NP
O	virus	virus	NN	I-NP
O	(	(	(	O
O	HCV	HCV	NN	B-NP
O	)	)	)	O
O	have	have	VBP	B-VP
O	heavily	heavily	RB	I-VP
O	glycosylated	glycosylate	VBN	I-VP
O	,	,	,	O
O	highly	highly	RB	B-NP
O	variable	variable	JJ	I-NP
O	surface	surface	NN	I-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	we	we	PRP	B-NP
O	explore	explore	VBP	B-VP
O	N	N	NN	B-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	(	(	(	O
O	sequon	sequon	NN	B-NP
O	)	)	)	O
O	variation	variation	NN	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	population	population	NN	I-NP
O	level	level	NN	I-NP
O	in	in	IN	B-PP
O	these	these	DT	B-NP
O	viruses	virus	NNS	I-NP
O	,	,	,	O
O	using	use	VBG	B-VP
O	a	a	DT	B-NP
O	new	new	JJ	I-NP
O	Web	Web	NN	I-NP
O	-	-	HYPH	B-VP
O	based	base	VBN	B-NP
O	program	program	NN	I-NP
O	developed	develop	VBN	B-VP
O	to	to	TO	I-VP
O	facilitate	facilitate	VB	I-VP
O	the	the	DT	B-NP
O	sequon	sequon	NN	I-NP
O	tracking	tracking	NN	I-NP
O	and	and	CC	O
O	to	to	TO	B-VP
O	define	define	VB	I-VP
O	patterns	pattern	NNS	B-NP
O	(	(	(	O
O	www	www	JJ	B-ADJP
O	.	.	.	O
O	hiv	hiv	''	O
O	.	.	.	O
O	lanl	lanl	``	O
O	.	.	.	O
O	gov	gov	''	O
O	)	)	)	O
O	.	.	.	O

O	This	This	DT	B-NP
O	tool	tool	NN	I-NP
O	allowed	allow	VBD	B-VP
O	rapid	rapid	JJ	B-NP
O	visualization	visualization	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	distinctive	distinctive	JJ	I-NP
O	patterns	pattern	NNS	I-NP
O	of	of	IN	B-PP
O	sequon	sequon	NN	B-NP
O	variation	variation	NN	I-NP
O	found	find	VBN	B-VP
O	in	in	IN	B-PP
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	,	,	,	O
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	O
O	2	2	CD	B-NP
O	,	,	,	O
O	and	and	CC	O
O	SIV	SIV	NN	B-NP
O	CPZ	CPZ	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	first	first	JJ	I-NP
O	pattern	pattern	NN	I-NP
O	(	(	(	O
O	fixed	fix	VBN	B-VP
O	)	)	)	O
O	describes	describe	VBZ	B-VP
O	readily	readily	RB	B-NP
O	aligned	align	VBN	I-NP
O	sites	site	NNS	I-NP
O	that	that	WDT	B-NP
O	are	be	VBP	B-VP
O	either	either	RB	B-ADVP
O	simply	simply	RB	B-ADJP
O	present	present	JJ	I-ADJP
O	or	or	CC	I-ADJP
O	absent	absent	JJ	I-ADJP
O	.	.	.	O

O	These	These	DT	B-NP
O	sites	site	NNS	I-NP
O	tend	tend	VBP	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	occupied	occupy	VBN	I-VP
O	by	by	IN	B-PP
O	high	high	JJ	B-NP
O	-	-	HYPH	I-NP
O	mannose	mannose	NN	I-NP
O	glycans	glycan	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	second	second	JJ	I-NP
O	pattern	pattern	NN	I-NP
O	(	(	(	O
O	shifting	shift	VBG	B-VP
O	)	)	)	O
O	refers	refer	NNS	B-NP
O	to	to	TO	B-PP
O	sites	site	NNS	B-NP
O	embedded	embed	VBN	B-VP
O	in	in	IN	B-PP
O	regions	region	NNS	B-NP
O	of	of	IN	B-PP
O	extreme	extreme	JJ	B-NP
O	local	local	JJ	I-NP
O	length	length	NN	I-NP
O	variation	variation	NN	I-NP
O	and	and	CC	O
O	is	be	VBZ	B-VP
O	characterized	characterize	VBN	I-VP
O	by	by	IN	B-PP
O	shifts	shift	NNS	B-NP
O	in	in	IN	B-PP
O	terms	term	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	relative	relative	JJ	I-NP
O	position	position	NN	I-NP
O	and	and	CC	I-NP
O	local	local	JJ	I-NP
O	density	density	NN	I-NP
O	of	of	IN	B-PP
O	sequons	sequon	NNS	B-NP
O	;	;	:	O
O	these	these	DT	B-NP
O	sites	site	NNS	I-NP
O	tend	tend	VBP	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	populated	populate	VBN	I-VP
O	by	by	IN	B-PP
O	complex	complex	JJ	B-NP
O	carbohydrates	carbohydrate	NNS	I-NP
O	.	.	.	O

O	HIV	HIV	NN	B-NP
O	,	,	,	O
O	with	with	IN	B-PP
O	its	its	PRP$	B-NP
O	extreme	extreme	JJ	I-NP
O	variation	variation	NN	I-NP
O	in	in	IN	B-PP
O	number	number	NN	B-NP
O	and	and	CC	O
O	precise	precise	JJ	B-NP
O	location	location	NN	I-NP
O	of	of	IN	B-PP
O	sequons	sequon	NNS	B-NP
O	,	,	,	O
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	have	have	VB	I-VP
O	a	a	DT	B-NP
O	net	net	JJ	I-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	sites	site	NNS	B-NP
O	over	over	IN	B-PP
O	time	time	NN	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	population	population	NN	I-NP
O	level	level	NN	I-NP
O	.	.	.	O

O	Primate	Primate	JJ	B-NP
O	lentiviral	lentiviral	JJ	I-NP
O	lineages	lineage	NNS	I-NP
O	have	have	VBP	B-VP
O	host	host	NN	B-NP
O	species	species	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	sequon	sequon	NN	B-NP
O	shifting	shifting	NN	I-NP
O	,	,	,	O
O	with	with	IN	B-PP
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	in	in	IN	B-PP
O	humans	human	NNS	B-NP
O	the	the	DT	B-NP
O	most	most	RBS	I-NP
O	extreme	extreme	JJ	I-NP
O	.	.	.	O

O	HCV	HCV	NN	B-NP
B-GGP	E1	E1	NN	I-NP
O	and	and	CC	I-NP
B-GGP	E2	E2	NN	I-NP
O	proteins	protein	NNS	I-NP
O	,	,	,	O
O	despite	despite	IN	B-PP
O	evolving	evolve	VBG	B-VP
O	extremely	extremely	RB	B-ADVP
O	rapidly	rapidly	RB	I-ADVP
O	through	through	IN	B-PP
O	point	point	NN	B-NP
O	mutation	mutation	NN	I-NP
O	,	,	,	O
O	show	show	VBP	B-VP
O	limited	limit	VBN	B-VP
O	sequon	sequon	NN	B-NP
O	variation	variation	NN	I-NP
O	,	,	,	O
O	although	although	IN	B-SBAR
O	two	two	CD	B-NP
O	shifting	shift	VBG	I-NP
O	sites	site	NNS	I-NP
O	were	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	.	.	.	O

O	Human	Human	JJ	B-NP
O	influenza	influenza	NN	I-NP
O	A	A	NN	I-NP
B-GGP	hemagglutinin	hemagglutinin	NN	I-NP
O	H3	H3	NN	I-NP
B-GGP	HA1	HA1	NN	I-NP
O	is	be	VBZ	B-VP
O	accumulating	accumulate	VBG	I-VP
O	sequons	sequon	NNS	B-NP
O	over	over	IN	B-PP
O	time	time	NN	B-NP
O	,	,	,	O
O	but	but	CC	O
O	this	this	DT	B-NP
O	trend	trend	NN	I-NP
O	is	be	VBZ	B-VP
O	not	not	RB	O
O	evident	evident	JJ	B-ADJP
O	in	in	IN	B-PP
O	any	any	DT	B-NP
O	other	other	JJ	I-NP
O	avian	avian	JJ	I-NP
O	or	or	CC	I-NP
O	human	human	JJ	I-NP
O	influenza	influenza	NN	I-NP
O	A	A	NN	I-NP
O	serotypes	serotype	NNS	I-NP
O	.	.	.	O

O	Redox	Redox	NN	B-NP
O	state	state	NN	I-NP
O	regulates	regulate	VBZ	B-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	DNA	DNA	NN	I-NP
O	binding	binding	NN	I-NP
O	and	and	CC	I-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	in	in	IN	B-PP
O	salmonid	salmonid	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Rainbow	Rainbow	NN	B-NP
O	trout	trout	NNS	I-NP
O	(	(	(	O
O	Oncorhynchus	Oncorhynchus	RB	B-NP
O	mykiss	mykiss	NN	I-NP
O	)	)	)	O
O	hypoxia	hypoxia	NN	B-NP
O	-	-	HYPH	O
O	inducible	inducible	JJ	B-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	(	(	(	O
O	HIF	HIF	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	heterodimeric	heterodimeric	JJ	I-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
O	structurally	structurally	RB	B-ADJP
O	similar	similar	JJ	I-ADJP
O	to	to	TO	B-PP
O	mammalian	mammalian	JJ	B-NP
O	HIF	HIF	NN	I-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	consists	consist	VBZ	B-VP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	and	and	CC	I-NP
B-GGP	HIF	HIF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1beta	1beta	NN	I-NP
O	subunits	subunit	NNS	I-NP
O	,	,	,	O
O	of	of	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
B-GGP	HIF	HIF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	subunit	subunit	NN	I-NP
O	confers	confer	VBZ	B-VP
O	the	the	DT	B-NP
O	hypoxia	hypoxia	NN	I-NP
O	sensitivity	sensitivity	NN	I-NP
O	.	.	.	O

B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	is	be	VBZ	B-VP
O	rapidly	rapidly	RB	I-VP
O	degraded	degrade	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	proteasome	proteasome	NN	I-NP
O	under	under	IN	B-PP
O	normal	normal	JJ	B-NP
O	oxygen	oxygen	NN	I-NP
O	(	(	(	O
O	21	21	CD	B-NP
O	%	%	NN	I-NP
O	O2	O2	NN	I-NP
O	)	)	)	O
O	conditions	condition	NNS	B-NP
O	,	,	,	O
O	mainly	mainly	RB	B-ADVP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	result	result	NN	I-NP
O	of	of	IN	B-PP
O	prolyl	prolyl	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	needed	need	VBN	B-VP
O	for	for	IN	B-PP
O	protein	protein	NN	B-NP
O	destabilization	destabilization	NN	I-NP
O	.	.	.	O

O	Although	Although	IN	B-SBAR
O	prolyl	prolyl	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	at	at	IN	B-PP
O	conserved	conserve	VBN	B-NP
O	proline	proline	NN	I-NP
O	residues	residue	NNS	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	major	major	JJ	I-NP
O	factor	factor	NN	I-NP
O	controlling	control	VBG	B-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	stability	stability	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	redox	redox	NN	I-NP
O	state	state	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cells	cell	NNS	I-NP
O	may	may	MD	B-VP
O	,	,	,	O
O	in	in	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	influence	influence	VB	B-VP
O	the	the	DT	B-NP
O	function	function	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	like	like	IN	B-PP
O	proteins	protein	NNS	B-NP
O	by	by	IN	B-PP
O	influencing	influence	VBG	B-VP
O	their	their	PRP$	B-NP
O	stability	stability	NN	I-NP
O	,	,	,	O
O	DNA	DNA	NN	B-NP
O	binding	binding	NN	I-NP
O	and	and	CC	I-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	.	.	.	O

O	Sensitivity	Sensitivity	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	to	to	TO	B-PP
O	oxidation	oxidation	NN	B-NP
O	/	/	SYM	O
O	reduction	reduction	NN	B-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	due	due	JJ	B-ADJP
O	to	to	TO	B-PP
O	cysteine	cysteine	NN	B-NP
O	residues	residue	NNS	I-NP
O	at	at	IN	B-PP
O	critical	critical	JJ	B-NP
O	positions	position	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	predicted	predict	VBN	I-NP
O	amino	amino	NN	I-NP
O	acid	acid	NN	I-NP
O	sequence	sequence	NN	I-NP
O	of	of	IN	B-PP
O	rainbow	rainbow	NN	B-NP
O	trout	trout	NN	I-NP
B-GGP	HIF	HIF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	contains	contain	VBZ	B-VP
O	several	several	JJ	B-NP
O	unique	unique	JJ	I-NP
O	cysteine	cysteine	NN	I-NP
O	residues	residue	NNS	I-NP
O	,	,	,	O
O	notably	notably	RB	B-ADVP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	DNA	DNA	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	area	area	NN	B-NP
O	at	at	IN	B-PP
O	position	position	NN	B-NP
O	28	28	CD	I-NP
O	and	and	CC	O
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	transactivation	transactivation	NN	I-NP
O	domain	domain	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	molecule	molecule	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	vicinity	vicinity	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	proline	proline	NN	I-NP
O	residue	residue	NN	I-NP
O	at	at	IN	B-PP
O	position	position	NN	B-NP
O	564	564	CD	I-NP
O	of	of	IN	B-PP
O	mammalian	mammalian	JJ	B-NP
B-GGP	HIF	HIF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	studies	study	NNS	I-NP
O	we	we	PRP	B-NP
O	have	have	VBP	B-VP
O	investigated	investigate	VBN	I-VP
O	if	if	IN	B-SBAR
O	the	the	DT	B-NP
O	redox	redox	NN	I-NP
O	state	state	NN	I-NP
O	influences	influence	VBZ	B-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	stability	stability	NN	I-NP
O	,	,	,	O
O	DNA	DNA	NN	B-NP
O	binding	binding	NN	I-NP
O	and	and	CC	I-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	in	in	IN	B-PP
O	two	two	CD	B-NP
O	established	established	JJ	I-NP
O	salmonid	salmonid	NN	I-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	RTG	RTG	NN	B-NP
O	-	-	HYPH	B-NP
O	2	2	CD	I-NP
O	and	and	CC	I-NP
O	CHSE	CHSE	NN	I-NP
O	-	-	SYM	B-NP
O	214	214	CD	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	reducing	reduce	VBG	B-VP
O	conditions	condition	NNS	B-NP
O	,	,	,	O
O	achieved	achieve	VBN	B-VP
O	using	use	VBG	B-VP
O	N	N	NN	B-NP
O	-	-	HYPH	O
O	propylgallate	propylgallate	NN	B-NP
O	(	(	(	O
O	nPG	nPG	NN	B-NP
O	)	)	)	O
O	or	or	CC	O
O	N	N	NN	B-NP
O	-	-	HYPH	O
O	acetylcysteine	acetylcysteine	NN	B-NP
O	(	(	(	O
O	NAC	NAC	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	stabilize	stabilize	VBP	B-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	,	,	,	O
O	facilitate	facilitate	VB	B-VP
O	its	its	PRP$	B-NP
O	DNA	DNA	NN	I-NP
O	binding	binding	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	increase	increase	VB	B-VP
O	its	its	PRP$	B-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	even	even	RB	B-ADVP
O	under	under	IN	B-PP
O	normal	normal	JJ	B-NP
O	oxygen	oxygen	NN	I-NP
O	conditions	condition	NNS	I-NP
O	.	.	.	O

O	On	On	IN	B-PP
O	the	the	DT	B-NP
O	other	other	JJ	I-NP
O	hand	hand	NN	I-NP
O	,	,	,	O
O	oxidizing	oxidize	VBG	B-VP
O	conditions	condition	NNS	B-NP
O	,	,	,	O
O	achieved	achieve	VBN	B-VP
O	using	use	VBG	B-VP
O	L	L	NN	B-NP
O	-	-	HYPH	O
O	buthionine	buthionine	NN	B-NP
O	sulfoximine	sulfoximine	NN	I-NP
O	(	(	(	O
O	BSO	BSO	NN	B-NP
O	)	)	)	O
O	dampen	dampen	VBP	B-VP
O	the	the	DT	B-NP
O	hypoxia	hypoxia	NN	I-NP
O	response	response	NN	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	hypoxia	hypoxia	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	effect	effect	NN	I-NP
O	of	of	IN	B-PP
O	cobalt	cobalt	NN	B-NP
O	is	be	VBZ	B-VP
O	increased	increase	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	reducing	reduce	VBG	I-NP
O	agent	agent	NN	I-NP
O	.	.	.	O

O	On	On	IN	B-PP
O	the	the	DT	B-NP
O	basis	basis	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	results	result	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	redox	redox	NN	B-NP
O	state	state	NN	I-NP
O	influences	influence	VBZ	B-VP
O	the	the	DT	B-NP
O	accessibility	accessibility	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	prolyl	prolyl	NN	I-NP
O	residues	residue	NNS	I-NP
O	to	to	TO	B-PP
O	oxygen	oxygen	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	accessibility	accessibility	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	residues	residue	NNS	I-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	.	.	.	O

O	Induction	Induction	NN	B-NP
O	of	of	IN	B-PP
O	hypoxia	hypoxia	NN	B-NP
O	-	-	HYPH	B-NP
O	inducible	inducible	JJ	I-NP
O	factor	factor	NN	I-NP
O	1	1	CD	I-NP
O	activity	activity	NN	I-NP
O	by	by	IN	B-PP
O	muscarinic	muscarinic	JJ	B-NP
O	acetylcholine	acetylcholine	NN	I-NP
O	receptor	receptor	NN	I-NP
O	signaling	signaling	NN	I-NP
O	.	.	.	O

O	Hypoxia	Hypoxia	NN	B-NP
O	-	-	HYPH	O
O	inducible	inducible	JJ	B-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	(	(	(	O
O	HIF	HIF	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	master	master	NN	I-NP
O	regulator	regulator	NN	I-NP
O	of	of	IN	B-PP
O	cellular	cellular	JJ	B-NP
O	adaptive	adaptive	JJ	I-NP
O	responses	response	NNS	I-NP
O	to	to	TO	B-PP
O	hypoxia	hypoxia	NN	B-NP
O	.	.	.	O

O	Levels	Level	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	HIF	HIF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	subunit	subunit	NN	I-NP
O	increase	increase	NN	I-NP
O	under	under	IN	B-PP
O	hypoxic	hypoxic	JJ	B-NP
O	conditions	condition	NNS	I-NP
O	.	.	.	O

O	Exposure	Exposure	NN	B-NP
O	of	of	IN	B-PP
O	cells	cell	NNS	B-NP
O	to	to	TO	B-PP
O	growth	growth	NN	B-NP
O	factors	factor	NNS	I-NP
O	,	,	,	O
O	prostaglandin	prostaglandin	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	certain	certain	JJ	B-NP
O	nitric	nitric	JJ	I-NP
O	oxide	oxide	NN	I-NP
O	donors	donor	NNS	I-NP
O	also	also	RB	B-ADVP
O	induces	induce	VBZ	B-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	expression	expression	NN	I-NP
O	under	under	IN	B-PP
O	non	non	AFX	B-NP
O	-	-	HYPH	I-NP
O	hypoxic	hypoxic	JJ	I-NP
O	conditions	condition	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	muscarinic	muscarinic	JJ	B-NP
O	acetylcholine	acetylcholine	NN	I-NP
O	signals	signal	NNS	I-NP
O	induce	induce	VBP	B-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	expression	expression	NN	I-NP
O	and	and	CC	O
O	transcriptional	transcriptional	JJ	B-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	receptor	receptor	NN	I-NP
O	subtype	subtype	NN	I-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	manner	manner	NN	I-NP
O	using	use	VBG	B-VP
O	HEK293	HEK293	NN	B-NP
O	cells	cell	NNS	I-NP
O	transiently	transiently	RB	B-VP
O	overexpressing	overexpresse	VBG	I-VP
O	each	each	DT	B-NP
O	of	of	IN	B-PP
B-GGP	M1	M1	NN	B-NP
O	-	-	HYPH	I-NP
B-GGP	M4	M4	NN	I-NP
I-GGP	muscarinic	muscarinic	JJ	I-NP
I-GGP	acetylcholine	acetylcholine	NN	I-NP
I-GGP	receptors	receptor	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	muscarinic	muscarinic	JJ	I-NP
O	signaling	signaling	NN	I-NP
O	pathways	pathway	NNS	I-NP
O	inhibited	inhibit	VBD	B-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	and	and	CC	O
O	induced	induce	VBD	B-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	protein	protein	NN	I-NP
O	synthesis	synthesis	NN	I-NP
O	that	that	WDT	B-NP
O	was	be	VBD	B-VP
O	confirmed	confirm	VBN	I-VP
O	by	by	IN	B-PP
O	pulse	pulse	NN	B-NP
O	labeling	labeling	NN	I-NP
O	studies	study	NNS	I-NP
O	.	.	.	O

O	Muscarinic	Muscarinic	JJ	B-NP
O	signal	signal	NN	I-NP
O	-	-	HYPH	B-VP
O	induced	induce	VBN	B-NP
B-GGP	HIF	HIF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	protein	protein	NN	I-NP
O	and	and	CC	I-NP
O	HIF	HIF	NN	I-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	-	-	HYPH	I-NP
O	dependent	dependent	JJ	I-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	were	be	VBD	B-VP
O	blocked	block	VBN	I-VP
O	by	by	IN	B-PP
O	treating	treat	VBG	B-VP
O	cells	cell	NNS	B-NP
O	with	with	IN	B-PP
O	inhibitors	inhibitor	NNS	B-NP
O	of	of	IN	B-PP
O	phosphatidylinositol	phosphatidylinositol	NN	B-NP
O	3	3	CD	I-NP
O	-	-	HYPH	I-NP
O	kinase	kinase	NN	I-NP
O	,	,	,	O
O	MAP	MAP	NN	B-NP
O	kinase	kinase	NN	I-NP
O	kinase	kinase	NN	I-NP
O	,	,	,	O
O	or	or	CC	O
O	tyrosine	tyrosine	NN	B-NP
O	kinase	kinase	NN	I-NP
O	signaling	signaling	NN	I-NP
O	pathways	pathway	NNS	I-NP
O	.	.	.	O

O	Dominant	Dominant	JJ	B-NP
O	-	-	HYPH	I-NP
O	negative	negative	JJ	I-NP
O	forms	form	NNS	I-NP
O	of	of	IN	B-PP
O	Ras	Ras	NN	B-NP
O	and	and	CC	O
O	/	/	SYM	B-NP
O	or	or	CC	O
B-GGP	Rac	Rac	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	significantly	significantly	RB	B-ADVP
O	suppressed	suppress	VBD	B-VP
O	HIF	HIF	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	activation	activation	NN	I-NP
O	by	by	IN	B-PP
O	muscarinic	muscarinic	JJ	B-NP
O	signaling	signaling	NN	I-NP
O	.	.	.	O

O	Signaling	Signaling	NN	B-NP
O	via	via	IN	B-PP
B-GGP	M1	M1	NN	B-NP
I-GGP	-	-	HYPH	B-NP
O	and	and	CC	I-NP
B-GGP	M3	M3	NN	I-NP
I-GGP	-	-	HYPH	B-NP
O	but	but	CC	B-NP
O	not	not	RB	I-NP
B-GGP	M2	M2	NN	B-NP
I-GGP	-	-	HYPH	B-ADJP
O	or	or	CC	O
B-GGP	M4	M4	NN	O
I-GGP	-	-	HYPH	O
I-GGP	AchRs	AchR	NNS	B-NP
O	promote	promote	VBP	B-VP
O	accumulation	accumulation	NN	B-NP
O	and	and	CC	O
O	transcriptional	transcriptional	JJ	B-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	conclude	conclude	VBP	B-VP
O	that	that	IN	B-SBAR
O	muscarinic	muscarinic	JJ	B-NP
O	acetylcholine	acetylcholine	NN	I-NP
O	signals	signal	NNS	I-NP
O	activate	activate	VBP	B-VP
O	HIF	HIF	NN	B-NP
O	-	-	HYPH	O
O	1	1	CD	B-NP
O	by	by	IN	B-PP
O	both	both	CC	O
O	stabilization	stabilization	NN	B-NP
O	and	and	CC	O
O	synthesis	synthesis	NN	B-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	and	and	CC	B-PP
O	by	by	IN	B-PP
O	inducing	induce	VBG	B-VP
O	the	the	DT	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	.	.	.	O

B-GGP	Protein	Protein	NN	B-NP
I-GGP	C	C	NN	I-NP
I-GGP	inhibitor	inhibitor	NN	I-NP
O	as	as	IN	B-PP
O	an	an	DT	B-NP
O	anti	anti	AFX	I-NP
O	-	-	HYPH	I-NP
O	disseminated	disseminate	VBN	I-NP
O	intravascular	intravascular	JJ	I-NP
O	coagulation	coagulation	NN	I-NP
O	agent	agent	NN	I-NP
O	-	-	HYPH	B-NP
O	-	-	SYM	I-NP
O	mechanism	mechanism	NN	I-NP
O	and	and	CC	I-NP
O	modification	modification	NN	I-NP
O	.	.	.	O

O	Gram	Gram	NN	B-NP
O	-	-	HYPH	I-NP
O	negative	negative	JJ	I-NP
O	sepsis	sepsis	NN	I-NP
O	is	be	VBZ	B-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	disseminated	disseminate	VBN	B-NP
O	intravascular	intravascular	JJ	I-NP
O	coagulation	coagulation	NN	I-NP
O	(	(	(	O
O	DIC	DIC	NN	B-NP
O	)	)	)	O
O	due	due	JJ	B-PP
O	to	to	TO	B-PP
O	endothelial	endothelial	JJ	B-NP
O	damage	damage	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	induced	induce	VBN	I-VP
O	by	by	IN	B-PP
O	inflammatory	inflammatory	JJ	B-NP
O	mediators	mediator	NNS	I-NP
O	released	release	VBN	B-VP
O	from	from	IN	B-PP
O	phagocytes	phagocyte	NNS	B-NP
O	activated	activate	VBN	B-VP
O	by	by	IN	B-PP
O	lipopolysaccharide	lipopolysaccharide	NN	B-NP
O	(	(	(	O
O	LPS	LPS	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	DIC	DIC	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	systemic	systemic	JJ	I-NP
O	hemorrhagic	hemorrhagic	JJ	I-NP
O	syndrome	syndrome	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	results	result	VBZ	B-VP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	consumption	consumption	NN	I-NP
O	of	of	IN	B-PP
O	coagulation	coagulation	NN	B-NP
O	factors	factor	NNS	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	multiple	multiple	JJ	B-NP
O	thrombi	thrombi	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	systemic	systemic	JJ	I-NP
O	microvessels	microvessel	NNS	I-NP
O	;	;	:	O
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	multiple	multiple	JJ	B-NP
O	organ	organ	NN	I-NP
O	failure	failure	NN	I-NP
O	.	.	.	O

O	Therefore	Therefore	RB	B-ADVP
O	,	,	,	O
O	not	not	RB	B-CONJP
O	only	only	RB	I-CONJP
O	the	the	DT	B-NP
O	systemic	systemic	JJ	I-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
O	coagulation	coagulation	NN	B-NP
O	but	but	CC	B-CONJP
O	also	also	RB	I-CONJP
O	the	the	DT	B-NP
O	inflammatory	inflammatory	JJ	I-NP
O	response	response	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	perceived	perceive	VBN	I-VP
O	as	as	IN	B-PP
O	the	the	DT	B-NP
O	therapeutic	therapeutic	JJ	I-NP
O	target	target	NN	I-NP
O	for	for	IN	B-PP
O	DIC	DIC	NN	B-NP
O	in	in	IN	B-PP
O	sepsis	sepsis	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	gave	give	VBD	B-VP
O	attention	attention	NN	B-NP
O	that	that	IN	B-SBAR
B-GGP	protein	protein	NN	B-NP
I-GGP	C	C	NN	I-NP
I-GGP	inhibitor	inhibitor	NN	I-NP
O	(	(	(	O
B-GGP	PCI	PCI	NN	B-NP
O	)	)	)	O
O	acts	act	VBZ	B-VP
O	as	as	IN	B-PP
O	an	an	DT	B-NP
O	inhibitor	inhibitor	NN	I-NP
O	of	of	IN	B-PP
O	both	both	CC	O
O	plasma	plasma	NN	B-NP
O	kallikrein	kallikrein	NN	I-NP
O	and	and	CC	O
B-GGP	thrombin	thrombin	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	are	be	VBP	B-VP
O	known	know	VBN	I-VP
O	to	to	TO	I-VP
O	act	act	VB	I-VP
O	not	not	RB	B-CONJP
O	only	only	RB	I-CONJP
O	as	as	IN	B-PP
O	procoagulant	procoagulant	JJ	B-NP
O	proteases	protease	NNS	I-NP
O	but	but	CC	B-CONJP
O	also	also	RB	I-CONJP
O	as	as	IN	B-PP
O	chemotactic	chemotactic	JJ	B-NP
O	factors	factor	NNS	I-NP
O	toward	toward	IN	B-PP
O	phagocytes	phagocyte	NNS	B-NP
O	.	.	.	O

O	Then	Then	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	hypothesized	hypothesize	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	PCI	PCI	NN	B-NP
O	possibly	possibly	RB	B-ADVP
O	acts	act	VBZ	B-VP
O	as	as	IN	B-PP
O	an	an	DT	B-NP
O	anti	anti	AFX	I-NP
O	-	-	HYPH	I-NP
O	DIC	DIC	NN	I-NP
O	agent	agent	NN	I-NP
O	rather	rather	RB	B-CONJP
O	than	than	IN	I-CONJP
O	an	an	DT	B-NP
O	inhibitor	inhibitor	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	protein	protein	NN	I-NP
I-GGP	C	C	NN	I-NP
O	anticoagulant	anticoagulant	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	under	under	IN	B-PP
O	the	the	DT	B-NP
O	pathophysiology	pathophysiology	NN	I-NP
O	of	of	IN	B-PP
O	DIC	DIC	NN	B-NP
O	,	,	,	O
O	accompanied	accompany	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
B-GGP	thrombomodulin	thrombomodulin	NN	I-NP
O	expression	expression	NN	I-NP
O	on	on	IN	B-PP
O	endothelial	endothelial	JJ	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	studies	study	NNS	I-NP
O	have	have	VBP	B-VP
O	suggested	suggest	VBN	I-VP
O	that	that	IN	B-SBAR
B-GGP	PCI	PCI	NN	B-NP
O	purified	purify	VBN	B-VP
O	from	from	IN	B-PP
O	human	human	JJ	B-NP
O	urine	urine	NN	I-NP
O	(	(	(	O
B-GGP	uPCI	uPCI	NN	B-NP
O	)	)	)	O
O	improves	improve	VBZ	B-VP
O	the	the	DT	B-NP
O	pathophysiology	pathophysiology	NN	I-NP
O	of	of	IN	B-PP
O	DIC	DIC	NN	B-NP
O	through	through	IN	B-PP
O	the	the	DT	B-NP
O	inhibition	inhibition	NN	I-NP
O	of	of	IN	B-PP
O	activities	activity	NNS	B-NP
O	of	of	IN	B-PP
O	plasma	plasma	NN	B-NP
O	kallikrein	kallikrein	NN	I-NP
O	and	and	CC	I-NP
B-GGP	thrombin	thrombin	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	activities	activity	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	PCI	PCI	NN	B-NP
O	are	be	VBP	B-VP
O	regulated	regulate	VBN	I-VP
O	by	by	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	glycans	glycan	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	review	review	NN	I-NP
O	introduces	introduce	VBZ	B-VP
O	the	the	DT	B-NP
O	anti	anti	AFX	I-NP
O	-	-	HYPH	I-NP
O	DIC	DIC	NN	I-NP
O	action	action	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PCI	PCI	NN	B-NP
O	and	and	CC	B-PP
O	about	about	IN	B-PP
O	the	the	DT	B-NP
O	modification	modification	NN	I-NP
O	of	of	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	(	(	(	I-NP
O	s	s	NNS	I-NP
O	)	)	)	O
O	of	of	IN	B-PP
B-GGP	PCI	PCI	NN	B-NP
O	to	to	TO	B-VP
O	heighten	heighten	VB	I-VP
O	the	the	DT	B-NP
O	value	value	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PCI	PCI	NN	B-NP
O	as	as	IN	B-PP
O	an	an	DT	B-NP
O	anti	anti	AFX	I-NP
O	-	-	HYPH	I-NP
O	DIC	DIC	NN	I-NP
O	agent	agent	NN	I-NP
O	.	.	.	O

O	In	In	FW	B-NP
O	vitro	vitro	FW	I-NP
O	effects	effect	NNS	I-NP
O	of	of	IN	B-PP
O	high	high	JJ	B-NP
O	glucose	glucose	NN	I-NP
O	concentrations	concentration	NNS	I-NP
O	on	on	IN	B-PP
O	membrane	membrane	NN	B-NP
O	protein	protein	NN	I-NP
O	oxidation	oxidation	NN	I-NP
O	,	,	,	O
O	G	G	NN	B-NP
O	-	-	HYPH	B-NP
O	actin	actin	NN	I-NP
O	and	and	CC	I-NP
O	deformability	deformability	NN	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	erythrocytes	erythrocyte	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	object	object	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	was	be	VBD	B-VP
O	to	to	TO	B-VP
O	examine	examine	VB	I-VP
O	the	the	DT	B-NP
O	effect	effect	NN	I-NP
O	of	of	IN	B-PP
O	elevated	elevate	VBN	B-NP
O	in	in	FW	I-NP
O	vitro	vitro	FW	I-NP
O	glucose	glucose	NN	I-NP
O	concentrations	concentration	NNS	I-NP
O	on	on	IN	B-PP
O	protein	protein	NN	B-NP
O	modification	modification	NN	I-NP
O	and	and	CC	O
O	functional	functional	JJ	B-NP
O	changes	change	NNS	I-NP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	erythrocytes	erythrocyte	NNS	I-NP
O	.	.	.	O

O	Groups	Group	NNS	B-NP
O	were	be	VBD	B-VP
O	exposed	expose	VBN	I-VP
O	to	to	TO	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	45	45	CD	I-NP
O	mM	mM	NN	I-NP
O	glucose	glucose	NN	I-NP
O	concentrations	concentration	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	time	time	NN	I-NP
O	effect	effect	NN	I-NP
O	of	of	IN	B-PP
O	any	any	DT	B-NP
O	changes	change	NNS	I-NP
O	was	be	VBD	B-VP
O	also	also	RB	I-VP
O	evaluated	evaluate	VBN	I-VP
O	.	.	.	O

O	In	In	IN	B-PP
O	erythrocyte	erythrocyte	NN	B-NP
O	ghosts	ghost	NNS	I-NP
O	,	,	,	O
O	protein	protein	NN	B-NP
O	glycation	glycation	NN	I-NP
O	and	and	CC	I-NP
O	oxidation	oxidation	NN	I-NP
O	were	be	VBD	B-VP
O	evaluated	evaluate	VBN	I-VP
O	using	use	VBG	B-VP
O	spectrophotometric	spectrophotometric	JJ	B-NP
O	methods	method	NNS	I-NP
O	.	.	.	O

O	G	G	NN	B-NP
O	-	-	HYPH	I-NP
O	actin	actin	NN	I-NP
O	was	be	VBD	B-VP
O	measured	measure	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
B-GGP	DNase	DNase	NN	I-NP
I-GGP	I	I	CD	I-NP
O	inhibition	inhibition	NN	I-NP
O	assay	assay	NN	I-NP
O	in	in	IN	B-PP
O	cell	cell	NN	B-NP
O	lysates	lysate	NNS	I-NP
O	.	.	.	O

O	Erythrocyte	Erythrocyte	NN	B-NP
O	deformability	deformability	NN	I-NP
O	was	be	VBD	B-VP
O	assessed	assess	VBN	I-VP
O	using	use	VBG	B-VP
O	a	a	DT	B-NP
O	cell	cell	NN	I-NP
O	transit	transit	NN	I-NP
O	analyser	analyser	NN	I-NP
O	.	.	.	O

O	At	At	IN	B-PP
O	24	24	CD	B-NP
O	h	h	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	significant	significant	JJ	I-NP
O	protein	protein	NN	I-NP
O	oxidation	oxidation	NN	I-NP
O	(	(	(	O
O	at	at	IN	B-PP
O	25	25	CD	B-NP
O	and	and	CC	I-NP
O	45	45	CD	I-NP
O	mM	mM	NN	I-NP
O	glucose	glucose	NN	I-NP
O	;	;	:	O
O	p	p	NN	B-NP
O	<	<	SYM	B-ADJP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	05	05	CD	I-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
O	G	G	NN	B-NP
O	-	-	HYPH	I-NP
O	actin	actin	NN	I-NP
O	increase	increase	NN	I-NP
O	was	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	for	for	IN	B-PP
O	all	all	DT	B-NP
O	concentrations	concentration	NNS	I-NP
O	(	(	(	O
O	p	p	NN	B-NP
O	<	<	SYM	B-ADJP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	05	05	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	At	At	IN	B-PP
O	48	48	CD	B-NP
O	h	h	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	significant	significant	JJ	I-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
O	glycation	glycation	NN	B-NP
O	(	(	(	O
O	25	25	CD	B-NP
O	and	and	CC	I-NP
O	45	45	CD	I-NP
O	mM	mM	NN	I-NP
O	glucose	glucose	NN	I-NP
O	;	;	:	O
O	p	p	NN	B-NP
O	<	<	SYM	B-ADJP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	05	05	CD	I-NP
O	)	)	)	O
O	,	,	,	O
O	protein	protein	NN	B-NP
O	oxidation	oxidation	NN	I-NP
O	(	(	(	O
O	p	p	NN	B-NP
O	<	<	SYM	B-ADJP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	05	05	CD	I-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
O	G	G	NN	B-NP
O	-	-	HYPH	O
O	actin	actin	NN	B-NP
O	(	(	(	O
O	p	p	NN	B-NP
O	<	<	SYM	B-ADJP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	05	05	CD	I-NP
O	)	)	)	O
O	was	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	in	in	IN	B-PP
O	all	all	DT	B-NP
O	groups	group	NNS	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	significant	significant	JJ	I-NP
O	positive	positive	JJ	I-NP
O	correlation	correlation	NN	I-NP
O	was	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	between	between	IN	B-PP
O	glucose	glucose	NN	B-NP
O	/	/	SYM	I-NP
O	protein	protein	NN	I-NP
O	oxidation	oxidation	NN	I-NP
O	,	,	,	O
O	glucose	glucose	NN	B-NP
O	/	/	SYM	B-NP
O	G	G	NN	I-NP
O	-	-	SYM	B-NP
O	actin	actin	NN	I-NP
O	and	and	CC	I-NP
O	protein	protein	NN	I-NP
O	oxidation	oxidation	NN	I-NP
O	/	/	SYM	B-NP
O	G	G	NN	I-NP
O	-	-	SYM	B-NP
O	actin	actin	NN	I-NP
O	at	at	IN	B-PP
O	24	24	CD	B-NP
O	and	and	CC	I-NP
O	48	48	CD	I-NP
O	h	h	NN	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	findings	finding	NNS	I-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	oxidative	oxidative	JJ	I-NP
O	effect	effect	NN	I-NP
O	of	of	IN	B-PP
O	glucose	glucose	NN	B-NP
O	on	on	IN	B-PP
O	erythrocytes	erythrocyte	NNS	B-NP
O	depends	depend	VBZ	B-VP
O	on	on	IN	B-PP
O	concentration	concentration	NN	B-NP
O	and	and	CC	O
O	incubation	incubation	NN	B-NP
O	time	time	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	also	also	RB	B-ADVP
O	present	present	VBP	B-VP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	evidence	evidence	NN	I-NP
O	of	of	IN	B-PP
O	increased	increase	VBN	B-NP
O	G	G	NN	I-NP
O	-	-	HYPH	O
O	actin	actin	NN	B-NP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	erythrocytes	erythrocyte	NNS	I-NP
O	exposed	expose	VBN	B-VP
O	to	to	TO	B-PP
O	high	high	JJ	B-NP
O	glucose	glucose	NN	I-NP
O	concentrations	concentration	NNS	I-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	diabetes	diabetes	NN	I-NP
O	model	model	NN	I-NP
O	.	.	.	O

O	Determination	Determination	NN	B-NP
O	and	and	CC	I-NP
O	comparison	comparison	NN	I-NP
O	of	of	IN	B-PP
O	specific	specific	JJ	B-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	HIF	HIF	NN	I-NP
O	-	-	HYPH	B-NP
O	prolyl	prolyl	NN	I-NP
O	hydroxylases	hydroxylas	NNS	I-NP
O	.	.	.	O

O	Hypoxia	Hypoxia	NN	B-NP
O	-	-	HYPH	B-NP
O	inducible	inducible	JJ	I-NP
O	factor	factor	NN	I-NP
O	(	(	(	O
O	HIF	HIF	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	complex	complex	NN	I-NP
O	that	that	WDT	B-NP
O	is	be	VBZ	B-VP
O	regulated	regulate	VBN	I-VP
O	by	by	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	sensitive	sensitive	JJ	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	of	of	IN	B-PP
O	its	its	PRP$	B-NP
O	alpha	alpha	NN	I-NP
O	subunits	subunit	NNS	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	prolyl	prolyl	NN	I-NP
O	hydroxylases	hydroxylas	NNS	I-NP
B-GGP	PHD1	PHD1	NN	I-NP
O	,	,	,	O
B-GGP	2	2	CD	B-NP
O	and	and	CC	I-NP
B-GGP	3	3	CD	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	better	well	RBR	I-VP
O	understand	understand	VB	I-VP
O	the	the	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	enzymes	enzyme	NNS	I-NP
O	in	in	IN	B-PP
O	directing	direct	VBG	B-VP
O	cellular	cellular	JJ	B-NP
O	responses	response	NNS	I-NP
O	to	to	TO	B-PP
O	hypoxia	hypoxia	NN	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	derived	derive	VBD	B-VP
O	an	an	DT	B-NP
O	assay	assay	NN	I-NP
O	to	to	TO	B-VP
O	determine	determine	VB	I-VP
O	their	their	PRP$	B-NP
O	specific	specific	JJ	I-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	both	both	CC	B-NP
O	native	native	JJ	I-NP
O	cell	cell	NN	I-NP
O	extracts	extract	NNS	I-NP
O	and	and	CC	O
O	recombinant	recombinant	JJ	B-NP
O	sources	source	NNS	I-NP
O	of	of	IN	B-PP
O	enzyme	enzyme	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	all	all	DT	B-NP
O	three	three	CD	I-NP
O	are	be	VBP	B-VP
O	capable	capable	JJ	B-ADJP
O	of	of	IN	B-PP
O	high	high	JJ	B-NP
O	rates	rate	NNS	I-NP
O	of	of	IN	B-PP
O	catalysis	catalysis	NN	B-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	order	order	NN	I-NP
B-GGP	PHD2	PHD2	NN	I-NP
O	=	=	SYM	B-VP
B-GGP	PHD3	PHD3	NN	B-NP
O	>	>	SYM	B-NP
B-GGP	PHD1	PHD1	NN	I-NP
O	,	,	,	O
O	using	use	VBG	B-VP
O	substrate	substrate	NN	B-NP
O	peptides	peptide	NNS	I-NP
O	derived	derive	VBN	B-VP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	C	C	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	degradation	degradation	NN	I-NP
O	domain	domain	NN	I-NP
O	of	of	IN	B-PP
O	HIF	HIF	NN	B-NP
O	-	-	HYPH	O
O	alpha	alpha	SYM	B-NP
O	subunits	subunit	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	each	each	DT	B-NP
O	demonstrates	demonstrate	VBZ	B-VP
O	similar	similar	JJ	B-NP
O	and	and	CC	I-NP
O	remarkable	remarkable	JJ	I-NP
O	sensitivity	sensitivity	NN	I-NP
O	to	to	TO	B-PP
O	oxygen	oxygen	NN	B-NP
O	,	,	,	O
O	commensurate	commensurate	VBP	B-VP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	common	common	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	signaling	signaling	NN	B-NP
O	hypoxia	hypoxia	NN	I-NP
O	.	.	.	O

O	Many	Many	JJ	B-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	substitutions	substitution	NNS	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
B-GGP	hypoxia	hypoxia	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	inducible	inducible	JJ	I-NP
I-GGP	transcription	transcription	NN	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	(	(	(	O
I-GGP	HIF	HIF	NN	B-NP
I-GGP	)	)	)	O
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	peptide	peptide	NN	I-NP
O	cause	cause	VBP	B-VP
O	only	only	RB	B-NP
O	minor	minor	JJ	I-NP
O	changes	change	NNS	I-NP
O	in	in	IN	B-PP
O	its	its	PRP$	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	HIF	HIF	NN	I-NP
O	prolyl	prolyl	NN	I-NP
O	4	4	CD	I-NP
O	-	-	HYPH	I-NP
O	hydroxylases	hydroxylas	NNS	I-NP
O	:	:	:	O
O	substitution	substitution	NN	B-NP
O	of	of	IN	B-PP
O	3	3	CD	B-NP
O	,	,	,	I-NP
O	4	4	CD	I-NP
O	-	-	HYPH	I-NP
O	dehydroproline	dehydroproline	NN	I-NP
O	or	or	CC	I-NP
O	azetidine	azetidine	NN	I-NP
O	-	-	HYPH	B-NP
O	2	2	CD	I-NP
O	-	-	HYPH	I-NP
O	carboxylic	carboxylic	JJ	I-NP
O	acid	acid	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	proline	proline	NN	I-NP
O	leads	lead	VBZ	B-VP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	high	high	JJ	I-NP
O	rate	rate	NN	I-NP
O	of	of	IN	B-PP
O	uncoupled	uncoupled	JJ	B-NP
O	2	2	CD	I-NP
O	-	-	HYPH	I-NP
O	oxoglutarate	oxoglutarate	JJ	I-NP
O	decarboxylation	decarboxylation	NN	I-NP
O	.	.	.	O

O	Three	Three	CD	B-NP
O	human	human	JJ	I-NP
O	prolyl	prolyl	NN	I-NP
O	4	4	CD	I-NP
O	-	-	HYPH	I-NP
O	hydroxylases	hydroxylas	NNS	I-NP
O	(	(	(	O
O	P4Hs	P4H	NNS	B-NP
O	)	)	)	O
O	regulate	regulate	VBP	B-VP
O	the	the	DT	B-NP
O	hypoxia	hypoxia	NN	I-NP
O	-	-	HYPH	B-NP
O	inducible	inducible	JJ	I-NP
O	transcription	transcription	NN	I-NP
O	factors	factor	NNS	I-NP
O	(	(	(	O
O	HIFs	HIF	NNS	B-NP
O	)	)	)	O
O	by	by	IN	B-PP
O	hydroxylating	hydroxylate	VBG	B-VP
O	a	a	DT	B-NP
O	Leu	Leu	NN	I-NP
O	-	-	HYPH	B-NP
O	Xaa	Xaa	NN	I-NP
O	-	-	HYPH	B-NP
O	Xaa	Xaa	NN	I-NP
O	-	-	HYPH	B-NP
O	Leu	Leu	NN	I-NP
O	-	-	HYPH	B-NP
O	Ala	Ala	NN	I-NP
O	-	-	HYPH	I-NP
O	Pro	Pro	NN	I-NP
O	motif	motif	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	report	report	VBP	B-VP
O	here	here	RB	B-ADVP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	leucines	leucine	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	Leu	Leu	NN	I-NP
O	-	-	HYPH	B-NP
O	Glu	Glu	NN	I-NP
O	-	-	HYPH	B-NP
O	Met	Met	NN	I-NP
O	-	-	HYPH	B-NP
O	Leu	Leu	NN	I-NP
O	-	-	HYPH	B-NP
O	Ala	Ala	NN	I-NP
O	-	-	HYPH	I-NP
O	Pro	Pro	NN	I-NP
O	core	core	NN	I-NP
O	motif	motif	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	20	20	CD	I-NP
O	-	-	HYPH	I-NP
O	residue	residue	NN	I-NP
O	peptide	peptide	NN	I-NP
O	corresponding	correspond	VBG	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	sequence	sequence	NN	I-NP
O	around	around	IN	B-PP
O	Pro	Pro	NN	B-NP
O	(	(	(	O
O	564	564	CD	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	replaced	replace	VBN	I-VP
O	by	by	IN	B-PP
O	many	many	JJ	B-NP
O	residues	residue	NNS	I-NP
O	with	with	IN	B-PP
O	no	no	DT	B-NP
O	or	or	CC	I-NP
O	only	only	RB	I-NP
O	a	a	DT	I-NP
O	modest	modest	JJ	I-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
O	its	its	PRP$	B-NP
O	substrate	substrate	NN	I-NP
O	properties	property	NNS	I-NP
O	or	or	CC	B-PP
O	in	in	IN	B-PP
O	some	some	DT	B-NP
O	cases	case	NNS	I-NP
O	even	even	RB	B-NP
O	a	a	DT	I-NP
O	slight	slight	JJ	I-NP
O	increase	increase	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	glutamate	glutamate	NN	I-NP
O	and	and	CC	I-NP
O	methionine	methionine	NN	I-NP
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	substituted	substitute	VBN	I-VP
O	by	by	IN	B-PP
O	almost	almost	RB	B-NP
O	any	any	DT	I-NP
O	residue	residue	NN	I-NP
O	,	,	,	O
O	eight	eight	CD	B-NP
O	amino	amino	JJ	I-NP
O	acids	acid	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	former	former	JJ	I-NP
O	position	position	NN	I-NP
O	and	and	CC	I-NP
O	four	four	CD	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	latter	latter	JJ	I-NP
O	being	be	VBG	B-VP
O	even	even	RB	B-ADJP
O	better	good	JJR	I-ADJP
O	for	for	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	3	3	CD	I-NP
O	than	than	IN	B-PP
O	the	the	DT	B-NP
O	wild	wild	JJ	I-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	residues	residue	NNS	I-NP
O	.	.	.	O

O	Alanine	Alanine	NN	B-NP
O	was	be	VBD	B-VP
O	by	by	IN	B-PP
O	far	far	RB	B-ADVP
O	the	the	DT	B-NP
O	strictest	strict	JJS	I-NP
O	requirement	requirement	NN	I-NP
O	,	,	,	O
O	because	because	IN	B-SBAR
O	no	no	DT	B-NP
O	residue	residue	NN	I-NP
O	could	could	MD	B-VP
O	fully	fully	RB	I-VP
O	substitute	substitute	VB	I-VP
O	for	for	IN	B-PP
O	it	it	PRP	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	case	case	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	,	,	,	O
O	and	and	CC	O
O	only	only	RB	B-NP
O	serine	serine	NN	I-NP
O	or	or	CC	I-NP
O	isoleucine	isoleucine	NN	I-NP
O	,	,	,	O
O	valine	valine	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	serine	serine	NN	B-NP
O	did	do	VBD	B-VP
O	this	this	DT	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	cases	case	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	P4Hs	P4H	NNS	I-NP
I-GGP	2	2	CD	I-NP
O	and	and	CC	I-NP
B-GGP	3	3	CD	I-NP
O	.	.	.	O

O	Peptides	Peptide	NNS	B-NP
O	with	with	IN	B-PP
O	more	more	JJR	B-NP
O	than	than	IN	I-NP
O	one	one	CD	I-NP
O	substitution	substitution	NN	I-NP
O	,	,	,	O
O	having	have	VBG	B-VP
O	the	the	DT	B-NP
O	core	core	NN	I-NP
O	sequences	sequence	VBZ	B-VP
O	Trp	Trp	NN	B-NP
O	-	-	HYPH	B-NP
O	Glu	Glu	NN	I-NP
O	-	-	HYPH	B-NP
O	Met	Met	NN	I-NP
O	-	-	HYPH	B-NP
O	Val	Val	NN	I-NP
O	-	-	HYPH	B-NP
O	Ala	Ala	NN	I-NP
O	-	-	HYPH	I-NP
O	Pro	Pro	NN	I-NP
O	,	,	,	O
O	Tyr	Tyr	NN	B-NP
O	-	-	HYPH	B-NP
O	Glu	Glu	NN	I-NP
O	-	-	HYPH	B-NP
O	Met	Met	NN	I-NP
O	-	-	HYPH	B-NP
O	Ile	Ile	NN	I-NP
O	-	-	HYPH	B-NP
O	Ala	Ala	NN	I-NP
O	-	-	HYPH	I-NP
O	Pro	Pro	NN	I-NP
O	,	,	,	O
O	Ile	Ile	NN	B-NP
O	-	-	HYPH	B-NP
O	Glu	Glu	NN	I-NP
O	-	-	HYPH	B-NP
O	Met	Met	NN	I-NP
O	-	-	HYPH	B-NP
O	Ile	Ile	NN	I-NP
O	-	-	HYPH	B-NP
O	Ala	Ala	NN	I-NP
O	-	-	HYPH	I-NP
O	Pro	Pro	NN	I-NP
O	,	,	,	O
O	Trp	Trp	NN	B-NP
O	-	-	HYPH	B-NP
O	Glu	Glu	NN	I-NP
O	-	-	HYPH	B-NP
O	Met	Met	NN	I-NP
O	-	-	HYPH	B-NP
O	Val	Val	NN	I-NP
O	-	-	HYPH	B-NP
O	Ser	Ser	NN	I-NP
O	-	-	HYPH	I-NP
O	Pro	Pro	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	Trp	Trp	NN	B-NP
O	-	-	HYPH	B-NP
O	Glu	Glu	NN	I-NP
O	-	-	HYPH	B-NP
O	Ala	Ala	NN	I-NP
O	-	-	HYPH	B-NP
O	Val	Val	NN	I-NP
O	-	-	HYPH	B-NP
O	Ser	Ser	NN	I-NP
O	-	-	HYPH	I-NP
O	Pro	Pro	NN	I-NP
O	were	be	VBD	B-VP
O	in	in	IN	B-PP
O	most	most	JJS	B-NP
O	cases	case	NNS	I-NP
O	equally	equally	RB	B-ADJP
O	as	as	RB	I-ADJP
O	good	good	JJ	I-ADJP
O	or	or	CC	O
O	almost	almost	RB	B-ADVP
O	as	as	IN	B-PP
O	good	good	JJ	B-NP
O	substrates	substrate	NNS	I-NP
O	as	as	IN	B-PP
O	the	the	DT	B-NP
O	wild	wild	JJ	I-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	peptide	peptide	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	acidic	acidic	JJ	I-NP
O	residues	residue	NNS	I-NP
O	present	present	JJ	B-ADJP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	20	20	CD	I-NP
O	-	-	HYPH	I-NP
O	residue	residue	NN	I-NP
O	peptide	peptide	NN	I-NP
O	also	also	RB	B-ADVP
O	played	play	VBD	B-VP
O	a	a	DT	B-NP
O	distinct	distinct	JJ	I-NP
O	role	role	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
O	alanine	alanine	NN	B-NP
O	substitution	substitution	NN	I-NP
O	for	for	IN	B-PP
O	any	any	DT	B-NP
O	six	six	CD	I-NP
O	of	of	IN	B-PP
O	them	them	PRP	B-NP
O	,	,	,	O
O	and	and	CC	O
O	in	in	IN	B-PP
O	some	some	DT	B-NP
O	combinations	combination	NNS	I-NP
O	even	even	RB	B-NP
O	three	three	CD	I-NP
O	of	of	IN	B-PP
O	them	them	PRP	B-NP
O	,	,	,	O
O	had	have	VBD	B-VP
O	no	no	DT	B-NP
O	negative	negative	JJ	I-NP
O	effects	effect	NNS	I-NP
O	.	.	.	O

O	Substitution	Substitution	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	proline	proline	NN	I-NP
O	by	by	IN	B-PP
O	3	3	CD	B-NP
O	,	,	,	I-NP
O	4	4	CD	I-NP
O	-	-	HYPH	I-NP
O	dehydroproline	dehydroproline	NN	I-NP
O	or	or	CC	I-NP
O	l	l	NN	I-NP
O	-	-	HYPH	B-NP
O	azetidine	azetidine	NN	I-NP
O	-	-	HYPH	B-NP
O	2	2	CD	I-NP
O	-	-	HYPH	I-NP
O	carboxylic	carboxylic	JJ	I-NP
O	acid	acid	NN	I-NP
O	,	,	,	O
O	but	but	CC	B-CONJP
O	not	not	RB	I-CONJP
O	any	any	DT	B-NP
O	other	other	JJ	I-NP
O	residue	residue	NN	I-NP
O	,	,	,	O
O	led	lead	VBD	B-VP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	high	high	JJ	I-NP
O	rate	rate	NN	I-NP
O	of	of	IN	B-PP
O	uncoupled	uncoupled	JJ	B-NP
O	2	2	CD	I-NP
O	-	-	HYPH	I-NP
O	oxoglutarate	oxoglutarate	JJ	I-NP
O	decarboxylation	decarboxylation	NN	I-NP
O	with	with	IN	B-PP
O	no	no	DT	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	data	datum	NNS	I-NP
O	obtained	obtain	VBN	B-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	three	three	CD	I-NP
O	HIF	HIF	NN	I-NP
O	-	-	HYPH	I-NP
O	P4Hs	P4H	NNS	I-NP
O	in	in	IN	B-PP
O	various	various	JJ	B-NP
O	experiments	experiment	NNS	I-NP
O	were	be	VBD	B-VP
O	in	in	IN	B-PP
O	most	most	JJS	B-NP
O	cases	case	NNS	I-NP
O	similar	similar	JJ	B-ADJP
O	,	,	,	O
O	but	but	CC	O
O	in	in	IN	B-PP
O	some	some	DT	B-NP
O	cases	case	NNS	I-NP
B-GGP	HIF	HIF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	SYM	B-NP
I-GGP	3	3	CD	I-NP
O	showed	show	VBD	B-VP
O	distinctly	distinctly	RB	B-NP
O	different	different	JJ	I-NP
O	properties	property	NNS	I-NP
O	.	.	.	O

O	Genetics	Genetic	NNS	B-NP
O	and	and	CC	I-NP
O	epigenetics	epigenetic	NNS	I-NP
O	in	in	IN	B-PP
O	flower	flower	NN	B-NP
O	pigmentation	pigmentation	NN	I-NP
O	associated	associate	VBN	B-VP
O	with	with	IN	B-PP
O	transposable	transposable	JJ	B-NP
O	elements	element	NNS	I-NP
O	in	in	IN	B-PP
O	morning	morning	NN	B-NP
O	glories	glory	NNS	I-NP
O	.	.	.	O

O	Among	Among	IN	B-PP
O	the	the	DT	B-NP
O	genus	genus	NN	I-NP
O	Ipomoea	Ipomoea	NNP	I-NP
O	,	,	,	O
O	three	three	CD	B-NP
O	morning	morning	NN	I-NP
O	glories	glory	NNS	I-NP
O	,	,	,	O
O	I	I	NN	B-NP
O	.	.	.	I-NP
O	nil	nil	NN	I-NP
O	(	(	(	O
O	the	the	DT	B-NP
O	Japanese	Japanese	JJ	I-NP
O	morning	morning	NN	I-NP
O	glory	glory	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	I	I	NN	B-NP
O	.	.	.	O
O	purpurea	purpurea	NN	B-NP
O	(	(	(	O
O	the	the	DT	B-NP
O	common	common	JJ	I-NP
O	morning	morning	NN	I-NP
O	glory	glory	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
O	I	I	NN	B-NP
O	.	.	.	I-NP
O	tricolor	tricolor	NN	I-NP
O	,	,	,	O
O	were	be	VBD	B-VP
O	domesticated	domesticate	VBN	I-VP
O	well	well	RB	B-ADVP
O	for	for	IN	B-PP
O	floricultural	floricultural	JJ	B-NP
O	plants	plant	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	many	many	JJ	B-NP
O	spontaneous	spontaneous	JJ	I-NP
O	mutants	mutant	NNS	I-NP
O	displaying	display	VBG	B-VP
O	various	various	JJ	B-NP
O	flower	flow	JJR	I-NP
O	pigmentation	pigmentation	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	were	be	VBD	B-VP
O	isolated	isolate	VBN	I-VP
O	.	.	.	O

O	Most	Most	JJS	B-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	spontaneous	spontaneous	JJ	I-NP
O	mutations	mutation	NNS	I-NP
O	were	be	VBD	B-VP
O	found	find	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	caused	cause	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	insertion	insertion	NN	I-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	transposable	transposable	JJ	I-NP
O	elements	element	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	genes	gene	NNS	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	anthocyanin	anthocyanin	NN	I-NP
O	pigmentation	pigmentation	NN	I-NP
O	in	in	IN	B-PP
O	flowers	flower	NNS	B-NP
O	,	,	,	O
O	and	and	CC	O
O	many	many	JJ	B-NP
O	of	of	IN	B-PP
O	them	them	PRP	B-NP
O	exhibited	exhibit	VBD	B-VP
O	variegated	variegate	VBN	B-NP
O	flowers	flower	NNS	I-NP
O	,	,	,	O
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	white	white	JJ	B-NP
O	flowers	flower	NNS	I-NP
O	with	with	IN	B-PP
O	pigmented	pigment	VBN	B-NP
O	spots	spot	NNS	I-NP
O	and	and	CC	I-NP
O	sectors	sector	NNS	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	describe	describe	VBP	B-VP
O	the	the	DT	B-NP
O	historical	historical	JJ	I-NP
O	background	background	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mutants	mutant	NNS	I-NP
O	displaying	display	VBG	B-VP
O	variegated	variegate	VBN	B-NP
O	flowers	flower	NNS	I-NP
O	and	and	CC	O
O	review	review	VB	B-VP
O	the	the	DT	B-NP
O	genetic	genetic	JJ	I-NP
O	and	and	CC	I-NP
O	epigenetic	epigenetic	JJ	I-NP
O	regulation	regulation	NN	I-NP
O	in	in	IN	B-PP
O	flower	flower	NN	B-NP
O	pigmentation	pigmentation	NN	I-NP
O	associated	associate	VBN	B-VP
O	with	with	IN	B-PP
O	transposable	transposable	JJ	B-NP
O	elements	element	NNS	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	morning	morning	NN	I-NP
O	glories	glory	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	flecked	flecked	JJ	I-NP
O	,	,	,	I-NP
O	speckled	speckled	JJ	I-NP
O	,	,	,	I-NP
O	r	r	NN	I-NP
O	-	-	HYPH	I-NP
O	1	1	CD	I-NP
O	,	,	,	O
O	and	and	CC	O
O	purple	purple	NN	B-NP
O	mutations	mutation	NNS	I-NP
O	in	in	IN	B-PP
O	I	I	PRP	B-NP
O	.	.	.	O
O	nil	nil	''	O
O	were	be	VBD	B-VP
O	caused	cause	VBN	I-VP
O	by	by	IN	B-PP
O	insertions	insertion	NNS	B-NP
O	of	of	IN	B-PP
O	Tpn1	Tpn1	NN	B-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	relatives	relative	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	En	En	NN	I-NP
O	/	/	SYM	B-NP
O	Spm	Spm	NN	I-NP
O	superfamily	superfamily	NN	I-NP
O	,	,	,	O
O	Tpn2	Tpn2	NN	B-NP
O	,	,	,	O
O	Tpn3	Tpn3	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	Tpn4	Tpn4	NN	B-NP
O	,	,	,	O
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	genes	gene	NNS	I-NP
O	for	for	IN	B-PP
O	anthocyanin	anthocyanin	NN	B-NP
O	coloration	coloration	NN	I-NP
O	in	in	IN	B-PP
O	flowers	flower	NNS	B-NP
O	,	,	,	O
O	i	i	NN	B-NP
O	.	.	.	O
O	e	e	NN	B-NP
O	.	.	NN	I-NP
O	,	,	,	O
B-GGP	DFR	DFR	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	B	B	NN	B-NP
O	,	,	,	O
B-GGP	CHI	CHI	NN	B-NP
O	,	,	,	O
B-GGP	CHS	CHS	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	D	D	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	InNHX1	InNHX1	NN	B-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	Similarly	Similarly	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	flaked	flaked	JJ	I-NP
O	and	and	CC	I-NP
O	pink	pink	JJ	I-NP
O	mutants	mutant	NNS	I-NP
O	of	of	IN	B-PP
O	I	I	NN	B-NP
O	.	.	.	O
O	purpurea	purpurea	NN	B-NP
O	have	have	VBP	B-VP
O	distantly	distantly	RB	I-VP
O	related	relate	VBN	I-VP
O	elements	element	NNS	B-NP
O	,	,	,	O
O	Tip100	Tip100	NN	B-NP
O	and	and	CC	I-NP
O	Tip201	Tip201	NN	I-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	Ac	Ac	NN	I-NP
O	/	/	SYM	B-NP
O	Ds	Ds	NN	I-NP
O	superfamily	superfamily	NN	I-NP
O	inserted	insert	VBN	B-VP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
B-GGP	CHS	CHS	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	D	D	NN	I-NP
O	and	and	CC	I-NP
B-GGP	F3	F3	NN	I-NP
I-GGP	'	'	''	I-NP
I-GGP	H	H	NN	I-NP
O	genes	gene	NNS	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	The	The	DT	B-NP
O	flower	flow	JJR	I-NP
O	variegation	variegation	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	determined	determine	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	frequency	frequency	NN	I-NP
O	and	and	CC	I-NP
O	timing	timing	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	excision	excision	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	transposons	transposon	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	their	their	PRP$	B-NP
O	stable	stable	JJ	I-NP
O	insertions	insertion	NNS	I-NP
O	produce	produce	VBP	B-VP
O	plain	plain	JJ	B-NP
O	color	color	NN	I-NP
O	flowers	flower	NNS	I-NP
O	without	without	IN	B-PP
O	generating	generate	VBG	B-VP
O	pigmented	pigment	VBN	B-NP
O	spots	spot	NNS	I-NP
O	or	or	CC	I-NP
O	sectors	sector	NNS	I-NP
O	;	;	:	O
O	furthermore	furthermore	RB	B-ADVP
O	,	,	,	O
O	both	both	DT	B-NP
O	genetic	genetic	JJ	I-NP
O	and	and	CC	I-NP
O	epigenetic	epigenetic	JJ	I-NP
O	regulation	regulation	NN	I-NP
O	appeared	appear	VBD	B-VP
O	to	to	TO	I-VP
O	play	play	VB	I-VP
O	important	important	JJ	B-NP
O	roles	role	NNS	I-NP
O	in	in	IN	B-PP
O	determining	determine	VBG	B-VP
O	the	the	DT	B-NP
O	frequency	frequency	NN	I-NP
O	and	and	CC	I-NP
O	timing	timing	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	excision	excision	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	transposons	transposon	NNS	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	flower	flower	NN	B-NP
O	variegation	variegation	NN	I-NP
O	is	be	VBZ	B-VP
O	not	not	RB	I-VP
O	always	always	RB	I-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	excision	excision	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	integrated	integrate	VBN	I-NP
O	DNA	DNA	NN	I-NP
O	transposon	transposon	NN	I-NP
O	from	from	IN	B-PP
O	one	one	CD	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	genes	gene	NNS	I-NP
O	for	for	IN	B-PP
O	anthocyanin	anthocyanin	NN	B-NP
O	pigmentation	pigmentation	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	mutant	mutant	JJ	I-NP
O	Flying	Flying	NNP	I-NP
O	Saucers	Saucers	NNP	I-NP
O	of	of	IN	B-PP
O	I	I	NNP	B-NP
O	.	.	.	O
O	tricolor	tricolor	''	O
O	displaying	display	VBG	B-VP
O	variegated	variegate	VBN	B-NP
O	flowers	flower	NNS	I-NP
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	to	to	TO	I-VP
O	have	have	VB	I-VP
O	the	the	DT	B-NP
O	transposon	transposon	NN	I-NP
O	ItMULE1	ItMULE1	NN	I-NP
O	inserted	insert	VBN	B-VP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
B-GGP	DFR	DFR	NN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	B	B	NN	I-NP
O	promoter	promoter	NN	I-NP
O	region	region	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
O	no	no	DT	B-NP
O	excision	excision	NN	I-NP
O	of	of	IN	B-PP
O	ItMULE1	ItMULE1	NN	B-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
B-GGP	DFR	DFR	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	B	B	NN	B-NP
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	detected	detect	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	variegated	variegate	VBN	I-NP
O	flower	flower	NN	I-NP
O	lines	line	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	instable	instable	JJ	I-NP
O	pearly	pearly	NN	I-NP
O	-	-	HYPH	B-NP
O	vrg	vrg	NN	I-NP
O	allele	allele	NN	I-NP
O	in	in	IN	B-PP
O	cv	cv	NN	B-NP
O	.	.	.	O

O	Flying	Fly	VBG	B-NP
O	Saucers	Saucer	NNS	I-NP
O	is	be	VBZ	B-VP
O	likely	likely	JJ	B-ADJP
O	to	to	TO	B-VP
O	be	be	VB	I-VP
O	an	an	DT	B-NP
O	epiallele	epiallele	NN	I-NP
O	because	because	IN	B-SBAR
O	the	the	DT	B-NP
O	DNA	DNA	NN	I-NP
O	methylation	methylation	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
B-GGP	DFR	DFR	NN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	B	B	NN	I-NP
O	promoter	promoter	NN	I-NP
O	appeared	appear	VBD	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	flower	flower	NN	B-NP
O	pigmentation	pigmentation	NN	I-NP
O	.	.	.	O

O	Characterization	Characterization	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	second	second	JJ	I-NP
O	Arabidopsis	Arabidopsis	NN	I-NP
O	thaliana	thaliana	IN	B-PP
O	prolyl	prolyl	NN	B-NP
O	4	4	CD	I-NP
O	-	-	HYPH	I-NP
O	hydroxylase	hydroxylase	NN	I-NP
O	with	with	IN	B-PP
O	distinct	distinct	JJ	B-NP
O	substrate	substrate	NN	I-NP
O	specificity	specificity	NN	I-NP
O	.	.	.	O

O	4	4	CD	B-NP
O	-	-	HYPH	I-NP
O	Hydroxyproline	Hydroxyproline	NN	I-NP
O	is	be	VBZ	B-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	collagens	collagen	NNS	B-NP
O	,	,	,	O
O	collagen	collagen	NN	B-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	,	,	,	O
B-GGP	elastin	elastin	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	hypoxia	hypoxia	NN	I-NP
O	-	-	HYPH	B-NP
O	inducible	inducible	JJ	I-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
O	in	in	IN	B-PP
O	animals	animal	NNS	B-NP
O	and	and	CC	B-PP
O	in	in	IN	B-PP
O	many	many	JJ	B-NP
O	hydroxyproline	hydroxyproline	NN	I-NP
O	-	-	HYPH	I-NP
O	rich	rich	JJ	I-NP
O	glycoproteins	glycoprotein	NNS	I-NP
O	in	in	IN	B-PP
O	plants	plant	NNS	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	report	report	VBP	B-VP
O	here	here	RB	B-ADVP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	cloning	cloning	NN	I-NP
O	and	and	CC	I-NP
O	characterization	characterization	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	second	second	JJ	I-NP
O	plant	plant	NN	I-NP
O	P4H	P4H	NN	I-NP
O	(	(	(	O
O	prolyl	prolyl	NN	B-NP
O	4	4	CD	I-NP
O	-	-	HYPH	B-NP
O	hydroxylase	hydroxylase	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	At	At	IN	B-PP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	2	2	CD	I-NP
O	,	,	,	O
O	from	from	IN	B-PP
O	Arabidopsis	Arabidopsis	NNP	B-NP
O	thaliana	thaliana	NNP	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	consists	consist	VBZ	B-VP
O	of	of	IN	B-PP
O	299	299	CD	B-NP
O	amino	amino	NN	I-NP
O	acids	acid	NNS	I-NP
O	and	and	CC	O
O	shows	show	VBZ	B-VP
O	33	33	CD	B-NP
O	%	%	NN	I-NP
O	sequence	sequence	NN	I-NP
O	identity	identity	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	characterized	characterize	VBN	I-NP
O	isoenzyme	isoenzyme	NN	I-NP
O	,	,	,	O
O	At	At	IN	B-PP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	SYM	B-NP
I-GGP	1	1	CD	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	characteristic	characteristic	JJ	I-NP
O	feature	feature	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	At	At	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	2	2	CD	I-NP
O	polypeptide	polypeptide	NN	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	49	49	CD	I-NP
O	-	-	HYPH	I-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	acid	acid	NN	I-NP
O	C	C	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	toxin	toxin	NN	I-NP
O	homology	homology	NN	I-NP
O	domain	domain	NN	I-NP
O	with	with	IN	B-PP
O	6	6	CD	B-NP
O	cysteines	cysteine	NNS	I-NP
O	that	that	WDT	B-NP
O	is	be	VBZ	B-VP
O	not	not	RB	I-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	At	At	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	but	but	CC	O
O	is	be	VBZ	B-VP
O	present	present	JJ	B-ADJP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	putative	putative	JJ	I-NP
O	rice	rice	NN	I-NP
O	P4H	P4H	NN	I-NP
O	homologue	homologue	NN	I-NP
O	.	.	.	O

O	At	At	IN	B-PP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	SYM	B-NP
I-GGP	2	2	CD	B-NP
O	differed	differ	VBD	B-VP
O	distinctly	distinctly	RB	B-ADVP
O	from	from	IN	B-PP
O	At	At	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	in	in	IN	B-PP
O	its	its	PRP$	B-NP
O	substrate	substrate	NN	I-NP
O	specificity	specificity	NN	I-NP
O	.	.	.	O

O	Recombinant	Recombinant	JJ	B-NP
O	At	At	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	SYM	I-NP
I-GGP	2	2	CD	I-NP
O	hydroxylated	hydroxylate	VBN	I-NP
O	poly	poly	NN	I-NP
O	(	(	(	O
O	L	L	NN	B-NP
O	-	-	HYPH	O
O	proline	proline	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	extensin	extensin	NN	B-NP
O	and	and	CC	I-NP
O	arabinogalactan	arabinogalactan	NN	I-NP
O	-	-	HYPH	O
O	like	like	JJ	B-NP
O	peptides	peptide	NNS	I-NP
O	effectively	effectively	RB	B-ADVP
O	but	but	CC	O
O	with	with	IN	B-PP
O	much	much	RB	B-NP
O	higher	high	JJR	I-NP
O	Km	Km	NN	I-NP
O	values	value	NNS	I-NP
O	than	than	IN	B-PP
O	At	At	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	different	different	JJ	B-NP
O	roles	role	NNS	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	At	At	IN	B-PP
O	-	-	HYPH	B-NP
O	P4Hs	P4H	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	plant	plant	NN	I-NP
O	cell	cell	NN	I-NP
O	.	.	.	O

O	Unlike	Unlike	IN	B-PP
O	At	At	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	,	,	,	O
O	At	At	IN	B-PP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	SYM	B-NP
I-GGP	2	2	CD	I-NP
O	hydroxylated	hydroxylate	VBN	I-NP
O	collagen	collagen	NN	I-NP
O	-	-	HYPH	O
O	like	like	JJ	B-NP
O	peptides	peptide	NNS	I-NP
O	only	only	RB	B-ADVP
O	very	very	RB	B-ADVP
O	inefficiently	inefficiently	RB	I-ADVP
O	and	and	CC	O
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	hydroxylate	hydroxylate	VB	I-VP
O	hypoxia	hypoxia	NN	B-NP
O	-	-	HYPH	B-NP
O	inducible	inducible	JJ	I-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
O	alpha	alpha	SYM	B-NP
O	-	-	HYPH	B-VP
O	like	like	JJ	B-NP
O	peptides	peptide	NNS	I-NP
O	at	at	IN	B-ADVP
O	all	all	DT	I-ADVP
O	.	.	.	O

O	All	All	PDT	B-NP
O	the	the	DT	I-NP
O	peptides	peptide	NNS	I-NP
O	efficiently	efficiently	RB	B-VP
O	hydroxylated	hydroxylate	VBN	I-VP
O	by	by	IN	B-PP
O	At	At	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	SYM	B-NP
I-GGP	2	2	CD	B-NP
O	had	have	VBD	B-VP
O	at	at	IN	B-NP
O	least	least	JJS	I-NP
O	3	3	CD	I-NP
O	consecutive	consecutive	JJ	I-NP
O	prolines	proline	NNS	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	these	these	DT	B-NP
O	may	may	MD	B-VP
O	represent	represent	VB	I-VP
O	a	a	DT	B-NP
O	minimum	minimum	NN	I-NP
O	requirement	requirement	NN	I-NP
O	for	for	IN	B-PP
O	efficient	efficient	JJ	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	by	by	IN	B-PP
O	this	this	DT	B-NP
O	isoenzyme	isoenzyme	NN	I-NP
O	.	.	.	O

O	N	N	NN	B-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	sequencing	sequencing	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	extensin	extensin	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	peptide	peptide	NN	I-NP
O	SPPPVYKSPPPPVKHYSPPPV	SPPPVYKSPPPPVKHYSPPPV	NN	I-NP
O	indicated	indicate	VBD	B-VP
O	that	that	IN	B-SBAR
O	At	At	IN	B-PP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	SYM	O
I-GGP	2	2	CD	B-NP
O	preferentially	preferentially	RB	B-ADVP
O	hydroxylated	hydroxylate	VBD	B-VP
O	the	the	DT	B-NP
O	3rd	3rd	JJ	I-NP
O	proline	proline	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	C	C	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	PPP	PPP	NN	I-NP
O	triplet	triplet	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	Km	Km	NN	I-NP
O	values	value	NNS	I-NP
O	of	of	IN	B-PP
O	At	At	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	2	2	CD	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	reaction	reaction	NN	I-NP
O	cosubstrates	cosubstrate	VBZ	B-VP
O	Fe2	Fe2	NN	B-NP
O	+	+	SYM	O
O	,	,	,	O
O	2	2	CD	B-NP
O	-	-	HYPH	B-ADJP
O	oxoglutarate	oxoglutarate	JJ	I-ADJP
O	,	,	,	O
O	and	and	CC	O
O	ascorbate	ascorbate	NN	B-NP
O	were	be	VBD	B-VP
O	similar	similar	JJ	B-ADJP
O	to	to	TO	B-PP
O	those	those	DT	B-NP
O	of	of	IN	B-PP
O	At	At	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	exception	exception	NN	I-NP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	Km	Km	NN	I-NP
O	for	for	IN	B-PP
O	iron	iron	NN	B-NP
O	was	be	VBD	B-VP
O	about	about	RB	B-NP
O	3	3	CD	I-NP
O	-	-	HYPH	I-NP
O	fold	fold	RB	B-ADJP
O	lower	low	JJR	I-ADJP
O	.	.	.	O

O	Pyridine	Pyridine	NN	B-NP
O	-	-	HYPH	B-NP
O	2	2	CD	I-NP
O	,	,	,	I-NP
O	4	4	CD	I-NP
O	-	-	HYPH	I-NP
O	dicarboxylate	dicarboxylate	NN	I-NP
O	and	and	CC	I-NP
O	pyridine	pyridine	NN	I-NP
O	-	-	HYPH	B-NP
O	2	2	CD	I-NP
O	,	,	,	I-NP
O	5	5	CD	I-NP
O	-	-	HYPH	I-NP
O	dicarboxylate	dicarboxylate	NN	I-NP
O	,	,	,	O
O	well	well	RB	B-NP
O	known	know	VBN	I-NP
O	competitive	competitive	JJ	I-NP
O	inhibitors	inhibitor	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	vertebrate	vertebrate	NN	I-NP
O	P4Hs	P4H	NNS	I-NP
O	with	with	IN	B-PP
O	respect	respect	NN	B-NP
O	to	to	TO	B-PP
O	2	2	CD	B-NP
O	-	-	HYPH	I-NP
O	oxoglutarate	oxoglutarate	NN	I-NP
O	,	,	,	O
O	were	be	VBD	B-VP
O	also	also	RB	B-ADVP
O	competitive	competitive	JJ	B-NP
O	inhibitors	inhibitor	NNS	I-NP
O	of	of	IN	B-PP
O	At	At	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	2	2	CD	I-NP
O	but	but	CC	B-PP
O	with	with	IN	B-PP
O	Ki	Ki	NN	B-NP
O	values	value	NNS	I-NP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	100	100	CD	I-NP
O	-	-	HYPH	O
O	fold	fold	RB	B-ADJP
O	higher	high	JJR	I-ADJP
O	than	than	IN	B-PP
O	those	those	DT	B-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	type	type	NN	I-NP
O	I	I	CD	I-NP
O	collagen	collagen	NN	I-NP
O	P4H	P4H	NN	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	thus	thus	RB	B-ADVP
O	seems	seem	VBZ	B-VP
O	that	that	IN	B-SBAR
O	there	there	EX	B-NP
O	are	be	VBP	B-VP
O	some	some	DT	B-NP
O	distinct	distinct	JJ	I-NP
O	differences	difference	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	2	2	CD	I-NP
O	-	-	HYPH	I-NP
O	oxoglutarate	oxoglutarate	NN	I-NP
O	-	-	HYPH	B-PP
O	binding	bind	VBG	B-NP
O	site	site	NN	I-NP
O	between	between	IN	B-PP
O	At	At	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	P4H	P4H	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	2	2	CD	B-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	animal	animal	NN	I-NP
O	collagen	collagen	NN	I-NP
O	P4Hs	P4H	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	protein	protein	NN	B-NP
O	kinase	kinase	NN	I-NP
O	A	A	NN	I-NP
O	pathway	pathway	NN	I-NP
O	and	and	CC	O
O	cAMP	cAMP	NN	B-NP
O	responsive	responsive	JJ	I-NP
O	element	element	NN	I-NP
O	-	-	HYPH	B-PP
O	binding	bind	VBG	B-NP
O	protein	protein	NN	I-NP
O	in	in	IN	B-PP
B-GGP	androgen	androgen	NN	B-NP
I-GGP	receptor	receptor	NN	I-NP
O	-	-	HYPH	B-VP
O	mediated	mediate	VBN	B-NP
O	transcription	transcription	NN	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
B-GGP	prostate	prostate	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	antigen	antigen	NN	I-NP
O	locus	locus	NN	I-NP
O	.	.	.	O

O	Androgen	Androgen	NN	B-NP
O	-	-	HYPH	I-NP
O	independent	independent	JJ	I-NP
O	prostate	prostate	NN	I-NP
O	cancer	cancer	NN	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	lethal	lethal	JJ	I-NP
O	form	form	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	disease	disease	NN	I-NP
O	that	that	WDT	B-NP
O	is	be	VBZ	B-VP
O	marked	mark	VBN	I-VP
O	by	by	IN	B-PP
O	metastasis	metastasis	NN	B-NP
O	and	and	CC	O
O	rapid	rapid	JJ	B-NP
O	proliferation	proliferation	NN	I-NP
O	in	in	IN	B-PP
O	its	its	PRP$	B-NP
O	final	final	JJ	I-NP
O	stages	stage	NNS	I-NP
O	.	.	.	O

O	As	As	IN	B-SBAR
O	no	no	DT	B-NP
O	effective	effective	JJ	I-NP
O	therapy	therapy	NN	I-NP
O	for	for	IN	B-PP
O	this	this	DT	B-NP
O	aggressive	aggressive	JJ	I-NP
O	tumor	tumor	NN	I-NP
O	currently	currently	RB	B-ADVP
O	exists	exist	VBZ	B-VP
O	,	,	,	O
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	imperative	imperative	JJ	B-ADJP
O	to	to	TO	B-VP
O	elucidate	elucidate	VB	I-VP
O	and	and	CC	I-VP
O	target	target	VB	I-VP
O	the	the	DT	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	progression	progression	NN	I-NP
O	to	to	TO	B-PP
O	androgen	androgen	NN	B-NP
O	independence	independence	NN	I-NP
O	.	.	.	O

O	Accumulating	Accumulate	VBG	B-NP
O	evidence	evidence	NN	I-NP
O	indicates	indicate	VBZ	B-VP
O	that	that	IN	B-SBAR
O	aberrant	aberrant	JJ	B-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	androgen	androgen	NN	B-NP
I-GGP	receptor	receptor	NN	I-NP
O	(	(	(	O
B-GGP	AR	AR	NN	B-NP
O	)	)	)	O
O	via	via	IN	B-PP
O	signal	signal	NN	B-NP
O	transduction	transduction	NN	I-NP
O	pathways	pathway	NNS	I-NP
O	,	,	,	O
B-GGP	AR	AR	NN	B-NP
O	gene	gene	NN	I-NP
O	mutation	mutation	NN	I-NP
O	and	and	CC	O
O	/	/	SYM	B-NP
O	or	or	CC	O
O	amplification	amplification	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	/	/	SYM	B-NP
O	or	or	CC	O
O	coregulator	coregulator	NN	B-NP
O	alterations	alteration	NNS	I-NP
O	may	may	MD	B-VP
O	contribute	contribute	VB	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	progression	progression	NN	I-NP
O	of	of	IN	B-PP
O	prostate	prostate	NN	B-NP
O	cancer	cancer	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	effects	effect	NNS	I-NP
O	of	of	IN	B-PP
O	protein	protein	NN	B-NP
O	kinase	kinase	NN	I-NP
O	A	A	NN	I-NP
O	(	(	(	O
O	PKA	PKA	NN	B-NP
O	)	)	)	O
O	signaling	signaling	NN	B-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	downstream	downstream	JJ	I-NP
O	factors	factor	NNS	I-NP
O	on	on	IN	B-PP
B-GGP	AR	AR	NN	B-NP
O	activity	activity	NN	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
B-GGP	prostate	prostate	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	antigen	antigen	NN	I-NP
O	(	(	(	O
B-GGP	PSA	PSA	NN	B-NP
O	)	)	)	O
O	gene	gene	NN	B-NP
O	were	be	VBD	B-VP
O	tested	test	VBN	I-VP
O	.	.	.	O

O	Activation	Activation	NN	B-NP
O	of	of	IN	B-PP
O	PKA	PKA	NN	B-NP
O	by	by	IN	B-PP
O	forskolin	forskolin	NN	B-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	enhanced	enhance	VBN	B-NP
O	androgen	androgen	NN	I-NP
O	-	-	HYPH	O
O	induced	induce	VBN	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	PSA	PSA	NN	I-NP
O	gene	gene	NN	I-NP
O	,	,	,	O
O	an	an	DT	B-NP
O	effect	effect	NN	I-NP
O	that	that	WDT	B-NP
O	was	be	VBD	B-VP
O	blocked	block	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
B-GGP	AR	AR	NN	I-NP
O	antagonist	antagonist	NN	I-NP
O	,	,	,	O
O	bicalutamide	bicalutamide	NN	B-NP
O	.	.	.	O

O	Interestingly	Interestingly	RB	B-ADVP
O	,	,	,	O
O	when	when	WRB	B-ADVP
O	either	either	CC	O
B-GGP	p300	p300	NN	B-NP
O	or	or	CC	I-NP
B-GGP	CBP	CBP	NN	I-NP
O	was	be	VBD	B-VP
O	overexpressed	overexpresse	VBN	I-VP
O	,	,	,	O
O	PKA	PKA	NN	B-NP
O	activation	activation	NN	I-NP
O	was	be	VBD	B-VP
O	sufficient	sufficient	JJ	B-ADJP
O	to	to	TO	B-VP
O	stimulate	stimulate	VB	I-VP
B-GGP	PSA	PSA	NN	B-NP
O	promoter	promoter	NN	I-NP
O	-	-	HYPH	B-VP
O	driven	drive	VBN	B-NP
O	transcription	transcription	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	absence	absence	NN	I-NP
O	of	of	IN	B-PP
O	androgen	androgen	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	inhibited	inhibit	VBN	I-VP
O	by	by	IN	B-PP
O	bicalutamide	bicalutamide	NN	B-NP
O	.	.	.	O

O	PKA	PKA	NN	B-NP
O	activation	activation	NN	I-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	significantly	significantly	RB	I-VP
O	alter	alter	VB	I-VP
B-GGP	AR	AR	NN	B-NP
O	protein	protein	NN	I-NP
O	levels	level	NNS	I-NP
O	but	but	CC	O
O	significantly	significantly	RB	B-VP
O	increased	increase	VBD	I-VP
O	the	the	DT	B-NP
O	phosphorylated	phosphorylated	JJ	I-NP
O	form	form	NN	I-NP
O	of	of	IN	B-PP
O	its	its	PRP$	B-NP
O	downstream	downstream	JJ	I-NP
O	effector	effector	NN	I-NP
O	,	,	,	O
O	cAMP	cAMP	NN	B-NP
O	responsive	responsive	JJ	I-NP
O	element	element	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	protein	protein	NN	B-NP
O	(	(	(	O
O	CREB	CREB	NN	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	the	the	DT	I-PP
O	presence	presence	NN	I-PP
O	of	of	IN	I-PP
O	androgen	androgen	NN	B-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	chromatin	chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	combination	combination	NN	I-NP
O	of	of	IN	B-PP
O	androgen	androgen	NN	B-NP
O	and	and	CC	I-NP
O	forskolin	forskolin	NN	I-NP
O	increased	increase	VBD	B-VP
O	phosphorylated	phosphorylate	VBN	I-VP
O	CREB	CREB	NN	B-NP
O	occupancy	occupancy	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	was	be	VBD	B-VP
O	accompanied	accompany	VBN	I-VP
O	by	by	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	,	,	,	O
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	putative	putative	JJ	I-NP
O	cAMP	cAMP	NN	I-NP
O	responsive	responsive	JJ	I-NP
O	element	element	NN	I-NP
O	located	located	JJ	B-ADJP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	5	5	CD	I-NP
O	'	'	SYM	I-NP
O	upstream	upstream	JJ	I-NP
O	regulatory	regulatory	JJ	I-NP
O	region	region	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	PSA	PSA	NN	I-NP
O	gene	gene	NN	I-NP
O	.	.	.	O

O	Remarkably	Remarkably	RB	B-ADVP
O	,	,	,	O
O	mammalian	mammalian	JJ	B-NP
O	two	two	CD	I-NP
O	-	-	HYPH	I-NP
O	hybrid	hybrid	NN	I-NP
O	assay	assay	NN	I-NP
O	indicated	indicate	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	p300	p300	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	CBP	CBP	NN	I-NP
O	may	may	MD	B-VP
O	bridge	bridge	VB	I-VP
O	the	the	DT	B-NP
O	interaction	interaction	NN	I-NP
O	between	between	IN	B-PP
B-GGP	AR	AR	NN	B-NP
O	and	and	CC	I-NP
O	CREB	CREB	NN	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	enhanceosomal	enhanceosomal	JJ	I-NP
O	cooperation	cooperation	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	demonstrate	demonstrate	VBP	B-VP
O	an	an	DT	B-NP
O	intriguing	intriguing	JJ	I-NP
O	interplay	interplay	NN	I-NP
O	between	between	IN	B-PP
O	a	a	DT	B-NP
O	signal	signal	NN	I-NP
O	transduction	transduction	NN	I-NP
O	pathway	pathway	NN	I-NP
O	,	,	,	O
O	coactivator	coactivator	NN	B-NP
O	overexpression	overexpression	NN	I-NP
O	and	and	CC	I-NP
B-GGP	AR	AR	NN	I-NP
O	signaling	signaling	NN	I-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	possible	possible	JJ	I-NP
O	combined	combine	VBN	I-NP
O	mechanism	mechanism	NN	I-NP
O	of	of	IN	B-PP
O	progression	progression	NN	B-NP
O	to	to	TO	B-PP
O	androgen	androgen	NN	B-NP
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	prostate	prostate	NN	I-NP
O	cancer	cancer	NN	I-NP
O	.	.	.	O

O	Oxidative	Oxidative	JJ	B-NP
O	stress	stress	NN	I-NP
O	is	be	VBZ	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	inhibition	inhibition	NN	B-NP
O	of	of	IN	B-PP
O	copper	copper	NN	B-NP
O	on	on	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	previous	previous	JJ	I-NP
O	study	study	NN	I-NP
O	demonstrates	demonstrate	VBZ	B-VP
O	that	that	IN	B-SBAR
O	copper	copper	NN	B-NP
O	induces	induce	VBZ	B-VP
B-GGP	histone	histone	NN	B-NP
O	hypoacetylation	hypoacetylation	NN	I-NP
O	by	by	IN	B-PP
O	inhibiting	inhibit	VBG	B-VP
B-GGP	histone	histone	NN	B-NP
O	acetyltransferase	acetyltransferase	NN	I-NP
O	(	(	(	O
O	HAT	HAT	NN	B-NP
O	)	)	)	O
O	activity	activity	NN	B-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	it	it	PRP	B-NP
O	lacks	lack	VBZ	B-VP
O	direct	direct	JJ	B-NP
O	evidences	evidence	NNS	I-NP
O	whether	whether	IN	B-SBAR
O	copper	copper	NN	B-NP
O	-	-	HYPH	B-NP
O	inhibited	inhibit	VBN	I-NP
B-GGP	histone	histone	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	right	right	NN	I-NP
O	contributes	contribute	VBZ	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	toxicity	toxicity	NN	I-NP
O	of	of	IN	B-PP
O	copper	copper	NN	B-NP
O	.	.	.	O

O	Exposure	Exposure	NN	B-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	leukemia	leukemia	NN	I-NP
O	cells	cell	NNS	I-NP
O	(	(	(	O
O	HL	HL	NN	B-NP
O	-	-	HYPH	B-NP
O	60	60	CD	I-NP
O	)	)	)	O
O	to	to	TO	B-PP
O	Cu2	Cu2	NN	B-NP
O	+	+	SYM	B-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	cell	cell	NN	B-NP
O	proliferation	proliferation	NN	I-NP
O	arrest	arrest	NN	I-NP
O	and	and	CC	O
O	a	a	DT	B-NP
O	concentration	concentration	NN	I-NP
O	-	-	HYPH	O
O	and	and	CC	O
O	time	time	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	decrease	decrease	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	.	.	.	O

O	At	At	IN	B-PP
O	the	the	DT	B-NP
O	same	same	JJ	I-NP
O	time	time	NN	I-NP
O	,	,	,	O
O	Cu2	Cu2	NN	B-NP
O	+	+	SYM	O
O	-	-	HYPH	O
O	induced	induce	VBN	B-NP
O	significant	significant	JJ	I-NP
O	increase	increase	NN	I-NP
O	of	of	IN	B-PP
O	H2O2	H2O2	NN	B-NP
O	and	and	CC	I-NP
O	O2	O2	NN	I-NP
O	.	.	.	O
O	-	-	HYPH	B-NP
O	generation	generation	NN	I-NP
O	via	via	IN	B-PP
O	a	a	DT	B-NP
O	concentration	concentration	NN	I-NP
O	-	-	HYPH	O
O	and	and	CC	O
O	time	time	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	manner	manner	NN	I-NP
O	too	too	RB	B-ADVP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	histone	histone	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	was	be	VBD	B-VP
O	efficiently	efficiently	RB	I-VP
O	suppressed	suppress	VBN	I-VP
O	by	by	IN	B-PP
O	exogenous	exogenous	JJ	B-NP
O	H2O2	H2O2	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	enhanced	enhance	VBN	B-VP
O	by	by	IN	B-PP
O	superoxide	superoxide	NN	B-NP
O	dismutase	dismutase	NN	I-NP
O	(	(	(	O
O	the	the	DT	B-NP
O	scavenger	scavenger	NN	I-NP
O	of	of	IN	B-PP
O	O2	O2	NN	B-NP
O	.	.	.	O
O	-	-	SYM	O
O	)	)	)	O
O	,	,	,	O
B-GGP	catalase	catalase	NN	B-NP
O	(	(	(	O
O	the	the	DT	B-NP
O	scavenger	scavenger	NN	I-NP
O	of	of	IN	B-PP
O	H2O2	H2O2	NN	B-NP
O	)	)	)	O
O	or	or	CC	O
O	the	the	DT	B-NP
O	combination	combination	NN	I-NP
O	of	of	IN	B-PP
O	both	both	DT	B-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
O	Cu2	Cu2	NN	B-NP
O	+	+	SYM	O
O	at	at	IN	B-ADVP
O	least	least	JJS	I-ADVP
O	partially	partially	RB	B-ADVP
O	inhibited	inhibit	VBD	B-VP
B-GGP	histone	histone	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	through	through	IN	B-PP
O	triggering	trigger	VBG	B-VP
O	oxidative	oxidative	JJ	B-NP
O	stress	stress	NN	I-NP
O	.	.	.	O

O	Further	Further	JJ	B-NP
O	studies	study	NNS	I-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
O	sodium	sodium	NN	B-NP
O	butyrate	butyrate	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	inhibitor	inhibitor	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	deacetylase	deacetylase	NN	I-NP
O	(	(	(	O
O	HDAC	HDAC	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	which	which	WDT	B-NP
O	had	have	VBD	B-VP
O	no	no	DT	B-NP
O	obvious	obvious	JJ	I-NP
O	effect	effect	NN	I-NP
O	on	on	IN	B-PP
O	oxidative	oxidative	JJ	B-NP
O	stress	stress	NN	I-NP
O	but	but	CC	O
O	increased	increase	VBD	B-VP
B-GGP	histone	histone	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	concentration	concentration	NN	I-NP
O	of	of	IN	B-PP
O	50	50	CD	B-NP
O	microM	microM	NN	I-NP
O	,	,	,	O
O	attenuated	attenuate	VBD	B-VP
O	Cu2	Cu2	NN	B-NP
O	+	+	SYM	B-NP
O	-	-	HYPH	B-VP
O	inhibited	inhibit	VBN	B-NP
O	cell	cell	NN	I-NP
O	proliferation	proliferation	NN	I-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
B-GGP	histone	histone	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	inhibition	inhibition	NN	I-NP
O	is	be	VBZ	B-VP
O	simultaneously	simultaneously	RB	I-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	cytotoxicity	cytotoxicity	NN	I-NP
O	of	of	IN	B-PP
O	Cu2	Cu2	NN	B-NP
O	+	+	SYM	B-NP
O	.	.	.	O

O	Considering	Consider	VBG	B-VP
O	the	the	DT	B-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	in	in	IN	B-PP
O	gene	gene	NN	B-NP
O	transcription	transcription	NN	I-NP
O	and	and	CC	O
O	regulation	regulation	NN	B-NP
O	of	of	IN	B-PP
O	cell	cell	NN	B-NP
O	fate	fate	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	study	study	NN	I-NP
O	may	may	MD	B-VP
O	open	open	VB	I-VP
O	a	a	DT	B-NP
O	new	new	JJ	I-NP
O	door	door	NN	I-NP
O	to	to	TO	B-VP
O	further	further	RB	I-VP
O	understand	understand	VB	I-VP
O	the	the	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	of	of	IN	B-PP
O	Cu2	Cu2	NN	B-NP
O	+	+	SYM	B-NP
O	-	-	HYPH	B-VP
O	induced	induce	VBN	B-NP
O	toxicity	toxicity	NN	I-NP
O	.	.	.	O

O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	-	-	HYPH	B-NP
O	related	relate	VBN	I-NP
O	chromatin	chromatin	NN	I-NP
O	modification	modification	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	mouse	mouse	NN	B-NP
B-GGP	delta	delta	SYM	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	opioid	opioid	JJ	I-NP
I-GGP	receptor	receptor	NN	I-NP
O	gene	gene	NN	I-NP
O	.	.	.	O

O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	plays	play	VBZ	B-VP
O	critical	critical	JJ	B-NP
O	roles	role	NNS	I-NP
O	in	in	IN	B-PP
O	gene	gene	NN	B-NP
O	-	-	HYPH	O
O	silencing	silence	VBG	B-VP
O	through	through	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	modification	modification	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	reported	report	VBD	B-VP
O	previously	previously	RB	B-ADVP
O	that	that	IN	B-SBAR
O	promoter	promoter	NN	B-NP
O	-	-	HYPH	I-NP
O	region	region	NN	I-NP
O	CpG	CpG	NN	I-NP
O	methylation	methylation	NN	I-NP
O	repressed	repress	VBD	B-VP
O	mouse	mouse	NN	B-NP
B-GGP	delta	delta	SYM	B-VP
I-GGP	-	-	HYPH	B-NP
I-GGP	opioid	opioid	JJ	I-NP
I-GGP	receptor	receptor	NN	I-NP
O	(	(	(	O
B-GGP	mDOR	mDOR	NN	B-NP
O	)	)	)	O
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	current	current	JJ	I-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	demonstrated	demonstrate	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	methylation	methylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	mDOR	mDOR	NN	B-NP
O	gene	gene	NN	I-NP
O	promoter	promoter	NN	I-NP
O	is	be	VBZ	B-VP
O	correlated	correlate	VBN	I-VP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	repressive	repressive	JJ	I-NP
O	chromatin	chromatin	NN	I-NP
O	structure	structure	NN	I-NP
O	that	that	WDT	B-NP
O	has	have	VBZ	B-VP
O	less	less	JJR	B-NP
B-GGP	HaeIII	HaeIII	NNP	I-NP
O	and	and	CC	I-NP
B-GGP	MspI	MspI	NNP	I-NP
O	nuclear	nuclear	JJ	I-NP
O	accessibility	accessibility	NN	I-NP
O	and	and	CC	O
O	more	more	RBR	B-NP
O	deacetylated	deacetylate	VBN	I-NP
B-GGP	histone	histone	NN	I-NP
I-GGP	H3	H3	NN	I-NP
O	and	and	CC	I-NP
B-GGP	H4	H4	NN	I-NP
O	than	than	IN	B-PP
O	that	that	DT	B-NP
O	of	of	IN	B-PP
O	unmethylated	unmethylated	JJ	B-NP
B-GGP	mDOR	mDOR	NN	I-NP
O	promoter	promoter	NN	I-NP
O	.	.	.	O

O	Chromatin	Chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	analysis	analysis	NN	I-NP
O	showed	show	VBD	B-VP
O	the	the	DT	B-NP
O	association	association	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
B-GGP	methyl	methyl	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	CpG	CpG	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	binding	bind	VBG	B-VP
I-GGP	domain	domain	NN	B-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	2	2	CD	I-NP
O	(	(	(	O
B-GGP	MBD2	MBD2	NN	B-NP
O	)	)	)	O
O	with	with	IN	B-PP
O	methylated	methylate	VBN	B-NP
B-GGP	mDOR	mDOR	NN	I-NP
O	promoter	promoter	NN	I-NP
O	.	.	.	O

O	Transient	Transient	JJ	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	MBD2	MBD2	NN	B-NP
O	enhanced	enhance	VBD	B-VP
O	the	the	DT	B-NP
O	repression	repression	NN	I-NP
O	of	of	IN	B-PP
O	partially	partially	RB	B-NP
O	methylated	methylate	VBN	I-NP
B-GGP	mDOR	mDOR	NN	I-NP
O	promoter	promoter	NN	I-NP
O	activity	activity	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	this	this	DT	B-NP
O	repression	repression	NN	I-NP
O	was	be	VBD	B-VP
O	partially	partially	RB	I-VP
O	reversed	reverse	VBN	I-VP
O	by	by	IN	B-PP
O	treatment	treatment	NN	B-NP
O	of	of	IN	B-PP
O	trichostatin	trichostatin	NN	B-NP
O	A	A	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	specific	specific	JJ	I-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylase	deacetylase	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
B-GGP	MBD2	MBD2	NN	B-NP
O	may	may	MD	B-VP
O	mediate	mediate	VB	I-VP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	-	-	HYPH	B-NP
O	related	relate	VBN	I-NP
O	chromatin	chromatin	NN	I-NP
O	modification	modification	NN	I-NP
O	through	through	IN	B-PP
O	recruiting	recruit	VBG	B-VP
O	histone	histone	NN	B-NP
O	deacetylases	deacetylas	NNS	I-NP
O	to	to	TO	B-PP
B-GGP	mDOR	mDOR	NN	B-NP
O	promoter	promoter	NN	I-NP
O	region	region	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	trichostatin	trichostatin	NN	B-NP
O	A	A	NN	I-NP
O	treatment	treatment	NN	I-NP
O	increased	increase	VBD	B-VP
O	both	both	CC	O
O	methylated	methylate	VBN	B-NP
B-GGP	mDOR	mDOR	NN	I-NP
O	promoter	promoter	NN	I-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	transient	transient	JJ	I-NP
O	transfection	transfection	NN	I-NP
O	assay	assay	NN	I-NP
O	and	and	CC	O
O	endogenous	endogenous	JJ	B-NP
B-GGP	mDOR	mDOR	NN	I-NP
O	mRNA	mRNA	NN	I-NP
O	level	level	NN	I-NP
O	in	in	IN	B-PP
O	Neuro2A	Neuro2A	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Taken	Take	VBN	B-VP
O	together	together	RB	B-ADVP
O	,	,	,	O
O	these	these	DT	B-NP
O	results	result	NNS	I-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
B-GGP	mDOR	mDOR	NN	I-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	is	be	VBZ	B-VP
O	regulated	regulate	VBN	I-VP
O	by	by	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	-	-	HYPH	B-NP
O	related	relate	VBN	I-NP
O	chromatin	chromatin	NN	I-NP
O	modification	modification	NN	I-NP
O	,	,	,	O
O	especially	especially	RB	B-NP
B-GGP	histone	histone	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	and	and	CC	I-NP
O	deacetylation	deacetylation	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	potential	potential	NN	I-NP
O	of	of	IN	B-PP
O	Pseudozyma	Pseudozyma	NN	B-NP
O	yeastlike	yeastlike	JJ	I-NP
O	epiphytes	epiphyte	NNS	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	production	production	NN	I-NP
O	of	of	IN	B-PP
O	heterologous	heterologous	JJ	B-NP
O	recombinant	recombinant	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	Although	Although	IN	B-SBAR
O	Basidiomycetes	Basidiomycete	NNS	B-NP
O	represent	represent	VBP	B-VP
O	the	the	DT	B-NP
O	most	most	RBS	I-NP
O	evolved	evolved	JJ	I-NP
O	class	class	NN	I-NP
O	of	of	IN	B-PP
O	fungi	fungus	NNS	B-NP
O	,	,	,	O
O	they	they	PRP	B-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	neglected	neglect	VBN	I-VP
O	with	with	IN	B-PP
O	regard	regard	NN	B-NP
O	to	to	TO	B-PP
O	recombinant	recombinant	JJ	B-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	work	work	NN	I-NP
O	,	,	,	O
O	basidiomycetous	basidiomycetous	JJ	B-NP
O	yeasts	yeast	NNS	I-NP
O	belonging	belong	VBG	B-VP
O	to	to	TO	B-PP
O	Pseudozyma	Pseudozyma	NN	B-NP
O	spp	spp	NN	I-NP
O	.	.	.	O

O	were	be	VBD	B-VP
O	studied	study	VBN	I-VP
O	with	with	IN	B-PP
O	respect	respect	NN	B-NP
O	to	to	TO	B-PP
O	their	their	PRP$	B-NP
O	amenability	amenability	NN	I-NP
O	to	to	TO	B-PP
O	heterologous	heterologous	JJ	B-NP
O	protein	protein	NN	I-NP
O	production	production	NN	I-NP
O	.	.	.	O

O	Single	Single	JJ	B-NP
O	plasmid	plasmid	NN	I-NP
O	or	or	CC	I-NP
O	cotransformation	cotransformation	NN	I-NP
O	experiments	experiment	NNS	I-NP
O	routinely	routinely	RB	B-ADVP
O	afforded	afford	VBD	B-VP
O	100	100	CD	B-NP
O	to	to	TO	B-PP
O	200	200	CD	B-NP
O	independent	independent	JJ	I-NP
O	transformants	transformant	NNS	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	tested	test	VBN	I-NP
O	species	specie	NNS	I-NP
O	of	of	IN	B-PP
O	Pseudozyma	Pseudozyma	NN	B-NP
O	.	.	.	O

B-GGP	Green	Green	JJ	B-NP
I-GGP	fluorescent	fluorescent	JJ	I-NP
I-GGP	protein	protein	NN	I-NP
O	(	(	(	O
B-GGP	GFP	GFP	NN	B-NP
O	)	)	)	O
O	was	be	VBD	B-VP
O	expressed	express	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	correctly	correctly	RB	I-NP
O	folded	fold	VBN	I-NP
O	conformation	conformation	NN	I-NP
O	,	,	,	O
O	as	as	IN	B-SBAR
O	demonstrated	demonstrate	VBN	B-VP
O	by	by	IN	B-PP
O	fluorescence	fluorescence	NN	B-NP
O	microscopy	microscopy	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	hen	hen	RB	B-ADVP
O	egg	egg	NN	B-NP
O	white	white	JJ	I-NP
B-GGP	lysozyme	lysozyme	NN	I-NP
O	(	(	(	O
O	HEWL	HEWL	NN	B-NP
O	)	)	)	O
O	was	be	VBD	B-VP
O	expressed	express	VBN	I-VP
O	in	in	IN	B-PP
O	its	its	PRP$	B-NP
O	active	active	JJ	I-NP
O	form	form	NN	I-NP
O	,	,	,	O
O	as	as	IN	B-SBAR
O	revealed	reveal	VBN	B-VP
O	by	by	IN	B-PP
O	its	its	PRP$	B-NP
O	lytic	lytic	JJ	I-NP
O	activity	activity	NN	I-NP
O	on	on	IN	B-PP
O	Micrococcus	Micrococcus	NNP	B-NP
O	lysodeikticus	lysodeikticus	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Protease	Protease	NN	B-NP
O	analysis	analysis	NN	I-NP
O	established	establish	VBD	B-VP
O	that	that	IN	B-SBAR
O	Pseudozyma	Pseudozyma	NN	B-NP
O	spp	spp	NN	I-NP
O	.	.	.	O

O	contained	contain	VBD	B-VP
O	equivalent	equivalent	JJ	B-ADJP
O	or	or	CC	O
O	less	less	RBR	B-NP
O	extracellular	extracellular	JJ	I-NP
O	protease	protease	NN	I-NP
O	activity	activity	NN	I-NP
O	than	than	IN	B-PP
O	yeasts	yeast	NNS	B-NP
O	and	and	CC	O
O	far	far	RB	B-NP
O	less	less	JJR	I-NP
O	protease	protease	NN	I-NP
O	activity	activity	NN	I-NP
O	than	than	IN	B-PP
O	ascomycetous	ascomycetous	JJ	B-NP
O	filamentous	filamentous	JJ	I-NP
O	fungi	fungus	NNS	I-NP
O	in	in	IN	B-PP
O	similar	similar	JJ	B-NP
O	culture	culture	NN	I-NP
O	conditions	condition	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	proteolytic	proteolytic	JJ	I-NP
O	activity	activity	NN	I-NP
O	was	be	VBD	B-VP
O	inhibited	inhibit	VBN	I-VP
O	by	by	IN	B-PP
O	over	over	IN	B-NP
O	97	97	CD	I-NP
O	%	%	NN	I-NP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	combination	combination	NN	I-NP
O	of	of	IN	B-PP
O	PMSF	PMSF	NN	B-NP
O	and	and	CC	I-NP
O	Pepstatin	Pepstatin	NN	I-NP
O	A	A	NN	I-NP
O	.	.	.	O

O	N	N	NN	B-NP
O	-	-	HYPH	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	of	of	IN	B-PP
O	native	native	JJ	B-NP
O	Pseudozyma	Pseudozyma	NN	I-NP
O	flocculosa	flocculosa	NN	I-NP
O	secreted	secrete	VBN	B-NP
O	proteins	protein	NNS	I-NP
O	were	be	VBD	B-VP
O	comprised	comprise	VBN	I-VP
O	of	of	IN	B-PP
O	one	one	CD	B-NP
O	or	or	CC	O
O	a	a	DT	B-NP
O	few	few	JJ	I-NP
O	short	short	JJ	I-NP
O	glycan	glycan	NN	I-NP
O	chains	chain	NNS	I-NP
O	that	that	WDT	B-NP
O	possess	possess	VBP	B-VP
O	a	a	DT	B-NP
O	classic	classic	JJ	I-NP
O	eukaryotic	eukaryotic	JJ	I-NP
O	structure	structure	NN	I-NP
O	typical	typical	JJ	B-ADJP
O	of	of	IN	B-PP
O	higher	high	JJR	B-NP
O	fungi	fungi	NN	I-NP
O	and	and	CC	I-NP
O	animal	animal	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	report	report	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	Basidiomycete	Basidiomycete	NNP	I-NP
O	that	that	WDT	B-NP
O	possesses	possess	VBZ	B-VP
O	multiple	multiple	JJ	B-NP
O	intrinsic	intrinsic	JJ	I-NP
O	characteristics	characteristic	NNS	I-NP
O	necessary	necessary	JJ	B-ADJP
O	for	for	IN	B-PP
O	use	use	NN	B-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	heterologous	heterologous	JJ	I-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	system	system	NN	I-NP
O	.	.	.	O

O	Interactions	Interaction	NNS	B-NP
O	of	of	IN	B-PP
O	whey	whey	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	during	during	IN	B-PP
O	heat	heat	NN	B-NP
O	treatment	treatment	NN	I-NP
O	of	of	IN	B-PP
O	oil	oil	NN	B-NP
O	-	-	HYPH	B-NP
O	in	in	IN	B-PP
O	-	-	HYPH	B-NP
O	water	water	NN	I-NP
O	emulsions	emulsion	NNS	I-NP
O	formed	form	VBN	B-VP
O	with	with	IN	B-PP
O	whey	whey	JJ	B-NP
O	protein	protein	NN	I-NP
O	isolate	isolate	NN	I-NP
O	and	and	CC	O
O	hydroxylated	hydroxylate	VBN	B-NP
O	lecithin	lecithin	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	interactions	interaction	NNS	I-NP
O	of	of	IN	B-PP
O	proteins	protein	NNS	B-NP
O	during	during	IN	B-PP
O	the	the	DT	B-NP
O	heat	heat	NN	I-NP
O	treatment	treatment	NN	I-NP
O	of	of	IN	B-PP
O	whey	whey	NN	B-NP
O	-	-	HYPH	B-NP
O	protein	protein	NN	I-NP
O	-	-	HYPH	O
O	isolate	isolate	NN	B-NP
O	(	(	(	O
O	WPI	WPI	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	O
O	based	base	VBN	B-NP
O	oil	oil	NN	I-NP
O	-	-	HYPH	B-ADJP
O	in	in	IN	B-PP
O	-	-	HYPH	B-NP
O	water	water	NN	I-NP
O	emulsions	emulsion	NNS	I-NP
O	with	with	IN	B-PP
O	and	and	CC	I-PP
O	without	without	IN	I-PP
O	added	add	VBN	B-NP
O	hydroxylated	hydroxylate	VBN	I-NP
O	lecithin	lecithin	NN	I-NP
O	were	be	VBD	B-VP
O	studied	study	VBN	I-VP
O	by	by	IN	B-PP
O	examining	examine	VBG	B-VP
O	the	the	DT	B-NP
O	changes	change	NNS	I-NP
O	in	in	IN	B-PP
O	droplet	droplet	NN	B-NP
O	size	size	NN	I-NP
O	distribution	distribution	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	quantity	quantity	NN	I-NP
O	and	and	CC	I-NP
O	type	type	NN	I-NP
O	of	of	IN	B-PP
O	adsorbed	adsorb	VBN	B-NP
O	and	and	CC	I-NP
O	unadsorbed	unadsorbed	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	Heat	Heat	NN	B-NP
O	treatment	treatment	NN	I-NP
O	at	at	IN	B-PP
O	90	90	CD	B-NP
O	degrees	degree	NNS	I-NP
O	C	C	NN	I-NP
O	of	of	IN	B-PP
O	WPI	WPI	NNP	B-NP
O	emulsions	emulsion	NNS	I-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	an	an	DT	B-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
O	total	total	JJ	B-NP
O	adsorbed	adsorb	VBN	I-NP
O	protein	protein	NN	I-NP
O	;	;	:	O
O	unadsorbed	unadsorbed	JJ	B-ADJP
B-GGP	beta	beta	SYM	O
I-GGP	-	-	HYPH	O
I-GGP	lactoglobulin	lactoglobulin	NN	B-NP
O	(	(	(	O
B-GGP	beta	beta	SYM	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	lg	lg	NN	I-NP
O	)	)	)	O
O	was	be	VBD	B-VP
O	the	the	DT	B-NP
O	main	main	JJ	I-NP
O	protein	protein	NN	I-NP
O	interacting	interact	VBG	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	adsorbed	adsorb	VBN	I-NP
O	proteins	protein	NNS	I-NP
O	during	during	IN	B-PP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	10	10	CD	I-NP
O	min	min	NN	I-NP
O	of	of	IN	B-PP
O	heating	heating	NN	B-NP
O	,	,	,	O
O	but	but	CC	O
O	after	after	IN	B-PP
O	this	this	DT	B-NP
O	time	time	NN	I-NP
O	,	,	,	O
O	unadsorbed	unadsorbed	JJ	B-ADJP
B-GGP	alpha	alpha	SYM	O
I-GGP	-	-	HYPH	O
I-GGP	lactalbumin	lactalbumin	NN	B-NP
O	(	(	(	O
B-GGP	alpha	alpha	SYM	O
I-GGP	-	-	HYPH	O
I-GGP	la	la	NN	B-NP
O	)	)	)	O
O	also	also	RB	B-ADVP
O	associated	associate	VBD	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	adsorbed	adsorb	VBN	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	emulsions	emulsion	NNS	B-NP
O	containing	contain	VBG	B-VP
O	hydroxylated	hydroxylate	VBN	B-NP
O	lecithin	lecithin	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
O	total	total	JJ	B-NP
O	adsorbed	adsorb	VBN	I-NP
O	protein	protein	NN	I-NP
O	during	during	IN	B-PP
O	heat	heat	NN	B-NP
O	treatment	treatment	NN	I-NP
O	was	be	VBD	B-VP
O	much	much	RB	B-ADJP
O	lower	low	JJR	I-ADJP
O	and	and	CC	O
O	the	the	DT	B-NP
O	unadsorbed	unadsorbed	JJ	I-NP
B-GGP	beta	beta	SYM	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	lg	lg	NN	I-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	appear	appear	VB	I-VP
O	to	to	TO	I-VP
O	interact	interact	VB	I-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	adsorbed	adsorb	VBN	I-NP
O	proteins	protein	NNS	I-NP
O	during	during	IN	B-PP
O	heating	heating	NN	B-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	behavior	behavior	NN	I-NP
O	of	of	IN	B-PP
B-GGP	alpha	alpha	SYM	B-NP
I-GGP	-	-	HYPH	O
I-GGP	la	la	NN	B-NP
O	during	during	IN	B-PP
O	heat	heat	NN	B-NP
O	treatment	treatment	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	emulsions	emulsion	NNS	I-NP
O	was	be	VBD	B-VP
O	similar	similar	JJ	B-ADJP
O	to	to	TO	B-PP
O	that	that	DT	B-NP
O	observed	observe	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	emulsions	emulsion	NNS	I-NP
O	containing	contain	VBG	B-VP
O	no	no	DT	B-NP
O	hydroxylated	hydroxylate	VBN	I-NP
O	lecithin	lecithin	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	NaCl	NaCl	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	particle	particle	NN	I-NP
O	size	size	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	emulsion	emulsion	NN	I-NP
O	droplets	droplet	NNS	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	quantities	quantity	NNS	I-NP
O	of	of	IN	B-PP
O	adsorbed	adsorb	VBN	B-NP
O	protein	protein	NN	I-NP
O	increased	increase	VBD	B-VP
O	markedly	markedly	RB	B-ADVP
O	during	during	IN	B-PP
O	heating	heating	NN	B-NP
O	.	.	.	O

O	Emulsions	Emulsion	NNS	B-NP
O	containing	contain	VBG	B-VP
O	hydroxylated	hydroxylate	VBN	B-NP
O	lecithin	lecithin	NN	I-NP
O	were	be	VBD	B-VP
O	less	less	RBR	B-ADJP
O	sensitive	sensitive	JJ	I-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	addition	addition	NN	I-NP
O	of	of	IN	B-PP
O	NaCl	NaCl	NN	B-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
O	hydroxylated	hydroxylate	VBN	B-NP
O	lecithin	lecithin	NN	I-NP
O	to	to	TO	B-PP
O	unfolded	unfolded	JJ	B-NP
O	monomers	monomer	NNS	I-NP
O	or	or	CC	O
O	intermediate	intermediate	JJ	B-NP
O	products	product	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	beta	beta	SYM	O
I-GGP	-	-	HYPH	O
I-GGP	lg	lg	NN	B-NP
O	reduces	reduce	VBZ	B-VP
O	the	the	DT	B-NP
O	extent	extent	NN	I-NP
O	of	of	IN	B-PP
O	heat	heat	NN	B-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	aggregation	aggregation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	beta	beta	SYM	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	lg	lg	NN	I-NP
O	and	and	CC	O
O	consequently	consequently	RB	B-VP
O	decreases	decrease	VBZ	I-VP
O	the	the	DT	B-NP
O	interactions	interaction	NNS	I-NP
O	between	between	IN	B-PP
O	unadsorbed	unadsorbed	JJ	B-NP
B-GGP	beta	beta	SYM	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	lg	lg	NN	I-NP
O	and	and	CC	O
O	adsorbed	adsorb	VBN	B-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	was	be	VBD	B-VP
O	confirmed	confirm	VBN	I-VP
O	by	by	IN	B-PP
O	sodium	sodium	NN	B-NP
O	dodecyl	dodecyl	NN	I-NP
O	sulfate	sulfate	NN	I-NP
O	-	-	HYPH	B-NP
O	polyacrylamide	polyacrylamide	NN	I-NP
O	gel	gel	NN	I-NP
O	electrophoresis	electrophoresis	NN	I-NP
O	(	(	(	O
O	SDS	SDS	NN	B-NP
O	-	-	HYPH	B-NP
O	PAGE	PAGE	NN	I-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	heated	heated	JJ	B-NP
O	whey	whey	JJ	I-NP
O	protein	protein	NN	I-NP
O	and	and	CC	O
O	hydroxylated	hydroxylate	VBN	B-NP
O	lecithin	lecithin	JJ	I-NP
O	solutions	solution	NNS	I-NP
O	.	.	.	O

O	Dynamic	Dynamic	JJ	B-NP
O	lysine	lysine	NN	I-NP
O	methylation	methylation	NN	I-NP
O	on	on	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	defines	define	VBZ	B-VP
O	the	the	DT	B-NP
O	regulatory	regulatory	JJ	I-NP
O	phase	phase	NN	I-NP
O	of	of	IN	B-PP
O	gene	gene	NN	B-NP
O	transcription	transcription	NN	I-NP
O	.	.	.	O

O	Covalent	Covalent	JJ	B-NP
O	modifications	modification	NNS	I-NP
O	to	to	TO	B-PP
B-GGP	histones	histone	NNS	B-NP
O	are	be	VBP	B-VP
O	key	key	JJ	B-NP
O	epigenetic	epigenetic	JJ	I-NP
O	marks	mark	NNS	I-NP
O	that	that	WDT	B-NP
O	control	control	VBP	B-VP
O	gene	gene	NN	B-NP
O	transcription	transcription	NN	I-NP
O	.	.	.	O

O	Multiple	Multiple	JJ	B-NP
O	lysine	lysine	NN	I-NP
O	residues	residue	NNS	I-NP
O	on	on	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	are	be	VBP	B-VP
O	methylated	methylate	VBN	I-VP
O	(	(	(	O
O	me	me	PRP	B-NP
O	)	)	)	O
O	,	,	,	O
O	but	but	CC	O
O	their	their	PRP$	B-NP
O	functions	function	NNS	I-NP
O	are	be	VBP	B-VP
O	unclear	unclear	JJ	B-ADJP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	demonstrate	demonstrate	VBP	B-VP
O	two	two	CD	B-NP
O	phases	phase	NNS	I-NP
O	of	of	IN	B-PP
O	combinatorial	combinatorial	JJ	B-NP
O	and	and	CC	I-NP
O	dynamic	dynamic	JJ	I-NP
B-GGP	H3	H3	NN	I-NP
O	methylation	methylation	NN	I-NP
O	during	during	IN	B-PP
O	induction	induction	NN	B-NP
O	of	of	IN	B-PP
O	transcription	transcription	NN	B-NP
O	at	at	IN	B-PP
B-GGP	MET16	MET16	NN	B-NP
O	in	in	IN	B-PP
O	yeast	yeast	NN	B-NP
O	.	.	.	O

O	K4me3	K4me3	NN	B-NP
O	with	with	IN	B-PP
O	K36me2	K36me2	NN	B-NP
O	/	/	SYM	O
O	3	3	CD	B-NP
O	define	define	NN	I-NP
O	a	a	DT	B-NP
O	postinitiation	postinitiation	NN	I-NP
O	regulatory	regulatory	JJ	I-NP
O	phase	phase	NN	I-NP
O	and	and	CC	O
O	precede	precede	VBP	B-VP
O	the	the	DT	B-NP
O	appearance	appearance	NN	I-NP
O	of	of	IN	B-PP
O	K4me2	K4me2	NN	B-NP
O	with	with	IN	B-PP
O	K79me2	K79me2	NN	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	onset	onset	NN	I-NP
O	of	of	IN	B-PP
O	transcript	transcript	NN	B-NP
O	elongation	elongation	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	Isw1	Isw1	NN	I-NP
O	ATPase	ATPase	NN	I-NP
O	delays	delay	VBZ	B-VP
O	the	the	DT	B-NP
O	release	release	NN	I-NP
O	of	of	IN	B-PP
O	initiated	initiate	VBN	B-NP
O	RNA	RNA	NN	I-NP
O	polymerase	polymerase	NN	I-NP
O	II	II	CD	I-NP
O	(	(	(	O
O	RNAPII	RNAPII	NN	B-NP
O	)	)	)	O
O	into	into	IN	B-PP
O	elongation	elongation	NN	B-NP
O	to	to	TO	B-VP
O	facilitate	facilitate	VB	I-VP
O	chromatin	chromatin	NN	B-NP
O	modifications	modification	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	Spp1	Spp1	NN	I-NP
O	subunit	subunit	NN	I-NP
O	of	of	IN	B-PP
O	complex	complex	NN	B-NP
O	associated	associate	VBN	B-VP
O	with	with	IN	B-PP
B-GGP	Set1	Set1	NN	B-NP
O	(	(	(	O
O	COMPASS	COMPASS	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	Set2	Set2	NN	B-NP
O	,	,	,	O
O	determining	determine	VBG	B-VP
O	K4me3	K4me3	NN	B-NP
O	and	and	CC	I-NP
O	K36me2	K36me2	NN	I-NP
O	/	/	SYM	B-NP
O	3	3	CD	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	,	,	,	O
O	are	be	VBP	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	transient	transient	JJ	B-NP
O	NuA4	NuA4	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	H4K8ac	H4K8ac	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	releases	release	VBZ	B-VP
O	RNAPII	RNAPII	NN	B-NP
O	from	from	IN	B-PP
B-GGP	Isw1	Isw1	NN	B-NP
O	control	control	NN	I-NP
O	and	and	CC	O
O	promotes	promote	VBZ	B-VP
O	controlled	control	VBN	B-NP
O	transcription	transcription	NN	I-NP
O	elongation	elongation	NN	I-NP
O	and	and	CC	I-NP
O	termination	termination	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	propose	propose	VBP	B-VP
O	that	that	IN	B-SBAR
O	newly	newly	RB	B-NP
O	initiated	initiate	VBN	I-NP
O	RNAPII	RNAPII	NN	I-NP
O	is	be	VBZ	B-VP
O	under	under	IN	B-PP
O	epigenetic	epigenetic	JJ	B-NP
O	control	control	NN	I-NP
O	.	.	.	O

O	Proline	Proline	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	and	and	CC	O
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	Hypoxia	Hypoxia	NN	B-NP
O	-	-	HYPH	B-NP
O	inducible	inducible	JJ	I-NP
O	factor	factor	NN	I-NP
O	(	(	(	O
O	HIF	HIF	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	master	master	NN	I-NP
O	transcriptional	transcriptional	JJ	I-NP
O	regulator	regulator	NN	I-NP
O	of	of	IN	B-PP
O	hypoxia	hypoxia	NN	B-NP
O	-	-	HYPH	B-NP
O	inducible	inducible	JJ	I-NP
O	genes	gene	NNS	I-NP
O	and	and	CC	O
O	consists	consist	VBZ	B-VP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	labile	labile	JJ	I-NP
O	alpha	alpha	NN	I-NP
O	subunit	subunit	NN	I-NP
O	(	(	(	O
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
B-GGP	HIF1alpha	HIF1alpha	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	a	a	DT	B-NP
O	stable	stable	JJ	I-NP
O	beta	beta	NN	I-NP
O	subunit	subunit	NN	I-NP
O	(	(	(	O
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
B-GGP	HIF1beta	HIF1beta	NN	B-NP
O	or	or	CC	O
B-GGP	ARNT	ARNT	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	,	,	,	O
O	HIFalpha	HIFalpha	NN	B-NP
O	family	family	NN	I-NP
O	members	member	NNS	I-NP
O	are	be	VBP	B-VP
O	hydroxylated	hydroxylate	VBN	I-VP
O	on	on	IN	B-PP
O	one	one	CD	B-NP
O	of	of	IN	B-PP
O	two	two	CD	B-NP
O	conserved	conserve	VBN	I-NP
O	prolyl	prolyl	JJ	I-NP
O	residues	residue	NNS	I-NP
O	by	by	IN	B-PP
O	members	member	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	egg	egg	NN	I-NP
O	-	-	HYPH	O
O	laying	lay	VBG	B-VP
O	-	-	HYPH	B-NP
O	defective	defective	JJ	I-NP
O	nine	nine	CD	I-NP
O	(	(	(	O
O	EGLN	EGLN	NN	B-NP
O	)	)	)	O
O	family	family	NN	B-NP
O	.	.	.	O

O	Prolyl	Prolyl	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	generates	generate	VBZ	B-VP
O	a	a	DT	B-NP
O	binding	bind	VBG	I-NP
O	site	site	NN	I-NP
O	for	for	IN	B-PP
O	a	a	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	complex	complex	NN	I-NP
O	containing	contain	VBG	B-VP
O	the	the	DT	B-NP
B-GGP	von	von	NNP	I-NP
I-GGP	Hippel	Hippel	NNP	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	Lindau	Lindau	NNP	I-NP
I-GGP	(	(	(	O
I-GGP	VHL	VHL	NNP	O
I-GGP	)	)	)	O
I-GGP	tumor	tumor	NN	B-NP
I-GGP	suppressor	suppressor	NN	I-NP
O	protein	protein	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	HIFalpha	HIFalpha	NN	B-NP
O	destruction	destruction	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	HIFalpha	HIFalpha	NN	I-NP
O	transcriptional	transcriptional	JJ	I-NP
O	activation	activation	NN	I-NP
O	function	function	NN	I-NP
O	is	be	VBZ	B-VP
O	modulated	modulate	VBN	I-VP
O	further	further	RB	B-ADVP
O	by	by	IN	B-PP
O	asparagine	asparagine	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	by	by	IN	B-PP
B-GGP	FIH	FIH	NN	B-NP
O	(	(	(	O
B-GGP	factor	factor	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	inhibiting	inhibit	VBG	B-VP
I-GGP	HIF	HIF	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	which	which	WDT	B-NP
O	affects	affect	VBZ	B-VP
O	recruitment	recruitment	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	coactivators	coactivator	NNS	I-NP
B-GGP	p300	p300	NN	I-NP
O	and	and	CC	I-NP
B-GGP	CBP	CBP	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	findings	finding	NNS	I-NP
O	provide	provide	VBP	B-VP
O	new	new	JJ	B-NP
O	mechanistic	mechanistic	JJ	I-NP
O	insights	insight	NNS	I-NP
O	into	into	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	sensing	sense	VBG	B-VP
O	by	by	IN	B-PP
O	metazoans	metazoan	NNS	B-NP
O	and	and	CC	O
O	are	be	VBP	B-VP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	examples	example	NNS	I-NP
O	of	of	IN	B-PP
O	protein	protein	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	being	be	VBG	B-VP
O	used	use	VBN	I-VP
O	in	in	IN	B-PP
O	intracellular	intracellular	JJ	B-NP
O	signaling	signaling	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	existence	existence	NN	I-NP
O	of	of	IN	B-PP
O	three	three	CD	B-NP
O	human	human	JJ	I-NP
O	EGLN	EGLN	NN	I-NP
O	family	family	NN	I-NP
O	members	member	NNS	I-NP
O	,	,	,	O
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	other	other	JJ	B-NP
O	putative	putative	JJ	I-NP
O	hydroxylases	hydroxylas	NNS	I-NP
O	,	,	,	O
O	raises	raise	VBZ	B-VP
O	the	the	DT	B-NP
O	possibility	possibility	NN	I-NP
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	signal	signal	NN	I-NP
O	is	be	VBZ	B-VP
O	used	use	VBN	I-VP
O	in	in	IN	B-PP
O	other	other	JJ	B-NP
O	contexts	context	NNS	I-NP
O	by	by	IN	B-PP
O	other	other	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

B-GGP	Histone	Histone	NN	B-NP
O	acetyltransferase	acetyltransferase	NN	I-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	p300	p300	NN	B-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	repression	repression	NN	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	promyelocytic	promyelocytic	JJ	I-NP
O	leukemia	leukemia	NN	I-NP
O	zinc	zinc	NN	I-NP
O	finger	finger	NN	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

B-GGP	Histone	Histone	NN	B-NP
O	acetyltransferase	acetyltransferase	NN	I-NP
O	(	(	(	O
O	HAT	HAT	NN	B-NP
O	)	)	)	O
O	activities	activity	NNS	B-NP
O	of	of	IN	B-PP
O	proteins	protein	NNS	B-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
B-GGP	p300	p300	NN	B-NP
O	,	,	,	O
B-GGP	CBP	CBP	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	P	P	NN	B-NP
I-GGP	/	/	SYM	B-NP
I-GGP	CAF	CAF	NN	B-NP
O	play	play	VBP	B-VP
O	important	important	JJ	B-NP
O	roles	role	NNS	I-NP
O	in	in	IN	B-PP
O	activation	activation	NN	B-NP
O	of	of	IN	B-PP
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	now	now	RB	B-ADVP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	HAT	HAT	NN	I-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	p300	p300	NN	B-NP
O	can	can	MD	B-VP
O	also	also	RB	I-VP
O	be	be	VB	I-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	down	down	RB	B-ADVP
O	-	-	HYPH	O
O	regulation	regulation	NN	B-NP
O	of	of	IN	B-PP
O	transcription	transcription	NN	B-NP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	DNA	DNA	NN	I-NP
O	binding	binding	NN	I-NP
O	repressor	repressor	NN	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

B-GGP	Promyelocytic	Promyelocytic	JJ	B-NP
I-GGP	leukemia	leukemia	NN	I-NP
I-GGP	zinc	zinc	NN	I-NP
I-GGP	finger	finger	NN	I-NP
O	(	(	(	O
B-GGP	PLZF	PLZF	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	originally	originally	RB	B-VP
O	identified	identify	VBN	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	fusion	fusion	NN	I-NP
O	with	with	IN	B-PP
B-GGP	retinoic	retinoic	JJ	B-NP
I-GGP	acid	acid	NN	I-NP
I-GGP	receptor	receptor	NN	I-NP
I-GGP	alpha	alpha	NN	I-NP
O	in	in	IN	B-PP
O	rare	rare	JJ	B-NP
O	cases	case	NNS	I-NP
O	of	of	IN	B-PP
O	all	all	RB	B-ADJP
O	-	-	HYPH	I-ADJP
O	trans	trans	AFX	I-ADJP
O	-	-	HYPH	I-ADJP
O	retinoic	retinoic	JJ	B-NP
O	acid	acid	NN	I-NP
O	-	-	HYPH	B-NP
O	resistant	resistant	JJ	I-NP
O	acute	acute	JJ	I-NP
O	promyelocytic	promyelocytic	JJ	I-NP
O	leukemia	leukemia	NN	I-NP
O	,	,	,	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	repressor	repressor	NN	I-NP
O	that	that	WDT	B-NP
O	recruits	recruit	VBZ	B-VP
B-GGP	histone	histone	NN	B-NP
O	deacetylase	deacetylase	NN	I-NP
O	-	-	HYPH	O
O	containing	contain	VBG	B-VP
O	corepressor	corepressor	NN	B-NP
O	complexes	complex	NNS	I-NP
O	to	to	TO	B-PP
O	specific	specific	JJ	B-NP
O	DNA	DNA	NN	I-NP
O	binding	binding	NN	I-NP
O	sites	site	NNS	I-NP
O	.	.	.	O

B-GGP	PLZF	PLZF	NN	B-NP
O	associates	associate	VBZ	B-VP
O	with	with	IN	B-PP
B-GGP	p300	p300	NN	B-NP
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	,	,	,	O
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	ability	ability	NN	I-NP
O	to	to	TO	B-VP
O	repress	repress	VB	I-VP
O	transcription	transcription	NN	B-NP
O	is	be	VBZ	B-VP
O	specifically	specifically	RB	B-ADJP
O	dependent	dependent	JJ	I-ADJP
O	on	on	IN	B-PP
O	HAT	HAT	NN	B-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	p300	p300	NN	B-NP
O	and	and	CC	I-NP
O	acetylation	acetylation	NN	I-NP
O	of	of	IN	B-PP
O	lysines	lysine	NNS	B-NP
O	in	in	IN	B-PP
O	its	its	PRP$	B-NP
O	C	C	NN	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	B-NP
O	C2	C2	NN	I-NP
O	-	-	HYPH	B-NP
O	H2	H2	NN	I-NP
O	zinc	zinc	NN	I-NP
O	finger	finger	NN	I-NP
O	motif	motif	NN	I-NP
O	.	.	.	O

O	An	An	DT	B-NP
O	acetylation	acetylation	NN	I-NP
O	site	site	NN	I-NP
O	mutant	mutant	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PLZF	PLZF	NN	B-NP
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	repress	repress	VB	I-VP
O	transcription	transcription	NN	B-NP
O	and	and	CC	O
O	is	be	VBZ	B-VP
O	functionally	functionally	RB	B-ADJP
O	deficient	deficient	JJ	I-ADJP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	colony	colony	NN	I-NP
O	suppression	suppression	NN	I-NP
O	assay	assay	NN	I-NP
O	despite	despite	IN	B-PP
O	retaining	retain	VBG	B-VP
O	its	its	PRP$	B-NP
O	abilities	ability	NNS	I-NP
O	to	to	TO	B-VP
O	interact	interact	VB	I-VP
O	with	with	IN	B-PP
O	corepressor	corepressor	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylase	deacetylase	NN	I-NP
O	complexes	complex	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	is	be	VBZ	B-VP
O	due	due	IN	B-PP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	fact	fact	NN	I-NP
O	that	that	IN	B-SBAR
O	acetylation	acetylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	PLZF	PLZF	NN	B-NP
O	activates	activate	VBZ	B-VP
O	its	its	PRP$	B-NP
O	ability	ability	NN	I-NP
O	to	to	TO	B-VP
O	bind	bind	VB	I-VP
O	specific	specific	JJ	B-NP
O	DNA	DNA	NN	I-NP
O	sequences	sequence	NNS	I-NP
O	both	both	CC	O
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	and	and	CC	O
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	.	.	.	O

O	Taken	Take	VBN	B-VP
O	together	together	RB	B-ADVP
O	,	,	,	O
O	our	our	PRP$	B-NP
O	results	result	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	a	a	DT	B-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylase	deacetylase	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	transcriptional	transcriptional	JJ	I-NP
O	repressor	repressor	NN	I-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	positively	positively	RB	I-VP
O	regulated	regulate	VBN	I-VP
O	through	through	IN	B-PP
O	acetylation	acetylation	NN	B-NP
O	and	and	CC	I-NP
O	point	point	NN	I-NP
O	to	to	TO	B-PP
O	an	an	DT	B-NP
O	unexpected	unexpected	JJ	I-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	coactivator	coactivator	NN	I-NP
O	protein	protein	NN	I-NP
O	in	in	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	repression	repression	NN	I-NP
O	.	.	.	O

O	Coordinate	Coordinate	JJ	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	oxygen	oxygen	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	degradation	degradation	NN	I-NP
O	domains	domain	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	hypoxia	hypoxia	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	inducible	inducible	JJ	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	1	1	CD	I-NP
I-GGP	alpha	alpha	NN	I-NP
O	.	.	.	O

O	Oxygen	Oxygen	NN	B-NP
O	-	-	HYPH	I-NP
O	dependent	dependent	JJ	I-NP
O	proteolysis	proteolysis	NN	I-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	primary	primary	JJ	I-NP
O	means	mean	NNS	I-NP
O	of	of	IN	B-PP
O	regulating	regulate	VBG	B-VP
O	the	the	DT	B-NP
O	hypoxia	hypoxia	NN	I-NP
O	-	-	HYPH	B-NP
O	inducible	inducible	JJ	I-NP
O	factor	factor	NN	I-NP
O	(	(	(	O
O	HIF	HIF	NN	B-NP
O	)	)	)	O
O	family	family	NN	B-NP
O	of	of	IN	B-PP
O	transcription	transcription	NN	B-NP
O	factors	factor	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	alpha	alpha	SYM	I-NP
O	-	-	HYPH	I-NP
O	subunit	subunit	NN	I-NP
O	of	of	IN	B-PP
O	HIF	HIF	NN	B-NP
O	factor	factor	NN	I-NP
O	1	1	CD	I-NP
O	(	(	(	O
O	HIF	HIF	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	)	)	)	O
O	contains	contain	VBZ	B-VP
O	two	two	CD	B-NP
O	highly	highly	RB	I-NP
O	conserved	conserve	VBN	I-NP
O	oxygen	oxygen	NN	I-NP
O	-	-	HYPH	I-NP
O	dependent	dependent	JJ	I-NP
O	degradation	degradation	NN	I-NP
O	domains	domain	NNS	I-NP
O	(	(	(	O
O	402	402	CD	B-NP
O	ODD	ODD	NN	I-NP
O	and	and	CC	O
O	564	564	CD	B-NP
O	ODD	ODD	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	each	each	DT	B-NP
O	of	of	IN	B-PP
O	which	which	WDT	B-NP
O	includes	include	VBZ	B-VP
O	a	a	DT	B-NP
O	proline	proline	NN	I-NP
O	that	that	WDT	B-NP
O	is	be	VBZ	B-VP
O	hydroxylated	hydroxylate	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	,	,	,	O
O	allowing	allow	VBG	B-VP
O	the	the	DT	B-NP
B-GGP	von	von	NNP	I-NP
I-GGP	Hippel	Hippel	NNP	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	Lindau	Lindau	NNP	I-NP
O	(	(	(	O
B-GGP	VHL	VHL	NNP	O
O	)	)	)	O
O	E3	E3	NN	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	to	to	TO	B-VP
O	interact	interact	VB	I-VP
O	and	and	CC	I-VP
O	target	target	VB	I-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	1alpha	1alpha	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	proteasome	proteasome	NN	I-NP
O	for	for	IN	B-PP
O	degradation	degradation	NN	B-NP
O	.	.	.	O

O	Mutation	Mutation	NN	B-NP
O	of	of	IN	B-PP
O	either	either	DT	B-NP
O	proline	proline	NN	I-NP
O	is	be	VBZ	B-VP
O	sufficient	sufficient	JJ	B-ADJP
O	to	to	TO	B-VP
O	partially	partially	RB	I-VP
O	stabilize	stabilize	VB	I-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	under	under	IN	B-PP
O	conditions	condition	NNS	B-NP
O	of	of	IN	B-PP
O	normoxia	normoxia	NN	B-NP
O	,	,	,	O
O	but	but	CC	O
O	the	the	DT	B-NP
O	specific	specific	JJ	I-NP
O	contributions	contribution	NNS	I-NP
O	of	of	IN	B-PP
O	each	each	DT	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	event	event	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	are	be	VBP	B-VP
O	unknown	unknown	JJ	B-ADJP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	ODDs	ODD	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	have	have	VBP	B-VP
O	independent	independent	JJ	B-NP
O	yet	yet	RB	I-NP
O	interactive	interactive	JJ	I-NP
O	roles	role	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	protein	protein	NN	I-NP
O	turnover	turnover	NN	I-NP
O	,	,	,	O
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	relative	relative	JJ	I-NP
O	involvement	involvement	NN	I-NP
O	of	of	IN	B-PP
O	each	each	DT	B-NP
O	ODD	ODD	NN	I-NP
O	depending	depend	VBG	B-PP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	hydroxylation	hydroxylation	NN	B-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	antibodies	antibody	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
O	under	under	IN	B-PP
O	conditions	condition	NNS	B-NP
O	of	of	IN	B-PP
O	normoxia	normoxia	NN	B-NP
O	proline	proline	NN	I-NP
O	564	564	CD	I-NP
O	is	be	VBZ	B-VP
O	hydroxylated	hydroxylate	VBN	I-VP
O	prior	prior	RB	B-ADVP
O	to	to	TO	B-PP
O	proline	proline	NN	B-NP
O	402	402	CD	I-NP
O	,	,	,	O
O	and	and	CC	O
O	mutation	mutation	NN	B-NP
O	of	of	IN	B-PP
O	proline	proline	NN	B-NP
O	564	564	CD	I-NP
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	significant	significant	JJ	I-NP
O	reduction	reduction	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	of	of	IN	B-PP
O	proline	proline	NN	B-NP
O	402	402	CD	I-NP
O	.	.	.	O

O	Mutation	Mutation	NN	B-NP
O	of	of	IN	B-PP
O	proline	proline	NN	B-NP
O	402	402	CD	I-NP
O	,	,	,	O
O	however	however	RB	B-ADVP
O	,	,	,	O
O	has	have	VBZ	B-VP
O	little	little	JJ	B-NP
O	effect	effect	NN	I-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	of	of	IN	B-PP
O	proline	proline	NN	B-NP
O	564	564	CD	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	determine	determine	VB	I-VP
O	whether	whether	IN	B-SBAR
O	the	the	DT	B-NP
O	more	more	RBR	I-NP
O	rapid	rapid	JJ	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	proline	proline	NN	I-NP
O	564	564	CD	I-NP
O	under	under	IN	B-PP
O	conditions	condition	NNS	B-NP
O	of	of	IN	B-PP
O	normoxia	normoxia	NN	B-NP
O	is	be	VBZ	B-VP
O	due	due	IN	B-PP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	preference	preference	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	particular	particular	JJ	I-NP
O	sequence	sequence	NN	I-NP
O	surrounding	surround	VBG	B-VP
O	proline	proline	NN	B-NP
O	564	564	CD	I-NP
O	or	or	CC	B-PP
O	for	for	IN	B-PP
O	that	that	DT	B-NP
O	site	site	NN	I-NP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	exchanged	exchange	VBD	B-VP
O	the	the	DT	B-NP
O	degradation	degradation	NN	I-NP
O	domains	domain	NNS	I-NP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	full	full	JJ	I-NP
O	-	-	HYPH	I-NP
O	length	length	NN	I-NP
B-GGP	HIF	HIF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	these	these	DT	B-NP
O	domain	domain	NN	I-NP
O	-	-	HYPH	O
O	swapping	swap	VBG	B-VP
O	experiments	experiment	NNS	B-NP
O	,	,	,	O
O	prolyl	prolyl	NN	B-NP
O	hydroxylase	hydroxylase	NN	I-NP
O	domain	domain	NN	I-NP
O	1	1	CD	I-NP
O	(	(	(	O
O	PHD1	PHD1	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	PHD2	PHD2	NN	B-NP
O	preferentially	preferentially	RB	B-ADVP
O	hydroxylated	hydroxylate	VBD	B-VP
O	the	the	DT	B-NP
O	proline	proline	NN	I-NP
O	located	locate	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	site	site	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	original	original	JJ	I-NP
O	564	564	CD	I-NP
O	ODD	ODD	NN	I-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	PHD3	PHD3	NN	B-NP
O	preferred	prefer	VBD	B-VP
O	the	the	DT	B-NP
O	proline	proline	NN	I-NP
O	564	564	CD	I-NP
O	sequence	sequence	NN	I-NP
O	,	,	,	O
O	regardless	regardless	RB	B-ADVP
O	of	of	IN	B-PP
O	its	its	PRP$	B-NP
O	location	location	NN	I-NP
O	.	.	.	O

O	At	At	IN	B-PP
O	limiting	limit	VBG	B-VP
O	oxygen	oxygen	NN	B-NP
O	tensions	tension	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
O	proline	proline	NN	B-NP
O	402	402	CD	I-NP
O	exhibits	exhibit	VBZ	B-VP
O	an	an	DT	B-NP
O	oxygen	oxygen	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
O	hydroxylation	hydroxylation	NN	B-NP
O	at	at	IN	B-PP
O	higher	high	JJR	B-NP
O	oxygen	oxygen	NN	I-NP
O	tensions	tension	NNS	I-NP
O	relative	relative	JJ	B-ADJP
O	to	to	TO	B-PP
O	proline	proline	NN	B-NP
O	564	564	CD	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	hydroxylation	hydroxylation	NN	B-NP
O	of	of	IN	B-PP
O	proline	proline	NN	B-NP
O	402	402	CD	I-NP
O	is	be	VBZ	B-VP
O	highly	highly	RB	B-ADJP
O	responsive	responsive	JJ	I-ADJP
O	to	to	TO	B-PP
O	physiologic	physiologic	JJ	B-NP
O	changes	change	NNS	I-NP
O	in	in	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	and	and	CC	O
O	,	,	,	O
O	therefore	therefore	RB	B-ADVP
O	,	,	,	O
O	plays	play	VBZ	B-VP
O	a	a	DT	B-NP
O	more	more	RBR	I-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	regulation	regulation	NN	I-NP
O	under	under	IN	B-PP
O	conditions	condition	NNS	B-NP
O	of	of	IN	B-PP
O	hypoxia	hypoxia	NN	B-NP
O	than	than	IN	B-PP
O	under	under	IN	B-PP
O	conditions	condition	NNS	B-NP
O	of	of	IN	B-PP
O	normoxia	normoxia	NN	B-NP
O	.	.	.	O

O	Together	Together	RB	B-ADVP
O	,	,	,	O
O	these	these	DT	B-NP
O	findings	finding	NNS	I-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	each	each	DT	B-NP
O	hydroxylated	hydroxylate	VBN	I-NP
O	proline	proline	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	has	have	VBZ	B-VP
O	a	a	DT	B-NP
O	distinct	distinct	JJ	I-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	controlling	control	VBG	B-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	stability	stability	NN	I-NP
O	in	in	IN	B-PP
O	response	response	NN	I-PP
O	to	to	TO	I-PP
O	different	different	JJ	B-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	oxygenation	oxygenation	NN	B-NP
O	.	.	.	O

O	Carboxyl	Carboxyl	NN	B-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	extensions	extension	NNS	I-NP
O	beyond	beyond	IN	B-PP
O	the	the	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	pentapeptide	pentapeptide	NN	I-NP
O	reduce	reduce	NN	I-NP
O	rates	rate	NNS	I-NP
O	of	of	IN	B-PP
O	chemoreceptor	chemoreceptor	NN	B-NP
O	adaptational	adaptational	JJ	I-NP
O	modification	modification	NN	I-NP
O	.	.	.	O

O	Sensory	Sensory	JJ	B-NP
O	adaptation	adaptation	NN	I-NP
O	in	in	IN	B-PP
O	bacterial	bacterial	JJ	B-NP
O	chemotaxis	chemotaxis	NN	I-NP
O	is	be	VBZ	B-VP
O	mediated	mediate	VBN	I-VP
O	by	by	IN	B-PP
O	covalent	covalent	JJ	B-NP
O	modification	modification	NN	I-NP
O	of	of	IN	B-PP
O	chemoreceptors	chemoreceptor	NNS	B-NP
O	.	.	.	O

O	Specific	Specific	JJ	B-NP
O	glutamyl	glutamyl	NN	I-NP
O	residues	residue	NNS	I-NP
O	are	be	VBP	B-VP
O	methylated	methylate	VBN	I-VP
O	and	and	CC	I-VP
O	demethylated	demethylate	VBN	I-VP
O	in	in	IN	B-PP
O	reactions	reaction	NNS	B-NP
O	catalyzed	catalyze	VBN	B-VP
O	by	by	IN	B-PP
O	methyltransferase	methyltransferase	NN	B-NP
B-GGP	CheR	CheR	NN	I-NP
O	and	and	CC	O
O	methylesterase	methylesterase	NN	B-NP
B-GGP	CheB	CheB	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	well	well	RB	I-NP
O	-	-	HYPH	I-NP
O	characterized	characterize	VBN	I-NP
O	chemosensory	chemosensory	JJ	I-NP
O	systems	system	NNS	I-NP
O	of	of	IN	B-PP
O	Escherichia	Escherichia	NNP	B-NP
O	coli	coli	NNP	I-NP
O	and	and	CC	O
O	Salmonella	Salmonella	NNP	B-NP
O	spp	spp	NN	I-NP
O	.	.	.	O
O	,	,	,	O
O	efficient	efficient	JJ	B-NP
O	modification	modification	NN	I-NP
O	by	by	IN	B-PP
O	either	either	DT	B-NP
O	enzyme	enzyme	NN	I-NP
O	is	be	VBZ	B-VP
O	dependent	dependent	JJ	B-ADJP
O	on	on	IN	B-PP
O	a	a	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	pentapeptide	pentapeptide	NN	I-NP
O	sequence	sequence	NN	I-NP
O	,	,	,	O
O	NWETF	NWETF	NN	B-NP
O	or	or	CC	I-NP
O	NWESF	NWESF	NN	I-NP
O	,	,	,	O
O	present	present	JJ	B-ADJP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	extreme	extreme	JJ	I-NP
O	carboxyl	carboxyl	NN	I-NP
O	terminus	terminus	NN	I-NP
O	of	of	IN	B-PP
O	high	high	JJ	B-NP
O	-	-	HYPH	I-NP
O	abundance	abundance	NN	I-NP
O	chemoreceptors	chemoreceptor	NNS	I-NP
O	.	.	.	O

O	To	To	TO	B-PP
O	what	what	WP	B-NP
O	extent	extent	NN	I-NP
O	is	be	VBZ	B-VP
O	position	position	NN	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	extreme	extreme	JJ	I-NP
O	carboxyl	carboxyl	NN	I-NP
O	terminus	terminus	NN	I-NP
O	important	important	JJ	B-ADJP
O	for	for	IN	B-PP
O	pentapeptide	pentapeptide	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	enhancement	enhancement	NN	I-NP
O	of	of	IN	B-PP
O	adaptational	adaptational	JJ	B-NP
O	modification	modification	NN	I-NP
O	?	?	.	O
O	Is	Be	VBZ	O
O	this	this	DT	B-NP
O	position	position	NN	I-NP
O	equally	equally	RB	B-ADJP
O	important	important	JJ	I-ADJP
O	for	for	IN	B-PP
O	enhancement	enhancement	NN	B-NP
O	of	of	IN	B-PP
O	both	both	DT	B-NP
O	enzyme	enzyme	NN	I-NP
O	activities	activity	NNS	I-NP
O	?	?	.	O
O	To	To	TO	B-VP
O	address	address	VB	I-VP
O	these	these	DT	B-NP
O	questions	question	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	created	create	VBD	B-VP
O	forms	form	NNS	B-NP
O	of	of	IN	B-PP
O	high	high	JJ	B-NP
O	-	-	HYPH	I-NP
O	abundance	abundance	NN	I-NP
O	receptor	receptor	NN	I-NP
B-GGP	Tsr	Tsr	NN	I-NP
O	or	or	CC	I-NP
B-GGP	Tar	Tar	NN	I-NP
O	carrying	carry	VBG	B-VP
O	one	one	CD	B-NP
O	,	,	,	I-NP
O	six	six	CD	I-NP
O	,	,	,	O
O	or	or	CC	O
O	eight	eight	CD	B-NP
O	additional	additional	JJ	I-NP
O	amino	amino	JJ	I-NP
O	acids	acid	NNS	I-NP
O	extending	extend	VBG	B-VP
O	beyond	beyond	IN	B-PP
O	the	the	DT	B-NP
O	pentapeptide	pentapeptide	NN	I-NP
O	at	at	IN	B-PP
O	their	their	PRP$	B-NP
O	carboxyl	carboxyl	NN	I-NP
O	termini	terminus	NNS	I-NP
O	and	and	CC	O
O	assayed	assay	VBN	B-VP
O	methylation	methylation	NN	B-NP
O	,	,	,	O
O	demethylation	demethylation	NN	B-NP
O	,	,	,	O
O	deamidation	deamidation	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	ability	ability	NN	B-NP
O	to	to	TO	B-VP
O	mediate	mediate	VB	I-VP
O	chemotaxis	chemotaxis	NN	B-NP
O	.	.	.	O

O	In	In	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	and	and	CC	O
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	,	,	,	O
O	all	all	DT	B-NP
O	three	three	CD	I-NP
O	carboxyl	carboxyl	NN	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	extensions	extension	NNS	I-NP
O	reduced	reduce	VBD	B-VP
O	pentapeptide	pentapeptide	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	enhancement	enhancement	NN	I-NP
O	of	of	IN	B-PP
O	rates	rate	NNS	B-NP
O	of	of	IN	B-PP
O	adaptational	adaptational	JJ	B-NP
O	modification	modification	NN	I-NP
O	.	.	.	O

B-GGP	CheB	CheB	NN	B-NP
O	-	-	HYPH	B-NP
O	catalyzed	catalyze	VBN	I-NP
O	reactions	reaction	NNS	I-NP
O	were	be	VBD	B-VP
O	more	more	RBR	B-ADJP
O	affected	affected	JJ	I-ADJP
O	than	than	IN	B-PP
B-GGP	CheR	CheR	NN	B-NP
O	-	-	HYPH	B-NP
O	catalyzed	catalyze	VBN	I-NP
O	reactions	reaction	NNS	I-NP
O	.	.	.	O

O	Effects	Effect	NNS	B-NP
O	were	be	VBD	B-VP
O	less	less	RBR	B-ADJP
O	severe	severe	JJ	I-ADJP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	complete	complete	JJ	I-NP
O	sensory	sensory	JJ	I-NP
O	system	system	NN	I-NP
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	than	than	IN	B-PP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	minimal	minimal	JJ	I-NP
O	system	system	NN	I-NP
O	of	of	IN	B-PP
O	receptor	receptor	NN	B-NP
O	and	and	CC	I-NP
O	modification	modification	NN	I-NP
O	enzymes	enzyme	NNS	I-NP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	.	.	.	O

O	Notably	Notably	RB	B-ADVP
O	,	,	,	O
O	extended	extend	VBN	B-NP
O	receptors	receptor	NNS	I-NP
O	mediated	mediate	VBD	B-VP
O	chemotaxis	chemotaxis	NN	B-NP
O	as	as	RB	B-ADVP
O	efficiently	efficiently	RB	I-ADVP
O	as	as	IN	B-PP
O	wild	wild	JJ	B-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	receptors	receptor	NNS	I-NP
O	,	,	,	O
O	providing	provide	VBG	B-VP
O	a	a	DT	B-NP
O	striking	striking	JJ	I-NP
O	example	example	NN	I-NP
O	of	of	IN	B-PP
O	robustness	robustness	NN	B-NP
O	in	in	IN	B-PP
O	chemotactic	chemotactic	JJ	B-NP
O	systems	system	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	could	could	MD	B-VP
O	reflect	reflect	VB	I-VP
O	compensatory	compensatory	JJ	B-NP
O	reductions	reduction	NNS	I-NP
O	of	of	IN	B-PP
O	rates	rate	NNS	B-NP
O	for	for	IN	B-PP
O	both	both	DT	B-NP
O	modification	modification	NN	I-NP
O	reactions	reaction	NNS	I-NP
O	,	,	,	O
O	mitigation	mitigation	NN	B-NP
O	of	of	IN	B-PP
O	effects	effect	NNS	B-NP
O	of	of	IN	B-PP
O	slower	slow	JJR	B-NP
O	reactions	reaction	NNS	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	intertwined	intertwined	JJ	I-NP
O	circuitry	circuitry	NN	I-NP
O	of	of	IN	B-PP
O	signaling	signaling	NN	B-NP
O	and	and	CC	I-NP
O	adaptation	adaptation	NN	I-NP
O	,	,	,	O
O	or	or	CC	O
O	tolerance	tolerance	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	range	range	NN	I-NP
O	of	of	IN	B-PP
O	reactions	reaction	NNS	B-NP
O	rates	rate	NNS	I-NP
O	for	for	IN	B-PP
O	adaptational	adaptational	JJ	B-NP
O	modification	modification	NN	I-NP
O	.	.	.	O

O	No	No	DT	B-ADVP
O	matter	matter	NN	I-ADVP
O	what	what	WP	B-NP
O	the	the	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	observations	observation	NNS	I-NP
O	provide	provide	VBP	B-VP
O	a	a	DT	B-NP
O	challenging	challenging	JJ	I-NP
O	test	test	NN	I-NP
O	for	for	IN	B-PP
O	mathematical	mathematical	JJ	B-NP
O	models	model	NNS	I-NP
O	of	of	IN	B-PP
O	chemotaxis	chemotaxis	NN	B-NP
O	.	.	.	O

O	Dimethylation	Dimethylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	at	at	IN	B-PP
O	lysine	lysine	NN	B-NP
O	36	36	CD	I-NP
O	demarcates	demarcate	VBZ	B-VP
O	regulatory	regulatory	JJ	B-NP
O	and	and	CC	I-NP
O	nonregulatory	nonregulatory	JJ	I-NP
O	chromatin	chromatin	NN	I-NP
O	genome	genome	NN	I-NP
O	-	-	HYPH	B-VP
O	wide	wide	JJ	B-ADJP
O	.	.	.	O

B-GGP	Set2p	Set2p	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	mediates	mediate	VBZ	B-VP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	lysine	lysine	NN	I-NP
O	36	36	CD	I-NP
O	dimethylation	dimethylation	NN	I-NP
O	(	(	(	O
B-GGP	H3K36me2	H3K36me2	NN	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	Saccharomyces	Saccharomyces	FW	B-NP
O	cerevisiae	cerevisiae	FW	I-NP
O	,	,	,	O
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	associate	associate	VB	I-VP
O	with	with	IN	B-PP
O	RNA	RNA	NN	B-NP
O	polymerase	polymerase	NN	I-NP
O	II	II	CD	I-NP
O	(	(	(	O
O	RNAP	RNAP	NN	B-NP
O	II	II	CD	I-NP
O	)	)	)	O
O	at	at	IN	B-PP
O	individual	individual	JJ	B-NP
O	loci	locus	NNS	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	chromatin	chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	-	-	HYPH	B-NP
O	microarray	microarray	NN	I-NP
O	experiments	experiment	NNS	I-NP
O	normalized	normalize	VBD	B-VP
O	to	to	TO	B-PP
O	general	general	JJ	B-NP
O	nucleosome	nucleosome	NN	I-NP
O	occupancy	occupancy	NN	I-NP
O	reveal	reveal	VBP	B-VP
O	that	that	IN	B-SBAR
O	nucleosomes	nucleosome	NNS	B-NP
O	within	within	IN	B-PP
O	open	open	JJ	B-NP
O	reading	reading	NN	I-NP
O	frames	frame	NNS	I-NP
O	(	(	(	O
O	ORFs	ORF	NNS	B-NP
O	)	)	)	O
O	and	and	CC	O
O	downstream	downstream	JJ	B-NP
O	noncoding	noncoding	JJ	I-NP
O	chromatin	chromatin	NN	I-NP
O	were	be	VBD	B-VP
O	highly	highly	RB	I-VP
O	dimethylated	dimethylate	VBN	I-VP
O	at	at	IN	B-PP
B-GGP	H3K36	H3K36	NN	B-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
B-GGP	Set2p	Set2p	NN	B-NP
O	activity	activity	NN	I-NP
O	begins	begin	VBZ	B-VP
O	at	at	IN	B-PP
O	a	a	DT	B-NP
O	stereotypic	stereotypic	JJ	I-NP
O	distance	distance	NN	I-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	initiation	initiation	NN	I-NP
O	of	of	IN	B-PP
O	transcription	transcription	NN	B-NP
O	genome	genome	NN	I-NP
O	-	-	HYPH	B-VP
O	wide	wide	JJ	B-ADJP
O	.	.	.	O

B-GGP	H3K36me2	H3K36me2	NN	B-NP
O	is	be	VBZ	B-VP
O	scarce	scarce	JJ	B-ADJP
O	in	in	IN	B-PP
O	regions	region	NNS	B-NP
O	upstream	upstream	RB	B-PP
O	of	of	IN	B-PP
O	divergently	divergently	RB	B-NP
O	transcribed	transcribe	VBN	I-NP
O	genes	gene	NNS	I-NP
O	,	,	,	O
O	telomeres	telomere	VBZ	B-VP
O	,	,	,	O
O	silenced	silenced	JJ	B-NP
O	mating	mating	NN	I-NP
O	loci	locus	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	regions	region	NNS	B-NP
O	transcribed	transcribe	VBN	B-VP
O	by	by	IN	B-PP
O	RNA	RNA	NN	B-NP
O	polymerase	polymerase	NN	I-NP
O	III	III	CD	I-NP
O	,	,	,	O
O	providing	provide	VBG	B-VP
O	evidence	evidence	NN	B-NP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	enzymatic	enzymatic	JJ	I-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Set2p	Set2p	NN	B-NP
O	is	be	VBZ	B-VP
O	restricted	restricted	JJ	B-ADJP
O	to	to	TO	B-PP
O	its	its	PRP$	B-NP
O	association	association	NN	I-NP
O	with	with	IN	B-PP
O	RNAP	RNAP	NN	B-NP
O	II	II	CD	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
B-GGP	H3K36me2	H3K36me2	NN	B-NP
O	within	within	IN	B-PP
O	ORFs	ORF	NNS	B-NP
O	correlated	correlate	VBD	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	"	"	``	I-NP
O	on	on	IN	B-PP
O	"	"	''	O
O	or	or	CC	O
O	"	"	``	O
O	off	off	RP	B-PRT
O	"	"	''	O
O	state	state	NN	B-NP
O	of	of	IN	B-PP
O	transcription	transcription	NN	B-NP
O	,	,	,	O
O	but	but	CC	O
O	the	the	DT	B-NP
O	degree	degree	NN	I-NP
O	of	of	IN	B-PP
B-GGP	H3K36	H3K36	NN	B-NP
O	dimethylation	dimethylation	NN	I-NP
O	within	within	IN	B-PP
O	ORFs	ORF	NNS	B-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	correlate	correlate	VB	I-VP
O	with	with	IN	B-PP
O	transcription	transcription	NN	B-NP
O	frequency	frequency	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	provides	provide	VBZ	B-VP
O	evidence	evidence	NN	B-NP
O	that	that	IN	B-SBAR
B-GGP	H3K36me2	H3K36me2	NN	B-NP
O	is	be	VBZ	B-VP
O	established	establish	VBN	I-VP
O	during	during	IN	B-PP
O	the	the	DT	B-NP
O	initial	initial	JJ	I-NP
O	instances	instance	NNS	I-NP
O	of	of	IN	B-PP
O	gene	gene	NN	B-NP
O	transcription	transcription	NN	I-NP
O	,	,	,	O
O	with	with	IN	B-PP
O	subsequent	subsequent	JJ	B-NP
O	transcription	transcription	NN	I-NP
O	having	have	VBG	B-VP
O	at	at	IN	B-PP
O	most	most	JJS	B-NP
O	a	a	DT	I-NP
O	maintenance	maintenance	NN	I-NP
O	role	role	NN	I-NP
O	.	.	.	O

O	Accordingly	Accordingly	RB	B-ADVP
O	,	,	,	O
O	newly	newly	RB	B-NP
O	activated	activate	VBN	I-NP
O	genes	gene	NNS	I-NP
O	acquire	acquire	VBP	B-VP
B-GGP	H3K36me2	H3K36me2	NN	B-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	manner	manner	NN	I-NP
O	that	that	WDT	B-NP
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	correlate	correlate	VB	I-VP
O	with	with	IN	B-PP
O	gene	gene	NN	B-NP
O	transcript	transcript	NN	I-NP
O	levels	level	NNS	I-NP
O	.	.	.	O

O	Finally	Finally	RB	B-ADVP
O	,	,	,	O
O	nucleosomes	nucleosome	NNS	B-NP
O	dimethylated	dimethylate	VBN	B-VP
O	at	at	IN	B-PP
B-GGP	H3K36	H3K36	NN	B-NP
O	appear	appear	VBP	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	refractory	refractory	JJ	B-ADJP
O	to	to	TO	B-PP
O	loss	loss	NN	B-NP
O	from	from	IN	B-PP
O	highly	highly	RB	B-NP
O	transcribed	transcribe	VBN	I-NP
O	chromatin	chromatin	NN	I-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
B-GGP	H3K36me2	H3K36me2	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	highly	highly	RB	I-VP
O	conserved	conserve	VBN	I-VP
O	throughout	throughout	IN	B-PP
O	eukaryotic	eukaryotic	JJ	B-NP
O	evolution	evolution	NN	I-NP
O	,	,	,	O
O	provides	provide	VBZ	B-VP
O	a	a	DT	B-NP
O	stable	stable	JJ	I-NP
O	molecular	molecular	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	for	for	IN	B-PP
O	establishing	establish	VBG	B-VP
O	chromatin	chromatin	NN	B-NP
O	context	context	NN	I-NP
O	throughout	throughout	IN	B-PP
O	the	the	DT	B-NP
O	genome	genome	NN	I-NP
O	by	by	IN	B-PP
O	distinguishing	distinguish	VBG	B-VP
O	potential	potential	JJ	B-NP
O	regulatory	regulatory	JJ	I-NP
O	regions	region	NNS	I-NP
O	from	from	IN	B-PP
O	transcribed	transcribe	VBN	B-NP
O	chromatin	chromatin	NN	I-NP
O	.	.	.	O

O	Versatile	Versatile	JJ	B-NP
O	peroxidase	peroxidase	NN	I-NP
O	oxidation	oxidation	NN	I-NP
O	of	of	IN	B-PP
O	high	high	JJ	B-NP
O	redox	redox	NN	I-NP
O	potential	potential	JJ	I-NP
O	aromatic	aromatic	JJ	I-NP
O	compounds	compound	NNS	I-NP
O	:	:	:	O
O	site	site	NN	B-NP
O	-	-	HYPH	O
O	directed	direct	VBN	B-NP
O	mutagenesis	mutagenesis	NN	I-NP
O	,	,	,	O
O	spectroscopic	spectroscopic	JJ	B-NP
O	and	and	CC	I-NP
O	crystallographic	crystallographic	JJ	I-NP
O	investigation	investigation	NN	I-NP
O	of	of	IN	B-PP
O	three	three	CD	B-NP
O	long	long	JJ	I-NP
O	-	-	HYPH	I-NP
O	range	range	NN	I-NP
O	electron	electron	NN	I-NP
O	transfer	transfer	NN	I-NP
O	pathways	pathway	NNS	I-NP
O	.	.	.	O

O	Versatile	Versatile	JJ	B-NP
O	peroxidases	peroxidas	NNS	I-NP
O	(	(	(	O
O	VP	VP	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	a	a	DT	B-NP
O	recently	recently	RB	I-NP
O	described	describe	VBN	I-NP
O	family	family	NN	I-NP
O	of	of	IN	B-PP
O	ligninolytic	ligninolytic	JJ	B-NP
O	peroxidases	peroxidas	NNS	I-NP
O	,	,	,	O
O	show	show	VBP	B-VP
O	a	a	DT	B-NP
O	hybrid	hybrid	JJ	I-NP
O	molecular	molecular	JJ	I-NP
O	architecture	architecture	NN	I-NP
O	combining	combine	VBG	B-VP
O	different	different	JJ	B-NP
O	oxidation	oxidation	NN	I-NP
O	sites	site	NNS	I-NP
O	connected	connect	VBN	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	heme	heme	NN	I-NP
O	cofactor	cofactor	NN	I-NP
O	.	.	.	O

O	High	High	JJ	B-NP
O	-	-	HYPH	I-NP
O	resolution	resolution	NN	I-NP
O	crystal	crystal	JJ	I-NP
O	structures	structure	NNS	I-NP
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	homology	homology	NN	B-NP
O	models	model	NNS	I-NP
O	of	of	IN	B-PP
O	VP	VP	NN	B-NP
O	isoenzymes	isoenzyme	NNS	I-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	fungus	fungus	NNP	I-NP
O	Pleurotus	Pleurotus	NNP	I-NP
O	eryngii	eryngii	NNP	I-NP
O	revealed	reveal	VBD	B-VP
O	three	three	CD	B-NP
O	possibilities	possibility	NNS	I-NP
O	for	for	IN	B-PP
O	long	long	JJ	B-NP
O	-	-	HYPH	I-NP
O	range	range	NN	I-NP
O	electron	electron	NN	I-NP
O	transfer	transfer	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	oxidation	oxidation	NN	I-NP
O	of	of	IN	B-PP
O	high	high	JJ	B-NP
O	redox	redox	NN	I-NP
O	potential	potential	JJ	I-NP
O	aromatic	aromatic	JJ	I-NP
O	compounds	compound	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	possible	possible	JJ	I-NP
O	pathways	pathway	NNS	I-NP
O	would	would	MD	B-VP
O	start	start	VB	I-VP
O	either	either	CC	O
O	at	at	IN	B-PP
O	Trp164	Trp164	NN	B-NP
O	or	or	CC	I-NP
O	His232	His232	NN	I-NP
O	of	of	IN	B-PP
O	isoenzyme	isoenzyme	NN	B-NP
O	VPL	VPL	NN	I-NP
O	,	,	,	B-PP
O	and	and	CC	I-PP
O	at	at	IN	B-PP
O	His82	His82	NN	B-NP
O	or	or	CC	I-NP
O	Trp170	Trp170	NN	I-NP
O	of	of	IN	B-PP
O	isoenzyme	isoenzyme	NN	B-NP
B-GGP	VPS1	VPS1	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	residues	residue	NNS	I-NP
O	are	be	VBP	B-VP
O	exposed	expose	VBN	I-VP
O	,	,	,	O
O	and	and	CC	O
O	less	less	JJR	B-NP
O	than	than	IN	I-NP
O	11	11	CD	I-NP
O	A	A	NN	I-NP
O	apart	apart	RB	B-ADVP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	heme	heme	NN	I-NP
O	.	.	.	O

O	With	With	IN	B-PP
O	the	the	DT	B-NP
O	purpose	purpose	NN	I-NP
O	of	of	IN	B-PP
O	investigating	investigate	VBG	B-VP
O	their	their	PRP$	B-NP
O	functionality	functionality	NN	I-NP
O	,	,	,	O
O	two	two	CD	B-NP
O	single	single	JJ	I-NP
O	mutations	mutation	NNS	I-NP
O	(	(	(	O
O	W164S	W164S	NN	B-NP
O	and	and	CC	O
O	H232F	H232F	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	one	one	CD	B-NP
O	double	double	JJ	I-NP
O	mutation	mutation	NN	I-NP
O	(	(	(	O
O	W164S	W164S	NN	B-NP
O	/	/	SYM	B-NP
O	P76H	P76H	NN	I-NP
O	)	)	)	O
O	were	be	VBD	B-VP
O	introduced	introduce	VBN	I-VP
O	in	in	IN	B-PP
O	VPL	VPL	NN	B-NP
O	that	that	IN	B-NP
O	:	:	:	O
O	(	(	(	B-LST
O	i	i	LS	I-LST
O	)	)	)	O
O	removed	remove	VBD	B-VP
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	pathways	pathway	NNS	I-NP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	isoenzyme	isoenzyme	NN	I-NP
O	;	;	:	O
O	and	and	CC	O
O	(	(	(	B-LST
O	ii	ii	LS	I-LST
O	)	)	)	O
O	incorporated	incorporate	VBD	B-VP
O	the	the	DT	B-NP
O	absent	absent	JJ	I-NP
O	putative	putative	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

O	Analysis	Analysis	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	variants	variant	NNS	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	Trp164	Trp164	NN	B-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	oxidation	oxidation	NN	B-NP
O	of	of	IN	B-PP
O	two	two	CD	B-NP
O	high	high	JJ	I-NP
O	redox	redox	NN	I-NP
O	potential	potential	NN	I-NP
O	model	model	NN	I-NP
O	substrates	substrate	NNS	I-NP
O	(	(	(	O
O	veratryl	veratryl	NN	B-NP
O	alcohol	alcohol	NN	I-NP
O	and	and	CC	O
O	Reactive	Reactive	JJ	B-NP
O	Black	Black	NN	I-NP
O	5	5	CD	I-NP
O	)	)	)	O
O	,	,	,	O
O	whereas	whereas	IN	O
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	other	other	JJ	I-NP
O	pathways	pathway	NNS	I-NP
O	(	(	(	O
O	starting	start	VBG	B-VP
O	at	at	IN	B-PP
O	His232	His232	NN	B-NP
O	and	and	CC	I-NP
O	His82	His82	NN	I-NP
O	)	)	)	O
O	are	be	VBP	B-VP
O	not	not	RB	I-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	long	long	JJ	B-NP
O	-	-	HYPH	I-NP
O	range	range	NN	I-NP
O	electron	electron	NN	I-NP
O	transfer	transfer	NN	I-NP
O	(	(	(	O
O	LRET	LRET	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	None	None	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mutations	mutation	NNS	I-NP
O	affected	affect	VBD	B-VP
O	Mn2	Mn2	NN	B-NP
O	+	+	SYM	O
O	oxidation	oxidation	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	would	would	MD	B-VP
O	take	take	VB	I-VP
O	place	place	NN	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	opposite	opposite	JJ	I-NP
O	side	side	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	enzyme	enzyme	NN	I-NP
O	.	.	.	O

O	Substitution	Substitution	NN	B-NP
O	of	of	IN	B-PP
O	Trp164	Trp164	NN	B-NP
O	by	by	IN	B-PP
O	His	His	NNP	B-NP
O	also	also	RB	B-ADVP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	an	an	DT	B-NP
O	inactive	inactive	JJ	I-NP
O	variant	variant	NN	I-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
O	an	an	DT	B-NP
O	indole	indole	NN	I-NP
O	side	side	NN	I-NP
O	-	-	HYPH	B-NP
O	chain	chain	NN	I-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	activity	activity	NN	B-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	is	be	VBZ	B-VP
O	proposed	propose	VBN	I-VP
O	that	that	IN	B-SBAR
O	substrate	substrate	NN	B-NP
O	oxidation	oxidation	NN	I-NP
O	occurs	occur	VBZ	B-VP
O	via	via	IN	B-PP
O	a	a	DT	B-NP
O	protein	protein	NN	I-NP
O	-	-	HYPH	O
O	based	base	VBN	B-NP
O	radical	radical	NN	I-NP
O	.	.	.	O

O	For	For	IN	B-PP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	time	time	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	ligninolytic	ligninolytic	JJ	I-NP
O	peroxidase	peroxidase	NN	I-NP
O	such	such	JJ	B-NP
O	an	an	DT	I-NP
O	intermediate	intermediate	JJ	I-NP
O	species	specie	NNS	I-NP
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	detected	detect	VBN	I-VP
O	by	by	IN	B-PP
O	low	low	JJ	B-NP
O	-	-	HYPH	I-NP
O	temperature	temperature	NN	I-NP
O	electron	electron	NN	I-NP
O	paramagnetic	paramagnetic	JJ	I-NP
O	resonance	resonance	NN	I-NP
O	of	of	IN	B-PP
O	H2O2	H2O2	NN	B-NP
O	-	-	HYPH	B-NP
O	activated	activate	VBN	I-NP
O	VP	VP	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	to	to	TO	I-VP
O	exist	exist	VB	I-VP
O	at	at	IN	B-PP
O	Trp164	Trp164	NN	B-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	neutral	neutral	JJ	I-NP
O	radical	radical	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	H2O2	H2O2	NN	I-NP
O	-	-	HYPH	B-VP
O	activated	activate	VBN	B-NP
O	VP	VP	NN	I-NP
O	was	be	VBD	B-VP
O	self	self	AFX	B-ADJP
O	-	-	HYPH	B-NP
O	reduced	reduce	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	absence	absence	NN	I-NP
O	of	of	IN	B-PP
O	reducing	reduce	VBG	B-VP
O	substrates	substrate	NNS	B-NP
O	.	.	.	O

O	Trp164	Trp164	NN	B-NP
O	is	be	VBZ	B-VP
O	also	also	RB	I-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	reaction	reaction	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	W164S	W164S	NN	I-NP
O	variant	variant	NN	I-NP
O	was	be	VBD	B-VP
O	blocked	block	VBN	I-VP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	level	level	NN	I-NP
O	of	of	IN	B-PP
O	compound	compound	NN	B-NP
O	II	II	CD	I-NP
O	.	.	.	O

O	When	When	WRB	B-ADVP
O	analyzing	analyze	VBG	B-VP
O	VP	VP	NN	B-NP
O	crystal	crystal	JJ	I-NP
O	structures	structure	NNS	I-NP
O	close	close	RB	B-ADVP
O	to	to	TO	B-PP
O	atomic	atomic	JJ	B-NP
O	resolution	resolution	NN	I-NP
O	,	,	,	O
O	no	no	DT	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Trp164	Trp164	NN	I-NP
O	Cbeta	Cbeta	NN	I-NP
O	atom	atom	NN	I-NP
O	was	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	(	(	(	O
O	even	even	RB	B-PP
O	after	after	IN	I-PP
O	addition	addition	NN	B-NP
O	of	of	IN	B-PP
O	several	several	JJ	B-NP
O	equivalents	equivalent	NNS	I-NP
O	of	of	IN	B-PP
O	H2O2	H2O2	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	This	This	DT	B-NP
O	is	be	VBZ	B-VP
O	in	in	IN	B-PP
O	contrast	contrast	NN	B-NP
O	to	to	TO	B-PP
O	lignin	lignin	NN	B-NP
O	peroxidase	peroxidase	NN	I-NP
O	Trp171	Trp171	NN	I-NP
O	.	.	.	O

O	Analysis	Analysis	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	crystal	crystal	JJ	I-NP
O	structures	structure	NNS	I-NP
O	of	of	IN	B-PP
O	both	both	DT	B-NP
O	peroxidases	peroxidas	NNS	I-NP
O	showed	show	VBD	B-VP
O	differences	difference	NNS	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	environment	environment	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	radical	radical	NN	I-NP
O	-	-	HYPH	O
O	forming	form	VBG	B-VP
O	residue	residue	NN	B-NP
O	that	that	WDT	B-NP
O	could	could	MD	B-VP
O	affect	affect	VB	I-VP
O	its	its	PRP$	B-NP
O	reactivity	reactivity	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	variations	variation	NNS	I-NP
O	would	would	MD	B-VP
O	also	also	RB	I-VP
O	explain	explain	VB	I-VP
O	differences	difference	NNS	B-NP
O	found	find	VBN	B-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	oxidation	oxidation	NN	I-NP
O	of	of	IN	B-PP
O	some	some	DT	B-NP
O	high	high	JJ	I-NP
O	redox	redox	NN	I-NP
O	potential	potential	NN	I-NP
O	aromatic	aromatic	JJ	I-NP
O	substrates	substrate	NNS	I-NP
O	.	.	.	O

O	Promoter	Promoter	NN	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	profile	profile	NN	I-NP
O	of	of	IN	B-PP
B-GGP	RASSF1A	RASSF1A	NN	B-NP
O	,	,	,	O
B-GGP	FHIT	FHIT	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	sFRP1	sFRP1	NN	B-NP
O	in	in	IN	B-PP
O	intracranial	intracranial	JJ	B-NP
O	primitive	primitive	JJ	I-NP
O	neuroectodermal	neuroectodermal	JJ	I-NP
O	tumors	tumor	NNS	I-NP
O	.	.	.	O

O	Medulloblastomas	Medulloblastoma	NNS	B-NP
O	(	(	(	O
O	MBs	MB	NNS	B-NP
O	)	)	)	O
O	and	and	CC	O
O	supratentorial	supratentorial	JJ	B-NP
O	primitive	primitive	JJ	I-NP
O	neuroectodermal	neuroectodermal	JJ	I-NP
O	tumors	tumor	NNS	I-NP
O	(	(	(	O
O	SPNETs	SPNET	NNS	B-NP
O	)	)	)	O
O	are	be	VBP	B-VP
O	histologically	histologically	RB	B-NP
O	alike	alike	RB	I-NP
O	intracranial	intracranial	JJ	I-NP
O	PNETs	PNET	NNS	I-NP
O	found	find	VBN	B-VP
O	in	in	IN	B-PP
O	different	different	JJ	B-NP
O	anatomical	anatomical	JJ	I-NP
O	locations	location	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	brain	brain	NN	I-NP
O	.	.	.	O

O	Current	Current	JJ	B-NP
O	evidence	evidence	NN	I-NP
O	suggests	suggest	VBZ	B-VP
O	that	that	IN	B-SBAR
O	hypermethylation	hypermethylation	NN	B-NP
O	of	of	IN	B-PP
O	promoter	promoter	NN	B-NP
O	CpG	CpG	NN	I-NP
O	islands	island	NNS	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	common	common	JJ	I-NP
O	epigenetic	epigenetic	JJ	I-NP
O	event	event	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	variety	variety	NN	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	cancers	cancer	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	aim	aim	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	was	be	VBD	B-VP
O	to	to	TO	B-VP
O	investigate	investigate	VB	I-VP
O	whether	whether	IN	B-SBAR
O	promoter	promoter	NN	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	of	of	IN	B-PP
O	putative	putative	JJ	B-NP
O	tumor	tumor	NN	I-NP
O	suppressor	suppressor	NN	I-NP
O	genes	gene	NNS	I-NP
O	was	be	VBD	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	both	both	DT	B-NP
O	types	type	NNS	I-NP
O	of	of	IN	B-PP
O	intracranial	intracranial	JJ	B-NP
O	PNETs	PNET	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	examined	examine	VBD	B-VP
O	the	the	DT	B-NP
O	methylation	methylation	NN	I-NP
O	status	status	NN	I-NP
O	at	at	IN	B-PP
O	promoter	promoter	NN	B-NP
O	regions	region	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	RASSF1A	RASSF1A	NN	B-NP
O	,	,	,	O
B-GGP	FHIT	FHIT	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	sFRP1	sFRP1	NN	B-NP
O	by	by	IN	B-PP
O	methylation	methylation	NN	B-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	polymerase	polymerase	NN	I-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	cohort	cohort	NN	I-NP
O	of	of	IN	B-PP
O	25	25	CD	B-NP
O	primary	primary	JJ	I-NP
O	MBs	MB	NNS	I-NP
O	,	,	,	O
O	9	9	CD	B-NP
O	primary	primary	JJ	I-NP
O	SPNETs	SPNET	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	3	3	CD	B-NP
O	MB	MB	NN	I-NP
O	and	and	CC	O
O	2	2	CD	B-NP
O	SPNET	SPNET	NN	I-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	results	result	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	no	no	DT	B-NP
O	promoter	promoter	NN	I-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	RASSF1A	RASSF1A	NN	B-NP
O	,	,	,	O
B-GGP	FHIT	FHIT	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	sFRP1	sFRP1	NN	B-NP
O	in	in	IN	B-PP
O	2	2	CD	B-NP
O	normal	normal	JJ	I-NP
O	cerebellar	cerebellar	NN	I-NP
O	and	and	CC	O
O	5	5	CD	B-NP
O	normal	normal	JJ	I-NP
O	cerebral	cerebral	JJ	I-NP
O	tissue	tissue	NN	I-NP
O	specimens	specimen	NNS	I-NP
O	examined	examine	VBN	B-VP
O	.	.	.	O

O	In	In	IN	B-PP
O	contrast	contrast	NN	B-NP
O	,	,	,	O
O	promoter	promoter	NN	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	RASSF1A	RASSF1A	NN	B-NP
O	was	be	VBD	B-VP
O	detected	detect	VBN	I-VP
O	in	in	IN	B-PP
O	100	100	CD	B-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	primary	primary	JJ	B-NP
O	MBs	MB	NNS	I-NP
O	,	,	,	O
O	67	67	CD	B-NP
O	%	%	NN	I-NP
O	(	(	(	O
O	6	6	CD	B-NP
O	/	/	SYM	O
O	9	9	CD	B-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	primary	primary	JJ	B-NP
O	SPNETs	SPNET	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	all	all	DT	B-NP
O	PNET	PNET	NN	I-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	frequency	frequency	NN	I-NP
O	of	of	IN	B-PP
O	promoter	promoter	NN	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	RASSF1A	RASSF1A	NN	B-NP
O	was	be	VBD	B-VP
O	significantly	significantly	RB	B-ADJP
O	lower	low	JJR	I-ADJP
O	in	in	IN	B-PP
O	SPNETs	SPNET	NNS	B-NP
O	than	than	IN	B-PP
O	in	in	IN	B-PP
O	MBs	MB	NNS	B-NP
O	(	(	(	O
O	Fisher	Fisher	NNP	B-NP
O	exact	exact	JJ	I-NP
O	test	test	NN	I-NP
O	,	,	,	O
O	P	P	NN	B-NP
O	=	=	SYM	B-VP
O	.	.	.	O
O	014	014	CD	B-NP
O	)	)	)	O
O	.	.	.	O

O	Treatment	Treatment	NN	B-NP
O	of	of	IN	B-PP
B-GGP	RASSF1A	RASSF1A	NN	B-NP
O	-	-	HYPH	B-NP
O	deficient	deficient	JJ	I-NP
O	PNET	PNET	NN	I-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	with	with	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	I-NP
O	2	2	CD	I-NP
O	'	'	SYM	I-NP
O	deoxycytidine	deoxycytidine	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	demethylating	demethylate	VBG	I-NP
O	agent	agent	NN	I-NP
O	,	,	,	O
O	restored	restore	VBD	B-VP
B-GGP	RASSF1A	RASSF1A	NN	B-NP
O	expression	expression	NN	I-NP
O	,	,	,	O
O	providing	provide	VBG	B-VP
O	evidence	evidence	NN	B-NP
O	that	that	IN	B-SBAR
O	promoter	promoter	NN	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	contributes	contribute	VBZ	B-VP
O	to	to	TO	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	silencing	silencing	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	promoter	promoter	NN	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	FHIT	FHIT	NN	B-NP
O	and	and	CC	I-NP
B-GGP	sFRP1	sFRP1	NN	I-NP
O	was	be	VBD	B-VP
O	detected	detect	VBN	I-VP
O	in	in	IN	B-PP
O	22	22	CD	B-NP
O	%	%	NN	I-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	/	/	SYM	O
O	9	9	CD	B-NP
O	)	)	)	O
O	and	and	CC	O
O	11	11	CD	B-NP
O	%	%	NN	I-NP
O	(	(	(	O
O	1	1	CD	B-NP
O	/	/	SYM	O
O	9	9	CD	O
O	)	)	)	O
O	of	of	IN	B-PP
O	SPNETs	SPNET	NNS	B-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	,	,	,	O
O	but	but	CC	B-PP
O	not	not	RB	B-PP
O	in	in	IN	I-PP
O	any	any	DT	B-NP
O	MBs	MB	NNS	I-NP
O	studied	study	VBN	B-VP
O	.	.	.	O

O	In	In	IN	B-PP
O	conclusion	conclusion	NN	B-NP
O	,	,	,	O
O	our	our	PRP$	B-NP
O	study	study	NN	I-NP
O	demonstrates	demonstrate	VBZ	B-VP
O	that	that	IN	B-SBAR
O	promoter	promoter	NN	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	RASSF1A	RASSF1A	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	common	common	JJ	I-NP
O	event	event	NN	I-NP
O	in	in	IN	B-PP
O	intracranial	intracranial	JJ	B-NP
O	PNETs	PNET	NNS	I-NP
O	,	,	,	O
O	whereas	whereas	IN	O
B-GGP	FHIT	FHIT	NN	B-NP
O	and	and	CC	I-NP
B-GGP	sFRP1	sFRP1	NN	I-NP
O	are	be	VBP	B-VP
O	epigenetically	epigenetically	RB	I-VP
O	affected	affect	VBN	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	fraction	fraction	NN	I-NP
O	of	of	IN	B-PP
O	SPNETs	SPNET	NNS	B-NP
O	.	.	.	O

B-GGP	Macroprolactin	Macroprolactin	NN	B-NP
O	(	(	(	I-NP
O	s	s	NNS	I-NP
O	)	)	)	O
O	:	:	:	O
O	composition	composition	NN	B-NP
O	and	and	CC	I-NP
O	reactivity	reactivity	NN	I-NP
O	in	in	IN	B-PP
O	immunoassays	immunoassay	NNS	B-NP
O	and	and	CC	O
O	laboratory	laboratory	JJ	B-NP
O	interpretation	interpretation	NN	I-NP
O	of	of	IN	B-PP
O	results	result	NNS	B-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	unusual	unusual	JJ	I-NP
O	patient	patient	NN	I-NP
O	serum	serum	NN	I-NP
O	.	.	.	O

O	BACKGROUND	BACKGROUND	NN	B-NP
O	:	:	:	O
B-GGP	Macroprolactin	Macroprolactin	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	high	high	JJ	I-NP
O	molecular	molecular	JJ	I-NP
O	mass	mass	NN	I-NP
O	complex	complex	NN	I-NP
O	of	of	IN	B-PP
B-GGP	prolactin	prolactin	NN	B-NP
O	that	that	WDT	B-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	the	the	DT	B-NP
O	cause	cause	NN	I-NP
O	of	of	IN	B-PP
O	elevated	elevated	JJ	B-NP
O	serum	serum	NN	I-NP
B-GGP	prolactin	prolactin	NN	I-NP
O	as	as	IN	B-SBAR
O	determined	determine	VBN	B-VP
O	by	by	IN	B-PP
O	immunoassay	immunoassay	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	composition	composition	NN	I-NP
O	of	of	IN	B-PP
B-GGP	macroprolactin	macroprolactin	NN	B-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	reactivity	reactivity	NN	I-NP
O	in	in	IN	B-PP
O	immunoassays	immunoassay	NNS	B-NP
O	are	be	VBP	B-VP
O	variable	variable	JJ	B-ADJP
O	but	but	CC	O
O	the	the	DT	B-NP
O	complex	complex	NN	I-NP
O	has	have	VBZ	B-VP
O	minimal	minimal	JJ	B-NP
O	bioactivity	bioactivity	NN	I-NP
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	.	.	.	O

O	Hyperprolactinaemia	Hyperprolactinaemia	NN	B-NP
O	due	due	IN	B-PP
O	to	to	TO	B-PP
O	unrecognized	unrecognized	JJ	B-NP
O	macroprolactinaemia	macroprolactinaemia	NN	I-NP
O	can	can	MD	B-VP
O	lead	lead	VB	I-VP
O	to	to	TO	B-PP
O	misdiagnosis	misdiagnosis	NN	B-NP
O	and	and	CC	I-NP
O	mistreatment	mistreatment	NN	I-NP
O	.	.	.	O

O	METHODS	METHODS	NNS	B-NP
O	:	:	:	O
O	Serum	Serum	NN	B-NP
O	from	from	IN	B-PP
O	a	a	DT	B-NP
O	patient	patient	NN	I-NP
O	with	with	IN	B-PP
O	an	an	DT	B-NP
O	unusual	unusual	JJ	I-NP
O	pattern	pattern	NN	I-NP
O	of	of	IN	B-PP
O	immunoreactivity	immunoreactivity	NN	B-NP
O	was	be	VBD	B-VP
O	distributed	distribute	VBN	I-VP
O	to	to	TO	B-PP
O	three	three	CD	B-NP
O	users	user	NNS	I-NP
O	of	of	IN	B-PP
O	each	each	DT	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	most	most	RBS	I-NP
O	popular	popular	JJ	I-NP
O	immunoassays	immunoassay	NNS	I-NP
O	represented	represent	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	UK	UK	NNP	I-NP
O	National	National	NNP	I-NP
O	External	External	NNP	I-NP
O	Quality	Quality	NNP	I-NP
O	Assessment	Assessment	NNP	I-NP
O	Scheme	Scheme	NNP	I-NP
O	(	(	(	O
O	NEQAS	NEQAS	NNP	B-NP
O	)	)	)	O
O	for	for	IN	B-PP
B-GGP	prolactin	prolactin	NN	B-NP
O	.	.	.	O

O	Clinical	Clinical	JJ	B-NP
O	details	detail	NNS	I-NP
O	were	be	VBD	B-VP
O	provided	provide	VBN	I-VP
O	and	and	CC	O
O	participating	participate	VBG	B-NP
O	centres	centre	NNS	I-NP
O	were	be	VBD	B-VP
O	invited	invite	VBN	I-VP
O	to	to	TO	B-VP
O	investigate	investigate	VB	I-VP
O	the	the	DT	B-NP
B-GGP	prolactin	prolactin	NN	I-NP
O	content	content	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	specimen	specimen	NN	I-NP
O	according	accord	VBG	B-PP
O	to	to	TO	B-PP
O	their	their	PRP$	B-NP
O	local	local	JJ	I-NP
O	protocol	protocol	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	to	to	TO	B-VP
O	comment	comment	VB	I-VP
O	on	on	IN	B-PP
O	their	their	PRP$	B-NP
O	results	result	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	nature	nature	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	macroprolactin	macroprolactin	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	specimen	specimen	NN	I-NP
O	was	be	VBD	B-VP
O	investigated	investigate	VBN	I-VP
O	in	in	IN	B-PP
O	detail	detail	NN	B-NP
O	by	by	IN	B-PP
O	gel	gel	NN	B-NP
O	filtration	filtration	NN	I-NP
O	chromatography	chromatography	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	native	native	JJ	I-NP
O	serum	serum	NN	I-NP
O	and	and	CC	B-PP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	serum	serum	NN	I-NP
O	after	after	IN	B-PP
O	adsorption	adsorption	NN	B-NP
O	of	of	IN	B-PP
O	IgG	IgG	NN	B-NP
O	with	with	IN	B-PP
O	protein	protein	NN	B-NP
O	A	A	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	by	by	IN	B-PP
O	affinity	affinity	NN	B-NP
O	chromatography	chromatography	NN	I-NP
O	with	with	IN	B-PP
B-GGP	concanavalin	concanavalin	NN	B-NP
I-GGP	A	A	NN	I-NP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
O	Gel	Gel	NN	B-NP
O	filtration	filtration	NN	I-NP
O	studies	study	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	two	two	CD	B-NP
O	peaks	peak	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	macroprolactin	macroprolactin	NN	B-NP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	serum	serum	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
B-GGP	macroprolactins	macroprolactin	NNS	I-NP
O	were	be	VBD	B-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	different	different	JJ	B-ADJP
O	in	in	IN	B-PP
O	their	their	PRP$	B-NP
O	IgG	IgG	NN	I-NP
O	content	content	NN	I-NP
O	and	and	CC	I-NP
O	degree	degree	NN	I-NP
O	of	of	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	.	.	.	O

O	All	All	DT	B-NP
O	eight	eight	CD	I-NP
O	immunoassays	immunoassay	NNS	I-NP
O	reacted	react	VBD	B-VP
O	strongly	strongly	RB	B-ADVP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
B-GGP	macroprolactin	macroprolactin	NN	I-NP
O	present	present	JJ	B-ADJP
O	.	.	.	O

O	The	The	DT	B-NP
O	majority	majority	NN	I-NP
O	(	(	(	O
O	78	78	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	centres	centre	NNS	B-NP
O	that	that	WDT	B-NP
O	interpreted	interpret	VBD	B-VP
O	their	their	PRP$	B-NP
O	results	result	NNS	I-NP
O	either	either	CC	O
O	demonstrated	demonstrate	VBD	B-VP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
B-GGP	macroprolactin	macroprolactin	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	specimen	specimen	NN	I-NP
O	,	,	,	O
O	or	or	CC	O
O	suggested	suggest	VBD	B-VP
O	it	it	PRP	B-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	likely	likely	JJ	I-NP
O	cause	cause	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	hyperprolactinaemia	hyperprolactinaemia	NN	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	two	two	CD	B-NP
O	centres	centre	NNS	I-NP
O	inappropriately	inappropriately	RB	B-ADVP
O	excluded	exclude	VBD	B-VP
O	macroprolactinaemia	macroprolactinaemia	NN	B-NP
O	as	as	IN	B-PP
O	the	the	DT	B-NP
O	cause	cause	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	elevated	elevated	JJ	I-NP
B-GGP	prolactin	prolactin	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	a	a	DT	B-NP
O	further	further	JJ	I-NP
O	two	two	CD	I-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	consider	consider	VB	I-VP
O	it	it	PRP	B-NP
O	at	at	IN	B-ADVP
O	all	all	DT	I-ADVP
O	.	.	.	O

O	Data	Datum	NNS	B-NP
O	from	from	IN	B-PP
O	previous	previous	JJ	B-NP
O	UK	UK	NN	I-NP
O	NEQAS	NEQAS	NN	I-NP
O	distributions	distribution	NNS	I-NP
O	(	(	(	O
O	between	between	IN	B-PP
O	1996	1996	CD	B-NP
O	and	and	CC	I-NP
O	2003	2003	CD	I-NP
O	)	)	)	O
O	of	of	IN	B-PP
B-GGP	macroprolactin	macroprolactin	NN	B-NP
O	containing	contain	VBG	B-VP
O	sera	serum	NNS	B-NP
O	are	be	VBP	B-VP
O	presented	present	VBN	I-VP
O	which	which	WDT	B-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	frequency	frequency	NN	I-NP
O	of	of	IN	B-PP
O	recognition	recognition	NN	B-NP
O	of	of	IN	B-PP
B-GGP	macroprolactin	macroprolactin	NN	B-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	possible	possible	JJ	I-NP
O	cause	cause	NN	I-NP
O	of	of	IN	B-PP
O	hyperprolactinaemia	hyperprolactinaemia	NN	B-NP
O	has	have	VBZ	B-VP
O	increased	increase	VBN	I-VP
O	over	over	IN	B-PP
O	time	time	NN	B-NP
O	.	.	.	O

O	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	:	:	:	O
O	Very	Very	JJ	B-NP
O	high	high	JJ	I-NP
O	molecular	molecular	JJ	I-NP
O	mass	mass	NN	I-NP
O	forms	form	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	prolactin	prolactin	NN	B-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	multiple	multiple	JJ	B-NP
O	molecular	molecular	JJ	I-NP
O	mass	mass	NN	I-NP
O	forms	form	NNS	I-NP
O	,	,	,	O
O	as	as	IN	B-SBAR
O	detected	detect	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	case	case	NN	I-NP
O	presented	present	VBN	B-VP
O	here	here	RB	B-ADVP
O	,	,	,	O
O	are	be	VBP	B-VP
O	uncommon	uncommon	JJ	B-ADJP
O	.	.	.	O

O	Also	Also	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	pattern	pattern	NN	I-NP
O	of	of	IN	B-PP
O	immunoreactivity	immunoreactivity	NN	B-NP
O	reported	report	VBN	B-VP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	specimen	specimen	NN	I-NP
O	was	be	VBD	B-VP
O	unusual	unusual	JJ	B-ADJP
O	as	as	IN	B-SBAR
O	most	most	JJS	B-NP
B-GGP	macroprolactins	macroprolactin	NNS	I-NP
O	studied	study	VBN	B-VP
O	previously	previously	RB	B-ADVP
O	react	react	VB	B-VP
O	less	less	RBR	B-ADVP
O	strongly	strongly	RB	I-ADVP
O	in	in	IN	B-PP
O	,	,	,	O
O	for	for	IN	B-PP
O	example	example	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	Bayer	Bayer	NNP	I-NP
O	ADVIA	ADVIA	NNP	I-NP
O	Centaur	Centaur	NNP	I-NP
O	assay	assay	NN	I-NP
O	compared	compare	VBN	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	Roche	Roche	NNP	I-NP
O	E170	E170	NN	I-NP
O	assay	assay	NN	I-NP
O	.	.	.	O

O	Both	Both	DT	B-NP
O	peaks	peak	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	macroprolactin	macroprolactin	NN	B-NP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	serum	serum	NN	I-NP
O	reacted	react	VBD	B-VP
O	in	in	IN	B-PP
O	all	all	DT	B-NP
O	assays	assay	NNS	I-NP
O	tested	test	VBN	B-VP
O	.	.	.	O

O	This	This	DT	B-NP
O	case	case	NN	I-NP
O	highlights	highlight	VBZ	B-VP
O	the	the	DT	B-NP
O	variable	variable	JJ	I-NP
O	nature	nature	NN	I-NP
O	and	and	CC	O
O	immunoreactive	immunoreactive	JJ	B-NP
O	behaviour	behaviour	NN	I-NP
O	of	of	IN	B-PP
B-GGP	macroprolactin	macroprolactin	NN	B-NP
O	species	specie	NNS	I-NP
O	.	.	.	O

O	Sodium	Sodium	NN	B-NP
O	butyrate	butyrate	NN	I-NP
O	ameliorates	ameliorate	VBZ	B-VP
B-GGP	histone	histone	NN	B-NP
O	hypoacetylation	hypoacetylation	NN	I-NP
O	and	and	CC	O
O	neurodegenerative	neurodegenerative	JJ	B-NP
O	phenotypes	phenotype	NNS	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	mouse	mouse	NN	I-NP
O	model	model	NN	I-NP
O	for	for	IN	B-PP
O	DRPLA	DRPLA	NN	B-NP
O	.	.	.	O

O	Dentatorubral	Dentatorubral	JJ	B-NP
O	-	-	HYPH	I-NP
O	pallidoluysian	pallidoluysian	JJ	I-NP
O	atrophy	atrophy	NN	I-NP
O	(	(	(	O
O	DRPLA	DRPLA	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	progressive	progressive	JJ	I-NP
O	neurodegenerative	neurodegenerative	JJ	I-NP
O	disease	disease	NN	I-NP
O	caused	cause	VBN	B-VP
O	by	by	IN	B-PP
O	polyglutamine	polyglutamine	NN	B-NP
O	expansion	expansion	NN	I-NP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
B-GGP	Atrophin	Atrophin	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	study	study	VB	I-VP
O	the	the	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	disease	disease	NN	I-NP
O	and	and	CC	O
O	to	to	TO	B-VP
O	test	test	VB	I-VP
O	potential	potential	JJ	B-NP
O	therapeutic	therapeutic	JJ	I-NP
O	methods	method	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	established	establish	VBD	B-VP
O	Atro	Atro	AFX	B-NP
O	-	-	HYPH	I-NP
O	118Q	118Q	NN	I-NP
O	transgenic	transgenic	JJ	I-NP
O	mice	mouse	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	express	express	VBP	B-VP
O	in	in	IN	B-PP
O	neurons	neuron	NNS	B-NP
O	a	a	DT	B-NP
O	mutant	mutant	JJ	I-NP
O	human	human	JJ	I-NP
B-GGP	Atrophin	Atrophin	NNP	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1	1	CD	I-NP
O	protein	protein	NN	I-NP
O	that	that	WDT	B-NP
O	contains	contain	VBZ	B-VP
O	an	an	DT	B-NP
O	expanded	expand	VBN	I-NP
O	stretch	stretch	NN	I-NP
O	of	of	IN	B-PP
O	118	118	CD	B-NP
O	glutamines	glutamine	NNS	I-NP
O	.	.	.	O

O	Consistent	Consistent	JJ	B-ADJP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	results	result	NNS	I-NP
O	from	from	IN	B-PP
O	previous	previous	JJ	B-NP
O	studies	study	NNS	I-NP
O	on	on	IN	B-PP
O	transgenic	transgenic	JJ	B-NP
O	mice	mouse	NNS	I-NP
O	that	that	WDT	B-NP
O	expressed	express	VBD	B-VP
O	mutant	mutant	JJ	B-NP
B-GGP	Atrophin	Atrophin	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	with	with	IN	B-PP
O	65	65	CD	B-NP
O	glutamines	glutamine	NNS	I-NP
O	,	,	,	O
O	Atro	Atro	AFX	B-NP
O	-	-	HYPH	I-NP
O	118Q	118Q	NN	B-NP
O	mice	mouse	NNS	I-NP
O	exhibited	exhibit	VBD	B-VP
O	several	several	JJ	B-NP
O	neurodegenerative	neurodegenerative	JJ	I-NP
O	phenotypes	phenotype	NNS	I-NP
O	that	that	WDT	B-NP
O	are	be	VBP	B-VP
O	commonly	commonly	RB	I-VP
O	seen	see	VBN	I-VP
O	in	in	IN	B-PP
O	DRPLA	DRPLA	NN	B-NP
O	patients	patient	NNS	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	ataxia	ataxia	NN	B-NP
O	,	,	,	O
O	tremors	tremor	NNS	B-NP
O	,	,	,	O
O	and	and	CC	O
O	other	other	JJ	B-NP
O	motor	motor	NN	I-NP
O	defects	defect	NNS	I-NP
O	.	.	.	O

O	Overexpression	Overexpression	NN	B-NP
O	of	of	IN	B-PP
O	wild	wild	JJ	B-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	human	human	JJ	I-NP
B-GGP	Atrophin	Atrophin	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	could	could	MD	B-VP
O	not	not	RB	I-VP
O	rescue	rescue	VB	I-VP
O	the	the	DT	B-NP
O	motor	motor	NN	I-NP
O	and	and	CC	I-NP
O	survival	survival	NN	I-NP
O	defects	defect	NNS	I-NP
O	in	in	IN	B-PP
O	Atro	Atro	NN	B-NP
O	-	-	HYPH	B-NP
O	118Q	118Q	NN	I-NP
O	mice	mouse	NNS	I-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	mutant	mutant	JJ	I-NP
O	protein	protein	NN	I-NP
O	with	with	IN	B-PP
O	polyglutamine	polyglutamine	NN	B-NP
O	expansion	expansion	NN	I-NP
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	simply	simply	RB	I-VP
O	function	function	VB	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	dominant	dominant	JJ	I-NP
O	negative	negative	JJ	I-NP
O	manner	manner	NN	I-NP
O	.	.	.	O

O	Biochemical	Biochemical	JJ	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	Atro	Atro	AFX	B-NP
O	-	-	HYPH	I-NP
O	118Q	118Q	NN	I-NP
O	mice	mouse	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	hypoacetylation	hypoacetylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	in	in	IN	B-PP
O	brain	brain	NN	B-NP
O	tissues	tissue	NNS	I-NP
O	and	and	CC	O
O	thus	thus	RB	B-VP
O	suggested	suggest	VBD	I-VP
O	that	that	IN	B-SBAR
O	global	global	JJ	B-NP
O	gene	gene	NN	I-NP
O	repression	repression	NN	I-NP
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	underlying	underlie	VBG	I-NP
O	mechanism	mechanism	NN	I-NP
O	for	for	IN	B-PP
O	neurodegeneration	neurodegeneration	NN	B-NP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	mouse	mouse	NN	I-NP
O	model	model	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	further	further	RB	B-ADVP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	intraperitoneal	intraperitoneal	JJ	B-NP
O	administration	administration	NN	I-NP
O	of	of	IN	B-PP
O	sodium	sodium	NN	B-NP
O	butyrate	butyrate	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylase	deacetylase	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	,	,	,	O
O	ameliorated	ameliorate	VBD	B-VP
O	the	the	DT	B-NP
B-GGP	histone	histone	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	defects	defect	NNS	I-NP
O	,	,	,	O
O	significantly	significantly	RB	B-VP
O	improved	improve	VBD	I-VP
O	motor	motor	NN	B-NP
O	performance	performance	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	extended	extend	VBD	B-VP
O	the	the	DT	B-NP
O	average	average	JJ	I-NP
O	life	life	NN	I-NP
O	span	span	NN	I-NP
O	of	of	IN	B-PP
O	Atro	Atro	AFX	B-NP
O	-	-	HYPH	I-NP
O	118Q	118Q	NN	I-NP
O	mice	mouse	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	support	support	VBP	B-VP
O	the	the	DT	B-NP
O	hypothesis	hypothesis	NN	I-NP
O	that	that	IN	B-SBAR
O	transcription	transcription	NN	B-NP
O	deregulation	deregulation	NN	I-NP
O	plays	play	VBZ	B-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	pathogenesis	pathogenesis	NN	I-NP
O	of	of	IN	B-PP
O	polyglutamine	polyglutamine	NN	B-NP
O	expansion	expansion	NN	I-NP
O	diseases	disease	NNS	I-NP
O	and	and	CC	O
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	reversion	reversion	NN	B-NP
O	of	of	IN	B-PP
O	transcription	transcription	NN	B-NP
O	repression	repression	NN	I-NP
O	with	with	IN	B-PP
O	small	small	JJ	B-NP
O	molecules	molecule	NNS	I-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	sodium	sodium	NN	B-NP
O	butyrate	butyrate	NN	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	feasible	feasible	JJ	I-NP
O	approach	approach	NN	I-NP
O	to	to	TO	B-PP
O	treating	treat	VBG	B-VP
O	DRPLA	DRPLA	NN	B-NP
O	symptoms	symptom	NNS	I-NP
O	.	.	.	O

O	Changes	Change	NNS	B-NP
O	in	in	IN	B-PP
O	liver	liver	NN	B-NP
O	and	and	CC	O
O	plasma	plasma	NN	B-NP
B-GGP	acetylcholinesterase	acetylcholinesterase	NN	I-NP
O	in	in	IN	B-PP
O	rats	rat	NNS	B-NP
O	with	with	IN	B-PP
O	cirrhosis	cirrhosis	NN	B-NP
O	induced	induce	VBN	B-VP
O	by	by	IN	B-PP
O	bile	bile	NN	B-NP
O	duct	duct	NN	I-NP
O	ligation	ligation	NN	I-NP
O	.	.	.	O

O	Classical	Classical	JJ	B-NP
O	studies	study	NNS	I-NP
O	of	of	IN	B-PP
O	cholinesterase	cholinesterase	NN	B-NP
O	activity	activity	NN	I-NP
O	during	during	IN	B-PP
O	liver	liver	NN	B-NP
O	dysfunction	dysfunction	NN	I-NP
O	have	have	VBP	B-VP
O	focused	focus	VBN	I-VP
O	on	on	IN	B-PP
B-GGP	butyrylcholinesterase	butyrylcholinesterase	NN	B-NP
O	(	(	(	O
B-GGP	BuChE	BuChE	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	whereas	whereas	IN	O
B-GGP	acetylcholinesterase	acetylcholinesterase	NN	B-NP
O	(	(	(	O
B-GGP	AChE	AChE	NN	B-NP
O	)	)	)	O
O	has	have	VBZ	B-VP
O	not	not	RB	I-VP
O	received	receive	VBN	I-VP
O	much	much	JJ	B-NP
O	attention	attention	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	current	current	JJ	I-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	liver	liver	NN	B-NP
O	and	and	CC	O
O	plasma	plasma	NN	B-NP
B-GGP	AChE	AChE	NN	I-NP
O	levels	level	NNS	I-NP
O	were	be	VBD	B-VP
O	investigated	investigate	VBN	I-VP
O	in	in	IN	B-PP
O	rats	rat	NNS	B-NP
O	with	with	IN	B-PP
O	cirrhosis	cirrhosis	NN	B-NP
O	induced	induce	VBN	B-VP
O	after	after	IN	B-PP
O	3	3	CD	B-NP
O	weeks	week	NNS	I-NP
O	of	of	IN	B-PP
O	bile	bile	NN	B-NP
O	duct	duct	NN	I-NP
O	ligation	ligation	NN	I-NP
O	(	(	(	O
O	BDL	BDL	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	BDL	BDL	NN	B-NP
O	rats	rat	NNS	I-NP
O	showed	show	VBD	B-VP
O	a	a	DT	B-NP
O	pronounced	pronounced	JJ	I-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
O	liver	liver	NN	B-NP
B-GGP	AChE	AChE	NN	I-NP
O	levels	level	NNS	I-NP
O	(	(	(	O
O	approximately	approximately	RB	B-NP
O	50	50	CD	I-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	sham	sham	NN	B-NP
O	-	-	HYPH	O
O	operated	operate	VBN	B-VP
O	(	(	(	O
O	non	non	AFX	O
O	-	-	HYPH	O
O	ligated	ligate	VBN	B-VP
O	,	,	,	O
O	NL	NL	NNP	B-NP
O	)	)	)	O
O	controls	control	NNS	B-NP
O	;	;	:	O
O	whereas	whereas	IN	O
O	liver	liver	NN	B-NP
B-GGP	BuChE	BuChE	NN	I-NP
O	appeared	appear	VBD	B-VP
O	unaffected	unaffected	JJ	B-ADJP
O	.	.	.	O

O	A	A	DT	B-NP
O	selective	selective	JJ	I-NP
O	loss	loss	NN	I-NP
O	of	of	IN	B-PP
O	tetrameric	tetrameric	JJ	B-NP
O	(	(	(	O
O	G4	G4	NN	B-NP
O	)	)	)	O
B-GGP	AChE	AChE	NN	B-NP
O	was	be	VBD	B-VP
O	detected	detect	VBN	I-VP
O	in	in	IN	B-PP
O	BDL	BDL	NN	B-NP
O	rats	rat	NNS	I-NP
O	,	,	,	O
O	an	an	DT	B-NP
O	effect	effect	NN	I-NP
O	also	also	RB	B-ADVP
O	observed	observe	VBN	B-VP
O	in	in	IN	B-PP
O	rats	rat	NNS	B-NP
O	with	with	IN	B-PP
O	carbon	carbon	NN	B-NP
O	tetrachloride	tetrachloride	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	cirrhosis	cirrhosis	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	accordance	accordance	NN	B-NP
O	,	,	,	O
O	SDS	SDS	NN	B-NP
O	-	-	HYPH	B-NP
O	PAGE	PAGE	NN	I-NP
O	analysis	analysis	NN	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	major	major	JJ	I-NP
O	55	55	CD	I-NP
O	-	-	HYPH	I-NP
O	kd	kd	NN	I-NP
O	immunoreactive	immunoreactive	JJ	I-NP
B-GGP	AChE	AChE	NN	I-NP
O	band	band	NN	I-NP
O	was	be	VBD	B-VP
O	decreased	decrease	VBN	I-VP
O	in	in	IN	B-PP
O	BDL	BDL	NN	B-NP
O	as	as	IN	B-PP
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	NL	NL	NN	B-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	65	65	CD	I-NP
O	-	-	HYPH	I-NP
O	kd	kd	NN	I-NP
O	band	band	NN	I-NP
O	,	,	,	O
O	attributed	attribute	VBN	B-VP
O	in	in	IN	B-PP
O	part	part	NN	B-NP
O	to	to	TO	B-PP
O	inactive	inactive	JJ	B-NP
B-GGP	AChE	AChE	NN	I-NP
O	,	,	,	O
O	was	be	VBD	B-VP
O	increased	increase	VBN	I-VP
O	as	as	IN	B-SBAR
O	became	become	VBD	B-VP
O	the	the	DT	B-NP
O	most	most	RBS	I-NP
O	abundant	abundant	JJ	I-NP
B-GGP	AChE	AChE	NN	I-NP
O	subunit	subunit	NN	I-NP
O	in	in	IN	B-PP
O	BDL	BDL	NN	B-NP
O	liver	liver	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	overall	overall	JJ	I-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
B-GGP	AChE	AChE	NN	B-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	BDL	BDL	NN	B-NP
O	liver	liver	NN	I-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	accompanied	accompany	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	reduction	reduction	NN	I-NP
O	of	of	IN	B-PP
B-GGP	AChE	AChE	NN	B-NP
O	transcripts	transcript	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	loss	loss	NN	I-NP
O	of	of	IN	B-PP
O	G4	G4	NN	B-NP
O	was	be	VBD	B-VP
O	also	also	RB	I-VP
O	reflected	reflect	VBN	I-VP
O	by	by	IN	B-PP
O	changes	change	NNS	B-NP
O	observed	observe	VBN	B-VP
O	in	in	IN	B-PP
B-GGP	AChE	AChE	NN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	pattern	pattern	NN	I-NP
O	attributable	attributable	JJ	B-ADJP
O	to	to	TO	B-PP
O	different	different	JJ	B-NP
O	liver	liver	NN	I-NP
B-GGP	AChE	AChE	NN	I-NP
O	forms	form	NNS	I-NP
O	being	be	VBG	B-VP
O	differentially	differentially	RB	I-VP
O	glycosylated	glycosylate	VBN	I-VP
O	.	.	.	O

O	BDL	BDL	NN	B-NP
O	affects	affect	VBZ	B-VP
B-GGP	AChE	AChE	NN	B-NP
O	levels	level	NNS	I-NP
O	in	in	IN	B-PP
O	both	both	CC	O
O	hepatocytes	hepatocyte	NNS	B-NP
O	and	and	CC	O
O	Kupffer	Kupffer	NNP	B-NP
O	cells	cell	NNS	I-NP
O	;	;	:	O
O	however	however	RB	O
O	,	,	,	O
O	altered	alter	VBN	B-VP
B-GGP	AChE	AChE	NN	B-NP
O	expression	expression	NN	I-NP
O	was	be	VBD	B-VP
O	mainly	mainly	RB	I-VP
O	reflected	reflect	VBN	I-VP
O	in	in	IN	B-PP
O	an	an	DT	B-NP
O	alteration	alteration	NN	I-NP
O	in	in	IN	B-PP
O	hepatocyte	hepatocyte	NN	B-NP
B-GGP	AChE	AChE	NN	I-NP
O	pattern	pattern	NN	I-NP
O	.	.	.	O

O	Plasma	Plasma	NN	B-NP
O	from	from	IN	B-PP
O	BDL	BDL	NN	B-NP
O	rats	rat	NNS	I-NP
O	had	have	VBD	B-VP
O	approximately	approximately	RB	B-NP
O	45	45	CD	I-NP
O	%	%	NN	I-NP
O	lower	low	JJR	B-NP
B-GGP	AChE	AChE	NN	I-NP
O	activity	activity	NN	I-NP
O	than	than	IN	B-PP
O	controls	control	NNS	B-NP
O	,	,	,	O
O	displaying	display	VBG	B-VP
O	decreased	decrease	VBN	B-NP
O	G4	G4	NN	I-NP
O	levels	level	NNS	I-NP
O	and	and	CC	O
O	altered	alter	VBN	B-NP
O	lectin	lectin	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-NP
O	patterns	pattern	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	conclusion	conclusion	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	liver	liver	NN	I-NP
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	source	source	NN	I-NP
O	of	of	IN	B-PP
O	serum	serum	NN	B-NP
B-GGP	AChE	AChE	NN	I-NP
O	;	;	:	O
O	altered	alter	VBN	B-NP
B-GGP	AChE	AChE	NN	I-NP
O	levels	level	NNS	I-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	a	a	DT	B-NP
O	useful	useful	JJ	I-NP
O	biomarker	biomarker	NN	I-NP
O	for	for	IN	B-PP
O	liver	liver	NN	B-NP
O	cirrhosis	cirrhosis	NN	I-NP
O	.	.	.	O

O	NF	NF	NN	B-NP
O	-	-	HYPH	I-NP
O	kappaB	kappaB	NN	I-NP
O	activation	activation	NN	I-NP
O	upregulates	upregulate	VBZ	B-VP
B-GGP	fibroblast	fibroblast	NN	B-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	8	8	CD	B-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	prostate	prostate	NN	B-NP
O	cancer	cancer	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	BACKGROUND	BACKGROUND	NN	B-NP
O	:	:	:	O
B-GGP	Fibroblast	Fibroblast	NN	B-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	8	8	CD	I-NP
O	(	(	(	O
B-GGP	FGF8	FGF8	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	over	over	AFX	B-PP
O	-	-	HYPH	B-NP
O	expressed	express	VBN	B-VP
O	in	in	IN	B-PP
O	prostate	prostate	NN	B-NP
O	cancer	cancer	NN	I-NP
O	(	(	(	O
O	CaP	CaP	NN	B-NP
O	)	)	)	O
O	correlating	correlate	VBG	B-VP
O	with	with	IN	B-PP
O	high	high	JJ	B-NP
O	-	-	HYPH	I-NP
O	grade	grade	NN	I-NP
O	disease	disease	NN	I-NP
O	and	and	CC	O
O	reduced	reduce	VBN	B-NP
O	survival	survival	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	acetylation	acetylation	NN	B-NP
O	in	in	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	FGF8	FGF8	NN	B-NP
O	was	be	VBD	B-VP
O	investigated	investigate	VBN	I-VP
O	using	use	VBG	B-VP
O	the	the	DT	B-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylase	deacetylase	NN	I-NP
O	(	(	(	O
O	HDAC	HDAC	NN	B-NP
O	)	)	)	O
O	inhibitor	inhibitor	NN	B-NP
O	Trichostatin	Trichostatin	NN	I-NP
O	A	A	NN	I-NP
O	(	(	(	O
O	TSA	TSA	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	METHODS	METHODS	NNS	B-NP
O	:	:	:	O
B-GGP	FGF8	FGF8	NN	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
O	TSA	TSA	NN	B-NP
O	was	be	VBD	B-VP
O	investigated	investigate	VBN	I-VP
O	by	by	IN	B-PP
O	gene	gene	NN	B-NP
O	reporter	reporter	NN	I-NP
O	assays	assay	NNS	I-NP
O	,	,	,	O
O	RT	RT	NN	B-NP
O	-	-	HYPH	I-NP
O	PCR	PCR	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	Western	Western	NN	B-NP
O	blotting	blotting	NN	I-NP
O	.	.	.	O

O	Chromatin	Chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	(	(	(	O
O	ChIP	ChIP	NN	B-NP
O	)	)	)	O
O	assays	assay	NNS	B-NP
O	were	be	VBD	B-VP
O	also	also	RB	I-VP
O	performed	perform	VBN	I-VP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
B-GGP	FGF8	FGF8	NN	B-NP
O	is	be	VBZ	B-VP
O	upregulated	upregulate	VBN	I-VP
O	in	in	IN	B-PP
O	response	response	NN	B-NP
O	to	to	TO	B-PP
O	TSA	TSA	NN	B-NP
O	treatment	treatment	NN	I-NP
O	along	along	IN	B-PP
O	with	with	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	transcriptional	transcriptional	JJ	I-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	Over	Over	AFX	B-NP
O	-	-	HYPH	I-NP
O	expression	expression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	p65	p65	NN	B-NP
O	activated	activate	VBD	B-VP
B-GGP	FGF8	FGF8	NN	B-NP
O	transcription	transcription	NN	I-NP
O	.	.	.	O

O	ChIP	ChIP	NN	B-NP
O	assays	assay	NNS	I-NP
O	revealed	reveal	VBD	B-VP
B-GGP	p65	p65	NN	B-NP
O	recruitment	recruitment	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
B-GGP	fgf8	fgf8	NN	I-NP
O	promoter	promoter	NN	I-NP
O	,	,	,	O
O	containing	contain	VBG	B-VP
O	putative	putative	JJ	B-NP
O	NF	NF	NN	I-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	binding	binding	NN	I-NP
O	sites	site	NNS	I-NP
O	,	,	,	O
O	post	post	IN	B-PP
O	TSA	TSA	NN	B-NP
O	stimulation	stimulation	NN	I-NP
O	.	.	.	O

O	PI	PI	NN	B-NP
O	-	-	HYPH	I-NP
O	3K	3K	NN	I-NP
O	activity	activity	NN	I-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	TSA	TSA	NN	B-NP
O	mediated	mediate	VBN	I-NP
B-GGP	FGF8	FGF8	NN	I-NP
O	upregulation	upregulation	NN	I-NP
O	.	.	.	O

O	CONCLUSION	CONCLUSION	NN	B-NP
O	:	:	:	O
O	Using	Use	VBG	B-VP
O	TSA	TSA	NN	B-NP
O	treatment	treatment	NN	I-NP
O	in	in	IN	B-PP
O	prostate	prostate	NN	B-NP
O	cancer	cancer	NN	I-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	requirement	requirement	NN	I-NP
O	of	of	IN	B-PP
O	PI	PI	NN	B-NP
O	-	-	HYPH	B-NP
O	3K	3K	NN	I-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	mediating	mediate	VBG	B-VP
O	TSA	TSA	NN	B-NP
O	function	function	NN	I-NP
O	is	be	VBZ	B-VP
O	demonstrated	demonstrate	VBN	I-VP
O	and	and	CC	O
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	role	role	NN	I-NP
O	for	for	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	FGF8	FGF8	NN	B-NP
O	expression	expression	NN	I-NP
O	is	be	VBZ	B-VP
O	uncovered	uncovered	JJ	B-ADJP
O	.	.	.	O

O	Epigenetics	Epigenetic	NNS	B-NP
O	of	of	IN	B-PP
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	hepatoma	hepatoma	NN	I-NP
O	cells	cell	NNS	I-NP
O	:	:	:	O
O	expression	expression	NN	B-NP
O	profiling	profile	VBG	B-VP
O	the	the	DT	B-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
O	inhibition	inhibition	NN	B-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	I-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylation	deacetylation	NN	I-NP
O	.	.	.	O

O	BACKGROUND	BACKGROUND	NN	B-NP
O	:	:	:	O
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	O
B-GGP	histone	histone	NN	B-NP
O	deacetylation	deacetylation	NN	I-NP
O	are	be	VBP	B-VP
O	epigenetic	epigenetic	JJ	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	that	that	WDT	B-NP
O	play	play	VBP	B-VP
O	major	major	JJ	B-NP
O	roles	role	NNS	I-NP
O	in	in	IN	B-PP
O	eukaryotic	eukaryotic	JJ	B-NP
O	gene	gene	NN	I-NP
O	regulation	regulation	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	hypothesize	hypothesize	VBP	B-VP
O	that	that	IN	B-SBAR
O	many	many	JJ	B-NP
O	genes	gene	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	human	human	JJ	I-NP
O	hepatoma	hepatoma	NN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	HepG2	HepG2	NN	I-NP
O	are	be	VBP	B-VP
O	regulated	regulate	VBN	I-VP
O	by	by	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	I-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylation	deacetylation	NN	I-NP
O	.	.	.	O

O	Treatment	Treatment	NN	B-NP
O	with	with	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	I-NP
O	2	2	CD	I-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	deoxycytidine	deoxycytidine	NN	I-NP
O	(	(	(	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	O
O	dC	dC	NN	B-NP
O	)	)	)	O
O	to	to	TO	B-VP
O	inhibit	inhibit	VB	I-VP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	with	with	IN	B-PP
O	and	and	CC	O
O	/	/	SYM	B-NP
O	or	or	CC	O
O	Trichostatin	Trichostatin	NN	B-NP
O	A	A	NN	I-NP
O	(	(	(	O
O	TSA	TSA	NN	B-NP
O	)	)	)	O
O	to	to	TO	B-VP
O	inhibit	inhibit	VB	I-VP
B-GGP	histone	histone	NN	B-NP
O	deacetylation	deacetylation	NN	I-NP
O	should	should	MD	B-VP
O	allow	allow	VB	I-VP
O	us	us	PRP	B-NP
O	to	to	TO	B-VP
O	identify	identify	VB	I-VP
O	genes	gene	NNS	B-NP
O	that	that	WDT	B-NP
O	are	be	VBP	B-VP
O	regulated	regulate	VBN	I-VP
O	epigenetically	epigenetically	RB	B-ADVP
O	in	in	IN	B-PP
O	hepatoma	hepatoma	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	B-NP
O	dC	dC	NN	I-NP
O	had	have	VBD	B-VP
O	a	a	DT	B-NP
O	much	much	RB	I-NP
O	larger	large	JJR	I-NP
O	effect	effect	NN	I-NP
O	on	on	IN	B-PP
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	HepG2	HepG2	NN	B-NP
O	cells	cell	NNS	I-NP
O	than	than	IN	B-SBAR
O	did	do	VBD	O
O	TSA	TSA	NN	B-NP
O	,	,	,	O
O	as	as	IN	B-SBAR
O	measured	measure	VBN	B-VP
O	using	use	VBG	B-VP
O	Affymetrix	Affymetrix	NN	B-NP
O	HG	HG	NN	I-NP
O	-	-	HYPH	B-NP
O	U133	U133	NN	I-NP
O	Plus	Plus	NN	I-NP
O	2	2	CD	I-NP
O	.	.	.	O
O	0	0	CD	B-NP
O	microarrays	microarray	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	1504	1504	CD	B-NP
O	probe	probe	NN	I-NP
O	sets	set	NNS	I-NP
O	was	be	VBD	B-VP
O	affected	affect	VBN	I-VP
O	by	by	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	B-NP
O	dC	dC	NN	I-NP
O	(	(	(	O
O	at	at	IN	B-PP
O	p	p	NN	B-NP
O	<	<	SYM	O
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	01	01	CD	I-NP
O	)	)	)	O
O	,	,	,	O
O	535	535	CD	B-NP
O	probe	probe	NN	I-NP
O	sets	set	NNS	I-NP
O	by	by	IN	B-PP
O	TSA	TSA	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	1929	1929	CD	B-NP
O	probe	probe	NN	I-NP
O	sets	set	NNS	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	combination	combination	NN	I-NP
O	of	of	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	I-NP
O	dC	dC	NN	I-NP
O	and	and	CC	I-NP
O	TSA	TSA	NN	I-NP
O	.	.	.	O

O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	B-NP
O	dC	dC	NN	I-NP
O	treatment	treatment	NN	I-NP
O	turned	turn	VBD	B-VP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	211	211	CD	B-NP
O	probe	probe	NN	I-NP
O	sets	set	NNS	I-NP
O	that	that	WDT	B-NP
O	were	be	VBD	B-VP
O	not	not	RB	I-VP
O	detectably	detectably	RB	I-VP
O	expressed	express	VBN	I-VP
O	in	in	IN	B-PP
O	its	its	PRP$	B-NP
O	absence	absence	NN	I-NP
O	.	.	.	O

O	Expression	Expression	NN	B-NP
O	of	of	IN	B-PP
O	imprinted	imprint	VBN	B-NP
O	genes	gene	NNS	I-NP
O	regulated	regulate	VBN	B-VP
O	by	by	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	,	,	,	O
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
B-GGP	H19	H19	NN	B-NP
O	and	and	CC	I-NP
B-GGP	NNAT	NNAT	NN	I-NP
O	,	,	,	O
O	was	be	VBD	B-VP
O	turned	turn	VBN	I-VP
O	on	on	RP	B-PRT
O	or	or	CC	O
O	greatly	greatly	RB	B-VP
O	increased	increase	VBD	I-VP
O	in	in	IN	B-PP
O	response	response	NN	B-NP
O	to	to	TO	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	I-NP
O	dC	dC	NN	I-NP
O	.	.	.	O

O	Genes	Gene	NNS	B-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	liver	liver	NN	B-NP
O	processes	process	NNS	I-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	xenobiotic	xenobiotic	JJ	B-NP
O	metabolism	metabolism	NN	I-NP
O	(	(	(	O
B-GGP	CYP3A4	CYP3A4	NN	B-NP
O	,	,	,	O
B-GGP	CYP3A5	CYP3A5	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	CYP3A7	CYP3A7	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	steroid	steroid	NN	B-NP
O	biosynthesis	biosynthesis	NN	I-NP
O	(	(	(	O
B-GGP	CYP17A1	CYP17A1	NN	B-NP
O	and	and	CC	O
B-GGP	CYP19A1	CYP19A1	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
O	genes	gene	NNS	B-NP
O	encoding	encode	VBG	B-VP
O	CCAAT	CCAAT	NN	B-NP
O	element	element	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	proteins	protein	NNS	B-NP
O	(	(	(	O
B-GGP	C	C	NN	B-NP
I-GGP	/	/	SYM	I-NP
I-GGP	EBPalpha	EBPalpha	NN	I-NP
O	,	,	,	O
B-GGP	C	C	NN	B-NP
I-GGP	/	/	SYM	I-NP
I-GGP	EBPbeta	EBPbeta	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	C	C	NN	B-NP
I-GGP	/	/	SYM	B-NP
I-GGP	EBPgamma	EBPgamma	NN	I-NP
O	)	)	)	O
O	were	be	VBD	B-VP
O	affected	affect	VBN	I-VP
O	by	by	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	I-NP
O	dC	dC	NN	I-NP
O	or	or	CC	O
O	the	the	DT	B-NP
O	combination	combination	NN	I-NP
O	.	.	.	O

O	Many	Many	JJ	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	genes	gene	NNS	I-NP
O	that	that	WDT	B-NP
O	fall	fall	VBP	B-VP
O	within	within	IN	B-PP
O	these	these	DT	B-NP
O	groups	group	NNS	I-NP
O	are	be	VBP	B-VP
O	also	also	RB	I-VP
O	expressed	express	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	developing	develop	VBG	I-NP
O	fetal	fetal	JJ	I-NP
O	liver	liver	NN	I-NP
O	and	and	CC	O
O	adult	adult	JJ	B-NP
O	liver	liver	NN	I-NP
O	.	.	.	O

O	Quantitative	Quantitative	JJ	B-NP
O	real	real	JJ	I-NP
O	-	-	HYPH	I-NP
O	time	time	NN	I-NP
O	RT	RT	NN	I-NP
O	-	-	HYPH	B-NP
O	PCR	PCR	NN	I-NP
O	assays	assay	NNS	I-NP
O	confirmed	confirm	VBD	B-VP
O	selected	select	VBN	I-VP
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	changes	change	NNS	I-NP
O	seen	see	VBN	B-VP
O	in	in	IN	B-PP
O	microarray	microarray	NN	B-NP
O	analyses	analysis	NNS	I-NP
O	.	.	.	O

O	CONCLUSION	CONCLUSION	NN	B-NP
O	:	:	:	O
O	Epigenetics	Epigenetic	NNS	B-NP
O	play	play	VBP	B-VP
O	a	a	DT	B-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	regulating	regulate	VBG	B-VP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	several	several	JJ	B-NP
O	genes	gene	NNS	I-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	essential	essential	JJ	B-NP
O	liver	liver	NN	I-NP
O	processes	process	NNS	I-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	xenobiotic	xenobiotic	JJ	B-NP
O	metabolism	metabolism	NN	I-NP
O	and	and	CC	I-NP
O	steroid	steroid	NN	I-NP
O	biosynthesis	biosynthesis	NN	I-NP
O	in	in	IN	B-PP
O	HepG2	HepG2	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Many	Many	JJ	B-NP
O	genes	gene	NNS	I-NP
O	whose	whose	WP$	B-NP
O	expression	expression	NN	I-NP
O	is	be	VBZ	B-VP
O	normally	normally	RB	I-VP
O	silenced	silence	VBN	I-VP
O	in	in	IN	B-PP
O	these	these	DT	B-NP
O	hepatoma	hepatoma	NN	I-NP
O	cells	cell	NNS	I-NP
O	were	be	VBD	B-VP
O	re	re	AFX	B-ADJP
O	-	-	HYPH	B-NP
O	expressed	express	VBN	B-VP
O	by	by	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	B-NP
O	dC	dC	NN	I-NP
O	treatment	treatment	NN	I-NP
O	.	.	.	O

O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	a	a	DT	B-NP
O	factor	factor	NN	I-NP
O	in	in	IN	B-PP
O	restricting	restrict	VBG	B-VP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	fetal	fetal	JJ	B-NP
O	genes	gene	NNS	I-NP
O	during	during	IN	B-PP
O	liver	liver	NN	B-NP
O	development	development	NN	I-NP
O	and	and	CC	B-PP
O	in	in	IN	B-PP
O	shutting	shut	VBG	B-VP
O	down	down	RP	B-PRT
O	expression	expression	NN	B-NP
O	in	in	IN	B-PP
O	hepatoma	hepatoma	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Epigenetic	Epigenetic	JJ	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	imprinted	imprint	VBN	I-NP
B-GGP	U2af1	U2af1	NN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	rs1	rs1	NN	I-NP
O	gene	gene	NN	I-NP
O	during	during	IN	B-PP
O	retinoic	retinoic	JJ	B-NP
O	acid	acid	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	differentiation	differentiation	NN	I-NP
O	of	of	IN	B-PP
O	embryonic	embryonic	JJ	B-NP
O	stem	stem	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Epigenetic	Epigenetic	JJ	B-NP
O	modifications	modification	NNS	I-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	O
O	changes	change	NNS	B-NP
O	in	in	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	structure	structure	NN	I-NP
O	are	be	VBP	B-VP
O	changes	change	NNS	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	chemical	chemical	JJ	I-NP
O	composition	composition	NN	I-NP
O	or	or	CC	I-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	that	that	WDT	B-NP
O	work	work	VBP	B-VP
O	by	by	IN	B-PP
O	regulating	regulate	VBG	B-VP
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	Their	Their	PRP$	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	of	of	IN	B-PP
O	action	action	NN	B-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	generally	generally	RB	I-VP
O	studied	study	VBN	I-VP
O	in	in	IN	B-PP
O	imprinted	imprinted	JJ	B-NP
O	genes	gene	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	present	present	JJ	I-NP
O	work	work	NN	I-NP
O	analyzes	analyze	VBZ	B-VP
O	the	the	DT	B-NP
O	involvement	involvement	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	U2af1	U2af1	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	rs1	rs1	NN	I-NP
O	imprinted	imprint	VBD	B-VP
O	gene	gene	NN	B-NP
O	during	during	IN	B-PP
O	the	the	DT	B-NP
O	differentiation	differentiation	NN	I-NP
O	process	process	NN	I-NP
O	of	of	IN	B-PP
O	embryonic	embryonic	JJ	B-NP
O	stem	stem	NN	I-NP
O	(	(	(	O
O	ES	ES	NN	B-NP
O	)	)	)	O
O	cells	cell	NNS	B-NP
O	induced	induce	VBN	B-VP
O	by	by	IN	B-PP
O	retinoic	retinoic	JJ	B-NP
O	acid	acid	NN	I-NP
O	.	.	.	O

O	By	By	IN	B-PP
O	DNA	DNA	NN	B-NP
O	digestion	digestion	NN	I-NP
O	with	with	IN	B-PP
O	methylation	methylation	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	or	or	CC	I-NP
O	independent	independent	JJ	I-NP
O	restriction	restriction	NN	I-NP
O	enzymes	enzyme	NNS	I-NP
O	and	and	CC	O
O	consecutive	consecutive	JJ	B-NP
O	Southern	Southern	JJ	I-NP
O	blot	blot	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	have	have	VBP	B-VP
O	found	find	VBN	I-VP
O	that	that	IN	B-SBAR
O	methylation	methylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	U2af1	U2af1	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	rs1	rs1	NN	I-NP
O	gene	gene	NN	I-NP
O	increases	increase	VBZ	B-VP
O	in	in	IN	B-PP
O	differentiated	differentiate	VBN	B-NP
O	ES	ES	NN	I-NP
O	cells	cell	NNS	I-NP
O	and	and	CC	B-PP
O	in	in	IN	B-PP
O	embryoid	embryoid	JJ	B-NP
O	bodies	body	NNS	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	northern	northern	JJ	B-NP
O	blot	blot	NN	I-NP
O	and	and	CC	O
O	real	real	JJ	B-NP
O	-	-	HYPH	I-NP
O	time	time	NN	I-NP
O	reverse	reverse	JJ	B-NP
O	transcription	transcription	NN	I-NP
O	-	-	HYPH	B-NP
O	polymerase	polymerase	NN	I-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	analysis	analysis	NN	I-NP
O	showed	show	VBD	B-VP
O	a	a	DT	B-NP
O	higher	high	JJR	I-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	U2af1	U2af1	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	rs1	rs1	NN	I-NP
O	gene	gene	NN	I-NP
O	in	in	IN	B-PP
O	differentiated	differentiate	VBN	B-NP
O	ES	ES	NN	I-NP
O	cells	cell	NNS	I-NP
O	and	and	CC	B-PP
O	in	in	IN	B-PP
O	embryoid	embryoid	JJ	B-NP
O	bodies	body	NNS	I-NP
O	than	than	IN	B-PP
O	in	in	IN	B-PP
O	undifferentiated	undifferentiated	JJ	B-NP
O	ones	one	NNS	I-NP
O	.	.	.	O

O	On	On	IN	B-PP
O	the	the	DT	B-NP
O	other	other	JJ	I-NP
O	hand	hand	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	sensitivity	sensitivity	NN	I-NP
O	to	to	TO	B-PP
B-GGP	DNase	DNase	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	I	I	NN	I-NP
O	assay	assay	NN	I-NP
O	demonstrated	demonstrate	VBD	B-VP
O	an	an	DT	B-NP
O	open	open	JJ	I-NP
O	chromatin	chromatin	NN	I-NP
O	conformation	conformation	NN	I-NP
O	for	for	IN	B-PP
O	differentiated	differentiate	VBN	B-NP
O	cells	cell	NNS	I-NP
O	with	with	IN	B-PP
O	regard	regard	NN	B-NP
O	to	to	TO	B-PP
O	undifferentiated	undifferentiated	JJ	B-NP
O	ES	ES	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	U2af1	U2af1	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	rs1	rs1	NN	I-NP
O	gene	gene	NN	I-NP
O	would	would	MD	B-VP
O	be	be	VB	I-VP
O	regulated	regulate	VBN	I-VP
O	by	by	IN	B-PP
O	changes	change	NNS	B-NP
O	in	in	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	structure	structure	NN	I-NP
O	rather	rather	RB	B-CONJP
O	than	than	IN	I-CONJP
O	by	by	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	during	during	IN	B-PP
O	the	the	DT	B-NP
O	RA	RA	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	process	process	NN	I-NP
O	of	of	IN	B-PP
O	differentiation	differentiation	NN	B-NP
O	of	of	IN	B-PP
O	ES	ES	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	Yng1p	Yng1p	NN	I-NP
O	plant	plant	NN	I-NP
O	homeodomain	homeodomain	NN	I-NP
O	finger	finger	NN	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	histone	histone	NN	I-NP
O	binding	binding	NN	I-NP
O	module	module	NN	I-NP
O	that	that	WDT	B-NP
O	recognizes	recognize	VBZ	B-VP
O	lysine	lysine	NN	B-NP
O	4	4	CD	I-NP
O	-	-	HYPH	B-NP
O	methylated	methylate	VBN	I-NP
B-GGP	histone	histone	NN	I-NP
I-GGP	H3	H3	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	ING	ING	NN	I-NP
O	(	(	(	O
O	inhibitor	inhibitor	NN	B-NP
O	of	of	IN	B-PP
O	growth	growth	NN	B-NP
O	)	)	)	O
O	protein	protein	NN	B-NP
O	family	family	NN	I-NP
O	includes	include	VBZ	B-VP
O	a	a	DT	B-NP
O	group	group	NN	I-NP
O	of	of	IN	B-PP
O	homologous	homologous	JJ	B-NP
O	nuclear	nuclear	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	that	that	WDT	B-NP
O	share	share	VBP	B-VP
O	a	a	DT	B-NP
O	highly	highly	RB	I-NP
O	conserved	conserve	VBN	I-NP
O	plant	plant	NN	I-NP
O	homeodomain	homeodomain	NN	I-NP
O	(	(	(	O
O	PHD	PHD	NN	B-NP
O	)	)	)	O
O	finger	finger	NN	B-NP
O	domain	domain	NN	I-NP
O	at	at	IN	B-PP
O	their	their	PRP$	B-NP
O	carboxyl	carboxyl	NN	I-NP
O	termini	terminus	NNS	I-NP
O	.	.	.	O

O	Members	Member	NNS	B-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	family	family	NN	I-NP
O	are	be	VBP	B-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	multiprotein	multiprotein	NN	B-NP
O	complexes	complex	NNS	I-NP
O	that	that	WDT	B-NP
O	posttranslationally	posttranslationally	RB	B-ADVP
O	modify	modify	VBP	B-VP
B-GGP	histones	histone	NNS	B-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	these	these	DT	B-NP
O	proteins	protein	NNS	I-NP
O	serve	serve	VBP	B-VP
O	a	a	DT	B-NP
O	general	general	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	permitting	permit	VBG	B-VP
O	various	various	JJ	B-NP
O	enzymatic	enzymatic	JJ	I-NP
O	activities	activity	NNS	I-NP
O	to	to	TO	B-VP
O	interact	interact	VB	I-VP
O	with	with	IN	B-PP
O	nucleosomes	nucleosome	NNS	B-NP
O	.	.	.	O

O	There	There	EX	B-NP
O	are	be	VBP	B-VP
O	three	three	CD	B-NP
O	members	member	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	ING	ING	NN	I-NP
O	family	family	NN	I-NP
O	in	in	IN	B-PP
O	Saccharomyces	Saccharomyces	NNP	B-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	:	:	:	O
B-GGP	Yng1p	Yng1p	NN	B-NP
O	,	,	,	O
B-GGP	Yng2p	Yng2p	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	Pho23p	Pho23p	NN	B-NP
O	.	.	.	O

B-GGP	Yng1p	Yng1p	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	component	component	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	NuA3	NuA3	NN	I-NP
B-GGP	histone	histone	NN	I-NP
O	acetyltransferase	acetyltransferase	NN	I-NP
O	complex	complex	NN	I-NP
O	and	and	CC	O
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	interaction	interaction	NN	I-NP
O	of	of	IN	B-PP
O	NuA3	NuA3	NN	B-NP
O	with	with	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	gain	gain	VB	I-VP
O	insight	insight	NN	B-NP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	function	function	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	ING	ING	NN	I-NP
O	proteins	protein	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	made	make	VBD	B-VP
O	use	use	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	genetic	genetic	JJ	I-NP
O	strategy	strategy	NN	I-NP
O	to	to	TO	B-VP
O	identify	identify	VB	I-VP
O	genes	gene	NNS	B-NP
O	required	require	VBN	B-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Yng1p	Yng1p	NN	B-NP
O	to	to	TO	B-PP
B-GGP	histones	histone	NNS	B-NP
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	the	the	DT	B-NP
O	toxicity	toxicity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	YNG1	YNG1	NN	B-NP
O	overexpression	overexpression	NN	I-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	tool	tool	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	Yng1p	Yng1p	NN	B-NP
O	interacts	interact	VBZ	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	tail	tail	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	interaction	interaction	NN	I-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	disrupted	disrupt	VBN	I-VP
O	by	by	IN	B-PP
O	loss	loss	NN	B-NP
O	of	of	IN	B-PP
O	lysine	lysine	NN	B-NP
O	4	4	CD	I-NP
O	methylation	methylation	NN	I-NP
O	within	within	IN	B-PP
O	this	this	DT	B-NP
O	tail	tail	NN	I-NP
O	.	.	.	O

O	Additionally	Additionally	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	mapped	map	VBD	B-VP
O	the	the	DT	B-NP
O	region	region	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Yng1p	Yng1p	NN	B-NP
O	required	require	VBN	B-VP
O	for	for	IN	B-PP
O	overexpression	overexpression	NN	B-NP
O	of	of	IN	B-PP
O	toxicity	toxicity	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	PHD	PHD	NN	I-NP
O	finger	finger	NN	I-NP
O	,	,	,	O
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	region	region	NN	I-NP
O	capable	capable	JJ	B-ADJP
O	of	of	IN	B-PP
O	binding	bind	VBG	B-VP
O	lysine	lysine	NN	B-NP
O	4	4	CD	I-NP
O	-	-	HYPH	B-NP
O	methylated	methylate	VBN	I-NP
B-GGP	histone	histone	NN	I-NP
I-GGP	H3	H3	NN	I-NP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	,	,	,	O
O	and	and	CC	O
O	demonstrated	demonstrate	VBD	B-VP
O	that	that	IN	B-SBAR
O	mutations	mutation	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	PHD	PHD	NN	I-NP
O	finger	finger	NN	I-NP
O	that	that	WDT	B-NP
O	abolish	abolish	VBP	B-VP
O	binding	binding	NN	B-NP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	are	be	VBP	B-VP
O	no	no	RB	I-VP
O	longer	longer	RB	I-VP
O	toxic	toxic	JJ	I-ADJP
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	identify	identify	VBP	B-VP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	function	function	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
B-GGP	Yng1p	Yng1p	NN	I-NP
O	PHD	PHD	NN	I-NP
O	finger	finger	NN	I-NP
O	in	in	IN	B-PP
O	promoting	promote	VBG	B-VP
O	stabilization	stabilization	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	NuA3	NuA3	NN	I-NP
O	complex	complex	NN	I-NP
O	at	at	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	through	through	IN	B-PP
O	recognition	recognition	NN	B-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	lysine	lysine	NN	I-NP
O	4	4	CD	I-NP
O	methylation	methylation	NN	I-NP
O	.	.	.	O

O	Clioquinol	Clioquinol	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	Cu	Cu	NN	I-NP
O	(	(	(	O
O	II	II	CD	B-NP
O	)	)	)	O
O	/	/	SYM	B-NP
O	Zn	Zn	NN	I-NP
O	(	(	(	O
O	II	II	CD	B-NP
O	)	)	)	O
O	chelator	chelator	NN	B-NP
O	,	,	,	O
O	inhibits	inhibit	VBZ	B-VP
O	both	both	CC	O
O	ubiquitination	ubiquitination	NN	B-NP
O	and	and	CC	I-NP
O	asparagine	asparagine	NN	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	hypoxia	hypoxia	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	inducible	inducible	JJ	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	,	,	,	O
O	leading	lead	VBG	B-VP
O	to	to	TO	B-PP
O	expression	expression	NN	B-NP
O	of	of	IN	B-PP
O	vascular	vascular	JJ	B-NP
O	endothelial	endothelial	JJ	I-NP
O	growth	growth	NN	I-NP
O	factor	factor	NN	I-NP
O	and	and	CC	O
B-GGP	erythropoietin	erythropoietin	NN	B-NP
O	in	in	IN	B-PP
O	normoxic	normoxic	JJ	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	Cu	Cu	NN	I-NP
O	(	(	(	O
O	II	II	CD	B-NP
O	)	)	)	O
O	and	and	CC	O
O	Zn	Zn	NN	B-NP
O	(	(	(	O
O	II	II	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	chelator	chelator	NN	I-NP
O	Clioquinol	Clioquinol	NN	I-NP
O	(	(	(	O
O	10	10	CD	B-NP
O	-	-	HYPH	I-NP
O	50	50	CD	I-NP
O	microM	microM	NN	I-NP
O	)	)	)	O
O	increased	increase	VBD	B-VP
O	functional	functional	JJ	B-NP
B-GGP	hypoxia	hypoxia	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	inducible	inducible	JJ	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	(	(	(	O
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	)	)	)	O
O	protein	protein	NN	B-NP
O	,	,	,	O
O	leading	lead	VBG	B-VP
O	to	to	TO	B-PP
O	increased	increase	VBN	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	its	its	PRP$	B-NP
O	target	target	NN	I-NP
O	genes	gene	NNS	I-NP
O	,	,	,	O
O	vascular	vascular	JJ	B-NP
O	endothelial	endothelial	JJ	I-NP
O	growth	growth	NN	I-NP
O	factors	factor	NNS	I-NP
O	and	and	CC	O
B-GGP	erythropoietin	erythropoietin	NN	B-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	SH	SH	NN	B-NP
O	-	-	HYPH	B-NP
O	SY5Y	SY5Y	NN	I-NP
O	cells	cell	NNS	I-NP
O	and	and	CC	O
O	HepG2	HepG2	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Clioquinol	Clioquinol	NN	B-NP
O	inhibited	inhibit	VBD	B-VP
O	ubiquitination	ubiquitination	NN	B-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	Cu	Cu	NN	I-NP
O	(	(	(	O
O	II	II	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	O
O	and	and	CC	O
O	Zn	Zn	NN	B-NP
O	(	(	(	O
O	II	II	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	manner	manner	NN	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	prevents	prevent	VBZ	B-VP
B-GGP	FIH	FIH	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	from	from	IN	B-PP
O	hydroxylating	hydroxylate	VBG	B-VP
O	the	the	DT	B-NP
O	asparagine	asparagine	NN	I-NP
O	residue	residue	NN	I-NP
O	(	(	(	O
O	803	803	CD	B-NP
O	)	)	)	O
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	Cu	Cu	NN	I-NP
O	(	(	(	O
O	II	II	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	O
O	and	and	CC	O
O	Zn	Zn	NN	B-NP
O	(	(	(	O
O	II	II	CD	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	fashion	fashion	NN	I-NP
O	.	.	.	O

O	Therefore	Therefore	RB	B-ADVP
O	,	,	,	O
O	it	it	PRP	B-NP
O	leads	lead	VBZ	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	accumulation	accumulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	that	that	WDT	B-NP
O	is	be	VBZ	B-VP
O	prolyl	prolyl	JJ	B-ADJP
O	but	but	CC	B-ADJP
O	not	not	RB	I-ADJP
O	asparaginyl	asparaginyl	NN	B-NP
O	hydroxylated	hydroxylate	VBN	B-VP
O	.	.	.	O

O	Consistent	Consistent	JJ	B-ADJP
O	with	with	IN	B-PP
O	this	this	DT	B-NP
O	,	,	,	O
O	co	co	AFX	B-NP
O	-	-	HYPH	I-NP
O	immunoprecipitation	immunoprecipitation	NN	B-NP
O	assays	assay	NNS	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	Clioquinol	Clioquinol	NN	B-NP
O	-	-	HYPH	B-VP
O	induced	induce	VBN	B-NP
B-GGP	HIF	HIF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	interacted	interact	VBD	B-VP
O	with	with	IN	B-PP
O	cAMP	cAMP	NN	B-NP
O	-	-	HYPH	O
O	responsive	responsive	JJ	B-NP
O	element	element	NN	I-NP
O	-	-	HYPH	B-PP
O	binding	bind	VBG	B-NP
O	protein	protein	NN	I-NP
O	in	in	IN	B-PP
O	normoxic	normoxic	JJ	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	implying	imply	VBG	B-VP
O	that	that	IN	B-SBAR
O	Clioquinol	Clioquinol	NN	B-NP
O	stabilizes	stabilize	VBZ	B-VP
O	the	the	DT	B-NP
O	trans	trans	AFX	I-NP
O	-	-	HYPH	I-NP
O	active	active	JJ	I-NP
O	form	form	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	results	result	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	Clioquinol	Clioquinol	NN	B-NP
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	useful	useful	JJ	B-ADJP
O	as	as	IN	B-PP
O	an	an	DT	B-NP
O	inducer	inducer	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	target	target	NN	I-NP
O	genes	gene	NNS	I-NP
O	in	in	IN	B-PP
O	ischemic	ischemic	JJ	B-NP
O	diseases	disease	NNS	I-NP
O	.	.	.	O

O	Interaction	Interaction	NN	B-NP
O	of	of	IN	B-PP
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	with	with	IN	B-PP
B-GGP	dendritic	dendritic	JJ	B-NP
I-GGP	cell	cell	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	intercellular	intercellular	JJ	I-NP
I-GGP	adhesion	adhesion	NN	I-NP
I-GGP	molecule	molecule	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	grabbing	grab	VBG	I-NP
I-GGP	nonintegrin	nonintegrin	NN	I-NP
O	-	-	HYPH	O
O	expressing	express	VBG	B-VP
O	cells	cell	NNS	B-NP
O	is	be	VBZ	B-VP
O	influenced	influence	VBN	I-VP
O	by	by	IN	B-PP
B-GGP	gp120	gp120	NN	B-NP
O	envelope	envelope	NN	I-NP
O	modifications	modification	NNS	I-NP
O	associated	associate	VBN	B-VP
O	with	with	IN	B-PP
O	disease	disease	NN	B-NP
O	progression	progression	NN	I-NP
O	.	.	.	O

O	Dendritic	Dendritic	JJ	B-NP
O	cells	cell	NNS	I-NP
O	can	can	MD	B-VP
O	enhance	enhance	VB	I-VP
O	the	the	DT	B-NP
O	replication	replication	NN	I-NP
O	of	of	IN	B-PP
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	in	in	IN	B-PP
B-GGP	CD4	CD4	NN	B-NP
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	lymphocytes	lymphocyte	NNS	B-NP
O	through	through	IN	B-PP
O	the	the	DT	B-NP
O	interaction	interaction	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	gp120	gp120	NN	I-NP
O	envelope	envelope	NN	I-NP
O	protein	protein	NN	I-NP
O	with	with	IN	B-PP
O	such	such	JJ	B-NP
O	molecules	molecule	NNS	I-NP
O	as	as	IN	B-PP
B-GGP	dendritic	dendritic	JJ	B-NP
I-GGP	cell	cell	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	intercellular	intercellular	JJ	I-NP
I-GGP	adhesion	adhesion	NN	I-NP
I-GGP	molecule	molecule	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	grabbing	grab	VBG	I-NP
I-GGP	nonintegrin	nonintegrin	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	variable	variable	JJ	I-NP
O	loops	loop	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	gp120	gp120	NN	B-NP
O	have	have	VBP	B-VP
O	previously	previously	RB	I-VP
O	been	be	VBN	I-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	modulate	modulate	VB	I-VP
O	the	the	DT	B-NP
O	interaction	interaction	NN	I-NP
O	of	of	IN	B-PP
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	with	with	IN	B-PP
O	its	its	PRP$	B-NP
O	principal	principal	JJ	I-NP
O	receptor	receptor	NN	I-NP
B-GGP	CD4	CD4	NN	I-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	various	various	JJ	I-NP
O	coreceptors	coreceptor	NNS	I-NP
O	,	,	,	O
O	namely	namely	RB	B-NP
B-GGP	CCR5	CCR5	NN	I-NP
O	and	and	CC	I-NP
B-GGP	CXCR4	CXCR4	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	utilized	utilize	VBD	B-VP
O	a	a	DT	B-NP
O	panel	panel	NN	I-NP
O	of	of	IN	B-PP
O	molecular	molecular	JJ	B-NP
O	cloned	clone	VBN	I-NP
O	viruses	virus	NNS	I-NP
O	to	to	TO	B-VP
O	identify	identify	VB	I-VP
O	whether	whether	IN	B-SBAR
B-GGP	gp120	gp120	NN	B-NP
O	modifications	modification	NNS	I-NP
O	can	can	MD	B-VP
O	influence	influence	VB	I-VP
O	the	the	DT	B-NP
O	virus	virus	NN	I-NP
O	interaction	interaction	NN	I-NP
O	with	with	IN	B-PP
O	immature	immature	JJ	B-NP
O	dendritic	dendritic	JJ	I-NP
O	cells	cell	NNS	I-NP
O	or	or	CC	O
O	a	a	DT	B-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	expressing	express	VBG	B-VP
B-GGP	dendritic	dendritic	JJ	B-NP
I-GGP	cell	cell	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	intercellular	intercellular	JJ	I-NP
I-GGP	adhesion	adhesion	NN	I-NP
I-GGP	molecule	molecule	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	grabbing	grab	VBG	I-NP
I-GGP	nonintegrin	nonintegrin	NN	I-NP
O	(	(	(	O
O	Raji	Raji	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	DC	DC	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	SIGN	SIGN	NN	I-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	viruses	virus	NNS	I-NP
O	encompass	encompass	VBP	B-VP
O	the	the	DT	B-NP
O	R5	R5	NN	I-NP
O	,	,	,	I-NP
O	R5X4	R5X4	NN	I-NP
O	and	and	CC	I-NP
O	X4	X4	NN	I-NP
O	phenotypes	phenotype	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	are	be	VBP	B-VP
O	based	base	VBN	I-VP
O	upon	upon	IN	B-PP
O	V1V2	V1V2	NN	B-NP
O	and	and	CC	I-NP
O	V3	V3	NN	I-NP
O	sequences	sequence	NNS	I-NP
O	from	from	IN	B-PP
O	a	a	DT	B-NP
O	patient	patient	NN	I-NP
O	with	with	IN	B-PP
O	disease	disease	NN	B-NP
O	progression	progression	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	dendritic	dendritic	JJ	B-NP
I-GGP	cell	cell	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	intercellular	intercellular	JJ	I-NP
I-GGP	adhesion	adhesion	NN	I-NP
I-GGP	molecule	molecule	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	O
I-GGP	grabbing	grab	VBG	B-VP
I-GGP	nonintegrin	nonintegrin	JJ	B-NP
O	enhancement	enhancement	NN	I-NP
O	of	of	IN	B-PP
O	virus	virus	NN	B-NP
O	replication	replication	NN	I-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	modulated	modulate	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	V1V2	V1V2	NN	I-NP
O	length	length	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	overall	overall	JJ	I-NP
O	V3	V3	NN	I-NP
O	charge	charge	NN	I-NP
O	and	and	CC	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	;	;	:	O
O	similar	similar	JJ	B-NP
O	results	result	NNS	I-NP
O	were	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	with	with	IN	B-PP
O	immature	immature	JJ	B-NP
O	dendritic	dendritic	JJ	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Viruses	Virus	NNS	B-NP
O	with	with	IN	B-PP
O	higher	high	JJR	B-NP
O	V3	V3	NN	I-NP
O	charges	charge	NNS	I-NP
O	are	be	VBP	B-VP
O	more	more	RBR	I-VP
O	readily	readily	RB	I-VP
O	transferred	transfer	VBN	I-VP
O	to	to	TO	B-PP
B-GGP	CD4	CD4	NN	B-NP
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	lymphocytes	lymphocyte	NNS	B-NP
O	when	when	WRB	B-ADVP
O	the	the	DT	B-NP
O	V1V2	V1V2	NN	I-NP
O	region	region	NN	I-NP
O	is	be	VBZ	B-VP
O	longer	long	JJR	B-ADJP
O	and	and	CC	O
O	contains	contain	VBZ	B-VP
O	an	an	DT	B-NP
O	additional	additional	JJ	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	transfer	transfer	NN	B-NP
O	of	of	IN	B-PP
O	viruses	virus	NNS	B-NP
O	with	with	IN	B-PP
O	lower	low	JJR	B-NP
O	V3	V3	NN	I-NP
O	charges	charge	NNS	I-NP
O	is	be	VBZ	B-VP
O	greater	great	JJR	B-ADJP
O	when	when	WRB	B-ADVP
O	the	the	DT	B-NP
O	V1V2	V1V2	NN	I-NP
O	region	region	NN	I-NP
O	is	be	VBZ	B-VP
O	shorter	short	JJR	B-ADJP
O	.	.	.	O

O	Viruses	Virus	NNS	B-NP
O	differing	differ	VBG	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	V1V2	V1V2	NN	I-NP
O	and	and	CC	I-NP
O	V3	V3	NN	I-NP
O	regions	region	NNS	I-NP
O	also	also	RB	B-ADVP
O	demonstrated	demonstrate	VBD	B-VP
O	differential	differential	JJ	B-NP
O	capture	capture	NN	I-NP
O	by	by	IN	B-PP
O	Raji	Raji	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	DC	DC	NN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	SIGN	SIGN	NN	I-NP
O	cells	cell	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	I-PP
O	presence	presence	NN	I-PP
O	of	of	IN	I-PP
O	mannan	mannan	NN	B-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	interaction	interaction	NN	I-NP
O	between	between	IN	B-PP
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	and	and	CC	O
O	immature	immature	JJ	B-NP
O	dendritic	dendritic	JJ	I-NP
O	cells	cell	NNS	I-NP
O	via	via	IN	B-PP
O	such	such	JJ	B-NP
O	molecules	molecule	NNS	I-NP
O	as	as	IN	B-PP
B-GGP	dendritic	dendritic	JJ	B-NP
I-GGP	cell	cell	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	intercellular	intercellular	JJ	I-NP
I-GGP	adhesion	adhesion	NN	I-NP
I-GGP	molecule	molecule	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	grabbing	grab	VBG	I-NP
I-GGP	nonintegrin	nonintegrin	NN	I-NP
O	may	may	MD	B-VP
O	have	have	VB	I-VP
O	a	a	DT	B-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	selecting	select	VBG	B-VP
O	viruses	virus	NNS	B-NP
O	undergoing	undergo	VBG	B-VP
O	transmission	transmission	NN	B-NP
O	and	and	CC	I-NP
O	evolution	evolution	NN	I-NP
O	during	during	IN	B-PP
O	disease	disease	NN	B-NP
O	progression	progression	NN	I-NP
O	.	.	.	O

O	Knockdown	Knockdown	NN	B-NP
O	of	of	IN	B-PP
B-GGP	ALR	ALR	NN	B-NP
O	(	(	(	O
B-GGP	MLL2	MLL2	NN	B-NP
O	)	)	)	O
O	reveals	reveal	VBZ	B-VP
B-GGP	ALR	ALR	NN	B-NP
O	target	target	NN	I-NP
O	genes	gene	NNS	I-NP
O	and	and	CC	O
O	leads	lead	VBZ	B-VP
O	to	to	TO	B-PP
O	alterations	alteration	NNS	B-NP
O	in	in	IN	B-PP
O	cell	cell	NN	B-NP
O	adhesion	adhesion	NN	I-NP
O	and	and	CC	I-NP
O	growth	growth	NN	I-NP
O	.	.	.	O

B-GGP	ALR	ALR	NN	B-NP
O	(	(	(	O
B-GGP	MLL2	MLL2	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	member	member	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	human	human	JJ	I-NP
O	MLL	MLL	NN	I-NP
O	family	family	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	belongs	belong	VBZ	B-VP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	larger	large	JJR	I-NP
O	SET1	SET1	NN	I-NP
O	family	family	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	methyltransferases	methyltransferas	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	ALR	ALR	NN	B-NP
O	is	be	VBZ	B-VP
O	present	present	JJ	B-ADJP
O	within	within	IN	B-PP
O	a	a	DT	B-NP
O	stable	stable	JJ	I-NP
O	multiprotein	multiprotein	NN	I-NP
O	complex	complex	NN	I-NP
O	containing	contain	VBG	B-VP
O	a	a	DT	B-NP
O	cohort	cohort	NN	I-NP
O	of	of	IN	B-PP
O	proteins	protein	NNS	B-NP
O	shared	share	VBN	B-VP
O	with	with	IN	B-PP
O	other	other	JJ	B-NP
O	SET1	SET1	NN	I-NP
O	family	family	NN	I-NP
O	complexes	complex	NNS	I-NP
O	and	and	CC	O
O	several	several	JJ	B-NP
O	unique	unique	JJ	I-NP
O	components	component	NNS	I-NP
O	,	,	,	O
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
B-GGP	PTIP	PTIP	NN	B-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	jumonji	jumonji	NN	I-NP
O	family	family	NN	I-NP
O	member	member	NN	I-NP
B-GGP	UTX	UTX	NN	I-NP
O	.	.	.	O

O	Like	Like	IN	B-PP
O	other	other	JJ	B-NP
O	complexes	complex	NNS	I-NP
O	formed	form	VBN	B-VP
O	by	by	IN	B-PP
O	SET1	SET1	NN	B-NP
O	family	family	NN	I-NP
O	members	member	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
B-GGP	ALR	ALR	NN	I-NP
O	complex	complex	NN	I-NP
O	exhibited	exhibit	VBD	B-VP
O	strong	strong	JJ	B-NP
B-GGP	H3K4	H3K4	NN	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	activity	activity	NN	I-NP
O	,	,	,	O
O	conferred	confer	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ALR	ALR	NN	I-NP
O	SET	SET	NN	I-NP
O	domain	domain	NN	I-NP
O	.	.	.	O

O	By	By	IN	B-PP
O	generating	generate	VBG	B-VP
B-GGP	ALR	ALR	NN	B-NP
O	knockdown	knockdown	NN	I-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	and	and	CC	O
O	comparing	compare	VBG	B-VP
O	their	their	PRP$	B-NP
O	expression	expression	NN	I-NP
O	profiles	profile	NNS	I-NP
O	to	to	TO	B-PP
O	that	that	DT	B-NP
O	of	of	IN	B-PP
O	control	control	NN	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	identified	identify	VBD	B-VP
O	a	a	DT	B-NP
O	set	set	NN	I-NP
O	of	of	IN	B-PP
O	genes	gene	NNS	B-NP
O	whose	whose	WP$	B-NP
O	expression	expression	NN	I-NP
O	is	be	VBZ	B-VP
O	activated	activate	VBN	I-VP
O	by	by	IN	B-PP
B-GGP	ALR	ALR	NN	B-NP
O	.	.	.	O

O	Some	Some	DT	B-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	genes	gene	NNS	I-NP
O	were	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	by	by	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	as	as	IN	B-PP
O	direct	direct	JJ	B-NP
B-GGP	ALR	ALR	NN	I-NP
O	targets	target	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	ALR	ALR	NN	I-NP
O	complex	complex	NN	I-NP
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	to	to	TO	I-VP
O	associate	associate	VB	I-VP
O	in	in	IN	B-PP
O	an	an	DT	B-NP
B-GGP	ALR	ALR	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	fashion	fashion	NN	I-NP
O	with	with	IN	B-PP
O	promoters	promoter	NNS	B-NP
O	and	and	CC	O
O	transcription	transcription	NN	B-NP
O	initiation	initiation	NN	I-NP
O	sites	site	NNS	I-NP
O	of	of	IN	B-PP
O	target	target	NN	B-NP
O	genes	gene	NNS	I-NP
O	and	and	CC	O
O	to	to	TO	B-VP
O	induce	induce	VB	I-VP
B-GGP	H3K4	H3K4	NN	B-NP
O	trimethylation	trimethylation	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	most	most	RBS	I-NP
O	characteristic	characteristic	JJ	I-NP
O	features	feature	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ALR	ALR	NN	I-NP
O	knockdown	knockdown	JJ	I-NP
O	cells	cell	NNS	I-NP
O	were	be	VBD	B-VP
O	changes	change	NNS	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	dynamics	dynamic	NNS	I-NP
O	and	and	CC	I-NP
O	mode	mode	NN	I-NP
O	of	of	IN	B-PP
O	cell	cell	NN	B-NP
O	spreading	spreading	NN	I-NP
O	/	/	SYM	B-NP
O	polarization	polarization	NN	I-NP
O	,	,	,	O
O	reduced	reduce	VBD	B-VP
O	migration	migration	NN	B-NP
O	capacity	capacity	NN	I-NP
O	,	,	,	O
O	impaired	impaired	JJ	B-NP
O	anchorage	anchorage	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	and	and	CC	I-NP
O	-	-	HYPH	I-NP
O	independent	independent	JJ	I-NP
O	growth	growth	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	decreased	decrease	VBD	B-VP
O	tumorigenicity	tumorigenicity	NN	B-NP
O	in	in	IN	B-PP
O	mice	mouse	NNS	B-NP
O	.	.	.	O

O	Taken	Take	VBN	B-VP
O	together	together	RB	B-ADVP
O	,	,	,	O
O	our	our	PRP$	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	ALR	ALR	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	activator	activator	NN	I-NP
O	that	that	WDT	B-NP
O	induces	induce	VBZ	B-VP
O	the	the	DT	B-NP
O	transcription	transcription	NN	I-NP
O	of	of	IN	B-PP
O	target	target	NN	B-NP
O	genes	gene	NNS	I-NP
O	by	by	IN	B-PP
O	covalent	covalent	JJ	B-NP
O	histone	histone	NN	I-NP
O	modification	modification	NN	I-NP
O	.	.	.	O

B-GGP	ALR	ALR	NN	B-NP
O	appears	appear	VBZ	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	adhesion	adhesion	NN	B-NP
O	-	-	HYPH	O
O	related	relate	VBN	B-NP
O	cytoskeletal	cytoskeletal	JJ	I-NP
O	events	event	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	might	might	MD	B-VP
O	affect	affect	VB	I-VP
O	cell	cell	NN	B-NP
O	growth	growth	NN	I-NP
O	and	and	CC	I-NP
O	survival	survival	NN	I-NP
O	.	.	.	O

O	Glycogen	Glycogen	NN	B-NP
O	synthase	synthase	NN	I-NP
O	kinase	kinase	NN	I-NP
O	3	3	CD	I-NP
O	phosphorylates	phosphorylate	VBZ	B-VP
B-GGP	hypoxia	hypoxia	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	inducible	inducible	JJ	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	and	and	CC	O
O	mediates	mediate	VBZ	B-VP
O	its	its	PRP$	B-NP
O	destabilization	destabilization	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	VHL	VHL	NN	I-NP
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	manner	manner	NN	I-NP
O	.	.	.	O

B-GGP	Hypoxia	Hypoxia	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	inducible	inducible	JJ	I-NP
I-GGP	transcription	transcription	NN	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	(	(	(	O
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	key	key	JJ	I-NP
O	player	player	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
O	hypoxia	hypoxia	NN	B-NP
O	.	.	.	O

O	Additionally	Additionally	RB	B-ADVP
O	,	,	,	O
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	1alpha	1alpha	NN	B-NP
O	responds	respond	VBZ	B-VP
O	to	to	TO	B-PP
O	growth	growth	NN	B-NP
O	factors	factor	NNS	I-NP
O	and	and	CC	O
O	hormones	hormone	NNS	B-NP
O	which	which	WDT	B-NP
O	can	can	MD	B-VP
O	act	act	VB	I-VP
O	via	via	IN	B-PP
B-GGP	protein	protein	NN	B-NP
I-GGP	kinase	kinase	NN	I-NP
I-GGP	B	B	NN	I-NP
O	(	(	(	O
B-GGP	Akt	Akt	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	1alpha	1alpha	NN	B-NP
O	is	be	VBZ	B-VP
O	not	not	RB	O
O	a	a	DT	B-NP
O	direct	direct	JJ	I-NP
O	substrate	substrate	NN	I-NP
O	for	for	IN	B-PP
O	this	this	DT	B-NP
O	kinase	kinase	NN	I-NP
O	.	.	.	O

O	Therefore	Therefore	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	investigated	investigate	VBD	B-VP
O	whether	whether	IN	B-SBAR
O	the	the	DT	B-NP
B-GGP	protein	protein	NN	I-NP
I-GGP	kinase	kinase	NN	I-NP
I-GGP	B	B	NN	I-NP
O	target	target	NN	I-NP
O	glycogen	glycogen	NN	I-NP
O	synthase	synthase	NN	I-NP
O	kinase	kinase	NN	I-NP
O	3	3	CD	I-NP
O	(	(	(	O
O	GSK	GSK	NN	B-NP
O	-	-	HYPH	B-NP
O	3	3	CD	I-NP
O	)	)	)	O
O	may	may	MD	B-VP
O	have	have	VB	I-VP
O	an	an	DT	B-NP
O	impact	impact	NN	I-NP
O	on	on	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	inhibition	inhibition	NN	I-NP
O	or	or	CC	I-NP
O	depletion	depletion	NN	I-NP
O	of	of	IN	B-PP
O	GSK	GSK	NN	B-NP
O	-	-	HYPH	B-NP
O	3	3	CD	I-NP
O	induced	induce	VBN	I-NP
B-GGP	HIF	HIF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	whereas	whereas	IN	B-PP
O	the	the	DT	B-NP
O	overexpression	overexpression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	GSK	GSK	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	3beta	3beta	NN	I-NP
O	reduced	reduce	VBD	B-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	effects	effect	NNS	I-NP
O	were	be	VBD	B-VP
O	mediated	mediate	VBN	I-VP
O	via	via	IN	B-PP
O	three	three	CD	B-NP
O	amino	amino	NN	I-NP
O	acid	acid	NN	I-NP
O	residues	residue	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	oxygen	oxygen	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	degradation	degradation	NN	I-NP
O	domain	domain	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	mutation	mutation	NN	B-NP
O	analyses	analysis	NNS	I-NP
O	and	and	CC	I-NP
O	experiments	experiment	NNS	I-NP
O	with	with	IN	B-PP
B-GGP	von	von	NNP	B-NP
I-GGP	Hippel	Hippel	NNP	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	Lindau	Lindau	NNP	I-NP
O	(	(	(	O
B-GGP	VHL	VHL	NNP	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	defective	defective	JJ	I-NP
O	cells	cell	NNS	I-NP
O	indicated	indicate	VBD	B-VP
O	that	that	IN	B-SBAR
O	GSK	GSK	NN	B-NP
O	-	-	HYPH	B-NP
O	3	3	CD	I-NP
O	mediates	mediate	VBZ	B-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	degradation	degradation	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
B-GGP	VHL	VHL	NN	I-NP
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	manner	manner	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	line	line	NN	B-NP
O	with	with	IN	B-PP
O	these	these	DT	B-NP
O	observations	observation	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	inhibition	inhibition	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	proteasome	proteasome	NN	I-NP
O	reversed	reverse	VBD	B-VP
O	the	the	DT	B-NP
O	GSK	GSK	NN	I-NP
O	-	-	HYPH	B-NP
O	3	3	CD	I-NP
O	effects	effect	NNS	I-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
O	GSK	GSK	NN	B-NP
O	-	-	HYPH	B-NP
O	3	3	CD	I-NP
O	may	may	MD	B-VP
O	target	target	VB	I-VP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	proteasome	proteasome	NN	I-NP
O	by	by	IN	B-PP
O	phosphorylation	phosphorylation	NN	B-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	direct	direct	JJ	I-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HIF	HIF	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1alpha	1alpha	NN	I-NP
O	stability	stability	NN	I-NP
O	by	by	IN	B-PP
O	GSK	GSK	NN	B-NP
O	-	-	HYPH	B-NP
O	3	3	CD	I-NP
O	may	may	MD	B-VP
O	influence	influence	VB	I-VP
O	physiological	physiological	JJ	B-NP
O	processes	process	NNS	I-NP
O	or	or	CC	O
O	pathophysiological	pathophysiological	JJ	B-NP
O	situations	situation	NNS	I-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	metabolic	metabolic	JJ	B-NP
O	diseases	disease	NNS	I-NP
O	or	or	CC	I-NP
O	tumors	tumor	NNS	I-NP
O	.	.	.	O

O	Kinetic	Kinetic	JJ	B-NP
O	manifestation	manifestation	NN	I-NP
O	of	of	IN	B-PP
O	processivity	processivity	NN	B-NP
O	during	during	IN	B-PP
O	multiple	multiple	JJ	B-NP
O	methylations	methylation	NNS	I-NP
O	catalyzed	catalyze	VBN	B-VP
O	by	by	IN	B-PP
O	SET	SET	NN	B-NP
O	domain	domain	NN	I-NP
O	protein	protein	NN	I-NP
O	methyltransferases	methyltransferas	NNS	I-NP
O	.	.	.	O

O	Processive	Processive	JJ	B-ADJP
O	versus	versus	IN	B-PP
O	distributive	distributive	JJ	B-NP
O	methyl	methyl	NN	I-NP
O	group	group	NN	I-NP
O	transfer	transfer	NN	I-NP
O	was	be	VBD	B-VP
O	assessed	assess	VBN	I-VP
O	for	for	IN	B-PP
O	pea	pea	NN	B-NP
B-GGP	Rubisco	Rubisco	NNP	I-NP
I-GGP	large	large	JJ	I-NP
I-GGP	subunit	subunit	NN	I-NP
I-GGP	methyltransferase	methyltransferase	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	SET	SET	NN	I-NP
O	domain	domain	NN	I-NP
O	protein	protein	NN	I-NP
O	lysine	lysine	NN	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	catalyzing	catalyze	VBG	B-VP
O	the	the	DT	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	trimethyllysine	trimethyllysine	NN	B-NP
O	-	-	HYPH	B-NP
O	14	14	CD	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	large	large	JJ	I-NP
O	subunit	subunit	NN	I-NP
O	of	of	IN	B-PP
O	Rubisco	Rubisco	NNP	B-NP
O	.	.	.	O

O	Catalytically	Catalytically	RB	B-NP
O	competent	competent	JJ	I-NP
O	complexes	complex	NNS	I-NP
O	between	between	IN	B-PP
O	an	an	DT	B-NP
O	immobilized	immobilize	VBN	I-NP
O	form	form	NN	I-NP
O	of	of	IN	B-PP
O	des	de	NNS	B-NP
O	(	(	(	O
O	methyl	methyl	NN	B-NP
O	)	)	)	O
O	Rubisco	Rubisco	NNP	B-NP
O	and	and	CC	I-NP
B-GGP	Rubisco	Rubisco	NNP	I-NP
I-GGP	large	large	JJ	I-NP
I-GGP	subunit	subunit	NN	I-NP
I-GGP	methyltransferase	methyltransferase	NN	I-NP
O	were	be	VBD	B-VP
O	used	use	VBN	I-VP
O	to	to	TO	B-VP
O	demonstrate	demonstrate	VB	I-VP
O	enzyme	enzyme	NN	B-NP
O	release	release	NN	I-NP
O	that	that	WDT	B-NP
O	was	be	VBD	B-VP
O	co	co	AFX	O
O	-	-	HYPH	O
O	incident	incident	NN	B-NP
O	with	with	IN	B-PP
O	and	and	CC	O
O	dependent	dependent	JJ	B-ADJP
O	on	on	IN	B-PP
O	formation	formation	NN	B-NP
O	of	of	IN	B-PP
O	trimethyllysine	trimethyllysine	NN	B-NP
O	.	.	.	O

O	Catalytic	Catalytic	JJ	B-NP
O	rate	rate	NN	I-NP
O	constants	constant	NNS	I-NP
O	determined	determine	VBN	B-VP
O	for	for	IN	B-PP
O	formation	formation	NN	B-NP
O	of	of	IN	B-PP
O	trimethyllysine	trimethyllysine	NN	B-NP
O	were	be	VBD	B-VP
O	considerably	considerably	RB	B-ADJP
O	lower	low	JJR	I-ADJP
O	(	(	(	O
O	approximately	approximately	RB	B-NP
O	10	10	CD	I-NP
O	-	-	HYPH	O
O	fold	fold	RB	B-ADVP
O	)	)	)	O
O	than	than	IN	B-PP
O	rate	rate	NN	B-NP
O	constants	constant	NNS	I-NP
O	determined	determine	VBN	B-VP
O	for	for	IN	B-PP
O	total	total	JJ	B-NP
O	radiolabel	radiolabel	NN	I-NP
O	incorporation	incorporation	NN	I-NP
O	from	from	IN	B-PP
O	[	[	(	B-NP
O	3H	3H	NN	I-NP
O	-	-	HYPH	I-NP
O	methyl	methyl	NN	I-NP
O	]	]	)	O
O	-	-	HYPH	B-NP
O	S	S	NN	I-NP
O	-	-	HYPH	B-NP
O	adenosylmethionine	adenosylmethionine	NN	I-NP
O	.	.	.	O

O	Double	Double	JJ	B-NP
O	-	-	HYPH	I-NP
O	reciprocal	reciprocal	JJ	I-NP
O	velocity	velocity	NN	I-NP
O	plots	plot	NNS	I-NP
O	under	under	IN	B-PP
O	catalytic	catalytic	JJ	B-NP
O	conditions	condition	NNS	I-NP
O	favoring	favor	VBG	B-VP
O	monomethyllysine	monomethyllysine	NN	B-NP
O	indicated	indicate	VBD	B-VP
O	a	a	DT	B-NP
O	random	random	JJ	I-NP
O	or	or	CC	I-NP
O	ordered	order	VBN	I-NP
O	reaction	reaction	NN	I-NP
O	mechanism	mechanism	NN	I-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	conditions	condition	NNS	B-NP
O	favoring	favor	VBG	B-VP
O	trimethyllysine	trimethyllysine	NN	B-NP
O	suggested	suggest	VBD	B-VP
O	a	a	DT	B-NP
O	hybrid	hybrid	NN	I-NP
O	ping	ping	NN	I-NP
O	-	-	HYPH	B-NP
O	pong	pong	NN	I-NP
O	mechanism	mechanism	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	were	be	VBD	B-VP
O	compared	compare	VBN	I-VP
O	with	with	IN	B-PP
O	double	double	JJ	B-NP
O	-	-	HYPH	I-NP
O	reciprocal	reciprocal	JJ	I-NP
O	velocity	velocity	NN	I-NP
O	plots	plot	NNS	I-NP
O	and	and	CC	O
O	product	product	NN	B-NP
O	analyses	analysis	NNS	I-NP
O	obtained	obtain	VBN	B-VP
O	for	for	IN	B-PP
B-GGP	HsSET7	HsSET7	NN	B-NP
I-GGP	/	/	SYM	B-NP
I-GGP	9	9	CD	I-NP
O	(	(	(	O
O	a	a	DT	B-NP
O	monomethyltransferase	monomethyltransferase	NN	I-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	SpCLR4	SpCLR4	NN	B-NP
O	(	(	(	O
O	a	a	DT	B-NP
O	dimethyltransferase	dimethyltransferase	NN	I-NP
O	)	)	)	O
O	and	and	CC	O
O	suggest	suggest	VBP	B-VP
O	a	a	DT	B-NP
O	predictive	predictive	JJ	I-NP
O	ability	ability	NN	I-NP
O	of	of	IN	B-PP
O	double	double	JJ	B-NP
O	-	-	HYPH	I-NP
O	reciprocal	reciprocal	JJ	I-NP
O	velocity	velocity	NN	I-NP
O	plots	plot	NNS	I-NP
O	for	for	IN	B-PP
O	single	single	JJ	B-NP
O	versus	versus	IN	B-PP
O	multiple	multiple	JJ	B-NP
O	methyl	methyl	NN	I-NP
O	group	group	NN	I-NP
O	transfers	transfer	VBZ	B-VP
O	by	by	IN	B-PP
O	SET	SET	NN	B-NP
O	domain	domain	NN	I-NP
O	protein	protein	NN	I-NP
O	lysine	lysine	NN	I-NP
O	methyltransferases	methyltransferas	NNS	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	model	model	NN	I-NP
O	is	be	VBZ	B-VP
O	proposed	propose	VBN	I-VP
O	for	for	IN	B-PP
O	SET	SET	NN	B-NP
O	domain	domain	NN	I-NP
O	protein	protein	NN	I-NP
O	lysine	lysine	NN	I-NP
O	methyltransferases	methyltransferas	NNS	I-NP
O	in	in	IN	B-PP
O	which	which	WDT	B-NP
O	initial	initial	JJ	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
O	polypeptide	polypeptide	NN	B-NP
O	substrate	substrate	NN	I-NP
O	and	and	CC	I-NP
O	S	S	NN	I-NP
O	-	-	HYPH	B-NP
O	adenosylmethionine	adenosylmethionine	NN	I-NP
O	is	be	VBZ	B-VP
O	random	random	JJ	B-ADJP
O	,	,	,	O
O	with	with	IN	B-PP
O	polypeptide	polypeptide	NN	B-NP
O	binding	binding	NN	I-NP
O	followed	follow	VBN	B-VP
O	by	by	IN	B-PP
O	deprotonation	deprotonation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	epsilon	epsilon	NN	I-NP
O	-	-	HYPH	B-NP
O	amine	amine	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	target	target	NN	I-NP
O	lysyl	lysyl	NN	I-NP
O	residue	residue	NN	I-NP
O	and	and	CC	O
O	subsequent	subsequent	JJ	B-NP
O	methylation	methylation	NN	I-NP
O	.	.	.	O

O	Following	Follow	VBG	B-NP
O	methyl	methyl	NN	I-NP
O	group	group	NN	I-NP
O	transfer	transfer	NN	I-NP
O	,	,	,	O
O	S	S	NN	B-NP
O	-	-	HYPH	I-NP
O	adenosylhomocysteine	adenosylhomocysteine	NN	I-NP
O	and	and	CC	O
O	monomethylated	monomethylate	VBN	B-NP
O	polypeptide	polypeptide	NN	I-NP
O	dissociate	dissociate	NN	I-NP
O	from	from	IN	B-PP
O	monomethyltransferases	monomethyltransferas	NNS	B-NP
O	,	,	,	O
O	but	but	CC	O
O	di	di	AFX	B-NP
O	-	-	HYPH	I-NP
O	and	and	CC	O
O	trimethyltransferases	trimethyltransferas	NNS	B-NP
O	begin	begin	VBP	B-VP
O	a	a	DT	B-NP
O	successive	successive	JJ	I-NP
O	and	and	CC	I-NP
O	catalytically	catalytically	RB	I-NP
O	obligatory	obligatory	JJ	I-NP
O	deprotonation	deprotonation	NN	I-NP
O	of	of	IN	B-PP
O	enzyme	enzyme	NN	B-NP
O	-	-	HYPH	O
O	bound	bind	VBN	B-VP
O	methylated	methylate	VBN	B-NP
O	lysyl	lysyl	NN	I-NP
O	intermediates	intermediate	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	along	along	IN	B-PP
O	with	with	IN	B-PP
O	binding	binding	NN	B-NP
O	and	and	CC	I-NP
O	release	release	NN	I-NP
O	of	of	IN	B-PP
O	S	S	NN	B-NP
O	-	-	HYPH	B-NP
O	adenosylmethionine	adenosylmethionine	NN	I-NP
O	and	and	CC	I-NP
O	S	S	NN	I-NP
O	-	-	HYPH	B-NP
O	adenosylhomocysteine	adenosylhomocysteine	NN	I-NP
O	is	be	VBZ	B-VP
O	manifested	manifest	VBN	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	hybrid	hybrid	NN	I-NP
O	ping	ping	NN	I-NP
O	-	-	HYPH	B-NP
O	pong	pong	NN	I-NP
O	-	-	HYPH	I-NP
O	like	like	JJ	I-NP
O	reaction	reaction	NN	I-NP
O	mechanism	mechanism	NN	I-NP
O	.	.	.	O

O	Aberrant	Aberrant	JJ	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	p14ARF	p14ARF	NN	B-NP
O	and	and	CC	I-NP
B-GGP	O6	O6	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	methylguanine	methylguanine	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	DNA	DNA	NN	I-NP
I-GGP	methyltransferase	methyltransferase	NN	I-NP
O	genes	gene	NNS	I-NP
O	in	in	IN	B-PP
O	astrocytoma	astrocytoma	NN	B-NP
O	progression	progression	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	aim	aim	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	study	study	NN	I-NP
O	was	be	VBD	B-VP
O	to	to	TO	B-VP
O	elucidate	elucidate	VB	I-VP
O	genetic	genetic	JJ	B-NP
O	alterations	alteration	NNS	I-NP
O	that	that	WDT	B-NP
O	are	be	VBP	B-VP
O	critically	critically	RB	I-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	astrocytoma	astrocytoma	NN	B-NP
O	progression	progression	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	characterized	characterize	VBD	B-VP
O	27	27	CD	B-NP
O	World	World	NNP	I-NP
O	Health	Health	NNP	I-NP
O	Organization	Organization	NNP	I-NP
O	grade	grade	NN	I-NP
O	II	II	CD	I-NP
O	fibrillary	fibrillary	JJ	I-NP
O	astrocytomas	astrocytoma	NNS	I-NP
O	which	which	WDT	B-NP
O	later	later	RB	B-ADVP
O	underwent	undergo	VBD	B-VP
O	recurrence	recurrence	NN	B-NP
O	or	or	CC	I-NP
O	progression	progression	NN	I-NP
O	,	,	,	O
O	paying	pay	VBG	B-VP
O	specific	specific	JJ	B-NP
O	attention	attention	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	CpG	CpG	NN	I-NP
O	island	island	NN	I-NP
O	methylation	methylation	NN	I-NP
O	status	status	NN	I-NP
O	of	of	IN	B-PP
O	critical	critical	JJ	B-NP
O	growth	growth	NN	I-NP
O	regulatory	regulatory	JJ	I-NP
O	genes	gene	NNS	I-NP
O	.	.	.	O

B-GGP	p14	p14	NN	B-NP
O	(	(	(	O
B-GGP	ARF	ARF	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	O	O	NN	B-NP
I-GGP	(	(	(	O
I-GGP	6	6	CD	B-NP
I-GGP	)	)	)	O
I-GGP	-	-	HYPH	B-NP
I-GGP	methylguanine	methylguanine	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	DNA	DNA	NN	B-NP
I-GGP	methyltransferase	methyltransferase	NN	I-NP
O	(	(	(	O
B-GGP	MGMT	MGMT	NN	B-NP
O	)	)	)	O
O	hypermethylation	hypermethylation	NN	B-NP
O	represented	represent	VBD	B-VP
O	frequent	frequent	JJ	B-NP
O	events	event	NNS	I-NP
O	(	(	(	O
O	26	26	CD	B-NP
O	%	%	NN	I-NP
O	and	and	CC	O
O	63	63	CD	B-NP
O	%	%	NN	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	)	)	)	O
O	,	,	,	O
O	which	which	WDT	B-NP
O	were	be	VBD	B-VP
O	mutually	mutually	RB	B-ADJP
O	exclusive	exclusive	JJ	I-ADJP
O	except	except	IN	B-PP
O	in	in	IN	B-PP
O	one	one	CD	B-NP
O	case	case	NN	I-NP
O	,	,	,	O
O	with	with	IN	B-PP
O	alternate	alternate	JJ	B-NP
O	or	or	CC	I-NP
O	simultaneous	simultaneous	JJ	I-NP
O	methylation	methylation	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	two	two	CD	I-NP
O	genes	gene	NNS	I-NP
O	occurring	occur	VBG	B-VP
O	in	in	IN	B-PP
O	85	85	CD	B-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	our	our	PRP$	B-NP
O	tumor	tumor	NN	I-NP
O	series	series	NN	I-NP
O	.	.	.	O

O	Seventeen	Seventeen	CD	B-NP
O	tumors	tumor	NNS	I-NP
O	(	(	(	O
O	63	63	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	contained	contain	VBD	B-VP
B-GGP	TP53	TP53	NN	B-NP
O	mutations	mutation	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	were	be	VBD	B-VP
O	closely	closely	RB	B-ADJP
O	related	related	JJ	I-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
B-GGP	MGMT	MGMT	NN	B-NP
O	methylation	methylation	NN	I-NP
O	.	.	.	O

O	Methylation	Methylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	p21	p21	NN	I-NP
O	(	(	(	O
B-GGP	Waf1	Waf1	NN	B-NP
O	/	/	SYM	O
B-GGP	Cip1	Cip1	NN	B-NP
O	)	)	)	O
O	,	,	,	O
B-GGP	p27	p27	NN	B-NP
O	(	(	(	O
B-GGP	Kip1	Kip1	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	p73	p73	NN	B-NP
O	genes	gene	NNS	I-NP
O	and	and	CC	O
O	homozygous	homozygous	JJ	B-NP
O	deletion	deletion	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	p16	p16	NN	I-NP
O	(	(	(	O
B-GGP	INK4a	INK4a	NN	B-NP
O	)	)	)	O
O	,	,	,	O
B-GGP	p15	p15	NN	B-NP
O	(	(	(	O
B-GGP	INK4b	INK4b	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	p14	p14	NN	B-NP
O	(	(	(	O
B-GGP	ARF	ARF	NN	B-NP
O	)	)	)	O
O	genes	gene	NNS	B-NP
O	were	be	VBD	B-VP
O	not	not	RB	I-VP
O	detected	detect	VBN	I-VP
O	in	in	IN	B-PP
O	any	any	DT	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	primary	primary	JJ	I-NP
O	low	low	JJ	I-NP
O	-	-	HYPH	I-NP
O	grade	grade	NN	I-NP
O	tumors	tumor	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
B-GGP	p14	p14	NN	B-NP
O	(	(	(	O
B-GGP	ARF	ARF	NN	B-NP
O	)	)	)	O
O	methylation	methylation	NN	B-NP
O	at	at	IN	B-PP
O	first	first	JJ	B-NP
O	biopsy	biopsy	NN	I-NP
O	was	be	VBD	B-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	shorter	short	JJR	B-NP
O	patient	patient	NN	I-NP
O	survival	survival	NN	I-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
B-GGP	MGMT	MGMT	NN	B-NP
O	methylation	methylation	NN	I-NP
O	carried	carry	VBD	B-VP
O	a	a	DT	B-NP
O	better	good	JJR	I-NP
O	clinical	clinical	JJ	I-NP
O	outcome	outcome	NN	I-NP
O	after	after	IN	B-PP
O	salvage	salvage	NN	B-NP
O	therapy	therapy	NN	I-NP
O	.	.	.	O

O	Examination	Examination	NN	B-NP
O	of	of	IN	B-PP
O	20	20	CD	B-NP
O	cases	case	NNS	I-NP
O	whose	whose	WP$	B-NP
O	histological	histological	JJ	I-NP
O	data	datum	NNS	I-NP
O	for	for	IN	B-PP
O	recurrent	recurrent	JJ	B-NP
O	tumors	tumor	NNS	I-NP
O	were	be	VBD	B-VP
O	available	available	JJ	B-ADJP
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
O	malignant	malignant	JJ	B-NP
O	progression	progression	NN	I-NP
O	occurred	occur	VBD	B-VP
O	in	in	IN	B-PP
O	all	all	DT	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	tumors	tumor	NNS	I-NP
O	with	with	IN	B-PP
B-GGP	p14	p14	NN	B-NP
O	(	(	(	O
B-GGP	ARF	ARF	NN	B-NP
O	)	)	)	O
O	methylation	methylation	NN	B-NP
O	but	but	CC	O
O	less	less	JJR	B-NP
O	frequently	frequently	RB	B-ADVP
O	(	(	(	O
O	50	50	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	lesions	lesion	NNS	I-NP
O	with	with	IN	B-PP
B-GGP	MGMT	MGMT	NN	B-NP
O	methylation	methylation	NN	I-NP
O	.	.	.	O

O	On	On	IN	B-PP
O	analysis	analysis	NN	B-NP
O	of	of	IN	B-PP
O	their	their	PRP$	B-NP
O	respective	respective	JJ	I-NP
O	recurrent	recurrent	JJ	I-NP
O	tumors	tumor	NNS	I-NP
O	,	,	,	O
O	five	five	CD	B-NP
O	of	of	IN	B-PP
O	six	six	CD	B-NP
O	patients	patient	NNS	I-NP
O	whose	whose	WP$	B-NP
O	primary	primary	JJ	I-NP
O	low	low	JJ	I-NP
O	-	-	HYPH	I-NP
O	grade	grade	NN	I-NP
O	tumors	tumor	NNS	I-NP
O	carried	carry	VBD	B-VP
B-GGP	p14	p14	NN	B-NP
O	(	(	(	O
B-GGP	ARF	ARF	NN	B-NP
O	)	)	)	O
O	methylation	methylation	NN	B-NP
O	exhibited	exhibit	VBD	B-VP
O	homozygous	homozygous	JJ	B-NP
O	co	co	AFX	I-NP
O	-	-	HYPH	I-NP
O	deletions	deletion	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	p14	p14	NN	I-NP
O	(	(	(	O
B-GGP	ARF	ARF	NN	B-NP
O	)	)	)	O
O	,	,	,	O
B-GGP	p15	p15	NN	B-NP
O	(	(	(	O
B-GGP	INK4b	INK4b	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	p16	p16	NN	B-NP
O	(	(	(	O
B-GGP	INK4a	INK4a	NN	B-NP
O	)	)	)	O
O	genes	gene	NNS	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	were	be	VBD	B-VP
O	restricted	restrict	VBN	I-VP
O	to	to	TO	B-PP
O	glioblastoma	glioblastoma	NN	B-NP
O	as	as	IN	B-PP
O	the	the	DT	B-NP
O	most	most	RBS	I-NP
O	malignant	malignant	JJ	I-NP
O	end	end	NN	I-NP
O	point	point	NN	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	findings	finding	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	p14	p14	NN	B-NP
O	(	(	(	O
B-GGP	ARF	ARF	NN	B-NP
O	)	)	)	O
O	hypermethylation	hypermethylation	NN	B-NP
O	and	and	CC	O
B-GGP	MGMT	MGMT	NN	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	constitute	constitute	VBP	B-VP
O	distinct	distinct	JJ	B-NP
O	molecular	molecular	JJ	I-NP
O	pathways	pathway	NNS	I-NP
O	of	of	IN	B-PP
O	astrocytoma	astrocytoma	NN	B-NP
O	progression	progression	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	could	could	MD	B-VP
O	differ	differ	VB	I-VP
O	in	in	IN	B-PP
O	biological	biological	JJ	B-NP
O	behavior	behavior	NN	I-NP
O	and	and	CC	O
O	clinical	clinical	JJ	B-NP
O	outcome	outcome	NN	I-NP
O	.	.	.	O

O	Mechanisms	Mechanism	NNS	B-NP
O	of	of	IN	B-PP
O	ceramide	ceramide	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	repression	repression	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	human	human	JJ	I-NP
B-GGP	telomerase	telomerase	NN	I-NP
I-GGP	reverse	reverse	JJ	I-NP
I-GGP	transcriptase	transcriptase	NN	I-NP
O	promoter	promoter	NN	I-NP
O	via	via	IN	B-PP
O	deacetylation	deacetylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	Sp3	Sp3	NN	B-NP
O	by	by	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	deacetylase	deacetylase	NN	I-NP
I-GGP	1	1	CD	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	distinct	distinct	JJ	B-NP
O	roles	role	NNS	I-NP
O	of	of	IN	B-PP
O	de	de	FW	B-NP
O	novo	novo	FW	I-NP
O	-	-	HYPH	B-NP
O	generated	generate	VBN	B-NP
O	endogenous	endogenous	JJ	I-NP
O	ceramides	ceramide	NNS	I-NP
O	and	and	CC	I-NP
O	mechanisms	mechanism	NNS	I-NP
O	by	by	IN	B-PP
O	which	which	WDT	B-NP
O	deacetylated	deacetylate	VBN	B-NP
B-GGP	Sp3	Sp3	NN	I-NP
O	regulates	regulate	VBZ	B-VP
O	the	the	DT	B-NP
B-GGP	hTERT	hTERT	NN	I-NP
O	promoter	promoter	NN	I-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	response	response	NN	I-PP
O	to	to	TO	I-PP
O	ceramide	ceramide	NN	B-NP
O	signaling	signaling	NN	I-NP
O	were	be	VBD	B-VP
O	explored	explore	VBN	I-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	generation	generation	NN	I-NP
O	of	of	IN	B-PP
O	C18	C18	NN	B-NP
O	-	-	HYPH	B-NP
O	ceramide	ceramide	NN	I-NP
O	via	via	IN	B-PP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	ceramide	ceramide	NN	B-NP
I-GGP	synthase	synthase	NN	I-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
B-GGP	CerS1	CerS1	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
O	not	not	RB	O
O	C16	C16	NN	B-NP
O	-	-	HYPH	O
O	ceramide	ceramide	NN	B-NP
O	by	by	IN	B-PP
B-GGP	CerS5	CerS5	NN	B-NP
O	or	or	CC	I-NP
B-GGP	CerS6	CerS6	NN	I-NP
O	expression	expression	NN	I-NP
O	,	,	,	O
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	repression	repression	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	hTERT	hTERT	NN	I-NP
O	promoter	promoter	NN	I-NP
O	via	via	IN	B-PP
O	deacetylation	deacetylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	Sp3	Sp3	NN	B-NP
O	by	by	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	deacetylase	deacetylase	NN	I-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
B-GGP	HDAC1	HDAC1	NN	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	A549	A549	NN	B-NP
O	human	human	JJ	I-NP
O	lung	lung	NN	I-NP
O	adenocarcinoma	adenocarcinoma	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Then	Then	RB	B-NP
O	roles	role	NNS	I-NP
O	and	and	CC	I-NP
O	mechanisms	mechanism	NNS	I-NP
O	of	of	IN	B-PP
O	action	action	NN	B-NP
O	of	of	IN	B-PP
O	ceramide	ceramide	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	deacetylation	deacetylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Sp3	Sp3	NN	B-NP
O	in	in	IN	B-PP
O	inhibiting	inhibit	VBG	B-VP
O	the	the	DT	B-NP
B-GGP	hTERT	hTERT	NN	I-NP
O	promoter	promoter	NN	I-NP
O	were	be	VBD	B-VP
O	determined	determine	VBN	I-VP
O	using	use	VBG	B-VP
O	constitutively	constitutively	RB	B-NP
O	deacetylated	deacetylate	VBN	I-NP
O	or	or	CC	I-NP
O	acetylated	acetylate	VBN	I-NP
B-GGP	Sp3	Sp3	NN	I-NP
O	mutants	mutant	NNS	I-NP
O	at	at	IN	B-PP
O	lysine	lysine	NN	B-NP
O	(	(	(	O
O	K	K	NN	B-NP
O	)	)	)	O
O	551	551	CD	B-NP
O	.	.	.	O

O	Expression	Expression	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	deacetylated	deacetylate	VBN	I-NP
B-GGP	Sp3	Sp3	NN	I-NP
O	mutant	mutant	NN	I-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	repression	repression	NN	B-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	its	its	PRP$	B-NP
O	acetylated	acetylate	VBN	I-NP
O	mutant	mutant	NN	I-NP
O	induced	induce	VBD	B-VP
O	basal	basal	JJ	B-NP
B-GGP	hTERT	hTERT	NN	I-NP
O	promoter	promoter	NN	I-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	Drosophila	Drosophila	FW	B-NP
O	S2	S2	NN	I-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	do	do	VBP	B-VP
O	not	not	RB	I-VP
O	express	express	VB	I-VP
O	any	any	DT	B-NP
O	endogenous	endogenous	JJ	I-NP
B-GGP	Sp3	Sp3	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	in	in	IN	B-PP
O	A549	A549	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Remarkably	Remarkably	RB	B-ADVP
O	,	,	,	O
O	chromatin	chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	data	datum	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
O	acetylated	acetylate	VBN	B-NP
B-GGP	Sp3	Sp3	NN	I-NP
O	mutant	mutant	NN	I-NP
O	(	(	(	O
O	K551Q	K551Q	NN	B-NP
O	-	-	HYPH	O
B-GGP	Sp3	Sp3	NN	B-NP
O	)	)	)	O
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	bind	bind	VB	I-VP
O	whereas	whereas	IN	B-PP
O	deacetylated	deacetylate	VBN	B-NP
B-GGP	Sp3	Sp3	NN	I-NP
O	(	(	(	O
O	K551R	K551R	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	Sp3	Sp3	NN	I-NP
O	)	)	)	O
O	mutant	mutant	NN	B-NP
O	bound	bind	VBD	B-VP
O	strongly	strongly	RB	B-ADVP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	promoter	promoter	NN	I-NP
O	DNA	DNA	NN	I-NP
O	,	,	,	O
O	resulting	result	VBG	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	recruitment	recruitment	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	deacetylase	deacetylase	NN	I-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
B-GGP	HDAC1	HDAC1	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	inhibition	inhibition	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	association	association	NN	I-NP
O	of	of	IN	B-PP
O	RNA	RNA	NN	B-NP
O	polymerase	polymerase	NN	I-NP
O	II	II	CD	I-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	promoter	promoter	NN	I-NP
O	.	.	.	O

O	Mechanistically	Mechanistically	RB	B-ADVP
O	,	,	,	O
O	increased	increase	VBN	B-NP
O	generation	generation	NN	I-NP
O	of	of	IN	B-PP
O	C18	C18	NN	B-NP
O	-	-	HYPH	B-NP
O	ceramide	ceramide	NN	I-NP
O	by	by	IN	B-PP
B-GGP	hCerS1	hCerS1	NN	B-NP
O	expression	expression	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
O	not	not	RB	O
O	by	by	IN	B-PP
O	its	its	PRP$	B-NP
O	catalytically	catalytically	RB	I-NP
O	inactive	inactive	JJ	I-NP
O	mutant	mutant	NN	I-NP
O	,	,	,	O
O	mediated	mediate	VBD	B-VP
O	the	the	DT	B-NP
O	association	association	NN	I-NP
O	and	and	CC	I-NP
O	recruitment	recruitment	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	deacetylated	deacetylate	VBN	I-NP
B-GGP	Sp3	Sp3	NN	I-NP
O	/	/	SYM	B-NP
B-GGP	HDAC1	HDAC1	NN	I-NP
O	complex	complex	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
B-GGP	hTERT	hTERT	NN	I-NP
O	promoter	promoter	NN	I-NP
O	DNA	DNA	NN	I-NP
O	,	,	,	O
O	resulting	result	VBG	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	local	local	JJ	I-NP
B-GGP	histone	histone	NN	I-NP
I-GGP	H3	H3	NN	I-NP
O	deacetylation	deacetylation	NN	I-NP
O	and	and	CC	I-NP
O	repression	repression	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	promoter	promoter	NN	I-NP
O	.	.	.	O

O	Drosophila	Drosophila	FW	B-NP
B-GGP	dSet2	dSet2	NN	I-NP
O	functions	function	NNS	I-NP
O	in	in	IN	B-PP
B-GGP	H3	H3	NN	B-NP
O	-	-	HYPH	B-NP
O	K36	K36	NN	I-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	O
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	development	development	NN	B-NP
O	.	.	.	O

O	Lysine	Lysine	NN	B-NP
O	methylation	methylation	NN	I-NP
O	has	have	VBZ	B-VP
O	important	important	JJ	B-NP
O	functions	function	NNS	I-NP
O	in	in	IN	B-PP
O	biological	biological	JJ	B-NP
O	processes	process	NNS	I-NP
O	that	that	WDT	B-NP
O	range	range	VBP	B-VP
O	from	from	IN	B-PP
O	heterochromatin	heterochromatin	NN	B-NP
O	formation	formation	NN	I-NP
O	to	to	TO	B-PP
O	transcription	transcription	NN	B-NP
O	regulation	regulation	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	Drosophila	Drosophila	FW	B-NP
B-GGP	dSet2	dSet2	NN	I-NP
O	encodes	encode	VBZ	B-VP
O	a	a	DT	B-NP
O	developmentally	developmentally	RB	I-NP
O	essential	essential	JJ	I-NP
B-GGP	histone	histone	NN	I-NP
I-GGP	H3	H3	NN	I-NP
O	lysine	lysine	NN	I-NP
O	36	36	CD	I-NP
O	(	(	(	O
O	K36	K36	NN	B-NP
O	)	)	)	O
O	methyltransferase	methyltransferase	NN	B-NP
O	.	.	.	O

O	Larvae	Larvae	NNP	B-NP
O	subjected	subject	VBD	B-VP
O	to	to	TO	B-PP
O	RNA	RNA	NN	B-NP
O	interference	interference	NN	I-NP
O	-	-	HYPH	B-VP
O	mediated	mediate	VBN	I-VP
O	(	(	(	O
O	RNAi	RNAi	NN	B-NP
O	)	)	)	O
O	suppression	suppression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	dSet2	dSet2	NN	B-NP
O	lack	lack	VBP	B-VP
B-GGP	dSet2	dSet2	NN	B-NP
O	expression	expression	NN	I-NP
O	and	and	CC	O
B-GGP	H3	H3	NN	B-NP
O	-	-	HYPH	B-NP
O	K36	K36	NN	I-NP
O	methylation	methylation	NN	I-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
B-GGP	dSet2	dSet2	NN	B-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	sole	sole	JJ	I-NP
O	enzyme	enzyme	NN	I-NP
O	responsible	responsible	JJ	B-ADJP
O	for	for	IN	B-PP
O	this	this	DT	B-NP
O	modification	modification	NN	I-NP
O	in	in	IN	B-PP
O	Drosophila	Drosophila	NNP	B-NP
O	melanogaster	melanogaster	NN	I-NP
O	.	.	.	O

B-GGP	dSet2	dSet2	NN	B-NP
O	RNAi	RNAi	NN	I-NP
O	blocks	block	VBZ	B-VP
O	puparium	puparium	NN	B-NP
O	formation	formation	NN	I-NP
O	and	and	CC	O
O	adult	adult	JJ	B-NP
O	development	development	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	causes	cause	VBZ	B-VP
O	partial	partial	JJ	O
O	(	(	(	O
O	blister	blister	JJ	B-ADJP
O	)	)	)	O
O	separation	separation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	dorsal	dorsal	JJ	I-NP
O	and	and	CC	I-NP
O	ventral	ventral	JJ	I-NP
O	wing	wing	NN	I-NP
O	epithelia	epithelia	NN	I-NP
O	,	,	,	O
O	defects	defect	VBZ	B-VP
O	suggesting	suggest	VBG	I-VP
O	a	a	DT	B-NP
O	failure	failure	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	ecdysone	ecdysone	NN	I-NP
O	-	-	HYPH	B-VP
O	controlled	control	VBN	B-NP
O	genetic	genetic	JJ	I-NP
O	program	program	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	transheterozygous	transheterozygous	JJ	I-NP
B-GGP	EcR	EcR	NN	I-NP
O	null	null	JJ	I-NP
O	mutation	mutation	NN	I-NP
O	/	/	SYM	B-NP
B-GGP	dSet2	dSet2	NN	I-NP
O	RNAi	RNAi	NN	I-NP
O	combination	combination	NN	I-NP
O	produces	produce	VBZ	B-VP
O	a	a	DT	B-NP
O	complete	complete	JJ	I-NP
O	(	(	(	O
O	balloon	balloon	NN	B-NP
O	)	)	)	O
O	separation	separation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	wing	wing	NN	I-NP
O	surfaces	surface	NNS	I-NP
O	,	,	,	O
O	revealing	reveal	VBG	B-VP
O	a	a	DT	B-NP
O	genetic	genetic	JJ	I-NP
O	interaction	interaction	NN	I-NP
O	between	between	IN	B-PP
B-GGP	EcR	EcR	NN	B-NP
O	and	and	CC	I-NP
B-GGP	dSet2	dSet2	NN	I-NP
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	immunoprecipitation	immunoprecipitation	NN	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	dSet2	dSet2	NN	B-NP
O	associates	associate	VBZ	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	hyperphosphorylated	hyperphosphorylate	VBN	I-NP
O	form	form	NN	I-NP
O	of	of	IN	B-PP
O	RNA	RNA	NN	B-NP
O	polymerase	polymerase	NN	I-NP
O	II	II	CD	I-NP
O	(	(	(	O
O	RNAPII	RNAPII	NN	B-NP
O	)	)	)	O
O	.	.	.	O

B-GGP	VIPL	VIPL	NN	B-NP
O	has	have	VBZ	B-VP
O	sugar	sugar	NN	B-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-NP
O	activity	activity	NN	I-NP
O	specific	specific	JJ	B-ADJP
O	for	for	IN	B-PP
O	high	high	JJ	B-NP
O	-	-	HYPH	I-NP
O	mannose	mannose	NN	I-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	glycans	glycan	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	glucosylation	glucosylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	alpha1	alpha1	NN	I-NP
O	,	,	,	O
O	2	2	CD	B-NP
O	mannotriosyl	mannotriosyl	NN	I-NP
O	branch	branch	NN	I-NP
O	blocks	block	VBZ	B-VP
O	its	its	PRP$	B-NP
O	binding	binding	NN	I-NP
O	.	.	.	O

B-GGP	VIP36	VIP36	CD	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	like	like	JJ	I-NP
I-GGP	protein	protein	NN	I-NP
O	(	(	(	O
B-GGP	VIPL	VIPL	NN	B-NP
O	)	)	)	O
O	was	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	as	as	IN	B-PP
O	an	an	DT	B-NP
O	endoplasmic	endoplasmic	JJ	I-NP
O	reticulum	reticulum	NN	I-NP
O	(	(	(	O
O	ER	ER	NN	B-NP
O	)	)	)	O
O	resident	resident	JJ	B-NP
O	protein	protein	NN	I-NP
O	with	with	IN	B-PP
O	homology	homology	NN	B-NP
O	to	to	TO	B-PP
B-GGP	VIP36	VIP36	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	cargo	cargo	NN	I-NP
O	receptor	receptor	NN	I-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	transport	transport	NN	I-NP
O	of	of	IN	B-PP
O	glycoproteins	glycoprotein	NNS	B-NP
O	within	within	IN	B-PP
O	cells	cell	NNS	B-NP
O	.	.	.	O

O	Although	Although	IN	B-SBAR
B-GGP	VIPL	VIPL	NN	B-NP
O	is	be	VBZ	B-VP
O	structurally	structurally	RB	B-ADJP
O	similar	similar	JJ	I-ADJP
O	to	to	TO	B-PP
B-GGP	VIP36	VIP36	NN	B-NP
O	,	,	,	O
B-GGP	VIPL	VIPL	NN	B-NP
O	is	be	VBZ	B-VP
O	thought	think	VBN	I-VP
O	not	not	RB	O
O	to	to	TO	B-VP
O	be	be	VB	I-VP
O	a	a	DT	B-NP
O	lectin	lectin	NN	I-NP
O	,	,	,	O
O	because	because	IN	B-SBAR
O	its	its	PRP$	B-NP
O	sugar	sugar	NN	I-NP
O	-	-	HYPH	I-NP
O	binding	binding	NN	B-NP
O	activity	activity	NN	I-NP
O	has	have	VBZ	B-VP
O	not	not	RB	I-VP
O	been	be	VBN	I-VP
O	detected	detect	VBN	I-VP
O	in	in	IN	B-PP
O	several	several	JJ	B-NP
O	experiments	experiment	NNS	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	recombinant	recombinant	JJ	B-NP
O	soluble	soluble	JJ	I-NP
B-GGP	VIPL	VIPL	NN	I-NP
O	proteins	protein	NNS	I-NP
O	(	(	(	O
B-GGP	sVIPL	sVIPL	NN	B-NP
O	)	)	)	O
O	were	be	VBD	B-VP
O	expressed	express	VBN	I-VP
O	in	in	IN	B-PP
O	Escherichia	Escherichia	NNP	B-NP
O	coli	coli	NNP	I-NP
O	,	,	,	O
O	biotinylated	biotinylate	VBN	B-VP
O	with	with	IN	B-PP
B-GGP	biotin	biotin	NN	B-NP
I-GGP	ligase	ligase	NN	I-NP
O	and	and	CC	O
O	oligomerized	oligomerize	VBN	B-VP
O	with	with	IN	B-PP
O	R	R	NN	B-NP
O	-	-	HYPH	O
O	phycoerythrin	phycoerythrin	NN	B-NP
O	(	(	(	O
O	PE	PE	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	O
O	labeled	label	VBN	B-NP
B-GGP	streptavidin	streptavidin	NN	I-NP
O	(	(	(	O
B-GGP	SA	SA	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	As	As	IN	B-SBAR
O	measured	measure	VBN	B-VP
O	with	with	IN	B-PP
O	flow	flow	NN	B-NP
O	cytometry	cytometry	NN	I-NP
O	,	,	,	O
O	PE	PE	NN	B-NP
O	-	-	HYPH	B-VP
O	labeled	label	VBN	B-NP
B-GGP	sVIPL	sVIPL	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	SA	SA	NN	I-NP
O	bound	bind	VBN	B-VP
O	to	to	TO	B-PP
O	deoxymannojirimycin	deoxymannojirimycin	NN	B-NP
O	(	(	(	O
O	DMJ	DMJ	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	or	or	CC	O
O	kifunensine	kifunensine	NN	B-NP
O	(	(	(	O
O	KIF	KIF	NN	B-NP
O	)	)	)	O
O	-	-	:	O
O	but	but	CC	O
O	not	not	RB	O
O	to	to	TO	B-PP
O	swainsonine	swainsonine	NN	B-NP
O	(	(	(	O
O	SW	SW	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	treated	treat	VBN	I-NP
O	HeLaS3	HeLaS3	NN	I-NP
O	cells	cell	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	I-PP
O	presence	presence	NN	I-PP
O	of	of	IN	I-PP
O	calcium	calcium	NN	B-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	surface	surface	NN	I-NP
O	plasmon	plasmon	NN	I-NP
O	resonance	resonance	NN	I-NP
O	analysis	analysis	NN	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	avidity	avidity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	sVIPL	sVIPL	NN	B-NP
O	was	be	VBD	B-VP
O	enhanced	enhance	VBN	I-VP
O	after	after	IN	B-SBAR
O	it	it	PRP	B-NP
O	formed	form	VBD	B-VP
O	a	a	DT	B-NP
O	complex	complex	NN	I-NP
O	with	with	IN	B-PP
B-GGP	SA	SA	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
O	PE	PE	NN	B-NP
O	-	-	HYPH	O
O	labeled	label	VBN	B-NP
B-GGP	sVIPL	sVIPL	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	SA	SA	NN	I-NP
O	was	be	VBD	B-VP
O	abrogated	abrogate	VBN	I-VP
O	by	by	IN	B-PP
B-GGP	endo	endo	NN	B-NP
I-GGP	beta	beta	SYM	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	N	N	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	acetylglucosaminidase	acetylglucosaminidase	NN	I-NP
I-GGP	H	H	NN	I-NP
O	treatment	treatment	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	DMJ	DMJ	NN	I-NP
O	-	-	HYPH	B-NP
O	or	or	CC	I-NP
O	KIF	KIF	NN	I-NP
O	-	-	HYPH	O
O	treated	treat	VBN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Competition	Competition	NN	B-NP
O	with	with	IN	B-PP
O	several	several	JJ	B-NP
O	high	high	JJ	I-NP
O	-	-	HYPH	I-NP
O	mannose	mannose	NN	I-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	glycans	glycan	NNS	I-NP
O	inhibited	inhibit	VBD	B-VP
B-GGP	VIPL	VIPL	NN	B-NP
O	binding	binding	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	indicated	indicate	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	VIPL	VIPL	NN	B-NP
O	recognizes	recognize	VBZ	B-VP
O	the	the	DT	B-NP
O	Manalpha1	Manalpha1	NN	I-NP
O	-	-	HYPH	B-NP
O	2Manalpha1	2Manalpha1	NN	I-NP
O	-	-	HYPH	I-NP
O	2Man	2Man	NN	I-NP
O	sequence	sequence	NN	I-NP
O	.	.	.	O

O	Glucosylation	Glucosylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	outer	outer	JJ	I-NP
O	mannose	mannose	NN	I-NP
O	residue	residue	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	portion	portion	NN	I-NP
O	decreased	decrease	VBD	B-VP
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	.	.	.	O

O	Although	Although	IN	B-SBAR
O	the	the	DT	B-NP
O	biochemical	biochemical	JJ	I-NP
O	characteristics	characteristic	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	VIPL	VIPL	NN	B-NP
O	are	be	VBP	B-VP
O	similar	similar	JJ	B-ADJP
O	to	to	TO	B-PP
O	those	those	DT	B-NP
O	of	of	IN	B-PP
B-GGP	VIP36	VIP36	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	sugar	sugar	NN	I-NP
O	-	-	HYPH	O
O	binding	binding	NN	B-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	VIPL	VIPL	NN	B-NP
O	was	be	VBD	B-VP
O	stronger	strong	JJR	B-ADJP
O	at	at	IN	B-PP
O	neutral	neutral	JJ	B-NP
O	pH	pH	NN	I-NP
O	,	,	,	O
O	corresponding	correspond	VBG	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	pH	pH	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	lumen	lumen	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	ER	ER	NN	I-NP
O	,	,	,	O
O	than	than	IN	B-PP
O	under	under	IN	B-PP
O	acidic	acidic	JJ	B-NP
O	conditions	condition	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
O	snail	snail	NN	I-NP
O	mediates	mediate	VBZ	B-VP
O	epithelial	epithelial	JJ	B-ADJP
O	to	to	TO	B-PP
O	mesenchymal	mesenchymal	JJ	B-NP
O	transitions	transition	NNS	I-NP
O	by	by	IN	B-PP
O	repression	repression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	estrogen	estrogen	NN	B-NP
I-GGP	receptor	receptor	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	alpha	alpha	SYM	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	estrogen	estrogen	NN	I-NP
I-GGP	receptor	receptor	NN	I-NP
I-GGP	(	(	(	O
I-GGP	ER	ER	NN	B-NP
I-GGP	)	)	)	O
I-GGP	-	-	HYPH	O
I-GGP	alpha	alpha	SYM	O
O	(	(	(	O
B-GGP	ESR1	ESR1	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	key	key	JJ	I-NP
O	regulatory	regulatory	JJ	I-NP
O	molecule	molecule	NN	I-NP
O	in	in	IN	B-PP
O	mammary	mammary	JJ	B-NP
O	epithelial	epithelial	JJ	I-NP
O	cell	cell	NN	I-NP
O	development	development	NN	I-NP
O	.	.	.	O

O	Loss	Loss	NN	B-NP
O	of	of	IN	B-PP
B-GGP	ER	ER	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	alpha	alpha	NN	I-NP
O	in	in	IN	B-PP
O	breast	breast	NN	B-NP
O	cancer	cancer	NN	I-NP
O	is	be	VBZ	B-VP
O	correlated	correlate	VBN	I-VP
O	with	with	IN	B-PP
O	poor	poor	JJ	B-NP
O	prognosis	prognosis	NN	I-NP
O	,	,	,	O
O	increased	increase	VBD	B-VP
O	recurrence	recurrence	NN	B-NP
O	after	after	IN	B-PP
O	treatment	treatment	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	an	an	DT	B-NP
O	elevated	elevate	VBN	I-NP
O	incidence	incidence	NN	I-NP
O	of	of	IN	B-PP
O	metastasis	metastasis	NN	B-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	proposed	propose	VBN	I-NP
O	molecular	molecular	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	by	by	IN	B-PP
O	which	which	WDT	B-NP
B-GGP	ER	ER	NN	B-VP
I-GGP	-	-	HYPH	O
I-GGP	alpha	alpha	SYM	B-NP
O	acts	act	VBZ	B-VP
O	to	to	TO	I-VP
O	constrain	constrain	VB	I-VP
O	invasive	invasive	JJ	B-NP
O	growth	growth	NN	I-NP
O	in	in	IN	B-PP
O	breast	breast	NN	B-NP
O	cancer	cancer	NN	I-NP
O	cells	cell	NNS	I-NP
O	involves	involve	VBZ	B-VP
O	direct	direct	JJ	B-NP
O	,	,	,	I-NP
B-GGP	ER	ER	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	alpha	alpha	SYM	O
O	-	-	HYPH	O
O	dependent	dependent	JJ	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	metastasis	metastasis	NN	B-NP
O	-	-	HYPH	O
O	associated	associate	VBN	B-VP
O	protein	protein	NN	B-NP
O	3	3	CD	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	cell	cell	NN	I-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	-	-	HYPH	I-NP
O	specific	specific	JJ	I-NP
O	component	component	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Mi	Mi	NNP	I-NP
O	-	-	HYPH	I-NP
O	2	2	CD	I-NP
O	/	/	SYM	I-NP
O	NuRD	NuRD	NN	I-NP
O	chromatin	chromatin	NN	I-NP
O	remodeling	remodeling	NN	I-NP
O	complex	complex	NN	I-NP
O	.	.	.	O

B-GGP	MTA3	MTA3	NN	B-NP
O	in	in	IN	B-PP
O	turn	turn	NN	B-NP
O	represses	repress	VBZ	B-VP
O	expression	expression	NN	B-NP
O	of	of	IN	B-PP
O	Snail	Snail	NNP	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
O	linked	link	VBN	B-VP
O	to	to	TO	B-PP
O	epithelial	epithelial	JJ	B-ADJP
O	to	to	TO	B-PP
O	mesenchymal	mesenchymal	JJ	B-NP
O	transition	transition	NN	I-NP
O	and	and	CC	I-NP
O	cancer	cancer	NN	I-NP
O	metastasis	metastasis	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	elucidate	elucidate	VB	I-VP
O	its	its	PRP$	B-NP
O	role	role	NN	I-NP
O	(	(	(	I-NP
O	s	s	NNS	I-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	epithelial	epithelial	JJ	B-ADJP
O	to	to	TO	B-PP
O	mesenchymal	mesenchymal	JJ	B-NP
O	transition	transition	NN	I-NP
O	(	(	(	O
O	EMT	EMT	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	we	we	PRP	B-NP
O	expressed	express	VBD	B-VP
O	Snail	Snail	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	noninvasive	noninvasive	JJ	I-NP
O	,	,	,	I-NP
B-GGP	ER	ER	NN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	alpha	alpha	SYM	I-NP
O	-	-	HYPH	I-NP
O	positive	positive	JJ	B-NP
O	MCF	MCF	NN	I-NP
O	-	-	HYPH	B-NP
O	7	7	CD	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	.	.	.	O

O	Snail	Snail	NN	B-NP
O	expression	expression	NN	I-NP
O	led	lead	VBD	B-VP
O	to	to	TO	B-PP
O	decreased	decrease	VBN	B-NP
O	cell	cell	NN	I-NP
O	-	-	HYPH	B-NP
O	cell	cell	NN	I-NP
O	adhesion	adhesion	NN	I-NP
O	and	and	CC	O
O	increased	increase	VBN	B-NP
O	cell	cell	NN	I-NP
O	invasiveness	invasiveness	NN	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	observed	observe	VBD	B-VP
O	loss	loss	NN	B-NP
O	of	of	IN	B-PP
B-GGP	ER	ER	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	alpha	alpha	SYM	B-NP
O	expression	expression	NN	B-NP
O	at	at	IN	B-PP
O	both	both	CC	O
O	the	the	DT	B-NP
O	RNA	RNA	NN	I-NP
O	and	and	CC	I-NP
O	protein	protein	NN	I-NP
O	level	level	NN	I-NP
O	that	that	WDT	B-NP
O	was	be	VBD	B-VP
O	accompanied	accompany	VBN	I-VP
O	by	by	IN	B-PP
O	direct	direct	JJ	B-NP
O	interaction	interaction	NN	I-NP
O	of	of	IN	B-PP
O	Snail	Snail	NN	B-NP
O	with	with	IN	B-PP
O	regulatory	regulatory	JJ	B-NP
O	DNA	DNA	NN	I-NP
O	sequences	sequence	NNS	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ESR1	ESR1	NN	I-NP
O	locus	locus	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	consequence	consequence	NN	I-NP
O	of	of	IN	B-PP
O	loss	loss	NN	B-NP
O	of	of	IN	B-PP
B-GGP	ER	ER	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	alpha	alpha	SYM	B-NP
O	function	function	NN	I-NP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	system	system	NN	I-NP
O	was	be	VBD	B-VP
O	the	the	DT	B-NP
O	increased	increase	VBN	I-NP
O	abundance	abundance	NN	I-NP
O	of	of	IN	B-PP
O	key	key	JJ	B-NP
O	components	component	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	TGF	TGF	NN	I-NP
O	-	-	HYPH	O
O	beta	beta	SYM	B-NP
O	signaling	signaling	NN	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
O	cross	cross	AFX	B-NP
O	-	-	HYPH	I-NP
O	talk	talk	NN	B-NP
O	among	among	IN	B-PP
B-GGP	ER	ER	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	alpha	alpha	SYM	B-NP
O	,	,	,	O
O	Snail	Snail	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	TGF	TGF	NN	I-NP
O	-	-	HYPH	O
O	beta	beta	SYM	B-NP
O	pathway	pathway	NN	B-NP
O	appears	appear	VBZ	B-VP
O	to	to	TO	I-VP
O	control	control	VB	I-VP
O	critical	critical	JJ	B-NP
O	phenotypic	phenotypic	JJ	I-NP
O	properties	property	NNS	I-NP
O	of	of	IN	B-PP
O	breast	breast	NN	B-NP
O	cancer	cancer	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	DNA	DNA	NN	B-NP
O	stool	stool	NN	I-NP
O	test	test	NN	I-NP
O	for	for	IN	B-PP
O	colorectal	colorectal	JJ	B-NP
O	cancer	cancer	NN	I-NP
O	:	:	:	O
O	hypermethylation	hypermethylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	secreted	secrete	VBN	I-NP
I-GGP	frizzled	frizzle	VBN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	related	relate	VBN	B-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	gene	gene	NN	I-NP
O	.	.	.	O

O	PURPOSE	PURPOSE	NN	B-NP
O	:	:	:	O
O	To	To	TO	B-VP
O	investigate	investigate	VB	I-VP
O	a	a	DT	B-NP
O	potential	potential	JJ	I-NP
O	mode	mode	NN	I-NP
O	of	of	IN	B-PP
O	noninvasive	noninvasive	JJ	B-NP
O	screening	screening	NN	I-NP
O	for	for	IN	B-PP
O	colorectal	colorectal	JJ	B-NP
O	cancer	cancer	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	evaluated	evaluate	VBD	B-VP
O	the	the	DT	B-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	secreted	secrete	VBN	I-NP
I-GGP	frizzled	frizzle	VBN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	related	relate	VBN	B-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	gene	gene	NN	I-NP
O	promoter	promoter	NN	I-NP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	stool	stool	NN	I-NP
O	DNA	DNA	NN	I-NP
O	.	.	.	O

O	METHODS	METHODS	NNS	B-NP
O	:	:	:	O
O	In	In	IN	B-PP
O	stool	stool	NN	B-NP
O	samples	sample	NNS	I-NP
O	from	from	IN	B-PP
O	36	36	CD	B-NP
O	patients	patient	NNS	I-NP
O	with	with	IN	B-PP
O	colorectal	colorectal	JJ	B-NP
O	neoplasia	neoplasia	NN	I-NP
O	(	(	(	O
O	7	7	CD	B-NP
O	adenoma	adenoma	NN	I-NP
O	,	,	,	O
O	29	29	CD	B-NP
O	colorectal	colorectal	JJ	I-NP
O	cancer	cancer	NN	I-NP
O	)	)	)	O
O	and	and	CC	O
O	17	17	CD	B-NP
O	healthy	healthy	JJ	I-NP
O	control	control	NN	I-NP
O	subjects	subject	NNS	I-NP
O	,	,	,	O
O	isolated	isolate	VBN	B-NP
O	DNA	DNA	NN	I-NP
O	was	be	VBD	B-VP
O	treated	treat	VBN	I-VP
O	with	with	IN	B-PP
O	sodium	sodium	NN	B-NP
O	bisulfite	bisulfite	NN	I-NP
O	and	and	CC	O
O	analyzed	analyze	VBN	B-VP
O	by	by	IN	B-PP
O	methylation	methylation	NN	B-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	polymerase	polymerase	NN	I-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	with	with	IN	B-PP
O	primers	primer	NNS	B-NP
O	specific	specific	JJ	B-ADJP
O	for	for	IN	B-PP
O	methylated	methylate	VBN	B-NP
O	or	or	CC	I-NP
O	unmethylated	unmethylate	VBN	I-NP
O	promoter	promoter	NN	I-NP
O	sequences	sequence	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	secreted	secrete	VBN	I-NP
I-GGP	frizzled	frizzle	VBN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	related	relate	VBN	B-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	gene	gene	NN	I-NP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
O	Hypermethylation	Hypermethylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	secreted	secrete	VBN	I-NP
I-GGP	frizzled	frizzle	VBN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	related	relate	VBN	B-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	promoter	promoter	NN	I-NP
O	was	be	VBD	B-VP
O	present	present	JJ	B-ADJP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	stool	stool	NN	I-NP
O	DNA	DNA	NN	I-NP
O	of	of	IN	B-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
O	adenoma	adenoma	NN	B-NP
O	and	and	CC	O
O	colorectal	colorectal	JJ	B-NP
O	cancer	cancer	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	sensitivity	sensitivity	NN	I-NP
O	of	of	IN	B-PP
O	89	89	CD	B-NP
O	percent	percent	NN	I-NP
O	and	and	CC	I-NP
O	specificity	specificity	NN	I-NP
O	of	of	IN	B-PP
O	86	86	CD	B-NP
O	percent	percent	NN	I-NP
O	were	be	VBD	B-VP
O	achieved	achieve	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	detection	detection	NN	I-NP
O	of	of	IN	B-PP
O	colorectal	colorectal	JJ	B-NP
O	neoplasia	neoplasia	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	difference	difference	NN	I-NP
O	in	in	IN	B-PP
O	hypermethylation	hypermethylation	NN	B-NP
O	status	status	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	secreted	secrete	VBN	I-NP
I-GGP	frizzled	frizzle	VBN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	related	relate	VBN	B-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	promoter	promoter	NN	I-NP
O	between	between	IN	B-PP
O	the	the	DT	B-NP
O	patients	patient	NNS	I-NP
O	with	with	IN	B-PP
O	colorectal	colorectal	JJ	B-NP
O	neoplasia	neoplasia	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	control	control	NN	I-NP
O	group	group	NN	I-NP
O	was	be	VBD	B-VP
O	statistically	statistically	RB	B-ADJP
O	highly	highly	RB	I-ADJP
O	significant	significant	JJ	I-ADJP
O	(	(	(	O
O	P	P	NN	B-NP
O	<	<	SYM	B-ADJP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	001	001	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	Adenoma	Adenoma	NN	B-NP
O	and	and	CC	O
O	early	early	JJ	B-NP
O	tumor	tumor	NN	I-NP
O	Stage	Stage	NN	I-NP
O	I	I	CD	I-NP
O	(	(	(	O
O	International	International	NNP	B-NP
O	Union	Union	NNP	I-NP
O	Against	Against	NNP	I-NP
O	Cancer	Cancer	NNP	I-NP
O	)	)	)	O
O	displayed	display	VBD	B-VP
O	both	both	CC	O
O	unmethylated	unmethylate	VBN	B-VP
O	and	and	CC	O
O	methylated	methylate	VBN	B-VP
B-GGP	secreted	secrete	VBN	I-VP
I-GGP	frizzled	frizzle	VBN	I-VP
I-GGP	-	-	HYPH	O
I-GGP	related	relate	VBN	B-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	promoter	promoter	NN	I-NP
O	sequences	sequence	NNS	I-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	advanced	advance	VBN	B-NP
O	tumor	tumor	NN	I-NP
O	stages	stage	NNS	I-NP
O	showed	show	VBD	B-VP
O	only	only	RB	I-VP
O	methylated	methylate	VBN	I-VP
B-GGP	secreted	secrete	VBN	I-VP
I-GGP	frizzled	frizzle	VBN	B-VP
I-GGP	-	-	HYPH	O
I-GGP	related	relate	VBN	B-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
O	P	P	NN	B-NP
O	=	=	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	05	05	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	:	:	:	O
O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	DNA	DNA	NN	I-NP
O	stool	stool	NN	I-NP
O	test	test	NN	I-NP
O	of	of	IN	B-PP
O	hypermethylation	hypermethylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	secreted	secrete	VBN	I-NP
I-GGP	frizzled	frizzle	VBN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	related	relate	VBN	B-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	promoter	promoter	NN	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	sensitive	sensitive	JJ	I-NP
O	and	and	CC	I-NP
O	specific	specific	JJ	I-NP
O	method	method	NN	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	has	have	VBZ	B-VP
O	the	the	DT	B-NP
O	potential	potential	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	clinically	clinically	RB	I-NP
O	useful	useful	JJ	I-NP
O	test	test	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	early	early	JJ	I-NP
O	detection	detection	NN	I-NP
O	of	of	IN	B-PP
O	colorectal	colorectal	JJ	B-NP
O	cancer	cancer	NN	I-NP
O	.	.	.	O

O	Characterization	Characterization	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
B-GGP	Cullin5	Cullin5	NN	I-NP
O	binding	binding	NN	I-NP
O	domain	domain	NN	I-NP
O	in	in	IN	B-PP
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
B-GGP	Vif	Vif	NN	I-NP
O	.	.	.	O

O	Human	Human	JJ	B-NP
O	immunodeficiency	immunodeficiency	NN	I-NP
O	virus	virus	NN	I-NP
O	tyoe	tyoe	NN	I-NP
O	1	1	CD	I-NP
O	(	(	(	O
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	)	)	)	O
O	Vif	Vif	NNP	B-NP
O	counteracts	counteract	VBZ	B-VP
O	host	host	NN	B-NP
O	restriction	restriction	NN	I-NP
O	cytidine	cytidine	NN	I-NP
O	deaminase	deaminase	NN	I-NP
O	(	(	(	O
B-GGP	APOBEC3G	APOBEC3G	NN	B-NP
O	)	)	)	O
B-GGP	A3G	A3G	NN	B-NP
O	by	by	IN	B-PP
O	co	co	AFX	B-NP
O	-	-	HYPH	I-NP
O	opting	opte	VBG	B-VP
O	the	the	DT	B-NP
O	cellular	cellular	JJ	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	-	-	HYPH	B-NP
O	proteasome	proteasome	NN	I-NP
O	machinery	machinery	NN	I-NP
O	.	.	.	O

B-GGP	Vif	Vif	NNP	B-NP
O	utilizes	utilize	VBZ	B-VP
O	a	a	DT	B-NP
O	viral	viral	JJ	I-NP
O	-	-	HYPH	I-NP
O	specific	specific	JJ	I-NP
O	BC	BC	NN	I-NP
O	-	-	HYPH	I-NP
O	box	box	NN	I-NP
O	to	to	TO	B-VP
O	recruit	recruit	VB	I-VP
B-GGP	ElonginB	ElonginB	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	ElonginC	ElonginC	NN	I-NP
O	and	and	CC	O
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	zinc	zinc	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	HCCH	HCCH	NN	B-NP
O	motif	motif	NN	I-NP
O	to	to	TO	B-VP
O	recruit	recruit	VB	I-VP
B-GGP	Cullin5	Cullin5	NN	B-NP
O	(	(	(	O
B-GGP	Cul5	Cul5	NN	B-NP
O	)	)	)	O
O	to	to	TO	B-VP
O	form	form	VB	I-VP
O	an	an	DT	B-NP
O	E3	E3	NN	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	targeting	target	VBG	B-VP
B-GGP	A3G	A3G	NN	B-NP
O	for	for	IN	B-PP
O	polyubiquitination	polyubiquitination	NN	B-NP
O	and	and	CC	O
O	subsequently	subsequently	RB	B-NP
O	proteasomal	proteasomal	JJ	I-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	determine	determine	VB	I-VP
O	the	the	DT	B-NP
O	structural	structural	JJ	I-NP
O	requirements	requirement	NNS	I-NP
O	in	in	IN	B-PP
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	Vif	Vif	NN	I-NP
O	HCCH	HCCH	NN	I-NP
O	motif	motif	NN	I-NP
O	for	for	IN	B-PP
B-GGP	Cul5	Cul5	NN	B-NP
O	binding	binding	NN	I-NP
O	and	and	CC	O
B-GGP	Vif	Vif	NN	B-NP
O	function	function	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	investigated	investigate	VBD	B-VP
O	the	the	DT	B-NP
O	arrangement	arrangement	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	His	His	NN	I-NP
O	and	and	CC	I-NP
O	Cys	Cys	NN	I-NP
O	residues	residue	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	spacing	spacing	NN	I-NP
O	between	between	IN	B-PP
O	them	them	PRP	B-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	requirement	requirement	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	residues	residue	NNS	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	data	datum	NNS	I-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	exchanging	exchange	VBG	B-VP
O	Cys	Cys	NN	B-NP
O	for	for	IN	B-PP
O	His	His	NN	B-NP
O	and	and	CC	I-NP
O	vice	vice	NN	I-NP
O	versa	versa	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	highly	highly	RB	I-NP
O	conserved	conserve	VBN	I-NP
O	Zn	Zn	NN	I-NP
O	-	-	HYPH	O
O	coordinating	coordinate	VBG	B-VP
O	HCCH	HCCH	NN	B-NP
O	motif	motif	NN	I-NP
O	disrupted	disrupt	VBD	B-VP
B-GGP	Vif	Vif	NN	B-NP
O	function	function	NN	I-NP
O	and	and	CC	O
O	interaction	interaction	NN	B-NP
O	with	with	IN	B-PP
B-GGP	Cul5	Cul5	NN	B-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	maintenance	maintenance	NN	I-NP
O	of	of	IN	B-PP
O	both	both	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	residues	residue	NNS	I-NP
O	and	and	CC	O
O	spacing	space	VBG	B-VP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	HCCH	HCCH	NN	I-NP
O	motif	motif	NN	I-NP
O	is	be	VBZ	B-VP
O	critical	critical	JJ	B-ADJP
O	for	for	IN	B-PP
B-GGP	Vif	Vif	NN	B-NP
O	function	function	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	have	have	VBP	B-VP
O	identified	identify	VBN	I-VP
O	a	a	DT	B-NP
O	"	"	``	I-NP
O	viral	viral	JJ	I-NP
B-GGP	Cul5	Cul5	NN	I-NP
O	box	box	NN	I-NP
O	"	"	''	O
O	with	with	IN	B-PP
O	consensus	consensus	NN	B-NP
O	Hx2YFxCFx4Phix2APhix7	Hx2YFxCFx4Phix2APhix7	NN	I-NP
O	-	-	HYPH	B-NP
O	8Cx5H	8Cx5H	NN	I-NP
O	that	that	WDT	B-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
B-GGP	Cul5	Cul5	NN	B-NP
O	selection	selection	NN	I-NP
O	and	and	CC	O
O	subsequent	subsequent	JJ	B-NP
B-GGP	A3G	A3G	NN	I-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	novel	novel	JJ	I-NP
O	motif	motif	NN	I-NP
O	may	may	MD	B-VP
O	represent	represent	VB	I-VP
O	a	a	DT	B-NP
O	potential	potential	JJ	I-NP
O	new	new	JJ	I-NP
O	target	target	NN	I-NP
O	for	for	IN	B-PP
O	anti	anti	AFX	B-NP
O	-	-	HYPH	I-NP
O	viral	viral	JJ	B-NP
O	drug	drug	NN	I-NP
O	development	development	NN	I-NP
O	.	.	.	O

O	Splicing	Splicing	NN	B-NP
O	determines	determine	VBZ	B-VP
O	the	the	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	state	state	NN	I-NP
O	of	of	IN	B-PP
B-GGP	ameloblastin	ameloblastin	NN	B-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	developing	develop	VBG	B-VP
O	porcine	porcine	JJ	B-NP
O	enamel	enamel	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	space	space	NN	I-NP
O	between	between	IN	B-PP
O	enamel	enamel	NN	B-NP
O	rods	rod	NNS	I-NP
O	selectively	selectively	RB	B-ADVP
O	binds	bind	VBZ	B-VP
O	lectins	lectin	NNS	B-NP
O	and	and	CC	O
B-GGP	ameloblastin	ameloblastin	NN	B-NP
O	(	(	(	O
B-GGP	Ambn	Ambn	NN	B-NP
O	)	)	)	O
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	antibodies	antibody	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	tested	test	VBD	B-VP
O	the	the	DT	B-NP
O	hypothesis	hypothesis	NN	I-NP
O	that	that	IN	B-SBAR
B-GGP	ameloblastin	ameloblastin	NN	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	cleavage	cleavage	NN	I-NP
O	products	product	NNS	I-NP
O	are	be	VBP	B-VP
O	glycosylated	glycosylate	VBN	I-VP
O	.	.	.	O

O	Assorted	Assorted	NNP	B-NP
B-GGP	Ambn	Ambn	NNP	I-NP
O	cleavage	cleavage	NN	I-NP
O	products	product	NNS	I-NP
O	showed	show	VBD	B-VP
O	positive	positive	JJ	B-NP
O	lectin	lectin	NN	I-NP
O	staining	staining	NN	I-NP
O	by	by	IN	B-PP
O	peanut	peanut	NN	B-NP
B-GGP	agglutinin	agglutinin	NN	I-NP
O	(	(	(	O
B-GGP	PNA	PNA	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	Maclura	Maclura	NNP	B-NP
O	pomifera	pomifera	NN	I-NP
O	agglutinin	agglutinin	NN	I-NP
O	(	(	(	O
O	MPA	MPA	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
O	Limulus	Limulus	NN	B-NP
O	polyphemus	polyphemus	NN	I-NP
O	agglutinin	agglutinin	NN	I-NP
O	(	(	(	O
O	LPA	LPA	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	O	O	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	containing	contain	VBG	B-VP
O	galactose	galactose	NN	B-NP
O	(	(	(	O
O	Gal	Gal	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	N	N	NN	B-NP
O	-	-	HYPH	O
O	acetylgalactosamine	acetylgalactosamine	NN	B-NP
O	(	(	(	O
O	GalNAc	GalNAc	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
O	sialic	sialic	JJ	B-NP
O	acid	acid	NN	I-NP
O	.	.	.	O

O	Edman	Edman	NN	B-NP
O	sequencing	sequencing	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	lectin	lectin	NN	I-NP
O	-	-	HYPH	B-NP
O	positive	positive	JJ	I-NP
O	bands	band	NNS	I-NP
O	gave	give	VBD	B-VP
O	the	the	DT	B-NP
B-GGP	Ambn	Ambn	NNP	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	sequence	sequence	NN	I-NP
O	:	:	:	O
O	VPAFPRQPGTXGVASLXLE	VPAFPRQPGTXGVASLXLE	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	blank	blank	JJ	I-NP
O	cycles	cycle	NNS	I-NP
O	for	for	IN	B-PP
O	Pro	Pro	NN	B-NP
O	(	(	(	O
O	11	11	CD	B-NP
O	)	)	)	O
O	and	and	CC	O
O	Ser	Ser	NN	B-NP
O	(	(	(	O
O	17	17	CD	B-NP
O	)	)	)	O
O	confirmed	confirm	VBD	B-VP
O	that	that	IN	B-SBAR
O	these	these	DT	B-NP
O	residues	residue	NNS	I-NP
O	are	be	VBP	B-VP
O	hydroxylated	hydroxylate	VBN	I-VP
O	and	and	CC	I-VP
O	phosphorylated	phosphorylate	VBN	I-VP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	The	The	DT	B-NP
O	O	O	NN	I-NP
O	-	-	HYPH	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	was	be	VBD	B-VP
O	determined	determine	VBN	I-VP
O	by	by	IN	B-PP
O	Edman	Edman	NNP	B-NP
O	sequencing	sequencing	NN	I-NP
O	of	of	IN	B-PP
O	pronase	pronase	NN	B-NP
O	-	-	HYPH	B-NP
O	digested	digest	VBN	I-NP
B-GGP	Ambn	Ambn	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	gave	give	VBD	B-VP
O	HPPPLPXQPS	HPPPLPXQPS	NN	B-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
O	Ser	Ser	NN	B-NP
O	(	(	(	O
O	86	86	CD	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	site	site	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	O	O	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	modification	modification	NN	I-NP
O	is	be	VBZ	B-VP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	15	15	CD	I-NP
O	-	-	HYPH	I-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	acid	acid	NN	I-NP
O	segment	segment	NN	I-NP
O	(	(	(	O
O	73	73	CD	B-NP
O	-	-	HYPH	I-NP
O	YEYSLPVHPPPLPSQ	YEYSLPVHPPPLPSQ	NN	I-NP
O	-	-	HYPH	B-NP
O	87	87	CD	I-NP
O	)	)	)	O
O	deleted	delete	VBN	B-VP
O	by	by	IN	B-PP
O	splicing	splicing	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	mRNA	mRNA	NN	I-NP
O	encoding	encode	VBG	B-VP
O	the	the	DT	B-NP
O	380	380	CD	I-NP
O	-	-	HYPH	I-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	acid	acid	NN	I-NP
B-GGP	Ambn	Ambn	NN	I-NP
O	isoform	isoform	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	conclude	conclude	VBP	B-VP
O	that	that	IN	B-SBAR
O	only	only	RB	B-NP
O	the	the	DT	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
B-GGP	Ambn	Ambn	NN	I-NP
O	products	product	NNS	I-NP
O	derived	derive	VBN	B-VP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	395	395	CD	I-NP
O	-	-	HYPH	I-NP
B-GGP	Ambn	Ambn	NN	I-NP
O	isoform	isoform	NN	I-NP
O	are	be	VBP	B-VP
O	glycosylated	glycosylate	VBN	I-VP
O	.	.	.	O

O	Chemical	Chemical	JJ	B-NP
O	genetic	genetic	JJ	I-NP
O	interrogation	interrogation	NN	I-NP
O	of	of	IN	B-PP
O	natural	natural	JJ	B-NP
O	variation	variation	NN	I-NP
O	uncovers	uncover	VBZ	B-VP
O	a	a	DT	B-NP
O	molecule	molecule	NN	I-NP
O	that	that	WDT	B-NP
O	is	be	VBZ	B-VP
O	glycoactivated	glycoactivate	VBN	I-VP
O	.	.	.	O

O	Natural	Natural	JJ	B-NP
O	variation	variation	NN	I-NP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	drug	drug	NN	I-NP
O	metabolism	metabolism	NN	I-NP
O	and	and	CC	O
O	target	target	NN	B-NP
O	genes	gene	NNS	I-NP
O	can	can	MD	B-VP
O	cause	cause	VB	I-VP
O	pharmacogenetic	pharmacogenetic	JJ	B-NP
O	or	or	CC	I-NP
O	interindividual	interindividual	JJ	I-NP
O	variation	variation	NN	I-NP
O	in	in	IN	B-PP
O	drug	drug	NN	B-NP
O	sensitivity	sensitivity	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	reasoned	reason	VBD	B-VP
O	that	that	IN	B-SBAR
O	natural	natural	JJ	B-NP
O	pharmacogenetic	pharmacogenetic	JJ	I-NP
O	variation	variation	NN	I-NP
O	in	in	IN	B-PP
O	model	model	NN	B-NP
O	organisms	organism	NNS	I-NP
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	systematically	systematically	RB	I-VP
O	exploited	exploit	VBN	I-VP
O	to	to	TO	I-VP
O	facilitate	facilitate	VB	I-VP
O	the	the	DT	B-NP
O	characterization	characterization	NN	I-NP
O	of	of	IN	B-PP
O	new	new	JJ	B-NP
O	small	small	JJ	I-NP
O	molecules	molecule	NNS	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	test	test	VB	I-VP
O	this	this	DT	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	subjected	subject	VBD	B-VP
O	multiple	multiple	JJ	B-NP
O	Arabidopsis	Arabidopsis	NNP	I-NP
O	thaliana	thaliana	IN	B-PP
O	accessions	accession	NNS	B-NP
O	to	to	TO	B-PP
O	chemical	chemical	JJ	B-NP
O	genetic	genetic	JJ	I-NP
O	screens	screen	NNS	I-NP
O	and	and	CC	O
O	discovered	discover	VBD	B-VP
O	12	12	CD	B-NP
O	accession	accession	NN	I-NP
O	-	-	HYPH	B-NP
O	selective	selective	JJ	I-NP
O	hit	hit	NN	I-NP
O	molecules	molecule	NNS	I-NP
O	.	.	.	O

O	As	As	IN	B-PP
O	a	a	DT	B-NP
O	model	model	NN	I-NP
O	for	for	IN	B-PP
O	understanding	understand	VBG	B-VP
O	this	this	DT	B-NP
O	variation	variation	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	characterized	characterize	VBD	B-VP
O	natural	natural	JJ	B-NP
O	resistance	resistance	NN	I-NP
O	to	to	TO	B-PP
O	hypostatin	hypostatin	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	new	new	JJ	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	of	of	IN	B-PP
O	cell	cell	NN	B-NP
O	expansion	expansion	NN	I-NP
O	.	.	.	O

O	Map	Map	NN	B-NP
O	-	-	HYPH	O
O	based	base	VBN	B-VP
O	cloning	clone	VBG	I-VP
O	identified	identify	VBN	B-NP
B-GGP	HYR1	HYR1	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	UDP	UDP	NN	I-NP
O	glycosyltransferase	glycosyltransferase	NN	I-NP
O	(	(	(	O
O	UGT	UGT	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	as	as	IN	B-PP
O	causative	causative	JJ	B-ADJP
O	for	for	IN	B-PP
O	hypostatin	hypostatin	NN	B-NP
O	resistance	resistance	NN	I-NP
O	.	.	.	O

O	Multiple	Multiple	JJ	B-NP
O	lines	line	NNS	I-NP
O	of	of	IN	B-PP
O	evidence	evidence	NN	B-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	HYR1	HYR1	NN	B-NP
O	glucosylates	glucosylate	VBZ	B-VP
O	hypostatin	hypostatin	NN	B-NP
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	to	to	TO	B-VP
O	form	form	VB	I-VP
O	a	a	DT	B-NP
O	bioactive	bioactive	JJ	I-NP
O	glucoside	glucoside	NN	I-NP
O	.	.	.	O

O	Additionally	Additionally	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	delineated	delineate	VBD	B-VP
O	a	a	DT	B-NP
B-GGP	HYR1	HYR1	NN	I-NP
O	substrate	substrate	NN	I-NP
O	motif	motif	NN	I-NP
O	and	and	CC	O
O	used	use	VBD	B-VP
O	it	it	PRP	B-NP
O	to	to	TO	B-VP
O	identify	identify	VB	I-VP
O	another	another	DT	B-NP
O	molecule	molecule	NN	I-NP
O	modulated	modulate	VBN	B-VP
O	by	by	IN	B-PP
O	glucosylation	glucosylation	NN	B-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	results	result	NNS	I-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	natural	natural	JJ	B-NP
O	variation	variation	NN	I-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	exploited	exploit	VBN	I-VP
O	to	to	TO	B-VP
O	inform	inform	VB	I-VP
O	the	the	DT	B-NP
O	biology	biology	NN	I-NP
O	of	of	IN	B-PP
O	new	new	JJ	B-NP
O	small	small	JJ	I-NP
O	molecules	molecule	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	UGT	UGT	NN	B-NP
O	sequence	sequence	NN	I-NP
O	variation	variation	NN	I-NP
O	affects	affect	VBZ	B-VP
O	xenobiotic	xenobiotic	JJ	B-NP
O	sensitivity	sensitivity	NN	I-NP
O	across	across	IN	B-PP
O	biological	biological	JJ	B-NP
O	kingdoms	kingdom	NNS	I-NP
O	.	.	.	O

O	Kaposi	Kaposi	NNP	B-NP
O	'	'	POS	B-NP
O	s	s	JJ	I-NP
O	sarcoma	sarcoma	NN	I-NP
O	herpesvirus	herpesvirus	NN	I-NP
O	-	-	HYPH	B-VP
O	encoded	encode	VBN	B-NP
B-GGP	latency	latency	NN	I-NP
I-GGP	-	-	HYPH	B-VP
I-GGP	associated	associate	VBN	I-VP
I-GGP	nuclear	nuclear	JJ	B-NP
I-GGP	antigen	antigen	NN	I-NP
O	stabilizes	stabilize	VBZ	B-VP
O	intracellular	intracellular	JJ	B-NP
O	activated	activate	VBN	I-NP
O	Notch	Notch	NN	I-NP
O	by	by	IN	B-PP
O	targeting	target	VBG	B-VP
O	the	the	DT	B-NP
B-GGP	Sel10	Sel10	NN	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	Deregulation	Deregulation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	evolutionarily	evolutionarily	RB	I-NP
O	conserved	conserve	VBN	I-NP
O	Notch	Notch	NN	I-NP
O	signaling	signaling	NN	I-NP
O	is	be	VBZ	B-VP
O	highly	highly	RB	I-VP
O	correlated	correlate	VBN	I-VP
O	with	with	IN	B-PP
O	oncogenesis	oncogenesis	NN	B-NP
O	.	.	.	O

O	Intracellular	Intracellular	JJ	B-NP
O	activated	activate	VBN	I-NP
O	Notch	Notch	NN	I-NP
O	(	(	(	O
O	ICN	ICN	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	protooncogene	protooncogene	NN	I-NP
O	linked	link	VBN	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	transcription	transcription	NN	I-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	cellular	cellular	JJ	B-NP
O	genes	gene	NNS	I-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	cell	cell	NN	B-NP
O	cycle	cycle	NN	I-NP
O	regulation	regulation	NN	I-NP
O	,	,	,	O
O	differentiation	differentiation	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	proliferation	proliferation	NN	B-NP
O	.	.	.	O

O	Stability	Stability	NN	B-NP
O	of	of	IN	B-PP
O	ICN	ICN	NN	B-NP
O	is	be	VBZ	B-VP
O	tightly	tightly	RB	I-VP
O	regulated	regulate	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
B-GGP	Sel10	Sel10	NN	I-NP
O	-	-	HYPH	B-VP
O	mediated	mediate	VBN	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	-	-	HYPH	B-NP
O	proteasome	proteasome	NN	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

B-GGP	Sel10	Sel10	NN	B-NP
O	can	can	MD	B-VP
O	function	function	VB	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	negative	negative	JJ	I-NP
O	regulator	regulator	NN	I-NP
O	of	of	IN	B-PP
O	Notch	Notch	NN	B-NP
O	and	and	CC	O
O	exhibits	exhibit	VBZ	B-VP
O	activities	activity	NNS	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	tumor	tumor	NN	I-NP
O	-	-	HYPH	B-NP
O	suppressor	suppressor	NN	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	article	article	NN	I-NP
O	shows	show	VBZ	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	Kaposi	Kaposi	NNP	I-NP
O	'	'	POS	B-NP
O	s	s	NN	I-NP
O	sarcoma	sarcoma	NN	I-NP
O	-	-	HYPH	O
O	associated	associate	VBN	B-VP
O	herpesvirus	herpesvirus	NN	B-NP
O	(	(	(	O
O	KSHV	KSHV	NN	B-NP
O	)	)	)	O
B-GGP	latency	latency	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	associated	associate	VBN	B-VP
I-GGP	nuclear	nuclear	JJ	B-NP
I-GGP	antigen	antigen	NN	I-NP
O	(	(	(	O
B-GGP	LANA	LANA	NN	B-NP
O	)	)	)	O
O	directly	directly	RB	B-ADVP
O	interacts	interact	VBZ	B-VP
O	with	with	IN	B-PP
B-GGP	Sel10	Sel10	NN	B-NP
O	and	and	CC	O
O	forms	form	VBZ	B-VP
O	a	a	DT	B-NP
O	complex	complex	NN	I-NP
O	in	in	IN	B-PP
O	KSHV	KSHV	NN	B-NP
O	-	-	HYPH	B-NP
O	infected	infect	VBN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	suppression	suppression	NN	B-NP
O	of	of	IN	B-PP
O	ICN	ICN	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	carboxyl	carboxyl	NN	I-NP
O	terminus	terminus	NN	I-NP
O	of	of	IN	B-PP
B-GGP	LANA	LANA	NN	B-NP
O	interacts	interact	VBZ	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	F	F	NN	I-NP
O	-	-	HYPH	I-NP
O	box	box	NN	I-NP
O	and	and	CC	I-NP
O	WD40	WD40	NN	I-NP
O	domains	domain	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	Sel10	Sel10	NN	B-NP
O	and	and	CC	O
O	competes	compete	VBZ	B-VP
O	with	with	IN	B-PP
O	ICN	ICN	NN	B-NP
O	for	for	IN	B-PP
O	binding	binding	NN	B-NP
O	to	to	TO	B-PP
B-GGP	Sel10	Sel10	NN	B-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	elevated	elevated	JJ	I-NP
O	level	level	NN	I-NP
O	of	of	IN	B-PP
O	ICN	ICN	NN	B-NP
O	is	be	VBZ	B-VP
O	also	also	RB	B-ADVP
O	critical	critical	JJ	B-ADJP
O	for	for	IN	B-PP
O	maintaining	maintain	VBG	B-VP
O	the	the	DT	B-NP
O	enhanced	enhance	VBN	I-NP
O	proliferation	proliferation	NN	I-NP
O	of	of	IN	B-PP
O	KSHV	KSHV	NN	B-NP
O	-	-	HYPH	B-NP
O	infected	infect	VBN	I-NP
O	tumor	tumor	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	findings	finding	NNS	I-NP
O	describe	describe	VBP	B-VP
O	a	a	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	by	by	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
O	KSHV	KSHV	NN	I-NP
O	-	-	HYPH	B-VP
O	encoded	encode	VBN	B-NP
B-GGP	LANA	LANA	NN	I-NP
O	protein	protein	NN	I-NP
O	regulates	regulate	VBZ	B-VP
O	ubiquitination	ubiquitination	NN	B-NP
O	of	of	IN	B-PP
O	ICN	ICN	NN	B-NP
O	mediated	mediate	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	F	F	NN	I-NP
O	-	-	HYPH	I-NP
O	box	box	NN	I-NP
O	component	component	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	E3	E3	NN	I-NP
O	ligase	ligase	NN	I-NP
B-GGP	Sel10	Sel10	NN	I-NP
O	,	,	,	O
O	leading	lead	VBG	B-VP
O	to	to	TO	B-PP
O	proliferation	proliferation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	virus	virus	NN	I-NP
O	-	-	HYPH	B-NP
O	infected	infect	VBN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	initiation	initiation	NN	I-NP
O	and	and	CC	I-NP
O	pattern	pattern	NN	I-NP
O	of	of	IN	B-PP
O	spread	spread	NN	B-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	parallel	parallel	VBP	B-VP
O	the	the	DT	B-NP
O	order	order	NN	I-NP
O	of	of	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
O	genes	gene	NNS	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	aflatoxin	aflatoxin	NN	I-NP
O	cluster	cluster	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	27	27	CD	I-NP
O	genes	gene	NNS	I-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	aflatoxin	aflatoxin	NN	B-NP
O	biosynthesis	biosynthesis	NN	I-NP
O	are	be	VBP	B-VP
O	clustered	cluster	VBN	I-VP
O	within	within	IN	B-PP
O	a	a	DT	B-NP
O	70	70	CD	I-NP
O	kb	kb	NN	I-NP
O	region	region	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	Aspergillus	Aspergillus	NN	I-NP
O	parasiticus	parasiticus	NN	I-NP
O	genome	genome	NN	I-NP
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	chromatin	chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	demonstrated	demonstrate	VBD	B-VP
O	a	a	DT	B-NP
O	positive	positive	JJ	I-NP
O	correlation	correlation	NN	I-NP
O	between	between	IN	B-PP
O	the	the	DT	B-NP
O	initiation	initiation	NN	I-NP
O	and	and	CC	I-NP
O	spread	spread	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	in	in	IN	B-PP
O	aflatoxin	aflatoxin	NN	B-NP
O	promoters	promoter	NNS	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	onset	onset	NN	I-NP
O	of	of	IN	B-PP
O	accumulation	accumulation	NN	B-NP
O	of	of	IN	B-PP
O	aflatoxin	aflatoxin	NN	B-NP
O	proteins	protein	NNS	I-NP
O	and	and	CC	O
O	aflatoxin	aflatoxin	NN	B-NP
O	.	.	.	O

B-GGP	Histone	Histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
B-GGP	pksA	pksA	NN	I-NP
O	(	(	(	O
O	encodes	encode	VBZ	B-VP
O	an	an	DT	B-NP
O	'	'	``	I-NP
O	early	early	JJ	I-NP
O	'	'	''	I-NP
O	biosynthetic	biosynthetic	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	enzyme	enzyme	NN	I-NP
O	)	)	)	O
O	promoter	promoter	NN	B-NP
O	peaked	peak	VBD	B-VP
O	at	at	IN	B-PP
O	30	30	CD	B-NP
O	h	h	NN	I-NP
O	,	,	,	O
O	prior	prior	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	increased	increase	VBN	I-NP
O	acetylation	acetylation	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
B-GGP	omtA	omtA	NN	I-NP
O	and	and	CC	I-NP
B-GGP	ordA	ordA	NN	I-NP
O	(	(	(	O
O	encode	encode	VBP	B-VP
O	'	'	``	O
O	late	late	JJ	B-NP
O	'	'	''	I-NP
O	enzymes	enzyme	NNS	I-NP
O	)	)	)	O
O	promoters	promoter	NNS	B-NP
O	detected	detect	VBN	B-VP
O	at	at	IN	B-PP
O	40	40	CD	B-NP
O	h	h	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	specific	specific	JJ	I-NP
O	order	order	NN	I-NP
O	in	in	IN	B-PP
O	which	which	WDT	B-NP
B-GGP	pksA	pksA	NN	B-NP
O	,	,	,	O
B-GGP	ver	ver	AFX	O
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
O	encodes	encode	VBZ	B-VP
O	a	a	DT	B-NP
O	'	'	``	I-NP
O	middle	middle	NN	I-NP
O	'	'	POS	B-NP
O	enzyme	enzyme	NN	I-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	omtA	omtA	NN	B-NP
O	transcripts	transcript	NNS	I-NP
O	accumulated	accumulate	VBN	B-VP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	paralleled	parallel	VBD	B-VP
O	the	the	DT	B-NP
O	pattern	pattern	NN	I-NP
O	of	of	IN	B-PP
O	spread	spread	NN	B-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	.	.	.	O

O	Binding	Binding	NN	B-NP
O	of	of	IN	B-PP
B-GGP	AflR	AflR	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	positive	positive	JJ	I-NP
O	regulator	regulator	NN	I-NP
O	of	of	IN	B-PP
O	aflatoxin	aflatoxin	NN	B-NP
O	biosynthesis	biosynthesis	NN	I-NP
O	,	,	,	O
O	to	to	TO	B-PP
O	the	the	DT	B-NP
B-GGP	ordA	ordA	NN	I-NP
O	promoter	promoter	NN	I-NP
O	showed	show	VBD	B-VP
O	a	a	DT	B-NP
O	positive	positive	JJ	I-NP
O	correlation	correlation	NN	I-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	spread	spread	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	data	datum	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	order	order	NN	I-NP
O	of	of	IN	B-PP
O	genes	gene	NNS	B-NP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	aflatoxin	aflatoxin	NN	I-NP
O	cluster	cluster	NN	I-NP
O	determines	determine	VBZ	B-VP
O	the	the	DT	B-NP
O	timing	timing	NN	I-NP
O	and	and	CC	I-NP
O	order	order	NN	I-NP
O	of	of	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	activation	activation	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	site	site	NN	I-NP
O	of	of	IN	B-PP
O	initiation	initiation	NN	B-NP
O	and	and	CC	I-NP
O	spread	spread	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	mediate	mediate	VBP	B-VP
O	this	this	DT	B-NP
O	process	process	NN	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	data	datum	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	aflatoxin	aflatoxin	NN	I-NP
O	and	and	CC	I-NP
O	adjacent	adjacent	JJ	I-NP
O	sugar	sugar	NN	I-NP
O	utilization	utilization	NN	I-NP
O	clusters	cluster	NNS	I-NP
O	are	be	VBP	B-VP
O	part	part	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	larger	large	JJR	I-NP
O	'	'	``	I-NP
O	regulatory	regulatory	JJ	I-NP
O	unit	unit	NN	I-NP
O	'	'	''	O
O	.	.	.	O

O	Correlation	Correlation	NN	B-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	with	with	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	modifications	modification	NNS	I-NP
O	across	across	IN	B-PP
O	the	the	DT	B-NP
B-GGP	HNRPA2B1	HNRPA2B1	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	CBX3	CBX3	NN	I-NP
O	ubiquitously	ubiquitously	RB	B-ADVP
O	-	-	HYPH	B-NP
O	acting	act	VBG	I-NP
O	chromatin	chromatin	NN	I-NP
O	open	open	JJ	I-NP
O	element	element	NN	I-NP
O	(	(	(	O
O	UCOE	UCOE	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	methylation	methylation	NN	I-NP
O	-	-	HYPH	O
O	free	free	JJ	B-NP
O	CpG	CpG	NN	I-NP
O	island	island	NN	I-NP
O	encompassing	encompass	VBG	B-VP
O	the	the	DT	B-NP
O	divergently	divergently	RB	I-NP
O	transcribed	transcribe	VBN	I-NP
O	promoters	promoter	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	HNRPA2B1	HNRPA2B1	NN	I-NP
O	and	and	CC	I-NP
B-GGP	CBX3	CBX3	NN	I-NP
O	housekeeping	housekeeping	NN	I-NP
O	genes	gene	NNS	I-NP
O	possesses	possess	VBZ	B-VP
O	a	a	DT	B-NP
O	dominant	dominant	JJ	I-NP
O	ubiquitously	ubiquitously	RB	B-ADVP
O	-	-	HYPH	B-PP
O	acting	act	VBG	B-NP
O	chromatin	chromatin	NN	I-NP
O	opening	opening	NN	I-NP
O	element	element	NN	I-NP
O	(	(	(	O
O	UCOE	UCOE	NN	B-NP
O	)	)	)	O
O	capability	capability	NN	B-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	element	element	NN	I-NP
O	allows	allow	VBZ	B-VP
O	reproducible	reproducible	JJ	B-NP
O	and	and	CC	I-NP
O	stable	stable	JJ	I-NP
O	transgene	transgene	NN	I-NP
O	expression	expression	NN	I-NP
O	including	include	VBG	B-PP
O	from	from	IN	B-PP
O	within	within	IN	B-PP
O	centromeric	centromeric	JJ	B-NP
O	heterochromatin	heterochromatin	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	present	present	VBP	B-VP
O	an	an	DT	B-NP
O	investigation	investigation	NN	I-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	I-NP
B-GGP	histone	histone	NN	I-NP
O	modification	modification	NN	I-NP
O	marks	mark	NNS	I-NP
O	across	across	IN	B-PP
O	the	the	DT	B-NP
B-GGP	HNRPA2B1	HNRPA2B1	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	CBX3	CBX3	NN	I-NP
O	locus	locus	NN	I-NP
O	in	in	IN	B-PP
O	primary	primary	JJ	B-NP
O	peripheral	peripheral	JJ	I-NP
O	blood	blood	NN	I-NP
O	mononuclear	mononuclear	JJ	I-NP
O	cells	cell	NNS	I-NP
O	(	(	(	O
O	PBMCs	PBMC	NNS	B-NP
O	)	)	)	O
O	to	to	TO	B-VP
O	characterise	characterise	VB	I-VP
O	the	the	DT	B-NP
O	chromatin	chromatin	NN	I-NP
O	structure	structure	NN	I-NP
O	that	that	WDT	B-NP
O	underlies	underlie	VBZ	B-VP
O	UCOE	UCOE	NN	B-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	CpG	CpG	NN	I-NP
O	methylation	methylation	NN	I-NP
O	-	-	HYPH	O
O	free	free	JJ	B-NP
O	region	region	NN	I-NP
O	associated	associate	VBN	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	UCOE	UCOE	NNP	I-NP
O	extends	extend	VBZ	B-VP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	central	central	JJ	I-NP
O	areas	area	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	HNRPA2B1	HNRPA2B1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	CBX3	CBX3	NN	I-NP
O	,	,	,	O
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	total	total	JJ	I-NP
O	length	length	NN	I-NP
O	of	of	IN	B-PP
O	approximately	approximately	RB	B-NP
O	5	5	CD	I-NP
O	kb	kb	NN	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	DNA	DNA	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	3	3	CD	I-NP
O	'	'	SYM	I-NP
O	half	half	NN	I-NP
O	of	of	IN	B-PP
O	both	both	DT	B-NP
O	genes	gene	NNS	I-NP
O	is	be	VBZ	B-VP
O	methylated	methylate	VBN	I-VP
O	.	.	.	O

B-GGP	Histone	Histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	lysine	lysine	NN	I-NP
O	(	(	(	O
O	K	K	NN	B-NP
O	)	)	)	O
O	acetylation	acetylation	NN	B-NP
O	shows	show	VBZ	B-VP
O	a	a	DT	B-NP
O	broad	broad	JJ	I-NP
O	distribution	distribution	NN	I-NP
O	across	across	IN	B-PP
O	both	both	DT	B-NP
O	genes	gene	NNS	I-NP
O	,	,	,	O
O	whilst	whilst	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	lysine	lysine	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	peaks	peak	NNS	I-NP
O	around	around	IN	B-PP
O	the	the	DT	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	start	start	NN	I-NP
O	sites	site	NNS	I-NP
O	and	and	CC	O
O	drops	drop	VBZ	B-VP
O	to	to	TO	B-PP
O	background	background	NN	B-NP
O	levels	level	NNS	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	3	3	CD	I-NP
O	'	'	SYM	I-NP
O	ends	end	NNS	I-NP
O	.	.	.	O

O	Higher	High	JJR	B-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	H3K4	H3K4	NN	B-NP
O	di	di	AFX	O
O	-	-	HYPH	O
O	methylation	methylation	NN	B-NP
O	are	be	VBP	B-VP
O	present	present	JJ	B-ADJP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	3	3	CD	I-NP
O	'	'	SYM	I-NP
O	end	end	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	genes	gene	NNS	I-NP
O	in	in	IN	B-PP
O	contrast	contrast	NN	B-NP
O	to	to	TO	B-PP
B-GGP	H3K4	H3K4	NN	B-NP
O	tri	tri	AFX	O
O	-	-	HYPH	O
O	methylation	methylation	NN	B-NP
O	which	which	WDT	B-NP
O	peaks	peak	VBZ	B-VP
O	around	around	IN	B-PP
O	the	the	DT	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	start	start	NN	I-NP
O	sites	site	NNS	I-NP
O	.	.	.	O

O	Therefore	Therefore	RB	B-ADVP
O	,	,	,	O
O	methylated	methylate	VBN	B-NP
O	DNA	DNA	NN	I-NP
O	in	in	IN	B-PP
O	transcribed	transcribe	VBN	B-NP
O	regions	region	NNS	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	genes	gene	NNS	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	shown	show	VBN	I-VP
O	here	here	RB	B-ADVP
O	to	to	TO	B-PP
O	co	co	AFX	B-NP
O	-	-	HYPH	B-NP
O	exist	exist	VBP	B-VP
O	with	with	IN	B-PP
O	active	active	JJ	B-NP
B-GGP	histone	histone	NN	I-NP
O	modification	modification	NN	I-NP
O	marks	mark	NNS	I-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
O	these	these	DT	B-NP
O	functionally	functionally	RB	I-NP
O	opposing	oppose	VBG	I-NP
O	epigenetic	epigenetic	JJ	B-NP
O	signatures	signature	NNS	I-NP
O	can	can	MD	B-VP
O	overlap	overlap	VB	I-VP
O	.	.	.	O

O	This	This	DT	B-NP
O	suggests	suggest	VBZ	B-VP
O	that	that	IN	B-SBAR
O	an	an	DT	B-NP
O	extended	extend	VBN	I-NP
O	large	large	JJ	I-NP
O	region	region	NN	I-NP
O	of	of	IN	B-PP
O	unmethylated	unmethylated	JJ	B-NP
O	DNA	DNA	NN	I-NP
O	in	in	IN	B-PP
O	combination	combination	NN	B-NP
O	with	with	IN	B-PP
O	distinct	distinct	JJ	B-NP
B-GGP	histone	histone	NN	I-NP
O	modification	modification	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	are	be	VBP	B-VP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	basis	basis	NN	I-NP
O	of	of	IN	B-PP
O	UCOE	UCOE	NNP	B-NP
O	function	function	NN	I-NP
O	.	.	.	O

B-GGP	Cdc42	Cdc42	NN	B-NP
O	regulates	regulate	VBZ	B-VP
B-GGP	E	E	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	cadherin	cadherin	NN	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	through	through	IN	B-PP
O	an	an	DT	B-NP
B-GGP	epidermal	epidermal	JJ	I-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	receptor	receptor	NN	I-NP
O	to	to	TO	B-PP
B-GGP	Src	Src	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

B-GGP	E	E	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	cadherins	cadherin	NNS	B-NP
O	play	play	VBP	B-VP
O	an	an	DT	B-NP
O	essential	essential	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	maintaining	maintain	VBG	B-VP
O	epithelial	epithelial	JJ	B-NP
O	polarity	polarity	NN	I-NP
O	by	by	IN	B-PP
O	forming	form	VBG	B-VP
O	Ca2	Ca2	NN	B-NP
O	+	+	SYM	B-VP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	adherens	adheren	NNS	I-NP
O	junctions	junction	NNS	I-NP
O	between	between	IN	B-PP
O	epithelial	epithelial	JJ	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	report	report	VBP	B-VP
O	that	that	IN	B-SBAR
O	Ca2	Ca2	NN	B-NP
O	+	+	SYM	B-NP
O	depletion	depletion	NN	I-NP
O	induces	induce	VBZ	B-VP
B-GGP	E	E	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	cadherin	cadherin	NN	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	O
O	lysosomal	lysosomal	JJ	B-NP
O	degradation	degradation	NN	I-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
B-GGP	Cdc42	Cdc42	NN	B-NP
O	plays	play	VBZ	B-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	regulating	regulate	VBG	B-VP
O	this	this	DT	B-NP
O	process	process	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	Ca2	Ca2	NN	B-NP
O	+	+	SYM	B-NP
O	depletion	depletion	NN	I-NP
O	induces	induce	VBZ	B-VP
O	activation	activation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	Cdc42	Cdc42	NN	B-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	in	in	IN	B-PP
O	turn	turn	NN	B-NP
O	up	up	RB	B-ADVP
O	-	-	HYPH	B-NP
O	regulates	regulate	VBZ	B-VP
B-GGP	epidermal	epidermal	JJ	B-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	receptor	receptor	NN	I-NP
O	(	(	(	O
B-GGP	EGFR	EGFR	NN	B-NP
O	)	)	)	O
O	signaling	signaling	NN	B-NP
O	to	to	TO	B-VP
O	mediate	mediate	VB	I-VP
B-GGP	Src	Src	NN	B-NP
O	activation	activation	NN	I-NP
O	,	,	,	O
O	leading	lead	VBG	B-VP
O	to	to	TO	B-PP
B-GGP	E	E	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	cadherin	cadherin	NN	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	O
O	lysosomal	lysosomal	JJ	B-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	Silencing	Silencing	NN	B-NP
B-GGP	Cdc42	Cdc42	NN	I-NP
O	blocks	block	VBZ	B-VP
O	activation	activation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	EGFR	EGFR	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Src	Src	NN	I-NP
O	induced	induce	VBN	B-VP
O	by	by	IN	B-PP
O	Ca2	Ca2	NN	B-NP
O	+	+	SYM	B-NP
O	depletion	depletion	NN	I-NP
O	,	,	,	O
O	resulting	result	VBG	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	reduction	reduction	NN	I-NP
O	in	in	IN	B-PP
B-GGP	E	E	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	cadherin	cadherin	NN	I-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Cdc42	Cdc42	NN	B-NP
O	in	in	IN	B-PP
O	regulating	regulate	VBG	B-VP
B-GGP	E	E	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	cadherin	cadherin	NN	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	is	be	VBZ	B-VP
O	underscored	underscore	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	fact	fact	NN	I-NP
O	that	that	IN	B-SBAR
O	constitutively	constitutively	RB	B-NP
O	active	active	JJ	I-NP
B-GGP	Cdc42	Cdc42	NN	I-NP
O	(	(	(	O
B-GGP	F28L	F28L	NN	B-NP
O	)	)	)	O
O	increases	increase	VBZ	B-VP
O	the	the	DT	B-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	EGFR	EGFR	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Src	Src	NN	I-NP
O	and	and	CC	O
O	significantly	significantly	RB	B-VP
O	enhances	enhance	VBZ	I-VP
B-GGP	E	E	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	cadherin	cadherin	NN	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	O
O	lysosomal	lysosomal	JJ	B-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
O	GTP	GTP	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Cdc42	Cdc42	NN	B-NP
O	to	to	TO	B-PP
B-GGP	E	E	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	cadherin	cadherin	NN	B-NP
O	is	be	VBZ	B-VP
O	critical	critical	JJ	B-ADJP
O	for	for	IN	B-PP
B-GGP	Cdc42	Cdc42	NN	B-NP
O	to	to	TO	B-VP
O	induce	induce	VB	I-VP
O	the	the	DT	B-NP
O	dissolution	dissolution	NN	I-NP
O	of	of	IN	B-PP
O	adherens	adheren	NNS	B-NP
O	junctions	junction	NNS	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	data	datum	NNS	I-NP
O	support	support	VBP	B-VP
O	a	a	DT	B-NP
O	model	model	NN	I-NP
O	that	that	IN	B-SBAR
O	activation	activation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	Cdc42	Cdc42	NN	B-NP
O	contributes	contribute	VBZ	B-VP
O	to	to	TO	B-PP
O	mesenchyme	mesenchyme	NN	B-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	phenotype	phenotype	NN	I-NP
O	by	by	IN	B-PP
O	targeting	target	VBG	B-VP
O	of	of	IN	B-PP
B-GGP	E	E	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	cadherin	cadherin	NN	I-NP
O	for	for	IN	B-PP
O	lysosomal	lysosomal	JJ	B-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	SET	SET	NN	I-NP
O	domain	domain	NN	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	,	,	,	O
B-GGP	Set11	Set11	NN	B-NP
O	,	,	,	O
O	modifies	modify	VBZ	B-VP
O	ribosomal	ribosomal	JJ	B-NP
O	protein	protein	NN	I-NP
B-GGP	Rpl12	Rpl12	NN	I-NP
O	in	in	IN	B-PP
O	fission	fission	NN	B-NP
O	yeast	yeast	NN	I-NP
O	.	.	.	O

O	SET	SET	NN	B-NP
O	domain	domain	NN	I-NP
O	-	-	HYPH	O
O	containing	contain	VBG	B-VP
O	methyltransferases	methyltransferas	NNS	B-NP
O	post	post	AFX	O
O	-	-	HYPH	B-VP
O	translationally	translationally	RB	I-VP
O	modify	modify	VB	I-VP
O	a	a	DT	B-NP
O	variety	variety	NN	I-NP
O	of	of	IN	B-PP
O	cellular	cellular	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	,	,	,	O
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
B-GGP	histones	histone	NNS	B-NP
O	,	,	,	O
B-GGP	cytochrome	cytochrome	NN	B-NP
I-GGP	c	c	NN	I-NP
O	,	,	,	O
O	ribulose	ribulose	NN	B-NP
O	-	-	HYPH	B-NP
O	bisphosphate	bisphosphate	NN	I-NP
O	carboxylase	carboxylase	NN	I-NP
O	/	/	SYM	B-NP
O	oxygenase	oxygenase	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	ribosomal	ribosomal	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	fission	fission	NN	I-NP
O	yeast	yeast	NN	I-NP
O	Schizosaccharomyces	Schizosaccharomyces	FW	B-ADVP
O	pombe	pombe	FW	I-ADVP
O	,	,	,	O
O	at	at	IN	B-NP
O	least	least	JJS	I-NP
O	13	13	CD	I-NP
O	SET	SET	NN	I-NP
O	domain	domain	NN	I-NP
O	-	-	HYPH	O
O	containing	contain	VBG	B-VP
O	proteins	protein	NNS	B-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	identified	identify	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	genome	genome	NN	I-NP
O	,	,	,	O
O	four	four	CD	B-NP
O	of	of	IN	B-PP
O	which	which	WDT	B-NP
O	are	be	VBP	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	regulation	regulation	NN	I-NP
O	through	through	IN	B-PP
O	their	their	PRP$	B-NP
O	modification	modification	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	tails	tail	NNS	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	roles	role	NNS	I-NP
O	played	play	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	other	other	JJ	I-NP
O	SET	SET	NN	I-NP
O	domain	domain	NN	I-NP
O	proteins	protein	NNS	I-NP
O	in	in	IN	B-PP
O	cellular	cellular	JJ	B-NP
O	processes	process	NNS	I-NP
O	and	and	CC	O
O	their	their	PRP$	B-NP
O	physiological	physiological	JJ	I-NP
O	substrates	substrate	NNS	I-NP
O	remain	remain	VBP	B-VP
O	unresolved	unresolved	JJ	B-ADJP
O	.	.	.	O

O	We	We	PRP	B-NP
O	show	show	VBP	B-VP
O	here	here	RB	B-ADVP
O	that	that	IN	B-SBAR
O	S	S	NN	B-NP
O	.	.	.	O
O	pombe	pombe	NN	B-NP
B-GGP	Set11	Set11	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	SET	SET	NN	I-NP
O	domain	domain	NN	I-NP
O	-	-	HYPH	O
O	containing	contain	VBG	B-VP
O	protein	protein	NN	B-NP
O	encoded	encode	VBN	B-VP
O	by	by	IN	B-PP
O	SPCC1223	SPCC1223	NN	B-NP
O	.	.	.	O
O	04c	04c	NN	B-NP
O	,	,	,	O
O	specifically	specifically	RB	B-VP
O	modifies	modify	VBZ	I-VP
B-GGP	Rpl12	Rpl12	NN	B-NP
O	(	(	(	O
B-GGP	ribosomal	ribosomal	JJ	B-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	L12	L12	NN	I-NP
O	)	)	)	O
O	.	.	.	O

O	Recombinant	Recombinant	JJ	B-NP
B-GGP	Set11	Set11	NN	I-NP
O	prepared	prepare	VBN	B-VP
O	from	from	IN	B-PP
O	Escherichia	Escherichia	FW	B-NP
O	coli	coli	FW	I-NP
O	had	have	VBD	B-VP
O	catalytic	catalytic	JJ	B-NP
O	activity	activity	NN	I-NP
O	and	and	CC	O
O	methylated	methylate	VBD	B-VP
O	a	a	DT	B-NP
O	17	17	CD	I-NP
O	-	-	HYPH	I-NP
O	kDa	kDa	NN	I-NP
O	polypeptide	polypeptide	NN	I-NP
O	in	in	IN	B-PP
O	cellular	cellular	JJ	B-NP
O	extracts	extract	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	set11	set11	NN	B-NP
O	mutant	mutant	JJ	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	methylated	methylate	VBN	I-NP
O	protein	protein	NN	I-NP
O	was	be	VBD	B-VP
O	isolated	isolate	VBN	I-VP
O	by	by	IN	B-PP
O	two	two	CD	B-NP
O	-	-	HYPH	I-NP
O	dimensional	dimensional	JJ	I-NP
O	gel	gel	NN	I-NP
O	electrophoresis	electrophoresis	NN	I-NP
O	or	or	CC	B-PP
O	by	by	IN	B-PP
O	reverse	reverse	JJ	B-NP
O	-	-	HYPH	I-NP
O	phase	phase	NN	I-NP
O	chromatography	chromatography	NN	I-NP
O	and	and	CC	O
O	was	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	as	as	IN	B-PP
B-GGP	Rpl12	Rpl12	NN	B-NP
O	by	by	IN	B-PP
O	mass	mass	NN	B-NP
O	spectrometry	spectrometry	NN	I-NP
O	.	.	.	O

O	In	In	FW	B-NP
O	vitro	vitro	FW	I-NP
O	methylation	methylation	NN	I-NP
O	experiments	experiment	NNS	I-NP
O	using	use	VBG	B-VP
O	wild	wild	JJ	B-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	and	and	CC	I-NP
O	mutant	mutant	JJ	I-NP
B-GGP	Rpl12	Rpl12	NN	I-NP
O	proteins	protein	NNS	I-NP
O	verified	verify	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	Set11	Set11	NN	B-NP
O	modified	modified	JJ	I-NP
O	recombinant	recombinant	JJ	I-NP
B-GGP	Rpl12	Rpl12	NN	I-NP
O	and	and	CC	O
O	suggested	suggest	VBD	B-VP
O	that	that	IN	B-SBAR
O	its	its	PRP$	B-NP
O	potential	potential	JJ	I-NP
O	target	target	NN	I-NP
O	site	site	NN	I-NP
O	was	be	VBD	B-VP
O	lysine	lysine	NN	B-NP
O	3	3	CD	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	methylation	methylation	NN	I-NP
O	site	site	NN	I-NP
O	modified	modify	VBN	B-VP
O	by	by	IN	B-PP
B-GGP	Set11	Set11	NN	B-NP
O	was	be	VBD	B-VP
O	also	also	RB	I-VP
O	confirmed	confirm	VBN	I-VP
O	by	by	IN	B-PP
O	mass	mass	NN	B-NP
O	spectrometric	spectrometric	JJ	I-NP
O	analysis	analysis	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	also	also	RB	B-ADVP
O	revealed	reveal	VBD	B-VP
O	other	other	JJ	B-NP
O	unique	unique	JJ	I-NP
O	methylation	methylation	NN	I-NP
O	sites	site	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	Rpl12	Rpl12	NN	B-NP
O	.	.	.	O

O	Finally	Finally	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	Set11	Set11	NN	B-NP
O	predominantly	predominantly	RB	B-ADJP
O	localized	localized	JJ	I-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	nucleolus	nucleolus	NN	I-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	overproduction	overproduction	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Set11	Set11	NN	B-NP
O	caused	cause	VBD	B-VP
O	a	a	DT	B-NP
O	severe	severe	JJ	I-NP
O	growth	growth	NN	I-NP
O	defect	defect	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	Rpl12	Rpl12	NN	B-NP
O	methylation	methylation	NN	I-NP
O	occurs	occur	VBZ	B-VP
O	during	during	IN	B-PP
O	the	the	DT	B-NP
O	ribosomal	ribosomal	JJ	I-NP
O	assembly	assembly	NN	I-NP
O	processes	process	NNS	I-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	control	control	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	Set11	Set11	NN	I-NP
O	expression	expression	NN	I-NP
O	level	level	NN	I-NP
O	is	be	VBZ	B-VP
O	important	important	JJ	B-ADJP
O	for	for	IN	B-PP
O	its	its	PRP$	B-NP
O	cellular	cellular	JJ	I-NP
O	function	function	NN	I-NP
O	.	.	.	O

O	Yeast	Yeast	NNP	B-NP
B-GGP	Chfr	Chfr	NNP	I-NP
O	homologs	homolog	VBZ	B-VP
O	retard	retard	NN	B-NP
O	cell	cell	NN	I-NP
O	cycle	cycle	NN	I-NP
O	at	at	IN	B-PP
O	G1	G1	NN	B-NP
O	and	and	CC	I-NP
O	G2	G2	NN	I-NP
O	/	/	SYM	O
O	M	M	NN	B-NP
O	via	via	IN	B-PP
B-GGP	Ubc4	Ubc4	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Ubc13	Ubc13	NN	I-NP
O	/	/	SYM	B-NP
B-GGP	Mms2	Mms2	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	.	.	.	O

B-GGP	Checkpoint	Checkpoint	NN	B-NP
I-GGP	with	with	IN	B-PP
I-GGP	forkhead	forkhead	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	associated	associate	VBN	B-VP
I-GGP	and	and	CC	O
I-GGP	RING	RING	NN	B-NP
O	(	(	(	O
B-GGP	Chfr	Chfr	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	(	(	(	O
O	E3	E3	NN	B-NP
O	)	)	)	O
O	that	that	WDT	B-NP
O	establishes	establish	VBZ	B-VP
O	an	an	DT	B-NP
O	antephase	antephase	NN	I-NP
O	or	or	CC	I-NP
O	prometaphase	prometaphase	NN	I-NP
O	checkpoint	checkpoint	NN	I-NP
O	in	in	IN	B-PP
O	response	response	NN	B-NP
O	to	to	TO	B-PP
O	mitotic	mitotic	JJ	B-NP
O	stress	stress	NN	I-NP
O	.	.	.	O

O	Though	Though	IN	B-SBAR
O	ubiquitination	ubiquitination	NN	B-NP
O	is	be	VBZ	B-VP
O	essential	essential	JJ	B-ADJP
O	for	for	IN	B-PP
O	checkpoint	checkpoint	NN	B-NP
O	function	function	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	sites	site	NNS	I-NP
O	,	,	,	O
O	linkages	linkage	NNS	B-NP
O	and	and	CC	O
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	conjugating	conjugate	VBG	B-VP
O	enzyme	enzyme	NN	B-NP
O	(	(	(	O
O	E2	E2	NN	B-NP
O	)	)	)	O
O	specificity	specificity	NN	B-NP
O	are	be	VBP	B-VP
O	controversial	controversial	JJ	B-ADJP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	we	we	PRP	B-NP
O	dissect	dissect	VBP	B-VP
O	the	the	DT	B-NP
O	function	function	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	two	two	CD	I-NP
B-GGP	Chfr	Chfr	NNP	I-NP
O	homologs	homolog	NNS	I-NP
O	in	in	IN	B-PP
O	S	S	NN	B-NP
O	.	.	FW	I-NP
O	cerevisiae	cerevisiae	FW	I-NP
O	,	,	,	I-NP
B-GGP	Chf1	Chf1	NN	I-NP
O	and	and	CC	I-NP
B-GGP	Chf2	Chf2	NN	I-NP
O	,	,	,	O
O	overexpression	overexpression	NN	B-NP
O	of	of	IN	B-PP
O	which	which	WDT	B-NP
O	retard	retard	NN	B-NP
O	cell	cell	NN	I-NP
O	cycle	cycle	NN	I-NP
O	at	at	IN	B-PP
O	both	both	CC	O
O	G	G	NN	B-NP
O	(	(	(	O
O	1	1	CD	B-NP
O	)	)	)	O
O	and	and	CC	O
O	G	G	NN	B-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	)	)	)	O
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	a	a	DT	B-NP
O	genetic	genetic	JJ	I-NP
O	assay	assay	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	establish	establish	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	Ubc4	Ubc4	NN	B-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
B-GGP	Chf2	Chf2	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	G	G	NN	I-NP
O	(	(	(	O
O	1	1	CD	B-NP
O	)	)	)	O
O	cell	cell	NN	B-NP
O	cycle	cycle	NN	I-NP
O	delay	delay	NN	I-NP
O	and	and	CC	O
O	Chf	Chf	NN	B-NP
O	protein	protein	NN	I-NP
O	turnover	turnover	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	contrast	contrast	NN	B-NP
O	,	,	,	O
B-GGP	Ubc13	Ubc13	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	Mms2	Mms2	NN	I-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	G	G	NN	B-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	)	)	)	O
O	delay	delay	NN	B-NP
O	and	and	CC	O
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	contribute	contribute	VB	I-VP
O	to	to	TO	B-PP
O	Chf	Chf	NNP	B-NP
O	protein	protein	NN	I-NP
O	turnover	turnover	NN	I-NP
O	.	.	.	O

O	By	By	IN	B-PP
O	reconstituting	reconstitute	VBG	B-VP
O	cis	cis	NN	B-NP
O	and	and	CC	O
O	trans	trans	AFX	B-NP
O	-	-	HYPH	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	activities	activity	NNS	I-NP
O	of	of	IN	B-PP
O	Chf	Chf	NNP	B-NP
O	proteins	protein	NNS	I-NP
O	in	in	IN	B-PP
O	purified	purify	VBN	B-NP
O	systems	system	NNS	I-NP
O	and	and	CC	O
O	characterizing	characterize	VBG	B-VP
O	sites	site	NNS	B-NP
O	modified	modify	VBN	B-VP
O	and	and	CC	O
O	linkages	linkage	NNS	B-NP
O	formed	form	VBN	B-VP
O	by	by	IN	B-PP
O	tandem	tandem	JJ	B-NP
O	mass	mass	NN	I-NP
O	spectrometry	spectrometry	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	discovered	discover	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	Ubc13	Ubc13	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	Mms2	Mms2	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	modifications	modification	NNS	I-NP
O	are	be	VBP	B-VP
O	a	a	DT	B-NP
O	distinct	distinct	JJ	I-NP
O	subset	subset	NN	I-NP
O	of	of	IN	B-PP
O	those	those	DT	B-NP
O	catalyzed	catalyze	VBN	B-VP
O	by	by	IN	B-PP
B-GGP	Ubc4	Ubc4	NN	B-NP
O	.	.	.	O

O	Mutagenesis	Mutagenesis	NN	B-NP
O	of	of	IN	B-PP
O	Lys	Lys	NNP	B-NP
O	residues	residue	NNS	I-NP
O	identified	identify	VBN	B-VP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	indicates	indicate	VBZ	B-VP
O	that	that	IN	B-SBAR
O	site	site	NN	B-NP
O	-	-	HYPH	O
O	specific	specific	JJ	B-NP
B-GGP	Ubc4	Ubc4	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	Chf	Chf	NN	I-NP
O	protein	protein	NN	I-NP
O	autoubiquitination	autoubiquitination	NN	I-NP
O	is	be	VBZ	B-VP
O	responsible	responsible	JJ	B-ADJP
O	for	for	IN	B-PP
O	Chf	Chf	NN	B-NP
O	protein	protein	NN	I-NP
O	turnover	turnover	NN	I-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
O	combined	combined	JJ	B-NP
O	genetic	genetic	JJ	I-NP
O	and	and	CC	I-NP
O	biochemical	biochemical	JJ	I-NP
O	analyses	analysis	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	Chf	Chf	NN	B-NP
O	proteins	protein	NNS	I-NP
O	have	have	VBP	B-VP
O	dual	dual	JJ	B-NP
O	E2	E2	NN	I-NP
O	specificity	specificity	NN	I-NP
O	accounting	account	VBG	B-VP
O	for	for	IN	B-PP
O	different	different	JJ	B-NP
O	functions	function	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	cell	cell	NN	I-NP
O	cycle	cycle	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	histone	histone	NN	I-NP
O	-	-	HYPH	B-VP
O	like	like	JJ	B-NP
O	NF	NF	NN	I-NP
O	-	-	HYPH	O
O	Y	Y	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	bifunctional	bifunctional	JJ	I-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
O	.	.	.	O

O	NF	NF	NN	B-NP
O	-	-	HYPH	I-NP
O	Y	Y	NN	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	trimeric	trimeric	JJ	I-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
O	containing	contain	VBG	B-VP
B-GGP	H2A	H2A	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	H2B	H2B	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	subunits	subunit	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	specifically	specifically	RB	B-ADVP
O	binds	bind	VBZ	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	CCAAT	CCAAT	NN	I-NP
O	box	box	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	common	common	JJ	I-NP
O	eukaryotic	eukaryotic	JJ	I-NP
O	promoter	promoter	NN	I-NP
O	element	element	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	gain	gain	VB	I-VP
O	insights	insight	NNS	B-NP
O	into	into	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	Y	Y	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	transcriptional	transcriptional	JJ	I-NP
O	regulation	regulation	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	assessed	assess	VBD	B-VP
O	its	its	PRP$	B-NP
O	relationships	relationship	NNS	I-NP
O	with	with	IN	B-PP
O	positive	positive	JJ	B-NP
B-GGP	histone	histone	NN	I-NP
O	marks	mark	NNS	I-NP
O	by	by	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	-	-	HYPH	B-ADJP
O	on	on	IN	B-PP
O	-	-	HYPH	B-NP
O	chip	chip	NN	I-NP
O	and	and	CC	I-NP
O	correlative	correlative	JJ	I-NP
O	-	-	HYPH	I-NP
O	profiling	profiling	NN	I-NP
O	studies	study	NNS	I-NP
O	.	.	.	O

O	Unbiased	Unbiased	JJ	B-NP
O	identification	identification	NN	I-NP
O	of	of	IN	B-PP
O	binding	bind	VBG	B-NP
O	sites	site	NNS	I-NP
O	shows	show	VBZ	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	majority	majority	NN	I-NP
O	of	of	IN	B-PP
O	genes	gene	NNS	B-NP
O	are	be	VBP	B-VP
O	bound	bind	VBN	I-VP
O	by	by	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	Y	Y	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	promoter	promoter	NN	I-NP
O	and	and	CC	O
O	/	/	SYM	B-NP
O	or	or	CC	O
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	coding	cod	VBG	I-NP
O	region	region	NN	I-NP
O	.	.	.	O

O	Parallel	Parallel	JJ	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
B-GGP	H3K9	H3K9	NN	B-NP
O	-	-	HYPH	B-NP
O	14ac	14ac	NN	I-NP
O	and	and	CC	I-NP
B-GGP	H3K4me3	H3K4me3	NN	I-NP
O	sites	site	NNS	I-NP
O	indicates	indicate	VBZ	B-VP
O	that	that	IN	B-SBAR
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	Y	Y	NN	I-NP
O	loci	locus	NNS	I-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	divided	divide	VBN	I-VP
O	in	in	IN	B-PP
O	two	two	CD	B-NP
O	distinct	distinct	JJ	I-NP
O	clusters	cluster	NNS	I-NP
O	:	:	:	O
O	(	(	(	B-LST
O	i	i	LS	I-LST
O	)	)	)	O
O	a	a	DT	B-NP
O	large	large	JJ	I-NP
O	cohort	cohort	NN	I-NP
O	contains	contain	VBZ	B-VP
B-GGP	H3K9	H3K9	NN	B-NP
O	-	-	HYPH	I-NP
O	14ac	14ac	NN	I-NP
O	and	and	CC	I-NP
B-GGP	H3K4me3	H3K4me3	NN	I-NP
O	marks	mark	NNS	I-NP
O	and	and	CC	O
O	correlates	correlate	VBZ	B-VP
O	with	with	IN	B-PP
O	expression	expression	NN	B-NP
O	and	and	CC	O
O	(	(	(	B-LST
O	ii	ii	LS	I-LST
O	)	)	)	O
O	a	a	DT	B-NP
O	sizeable	sizeable	JJ	I-NP
O	group	group	NN	I-NP
O	is	be	VBZ	B-VP
O	devoid	devoid	JJ	B-ADJP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	marks	mark	NNS	I-NP
O	and	and	CC	O
O	is	be	VBZ	B-VP
O	found	find	VBN	I-VP
O	on	on	IN	B-PP
O	transcriptionally	transcriptionally	RB	B-NP
O	silent	silent	JJ	I-NP
O	genes	gene	NNS	I-NP
O	.	.	.	O

O	Within	Within	IN	B-PP
O	this	this	DT	B-NP
O	class	class	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	find	find	VBP	B-VP
O	that	that	IN	B-SBAR
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	Y	Y	NN	I-NP
O	binding	binding	NN	I-NP
O	is	be	VBZ	B-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	negative	negative	JJ	B-NP
O	histone	histone	NN	I-NP
O	marks	mark	NNS	I-NP
O	,	,	,	O
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
B-GGP	H4K20me3	H4K20me3	NN	B-NP
O	and	and	CC	I-NP
B-GGP	H3K27me3	H3K27me3	NN	I-NP
O	.	.	.	O

O	NF	NF	NN	B-NP
O	-	-	HYPH	I-NP
O	Y	Y	NN	I-NP
O	removal	removal	NN	I-NP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	dominant	dominant	JJ	I-NP
O	negative	negative	JJ	I-NP
B-GGP	NF	NF	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	YA	YA	NN	I-NP
O	leads	lead	VBZ	B-VP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	transcription	transcription	NN	I-NP
O	of	of	IN	B-PP
O	expressed	express	VBN	B-NP
O	genes	gene	NNS	I-NP
O	associated	associate	VBN	B-VP
O	with	with	IN	B-PP
B-GGP	H3K4me3	H3K4me3	NN	B-NP
O	and	and	CC	I-NP
B-GGP	H3K9	H3K9	NN	I-NP
O	-	-	HYPH	B-NP
O	14ac	14ac	NN	I-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	increasing	increase	VBG	B-VP
O	the	the	DT	B-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	many	many	JJ	B-NP
O	inactive	inactive	JJ	I-NP
O	genes	gene	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	Y	Y	NN	I-NP
O	is	be	VBZ	B-VP
O	embedded	embed	VBN	I-VP
O	in	in	IN	B-PP
O	positive	positive	JJ	O
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	in	in	IN	B-PP
O	negative	negative	JJ	B-NP
O	methyl	methyl	NN	I-NP
B-GGP	histone	histone	NN	I-NP
O	marks	mark	NNS	I-NP
O	,	,	,	O
O	serving	serve	VBG	B-VP
O	a	a	DT	B-NP
O	dual	dual	JJ	I-NP
O	function	function	NN	I-NP
O	in	in	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	regulation	regulation	NN	I-NP
O	,	,	,	O
O	as	as	IN	B-PP
O	an	an	DT	B-NP
O	activator	activator	NN	I-NP
O	or	or	CC	B-PP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	repressor	repressor	NN	I-NP
O	.	.	.	O

O	Role	Role	NN	B-NP
O	of	of	IN	B-PP
O	S3	S3	NN	B-NP
O	and	and	CC	I-NP
O	S4	S4	NN	I-NP
O	transmembrane	transmembrane	JJ	I-NP
O	domain	domain	NN	I-NP
O	charged	charge	VBD	B-VP
O	amino	amino	JJ	B-NP
O	acids	acid	NNS	I-NP
O	in	in	IN	B-PP
O	channel	channel	NN	B-NP
O	biogenesis	biogenesis	NN	I-NP
O	and	and	CC	I-NP
O	gating	gating	NN	I-NP
O	of	of	IN	B-PP
B-GGP	KCa2	KCa2	NN	B-NP
I-GGP	.	.	.	O
I-GGP	3	3	CD	B-NP
O	and	and	CC	O
B-GGP	KCa3	KCa3	NN	B-NP
I-GGP	.	.	.	B-NP
I-GGP	1	1	CD	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	positively	positively	RB	B-NP
O	charged	charge	VBN	I-NP
O	arginines	arginine	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	fourth	fourth	JJ	I-NP
O	transmembrane	transmembrane	JJ	I-NP
O	domain	domain	NN	I-NP
O	(	(	(	O
O	S4	S4	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	a	a	DT	B-NP
O	single	single	JJ	I-NP
O	negatively	negatively	RB	I-NP
O	charged	charge	VBN	I-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	third	third	JJ	I-NP
O	transmembrane	transmembrane	JJ	I-NP
O	domain	domain	NN	I-NP
O	(	(	(	O
O	S3	S3	NN	B-NP
O	)	)	)	O
O	on	on	IN	B-PP
O	channel	channel	NN	B-NP
O	biogenesis	biogenesis	NN	I-NP
O	and	and	CC	I-NP
O	gating	gating	NN	I-NP
O	of	of	IN	B-PP
O	voltage	voltage	NN	B-NP
O	-	-	HYPH	O
O	gated	gate	VBN	B-NP
O	K	K	NN	I-NP
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	channels	channel	NNS	B-NP
O	(	(	(	O
O	Kv	Kv	NN	B-NP
O	)	)	)	O
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	well	well	RB	I-VP
O	established	establish	VBN	I-VP
O	.	.	.	O

O	Both	Both	CC	O
O	intermediate	intermediate	JJ	O
O	(	(	(	O
B-GGP	KCa3	KCa3	NN	B-NP
I-GGP	.	.	.	I-NP
I-GGP	1	1	CD	I-NP
O	)	)	)	O
O	and	and	CC	O
O	small	small	JJ	B-NP
O	(	(	(	O
O	KCa2	KCa2	NN	B-NP
O	.	.	.	O
O	x	x	NN	O
O	)	)	)	O
O	conductance	conductance	NN	B-NP
O	,	,	,	O
O	Ca	Ca	NN	B-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	+	+	SYM	O
O	)	)	)	O
O	-	-	HYPH	O
O	activated	activate	VBN	B-NP
O	K	K	NN	I-NP
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	channels	channel	NNS	B-NP
O	have	have	VBP	B-VP
O	two	two	CD	B-NP
O	conserved	conserve	VBN	I-NP
O	arginines	arginine	NNS	I-NP
O	in	in	IN	B-PP
O	S4	S4	NN	B-NP
O	and	and	CC	O
O	a	a	DT	B-NP
O	single	single	JJ	I-NP
O	conserved	conserve	VBN	I-NP
O	glutamic	glutamic	JJ	I-NP
O	acid	acid	NN	I-NP
O	in	in	IN	B-PP
O	S3	S3	NN	B-NP
O	,	,	,	O
O	although	although	IN	B-SBAR
O	these	these	DT	B-NP
O	channels	channel	NNS	I-NP
O	are	be	VBP	B-VP
O	voltage	voltage	NN	B-NP
O	-	-	HYPH	B-ADJP
O	independent	independent	JJ	I-ADJP
O	.	.	.	O

O	We	We	PRP	B-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	mutation	mutation	NN	B-NP
O	of	of	IN	B-PP
O	any	any	DT	B-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	charged	charge	VBN	I-NP
O	amino	amino	JJ	I-NP
O	acids	acid	NNS	I-NP
O	in	in	IN	B-PP
B-GGP	KCa3	KCa3	NN	B-NP
I-GGP	.	.	.	O
I-GGP	1	1	CD	B-NP
O	or	or	CC	I-NP
B-GGP	KCa2	KCa2	NN	I-NP
I-GGP	.	.	.	I-NP
I-GGP	3	3	CD	I-NP
O	to	to	TO	B-PP
O	alanine	alanine	NN	B-NP
O	,	,	,	O
O	glutamine	glutamine	NN	B-NP
O	,	,	,	O
O	or	or	CC	O
O	charge	charge	NN	B-NP
O	reversal	reversal	NN	I-NP
O	mutations	mutation	NNS	I-NP
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	rapid	rapid	JJ	I-NP
O	degradation	degradation	NN	I-NP
O	(	(	(	O
O	<	<	SYM	B-NP
O	30	30	CD	B-NP
O	min	min	NN	I-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	total	total	JJ	B-NP
O	protein	protein	NN	I-NP
O	,	,	,	O
O	confirming	confirm	VBG	B-VP
O	the	the	DT	B-NP
O	critical	critical	JJ	I-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	amino	amino	JJ	I-NP
O	acids	acid	NNS	I-NP
O	in	in	IN	B-PP
O	channel	channel	NN	B-NP
O	biogenesis	biogenesis	NN	I-NP
O	.	.	.	O

O	Mutation	Mutation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	S4	S4	NN	I-NP
O	arginine	arginine	NN	I-NP
O	closest	close	JJS	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	cytosolic	cytosolic	JJ	I-NP
O	side	side	NN	I-NP
O	of	of	IN	B-PP
B-GGP	KCa3	KCa3	NN	B-NP
I-GGP	.	.	.	O
I-GGP	1	1	CD	B-NP
O	to	to	TO	B-PP
O	histidine	histidine	NN	B-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	expression	expression	NN	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	cell	cell	NN	I-NP
O	surface	surface	NN	I-NP
O	.	.	.	O

O	Excised	Excise	VBN	B-NP
O	patch	patch	NN	I-NP
O	clamp	clamp	NN	I-NP
O	experiments	experiment	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	Arg	Arg	NN	I-NP
O	/	/	SYM	B-VP
O	His	His	NN	B-NP
O	mutation	mutation	NN	I-NP
O	had	have	VBD	B-VP
O	a	a	DT	B-NP
O	dramatically	dramatically	RB	I-NP
O	reduced	reduce	VBN	I-NP
O	open	open	JJ	I-NP
O	probability	probability	NN	I-NP
O	(	(	(	O
O	P	P	NN	B-NP
O	(	(	(	O
O	o	o	NN	B-NP
O	)	)	)	O
O	)	)	)	O
O	,	,	,	O
O	relative	relative	JJ	B-ADVP
O	to	to	TO	B-PP
O	wild	wild	JJ	B-NP
O	type	type	NN	I-NP
O	channels	channel	NNS	I-NP
O	.	.	.	O

O	Additionally	Additionally	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	demonstrate	demonstrate	VBP	B-VP
O	,	,	,	O
O	using	use	VBG	B-VP
O	a	a	DT	B-NP
O	combination	combination	NN	I-NP
O	of	of	IN	B-PP
O	short	short	JJ	B-NP
O	hairpin	hairpin	NN	I-NP
O	RNA	RNA	NN	I-NP
O	,	,	,	O
O	dominant	dominant	JJ	B-NP
O	negative	negative	JJ	I-NP
O	,	,	,	O
O	and	and	CC	O
O	co	co	AFX	B-NP
O	-	-	HYPH	I-NP
O	immunoprecipitation	immunoprecipitation	NN	B-NP
O	studies	study	NNS	I-NP
O	,	,	,	O
O	that	that	IN	B-SBAR
O	both	both	DT	B-NP
B-GGP	KCa3	KCa3	NN	I-NP
I-GGP	.	.	.	O
I-GGP	1	1	CD	B-NP
O	and	and	CC	I-NP
B-GGP	KCa2	KCa2	NN	I-NP
I-GGP	.	.	.	I-NP
I-GGP	3	3	CD	I-NP
O	are	be	VBP	B-VP
O	translocated	translocate	VBN	I-VP
O	out	out	IN	B-PP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	endoplasmic	endoplasmic	JJ	I-NP
O	reticulum	reticulum	NN	I-NP
O	associated	associate	VBN	B-VP
O	with	with	IN	B-PP
B-GGP	Derlin	Derlin	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	misfolded	misfolded	JJ	I-NP
O	channels	channel	NNS	I-NP
O	are	be	VBP	B-VP
O	poly	poly	RB	B-VP
O	-	-	HYPH	I-VP
O	ubiquitylated	ubiquitylate	VBN	I-VP
O	,	,	,	O
O	recognized	recognize	VBN	B-VP
O	by	by	IN	B-PP
B-GGP	p97	p97	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	targeted	target	VBN	B-VP
O	for	for	IN	B-PP
O	proteasomal	proteasomal	JJ	B-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	S3	S3	NN	B-NP
O	and	and	CC	I-NP
O	S4	S4	NN	I-NP
O	charged	charge	VBD	B-VP
O	amino	amino	JJ	B-NP
O	acids	acid	NNS	I-NP
O	play	play	VBP	B-VP
O	an	an	DT	B-NP
O	evolutionarily	evolutionarily	RB	I-NP
O	conserved	conserve	VBN	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	biogenesis	biogenesis	NN	I-NP
O	and	and	CC	I-NP
O	gating	gating	NN	I-NP
O	of	of	IN	B-PP
O	KCa	KCa	NN	B-NP
O	channels	channel	NNS	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	these	these	DT	B-NP
O	improperly	improperly	RB	I-NP
O	folded	fold	VBN	I-NP
O	K	K	NN	I-NP
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	channels	channel	NNS	B-NP
O	are	be	VBP	B-VP
O	translocated	translocate	VBN	I-VP
O	out	out	IN	B-PP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	endoplasmic	endoplasmic	JJ	I-NP
O	reticulum	reticulum	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
B-GGP	Derlin	Derlin	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	-	-	HYPH	I-NP
O	and	and	CC	I-NP
B-GGP	p97	p97	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	fashion	fashion	NN	I-NP
O	,	,	,	O
O	poly	poly	NN	B-NP
O	-	-	HYPH	O
O	ubiquitylated	ubiquitylate	VBN	B-VP
O	,	,	,	O
O	and	and	CC	O
O	targeted	target	VBN	B-VP
O	for	for	IN	B-PP
O	proteasomal	proteasomal	JJ	B-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	Role	Role	NN	B-NP
O	and	and	CC	I-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	prolyl	prolyl	NN	B-NP
O	hydroxylase	hydroxylase	NN	I-NP
O	domain	domain	NN	I-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	Oxygen	Oxygen	NN	B-NP
O	-	-	HYPH	I-NP
O	dependent	dependent	JJ	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	of	of	IN	B-PP
O	hypoxia	hypoxia	NN	B-NP
O	-	-	HYPH	B-NP
O	inducible	inducible	JJ	I-NP
O	factor	factor	NN	I-NP
O	(	(	(	O
O	HIF	HIF	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	O
O	alpha	alpha	SYM	O
O	subunits	subunit	NNS	B-NP
O	by	by	IN	B-PP
O	prolyl	prolyl	NN	B-NP
O	hydroxylase	hydroxylase	NN	I-NP
O	domain	domain	NN	I-NP
O	(	(	(	O
O	PHD	PHD	NN	B-NP
O	)	)	)	O
O	proteins	protein	NNS	B-NP
O	signals	signal	VBZ	B-VP
O	their	their	PRP$	B-NP
O	polyubiquitination	polyubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	proteasomal	proteasomal	JJ	I-NP
O	degradation	degradation	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	plays	play	VBZ	B-VP
O	a	a	DT	B-NP
O	critical	critical	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	regulating	regulate	VBG	B-VP
O	HIF	HIF	NN	B-NP
O	abundance	abundance	NN	I-NP
O	and	and	CC	O
O	oxygen	oxygen	NN	B-NP
O	homeostasis	homeostasis	NN	I-NP
O	.	.	.	O

O	While	While	IN	B-SBAR
O	oxygen	oxygen	NN	B-NP
O	concentration	concentration	NN	I-NP
O	plays	play	VBZ	B-VP
O	a	a	DT	B-NP
O	major	major	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	determining	determine	VBG	B-VP
O	the	the	DT	B-NP
O	efficiency	efficiency	NN	I-NP
O	of	of	IN	B-PP
O	PHD	PHD	NN	B-NP
O	-	-	HYPH	O
O	catalyzed	catalyze	VBN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	reactions	reaction	NNS	I-NP
O	,	,	,	O
O	many	many	JJ	B-NP
O	other	other	JJ	I-NP
O	environmental	environmental	JJ	I-NP
O	and	and	CC	I-NP
O	intracellular	intracellular	JJ	I-NP
O	factors	factor	NNS	I-NP
O	also	also	RB	B-ADVP
O	significantly	significantly	RB	B-VP
O	modulate	modulate	VB	I-VP
O	PHD	PHD	NN	B-NP
O	activities	activity	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	PHDs	PHD	NNS	B-NP
O	may	may	MD	B-VP
O	also	also	RB	I-VP
O	employ	employ	VB	I-VP
O	hydroxylase	hydroxylase	NN	B-NP
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	mechanisms	mechanism	NNS	I-NP
O	to	to	TO	B-VP
O	modify	modify	VB	I-VP
O	HIF	HIF	NN	B-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	Interestingly	Interestingly	RB	B-ADVP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	PHDs	PHD	NNS	B-NP
O	regulate	regulate	VBP	B-VP
O	HIF	HIF	NN	B-NP
O	-	-	HYPH	O
O	alpha	alpha	SYM	B-NP
O	protein	protein	NN	I-NP
O	stability	stability	NN	I-NP
O	,	,	,	O
B-GGP	PHD2	PHD2	NN	B-NP
O	and	and	CC	I-NP
B-GGP	PHD3	PHD3	NN	I-NP
O	themselves	themselves	PRP	B-NP
O	are	be	VBP	B-VP
O	subject	subject	JJ	B-ADJP
O	to	to	TO	B-PP
O	feedback	feedback	VB	B-VP
O	upregulation	upregulation	NN	B-NP
O	by	by	IN	B-PP
O	HIFs	HIF	NNS	B-NP
O	.	.	.	O

O	Functionally	Functionally	RB	B-ADVP
O	,	,	,	O
O	different	different	JJ	B-NP
O	PHD	PHD	NN	I-NP
O	isoforms	isoform	NNS	I-NP
O	may	may	MD	B-VP
O	differentially	differentially	RB	I-VP
O	contribute	contribute	VB	I-VP
O	to	to	TO	B-PP
O	specific	specific	JJ	B-NP
O	pathophysiological	pathophysiological	JJ	I-NP
O	processes	process	NNS	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	angiogenesis	angiogenesis	NN	B-NP
O	,	,	,	O
O	erythropoiesis	erythropoiesis	NN	B-NP
O	,	,	,	O
O	tumorigenesis	tumorigenesis	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	cell	cell	NN	B-NP
O	growth	growth	NN	I-NP
O	,	,	,	O
O	differentiation	differentiation	NN	B-NP
O	and	and	CC	O
O	survival	survival	NN	B-NP
O	.	.	.	O

O	Because	Because	IN	B-PP
O	of	of	IN	I-PP
O	diverse	diverse	JJ	B-NP
O	roles	role	NNS	I-NP
O	of	of	IN	B-PP
O	PHDs	PHD	NNS	B-NP
O	in	in	IN	B-PP
O	many	many	JJ	B-NP
O	different	different	JJ	I-NP
O	processes	process	NNS	I-NP
O	,	,	,	O
O	loss	loss	NN	B-NP
O	of	of	IN	B-PP
O	PHD	PHD	NN	B-NP
O	expression	expression	NN	I-NP
O	or	or	CC	O
O	function	function	NN	B-NP
O	triggers	trigger	VBZ	B-VP
O	multi	multi	AFX	B-NP
O	-	-	HYPH	I-NP
O	faceted	facet	VBN	B-NP
O	pathophysiological	pathophysiological	JJ	I-NP
O	changes	change	NNS	I-NP
O	as	as	IN	B-SBAR
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	shown	show	VBN	I-VP
O	in	in	IN	B-PP
O	mice	mouse	NNS	B-NP
O	lacking	lack	VBG	B-VP
O	different	different	JJ	B-NP
O	PHD	PHD	NN	I-NP
O	isoforms	isoform	NNS	I-NP
O	.	.	.	O

O	Future	Future	JJ	B-NP
O	investigations	investigation	NNS	I-NP
O	are	be	VBP	B-VP
O	needed	need	VBN	I-VP
O	to	to	TO	B-VP
O	explore	explore	VB	I-VP
O	in	in	FW	B-NP
O	vivo	vivo	FW	I-NP
O	specificity	specificity	NN	I-NP
O	of	of	IN	B-PP
O	PHDs	PHD	NNS	B-NP
O	over	over	IN	B-PP
O	different	different	JJ	B-NP
O	HIF	HIF	NN	I-NP
O	-	-	HYPH	O
O	alpha	alpha	SYM	B-NP
O	subunits	subunit	NNS	B-NP
O	and	and	CC	O
O	differential	differential	JJ	B-NP
O	roles	role	NNS	I-NP
O	of	of	IN	B-PP
O	PHD	PHD	NN	B-NP
O	isoforms	isoform	NNS	I-NP
O	in	in	IN	B-PP
O	different	different	JJ	B-NP
O	biological	biological	JJ	I-NP
O	processes	process	NNS	I-NP
O	.	.	.	O

O	Characterization	Characterization	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	molecular	molecular	JJ	I-NP
O	interaction	interaction	NN	I-NP
O	between	between	IN	B-PP
B-GGP	tropoelastin	tropoelastin	NN	B-NP
O	and	and	CC	I-NP
B-GGP	DANCE	DANCE	NN	I-NP
O	/	/	SYM	B-NP
B-GGP	fibulin	fibulin	NN	I-NP
I-GGP	-	-	SYM	B-NP
I-GGP	5	5	CD	B-NP
O	.	.	.	O

B-GGP	Fibulin	Fibulin	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	5	5	CD	B-NP
O	is	be	VBZ	B-VP
O	believed	believe	VBN	I-VP
O	to	to	TO	I-VP
O	play	play	VB	I-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	elastic	elastic	JJ	I-NP
O	fiber	fiber	NN	I-NP
O	formation	formation	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	present	present	JJ	I-NP
O	experiments	experiment	NNS	I-NP
O	were	be	VBD	B-VP
O	carried	carry	VBN	I-VP
O	out	out	RP	B-PRT
O	to	to	TO	B-VP
O	characterize	characterize	VB	I-VP
O	the	the	DT	B-NP
O	molecular	molecular	JJ	I-NP
O	interaction	interaction	NN	I-NP
O	between	between	IN	B-PP
B-GGP	fibulin	fibulin	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	5	5	CD	I-NP
O	and	and	CC	I-NP
B-GGP	tropoelastin	tropoelastin	NN	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	data	datum	NNS	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	divalent	divalent	JJ	I-NP
O	cations	cation	NNS	I-NP
O	of	of	IN	B-PP
O	Ca	Ca	NN	B-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	+	+	SYM	O
O	)	)	)	O
O	,	,	,	O
O	Ba	Ba	NN	B-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	+	+	SYM	O
O	)	)	)	O
O	and	and	CC	O
O	Mg	Mg	NN	B-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	+	+	SYM	O
O	)	)	)	O
O	significantly	significantly	RB	B-ADVP
O	enhanced	enhance	VBD	B-VP
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
B-GGP	fibulin	fibulin	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	5	5	CD	B-NP
O	to	to	TO	B-PP
B-GGP	tropoelastin	tropoelastin	NN	B-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	N	N	NN	B-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	fibulin	fibulin	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	5	5	CD	B-NP
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	require	require	VB	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	to	to	TO	B-PP
B-GGP	tropoelastin	tropoelastin	NN	B-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	address	address	VB	I-VP
O	the	the	DT	B-NP
B-GGP	fibulin	fibulin	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	5	5	CD	I-NP
O	binding	bind	VBG	I-NP
O	site	site	NN	I-NP
O	on	on	IN	B-PP
B-GGP	tropoelastin	tropoelastin	NN	B-NP
O	constructs	construct	NNS	I-NP
O	containing	contain	VBG	B-VP
O	,	,	,	O
O	exons	exon	NNS	B-NP
O	2	2	CD	I-NP
O	-	-	HYPH	I-NP
O	15	15	CD	I-NP
O	and	and	CC	I-NP
O	exons	exon	NNS	I-NP
O	16	16	CD	B-NP
O	-	-	HYPH	I-NP
O	36	36	CD	I-NP
O	,	,	,	O
O	of	of	IN	B-PP
B-GGP	tropoelastin	tropoelastin	NN	B-NP
O	were	be	VBD	B-VP
O	used	use	VBN	I-VP
O	.	.	.	O

B-GGP	Fibulin	Fibulin	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	5	5	CD	I-NP
O	binding	binding	NN	I-NP
O	was	be	VBD	B-VP
O	significantly	significantly	RB	I-VP
O	reduced	reduce	VBN	I-VP
O	to	to	TO	B-PP
O	either	either	CC	O
O	fragment	fragment	NN	B-NP
O	and	and	CC	O
O	also	also	RB	B-ADVP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	mixture	mixture	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	fragments	fragment	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	suggested	suggest	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	whole	whole	JJ	I-NP
O	molecule	molecule	NN	I-NP
O	of	of	IN	B-PP
B-GGP	tropoelastin	tropoelastin	NN	B-NP
O	was	be	VBD	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	interaction	interaction	NN	I-NP
O	with	with	IN	B-PP
B-GGP	fibulin	fibulin	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	5	5	CD	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	co	co	AFX	B-NP
O	-	-	HYPH	I-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	experiments	experiment	NNS	I-NP
O	,	,	,	O
B-GGP	tropoelastin	tropoelastin	NN	B-NP
O	binding	binding	NN	I-NP
O	to	to	TO	B-PP
B-GGP	fibulin	fibulin	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	5	5	CD	I-NP
O	was	be	VBD	B-VP
O	enhanced	enhance	VBN	I-VP
O	by	by	IN	B-PP
O	an	an	DT	B-NP
O	increase	increase	NN	I-NP
O	of	of	IN	B-PP
O	temperature	temperature	NN	B-NP
O	and	and	CC	I-NP
O	sodium	sodium	NN	I-NP
O	chloride	chloride	NN	I-NP
O	concentration	concentration	NN	I-NP
O	,	,	,	O
O	conditions	condition	NNS	B-NP
O	that	that	WDT	B-NP
O	enhance	enhance	VBP	B-VP
O	the	the	DT	B-NP
O	coacervation	coacervation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	tropoelastin	tropoelastin	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
B-GGP	tropoelastin	tropoelastin	NN	B-NP
O	fragments	fragment	NNS	I-NP
O	to	to	TO	B-PP
B-GGP	fibulin	fibulin	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	5	5	CD	B-NP
O	was	be	VBD	B-VP
O	directly	directly	RB	B-ADJP
O	proportional	proportional	JJ	I-ADJP
O	to	to	TO	B-PP
O	their	their	PRP$	B-NP
O	propensity	propensity	NN	I-NP
O	to	to	TO	B-VP
O	coacervate	coacervate	VB	I-VP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	addition	addition	NN	I-NP
O	of	of	IN	B-PP
B-GGP	fibulin	fibulin	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	5	5	CD	B-NP
O	to	to	TO	B-PP
B-GGP	tropoelastin	tropoelastin	NN	B-NP
O	facilitated	facilitated	JJ	I-NP
O	coacervation	coacervation	NN	I-NP
O	.	.	.	O

O	Taken	Take	VBN	B-VP
O	together	together	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	study	study	NN	I-NP
O	shows	show	VBZ	B-VP
O	that	that	IN	B-SBAR
B-GGP	fibulin	fibulin	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	5	5	CD	B-NP
O	enhances	enhance	VBZ	B-VP
O	elastic	elastic	JJ	B-NP
O	fiber	fiber	NN	I-NP
O	formation	formation	NN	I-NP
O	in	in	IN	B-PP
O	part	part	NN	B-NP
O	by	by	IN	B-PP
O	improving	improve	VBG	B-VP
O	the	the	DT	B-NP
O	self	self	AFX	I-NP
O	-	-	HYPH	I-NP
O	association	association	NN	I-NP
O	properties	property	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	tropoelastin	tropoelastin	NN	B-NP
O	.	.	.	O

O	E3	E3	NN	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
B-GGP	SIAH1	SIAH1	NN	I-NP
O	mediates	mediate	VBZ	B-VP
O	ubiquitination	ubiquitination	NN	B-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	TRB3	TRB3	NN	B-NP
O	.	.	.	O

B-GGP	Tribbles	Tribble	NNS	B-NP
I-GGP	3	3	CD	B-NP
I-GGP	homolog	homolog	NN	I-NP
O	(	(	(	O
B-GGP	TRB3	TRB3	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	recently	recently	RB	I-VP
O	identified	identify	VBN	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	scaffold	scaffold	RB	I-NP
O	-	-	HYPH	I-NP
O	like	like	JJ	I-NP
O	regulator	regulator	NN	I-NP
O	of	of	IN	B-PP
O	various	various	JJ	B-NP
O	signal	signal	NN	I-NP
O	transducers	transducer	NNS	I-NP
O	and	and	CC	O
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	implicated	implicate	VBN	I-VP
O	in	in	IN	B-PP
O	several	several	JJ	B-NP
O	processes	process	NNS	I-NP
O	including	include	VBG	B-PP
B-GGP	insulin	insulin	NN	B-NP
O	signaling	signaling	NN	I-NP
O	,	,	,	O
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	signaling	signaling	NN	I-NP
O	,	,	,	O
O	lipid	lipid	NN	B-NP
O	metabolism	metabolism	NN	I-NP
O	and	and	CC	O
O	BMP	BMP	NN	B-NP
O	signaling	signaling	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	further	further	RB	I-VP
O	understand	understand	VB	I-VP
O	cellular	cellular	JJ	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	TRB3	TRB3	NN	B-NP
O	regulation	regulation	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	performed	perform	VBD	B-VP
O	a	a	DT	B-NP
O	yeast	yeast	NN	I-NP
O	two	two	CD	I-NP
O	-	-	HYPH	I-NP
O	hybrid	hybrid	NN	I-NP
O	screen	screen	NN	I-NP
O	to	to	TO	B-VP
O	identify	identify	VB	I-VP
O	novel	novel	JJ	B-NP
O	TRB3	TRB3	NN	I-NP
O	interacting	interact	VBG	B-VP
O	proteins	protein	NNS	B-NP
O	and	and	CC	O
O	totally	totally	RB	B-VP
O	obtained	obtain	VBD	I-VP
O	ten	ten	CD	B-NP
O	in	in	IN	B-PP
O	-	-	HYPH	B-NP
O	frame	frame	NN	I-NP
O	fused	fuse	VBN	I-NP
O	preys	prey	NNS	I-NP
O	.	.	.	O

O	Candidate	Candidate	NN	B-NP
O	interactions	interaction	NNS	I-NP
O	were	be	VBD	B-VP
O	validated	validate	VBN	I-VP
O	by	by	IN	B-PP
O	co	co	AFX	B-NP
O	-	-	HYPH	I-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	assays	assay	NNS	I-NP
O	in	in	IN	B-PP
O	mammalian	mammalian	JJ	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	further	further	RB	B-ADVP
O	characterized	characterize	VBD	B-VP
O	the	the	DT	B-NP
O	identified	identify	VBN	I-NP
O	proteins	protein	NNS	I-NP
O	sorted	sort	VBN	B-VP
O	by	by	IN	B-PP
O	Gene	Gene	NNP	B-NP
O	Ontology	Ontology	NNP	I-NP
O	Annotation	Annotation	NNP	I-NP
O	.	.	.	O

O	Its	Its	PRP$	B-NP
O	interaction	interaction	NN	I-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	E3	E3	NN	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
B-GGP	SIAH1	SIAH1	NN	I-NP
O	was	be	VBD	B-VP
O	further	further	RB	I-VP
O	investigated	investigate	VBN	I-VP
O	.	.	.	O

B-GGP	SIAH1	SIAH1	NN	B-NP
O	could	could	MD	B-VP
O	interact	interact	VB	I-VP
O	with	with	IN	B-PP
B-GGP	TRB3	TRB3	NN	B-NP
O	both	both	CC	O
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	and	and	CC	O
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	.	.	.	O

O	Importantly	Importantly	RB	B-ADVP
O	,	,	,	O
B-GGP	SIAH1	SIAH1	NN	B-NP
O	targeted	target	VBD	B-VP
B-GGP	TRB3	TRB3	NN	B-NP
O	for	for	IN	B-PP
O	proteasome	proteasome	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	Cotransfection	Cotransfection	NN	B-NP
O	of	of	IN	B-PP
B-GGP	SIAH1	SIAH1	NN	B-NP
O	could	could	MD	B-VP
O	withdraw	withdraw	VB	I-VP
O	up	up	RB	B-ADVP
O	-	-	HYPH	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	TGF	TGF	NN	B-NP
O	-	-	HYPH	O
O	beta	beta	SYM	B-NP
O	signaling	signaling	NN	B-NP
O	by	by	IN	B-PP
B-GGP	TRB3	TRB3	NN	B-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
B-GGP	SIAH1	SIAH1	NN	B-NP
O	-	-	HYPH	O
O	induced	induce	VBN	B-NP
O	degradation	degradation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	TRB3	TRB3	NN	B-NP
O	represents	represent	VBZ	B-VP
O	a	a	DT	B-NP
O	potential	potential	JJ	I-NP
O	regulatory	regulatory	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	for	for	IN	B-PP
O	TGF	TGF	NN	B-NP
O	-	-	HYPH	O
O	beta	beta	SYM	B-NP
O	signaling	signaling	NN	I-NP
O	.	.	.	O

B-GGP	Histone	Histone	NN	B-NP
I-GGP	deacetylase	deacetylase	NN	I-NP
I-GGP	3	3	CD	I-NP
O	localizes	localize	VBZ	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	mitotic	mitotic	JJ	I-NP
O	spindle	spindle	NN	I-NP
O	and	and	CC	O
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	kinetochore	kinetochore	NN	B-NP
O	-	-	HYPH	B-NP
O	microtubule	microtubule	NN	I-NP
O	attachment	attachment	NN	I-NP
O	.	.	.	O

O	Protein	Protein	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	and	and	CC	O
O	deacetylation	deacetylation	NN	B-NP
O	play	play	VBP	B-VP
O	key	key	JJ	B-NP
O	roles	role	NNS	I-NP
O	in	in	IN	B-PP
O	multiple	multiple	JJ	B-NP
O	physiological	physiological	JJ	I-NP
O	functions	function	NNS	I-NP
O	.	.	.	O

B-GGP	Histone	Histone	NN	B-NP
I-GGP	deacetylase	deacetylase	NN	I-NP
I-GGP	3	3	CD	I-NP
O	(	(	(	O
B-GGP	HDAC3	HDAC3	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	highly	highly	RB	I-NP
O	conserved	conserve	VBN	I-NP
O	,	,	,	O
O	ubiquitously	ubiquitously	RB	B-NP
O	expressed	express	VBN	I-NP
O	protein	protein	NN	I-NP
O	that	that	WDT	B-NP
O	forms	form	VBZ	B-VP
O	multiprotein	multiprotein	NN	B-NP
O	corepressor	corepressor	NN	I-NP
O	complexes	complex	NNS	I-NP
O	to	to	TO	B-VP
O	repress	repress	VB	I-VP
O	gene	gene	NN	B-NP
O	transcription	transcription	NN	I-NP
O	.	.	.	O

O	Recent	Recent	JJ	B-NP
O	studies	study	NNS	I-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	HDAC3	HDAC3	NN	B-NP
O	may	may	MD	B-VP
O	play	play	VB	I-VP
O	a	a	DT	B-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	cell	cell	NN	B-NP
O	proliferation	proliferation	NN	I-NP
O	.	.	.	O

O	Altered	Alter	VBN	B-NP
B-GGP	HDAC3	HDAC3	NN	I-NP
O	level	level	NN	I-NP
O	increases	increase	VBZ	B-VP
O	G	G	NN	B-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	)	)	)	O
O	/	/	SYM	B-NP
O	M	M	NN	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	but	but	CC	O
O	the	the	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	remains	remain	VBZ	B-VP
O	unknown	unknown	JJ	B-ADJP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	time	time	NN	I-NP
O	,	,	,	O
O	to	to	TO	B-PP
O	our	our	PRP$	B-NP
O	knowledge	knowledge	NN	I-NP
O	,	,	,	O
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
B-GGP	HDAC3	HDAC3	NN	I-NP
O	complex	complex	NN	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	nuclear	nuclear	JJ	B-NP
O	receptor	receptor	NN	I-NP
O	corepressor	corepressor	NN	I-NP
O	(	(	(	O
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	CoR	CoR	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	transducin	transducin	NN	B-NP
O	-	-	HYPH	O
O	beta	beta	SYM	B-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	protein	protein	NN	I-NP
O	1	1	CD	I-NP
O	(	(	(	O
O	TBL1	TBL1	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
B-GGP	TBL1	TBL1	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	related	relate	VBN	B-VP
I-GGP	protein	protein	NN	B-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
B-GGP	TBLR1	TBLR1	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	is	be	VBZ	B-VP
O	localized	localize	VBN	I-VP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	mitotic	mitotic	JJ	I-NP
O	spindle	spindle	NN	I-NP
O	.	.	.	O

O	Knockdown	Knockdown	NN	B-NP
O	of	of	IN	B-PP
B-GGP	HDAC3	HDAC3	NN	B-NP
O	or	or	CC	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	CoR	CoR	NN	I-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	collapsed	collapsed	JJ	I-NP
O	mitotic	mitotic	JJ	I-NP
O	spindle	spindle	NN	I-NP
O	that	that	WDT	B-NP
O	was	be	VBD	B-VP
O	surrounded	surround	VBN	I-VP
O	by	by	IN	B-PP
O	chromosomes	chromosome	NNS	B-NP
O	arranged	arrange	VBN	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	dome	dome	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	configuration	configuration	NN	I-NP
O	.	.	.	O

O	Treatment	Treatment	NN	B-NP
O	of	of	IN	B-PP
O	mitotic	mitotic	JJ	B-NP
O	cells	cell	NNS	I-NP
O	with	with	IN	B-PP
O	Trichostatin	Trichostatin	NN	B-NP
O	A	A	NN	I-NP
O	,	,	,	O
O	an	an	DT	B-NP
O	HDAC	HDAC	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	,	,	,	O
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	similar	similar	JJ	B-NP
O	spindle	spindle	NN	I-NP
O	defects	defect	NNS	I-NP
O	independent	independent	JJ	B-ADJP
O	of	of	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	regulation	regulation	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	wild	wild	JJ	B-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
B-GGP	HDAC3	HDAC3	NN	I-NP
O	but	but	CC	B-CONJP
O	not	not	RB	I-CONJP
O	a	a	DT	B-NP
O	deacetylase	deacetylase	NN	I-NP
O	-	-	HYPH	B-NP
O	dead	dead	JJ	I-NP
O	mutant	mutant	JJ	I-NP
B-GGP	HDAC3	HDAC3	NN	I-NP
O	rescued	rescue	VBD	B-VP
O	the	the	DT	B-NP
O	phenotypes	phenotype	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	HDAC3	HDAC3	NN	B-NP
O	-	-	HYPH	B-NP
O	depleted	deplete	VBN	I-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	enzymatic	enzymatic	JJ	I-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HDAC3	HDAC3	NN	B-NP
O	is	be	VBZ	B-VP
O	important	important	JJ	B-ADJP
O	for	for	IN	B-PP
O	proper	proper	JJ	B-NP
O	spindle	spindle	NN	I-NP
O	function	function	NN	I-NP
O	.	.	.	O

O	Whereas	Whereas	IN	B-SBAR
O	the	the	DT	B-NP
O	kinetochores	kinetochore	NNS	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	spindle	spindle	NN	I-NP
O	assembly	assembly	NN	I-NP
O	checkpoint	checkpoint	NN	I-NP
O	appeared	appear	VBD	B-VP
O	intact	intact	JJ	B-ADJP
O	in	in	IN	B-PP
B-GGP	HDAC3	HDAC3	NN	B-NP
O	-	-	HYPH	B-NP
O	deficient	deficient	JJ	I-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	kinetochore	kinetochore	NN	B-NP
O	-	-	HYPH	B-NP
O	microtubule	microtubule	NN	I-NP
O	attachments	attachment	NNS	I-NP
O	were	be	VBD	B-VP
O	impaired	impair	VBN	I-VP
O	because	because	IN	B-SBAR
O	spindle	spindle	NN	B-NP
O	microtubules	microtubule	NNS	I-NP
O	were	be	VBD	B-VP
O	unstable	unstable	JJ	B-ADJP
O	in	in	IN	B-PP
O	response	response	NN	B-NP
O	to	to	TO	B-PP
O	cold	cold	JJ	B-NP
O	treatment	treatment	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
B-GGP	HDAC3	HDAC3	NN	I-NP
O	complex	complex	NN	I-NP
O	is	be	VBZ	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	functional	functional	JJ	B-NP
O	mitotic	mitotic	JJ	I-NP
O	spindles	spindle	NNS	I-NP
O	and	and	CC	O
O	proper	proper	JJ	B-NP
O	kinetochore	kinetochore	NN	I-NP
O	-	-	HYPH	B-NP
O	microtubule	microtubule	NN	I-NP
O	attachment	attachment	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	level	level	NN	I-NP
O	or	or	CC	I-NP
O	distribution	distribution	NN	I-NP
O	of	of	IN	B-PP
O	acetylated	acetylate	VBN	B-NP
O	alpha	alpha	SYM	I-NP
O	-	-	HYPH	I-NP
O	tubulin	tubulin	NN	B-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	altered	alter	VBN	I-VP
O	in	in	IN	B-PP
B-GGP	HDAC3	HDAC3	NN	B-NP
O	-	-	HYPH	B-NP
O	deficient	deficient	JJ	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Taken	Take	VBN	B-VP
O	together	together	RB	B-ADVP
O	,	,	,	O
O	our	our	PRP$	B-NP
O	studies	study	NNS	I-NP
O	raise	raise	VBP	B-VP
O	the	the	DT	B-NP
O	interesting	interesting	JJ	I-NP
O	possibility	possibility	NN	I-NP
O	that	that	IN	B-SBAR
O	acetylation	acetylation	NN	B-NP
O	-	-	HYPH	B-NP
O	deacetylation	deacetylation	NN	I-NP
O	of	of	IN	B-PP
O	mitotic	mitotic	JJ	B-NP
O	spindle	spindle	NN	I-NP
O	components	component	NNS	I-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	essential	essential	JJ	B-ADJP
O	for	for	IN	B-PP
O	mitotic	mitotic	JJ	B-NP
O	spindle	spindle	NN	I-NP
O	function	function	NN	I-NP
O	.	.	.	O

B-GGP	VprBP	VprBP	NN	B-NP
O	targets	target	VBZ	B-VP
B-GGP	Merlin	Merlin	NNP	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
B-GGP	Roc1	Roc1	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	Cul4A	Cul4A	NN	I-NP
O	-	-	HYPH	I-NP
B-GGP	DDB1	DDB1	NN	I-NP
O	E3	E3	NN	I-NP
O	ligase	ligase	NN	I-NP
O	complex	complex	NN	I-NP
O	for	for	IN	B-PP
O	degradation	degradation	NN	B-NP
O	.	.	.	O

O	Inactivation	Inactivation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	neurofibromatosis	neurofibromatosis	NN	I-NP
I-GGP	type	type	NN	I-NP
I-GGP	2	2	CD	I-NP
O	(	(	(	O
B-GGP	NF2	NF2	NN	B-NP
O	)	)	)	O
O	tumor	tumor	NN	B-NP
O	suppressor	suppressor	NN	I-NP
O	gene	gene	NN	I-NP
O	function	function	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	observed	observe	VBN	I-VP
O	not	not	RB	B-CONJP
O	only	only	RB	I-CONJP
O	in	in	IN	B-PP
O	familial	familial	JJ	B-NP
O	schwannomas	schwannoma	NNS	I-NP
O	and	and	CC	O
O	other	other	JJ	B-NP
O	central	central	JJ	I-NP
O	nervous	nervous	JJ	I-NP
O	system	system	NN	I-NP
O	tumors	tumor	NNS	I-NP
O	,	,	,	O
O	but	but	CC	B-CONJP
O	also	also	RB	I-CONJP
O	in	in	IN	B-PP
O	malignant	malignant	JJ	B-NP
O	tumors	tumor	NNS	I-NP
O	unrelated	unrelated	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
B-GGP	NF2	NF2	NN	I-NP
O	syndrome	syndrome	NN	I-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	a	a	DT	B-NP
O	broader	broad	JJR	I-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
B-GGP	NF2	NF2	NN	B-NP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	tumorigenesis	tumorigenesis	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	NF2	NF2	NN	I-NP
O	-	-	HYPH	B-VP
O	encoded	encode	VBN	B-NP
O	protein	protein	NN	I-NP
B-GGP	Merlin	Merlin	NN	I-NP
O	is	be	VBZ	B-VP
O	closely	closely	RB	B-ADJP
O	related	related	JJ	I-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
B-GGP	Ezrin	Ezrin	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	Radixin	Radixin	NN	I-NP
O	-	-	HYPH	I-NP
B-GGP	Moesin	Moesin	NN	I-NP
O	family	family	NN	I-NP
O	of	of	IN	B-PP
O	membrane	membrane	NN	B-NP
O	/	/	SYM	B-NP
O	cytoskeleton	cytoskeleton	NN	I-NP
O	linker	linker	NN	I-NP
O	proteins	protein	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	demonstrated	demonstrate	VBN	I-VP
O	to	to	TO	I-VP
O	suppress	suppress	VB	I-VP
O	tumor	tumor	NN	B-NP
O	growth	growth	NN	I-NP
O	by	by	IN	B-PP
O	inhibiting	inhibit	VBG	B-VP
O	extracellular	extracellular	JJ	B-NP
O	signal	signal	NN	I-NP
O	-	-	HYPH	B-NP
O	regulated	regulate	VBN	I-NP
O	kinase	kinase	NN	I-NP
O	(	(	(	O
O	ERK	ERK	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	Rac1	Rac1	NN	B-NP
O	activation	activation	NN	I-NP
O	.	.	.	O

O	Interestingly	Interestingly	RB	B-ADVP
O	,	,	,	O
O	serum	serum	NN	B-NP
O	deprivation	deprivation	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	regulate	regulate	VB	I-VP
B-GGP	Merlin	Merlin	NNP	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	level	level	NN	I-NP
O	,	,	,	O
O	however	however	RB	B-ADVP
O	,	,	,	O
O	exactly	exactly	RB	B-ADVP
O	how	how	WRB	I-ADVP
O	such	such	JJ	B-NP
O	condition	condition	NN	I-NP
O	affects	affect	VBZ	B-VP
B-GGP	Merlin	Merlin	NNP	B-NP
O	remains	remain	VBZ	B-VP
O	elusive	elusive	JJ	B-ADJP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	provide	provide	VBP	B-VP
O	evidence	evidence	NN	B-NP
O	to	to	TO	B-VP
O	show	show	VB	I-VP
O	that	that	IN	B-SBAR
B-GGP	Merlin	Merlin	NNP	B-NP
O	is	be	VBZ	B-VP
O	regulated	regulate	VBN	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
B-GGP	Roc1	Roc1	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	Cullin4A	Cullin4A	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	DDB1	DDB1	NN	I-NP
O	-	-	HYPH	I-NP
O	dependent	dependent	JJ	I-NP
O	manner	manner	NN	I-NP
O	.	.	.	O

O	Following	Follow	VBG	B-PP
O	serum	serum	NN	B-NP
O	stimulation	stimulation	NN	I-NP
O	,	,	,	O
B-GGP	Merlin	Merlin	NNP	B-NP
O	is	be	VBZ	B-VP
O	recruited	recruit	VBN	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	E3	E3	NN	I-NP
O	ligase	ligase	NN	I-NP
O	complex	complex	NN	I-NP
O	through	through	IN	B-PP
O	a	a	DT	B-NP
O	direct	direct	JJ	I-NP
O	interaction	interaction	NN	I-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	WD40	WD40	NN	I-NP
O	-	-	HYPH	O
O	containing	contain	VBG	B-VP
O	adaptor	adaptor	NN	B-NP
O	protein	protein	NN	I-NP
B-GGP	VprBP	VprBP	NN	I-NP
O	.	.	.	O

O	Loading	Load	VBG	B-VP
O	of	of	IN	B-PP
B-GGP	Merlin	Merlin	NNP	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	E3	E3	NN	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	complex	complex	NN	I-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	its	its	PRP$	B-NP
O	polyubiquitination	polyubiquitination	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	consequently	consequently	RB	B-ADVP
O	its	its	PRP$	B-NP
O	proteasome	proteasome	NN	I-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	Consistently	Consistently	RB	B-ADVP
O	,	,	,	O
B-GGP	VprBP	VprBP	NN	B-NP
O	depletion	depletion	NN	I-NP
O	abolished	abolish	VBD	B-VP
O	the	the	DT	B-NP
O	in	in	FW	I-NP
O	vivo	vivo	FW	I-NP
O	interaction	interaction	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Merlin	Merlin	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Roc1	Roc1	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	Cullin4A	Cullin4A	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	DDB1	DDB1	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
B-GGP	Merlin	Merlin	NNP	B-NP
O	stabilization	stabilization	NN	I-NP
O	and	and	CC	O
O	inhibited	inhibit	VBD	B-VP
O	ERK	ERK	NN	B-NP
O	and	and	CC	O
O	Rac	Rac	NN	B-NP
O	activation	activation	NN	I-NP
O	.	.	.	O

O	Together	Together	RB	B-ADVP
O	,	,	,	O
O	our	our	PRP$	B-NP
O	data	datum	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	regulatory	regulatory	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	tumor	tumor	NN	I-NP
O	suppressor	suppressor	NN	I-NP
O	function	function	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Merlin	Merlin	NNP	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	novel	novel	JJ	I-NP
O	gene	gene	NN	I-NP
B-GGP	LRP15	LRP15	NN	I-NP
O	is	be	VBZ	B-VP
O	regulated	regulate	VBN	I-VP
O	by	by	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	O
O	confers	confer	VBZ	B-VP
O	increased	increase	VBN	B-NP
O	efficiency	efficiency	NN	I-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	repair	repair	NN	I-NP
O	of	of	IN	B-PP
O	ultraviolet	ultraviolet	NN	B-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	DNA	DNA	NN	I-NP
O	damage	damage	NN	I-NP
O	.	.	.	O

B-GGP	LRP15	LRP15	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	gene	gene	NN	I-NP
O	cloned	clone	VBN	B-VP
O	from	from	IN	B-PP
O	lymphocytic	lymphocytic	JJ	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	function	function	NN	I-NP
O	is	be	VBZ	B-VP
O	still	still	RB	B-ADVP
O	unknown	unknown	JJ	B-ADJP
O	.	.	.	O

O	Bioinformatic	Bioinformatic	JJ	B-NP
O	data	datum	NNS	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	LRP15	LRP15	NN	B-NP
O	might	might	MD	B-VP
O	be	be	VB	I-VP
O	regulated	regulate	VBN	I-VP
O	by	by	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	O
O	had	have	VBD	B-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	DNA	DNA	NN	B-NP
O	repair	repair	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	investigate	investigate	VBP	B-VP
O	whether	whether	IN	B-SBAR
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	LRP15	LRP15	NN	B-NP
O	is	be	VBZ	B-VP
O	regulated	regulate	VBN	I-VP
O	by	by	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	whether	whether	IN	B-SBAR
O	overexpression	overexpression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	LRP15	LRP15	NN	B-NP
O	increases	increase	VBZ	B-VP
O	efficiency	efficiency	NN	B-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	repair	repair	NN	I-NP
O	of	of	IN	B-PP
O	UV	UV	NN	B-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	DNA	DNA	NN	I-NP
O	damage	damage	NN	I-NP
O	in	in	IN	B-PP
O	HeLa	HeLa	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	showed	show	VBD	B-VP
O	(	(	(	B-LST
O	1	1	LS	I-LST
O	)	)	)	O
O	the	the	DT	B-NP
O	promoter	promoter	NN	I-NP
O	of	of	IN	B-PP
B-GGP	LRP15	LRP15	NN	B-NP
O	was	be	VBD	B-VP
O	hypermethylated	hypermethylate	VBN	I-VP
O	in	in	IN	B-PP
O	HeLa	HeLa	NN	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	resulting	result	VBG	B-VP
O	a	a	DT	B-NP
O	silence	silence	NN	I-NP
O	of	of	IN	B-PP
O	its	its	PRP$	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	Gene	Gene	NN	B-NP
O	expression	expression	NN	I-NP
O	was	be	VBD	B-VP
O	restored	restore	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	demethylating	demethylate	VBG	I-NP
O	agent	agent	NN	I-NP
O	,	,	,	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	I-NP
O	2	2	CD	I-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	deoxycytidine	deoxycytidine	NN	I-NP
O	,	,	,	B-PP
O	but	but	CC	I-PP
O	not	not	RB	I-PP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylase	deacetylase	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	,	,	,	O
O	trichostatin	trichostatin	NN	B-NP
O	A	A	NN	I-NP
O	;	;	:	O
O	(	(	(	B-LST
O	2	2	LS	I-LST
O	)	)	)	O
O	overexpression	overexpression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	LRP15	LRP15	NN	B-NP
O	inhibited	inhibit	VBD	B-VP
O	HeLa	HeLa	NN	B-NP
O	cell	cell	NN	I-NP
O	proliferation	proliferation	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	numbers	number	NNS	I-NP
O	of	of	IN	B-PP
O	cells	cell	NNS	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	G2	G2	NN	I-NP
O	/	/	SYM	B-NP
O	M	M	NN	I-NP
O	phase	phase	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cell	cell	NN	I-NP
O	cycle	cycle	NN	I-NP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	transfected	transfecte	VBN	B-VP
O	with	with	IN	B-PP
B-GGP	LRP15	LRP15	NN	B-NP
O	increased	increase	VBD	B-VP
O	about	about	RB	B-NP
O	10	10	CD	I-NP
O	%	%	NN	I-NP
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	controls	control	NNS	B-NP
O	;	;	:	O
O	(	(	(	B-LST
O	3	3	LS	I-LST
O	)	)	)	O
O	cyclin	cyclin	NN	B-NP
O	B1	B1	NN	I-NP
O	level	level	NN	I-NP
O	was	be	VBD	B-VP
O	much	much	RB	B-ADJP
O	lower	low	JJR	I-ADJP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	overexpressing	overexpresse	VBG	B-VP
B-GGP	LRP15	LRP15	NN	B-NP
O	than	than	IN	B-PP
O	in	in	IN	B-PP
O	control	control	NN	B-NP
O	cells	cell	NNS	I-NP
O	;	;	:	O
O	and	and	CC	O
O	(	(	(	B-LST
O	4	4	LS	I-LST
O	)	)	)	O
O	after	after	IN	B-PP
O	exposure	exposure	NN	B-NP
O	to	to	TO	B-PP
O	UV	UV	NN	B-NP
O	radiation	radiation	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
B-GGP	LRP15	LRP15	NN	I-NP
O	-	-	HYPH	B-NP
O	positive	positive	JJ	I-NP
O	cells	cell	NNS	I-NP
O	showed	show	VBD	B-VP
O	shorter	short	JJR	B-NP
O	comet	comet	NN	I-NP
O	tails	tail	NNS	I-NP
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
B-GGP	LRP15	LRP15	NN	I-NP
O	-	-	HYPH	B-NP
O	negative	negative	JJ	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	From	From	IN	B-PP
O	these	these	DT	B-NP
O	results	result	NNS	I-NP
O	we	we	PRP	B-NP
O	conclude	conclude	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	LRP15	LRP15	NN	B-NP
O	is	be	VBZ	B-VP
O	controlled	control	VBN	I-VP
O	by	by	IN	B-PP
O	methylation	methylation	NN	B-NP
O	in	in	IN	B-PP
O	its	its	PRP$	B-NP
O	promoter	promoter	NN	I-NP
O	in	in	IN	B-PP
O	HeLa	HeLa	NN	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	LRP15	LRP15	NN	B-NP
O	confers	confer	VBZ	B-VP
O	resistance	resistance	NN	B-NP
O	to	to	TO	B-PP
O	UV	UV	NN	B-NP
O	damage	damage	NN	I-NP
O	and	and	CC	O
O	accelerates	accelerate	VBZ	B-VP
O	the	the	DT	B-NP
O	DNA	DNA	NN	I-NP
O	repair	repair	NN	I-NP
O	rate	rate	NN	I-NP
O	.	.	.	O

O	Enzymatic	Enzymatic	JJ	B-NP
O	mechanism	mechanism	NN	I-NP
O	and	and	CC	I-NP
O	product	product	NN	I-NP
O	specificity	specificity	NN	I-NP
O	of	of	IN	B-PP
O	SET	SET	NN	B-NP
O	-	-	HYPH	B-NP
O	domain	domain	NN	I-NP
O	protein	protein	NN	I-NP
O	lysine	lysine	NN	I-NP
O	methyltransferases	methyltransferas	NNS	I-NP
O	.	.	.	O

O	Molecular	Molecular	JJ	B-NP
O	dynamics	dynamic	NNS	I-NP
O	and	and	CC	O
O	hybrid	hybrid	JJ	B-NP
O	quantum	quantum	NN	I-NP
O	mechanics	mechanic	NNS	I-NP
O	/	/	SYM	B-VP
O	molecular	molecular	JJ	B-NP
O	mechanics	mechanic	NNS	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	used	use	VBN	I-VP
O	to	to	TO	B-VP
O	investigate	investigate	VB	I-VP
O	the	the	DT	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	of	of	IN	B-PP
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	AdoMet	AdoMet	NN	B-NP
O	methylation	methylation	NN	I-NP
O	of	of	IN	B-PP
O	protein	protein	NN	B-NP
O	-	-	HYPH	B-NP
O	Lys	Lys	NN	I-NP
O	-	-	HYPH	B-NP
O	NH	NH	NN	I-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	)	)	)	O
O	catalyzed	catalyze	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	lysine	lysine	NN	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	enzymes	enzyme	NNS	I-NP
O	:	:	:	O
O	histone	histone	NN	B-NP
O	lysine	lysine	NN	I-NP
O	monomethyltransferase	monomethyltransferase	NN	I-NP
B-GGP	SET7	SET7	NN	I-NP
I-GGP	/	/	SYM	O
I-GGP	9	9	CD	B-NP
O	,	,	,	O
O	Rubisco	Rubisco	NNP	B-NP
O	large	large	JJ	I-NP
O	-	-	HYPH	I-NP
O	subunit	subunit	NN	I-NP
O	dimethyltransferase	dimethyltransferase	NN	I-NP
O	,	,	,	O
O	viral	viral	JJ	B-NP
O	histone	histone	NN	I-NP
O	lysine	lysine	NN	I-NP
O	trimethyltransferase	trimethyltransferase	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	Tyr245Phe	Tyr245Phe	NN	I-NP
O	mutation	mutation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	SET7	SET7	NN	B-NP
I-GGP	/	/	SYM	B-NP
I-GGP	9	9	CD	I-NP
O	.	.	.	O

O	At	At	IN	B-PP
O	neutrality	neutrality	NN	B-NP
O	in	in	IN	B-PP
O	aqueous	aqueous	JJ	B-NP
O	solution	solution	NN	I-NP
O	,	,	,	O
O	primary	primary	JJ	B-NP
O	amines	amine	NNS	I-NP
O	are	be	VBP	B-VP
O	protonated	protonate	VBN	I-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	enzyme	enzyme	NN	I-NP
O	reacts	react	VBZ	B-VP
O	with	with	IN	B-PP
O	Lys	Lys	NN	B-NP
O	-	-	HYPH	B-NP
O	NH	NH	NN	I-NP
O	(	(	(	O
O	3	3	CD	B-NP
O	)	)	)	O
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	and	and	CC	O
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	AdoMet	AdoMet	NN	B-NP
O	species	specie	NNS	I-NP
O	to	to	TO	B-VP
O	provide	provide	VB	I-VP
O	an	an	DT	B-NP
O	Enz	Enz	NNP	I-NP
O	.	.	.	I-NP
O	Lys	Lys	NNP	I-NP
O	-	-	HYPH	B-NP
O	NH	NH	NN	I-NP
O	(	(	(	O
O	3	3	CD	B-NP
O	)	)	)	O
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	.	.	.	O
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	AdoMet	AdoMet	NN	B-NP
O	complex	complex	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	close	close	JJ	I-NP
O	positioning	positioning	NN	I-NP
O	of	of	IN	B-PP
O	two	two	CD	B-NP
O	positive	positive	JJ	I-NP
O	charges	charge	NNS	I-NP
O	lowers	lower	VBZ	B-VP
O	the	the	DT	B-NP
O	pK	pK	NN	I-NP
O	(	(	(	O
O	a	a	DT	O
O	)	)	)	O
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Lys	Ly	NNPS	I-NP
O	-	-	HYPH	I-NP
O	NH	NH	NN	I-NP
O	(	(	(	O
O	3	3	CD	B-NP
O	)	)	)	O
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	entity	entity	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	water	water	NN	I-NP
O	channel	channel	NN	I-NP
O	appears	appear	VBZ	B-VP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	proton	proton	NN	I-NP
O	escapes	escape	VBZ	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	aqueous	aqueous	JJ	I-NP
O	solvent	solvent	NN	I-NP
O	;	;	:	O
O	then	then	RB	B-ADVP
O	the	the	DT	B-NP
O	reaction	reaction	NN	I-NP
O	Enz	Enz	NNP	I-NP
O	.	.	.	I-NP
O	Lys	Lys	NNP	I-NP
O	-	-	HYPH	B-NP
O	NH	NH	NN	I-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	)	)	)	O
O	.	.	.	O
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	AdoMet	AdoMet	NN	B-NP
O	-	-	SYM	B-VP
O	-	-	HYPH	B-NP
O	>	>	SYM	I-NP
O	Enz	Enz	NN	I-NP
O	.	.	SYM	I-NP
O	Lys	Lys	NN	I-NP
O	-	-	HYPH	O
O	N	N	NN	B-NP
O	(	(	(	O
O	Me	Me	NN	B-NP
O	)	)	)	O
O	H	H	NN	B-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	)	)	)	O
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	.	.	.	O
O	AdoHcy	AdoHcy	NN	B-NP
O	occurs	occur	VBZ	B-VP
O	.	.	.	O

O	Repeat	Repeat	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	sequence	sequence	NN	I-NP
O	provides	provide	VBZ	B-VP
O	dimethylated	dimethylate	VBN	B-NP
O	lysine	lysine	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	another	another	DT	B-NP
O	repeat	repeat	NN	I-NP
O	yields	yield	VBZ	B-VP
O	a	a	DT	B-NP
O	trimethylated	trimethylate	VBN	I-NP
O	lysine	lysine	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	sequence	sequence	NN	I-NP
O	is	be	VBZ	B-VP
O	halted	halt	VBN	I-VP
O	at	at	IN	B-PP
O	monomethylation	monomethylation	NN	B-NP
O	when	when	WRB	B-ADVP
O	the	the	DT	B-NP
O	conformation	conformation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Enz	Enz	NNP	I-NP
O	.	.	.	I-NP
O	Lys	Lys	NNP	I-NP
O	-	-	HYPH	O
O	N	N	NN	B-NP
O	(	(	(	O
O	Me	Me	NN	B-NP
O	)	)	)	O
O	H	H	NN	B-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	)	)	)	O
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	.	.	.	O
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	AdoMet	AdoMet	NN	B-NP
O	has	have	VBZ	B-VP
O	the	the	DT	B-NP
O	methyl	methyl	NN	I-NP
O	positioned	position	VBD	B-VP
O	to	to	TO	I-VP
O	block	block	VB	I-VP
O	formation	formation	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	water	water	NN	I-NP
O	channel	channel	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	sequence	sequence	NN	I-NP
O	of	of	IN	B-PP
O	reactions	reaction	NNS	B-NP
O	stops	stop	NNS	I-NP
O	at	at	IN	B-PP
O	dimethylation	dimethylation	NN	B-NP
O	if	if	IN	B-SBAR
O	the	the	DT	B-NP
O	conformation	conformation	NN	I-NP
O	of	of	IN	B-PP
O	Enz	Enz	NNP	B-NP
O	.	.	.	I-NP
O	Lys	Lys	NNP	I-NP
O	-	-	HYPH	O
O	N	N	NN	B-NP
O	(	(	(	O
O	Me	Me	NN	B-NP
O	)	)	)	O
O	(	(	(	B-LST
O	2	2	LS	I-LST
O	)	)	)	O
O	H	H	NN	B-NP
O	(	(	(	O
O	+	+	SYM	B-NP
O	)	)	)	O
O	.	.	.	O
O	(	(	(	O
O	+	+	SYM	O
O	)	)	)	O
O	AdoMet	AdoMet	NN	B-NP
O	has	have	VBZ	B-VP
O	a	a	DT	B-NP
O	methyl	methyl	NN	I-NP
O	in	in	IN	B-PP
O	position	position	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	forbids	forbid	VBZ	B-VP
O	the	the	DT	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	water	water	NN	I-NP
O	channel	channel	NN	I-NP
O	.	.	.	O

B-GGP	Cdc34p	Cdc34p	NN	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	-	-	HYPH	O
O	conjugating	conjugate	VBG	B-VP
O	enzyme	enzyme	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	component	component	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	tombusvirus	tombusvirus	NN	I-NP
O	replicase	replicase	NN	I-NP
O	complex	complex	NN	I-NP
O	and	and	CC	O
O	ubiquitinates	ubiquitinate	VBZ	B-VP
B-GGP	p33	p33	NN	B-NP
O	replication	replication	NN	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	identify	identify	VB	I-VP
O	host	host	NN	B-NP
O	proteins	protein	NNS	I-NP
O	interacting	interact	VBG	B-VP
O	with	with	IN	B-PP
O	Tomato	Tomato	NNP	B-NP
O	bushy	bushy	JJ	I-NP
O	stunt	stunt	NN	I-NP
O	virus	virus	NN	I-NP
O	(	(	(	O
O	TBSV	TBSV	NN	B-NP
O	)	)	)	O
O	replication	replication	NN	B-NP
O	proteins	protein	NNS	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	genome	genome	NN	I-NP
O	-	-	HYPH	B-NP
O	wide	wide	JJ	I-NP
O	scale	scale	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	have	have	VBP	B-VP
O	used	use	VBN	I-VP
O	a	a	DT	B-NP
O	yeast	yeast	NN	I-NP
O	(	(	(	O
O	Saccharomyces	Saccharomyces	NNP	B-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	)	)	)	O
O	proteome	proteome	NN	B-NP
O	microarray	microarray	NN	I-NP
O	carrying	carry	VBG	B-VP
O	4	4	CD	B-NP
O	,	,	,	O
O	088	088	CD	B-NP
O	purified	purify	VBN	I-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	approach	approach	NN	I-NP
O	led	lead	VBD	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	identification	identification	NN	I-NP
O	of	of	IN	B-PP
O	58	58	CD	B-NP
O	yeast	yeast	NN	I-NP
O	proteins	protein	NNS	I-NP
O	that	that	WDT	B-NP
O	interacted	interact	VBD	B-VP
O	with	with	IN	B-PP
B-GGP	p33	p33	NN	B-NP
O	replication	replication	NN	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	identified	identify	VBN	I-NP
O	host	host	NN	I-NP
O	proteins	protein	NNS	I-NP
O	included	include	VBD	B-VP
O	protein	protein	NN	B-NP
O	chaperones	chaperone	NNS	I-NP
O	,	,	,	O
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	-	-	HYPH	B-NP
O	associated	associate	VBN	I-NP
O	proteins	protein	NNS	I-NP
O	,	,	,	O
O	translation	translation	NN	B-NP
O	factors	factor	NNS	I-NP
O	,	,	,	O
O	RNA	RNA	NN	B-NP
O	-	-	HYPH	O
O	modifying	modify	VBG	B-VP
O	enzymes	enzyme	NNS	B-NP
O	,	,	,	O
O	and	and	CC	O
O	other	other	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	with	with	IN	B-PP
O	yet	yet	RB	B-NP
O	-	-	HYPH	I-NP
O	unknown	unknown	JJ	I-NP
O	functions	function	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	confirmed	confirm	VBD	B-VP
O	that	that	IN	B-SBAR
O	19	19	CD	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	identified	identify	VBN	I-NP
O	host	host	NN	I-NP
O	proteins	protein	NNS	I-NP
O	bound	bind	VBN	B-VP
O	to	to	TO	B-PP
B-GGP	p33	p33	NN	B-NP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	or	or	CC	O
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	split	split	JJ	I-NP
O	-	-	HYPH	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	-	-	HYPH	O
O	based	base	VBN	B-VP
O	two	two	CD	B-NP
O	-	-	HYPH	I-NP
O	hybrid	hybrid	NN	I-NP
O	assay	assay	NN	I-NP
O	.	.	.	O

O	Further	Further	JJ	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Cdc34p	Cdc34p	NN	B-NP
O	E2	E2	NN	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	-	-	HYPH	O
O	conjugating	conjugate	VBG	B-VP
O	enzyme	enzyme	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	one	one	CD	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	host	host	NN	I-NP
O	proteins	protein	NNS	I-NP
O	interacting	interact	VBG	B-VP
O	with	with	IN	B-PP
B-GGP	p33	p33	NN	B-NP
O	,	,	,	O
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	Cdc34p	Cdc34p	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	component	component	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	purified	purify	VBN	I-NP
O	viral	viral	JJ	I-NP
O	replicase	replicase	NN	I-NP
O	.	.	.	O

O	Downregulation	Downregulation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	Cdc34p	Cdc34p	NN	B-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	yeast	yeast	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	supports	support	VBZ	B-VP
O	replication	replication	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	TBSV	TBSV	NN	I-NP
O	replicon	replicon	NN	I-NP
O	RNA	RNA	NN	I-NP
O	(	(	(	O
O	repRNA	repRNA	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	reduced	reduce	VBD	B-VP
O	repRNA	repRNA	NN	B-NP
O	accumulation	accumulation	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	tombusvirus	tombusvirus	NN	I-NP
O	replicase	replicase	NN	I-NP
O	by	by	IN	B-PP
O	up	up	RB	B-NP
O	to	to	TO	I-NP
O	fivefold	fivefold	RB	I-NP
O	.	.	.	O

O	Overexpression	Overexpression	NN	B-NP
O	of	of	IN	B-PP
O	wild	wild	JJ	B-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
B-GGP	Cdc34p	Cdc34p	NN	I-NP
O	,	,	,	O
O	but	but	CC	B-CONJP
O	not	not	RB	I-CONJP
O	that	that	DT	B-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	E2	E2	NN	I-NP
O	-	-	HYPH	B-NP
O	defective	defective	JJ	I-NP
O	mutant	mutant	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Cdc34p	Cdc34p	NN	B-NP
O	,	,	,	O
O	increased	increase	VBD	B-VP
O	repRNA	repRNA	NN	B-NP
O	accumulation	accumulation	NN	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	a	a	DT	B-NP
O	significant	significant	JJ	I-NP
O	role	role	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	-	-	HYPH	O
O	conjugating	conjugate	VBG	B-VP
O	enzyme	enzyme	NN	B-NP
O	function	function	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Cdc34p	Cdc34p	NN	B-NP
O	in	in	IN	B-PP
O	TBSV	TBSV	NN	B-NP
O	replication	replication	NN	I-NP
O	.	.	.	O

O	Also	Also	RB	B-ADVP
O	,	,	,	O
B-GGP	Cdc34p	Cdc34p	NN	B-NP
O	was	be	VBD	B-VP
O	able	able	JJ	B-ADJP
O	to	to	TO	B-VP
O	ubiquitinate	ubiquitinate	VB	I-VP
B-GGP	p33	p33	NN	B-NP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	have	have	VBP	B-VP
O	shown	show	VBN	I-VP
O	that	that	IN	B-SBAR
B-GGP	p33	p33	NN	B-NP
O	becomes	become	VBZ	B-VP
O	ubiquitinated	ubiquitinate	VBN	I-VP
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	.	.	.	O

O	We	We	PRP	B-NP
O	propose	propose	VBP	B-VP
O	that	that	IN	B-SBAR
O	ubiquitination	ubiquitination	NN	B-NP
O	of	of	IN	B-PP
B-GGP	p33	p33	NN	B-NP
O	likely	likely	RB	B-VP
O	alters	alter	VBZ	I-VP
O	its	its	PRP$	B-NP
O	function	function	NN	I-NP
O	or	or	CC	O
O	affects	affect	VBZ	B-VP
O	the	the	DT	B-NP
O	recruitment	recruitment	NN	I-NP
O	of	of	IN	B-PP
O	host	host	NN	B-NP
O	factors	factor	NNS	I-NP
O	during	during	IN	B-PP
O	TBSV	TBSV	NN	B-NP
O	replication	replication	NN	I-NP
O	.	.	.	O

B-GGP	O6	O6	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	Methylguanine	Methylguanine	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	DNA	DNA	NN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	methyltransferase	methyltransferase	NN	I-NP
O	in	in	IN	B-PP
O	recurring	recur	VBG	B-VP
O	anaplastic	anaplastic	JJ	B-NP
O	ependymomas	ependymoma	NNS	I-NP
O	:	:	:	O
O	PCR	PCR	NN	B-NP
O	and	and	CC	I-NP
O	immunohistochemistry	immunohistochemistry	NN	I-NP
O	.	.	.	O

O	Ependymomas	Ependymoma	NNS	B-NP
O	are	be	VBP	B-VP
O	the	the	DT	B-NP
O	third	third	JJ	I-NP
O	most	most	RBS	I-NP
O	common	common	JJ	I-NP
O	brain	brain	NN	I-NP
O	tumor	tumor	NN	I-NP
O	in	in	IN	B-PP
O	children	child	NNS	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	post	post	RBS	I-NP
O	surgical	surgical	JJ	I-NP
O	management	management	NN	I-NP
O	is	be	VBZ	B-VP
O	controversial	controversial	JJ	B-ADJP
O	.	.	.	O

O	There	There	EX	B-NP
O	are	be	VBP	B-VP
O	no	no	DT	B-NP
O	convincing	convincing	JJ	I-NP
O	data	datum	NNS	I-NP
O	on	on	IN	B-PP
O	an	an	DT	B-NP
O	effective	effective	JJ	I-NP
O	role	role	NN	I-NP
O	for	for	IN	B-PP
O	chemotherapy	chemotherapy	NN	B-NP
O	.	.	.	O

B-GGP	O	O	NN	B-NP
I-GGP	(	(	(	O
I-GGP	6	6	CD	B-NP
I-GGP	)	)	)	O
I-GGP	-	-	HYPH	B-NP
I-GGP	Methylguanine	Methylguanine	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	DNA	DNA	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	Methyltransferase	Methyltransferase	NN	B-NP
O	(	(	(	O
B-GGP	MGMT	MGMT	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	DNA	DNA	NN	I-NP
O	repair	repair	NN	I-NP
O	protein	protein	NN	I-NP
O	considered	consider	VBN	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	a	a	DT	B-NP
O	chemosensitivity	chemosensitivity	NN	I-NP
O	predictor	predictor	NN	I-NP
O	.	.	.	O

O	Hypermethylation	Hypermethylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	MGMT	MGMT	NN	I-NP
O	gene	gene	NN	I-NP
O	promoter	promoter	NN	I-NP
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	cause	cause	NN	I-NP
O	of	of	IN	B-PP
B-GGP	MGMT	MGMT	NN	B-NP
O	inactivation	inactivation	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	evaluated	evaluate	VBD	B-VP
O	the	the	DT	B-NP
B-GGP	MGMT	MGMT	NN	I-NP
O	gene	gene	NN	I-NP
O	promoter	promoter	NN	I-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	immunohistochemical	immunohistochemical	JJ	I-NP
B-GGP	MGMT	MGMT	NN	I-NP
O	protein	protein	NN	I-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	12	12	CD	B-NP
O	recurrent	recurrent	JJ	I-NP
O	anaplastic	anaplastic	JJ	I-NP
O	ependymomas	ependymoma	NNS	I-NP
O	affecting	affect	VBG	B-VP
O	children	child	NNS	B-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	purpose	purpose	NN	I-NP
O	was	be	VBD	B-VP
O	to	to	TO	B-VP
O	investigate	investigate	VB	I-VP
O	the	the	DT	B-NP
O	molecular	molecular	JJ	I-NP
O	rationale	rationale	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	administration	administration	NN	I-NP
O	of	of	IN	B-PP
O	alkylating	alkylate	VBG	B-VP
O	agents	agent	NNS	B-NP
O	to	to	TO	B-PP
O	children	child	NNS	B-NP
O	affected	affect	VBN	B-VP
O	by	by	IN	B-PP
O	recurrent	recurrent	JJ	B-NP
O	anaplastic	anaplastic	JJ	I-NP
O	ependymomas	ependymoma	NNS	I-NP
O	.	.	.	O

O	All	All	DT	B-NP
O	ependymomas	ependymoma	NNS	I-NP
O	lacked	lack	VBD	B-VP
B-GGP	MGMT	MGMT	NN	B-NP
O	promoter	promoter	NN	I-NP
O	hypermethylation	hypermethylation	NN	I-NP
O	and	and	CC	O
O	9	9	CD	B-NP
O	(	(	(	O
O	75	75	CD	B-NP
O	%	%	NN	I-NP
O	)	)	)	O
O	showed	show	VBD	B-VP
O	high	high	JJ	B-NP
B-GGP	MGMT	MGMT	NN	I-NP
O	protein	protein	NN	I-NP
O	expression	expression	NN	I-NP
O	(	(	(	O
O	>	>	SYM	B-NP
O	50	50	CD	B-NP
O	%	%	NN	I-NP
O	tumoral	tumoral	JJ	I-NP
O	cells	cell	NNS	I-NP
O	)	)	)	O
O	.	.	.	O

O	Differences	Difference	NNS	B-NP
O	between	between	IN	B-PP
O	different	different	JJ	B-NP
O	recurrences	recurrence	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	same	same	JJ	I-NP
O	patient	patient	NN	I-NP
O	were	be	VBD	B-VP
O	not	not	RB	I-VP
O	observed	observe	VBN	I-VP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	may	may	MD	B-VP
O	indicate	indicate	VB	I-VP
B-GGP	MGMT	MGMT	NNP	B-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	factor	factor	NN	I-NP
O	of	of	IN	B-PP
O	chemoresistance	chemoresistance	NN	B-NP
O	to	to	TO	B-PP
O	alkylating	alkylate	VBG	B-VP
O	drugs	drug	NNS	B-NP
O	in	in	IN	B-PP
O	anaplastic	anaplastic	JJ	B-NP
O	ependymomas	ependymoma	NNS	I-NP
O	and	and	CC	O
O	support	support	VBP	B-VP
O	the	the	DT	B-NP
O	uncertainties	uncertainty	NNS	I-NP
O	regarding	regard	VBG	B-VP
O	the	the	DT	B-NP
O	actual	actual	JJ	I-NP
O	benefit	benefit	NN	I-NP
O	of	of	IN	B-PP
O	chemotherapy	chemotherapy	NN	B-NP
O	for	for	IN	B-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
O	anaplastic	anaplastic	JJ	B-NP
O	ependymomas	ependymoma	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	aggresome	aggresome	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	target	target	NN	I-NP
O	for	for	IN	B-PP
O	therapy	therapy	NN	B-NP
O	in	in	IN	B-PP
O	hematologic	hematologic	JJ	B-NP
O	malignancies	malignancy	NNS	I-NP
O	.	.	.	O

O	Misfolded	Misfolde	VBN	B-NP
O	or	or	CC	I-NP
O	unfolded	unfolded	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	are	be	VBP	B-VP
O	often	often	RB	I-VP
O	refolded	refolde	VBN	I-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	help	help	NN	I-NP
O	of	of	IN	B-PP
O	chaperones	chaperone	NNS	B-NP
O	or	or	CC	O
O	degraded	degrade	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	26S	26S	NN	I-NP
O	proteasome	proteasome	NN	I-NP
O	.	.	.	O

O	An	An	DT	B-NP
O	alternative	alternative	JJ	I-NP
O	fate	fate	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	proteins	protein	NNS	I-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	aggresome	aggresome	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	microtubule	microtubule	NN	I-NP
O	-	-	HYPH	O
O	organizing	organize	VBG	B-VP
O	center	center	NN	B-NP
O	(	(	(	O
O	MTOC	MTOC	NN	B-NP
O	)	)	)	O
O	transports	transport	VBZ	B-VP
O	unfolded	unfolded	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	to	to	TO	B-PP
O	lysosomes	lysosome	NNS	B-NP
O	and	and	CC	O
O	are	be	VBP	B-VP
O	degraded	degrade	VBN	I-VP
O	through	through	IN	B-PP
O	autophagy	autophagy	NN	B-NP
O	.	.	.	O

B-GGP	Histone	Histone	NN	B-NP
I-GGP	deacetylase	deacetylase	NN	I-NP
I-GGP	6	6	CD	I-NP
O	(	(	(	O
B-GGP	HDAC6	HDAC6	NN	B-NP
O	)	)	)	O
O	deacetylates	deacetylate	VBZ	B-VP
O	alpha	alpha	SYM	O
O	-	-	HYPH	O
O	tubulin	tubulin	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	thought	think	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	a	a	DT	B-NP
O	component	component	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	MTOC	MTOC	NN	I-NP
O	.	.	.	O

O	Recently	Recently	RB	B-ADVP
O	,	,	,	O
O	two	two	CD	B-NP
O	small	small	JJ	I-NP
O	molecule	molecule	NN	I-NP
O	inhibitors	inhibitor	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	aggresome	aggresome	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	and	and	CC	I-NP
B-GGP	HDAC6	HDAC6	NN	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	described	describe	VBN	I-VP
O	.	.	.	O

O	One	One	CD	B-NP
O	inhibitor	inhibitor	NN	I-NP
O	,	,	,	O
O	tubacin	tubacin	NN	B-NP
O	,	,	,	O
O	prevents	prevent	VBZ	B-VP
O	deacetylation	deacetylation	NN	B-NP
O	of	of	IN	B-PP
O	alpha	alpha	SYM	O
O	-	-	HYPH	O
O	tubulin	tubulin	NN	B-NP
O	and	and	CC	O
O	produces	produce	VBZ	B-VP
O	accumulation	accumulation	NN	B-NP
O	of	of	IN	B-PP
O	polyubiquitinated	polyubiquitinated	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	and	and	CC	I-NP
O	apoptosis	apoptosis	NN	I-NP
O	.	.	.	O

O	Tubacin	Tubacin	NN	B-NP
O	acts	act	VBZ	B-VP
O	synergistically	synergistically	RB	B-ADVP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	proteasome	proteasome	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	,	,	,	O
O	bortezomib	bortezomib	NN	B-NP
O	,	,	,	O
O	to	to	TO	B-VP
O	induce	induce	VB	I-VP
O	cytotoxicity	cytotoxicity	NN	B-NP
O	in	in	IN	B-PP
O	one	one	CD	B-NP
O	type	type	NN	I-NP
O	of	of	IN	B-PP
O	hematologic	hematologic	JJ	B-NP
O	malignancy	malignancy	NN	I-NP
O	,	,	,	O
O	multiple	multiple	JJ	B-NP
O	myeloma	myeloma	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	other	other	JJ	I-NP
O	,	,	,	I-NP
O	LBH589	LBH589	NN	I-NP
O	,	,	,	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	pan	pan	NN	I-NP
O	HDAC	HDAC	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	and	and	CC	O
O	hydroxamic	hydroxamic	JJ	B-NP
O	acid	acid	NN	I-NP
O	derivative	derivative	NN	I-NP
O	that	that	WDT	B-NP
O	induces	induce	VBZ	B-VP
O	apoptosis	apoptosis	NN	B-NP
O	of	of	IN	B-PP
O	multiple	multiple	JJ	B-NP
O	myeloma	myeloma	NN	I-NP
O	cells	cell	NNS	I-NP
O	resistant	resistant	JJ	B-ADJP
O	to	to	TO	B-PP
O	conventional	conventional	JJ	B-NP
O	therapies	therapy	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	review	review	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	summarize	summarize	VBP	B-VP
O	recent	recent	JJ	B-NP
O	reports	report	NNS	I-NP
O	on	on	IN	B-PP
O	targeting	target	VBG	B-VP
O	the	the	DT	B-NP
O	aggresome	aggresome	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	and	and	CC	I-NP
B-GGP	HDAC6	HDAC6	NN	I-NP
O	in	in	IN	B-PP
O	hematologic	hematologic	JJ	B-NP
O	malignancies	malignancy	NNS	I-NP
O	.	.	.	O

O	Interactions	Interaction	NNS	B-NP
O	between	between	IN	B-PP
O	the	the	DT	B-NP
O	quality	quality	NN	I-NP
O	control	control	NN	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
B-GGP	CHIP	CHIP	NN	I-NP
O	and	and	CC	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	conjugating	conjugate	VBG	B-VP
O	enzymes	enzyme	NNS	B-NP
O	.	.	.	O

O	BACKGROUND	BACKGROUND	NN	B-NP
O	:	:	:	O
B-GGP	Ubiquitin	Ubiquitin	NN	B-NP
O	(	(	(	O
O	E3	E3	NN	B-NP
O	)	)	)	O
O	ligases	ligas	NNS	B-NP
O	interact	interact	VBP	B-VP
O	with	with	IN	B-PP
O	specific	specific	JJ	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	conjugating	conjugate	VBG	B-VP
O	(	(	(	O
O	E2	E2	NN	B-NP
O	)	)	)	O
O	enzymes	enzyme	NNS	B-NP
O	to	to	TO	B-VP
O	ubiquitinate	ubiquitinate	VB	I-VP
O	particular	particular	JJ	B-NP
O	substrate	substrate	NN	I-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	As	As	IN	B-SBAR
O	the	the	DT	B-NP
O	combination	combination	NN	I-NP
O	of	of	IN	B-PP
O	E2	E2	NN	B-NP
O	and	and	CC	I-NP
O	E3	E3	NN	I-NP
O	dictates	dictate	VBZ	B-VP
O	the	the	DT	B-NP
O	type	type	NN	I-NP
O	and	and	CC	I-NP
O	biological	biological	JJ	I-NP
O	consequence	consequence	NN	I-NP
O	of	of	IN	B-PP
O	ubiquitination	ubiquitination	NN	B-NP
O	,	,	,	O
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	important	important	JJ	B-ADJP
O	to	to	TO	B-VP
O	understand	understand	VB	I-VP
O	the	the	DT	B-NP
O	basis	basis	NN	I-NP
O	of	of	IN	B-PP
O	specificity	specificity	NN	B-NP
O	in	in	IN	B-PP
O	E2	E2	NN	B-NP
O	:	:	:	O
O	E3	E3	NN	B-NP
O	interactions	interaction	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	E3	E3	NN	I-NP
O	ligase	ligase	NN	I-NP
B-GGP	CHIP	CHIP	NN	I-NP
O	interacts	interact	VBZ	B-VP
O	with	with	IN	B-PP
O	Hsp70	Hsp70	NN	B-NP
O	and	and	CC	I-NP
O	Hsp90	Hsp90	NN	I-NP
O	and	and	CC	O
O	ubiquitinates	ubiquitinate	VBZ	B-VP
O	client	client	NN	B-NP
O	proteins	protein	NNS	I-NP
O	that	that	WDT	B-NP
O	are	be	VBP	B-VP
O	chaperoned	chaperon	VBN	I-VP
O	by	by	IN	B-PP
O	these	these	DT	B-NP
O	heat	heat	NN	I-NP
O	shock	shock	NN	I-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

B-GGP	CHIP	CHIP	NN	B-NP
O	interacts	interact	VBZ	B-VP
O	with	with	IN	B-PP
O	two	two	CD	B-NP
O	types	type	NNS	I-NP
O	of	of	IN	B-PP
O	E2	E2	NN	B-NP
O	enzymes	enzyme	NNS	I-NP
O	,	,	,	O
B-GGP	UbcH5	UbcH5	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Ubc13	Ubc13	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	Uev1a	Uev1a	NN	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	is	be	VBZ	B-VP
O	unclear	unclear	JJ	B-ADJP
O	,	,	,	O
O	however	however	RB	B-ADVP
O	,	,	,	O
O	why	why	WRB	B-ADVP
B-GGP	CHIP	CHIP	NN	B-NP
O	binds	bind	VBZ	B-VP
O	these	these	DT	B-NP
O	E2	E2	NN	I-NP
O	enzymes	enzyme	NNS	I-NP
O	rather	rather	RB	B-PP
O	than	than	IN	I-PP
O	others	other	NNS	B-NP
O	,	,	,	O
O	and	and	CC	O
O	whether	whether	IN	B-SBAR
B-GGP	CHIP	CHIP	NN	B-NP
O	interacts	interact	VBZ	B-VP
O	preferentially	preferentially	RB	B-ADVP
O	with	with	IN	B-PP
B-GGP	UbcH5	UbcH5	NN	B-NP
O	or	or	CC	I-NP
B-GGP	Ubc13	Ubc13	NN	I-NP
O	-	-	HYPH	O
B-GGP	Uev1a	Uev1a	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	form	form	VBP	B-VP
O	different	different	JJ	B-NP
O	types	type	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	polyubiquitin	polyubiquitin	NN	B-NP
O	chains	chain	NNS	I-NP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
O	The	The	DT	B-NP
O	2	2	CD	I-NP
O	.	.	.	I-NP
O	9	9	CD	I-NP
O	A	A	NN	I-NP
O	crystal	crystal	NN	I-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	CHIP	CHIP	NN	I-NP
O	U	U	NN	I-NP
O	-	-	HYPH	B-NP
O	box	box	NN	I-NP
O	domain	domain	NN	I-NP
O	complexed	complexe	VBN	B-VP
O	with	with	IN	B-PP
B-GGP	UbcH5a	UbcH5a	NN	B-NP
O	shows	show	VBZ	B-VP
O	that	that	IN	B-SBAR
B-GGP	CHIP	CHIP	NN	B-NP
O	binds	bind	VBZ	B-VP
O	to	to	TO	B-PP
B-GGP	UbcH5	UbcH5	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Ubc13	Ubc13	NN	I-NP
O	through	through	IN	B-PP
O	similar	similar	JJ	B-NP
O	specificity	specificity	NN	I-NP
O	determinants	determinant	NNS	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	a	a	DT	B-NP
O	key	key	JJ	I-NP
O	S	S	NN	I-NP
O	-	-	HYPH	B-NP
O	P	P	NN	I-NP
O	-	-	HYPH	I-NP
O	A	A	NN	I-NP
O	motif	motif	NN	I-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	E2	E2	NN	I-NP
O	enzymes	enzyme	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	determinants	determinant	NNS	I-NP
O	make	make	VBP	B-VP
O	different	different	JJ	B-NP
O	relative	relative	JJ	I-NP
O	contributions	contribution	NNS	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	overall	overall	JJ	I-NP
O	interactions	interaction	NNS	I-NP
O	between	between	IN	B-PP
B-GGP	CHIP	CHIP	NN	B-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	E2	E2	NN	I-NP
O	enzymes	enzyme	NNS	I-NP
O	.	.	.	O

B-GGP	CHIP	CHIP	NN	B-NP
O	undergoes	undergo	VBZ	B-VP
O	auto	auto	AFX	B-NP
O	-	-	HYPH	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	by	by	IN	B-PP
B-GGP	UbcH5	UbcH5	NN	B-NP
O	but	but	CC	B-PP
O	not	not	RB	B-PP
O	by	by	IN	I-PP
B-GGP	Ubc13	Ubc13	NN	B-NP
O	-	-	HYPH	I-NP
B-GGP	Uev1a	Uev1a	NN	I-NP
O	.	.	.	O

O	Instead	Instead	RB	B-ADVP
O	,	,	,	O
B-GGP	CHIP	CHIP	NN	B-NP
O	drives	drive	VBZ	B-VP
O	the	the	DT	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	unanchored	unanchored	JJ	B-NP
B-GGP	polyubiquitin	polyubiquitin	NN	I-NP
O	by	by	IN	B-PP
B-GGP	Ubc13	Ubc13	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	Uev1a	Uev1a	NN	I-NP
O	.	.	.	O

B-GGP	CHIP	CHIP	NN	B-NP
O	also	also	RB	B-ADVP
O	interacts	interact	VBZ	B-VP
O	productively	productively	RB	B-ADVP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	class	class	NN	I-NP
O	III	III	CD	I-NP
O	E2	E2	NN	I-NP
O	enzyme	enzyme	NN	I-NP
B-GGP	Ube2e2	Ube2e2	NN	I-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
B-GGP	UbcH5	UbcH5	NN	I-NP
O	-	-	HYPH	B-NP
O	and	and	CC	I-NP
B-GGP	Ubc13	Ubc13	NN	I-NP
O	-	-	HYPH	B-NP
O	binding	bind	VBG	B-VP
O	specificity	specificity	NN	B-NP
O	determinants	determinant	NNS	I-NP
O	are	be	VBP	B-VP
O	highly	highly	RB	I-VP
O	conserved	conserve	VBN	I-VP
O	.	.	.	O

O	CONCLUSION	CONCLUSION	NN	B-NP
O	:	:	:	O
O	The	The	DT	B-NP
B-GGP	CHIP	CHIP	NN	I-NP
O	:	:	:	O
B-GGP	UbcH5a	UbcH5a	NN	B-NP
O	structure	structure	NN	I-NP
O	emphasizes	emphasize	VBZ	B-VP
O	the	the	DT	B-NP
O	importance	importance	NN	I-NP
O	of	of	IN	B-PP
O	specificity	specificity	NN	B-NP
O	determinants	determinant	NNS	I-NP
O	located	located	JJ	B-ADJP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	long	long	JJ	I-NP
O	loops	loop	NNS	I-NP
O	and	and	CC	O
O	central	central	JJ	B-NP
O	helix	helix	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	CHIP	CHIP	NN	I-NP
O	U	U	NN	I-NP
O	-	-	HYPH	B-NP
O	box	box	NN	I-NP
O	,	,	,	B-PP
O	and	and	CC	I-PP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	helix	helix	NN	I-NP
O	and	and	CC	O
O	loops	loop	VBZ	B-VP
O	L4	L4	NN	B-NP
O	and	and	CC	I-NP
O	L7	L7	NN	I-NP
O	of	of	IN	B-PP
O	its	its	PRP$	B-NP
O	cognate	cognate	JJ	I-NP
O	E2	E2	NN	I-NP
O	enzymes	enzyme	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	S	S	NN	I-NP
O	-	-	HYPH	B-NP
O	P	P	NN	I-NP
O	-	-	HYPH	I-NP
O	A	A	NN	I-NP
O	motif	motif	NN	I-NP
O	and	and	CC	O
O	other	other	JJ	B-NP
O	specificity	specificity	NN	I-NP
O	determinants	determinant	NNS	I-NP
O	define	define	VBP	B-VP
O	the	the	DT	B-NP
O	set	set	NN	I-NP
O	of	of	IN	B-PP
O	cognate	cognate	JJ	B-NP
O	E2	E2	NN	I-NP
O	enzymes	enzyme	NNS	I-NP
O	for	for	IN	B-PP
B-GGP	CHIP	CHIP	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	likely	likely	RB	B-VP
O	includes	include	VBZ	I-VP
O	several	several	JJ	B-NP
O	Class	Class	NN	I-NP
O	III	III	CD	I-NP
O	E2	E2	NN	I-NP
O	enzymes	enzyme	NNS	I-NP
O	.	.	.	O

B-GGP	CHIP	CHIP	NN	B-NP
O	'	'	POS	B-NP
O	s	s	JJ	I-NP
O	interactions	interaction	NNS	I-NP
O	with	with	IN	B-PP
B-GGP	UbcH5	UbcH5	NN	B-NP
O	,	,	,	I-NP
B-GGP	Ube2e2	Ube2e2	NN	I-NP
O	and	and	CC	I-NP
B-GGP	Ubc13	Ubc13	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	Uev1a	Uev1a	NN	I-NP
O	are	be	VBP	B-VP
O	consistent	consistent	JJ	B-ADJP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	notion	notion	NN	I-NP
O	that	that	IN	B-SBAR
B-GGP	Ubc13	Ubc13	NN	B-NP
O	-	-	HYPH	I-NP
B-GGP	Uev1a	Uev1a	NN	I-NP
O	may	may	MD	B-VP
O	work	work	VB	I-VP
O	sequentially	sequentially	RB	B-ADVP
O	with	with	IN	B-PP
O	other	other	JJ	B-NP
O	E2	E2	NN	I-NP
O	enzymes	enzyme	NNS	I-NP
O	to	to	TO	B-VP
O	carry	carry	VB	I-VP
O	out	out	RP	B-PRT
O	K63	K63	NN	B-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	polyubiquitination	polyubiquitination	NN	I-NP
O	of	of	IN	B-PP
B-GGP	CHIP	CHIP	NN	B-NP
O	substrates	substrate	NNS	I-NP
O	.	.	.	O

O	Regulation	Regulation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	Nedd4	Nedd4	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	2	2	CD	I-NP
O	self	self	AFX	I-NP
O	-	-	HYPH	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	stability	stability	NN	I-NP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	PY	PY	NN	I-NP
O	motif	motif	NN	I-NP
O	located	located	JJ	B-ADJP
O	within	within	IN	B-PP
O	its	its	PRP$	B-NP
O	HECT	HECT	NN	I-NP
O	-	-	HYPH	I-NP
O	domain	domain	NN	I-NP
O	.	.	.	O

B-GGP	Ubiquitin	Ubiquitin	NN	B-NP
O	ligases	ligas	NNS	I-NP
O	play	play	VBP	B-VP
O	a	a	DT	B-NP
O	pivotal	pivotal	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	substrate	substrate	NN	B-NP
O	recognition	recognition	NN	I-NP
O	and	and	CC	O
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	transfer	transfer	NN	I-NP
O	,	,	,	O
O	yet	yet	RB	B-NP
O	little	little	JJ	I-NP
O	is	be	VBZ	B-VP
O	known	know	VBN	I-VP
O	about	about	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	their	their	PRP$	B-NP
O	catalytic	catalytic	JJ	I-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

B-GGP	Nedd4	Nedd4	NN	B-NP
I-GGP	(	(	(	O
I-GGP	neural	neural	JJ	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	precursor	precursor	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	cell	cell	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	expressed	express	VBN	B-VP
I-GGP	,	,	,	O
I-GGP	developmentally	developmentally	RB	B-ADVP
I-GGP	down	down	RB	I-ADVP
I-GGP	-	-	HYPH	O
I-GGP	regulated	regulate	VBN	B-VP
I-GGP	4	4	CD	B-NP
I-GGP	)	)	)	O
I-GGP	-	-	HYPH	B-NP
I-GGP	2	2	CD	I-NP
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	E3	E3	NN	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	composed	compose	VBN	B-VP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	C2	C2	NN	I-NP
O	domain	domain	NN	I-NP
O	,	,	,	O
O	four	four	CD	B-NP
O	WW	WW	NNP	I-NP
O	domains	domain	NNS	I-NP
O	(	(	(	O
O	protein	protein	NN	B-NP
O	-	-	HYPH	B-NP
O	protein	protein	NN	I-NP
O	interaction	interaction	NN	I-NP
O	domains	domain	NNS	I-NP
O	containing	contain	VBG	B-VP
O	two	two	CD	B-NP
O	conserved	conserve	VBN	I-NP
O	tryptophan	tryptophan	NN	I-NP
O	residues	residue	NNS	I-NP
O	)	)	)	O
O	that	that	WDT	B-NP
O	bind	bind	VBP	B-VP
O	PY	PY	NN	B-NP
O	motifs	motif	NNS	I-NP
O	(	(	(	O
O	L	L	NN	B-NP
O	/	/	SYM	O
O	PPXY	PPXY	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	a	a	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	HECT	HECT	NN	I-NP
O	(	(	(	O
O	homologous	homologous	JJ	B-ADJP
O	with	with	IN	B-PP
O	E6	E6	NN	B-NP
O	-	-	HYPH	B-NP
O	associated	associate	VBN	I-NP
O	protein	protein	NN	I-NP
O	C	C	NN	I-NP
O	-	-	HYPH	B-NP
O	terminus	terminus	NN	I-NP
O	)	)	)	O
O	domain	domain	NN	B-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	paper	paper	NN	I-NP
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	WW	WW	NNP	I-NP
O	domains	domain	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	Nedd4	Nedd4	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	2	2	CD	B-NP
O	bind	bind	NN	I-NP
O	(	(	(	O
O	weakly	weakly	RB	B-ADVP
O	)	)	)	O
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	PY	PY	NN	I-NP
O	motif	motif	NN	I-NP
O	(	(	(	O
O	LPXY	LPXY	NN	B-NP
O	)	)	)	O
O	located	located	JJ	B-ADJP
O	within	within	IN	B-PP
O	its	its	PRP$	B-NP
O	own	own	JJ	I-NP
O	HECT	HECT	NN	I-NP
O	domain	domain	NN	I-NP
O	and	and	CC	O
O	inhibit	inhibit	VBP	B-VP
O	auto	auto	NN	B-NP
O	-	-	HYPH	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	.	.	.	O

O	Pulse	Pulse	NN	B-NP
O	-	-	HYPH	I-NP
O	chase	chase	NN	I-NP
O	experiments	experiment	NNS	I-NP
O	demonstrated	demonstrate	VBD	B-VP
O	that	that	IN	B-SBAR
O	mutation	mutation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	HECT	HECT	NN	I-NP
O	PY	PY	NN	I-NP
O	-	-	HYPH	B-NP
O	motif	motif	NN	I-NP
O	decreases	decrease	VBZ	B-VP
O	the	the	DT	B-NP
O	stability	stability	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Nedd4	Nedd4	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	2	2	CD	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	stabilization	stabilization	NN	B-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	E3	E3	NN	I-NP
O	ligase	ligase	NN	I-NP
O	.	.	.	O

O	Interestingly	Interestingly	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	HECT	HECT	NN	I-NP
O	PY	PY	NN	I-NP
O	-	-	HYPH	B-NP
O	motif	motif	NN	I-NP
O	mutation	mutation	NN	I-NP
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	affect	affect	VB	I-VP
O	ubiquitination	ubiquitination	NN	B-NP
O	or	or	CC	O
O	down	down	RB	B-ADVP
O	-	-	HYPH	O
O	regulation	regulation	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	known	know	VBN	I-NP
B-GGP	Nedd4	Nedd4	NN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	2	2	CD	I-NP
O	substrate	substrate	NN	I-NP
O	,	,	,	O
O	ENaC	ENaC	NN	B-NP
O	(	(	(	O
O	epithelial	epithelial	JJ	B-NP
O	sodium	sodium	NN	I-NP
O	channel	channel	NN	I-NP
O	)	)	)	O
O	.	.	.	O

O	ENaC	ENaC	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	turn	turn	NN	B-NP
O	,	,	,	O
O	appears	appear	VBZ	B-VP
O	to	to	TO	I-VP
O	promote	promote	VB	I-VP
B-GGP	Nedd4	Nedd4	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	2	2	CD	I-NP
O	self	self	AFX	I-NP
O	-	-	HYPH	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	support	support	VBP	B-VP
O	a	a	DT	B-NP
O	model	model	NN	I-NP
O	in	in	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
O	inter	inter	AFX	I-NP
O	-	-	HYPH	I-NP
O	or	or	CC	I-NP
O	intra	intra	AFX	I-NP
O	-	-	HYPH	I-NP
O	molecular	molecular	JJ	B-NP
O	WW	WW	NN	I-NP
O	-	-	HYPH	B-NP
O	domain	domain	NN	I-NP
O	-	-	HYPH	O
O	HECT	HECT	NN	B-NP
O	PY	PY	NN	I-NP
O	-	-	HYPH	B-NP
O	motif	motif	NN	I-NP
O	interaction	interaction	NN	I-NP
O	stabilizes	stabilize	VBZ	B-VP
B-GGP	Nedd4	Nedd4	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	2	2	CD	B-NP
O	by	by	IN	B-PP
O	preventing	prevent	VBG	B-VP
O	self	self	AFX	B-NP
O	-	-	HYPH	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	.	.	.	O

O	Substrate	Substrate	NN	B-NP
O	binding	binding	NN	I-NP
O	disrupts	disrupt	NNS	I-NP
O	this	this	DT	B-NP
O	interaction	interaction	NN	I-NP
O	,	,	,	O
O	allowing	allow	VBG	B-VP
O	self	self	AFX	B-NP
O	-	-	HYPH	I-NP
O	ubiquitination	ubiquitination	NN	B-NP
O	of	of	IN	B-PP
B-GGP	Nedd4	Nedd4	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	2	2	CD	I-NP
O	and	and	CC	O
O	subsequent	subsequent	JJ	B-NP
O	degradation	degradation	NN	I-NP
O	,	,	,	O
O	resulting	result	VBG	B-VP
O	in	in	IN	B-PP
O	down	down	RB	B-ADVP
O	-	-	HYPH	I-ADVP
O	regulation	regulation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	Nedd4	Nedd4	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	2	2	CD	I-NP
O	once	once	IN	B-SBAR
O	it	it	PRP	B-NP
O	has	have	VBZ	B-VP
O	ubiquitinated	ubiquitinate	VBN	I-VP
O	its	its	PRP$	B-NP
O	target	target	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	findings	finding	NNS	I-NP
O	also	also	RB	B-ADVP
O	point	point	VBP	B-VP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	employed	employ	VBN	B-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	to	to	TO	B-VP
O	regulate	regulate	VB	I-VP
O	itself	itself	PRP	B-NP
O	differentially	differentially	RB	B-ADVP
O	compared	compare	VBD	B-VP
O	with	with	IN	B-PP
O	substrate	substrate	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	stability	stability	NN	I-NP
O	.	.	.	O

O	Polyubiquitination	Polyubiquitination	NN	B-NP
O	of	of	IN	B-PP
B-GGP	prolactin	prolactin	NN	B-NP
I-GGP	receptor	receptor	NN	I-NP
O	stimulates	stimulate	VBZ	B-VP
O	its	its	PRP$	B-NP
O	internalization	internalization	NN	I-NP
O	,	,	,	O
O	postinternalization	postinternalization	NN	B-NP
O	sorting	sorting	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	degradation	degradation	NN	B-NP
O	via	via	IN	B-PP
O	the	the	DT	B-NP
O	lysosomal	lysosomal	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	receptor	receptor	NN	I-NP
O	that	that	WDT	B-NP
O	mediates	mediate	VBZ	B-VP
O	signaling	signaling	NN	B-NP
O	induced	induce	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	polypeptide	polypeptide	NN	I-NP
O	pituitary	pituitary	JJ	I-NP
O	hormone	hormone	NN	I-NP
B-GGP	prolactin	prolactin	NN	I-NP
O	(	(	(	O
B-GGP	PRL	PRL	NN	B-NP
O	)	)	)	O
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	lead	lead	VB	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	degradation	degradation	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	receptor	receptor	NN	I-NP
O	and	and	CC	B-PP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	ensuing	ensue	VBG	I-NP
O	negative	negative	JJ	I-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	cellular	cellular	JJ	B-NP
O	responses	response	NNS	I-NP
O	to	to	TO	B-PP
B-GGP	PRL	PRL	NN	B-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	PRL	PRL	NN	B-NP
I-GGP	receptor	receptor	NN	I-NP
O	(	(	(	O
B-GGP	PRLr	PRLr	NN	B-NP
O	)	)	)	O
O	proteolysis	proteolysis	NN	B-NP
O	remain	remain	VBP	B-VP
O	largely	largely	RB	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	determined	determine	VBN	I-VP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	we	we	PRP	B-NP
O	provide	provide	VBP	B-VP
O	evidence	evidence	NN	B-NP
O	that	that	IN	B-SBAR
B-GGP	PRLr	PRLr	NN	B-NP
O	is	be	VBZ	B-VP
O	internalized	internalize	VBN	I-VP
O	and	and	CC	O
O	primarily	primarily	RB	B-VP
O	degraded	degrade	VBN	I-VP
O	via	via	IN	B-PP
O	the	the	DT	B-NP
O	lysosomal	lysosomal	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

O	Ubiquitination	Ubiquitination	NN	B-NP
O	of	of	IN	B-PP
B-GGP	PRLr	PRLr	NN	B-NP
O	is	be	VBZ	B-VP
O	essential	essential	JJ	B-ADJP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	rapid	rapid	JJ	I-NP
O	internalization	internalization	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PRLr	PRLr	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	proceeds	proceed	VBZ	B-VP
O	through	through	IN	B-PP
O	a	a	DT	B-NP
O	pathway	pathway	NN	I-NP
O	dependent	dependent	JJ	B-ADJP
O	on	on	IN	B-PP
O	clathrin	clathrin	NN	B-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	assembly	assembly	NN	I-NP
O	polypeptide	polypeptide	NN	I-NP
O	2	2	CD	I-NP
O	(	(	(	O
O	AP2	AP2	NN	B-NP
O	)	)	)	O
O	adaptor	adaptor	NN	B-NP
O	complexes	complex	NNS	I-NP
O	.	.	.	O

O	Recruitment	Recruitment	NN	B-NP
O	of	of	IN	B-PP
O	AP2	AP2	NN	B-NP
O	to	to	TO	B-PP
B-GGP	PRLr	PRLr	NN	B-NP
O	is	be	VBZ	B-VP
O	stimulated	stimulate	VBN	I-VP
O	by	by	IN	B-PP
B-GGP	PRLr	PRLr	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	also	also	RB	B-ADVP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	targeting	targeting	NN	I-NP
O	of	of	IN	B-PP
O	already	already	RB	B-NP
O	internalized	internalize	VBN	I-NP
O	PRLr	PRLr	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	lysosomal	lysosomal	JJ	I-NP
O	compartment	compartment	NN	I-NP
O	.	.	.	O

O	While	While	IN	B-SBAR
O	mass	mass	NN	B-NP
O	spectrometry	spectrometry	NN	I-NP
O	analysis	analysis	NN	I-NP
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
O	both	both	CC	O
O	monoubiquitination	monoubiquitination	NN	B-NP
O	and	and	CC	O
O	polyubiquitination	polyubiquitination	NN	B-NP
O	(	(	(	O
O	via	via	IN	B-PP
O	both	both	CC	O
O	K48	K48	NN	B-NP
O	-	-	HYPH	B-NP
O	and	and	CC	I-NP
O	K63	K63	NN	I-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	chains	chain	NNS	I-NP
O	)	)	)	O
O	occur	occur	VBP	B-VP
O	on	on	IN	B-PP
B-GGP	PRLr	PRLr	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	results	result	NNS	I-NP
O	of	of	IN	B-PP
O	experiments	experiment	NNS	B-NP
O	using	use	VBG	B-VP
O	forced	force	VBN	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	mutants	mutant	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	PRLr	PRLr	NN	B-NP
O	polyubiquitination	polyubiquitination	NN	I-NP
O	via	via	IN	B-PP
O	K63	K63	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	chains	chain	NNS	I-NP
O	is	be	VBZ	B-VP
O	important	important	JJ	B-ADJP
O	for	for	IN	B-PP
O	efficient	efficient	JJ	B-NP
O	interaction	interaction	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PRLr	PRLr	NN	B-NP
O	with	with	IN	B-PP
O	AP2	AP2	NN	B-NP
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	for	for	IN	B-PP
O	efficient	efficient	JJ	B-NP
O	internalization	internalization	NN	I-NP
O	,	,	,	O
O	postinternalization	postinternalization	NN	B-NP
O	sorting	sorting	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	proteolytic	proteolytic	JJ	B-NP
O	turnover	turnover	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PRLr	PRLr	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	discuss	discuss	VBP	B-VP
O	how	how	WRB	B-ADVP
O	specific	specific	JJ	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	may	may	MD	B-VP
O	regulate	regulate	VB	I-VP
O	early	early	JJ	B-NP
O	and	and	CC	I-NP
O	late	late	JJ	I-NP
O	stages	stage	NNS	I-NP
O	of	of	IN	B-PP
O	endocytosis	endocytosis	NN	B-NP
O	of	of	IN	B-PP
B-GGP	PRLr	PRLr	NN	B-NP
O	and	and	CC	B-PP
O	of	of	IN	B-PP
O	related	related	JJ	B-NP
O	receptors	receptor	NNS	I-NP
O	to	to	TO	B-VP
O	contribute	contribute	VB	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	negative	negative	JJ	I-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	magnitude	magnitude	NN	I-NP
O	and	and	CC	I-NP
O	duration	duration	NN	I-NP
O	of	of	IN	B-PP
O	downstream	downstream	JJ	B-NP
O	signaling	signaling	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	status	status	NN	I-NP
O	of	of	IN	B-PP
O	murine	murine	NN	B-NP
O	[	[	(	O
O	corrected	correct	VBN	B-VP
O	]	]	)	O
O	postnatal	postnatal	JJ	B-NP
O	thymus	thymus	NN	I-NP
O	:	:	:	O
O	a	a	DT	B-NP
O	study	study	NN	I-NP
O	by	by	IN	B-PP
O	histochemistry	histochemistry	NN	B-NP
O	and	and	CC	I-NP
O	lectin	lectin	NN	I-NP
O	blotting	blotting	NN	I-NP
O	.	.	.	O

O	During	During	IN	B-PP
O	the	the	DT	B-NP
O	intrathymic	intrathymic	JJ	I-NP
O	development	development	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	fate	fate	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	thymocytes	thymocyte	NNS	I-NP
O	depends	depend	VBZ	B-VP
O	largely	largely	RB	B-ADVP
O	on	on	IN	B-PP
O	variable	variable	JJ	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	CD4	CD4	NN	B-NP
O	/	/	SYM	B-NP
O	CD8	CD8	NN	I-NP
O	markers	marker	NNS	I-NP
O	and	and	CC	O
O	T	T	NN	B-NP
O	cell	cell	NN	I-NP
O	receptor	receptor	NN	I-NP
O	protein	protein	NN	I-NP
O	expressions	expression	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	changes	change	NNS	B-NP
O	of	of	IN	B-PP
O	cell	cell	NN	B-NP
O	surface	surface	NN	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	status	status	NN	I-NP
O	also	also	RB	B-ADVP
O	affect	affect	VBP	B-VP
O	the	the	DT	B-NP
O	thymocyte	thymocyte	NN	I-NP
O	maturation	maturation	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	the	the	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	alterations	alteration	NNS	I-NP
O	in	in	IN	B-PP
O	thymic	thymic	JJ	B-NP
O	tissues	tissue	NNS	I-NP
O	from	from	IN	B-PP
O	1	1	CD	B-NP
O	,	,	,	I-NP
O	9	9	CD	I-NP
O	,	,	,	I-NP
O	13	13	CD	I-NP
O	and	and	CC	I-NP
O	16	16	CD	I-NP
O	days	day	NNS	I-NP
O	old	old	JJ	I-NP
O	mice	mouse	NNS	I-NP
O	were	be	VBD	B-VP
O	evaluated	evaluate	VBN	I-VP
O	by	by	IN	B-PP
O	histochemical	histochemical	JJ	B-NP
O	and	and	CC	I-NP
O	lectin	lectin	NN	I-NP
O	blotting	blotting	NN	I-NP
O	techniques	technique	NNS	I-NP
O	.	.	.	O

O	With	With	IN	B-PP
O	alcian	alcian	JJ	B-NP
O	blue	blue	NN	I-NP
O	(	(	(	O
O	AB	AB	NN	B-NP
O	)	)	)	O
O	at	at	IN	B-PP
O	pH	pH	NN	B-NP
O	5	5	CD	I-NP
O	.	.	.	I-NP
O	7	7	CD	I-NP
O	/	/	SYM	O
O	periodic	periodic	JJ	B-NP
O	acid	acid	NN	I-NP
O	-	-	HYPH	O
O	Schiff	Schiff	NN	B-NP
O	(	(	(	O
O	PAS	PAS	NN	B-NP
O	)	)	)	O
O	stainings	staining	NNS	B-NP
O	,	,	,	O
O	it	it	PRP	B-NP
O	was	be	VBD	B-VP
O	shown	show	VBN	I-VP
O	that	that	IN	B-SBAR
O	thymic	thymic	JJ	B-NP
O	microenvironments	microenvironment	NNS	I-NP
O	contained	contain	VBD	B-VP
O	carboxlylated	carboxlylate	VBN	B-NP
O	and	and	CC	I-NP
O	sulfated	sulfate	VBN	I-NP
O	glycosaminoglycans	glycosaminoglycan	NNS	I-NP
O	(	(	(	O
O	GAGs	GAG	NNS	B-NP
O	)	)	)	O
O	.	.	.	O

O	Strong	Strong	JJ	B-NP
O	positivity	positivity	NN	I-NP
O	to	to	TO	B-PP
O	AB	AB	NN	B-NP
O	at	at	IN	B-PP
O	pH	pH	NN	B-NP
O	2	2	CD	I-NP
O	.	.	.	I-NP
O	5	5	CD	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	specific	specific	JJ	B-ADJP
O	for	for	IN	B-PP
O	sialomucins	sialomucin	NNS	B-NP
O	,	,	,	O
O	was	be	VBD	B-VP
O	seen	see	VBN	I-VP
O	in	in	IN	B-PP
O	some	some	DT	B-NP
O	medullary	medullary	JJ	I-NP
O	thymocytes	thymocyte	NNS	I-NP
O	.	.	.	O

O	Similarly	Similarly	RB	B-ADVP
O	,	,	,	O
O	it	it	PRP	B-NP
O	was	be	VBD	B-VP
O	shown	show	VBN	I-VP
O	that	that	IN	B-SBAR
O	with	with	IN	B-PP
O	Maackia	Maackia	NNP	B-NP
O	amurensis	amurensis	NN	I-NP
O	agglutinin	agglutinin	NN	I-NP
O	(	(	(	O
O	MAL	MAL	NN	B-NP
O	)	)	)	O
O	medullary	medullary	JJ	B-NP
O	thymocytes	thymocyte	NNS	I-NP
O	,	,	,	O
O	but	but	CC	O
O	not	not	RB	O
O	cortical	cortical	JJ	B-NP
O	ones	one	NNS	I-NP
O	,	,	,	O
O	contained	contain	VBD	B-VP
O	alpha	alpha	NN	B-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	-	-	HYPH	O
O	-	-	HYPH	O
O	>	>	SYM	B-NP
O	3	3	CD	I-NP
O	)	)	)	O
O	linked	link	VBN	B-VP
O	sialic	sialic	JJ	B-NP
O	acid	acid	NN	I-NP
O	structures	structure	NNS	I-NP
O	.	.	.	O

O	On	On	IN	B-PP
O	the	the	DT	B-NP
O	other	other	JJ	I-NP
O	hand	hand	NN	I-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	reaction	reaction	NN	B-NP
O	with	with	IN	B-PP
O	peanut	peanut	NN	B-NP
B-GGP	agglutinin	agglutinin	NN	I-NP
O	(	(	(	O
B-GGP	PNA	PNA	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	which	which	WDT	B-NP
O	specific	specific	JJ	B-ADJP
O	for	for	IN	B-PP
O	core	core	NN	B-NP
O	disaccharide	disaccharide	NN	I-NP
O	galactose	galactose	NN	I-NP
O	beta	beta	NN	I-NP
O	(	(	(	O
O	1	1	CD	B-NP
O	-	-	HYPH	O
O	-	-	HYPH	O
O	>	>	SYM	O
O	3	3	CD	O
O	)	)	)	O
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	acetylgalactosamine	acetylgalactosamine	NN	I-NP
O	,	,	,	O
O	was	be	VBD	B-VP
O	only	only	RB	I-VP
O	seen	see	VBN	I-VP
O	in	in	IN	B-PP
O	cortical	cortical	JJ	B-NP
O	thymocytes	thymocyte	NNS	I-NP
O	,	,	,	O
O	reaction	reaction	NN	B-NP
O	with	with	IN	B-PP
O	Galanthus	Galanthus	NN	B-NP
O	nivalis	nivalis	NN	I-NP
B-GGP	agglutinin	agglutinin	NN	I-NP
O	(	(	(	O
B-GGP	GNA	GNA	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	which	which	WDT	B-NP
O	specific	specific	JJ	B-ADJP
O	for	for	IN	B-PP
O	terminal	terminal	JJ	B-NP
O	mannose	mannose	NN	I-NP
O	residues	residue	NNS	I-NP
O	,	,	,	O
O	was	be	VBD	B-VP
O	seen	see	VBN	I-VP
O	in	in	IN	B-PP
O	both	both	CC	O
O	cortex	cortex	NN	B-NP
O	and	and	CC	I-NP
O	medulla	medulla	NN	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	Datura	Datura	NN	B-NP
O	stramonium	stramonium	NN	I-NP
O	agglutinin	agglutinin	NN	I-NP
O	(	(	(	O
O	DSA	DSA	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	which	which	WDT	B-NP
O	recognizes	recognize	VBZ	B-VP
O	galactose	galactose	NN	B-NP
O	beta	beta	NN	I-NP
O	(	(	(	O
O	1	1	CD	B-NP
O	-	-	HYPH	O
O	-	-	HYPH	O
O	>	>	SYM	O
O	4	4	CD	O
O	)	)	)	O
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	acetylglucosamine	acetylglucosamine	NN	I-NP
O	,	,	,	O
O	was	be	VBD	B-VP
O	not	not	RB	O
O	only	only	RB	B-ADJP
O	cell	cell	NN	I-ADJP
O	-	-	HYPH	I-ADJP
O	specific	specific	JJ	B-ADJP
O	,	,	,	O
O	but	but	CC	O
O	it	it	PRP	B-NP
O	was	be	VBD	B-VP
O	bound	bind	VBN	I-VP
O	some	some	DT	B-NP
O	thymic	thymic	JJ	I-NP
O	vessels	vessel	NNS	I-NP
O	.	.	.	O

O	With	With	IN	B-PP
O	lectin	lectin	NN	B-NP
O	blotting	blotting	NN	I-NP
O	studies	study	NNS	I-NP
O	,	,	,	O
O	five	five	CD	B-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	bands	band	NNS	I-NP
O	of	of	IN	B-PP
O	molecular	molecular	JJ	B-NP
O	weights	weight	NNS	I-NP
O	approximately	approximately	RB	B-ADVP
O	39	39	CD	B-NP
O	,	,	,	O
O	approximately	approximately	RB	B-NP
O	54	54	CD	I-NP
O	,	,	,	I-NP
O	100	100	CD	I-NP
O	,	,	,	O
O	approximately	approximately	RB	B-NP
O	110	110	CD	I-NP
O	and	and	CC	O
O	approximately	approximately	RB	B-NP
O	212	212	CD	I-NP
O	were	be	VBD	B-VP
O	found	find	VBN	I-VP
O	which	which	WDT	B-NP
O	reacted	react	VBD	B-VP
O	with	with	IN	B-PP
O	MAL	MAL	NN	B-NP
O	,	,	,	I-NP
B-GGP	PNA	PNA	NN	I-NP
O	and	and	CC	I-NP
O	DSA	DSA	NN	I-NP
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
B-GGP	GNA	GNA	NN	B-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	glycosylation	glycosylation	NN	B-NP
O	patterns	pattern	NNS	I-NP
O	of	of	IN	B-PP
O	cell	cell	NN	B-NP
O	surface	surface	NN	I-NP
O	glycoconjugates	glycoconjugate	NNS	I-NP
O	are	be	VBP	B-VP
O	modified	modify	VBN	I-VP
O	during	during	IN	B-PP
O	thymocyte	thymocyte	NN	B-NP
O	selection	selection	NN	I-NP
O	processes	process	NNS	I-NP
O	of	of	IN	B-PP
O	postnatal	postnatal	JJ	B-NP
O	days	day	NNS	I-NP
O	.	.	.	O

O	Chemical	Chemical	JJ	B-NP
O	and	and	CC	I-NP
O	structural	structural	JJ	I-NP
O	probing	probing	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	residues	residue	NNS	I-NP
O	encoded	encode	VBN	B-VP
O	by	by	IN	B-PP
B-GGP	FMR1	FMR1	NN	B-NP
O	exon	exon	NN	I-NP
O	15	15	CD	I-NP
O	and	and	CC	O
O	their	their	PRP$	B-NP
O	effect	effect	NN	I-NP
O	on	on	IN	B-PP
O	downstream	downstream	JJ	B-NP
O	arginine	arginine	NN	I-NP
O	methylation	methylation	NN	I-NP
O	.	.	.	O

O	Exon	Exon	NNP	B-NP
O	15	15	CD	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	fragile	fragile	JJ	I-NP
O	X	X	NN	I-NP
O	mental	mental	JJ	I-NP
O	retardation	retardation	NN	I-NP
O	protein	protein	NN	I-NP
O	gene	gene	NN	I-NP
O	(	(	(	O
B-GGP	FMR1	FMR1	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	alternatively	alternatively	RB	I-VP
O	spliced	splice	VBN	I-VP
O	into	into	IN	B-PP
O	three	three	CD	B-NP
O	variants	variant	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	amino	amino	JJ	I-NP
O	acids	acid	NNS	I-NP
O	encoded	encode	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	5	5	CD	I-NP
O	'	'	SYM	I-NP
O	end	end	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	exon	exon	NN	I-NP
O	contain	contain	VBP	B-VP
O	several	several	JJ	B-NP
O	regulatory	regulatory	JJ	I-NP
O	determinants	determinant	NNS	I-NP
O	including	include	VBG	B-PP
O	phosphorylation	phosphorylation	NN	B-NP
O	sites	site	NNS	I-NP
O	and	and	CC	O
O	a	a	DT	B-NP
O	potential	potential	JJ	I-NP
O	conformational	conformational	JJ	I-NP
O	switch	switch	NN	I-NP
O	.	.	.	O

O	Residues	Residue	NNS	B-NP
O	encoded	encode	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	3	3	CD	I-NP
O	'	'	SYM	I-NP
O	end	end	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	exon	exon	NN	I-NP
O	specify	specify	VB	B-VP
O	FMRP	FMRP	NN	B-NP
O	'	'	POS	B-NP
O	s	s	NN	I-NP
O	RGG	RGG	NN	I-NP
O	box	box	NN	I-NP
O	,	,	,	O
O	an	an	DT	B-NP
O	RNA	RNA	NN	I-NP
O	binding	binding	NN	I-NP
O	domain	domain	NN	I-NP
O	that	that	WDT	B-NP
O	interacts	interact	VBZ	B-VP
O	with	with	IN	B-PP
O	G	G	NN	B-NP
O	-	-	HYPH	B-NP
O	quartet	quartet	NN	I-NP
O	motifs	motif	NNS	I-NP
O	.	.	.	O

O	Previous	Previous	JJ	B-NP
O	studies	study	NNS	I-NP
O	demonstrated	demonstrate	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	exon	exon	NN	I-NP
O	15	15	CD	I-NP
O	-	-	HYPH	I-NP
O	encoded	encode	VBN	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	residues	residue	NNS	I-NP
O	influence	influence	VBP	B-VP
O	the	the	DT	B-NP
O	extent	extent	NN	I-NP
O	of	of	IN	B-PP
O	arginine	arginine	NN	B-NP
O	methylation	methylation	NN	I-NP
O	,	,	,	O
O	independent	independent	JJ	B-ADJP
O	of	of	IN	B-PP
O	S	S	NN	B-NP
O	500	500	CD	I-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	study	study	NN	I-NP
O	we	we	PRP	B-NP
O	focus	focus	VBP	B-VP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	role	role	NN	I-NP
O	the	the	DT	B-NP
O	putative	putative	JJ	I-NP
O	conformational	conformational	JJ	I-NP
O	switch	switch	NN	I-NP
O	plays	play	VBZ	B-VP
O	in	in	IN	B-PP
O	arginine	arginine	NN	B-NP
O	methylation	methylation	NN	I-NP
O	.	.	.	O

O	Chemical	Chemical	JJ	B-NP
O	and	and	CC	I-NP
O	structural	structural	JJ	I-NP
O	probing	probing	NN	I-NP
O	of	of	IN	B-PP
O	Ex15	Ex15	NN	B-NP
O	alternatively	alternatively	RB	B-ADVP
O	spliced	splice	VBD	B-VP
O	variant	variant	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	and	and	CC	O
O	several	several	JJ	B-NP
O	mutants	mutant	NNS	I-NP
O	leads	lead	VBZ	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	following	follow	VBG	I-NP
O	conclusions	conclusion	NNS	I-NP
O	:	:	:	O
O	Ex15c	Ex15c	NN	B-NP
O	resides	reside	VBZ	B-VP
O	largely	largely	RB	B-ADVP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	conformation	conformation	NN	I-NP
O	that	that	WDT	B-NP
O	is	be	VBZ	B-VP
O	refractory	refractory	JJ	B-ADJP
O	toward	toward	IN	B-PP
O	methylation	methylation	NN	B-NP
O	;	;	:	O
O	however	however	RB	B-ADVP
O	,	,	,	O
O	it	it	PRP	B-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	methylated	methylate	VBN	I-VP
O	by	by	IN	B-PP
O	supplementing	supplement	VBG	B-VP
O	extracts	extract	NNS	B-NP
O	with	with	IN	B-PP
O	recombinant	recombinant	JJ	B-NP
B-GGP	PRMT1	PRMT1	NN	I-NP
O	or	or	CC	I-NP
B-GGP	PRMT3	PRMT3	NN	I-NP
O	.	.	.	O

O	Protein	Protein	NN	B-NP
O	modeling	modeling	NN	I-NP
O	studies	study	NNS	I-NP
O	reveal	reveal	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	RG	RG	NN	I-NP
O	-	-	HYPH	B-NP
O	rich	rich	JJ	I-NP
O	region	region	NN	I-NP
O	is	be	VBZ	B-VP
O	part	part	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	three	three	CD	I-NP
O	to	to	TO	I-NP
O	four	four	CD	I-NP
O	strand	strand	NN	I-NP
O	antiparallel	antiparallel	JJ	B-ADJP
O	beta	beta	SYM	O
O	-	-	HYPH	O
O	sheet	sheet	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	in	in	IN	B-PP
O	other	other	JJ	B-NP
O	RNA	RNA	NN	I-NP
O	binding	binding	NN	I-NP
O	proteins	protein	NNS	I-NP
O	functions	function	VBZ	B-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	platform	platform	NN	I-NP
O	for	for	IN	B-PP
O	nucleic	nucleic	JJ	B-NP
O	acid	acid	NN	I-NP
O	interactions	interaction	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	Ex15c	Ex15c	NN	I-NP
O	variant	variant	NN	I-NP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	strand	strand	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	sheet	sheet	NN	I-NP
O	is	be	VBZ	B-VP
O	truncated	truncate	VBN	I-VP
O	,	,	,	O
O	and	and	CC	O
O	this	this	DT	B-NP
O	significantly	significantly	RB	B-ADVP
O	perturbs	perturb	VBZ	B-VP
O	the	the	DT	B-NP
O	side	side	NN	I-NP
O	-	-	HYPH	B-NP
O	chain	chain	NN	I-NP
O	conformations	conformation	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	arginine	arginine	NN	I-NP
O	residues	residue	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	RG	RG	NN	I-NP
O	-	-	HYPH	B-NP
O	rich	rich	JJ	I-NP
O	region	region	NN	I-NP
O	.	.	.	O

O	Mutating	Mutate	VBG	B-VP
O	R	R	NN	B-NP
O	507	507	CD	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	conformational	conformational	JJ	I-NP
O	switch	switch	NN	I-NP
O	to	to	TO	B-PP
O	K	K	NN	B-NP
O	also	also	RB	B-ADVP
O	truncates	truncate	VBZ	B-VP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	strand	strand	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	beta	beta	SYM	I-NP
O	-	-	HYPH	I-NP
O	sheet	sheet	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	corresponding	correspond	VBG	B-VP
O	decreases	decrease	NNS	B-NP
O	in	in	IN	B-PP
O	in	in	FW	B-NP
O	vitro	vitro	FW	I-NP
O	methylation	methylation	NN	I-NP
O	were	be	VBD	B-VP
O	found	find	VBN	I-VP
O	for	for	IN	B-PP
O	this	this	DT	B-NP
O	and	and	CC	O
O	R	R	NN	B-NP
O	507	507	CD	I-NP
O	/	/	SYM	B-VP
O	R	R	NN	B-NP
O	544	544	CD	I-NP
O	and	and	CC	O
O	R	R	NN	B-NP
O	507	507	CD	I-NP
O	/	/	SYM	B-VP
O	R	R	NN	B-NP
O	546	546	CD	I-NP
O	double	double	JJ	I-NP
O	mutants	mutant	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	effects	effect	NNS	I-NP
O	are	be	VBP	B-VP
O	not	not	RB	O
O	due	due	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	loss	loss	NN	I-NP
O	of	of	IN	B-PP
O	R	R	NN	B-NP
O	507	507	CD	I-NP
O	methylation	methylation	NN	I-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	conformational	conformational	JJ	I-NP
O	switch	switch	NN	I-NP
O	-	-	HYPH	O
O	containing	contain	VBG	B-VP
O	peptide	peptide	NN	B-NP
O	reacted	react	VBD	B-VP
O	under	under	IN	B-PP
O	substrate	substrate	NN	B-NP
O	excess	excess	NN	I-NP
O	and	and	CC	B-PP
O	in	in	IN	B-PP
O	methyl	methyl	NN	B-NP
O	donor	donor	NN	I-NP
O	excess	excess	NN	I-NP
O	was	be	VBD	B-VP
O	not	not	RB	O
O	significantly	significantly	RB	B-ADJP
O	methylated	methylate	VBN	I-ADJP
O	.	.	.	O

O	Consistent	Consistent	JJ	B-ADJP
O	with	with	IN	B-PP
O	this	this	DT	B-NP
O	,	,	,	O
O	similar	similar	JJ	B-NP
O	changes	change	NNS	I-NP
O	in	in	IN	B-PP
O	beta	beta	SYM	B-NP
O	-	-	HYPH	O
O	sheet	sheet	NN	B-NP
O	structure	structure	NN	I-NP
O	and	and	CC	O
O	decreases	decrease	VBZ	B-VP
O	in	in	IN	B-PP
O	in	in	FW	B-NP
O	vitro	vitro	FW	I-NP
O	methylation	methylation	NN	I-NP
O	were	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	W	W	NN	I-NP
O	513	513	CD	I-NP
O	-	-	HYPH	I-NP
O	K	K	NN	I-NP
O	mutant	mutant	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	support	support	VBP	B-VP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	model	model	NN	I-NP
O	for	for	IN	B-PP
O	FMRP	FMRP	NN	B-NP
O	arginine	arginine	NN	I-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	O
O	a	a	DT	B-NP
O	role	role	NN	I-NP
O	for	for	IN	B-PP
O	conformational	conformational	JJ	B-NP
O	switch	switch	NN	I-NP
O	residues	residue	NNS	I-NP
O	in	in	IN	B-PP
O	arginine	arginine	NN	B-NP
O	modification	modification	NN	I-NP
O	.	.	.	O

O	Oridonin	Oridonin	NN	B-NP
O	confers	confer	VBZ	B-VP
O	protection	protection	NN	B-NP
O	against	against	IN	B-PP
O	arsenic	arsenic	JJ	B-NP
O	-	-	HYPH	I-NP
O	induced	induce	VBN	I-NP
O	toxicity	toxicity	NN	I-NP
O	through	through	IN	B-PP
O	activation	activation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	Nrf2	Nrf2	NN	I-NP
O	-	-	HYPH	B-VP
O	mediated	mediate	VBN	B-NP
O	defensive	defensive	JJ	I-NP
O	response	response	NN	I-NP
O	.	.	.	O

O	BACKGROUND	BACKGROUND	NN	B-NP
O	:	:	:	O
O	Groundwater	Groundwater	NN	B-NP
O	contaminated	contaminate	VBN	B-VP
O	with	with	IN	B-PP
O	arsenic	arsenic	JJ	B-NP
O	imposes	impose	VBZ	B-VP
O	a	a	DT	B-NP
O	big	big	JJ	I-NP
O	challenge	challenge	NN	I-NP
O	to	to	TO	B-PP
O	human	human	JJ	B-NP
O	health	health	NN	I-NP
O	worldwide	worldwide	RB	B-ADVP
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	natural	natural	JJ	B-NP
O	compounds	compound	NNS	I-NP
O	to	to	TO	B-VP
O	subvert	subvert	VB	I-VP
O	the	the	DT	B-NP
O	detrimental	detrimental	JJ	I-NP
O	effects	effect	NNS	I-NP
O	of	of	IN	B-PP
O	arsenic	arsenic	JJ	B-NP
O	represents	represent	VBZ	B-VP
O	an	an	DT	B-NP
O	attractive	attractive	JJ	I-NP
O	strategy	strategy	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
B-GGP	nuclear	nuclear	JJ	B-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	erythroid	erythroid	JJ	B-NP
I-GGP	2	2	CD	I-NP
I-GGP	-	-	HYPH	O
I-GGP	related	relate	VBN	B-VP
I-GGP	factor	factor	NN	B-NP
I-GGP	2	2	CD	I-NP
O	(	(	(	O
B-GGP	Nrf2	Nrf2	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	critical	critical	JJ	I-NP
O	regulator	regulator	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cellular	cellular	JJ	I-NP
O	antioxidant	antioxidant	JJ	I-NP
O	response	response	NN	I-NP
O	and	and	CC	O
O	xenobiotic	xenobiotic	JJ	B-NP
O	metabolism	metabolism	NN	I-NP
O	.	.	.	O

O	Recently	Recently	RB	B-ADVP
O	,	,	,	O
O	activation	activation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	Nrf2	Nrf2	NN	I-NP
O	signaling	signaling	NN	I-NP
O	pathway	pathway	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	reported	report	VBN	I-VP
O	to	to	TO	I-VP
O	confer	confer	VB	I-VP
O	protection	protection	NN	B-NP
O	against	against	IN	B-PP
O	arsenic	arsenic	JJ	B-NP
O	-	-	HYPH	I-NP
O	induced	induce	VBN	I-NP
O	toxicity	toxicity	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	cell	cell	NN	I-NP
O	culture	culture	NN	I-NP
O	model	model	NN	I-NP
O	.	.	.	O

O	OBJECTIVES	OBJECTIVES	NNS	B-NP
O	:	:	:	O
O	The	The	DT	B-NP
O	goal	goal	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	work	work	NN	I-NP
O	was	be	VBD	B-VP
O	to	to	TO	B-VP
O	identify	identify	VB	I-VP
O	a	a	DT	B-NP
O	potent	potent	JJ	I-NP
B-GGP	Nrf2	Nrf2	NN	I-NP
O	activator	activator	NN	I-NP
O	from	from	IN	B-PP
O	plants	plant	NNS	B-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	chemopreventive	chemopreventive	JJ	I-NP
O	compound	compound	NN	I-NP
O	and	and	CC	O
O	to	to	TO	B-VP
O	demonstrate	demonstrate	VB	I-VP
O	the	the	DT	B-NP
O	efficacy	efficacy	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	compound	compound	NN	I-NP
O	in	in	IN	B-PP
O	battling	battle	VBG	B-VP
O	arsenic	arsenic	JJ	B-NP
O	-	-	HYPH	I-NP
O	induced	induce	VBN	I-NP
O	toxicity	toxicity	NN	I-NP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
O	Oridonin	Oridonin	NN	B-NP
O	activated	activate	VBD	B-VP
O	the	the	DT	B-NP
B-GGP	Nrf2	Nrf2	NN	I-NP
O	signaling	signaling	NN	I-NP
O	pathway	pathway	NN	I-NP
O	at	at	IN	B-PP
O	a	a	DT	B-NP
O	low	low	JJ	I-NP
O	subtoxic	subtoxic	JJ	I-NP
O	dose	dose	NN	I-NP
O	and	and	CC	O
O	was	be	VBD	B-VP
O	able	able	JJ	B-ADJP
O	to	to	TO	B-VP
O	stabilize	stabilize	VB	I-VP
B-GGP	Nrf2	Nrf2	NN	B-NP
O	by	by	IN	B-PP
O	blocking	block	VBG	B-VP
B-GGP	Nrf2	Nrf2	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	,	,	,	O
O	leading	lead	VBG	B-VP
O	to	to	TO	B-PP
O	accumulation	accumulation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	Nrf2	Nrf2	NN	I-NP
O	protein	protein	NN	I-NP
O	and	and	CC	O
O	activation	activation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	Nrf2	Nrf2	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	cytoprotective	cytoprotective	JJ	I-NP
O	response	response	NN	I-NP
O	.	.	.	O

O	Pretreatment	Pretreatment	NN	B-NP
O	of	of	IN	B-PP
O	UROtsa	UROtsa	NN	B-NP
O	cells	cell	NNS	I-NP
O	with	with	IN	B-PP
O	1	1	CD	B-NP
O	.	.	.	O
O	4	4	CD	B-NP
O	muM	muM	NN	I-NP
O	oridonin	oridonin	NN	I-NP
O	significantly	significantly	RB	B-ADVP
O	enhanced	enhance	VBD	B-VP
O	the	the	DT	B-NP
O	cellular	cellular	JJ	I-NP
O	redox	redox	NN	I-NP
O	capacity	capacity	NN	I-NP
O	,	,	,	O
O	reduced	reduce	VBD	B-VP
O	formation	formation	NN	B-NP
O	of	of	IN	B-PP
O	reactive	reactive	JJ	B-NP
O	oxygen	oxygen	NN	I-NP
O	species	specie	NNS	I-NP
O	(	(	(	O
O	ROS	ROS	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
O	improved	improve	VBN	B-NP
O	cell	cell	NN	I-NP
O	survival	survival	NN	I-NP
O	after	after	IN	B-PP
O	arsenic	arsenic	JJ	B-NP
O	challenge	challenge	NN	I-NP
O	.	.	.	O

O	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	:	:	:	O
O	We	We	PRP	B-NP
O	identified	identify	VBD	B-VP
O	oridonin	oridonin	NN	B-NP
O	as	as	IN	B-PP
O	representing	represent	VBG	B-VP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	class	class	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Nrf2	Nrf2	NN	B-NP
O	activators	activator	NNS	I-NP
O	and	and	CC	O
O	illustrated	illustrate	VBD	B-VP
O	the	the	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	by	by	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
B-GGP	Nrf2	Nrf2	NN	I-NP
O	pathway	pathway	NN	I-NP
O	is	be	VBZ	B-VP
O	activated	activate	VBN	I-VP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	demonstrated	demonstrate	VBD	B-VP
O	the	the	DT	B-NP
O	feasibility	feasibility	NN	I-NP
O	of	of	IN	B-PP
O	using	use	VBG	B-VP
O	natural	natural	JJ	B-NP
O	compounds	compound	NNS	I-NP
O	targeting	target	VBG	B-VP
B-GGP	Nrf2	Nrf2	NN	B-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	therapeutic	therapeutic	JJ	I-NP
O	approach	approach	NN	I-NP
O	to	to	TO	B-VP
O	protect	protect	VB	I-VP
O	humans	human	NNS	B-NP
O	from	from	IN	B-PP
O	various	various	JJ	B-NP
O	environmental	environmental	JJ	I-NP
O	insults	insult	NNS	I-NP
O	that	that	WDT	B-NP
O	may	may	MD	B-VP
O	occur	occur	VB	I-VP
O	daily	daily	RB	B-ADVP
O	.	.	.	O

O	beta	beta	SYM	B-NP
O	-	-	:	O
O	Hydroxylation	Hydroxylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	aspartyl	aspartyl	NN	I-NP
O	residue	residue	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	phytotoxin	phytotoxin	NN	I-NP
O	syringomycin	syringomycin	NN	I-NP
O	E	E	NN	I-NP
O	:	:	:	O
O	characterization	characterization	NN	B-NP
O	of	of	IN	B-PP
O	two	two	CD	B-NP
O	candidate	candidate	NN	I-NP
O	hydroxylases	hydroxylas	NNS	I-NP
B-GGP	AspH	AspH	NN	I-NP
O	and	and	CC	I-NP
B-GGP	SyrP	SyrP	NN	I-NP
O	in	in	IN	B-PP
O	Pseudomonas	Pseudomonas	NNP	B-NP
O	syringae	syringae	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	pseudomonal	pseudomonal	JJ	I-NP
O	phytotoxin	phytotoxin	NN	I-NP
O	syringomycin	syringomycin	NN	I-NP
O	E	E	NN	I-NP
O	and	and	CC	O
O	related	related	JJ	B-NP
O	nonribosomal	nonribosomal	JJ	I-NP
O	peptides	peptide	NNS	I-NP
O	contain	contain	VBP	B-VP
O	an	an	DT	B-NP
O	L	L	NN	I-NP
O	-	-	HYPH	O
O	threo	threo	SYM	B-NP
O	-	-	HYPH	B-NP
O	beta	beta	SYM	I-NP
O	-	-	HYPH	I-NP
O	hydroxyaspartyl	hydroxyaspartyl	NN	I-NP
O	residue	residue	NN	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	eighth	eighth	JJ	I-NP
O	position	position	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	lipodepsipeptide	lipodepsipeptide	NN	I-NP
O	backbone	backbone	NN	I-NP
O	as	as	IN	B-PP
O	part	part	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	nonproteinogenic	nonproteinogenic	JJ	I-NP
O	tripeptide	tripeptide	NN	I-NP
O	motif	motif	NN	I-NP
O	.	.	.	O

O	Informatic	Informatic	JJ	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	P	P	NN	I-NP
O	.	.	.	O
O	syringae	syringae	NN	B-NP
O	genome	genome	NN	I-NP
O	suggests	suggest	VBZ	B-VP
O	only	only	RB	B-NP
O	one	one	CD	I-NP
O	putative	putative	JJ	I-NP
O	non	non	AFX	I-NP
O	-	-	HYPH	I-NP
O	heme	heme	NN	I-NP
O	iron	iron	NN	I-NP
O	hydroxylase	hydroxylase	NN	I-NP
O	,	,	,	O
B-GGP	AspH	AspH	NN	B-NP
O	.	.	.	O

O	On	On	IN	B-PP
O	heterologous	heterologous	JJ	B-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	Escherichia	Escherichia	FW	B-NP
O	coli	coli	FW	I-NP
B-GGP	AspH	AspH	NN	I-NP
O	shows	show	VBZ	B-VP
O	robust	robust	JJ	B-NP
O	catalytic	catalytic	JJ	I-NP
O	activity	activity	NN	I-NP
O	with	with	IN	B-PP
O	free	free	JJ	B-NP
O	L	L	NN	I-NP
O	-	-	HYPH	B-NP
O	Asp	Asp	NN	I-NP
O	and	and	CC	I-NP
O	L	L	NN	I-NP
O	-	-	HYPH	B-NP
O	Asp	Asp	NN	I-NP
O	thioesters	thioester	NNS	I-NP
O	to	to	TO	B-VP
O	make	make	VB	I-VP
O	beta	beta	SYM	B-NP
O	-	-	HYPH	B-NP
O	OH	OH	NN	I-NP
O	-	-	HYPH	O
O	Asp	Asp	NN	B-NP
O	but	but	CC	O
O	yields	yield	VBZ	B-VP
O	the	the	DT	B-NP
O	erythro	erythro	NN	I-NP
O	diastereomer	diastereomer	NN	I-NP
O	rather	rather	RB	B-CONJP
O	than	than	IN	I-CONJP
O	the	the	DT	B-NP
O	threo	threo	NN	I-NP
O	configuration	configuration	NN	I-NP
O	that	that	WDT	B-NP
O	is	be	VBZ	B-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	syringomycin	syringomycin	NN	B-NP
O	.	.	.	O

O	Further	Further	JJ	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Syr	Syr	NN	I-NP
O	gene	gene	NN	I-NP
O	cluster	cluster	NN	I-NP
O	indicated	indicate	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	SyrP	SyrP	NN	B-NP
O	,	,	,	O
O	previously	previously	RB	B-VP
O	annotated	annotate	VBN	I-VP
O	as	as	IN	B-PP
O	the	the	DT	B-NP
O	gene	gene	NN	I-NP
O	regulatory	regulatory	JJ	I-NP
O	protein	protein	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	five	five	CD	I-NP
O	-	-	HYPH	I-NP
O	gene	gene	NN	I-NP
O	Syr	Syr	NN	I-NP
O	cluster	cluster	NN	I-NP
O	,	,	,	O
O	is	be	VBZ	B-VP
O	actually	actually	RB	B-ADJP
O	homologous	homologous	JJ	I-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	known	know	VBN	I-NP
O	non	non	AFX	I-NP
O	-	-	HYPH	I-NP
O	heme	heme	NN	I-NP
O	mononuclear	mononuclear	JJ	I-NP
O	iron	iron	NN	I-NP
O	hydroxylase	hydroxylase	NN	I-NP
B-GGP	TauD	TauD	NN	I-NP
O	.	.	.	O

O	Indeed	Indeed	RB	B-ADVP
O	,	,	,	O
O	purified	purify	VBN	B-NP
B-GGP	SyrP	SyrP	NN	I-NP
O	acts	act	VBZ	B-VP
O	on	on	IN	B-PP
O	Asp	Asp	NN	B-NP
O	tethered	tether	VBN	B-VP
O	as	as	IN	B-PP
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	-	-	HYPH	B-VP
O	bound	bind	VBN	B-NP
O	S	S	NN	I-NP
O	-	-	HYPH	B-NP
O	pantetheinyl	pantetheinyl	NN	I-NP
O	thioester	thioester	NN	I-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	eighth	eighth	JJ	I-NP
O	module	module	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	SyrE	SyrE	NN	I-NP
O	megasynthetase	megasynthetase	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	gives	give	VBZ	B-VP
O	the	the	DT	B-NP
O	anticipated	anticipate	VBN	I-NP
O	L	L	NN	I-NP
O	-	-	HYPH	O
O	threo	threo	AFX	O
O	-	-	HYPH	B-NP
O	3	3	CD	I-NP
O	-	-	HYPH	I-NP
O	OH	OH	NN	I-NP
O	-	-	HYPH	I-NP
O	Asp	Asp	NN	I-NP
O	diastereomer	diastereomer	NN	I-NP
O	found	find	VBN	B-VP
O	in	in	IN	B-PP
O	syringomycin	syringomycin	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	knockout	knockout	NN	I-NP
O	of	of	IN	B-PP
B-GGP	syrP	syrP	NN	B-NP
O	abolishes	abolish	VBZ	B-VP
O	the	the	DT	B-NP
O	production	production	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mature	mature	JJ	I-NP
O	syringomycin	syringomycin	NN	I-NP
O	E	E	NN	I-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	knockout	knockout	NN	B-NP
O	of	of	IN	B-PP
B-GGP	aspH	aspH	NN	B-NP
O	has	have	VBZ	B-VP
O	no	no	DT	B-NP
O	effect	effect	NN	I-NP
O	on	on	IN	B-PP
O	syringomycin	syringomycin	NN	B-NP
O	production	production	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	critical	critical	JJ	I-NP
O	role	role	NN	I-NP
O	for	for	IN	B-PP
B-GGP	CHIP	CHIP	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	aggresome	aggresome	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

O	Recent	Recent	JJ	B-NP
O	evidence	evidence	NN	I-NP
O	suggests	suggest	VBZ	B-VP
O	that	that	IN	B-SBAR
O	aggresome	aggresome	JJ	B-NP
O	formation	formation	NN	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	physiologic	physiologic	JJ	I-NP
O	stress	stress	NN	I-NP
O	response	response	NN	I-NP
O	not	not	RB	B-VP
O	limited	limit	VBN	I-VP
O	to	to	TO	B-PP
O	misfolded	misfolded	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	That	That	DT	B-NP
O	stress	stress	NN	I-NP
O	response	response	NN	I-NP
O	,	,	,	O
O	termed	term	VBN	B-VP
O	"	"	``	O
O	physiologic	physiologic	JJ	B-NP
O	aggresome	aggresome	JJ	I-NP
O	,	,	,	O
O	"	"	''	O
O	is	be	VBZ	B-VP
O	exemplified	exemplify	VBN	I-VP
O	by	by	IN	B-PP
O	aggresome	aggresome	JJ	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	inducible	inducible	JJ	B-NP
I-GGP	nitric	nitric	JJ	I-NP
I-GGP	oxide	oxide	NN	I-NP
I-GGP	synthase	synthase	NN	I-NP
O	(	(	(	O
B-GGP	iNOS	iNOS	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	host	host	NN	I-NP
O	defense	defense	NN	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

B-GGP	CHIP	CHIP	NN	B-NP
O	(	(	(	O
B-GGP	carboxy	carboxy	NN	B-NP
I-GGP	terminus	terminus	NN	I-NP
I-GGP	of	of	IN	B-PP
I-GGP	Hsp70	Hsp70	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	interacting	interact	VBG	B-VP
I-GGP	protein	protein	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	highly	highly	RB	I-NP
O	conserved	conserve	VBN	I-NP
O	protein	protein	NN	I-NP
O	that	that	WDT	B-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	mediate	mediate	VB	I-VP
O	substrate	substrate	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	proteasome	proteasome	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	CHIP	CHIP	NN	B-NP
O	has	have	VBZ	B-VP
O	a	a	DT	B-NP
O	previously	previously	RB	I-NP
O	unexpected	unexpected	JJ	I-NP
O	critical	critical	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	aggresome	aggresome	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

B-GGP	CHIP	CHIP	NN	B-NP
O	interacts	interact	VBZ	B-VP
O	with	with	IN	B-PP
B-GGP	iNOS	iNOS	NN	B-NP
O	and	and	CC	O
O	promotes	promote	VBZ	B-VP
O	its	its	PRP$	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	proteasome	proteasome	NN	I-NP
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	its	its	PRP$	B-NP
O	sequestration	sequestration	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	aggresome	aggresome	NN	I-NP
O	.	.	.	O

B-GGP	CHIP	CHIP	NN	B-NP
O	-	-	HYPH	B-PP
O	mediated	mediate	VBN	B-NP
B-GGP	iNOS	iNOS	NN	I-NP
O	targeting	target	VBG	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	proteasome	proteasome	NN	I-NP
O	sequentially	sequentially	RB	B-ADVP
O	precedes	precede	VBZ	B-VP
B-GGP	CHIP	CHIP	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
B-GGP	iNOS	iNOS	NN	I-NP
O	sequestration	sequestration	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	aggresome	aggresome	NN	I-NP
O	.	.	.	O

B-GGP	CHIP	CHIP	NN	B-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
B-GGP	iNOS	iNOS	NN	B-NP
O	preaggresome	preaggresome	JJ	I-NP
O	structures	structure	NNS	I-NP
O	to	to	TO	B-VP
O	form	form	VB	I-VP
O	a	a	DT	B-NP
O	mature	mature	JJ	I-NP
O	aggresome	aggresome	NN	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
B-GGP	CHIP	CHIP	NN	B-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	targeting	target	VBG	B-VP
O	the	the	DT	B-NP
O	mutant	mutant	JJ	I-NP
O	form	form	NN	I-NP
O	of	of	IN	B-PP
B-GGP	cystic	cystic	JJ	B-NP
I-GGP	fibrosis	fibrosis	NN	I-NP
I-GGP	transconductance	transconductance	NN	I-NP
I-GGP	regulator	regulator	NN	I-NP
O	(	(	(	O
B-GGP	CFTRDeltaF508	CFTRDeltaF508	NN	B-NP
O	)	)	)	O
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	aggresome	aggresome	NN	I-NP
O	.	.	.	O

O	Importantly	Importantly	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	function	function	NN	I-NP
O	of	of	IN	B-PP
B-GGP	CHIP	CHIP	NN	B-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	in	in	IN	B-PP
O	targeting	target	VBG	B-VP
O	preaggresomal	preaggresomal	JJ	B-NP
O	structures	structure	NNS	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	aggresome	aggresome	NN	I-NP
O	by	by	IN	B-PP
O	promoting	promote	VBG	B-VP
O	an	an	DT	B-NP
B-GGP	iNOS	iNOS	NN	I-NP
O	interaction	interaction	NN	I-NP
O	with	with	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	deacetylase	deacetylase	NN	I-NP
I-GGP	6	6	CD	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	serves	serve	VBZ	B-VP
O	as	as	IN	B-PP
O	an	an	DT	B-NP
O	adaptor	adaptor	NN	I-NP
O	between	between	IN	B-PP
O	ubiquitinated	ubiquitinate	VBN	B-NP
O	proteins	protein	NNS	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	dynein	dynein	NN	I-NP
O	motor	motor	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	study	study	NN	I-NP
O	reveals	reveal	VBZ	B-VP
O	a	a	DT	B-NP
O	critical	critical	JJ	I-NP
O	role	role	NN	I-NP
O	for	for	IN	B-PP
B-GGP	CHIP	CHIP	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	aggresome	aggresome	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

B-GGP	AZGP1	AZGP1	NN	B-NP
O	autoantibody	autoantibody	NN	I-NP
O	predicts	predict	VBZ	B-VP
O	survival	survival	NN	B-NP
O	and	and	CC	I-NP
B-GGP	histone	histone	NN	I-NP
O	deacetylase	deacetylase	NN	I-NP
O	inhibitors	inhibitor	NNS	I-NP
O	increase	increase	VBP	B-VP
O	expression	expression	NN	B-NP
O	in	in	IN	B-PP
O	lung	lung	NN	B-NP
O	adenocarcinoma	adenocarcinoma	NN	I-NP
O	.	.	.	O

O	INTRODUCTION	INTRODUCTION	NN	B-NP
O	:	:	:	O
O	The	The	DT	B-NP
O	importance	importance	NN	I-NP
O	of	of	IN	B-PP
B-GGP	alpha	alpha	SYM	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	2	2	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	glycoprotein	glycoprotein	NN	B-NP
I-GGP	1	1	CD	I-NP
I-GGP	,	,	,	O
I-GGP	zinc	zinc	NN	B-NP
O	(	(	(	O
B-GGP	AZGP1	AZGP1	NN	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	lung	lung	NN	B-NP
O	adenocarcinoma	adenocarcinoma	NN	I-NP
O	(	(	(	O
O	AD	AD	NN	B-NP
O	)	)	)	O
O	remains	remain	VBZ	B-VP
O	largely	largely	RB	B-ADJP
O	unknown	unknown	JJ	I-ADJP
O	.	.	.	O

O	Analysis	Analysis	NN	B-NP
O	of	of	IN	B-PP
O	serum	serum	NN	B-NP
O	autoantibodies	autoantibody	NNS	I-NP
O	to	to	TO	B-PP
O	tumor	tumor	NN	B-NP
O	antigens	antigen	NNS	I-NP
O	combined	combine	VBN	B-VP
O	with	with	IN	B-PP
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	profiling	profiling	NN	I-NP
O	of	of	IN	B-PP
O	primary	primary	JJ	B-NP
O	tumors	tumor	NNS	I-NP
O	may	may	MD	B-VP
O	provide	provide	VB	I-VP
O	insight	insight	NN	B-NP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	underlying	underlie	VBG	B-VP
O	lung	lung	NN	B-NP
O	carcinogenesis	carcinogenesis	NN	I-NP
O	and	and	CC	O
O	identify	identify	VB	B-VP
O	new	new	JJ	B-NP
O	AD	AD	NN	I-NP
O	biomarkers	biomarker	NNS	I-NP
O	.	.	.	O

O	METHODS	METHODS	NNS	B-NP
O	:	:	:	O
O	T7	T7	NN	B-NP
O	phage	phage	NN	I-NP
O	cDNA	cDNA	NN	I-NP
O	libraries	library	NNS	I-NP
O	were	be	VBD	B-VP
O	used	use	VBN	I-VP
O	to	to	TO	B-VP
O	identify	identify	VB	I-VP
B-GGP	AZGP1	AZGP1	NN	B-NP
O	autoantibodies	autoantibody	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	serum	serum	NN	I-NP
O	of	of	IN	B-PP
O	473	473	CD	B-NP
O	patients	patient	NNS	I-NP
O	(	(	(	O
O	192	192	CD	B-NP
O	ADs	AD	NNS	I-NP
O	,	,	,	O
O	192	192	CD	B-NP
O	matched	match	VBN	I-NP
O	controls	control	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	89	89	CD	B-NP
O	additional	additional	JJ	I-NP
O	ADs	AD	NNS	I-NP
O	for	for	IN	B-PP
O	confirmation	confirmation	NN	B-NP
O	of	of	IN	B-PP
O	findings	finding	NNS	B-NP
O	)	)	)	O
O	.	.	.	O

B-GGP	AZGP1	AZGP1	NN	B-NP
O	mRNA	mRNA	NN	I-NP
O	expression	expression	NN	I-NP
O	was	be	VBD	B-VP
O	examined	examine	VBN	I-VP
O	in	in	IN	B-PP
O	86	86	CD	B-NP
O	ADs	AD	NNS	I-NP
O	and	and	CC	O
O	10	10	CD	B-NP
O	control	control	NN	I-NP
O	lung	lung	NN	I-NP
O	tissue	tissue	NN	I-NP
O	samples	sample	NNS	I-NP
O	using	use	VBG	B-VP
O	oligonucleotide	oligonucleotide	NN	B-NP
O	microarrays	microarray	NNS	I-NP
O	.	.	.	O

B-GGP	AZGP1	AZGP1	NN	B-NP
O	protein	protein	NN	I-NP
O	expression	expression	NN	I-NP
O	was	be	VBD	B-VP
O	studied	study	VBN	I-VP
O	in	in	IN	B-PP
O	230	230	CD	B-NP
O	tissue	tissue	NN	I-NP
O	samples	sample	NNS	I-NP
O	(	(	(	O
O	222	222	CD	B-NP
O	ADs	AD	NNS	I-NP
O	;	;	:	O
O	8	8	CD	B-NP
O	controls	control	NNS	I-NP
O	)	)	)	O
O	with	with	IN	B-PP
O	immunohistochemistry	immunohistochemistry	NN	B-NP
O	.	.	.	O

O	Kaplan	Kaplan	NNP	B-NP
O	-	-	HYPH	I-NP
O	Meier	Meier	NNP	I-NP
O	analyses	analysis	NNS	I-NP
O	were	be	VBD	B-VP
O	used	use	VBN	I-VP
O	to	to	TO	B-VP
O	correlate	correlate	VB	I-VP
O	circulating	circulate	VBG	I-VP
O	autoantibody	autoantibody	NN	B-NP
O	and	and	CC	I-NP
O	tissue	tissue	NN	I-NP
O	mRNA	mRNA	NN	I-NP
O	production	production	NN	I-NP
O	with	with	IN	B-PP
O	survival	survival	NN	B-NP
O	.	.	.	O

O	AD	AD	NN	B-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	A549	A549	NN	B-NP
O	and	and	CC	I-NP
O	SKLU1	SKLU1	NN	I-NP
O	were	be	VBD	B-VP
O	treated	treat	VBN	I-VP
O	with	with	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	aza	aza	NN	I-NP
O	-	-	HYPH	B-ADJP
O	2	2	CD	B-NP
O	;	;	:	O
O	-	-	HYPH	B-NP
O	deoxycytidine	deoxycytidine	NN	I-NP
O	(	(	(	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	AZA	AZA	NN	I-NP
O	)	)	)	O
O	and	and	CC	O
O	trichostatin	trichostatin	NN	B-NP
O	A	A	NN	I-NP
O	(	(	(	O
O	TSA	TSA	NN	B-NP
O	)	)	)	O
O	to	to	TO	B-VP
O	examine	examine	VB	I-VP
O	the	the	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	promoter	promoter	NN	B-NP
O	methylation	methylation	NN	I-NP
O	and	and	CC	O
B-GGP	histone	histone	NN	B-NP
O	deacetylation	deacetylation	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	AZGP1	AZGP1	NN	B-NP
O	.	.	.	O

O	Real	Real	JJ	B-NP
O	-	-	HYPH	I-NP
O	time	time	NN	I-NP
O	polymerase	polymerase	NN	I-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	was	be	VBD	B-VP
O	used	use	VBN	I-VP
O	to	to	TO	B-VP
O	quantify	quantify	VB	I-VP
O	the	the	DT	B-NP
O	effects	effect	NNS	I-NP
O	of	of	IN	B-PP
O	treatment	treatment	NN	B-NP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
O	In	In	IN	B-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
O	AD	AD	NN	B-NP
O	,	,	,	O
B-GGP	AZGP1	AZGP1	NN	B-NP
O	autoantibodies	autoantibody	NNS	I-NP
O	were	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	in	in	IN	B-PP
O	40	40	CD	B-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	serum	serum	NN	B-NP
O	samples	sample	NNS	I-NP
O	.	.	.	O

O	Autoantibody	Autoantibody	NN	B-NP
O	production	production	NN	I-NP
O	correlated	correlate	VBD	B-VP
O	with	with	IN	B-PP
O	improved	improve	VBN	B-VP
O	overall	overall	RB	B-ADVP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	year	year	NN	I-NP
O	survival	survival	NN	I-NP
O	(	(	(	O
O	p	p	NN	B-NP
O	=	=	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	002	002	CD	I-NP
O	)	)	)	O
O	and	and	CC	O
O	improved	improve	VBN	B-NP
O	survival	survival	NN	I-NP
O	in	in	IN	B-PP
O	those	those	DT	B-NP
O	with	with	IN	B-PP
O	stage	stage	NN	B-NP
O	I	I	CD	I-NP
O	to	to	TO	I-NP
O	II	II	CD	I-NP
O	disease	disease	NN	I-NP
O	(	(	(	O
O	p	p	NN	B-NP
O	=	=	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	008	008	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	A	A	DT	B-NP
O	verification	verification	NN	I-NP
O	analysis	analysis	NN	I-NP
O	was	be	VBD	B-VP
O	performed	perform	VBN	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	survival	survival	NN	I-NP
O	benefit	benefit	NN	I-NP
O	and	and	CC	O
O	found	find	VBD	B-VP
O	similar	similar	JJ	B-NP
O	results	result	NNS	I-NP
O	with	with	IN	B-PP
O	p	p	NN	B-NP
O	values	value	NNS	I-NP
O	of	of	IN	B-PP
O	0	0	CD	B-NP
O	.	.	.	O
O	02	02	CD	B-NP
O	and	and	CC	I-NP
O	0	0	CD	I-NP
O	.	.	.	I-NP
O	036	036	CD	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	Although	Although	IN	B-SBAR
O	abundant	abundant	JJ	B-NP
O	mRNA	mRNA	NN	I-NP
O	expression	expression	NN	I-NP
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	subset	subset	NN	I-NP
O	of	of	IN	B-PP
O	tumors	tumor	NNS	B-NP
O	,	,	,	O
O	mRNA	mRNA	NN	B-NP
O	expression	expression	NN	I-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	correlate	correlate	VB	I-VP
O	with	with	IN	B-PP
O	prognosis	prognosis	NN	B-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	normal	normal	JJ	B-NP
O	lung	lung	NN	I-NP
O	,	,	,	O
B-GGP	AZGP1	AZGP1	NN	B-NP
O	mRNA	mRNA	NN	I-NP
O	and	and	CC	O
O	protein	protein	NN	B-NP
O	expression	expression	NN	I-NP
O	were	be	VBD	B-VP
O	low	low	JJ	B-ADJP
O	or	or	CC	I-ADJP
O	absent	absent	JJ	I-ADJP
O	,	,	,	O
O	whereas	whereas	IN	O
O	in	in	IN	B-PP
O	AD	AD	NN	B-NP
O	they	they	PRP	B-NP
O	were	be	VBD	B-VP
O	highly	highly	RB	I-VP
O	expressed	express	VBN	I-VP
O	in	in	IN	B-PP
O	31	31	CD	B-NP
O	.	.	.	O
O	3	3	CD	B-NP
O	%	%	NN	I-NP
O	and	and	CC	O
O	42	42	CD	B-NP
O	.	.	.	O
O	8	8	CD	B-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	samples	sample	NNS	B-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	To	To	TO	B-VP
O	determine	determine	VB	I-VP
O	whether	whether	IN	B-SBAR
B-GGP	AZGP1	AZGP1	NN	B-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	subset	subset	NN	I-NP
O	of	of	IN	B-PP
O	tumors	tumor	NNS	B-NP
O	might	might	MD	B-VP
O	be	be	VB	I-VP
O	affected	affect	VBN	I-VP
O	by	by	IN	B-PP
O	epigenetic	epigenetic	JJ	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	,	,	,	O
O	low	low	JJ	B-NP
B-GGP	AZGP1	AZGP1	NN	I-NP
O	-	-	HYPH	O
O	expressing	express	VBG	B-VP
O	A549	A549	NN	B-NP
O	and	and	CC	I-NP
O	SKLU1	SKLU1	NN	I-NP
O	AD	AD	NN	I-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	were	be	VBD	B-VP
O	treated	treat	VBN	I-VP
O	with	with	IN	B-PP
O	TSA	TSA	NN	B-NP
O	and	and	CC	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	AZA	AZA	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	713	713	CD	I-NP
O	-	-	HYPH	O
O	fold	fold	RB	B-ADVP
O	and	and	CC	O
O	169	169	CD	B-NP
O	-	-	HYPH	I-NP
O	fold	fold	JJ	I-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
O	mRNA	mRNA	NN	B-NP
O	expression	expression	NN	I-NP
O	were	be	VBD	B-VP
O	noted	note	VBN	I-VP
O	on	on	IN	B-PP
O	treatment	treatment	NN	B-NP
O	with	with	IN	B-PP
O	TSA	TSA	NN	B-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	Treatment	Treatment	NN	B-NP
O	with	with	IN	B-PP
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	AZA	AZA	NN	I-NP
O	had	have	VBD	B-VP
O	minimal	minimal	JJ	B-NP
O	effect	effect	NN	I-NP
O	on	on	IN	B-PP
B-GGP	AZGP1	AZGP1	NN	B-NP
O	mRNA	mRNA	NN	I-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	:	:	:	O
O	The	The	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
B-GGP	AZGP1	AZGP1	NN	B-NP
O	serum	serum	NN	I-NP
O	autoantibody	autoantibody	NN	I-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	used	use	VBN	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	prognostic	prognostic	JJ	I-NP
O	marker	marker	NN	I-NP
O	in	in	IN	B-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
O	AD	AD	NN	B-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	up	up	RB	B-ADVP
O	-	-	HYPH	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	AZGP1	AZGP1	NN	B-NP
O	mRNA	mRNA	NN	I-NP
O	in	in	IN	B-PP
O	AD	AD	NN	B-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	affected	affect	VBN	I-VP
O	by	by	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	remodeling	remodeling	NN	I-NP
O	by	by	IN	B-PP
O	means	mean	NNS	B-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	-	-	HYPH	I-NP
O	acetylation	acetylation	NN	I-NP
O	switch	switch	NN	I-NP
O	regulates	regulate	VBZ	B-VP
B-GGP	STAT1	STAT1	NN	B-NP
O	signaling	signaling	NN	I-NP
O	.	.	.	O

O	Cytokines	Cytokine	NNS	B-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	interferons	interferon	NNS	B-NP
O	(	(	(	O
O	IFNs	IFN	NNS	B-NP
O	)	)	)	O
O	activate	activate	VBP	B-VP
O	signal	signal	NN	B-NP
O	transducers	transducer	NNS	I-NP
O	and	and	CC	I-NP
O	activators	activator	NNS	I-NP
O	of	of	IN	B-PP
O	transcription	transcription	NN	B-NP
O	(	(	(	O
O	STATs	STAT	NNS	B-NP
O	)	)	)	O
O	via	via	IN	B-PP
O	phosphorylation	phosphorylation	NN	B-NP
O	.	.	.	O

B-GGP	Histone	Histone	NN	B-NP
O	deacetylases	deacetylas	NNS	I-NP
O	(	(	(	O
O	HDACs	HDAC	NNS	B-NP
O	)	)	)	O
O	and	and	CC	O
O	the	the	DT	B-NP
B-GGP	histone	histone	NN	I-NP
O	acetyltransferase	acetyltransferase	NN	I-NP
O	(	(	(	O
O	HAT	HAT	NN	B-NP
O	)	)	)	O
B-GGP	CBP	CBP	NN	B-NP
O	dynamically	dynamically	RB	B-ADVP
O	regulate	regulate	VBP	B-VP
B-GGP	STAT1	STAT1	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	acetylation	acetylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	STAT1	STAT1	NN	B-NP
O	counteracts	counteract	VBZ	B-VP
O	IFN	IFN	NN	B-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
B-GGP	STAT1	STAT1	NN	I-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	,	,	,	O
O	nuclear	nuclear	JJ	B-NP
O	translocation	translocation	NN	I-NP
O	,	,	,	O
O	DNA	DNA	NN	B-NP
O	binding	binding	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	target	target	NN	B-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	Biochemical	Biochemical	JJ	B-NP
O	and	and	CC	I-NP
O	genetic	genetic	JJ	I-NP
O	experiments	experiment	NNS	I-NP
O	altering	alter	VBG	B-VP
O	the	the	DT	B-NP
O	HAT	HAT	NN	I-NP
O	/	/	SYM	B-VP
O	HDAC	HDAC	NN	B-NP
O	activity	activity	NN	I-NP
O	ratio	ratio	NN	I-NP
O	and	and	CC	I-NP
B-GGP	STAT1	STAT1	NN	I-NP
O	mutants	mutant	NNS	I-NP
O	reveal	reveal	VBP	B-VP
O	that	that	IN	B-SBAR
O	a	a	DT	B-NP
O	phospho	phospho	AFX	I-NP
O	-	-	HYPH	I-NP
O	acetyl	acetyl	NN	I-NP
O	switch	switch	NN	I-NP
O	regulates	regulate	VBZ	B-VP
B-GGP	STAT1	STAT1	NN	B-NP
O	signaling	signaling	NN	I-NP
O	via	via	IN	B-PP
B-GGP	CBP	CBP	NN	B-NP
O	,	,	,	O
B-GGP	HDAC3	HDAC3	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
B-GGP	T	T	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	cell	cell	NN	I-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	tyrosine	tyrosine	NN	I-NP
I-GGP	phosphatase	phosphatase	NN	I-NP
O	(	(	(	O
B-GGP	TCP45	TCP45	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Strikingly	Strikingly	RB	B-ADVP
O	,	,	,	O
O	inhibition	inhibition	NN	B-NP
O	of	of	IN	B-PP
B-GGP	STAT1	STAT1	NN	B-NP
O	signaling	signaling	NN	I-NP
O	via	via	IN	B-PP
B-GGP	CBP	CBP	NN	B-NP
O	-	-	HYPH	B-NP
O	mediated	mediate	VBN	I-NP
O	acetylation	acetylation	NN	I-NP
O	is	be	VBZ	B-VP
O	distinct	distinct	JJ	B-ADJP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	functions	function	NNS	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	HAT	HAT	NN	I-NP
O	in	in	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	activation	activation	NN	I-NP
O	.	.	.	O

B-GGP	STAT1	STAT1	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	induces	induce	VBZ	B-VP
O	binding	binding	NN	B-NP
O	of	of	IN	B-PP
B-GGP	TCP45	TCP45	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	catalyzes	catalyze	VBZ	B-VP
O	dephosphorylation	dephosphorylation	NN	B-NP
O	and	and	CC	I-NP
O	latency	latency	NN	I-NP
O	of	of	IN	B-PP
B-GGP	STAT1	STAT1	NN	B-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	results	result	NNS	I-NP
O	provide	provide	VBP	B-VP
O	a	a	DT	B-NP
O	deeper	deep	JJR	I-NP
O	understanding	understanding	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	modulation	modulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	STAT1	STAT1	NN	B-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	findings	finding	NNS	I-NP
O	reveal	reveal	VBP	B-VP
O	a	a	DT	B-NP
O	new	new	JJ	I-NP
O	layer	layer	NN	I-NP
O	of	of	IN	B-PP
O	physiologically	physiologically	RB	B-NP
O	relevant	relevant	JJ	I-NP
B-GGP	STAT1	STAT1	NN	I-NP
O	regulation	regulation	NN	I-NP
O	and	and	CC	O
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	a	a	DT	B-NP
O	previously	previously	RB	I-NP
O	unidentified	unidentified	JJ	I-NP
O	balance	balance	NN	I-NP
O	between	between	IN	B-PP
O	phosphorylation	phosphorylation	NN	B-NP
O	and	and	CC	I-NP
O	acetylation	acetylation	NN	I-NP
O	affects	affect	VBZ	B-VP
O	cytokine	cytokine	NN	B-NP
O	signaling	signaling	NN	I-NP
O	.	.	.	O

B-GGP	Sem1p	Sem1p	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Ubp6p	Ubp6p	NN	I-NP
O	orchestrate	orchestrate	NN	I-NP
O	telomeric	telomeric	JJ	I-NP
O	silencing	silencing	NN	I-NP
O	by	by	IN	B-PP
O	modulating	modulate	VBG	B-VP
B-GGP	histone	histone	NN	B-NP
I-GGP	H2B	H2B	NN	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	O
B-GGP	H3	H3	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	.	.	.	O

B-GGP	Histone	Histone	NN	B-NP
O	covalent	covalent	JJ	I-NP
O	modifications	modification	NNS	I-NP
O	and	and	CC	O
O	26S	26S	NN	B-NP
O	proteasome	proteasome	NN	I-NP
O	-	-	HYPH	B-VP
O	mediated	mediate	VBN	B-NP
O	proteolysis	proteolysis	NN	I-NP
O	modulate	modulate	VBP	B-VP
O	many	many	JJ	B-NP
O	regulatory	regulatory	JJ	I-NP
O	events	event	NNS	I-NP
O	in	in	IN	B-PP
O	eukaryotes	eukaryote	NNS	B-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	Saccharomyces	Saccharomyces	NNP	B-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	,	,	,	O
O	heterochromatin	heterochromatin	NN	B-NP
O	mediates	mediate	VBZ	B-VP
O	transcriptional	transcriptional	JJ	B-NP
O	silencing	silencing	NN	I-NP
O	at	at	IN	B-PP
O	telomeres	telomere	NNS	B-NP
O	,	,	,	O
O	HM	HM	NN	B-NP
O	loci	locus	NNS	I-NP
O	and	and	CC	O
O	rDNA	rDNA	NN	B-NP
O	array	array	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	proteasome	proteasome	NN	B-NP
O	-	-	HYPH	B-VP
O	associated	associate	VBN	B-NP
B-GGP	Sem1p	Sem1p	NN	I-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	interacting	interact	VBG	I-NP
O	partner	partner	NN	I-NP
O	,	,	,	O
B-GGP	Ubp6p	Ubp6p	NN	B-NP
O	(	(	(	O
O	a	a	DT	B-NP
O	deubiquitinating	deubiquitinate	VBG	I-NP
O	enzyme	enzyme	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	are	be	VBP	B-VP
O	essential	essential	JJ	B-ADJP
O	to	to	TO	B-VP
O	maintain	maintain	VB	I-VP
O	telomeric	telomeric	JJ	B-NP
O	silencing	silencing	NN	I-NP
O	.	.	.	O

O	Simultaneous	Simultaneous	JJ	B-NP
O	deletion	deletion	NN	I-NP
O	of	of	IN	B-PP
B-GGP	SEM1	SEM1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	UBP6	UBP6	NN	I-NP
O	induces	induce	VBZ	B-VP
O	dramatic	dramatic	JJ	B-NP
O	silencing	silencing	NN	I-NP
O	defect	defect	NN	I-NP
O	accompanied	accompany	VBN	B-VP
O	by	by	IN	B-PP
O	significantly	significantly	RB	B-NP
O	increased	increase	VBN	I-NP
O	level	level	NN	I-NP
O	of	of	IN	B-PP
O	ubiquitinated	ubiquitinate	VBN	B-NP
O	-	-	HYPH	I-NP
B-GGP	histone	histone	NN	I-NP
I-GGP	H2B	H2B	NN	I-NP
O	and	and	CC	O
O	markedly	markedly	RB	B-NP
O	reduced	reduce	VBN	I-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	acetylated	acetylate	VBN	B-NP
O	-	-	HYPH	I-NP
O	lysine	lysine	NN	I-NP
O	14	14	CD	I-NP
O	and	and	CC	I-NP
O	23	23	CD	I-NP
O	on	on	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	telomeres	telomere	NNS	I-NP
O	.	.	.	O

O	Further	Further	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	loss	loss	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Sem1p	Sem1p	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Ubp6p	Ubp6p	NN	I-NP
O	triggers	trigger	VBZ	B-VP
O	relocation	relocation	NN	B-NP
O	of	of	IN	B-PP
O	silencing	silencing	JJ	B-NP
O	factors	factor	NNS	I-NP
O	(	(	(	O
O	e	e	JJ	B-NP
O	.	.	.	I-NP
O	g	g	NN	I-NP
O	.	.	.	O
O	Sir	Sir	NNP	B-NP
O	proteins	protein	NNS	I-NP
O	)	)	)	O
O	from	from	IN	B-PP
O	telomere	telomere	NN	B-NP
O	to	to	TO	B-PP
O	HM	HM	NN	B-NP
O	loci	locus	NNS	I-NP
O	and	and	CC	O
O	rDNA	rDNA	NN	B-NP
O	array	array	NN	I-NP
O	.	.	.	O

O	Such	Such	JJ	B-NP
O	relocation	relocation	NN	I-NP
O	of	of	IN	B-PP
O	silencing	silence	VBG	B-VP
O	factors	factor	NNS	B-NP
O	enhances	enhance	VBZ	B-VP
O	gene	gene	NN	B-NP
O	silencing	silencing	NN	I-NP
O	at	at	IN	B-PP
O	HM	HM	NN	B-NP
O	loci	locus	NNS	I-NP
O	and	and	CC	O
O	rDNA	rDNA	NN	B-NP
O	array	array	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
O	diminishes	diminish	VBZ	B-VP
O	telomeric	telomeric	JJ	B-NP
O	silencing	silencing	NN	I-NP
O	.	.	.	O

O	Interestingly	Interestingly	RB	B-ADVP
O	,	,	,	O
O	both	both	CC	O
B-GGP	Sem1p	Sem1p	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Ubp6p	Ubp6p	NN	I-NP
O	participate	participate	VBP	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	proteolytic	proteolytic	JJ	I-NP
O	function	function	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	proteasome	proteasome	NN	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	find	find	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	telomeric	telomeric	JJ	I-NP
O	silencing	silencing	NN	I-NP
O	is	be	VBZ	B-VP
O	not	not	RB	I-VP
O	influenced	influence	VBN	I-VP
O	by	by	IN	B-PP
O	proteolysis	proteolysis	NN	B-NP
O	.	.	.	O

O	Taken	Take	VBN	B-VP
O	together	together	RB	B-ADVP
O	,	,	,	O
O	our	our	PRP$	B-NP
O	data	datum	NNS	I-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	Sem1p	Sem1p	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Ubp6p	Ubp6p	NN	I-NP
O	maintain	maintain	VBP	B-VP
O	telomeric	telomeric	JJ	B-NP
O	heterochromatin	heterochromatin	NN	I-NP
O	structure	structure	NN	I-NP
O	(	(	(	O
O	and	and	CC	O
O	hence	hence	RB	B-VP
O	silencing	silence	VBG	I-VP
O	)	)	)	O
O	through	through	IN	B-PP
O	modulation	modulation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	covalent	covalent	JJ	I-NP
O	modifications	modification	NNS	I-NP
O	and	and	CC	O
O	association	association	NN	B-NP
O	of	of	IN	B-PP
O	silencing	silencing	JJ	B-NP
O	factors	factor	NNS	I-NP
O	independently	independently	RB	B-ADVP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	proteolytic	proteolytic	JJ	I-NP
O	function	function	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	proteasome	proteasome	NN	I-NP
O	,	,	,	O
O	thus	thus	RB	B-ADVP
O	offering	offer	VBG	B-VP
O	a	a	DT	B-NP
O	new	new	JJ	I-NP
O	regulatory	regulatory	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	of	of	IN	B-PP
O	telomeric	telomeric	JJ	B-NP
O	silencing	silencing	NN	I-NP
O	.	.	.	O

O	Ubiquitination	Ubiquitination	NN	B-NP
O	of	of	IN	B-PP
O	mammalian	mammalian	JJ	B-NP
O	AP	AP	NN	I-NP
O	endonuclease	endonuclease	NN	I-NP
O	(	(	(	O
B-GGP	APE1	APE1	NN	B-NP
O	)	)	)	O
O	regulated	regulate	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
B-GGP	p53	p53	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	MDM2	MDM2	NN	I-NP
O	signaling	signaling	NN	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

B-GGP	APE1	APE1	NN	B-NP
O	/	/	SYM	I-NP
B-GGP	Ref	Ref	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	essential	essential	JJ	I-NP
O	DNA	DNA	NN	I-NP
O	repair	repair	NN	I-NP
O	/	/	SYM	B-NP
O	gene	gene	NN	I-NP
O	regulatory	regulatory	JJ	I-NP
O	protein	protein	NN	I-NP
O	in	in	IN	B-PP
O	mammals	mammal	NNS	B-NP
O	of	of	IN	B-PP
O	which	which	WDT	B-NP
O	intracellular	intracellular	JJ	B-NP
O	level	level	NN	I-NP
O	significantly	significantly	RB	B-VP
O	affects	affect	VBZ	I-VP
O	cellular	cellular	JJ	B-NP
O	sensitivity	sensitivity	NN	I-NP
O	to	to	TO	B-PP
O	genotoxicants	genotoxicant	NNS	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	apurinic	apurinic	JJ	I-NP
I-GGP	/	/	SYM	I-NP
I-GGP	apyrimidinic	apyrimidinic	JJ	I-NP
I-GGP	endonuclease	endonuclease	NN	I-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
B-GGP	APE1	APE1	NN	B-NP
O	)	)	)	O
O	functions	function	NNS	B-NP
O	are	be	VBP	B-VP
O	altered	alter	VBN	I-VP
O	by	by	IN	B-PP
O	phosphorylation	phosphorylation	NN	B-NP
O	and	and	CC	I-NP
O	acetylation	acetylation	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	here	here	RB	B-ADVP
O	report	report	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	APE1	APE1	NN	B-NP
O	is	be	VBZ	B-VP
O	also	also	RB	I-VP
O	modified	modify	VBN	I-VP
O	by	by	IN	B-PP
O	ubiquitination	ubiquitination	NN	B-NP
O	.	.	.	O

B-GGP	APE1	APE1	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	occurred	occur	VBD	B-VP
O	specifically	specifically	RB	B-ADVP
O	at	at	IN	B-PP
O	Lys	Lys	NNP	B-NP
O	residues	residue	NNS	I-NP
O	near	near	IN	B-PP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminus	terminus	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	was	be	VBD	B-VP
O	markedly	markedly	RB	I-VP
O	enhanced	enhance	VBN	I-VP
O	by	by	IN	B-PP
B-GGP	mouse	mouse	NN	B-NP
I-GGP	double	double	JJ	I-NP
I-GGP	minute	minute	NN	I-NP
I-GGP	2	2	CD	I-NP
O	(	(	(	O
B-GGP	MDM2	MDM2	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	the	the	DT	B-NP
O	major	major	JJ	I-NP
O	intracellular	intracellular	JJ	I-NP
B-GGP	p53	p53	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	DNA	DNA	NN	B-NP
O	-	-	HYPH	O
O	damaging	damage	VBG	B-VP
O	reagents	reagent	NNS	B-NP
O	and	and	CC	I-NP
O	nutlin	nutlin	NN	I-NP
O	-	-	HYPH	B-NP
O	3	3	CD	I-NP
O	,	,	,	O
O	an	an	DT	B-NP
O	inhibitor	inhibitor	NN	I-NP
O	of	of	IN	B-PP
B-GGP	MDM2	MDM2	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	p53	p53	NN	I-NP
O	interaction	interaction	NN	I-NP
O	,	,	,	O
O	increased	increase	VBD	B-VP
B-GGP	APE1	APE1	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	I-PP
O	presence	presence	NN	I-PP
O	of	of	IN	I-PP
B-GGP	p53	p53	NN	B-NP
O	.	.	.	O

O	Downmodulation	Downmodulation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	MDM2	MDM2	NN	B-NP
O	increased	increase	VBD	B-VP
B-GGP	APE1	APE1	NN	B-NP
O	level	level	NN	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
B-GGP	MDM2	MDM2	NN	B-NP
O	-	-	HYPH	B-VP
O	mediated	mediate	VBN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	a	a	DT	B-NP
O	signal	signal	NN	I-NP
O	for	for	IN	B-PP
B-GGP	APE1	APE1	NN	B-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	unlike	unlike	IN	B-PP
O	the	the	DT	B-NP
O	wild	wild	JJ	I-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
B-GGP	APE1	APE1	NN	I-NP
O	,	,	,	O
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	APE1	APE1	NN	I-NP
O	fusion	fusion	NN	I-NP
O	proteins	protein	NNS	I-NP
O	were	be	VBD	B-VP
O	predominantly	predominantly	RB	B-ADJP
O	present	present	JJ	I-ADJP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	cytoplasm	cytoplasm	NN	I-NP
O	.	.	.	O

O	Therefore	Therefore	RB	B-ADVP
O	,	,	,	O
O	monoubiquitination	monoubiquitination	NN	B-NP
O	not	not	RB	B-CONJP
O	only	only	RB	I-CONJP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	prerequisite	prerequisite	NN	I-NP
O	for	for	IN	B-PP
O	degradation	degradation	NN	B-NP
O	,	,	,	O
O	but	but	CC	O
O	may	may	MD	B-VP
O	also	also	RB	I-VP
O	alter	alter	VB	I-VP
O	the	the	DT	B-NP
B-GGP	APE1	APE1	NN	I-NP
O	activities	activity	NNS	I-NP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	reveal	reveal	VBP	B-VP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	APE1	APE1	NN	B-NP
O	through	through	IN	B-PP
O	ubiquitination	ubiquitination	NN	B-NP
O	.	.	.	O

O	A	A	DT	B-NP
B-GGP	histone	histone	NN	I-NP
O	map	map	NN	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	chromosome	chromosome	NN	I-NP
O	20q13	20q13	CD	I-NP
O	.	.	.	I-NP
O	12	12	CD	I-NP
O	.	.	.	O

O	BACKGROUND	BACKGROUND	NN	B-NP
O	:	:	:	O
O	We	We	PRP	B-NP
O	present	present	VBP	B-VP
O	a	a	DT	B-NP
O	systematic	systematic	JJ	I-NP
O	search	search	NN	I-NP
O	for	for	IN	B-PP
O	regulatory	regulatory	JJ	B-NP
O	elements	element	NNS	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	3	3	CD	I-NP
O	.	.	SYM	I-NP
O	5	5	CD	I-NP
O	Mb	Mb	NN	I-NP
O	region	region	NN	I-NP
O	on	on	IN	B-PP
O	human	human	JJ	B-NP
O	chromosome	chromosome	NN	I-NP
O	20q13	20q13	CD	I-NP
O	.	.	.	I-NP
O	12	12	CD	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	region	region	NN	I-NP
O	associated	associate	VBN	B-VP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	medical	medical	JJ	B-NP
O	conditions	condition	NNS	I-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	type	type	NN	B-NP
O	II	II	CD	I-NP
O	diabetes	diabete	NNS	I-NP
O	and	and	CC	I-NP
O	obesity	obesity	NN	I-NP
O	.	.	.	O

O	METHODOLOGY	METHODOLOGY	NN	B-NP
O	/	/	SYM	I-NP
O	PRINCIPAL	PRINCIPAL	NN	I-NP
O	FINDINGS	FINDINGS	NNS	I-NP
O	:	:	:	O
O	We	We	PRP	B-NP
O	profiled	profile	VBD	B-VP
O	six	six	CD	B-NP
B-GGP	histone	histone	NN	I-NP
O	modifications	modification	NNS	I-NP
O	alongside	alongside	IN	B-PP
O	RNA	RNA	NN	B-NP
O	polymerase	polymerase	NN	I-NP
O	II	II	CD	I-NP
O	(	(	(	O
O	PolII	PolII	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	CTCF	CTCF	NN	B-NP
O	in	in	IN	B-PP
O	two	two	CD	B-NP
O	cell	cell	NN	I-NP
O	lines	line	NNS	I-NP
O	,	,	,	O
O	HeLa	HeLa	NN	B-NP
O	S3	S3	NN	I-NP
O	and	and	CC	I-NP
O	NTERA	NTERA	NN	I-NP
O	-	-	HYPH	B-NP
O	2	2	CD	I-NP
O	clone	clone	NN	I-NP
O	D1	D1	NN	I-NP
O	(	(	(	O
O	NT2	NT2	NN	B-NP
O	/	/	SYM	O
O	D1	D1	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	by	by	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	using	use	VBG	B-VP
O	an	an	DT	B-NP
O	in	in	IN	B-PP
O	-	-	HYPH	B-NP
O	house	house	NN	I-NP
O	spotted	spot	VBD	B-VP
O	DNA	DNA	NN	B-NP
O	array	array	NN	I-NP
O	,	,	,	O
O	constructed	construct	VBN	B-VP
O	with	with	IN	B-PP
O	1	1	CD	B-NP
O	.	.	.	O
O	8	8	CD	B-NP
O	kb	kb	NN	I-NP
O	overlapping	overlap	VBG	B-VP
O	plasmid	plasmid	NN	B-NP
O	clones	clone	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	both	both	DT	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	more	more	JJR	B-NP
O	than	than	IN	I-NP
O	90	90	CD	I-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	transcription	transcription	NN	B-NP
O	start	start	NN	I-NP
O	sites	site	NNS	I-NP
O	(	(	(	O
O	TSSs	TSS	NNS	B-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	expressed	express	VBN	B-NP
O	genes	gene	NNS	I-NP
O	showed	show	VBD	B-VP
O	enrichments	enrichment	NNS	B-NP
O	with	with	IN	B-PP
O	PolII	PolII	NN	B-NP
O	,	,	,	O
O	di	di	AFX	O
O	-	-	HYPH	O
O	methylated	methylate	VBN	B-VP
O	lysine	lysine	NN	B-NP
O	4	4	CD	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	(	(	(	O
B-GGP	H3K4me2	H3K4me2	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	tri	tri	AFX	O
O	-	-	HYPH	O
O	methylated	methylate	VBN	B-VP
O	lysine	lysine	NN	B-NP
O	4	4	CD	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	(	(	(	O
B-GGP	H3K4me3	H3K4me3	NN	B-NP
O	)	)	)	O
O	or	or	CC	O
O	acetylated	acetylate	VBN	B-VP
B-GGP	H3	H3	NN	B-NP
O	(	(	(	O
B-GGP	H3Ac	H3Ac	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	whereas	whereas	IN	O
O	mono	mono	AFX	O
O	-	-	HYPH	O
O	methylated	methylate	VBN	B-VP
O	lysine	lysine	NN	B-NP
O	4	4	CD	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	(	(	(	O
B-GGP	H3K4me1	H3K4me1	NN	B-NP
O	)	)	)	O
O	signals	signal	NNS	B-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	correlate	correlate	VB	I-VP
O	with	with	IN	B-PP
O	expression	expression	NN	B-NP
O	.	.	.	O

O	No	No	DT	B-NP
O	TSSs	TSS	NNS	I-NP
O	were	be	VBD	B-VP
O	enriched	enrich	VBN	I-VP
O	with	with	IN	B-PP
O	tri	tri	AFX	B-NP
O	-	-	HYPH	I-NP
O	methylated	methylate	VBN	B-VP
O	lysine	lysine	NN	B-NP
O	27	27	CD	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	(	(	(	O
B-GGP	H3K27me3	H3K27me3	NN	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	HeLa	HeLa	NN	B-NP
O	S3	S3	NN	I-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	eight	eight	CD	B-NP
O	TSSs	TSS	NNS	I-NP
O	(	(	(	O
O	4	4	CD	B-NP
O	expressed	express	VBN	B-VP
O	)	)	)	O
O	showed	show	VBD	B-VP
O	enrichments	enrichment	NNS	B-NP
O	in	in	IN	B-PP
O	NT2	NT2	NN	B-NP
O	/	/	SYM	B-NP
O	D1	D1	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	have	have	VBP	B-VP
O	also	also	RB	B-ADVP
O	located	located	JJ	B-NP
O	several	several	JJ	I-NP
B-GGP	CTCF	CTCF	NN	I-NP
O	binding	binding	NN	I-NP
O	sites	site	NNS	I-NP
O	that	that	WDT	B-NP
O	are	be	VBP	B-VP
O	potential	potential	JJ	B-NP
O	insulator	insulator	NN	I-NP
O	elements	element	NNS	I-NP
O	.	.	.	O

O	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	/	/	SYM	B-NP
O	SIGNIFICANCE	SIGNIFICANCE	NN	I-NP
O	:	:	:	O
O	In	In	IN	B-PP
O	summary	summary	NN	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	annotated	annotate	VBD	B-VP
O	a	a	DT	B-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	putative	putative	JJ	B-NP
O	regulatory	regulatory	JJ	I-NP
O	elements	element	NNS	I-NP
O	in	in	IN	B-PP
O	20q13	20q13	CD	B-NP
O	.	.	.	I-NP
O	12	12	CD	I-NP
O	and	and	CC	O
O	went	go	VBD	B-VP
O	on	on	RP	B-PRT
O	to	to	TO	B-VP
O	verify	verify	VB	I-VP
O	experimentally	experimentally	RB	B-ADVP
O	a	a	DT	B-NP
O	subset	subset	NN	I-NP
O	of	of	IN	B-PP
O	them	them	PRP	B-NP
O	using	use	VBG	B-VP
O	dual	dual	JJ	B-NP
B-GGP	luciferase	luciferase	NN	I-NP
O	reporter	reporter	NN	I-NP
O	assays	assay	NNS	I-NP
O	.	.	.	O

O	Correlating	Correlate	VBG	B-VP
O	this	this	DT	B-NP
O	data	datum	NNS	I-NP
O	to	to	TO	B-PP
O	sequence	sequence	NN	B-NP
O	variation	variation	NN	I-NP
O	can	can	MD	B-VP
O	aid	aid	VB	I-VP
O	identification	identification	NN	B-NP
O	of	of	IN	B-PP
O	disease	disease	NN	B-NP
O	causing	cause	VBG	B-VP
O	variants	variant	NNS	B-NP
O	.	.	.	O

O	Untargeted	Untargeted	JJ	B-NP
O	tail	tail	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histones	histone	NNS	B-NP
O	in	in	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	:	:	:	O
O	lessons	lesson	NNS	B-NP
O	from	from	IN	B-PP
O	yeast	yeast	NN	B-NP
O	.	.	.	O

O	Dynamic	Dynamic	JJ	B-NP
O	acetylation	acetylation	NN	I-NP
O	of	of	IN	B-PP
O	lysine	lysine	NN	B-NP
O	residues	residue	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	tails	tail	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	core	core	NN	I-NP
B-GGP	histones	histone	NNS	I-NP
O	is	be	VBZ	B-VP
O	functionally	functionally	RB	B-ADJP
O	important	important	JJ	I-ADJP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	diverse	diverse	JJ	B-NP
O	DNA	DNA	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	processes	process	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	nucleus	nucleus	NN	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	replication	replication	NN	B-NP
O	,	,	,	O
O	transcription	transcription	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	DNA	DNA	NN	B-NP
O	repair	repair	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	targeted	targeted	JJ	I-NP
O	and	and	CC	I-NP
O	untargeted	untargeted	JJ	I-NP
O	activities	activity	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	lysine	lysine	NN	I-NP
O	acetylases	acetylas	NNS	I-NP
O	(	(	(	O
O	KATs	KAT	NNS	B-NP
O	)	)	)	O
O	and	and	CC	O
O	deacetylases	deacetylas	NNS	B-NP
O	(	(	(	O
O	HDACs	HDAC	NNS	B-NP
O	)	)	)	O
O	both	both	DT	B-NP
O	contribute	contribute	VBP	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	dynamics	dynamic	NNS	I-NP
O	of	of	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	.	.	.	O

O	While	While	IN	B-SBAR
O	the	the	DT	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	and	and	CC	O
O	functional	functional	JJ	B-NP
O	consequences	consequence	NNS	I-NP
O	of	of	IN	B-PP
O	targeted	target	VBN	B-VP
O	on	on	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	are	be	VBP	B-VP
O	well	well	RB	I-VP
O	understood	understand	VBN	I-VP
O	,	,	,	O
O	relatively	relatively	RB	B-NP
O	little	little	JJ	I-NP
O	is	be	VBZ	B-VP
O	known	know	VBN	I-VP
O	about	about	IN	B-PP
O	untargeted	untargeted	JJ	B-NP
B-GGP	histone	histone	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	review	review	VBP	B-VP
O	the	the	DT	B-NP
O	current	current	JJ	I-NP
O	understanding	understanding	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	by	by	IN	B-PP
O	which	which	WDT	B-NP
O	untargeted	untargeted	JJ	B-NP
O	KAT	KAT	NN	I-NP
O	and	and	CC	I-NP
O	HDAC	HDAC	NN	I-NP
O	activities	activity	NNS	I-NP
O	modulate	modulate	VBP	B-VP
O	the	the	DT	B-NP
O	acetylation	acetylation	NN	I-NP
O	state	state	NN	I-NP
O	of	of	IN	B-PP
O	nucleosomal	nucleosomal	JJ	B-NP
B-GGP	histones	histone	NNS	I-NP
O	,	,	,	O
O	focusing	focus	VBG	B-VP
O	on	on	IN	B-PP
O	results	result	NNS	B-NP
O	obtained	obtain	VBN	B-VP
O	for	for	IN	B-PP
B-GGP	H3	H3	NN	B-NP
O	and	and	CC	I-NP
B-GGP	H4	H4	NN	I-NP
O	in	in	IN	B-PP
O	budding	bud	VBG	B-VP
O	yeast	yeast	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	also	also	RB	B-ADVP
O	highlight	highlight	VBP	B-VP
O	unresolved	unresolved	JJ	B-NP
O	problems	problem	NNS	I-NP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	area	area	NN	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	the	the	DT	B-NP
O	question	question	NN	I-NP
O	of	of	IN	B-PP
O	how	how	WRB	B-ADVP
O	a	a	DT	B-NP
O	particular	particular	JJ	I-NP
O	steady	steady	JJ	I-NP
O	-	-	HYPH	I-NP
O	state	state	NN	I-NP
O	level	level	NN	I-NP
O	of	of	IN	B-PP
O	untargeted	untargeted	JJ	B-NP
O	acetylation	acetylation	NN	I-NP
O	is	be	VBZ	B-VP
O	set	set	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	absence	absence	NN	I-NP
O	of	of	IN	B-PP
O	cis	cis	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	mechanisms	mechanism	NNS	I-NP
O	that	that	WDT	B-NP
O	instruct	instruct	VBP	B-VP
O	the	the	DT	B-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
O	KATs	KAT	NNS	B-NP
O	and	and	CC	I-NP
O	HDACs	HDAC	NNS	I-NP
O	.	.	.	O

B-GGP	Hdm2	Hdm2	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Ku70	Ku70	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	Akt	Akt	NN	I-NP
O	promotes	promote	VBZ	B-VP
O	cell	cell	NN	B-NP
O	survival	survival	NN	I-NP
O	by	by	IN	B-PP
O	inhibiting	inhibit	VBG	B-VP
B-GGP	Hdm2	Hdm2	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
B-GGP	Ku70	Ku70	NN	I-NP
O	destabilization	destabilization	NN	I-NP
O	.	.	.	O

O	Earlier	Earlier	RBR	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	have	have	VBP	B-VP
O	reported	report	VBN	I-VP
O	that	that	IN	B-SBAR
O	70	70	CD	B-NP
O	kDa	kDa	NN	I-NP
O	subunit	subunit	NN	I-NP
O	of	of	IN	B-PP
O	Ku	Ku	NN	B-NP
O	protein	protein	NN	I-NP
O	heterodimer	heterodimer	NN	I-NP
O	(	(	(	O
B-GGP	Ku70	Ku70	NN	B-NP
O	)	)	)	O
O	binds	bind	VBZ	B-VP
O	and	and	CC	I-VP
O	inhibits	inhibit	VBZ	I-VP
B-GGP	Bax	Bax	NN	B-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	cytosol	cytosol	NN	I-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	(	(	(	O
B-GGP	Ub	Ub	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	proteolysis	proteolysis	NN	I-NP
O	of	of	IN	B-PP
O	cytosolic	cytosolic	JJ	B-NP
B-GGP	Ku70	Ku70	NN	I-NP
O	facilitates	facilitate	VBZ	B-VP
B-GGP	Bax	Bax	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	apoptosis	apoptosis	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	Hdm2	Hdm2	NN	B-NP
O	(	(	(	O
O	human	human	JJ	B-NP
O	homolog	homolog	NN	I-NP
O	of	of	IN	B-PP
O	murine	murine	JJ	B-NP
O	double	double	JJ	I-NP
O	minute	minute	NN	I-NP
O	)	)	)	O
O	has	have	VBZ	B-VP
O	an	an	DT	B-NP
O	ability	ability	NN	I-NP
O	to	to	TO	B-VP
O	ubiquitinate	ubiquitinate	VB	I-VP
B-GGP	Ku70	Ku70	NN	B-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
B-GGP	Hdm2	Hdm2	NN	B-NP
O	overexpression	overexpression	NN	I-NP
O	in	in	IN	B-PP
O	cultured	culture	VBN	B-NP
O	cells	cell	NNS	I-NP
O	causes	cause	VBZ	B-VP
O	a	a	DT	B-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
B-GGP	Ku70	Ku70	NN	B-NP
O	expression	expression	NN	I-NP
O	levels	level	NNS	I-NP
O	.	.	.	O

O	An	An	DT	B-NP
O	interaction	interaction	NN	I-NP
O	between	between	IN	B-PP
B-GGP	Ku70	Ku70	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Hdm2	Hdm2	NN	I-NP
O	was	be	VBD	B-VP
O	shown	show	VBN	I-VP
O	by	by	IN	B-PP
O	means	mean	NNS	B-NP
O	of	of	IN	B-PP
O	immunoprecipitation	immunoprecipitation	NN	B-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	none	none	NN	B-NP
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	shown	show	VBN	I-VP
O	between	between	IN	B-PP
O	80	80	CD	B-NP
O	kDa	kDa	NN	I-NP
O	subunit	subunit	NN	I-NP
O	of	of	IN	B-PP
O	Ku	Ku	NN	B-NP
O	protein	protein	NN	I-NP
O	heterodimer	heterodimer	NN	I-NP
O	and	and	CC	I-NP
B-GGP	Hdm2	Hdm2	NN	I-NP
O	.	.	.	O

B-GGP	Vascular	Vascular	JJ	B-NP
I-GGP	endothelial	endothelial	JJ	I-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	(	(	(	O
B-GGP	VEGF	VEGF	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	known	know	VBN	I-VP
O	to	to	TO	I-VP
O	inhibit	inhibit	VB	I-VP
O	endothelial	endothelial	JJ	B-NP
O	cell	cell	NN	I-NP
O	(	(	(	O
O	EC	EC	NN	B-NP
O	)	)	)	O
O	apoptosis	apoptosis	NN	B-NP
O	through	through	IN	B-PP
O	an	an	DT	B-NP
O	Akt	Akt	NN	I-NP
O	-	-	HYPH	B-VP
O	mediated	mediate	VBN	B-NP
O	survival	survival	NN	I-NP
O	kinase	kinase	NN	I-NP
O	signal	signal	NN	I-NP
O	;	;	:	O
O	however	however	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	underlying	underlie	VBG	B-VP
O	this	this	DT	B-NP
O	inhibition	inhibition	NN	I-NP
O	of	of	IN	B-PP
O	apoptosis	apoptosis	NN	B-NP
O	has	have	VBZ	B-VP
O	not	not	RB	I-VP
O	been	be	VBN	I-VP
O	fully	fully	RB	B-ADJP
O	elucidated	elucidate	VBN	I-ADJP
O	.	.	.	O

O	We	We	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	VEGF	VEGF	NN	B-NP
O	inhibited	inhibit	VBD	B-VP
O	cytosolic	cytosolic	JJ	B-NP
B-GGP	Ku70	Ku70	NN	I-NP
O	degradation	degradation	NN	I-NP
O	induced	induce	VBN	B-VP
O	by	by	IN	B-PP
O	apoptotic	apoptotic	JJ	B-NP
O	stress	stress	NN	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	is	be	VBZ	B-VP
O	known	know	VBN	I-VP
O	that	that	IN	B-SBAR
O	Akt	Akt	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Hdm2	Hdm2	NN	B-NP
O	causes	cause	VBZ	B-VP
O	nuclear	nuclear	JJ	B-NP
O	translocation	translocation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Hdm2	Hdm2	NN	B-NP
O	followed	follow	VBN	B-VP
O	by	by	IN	B-PP
O	Hdm2	Hdm2	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	inactivation	inactivation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	p53	p53	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	VEGF	VEGF	NN	B-NP
O	stimulated	stimulate	VBD	B-VP
O	nuclear	nuclear	JJ	B-NP
O	translocation	translocation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Hdm2	Hdm2	NN	B-NP
O	in	in	IN	B-PP
O	EC	EC	NN	B-NP
O	and	and	CC	O
O	efficiently	efficiently	RB	B-VP
O	inhibited	inhibit	VBD	I-VP
B-GGP	Ku70	Ku70	NN	B-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	also	also	RB	B-ADVP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
O	constitutively	constitutively	RB	B-NP
O	active	active	JJ	I-NP
O	Akt	Akt	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
O	not	not	RB	O
O	kinase	kinase	NN	B-NP
O	-	-	HYPH	B-NP
O	dead	dead	JJ	I-NP
O	Akt	Akt	NN	I-NP
O	,	,	,	O
O	inhibited	inhibit	VBD	B-VP
B-GGP	Ku70	Ku70	NN	B-NP
O	degradation	degradation	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	cytosol	cytosol	NN	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
B-GGP	Ku70	Ku70	NN	B-NP
O	knockdown	knockdown	NN	I-NP
O	diminished	diminish	VBD	B-VP
O	antiapoptotic	antiapoptotic	JJ	B-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
O	Akt	Akt	NN	B-NP
O	.	.	.	O

O	Taken	Take	VBN	B-VP
O	together	together	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	propose	propose	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	Hdm2	Hdm2	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
B-GGP	Ku70	Ku70	NN	I-NP
B-GGP	Ub	Ub	NN	I-NP
O	ligase	ligase	NN	I-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	Akt	Akt	NN	B-NP
O	inhibits	inhibit	VBZ	B-VP
B-GGP	Bax	Bax	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	apoptosis	apoptosis	NN	I-NP
O	,	,	,	O
O	at	at	IN	B-ADVP
O	least	least	JJS	I-ADVP
O	in	in	IN	B-PP
O	part	part	NN	B-NP
O	,	,	,	O
O	by	by	IN	B-PP
O	maintaining	maintain	VBG	B-VP
B-GGP	Ku70	Ku70	NN	B-NP
O	levels	level	NNS	I-NP
O	through	through	IN	B-PP
O	the	the	DT	B-NP
O	promotion	promotion	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Hdm2	Hdm2	NN	B-NP
O	nuclear	nuclear	JJ	I-NP
O	translocation	translocation	NN	I-NP
O	.	.	.	O

B-GGP	TRIM21	TRIM21	NN	B-NP
O	is	be	VBZ	B-VP
O	essential	essential	JJ	B-ADJP
O	to	to	TO	B-VP
O	sustain	sustain	VB	I-VP
B-GGP	IFN	IFN	NN	B-NP
I-GGP	regulatory	regulatory	JJ	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	3	3	CD	I-NP
O	activation	activation	NN	I-NP
O	during	during	IN	B-PP
O	antiviral	antiviral	JJ	B-NP
O	response	response	NN	I-NP
O	.	.	.	O

O	Virus	Virus	NN	B-NP
O	infection	infection	NN	I-NP
O	induces	induce	VBZ	B-VP
O	host	host	NN	B-NP
O	antiviral	antiviral	JJ	I-NP
O	responses	response	NNS	I-NP
O	including	include	VBG	B-PP
O	induction	induction	NN	B-NP
O	of	of	IN	B-PP
O	type	type	NN	B-NP
O	I	I	CD	I-NP
O	IFNs	IFN	NNS	I-NP
O	.	.	.	O

O	Transcription	Transcription	NN	B-NP
O	factor	factor	NN	I-NP
B-GGP	IFN	IFN	NN	I-NP
I-GGP	regulatory	regulatory	JJ	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	3	3	CD	I-NP
O	(	(	(	O
B-GGP	IRF3	IRF3	NN	B-NP
O	)	)	)	O
O	plays	play	VBZ	B-VP
O	an	an	DT	B-NP
O	essential	essential	JJ	I-NP
O	role	role	NN	I-NP
O	and	and	CC	O
O	is	be	VBZ	B-VP
O	tightly	tightly	RB	I-VP
O	regulated	regulate	VBN	I-VP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	process	process	NN	I-NP
O	.	.	.	O

O	Herein	Herein	RB	B-ADVP
O	we	we	PRP	B-NP
O	report	report	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	TRIM21	TRIM21	NN	B-NP
O	(	(	(	O
B-GGP	tripartite	tripartite	JJ	B-NP
I-GGP	motif	motif	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	containing	contain	VBG	B-VP
I-GGP	21	21	CD	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	significantly	significantly	RB	I-VP
O	induced	induce	VBN	I-VP
O	and	and	CC	O
O	interacts	interact	VBZ	B-VP
O	with	with	IN	B-PP
B-GGP	IRF3	IRF3	NN	B-NP
O	upon	upon	IN	B-PP
O	RNA	RNA	NN	B-NP
O	virus	virus	NN	I-NP
O	infection	infection	NN	I-NP
O	.	.	.	O

O	Ectopic	Ectopic	JJ	B-NP
O	expression	expression	NN	I-NP
O	or	or	CC	I-NP
O	knockdown	knockdown	NN	I-NP
O	of	of	IN	B-PP
B-GGP	TRIM21	TRIM21	NN	B-NP
O	could	could	MD	B-VP
O	respectively	respectively	RB	I-VP
O	enhance	enhance	VB	I-VP
O	or	or	CC	I-VP
O	impair	impair	VB	I-VP
B-GGP	IRF3	IRF3	NN	B-NP
O	-	-	HYPH	B-NP
O	mediated	mediate	VBN	I-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	Mechanistically	Mechanistically	RB	B-ADVP
O	,	,	,	O
B-GGP	TRIM21	TRIM21	NN	B-NP
O	interferes	interfere	VBZ	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	interaction	interaction	NN	I-NP
O	between	between	IN	B-PP
B-GGP	Pin1	Pin1	NN	B-NP
O	(	(	(	O
B-GGP	peptidyl	peptidyl	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	prolyl	prolyl	NN	I-NP
I-GGP	cis	cis	NN	I-NP
I-GGP	/	/	SYM	B-NP
I-GGP	trans	trans	NN	I-NP
I-GGP	isomerase	isomerase	NN	I-NP
I-GGP	,	,	,	O
I-GGP	NIMA	NIMA	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	interacting	interact	VBG	B-VP
I-GGP	1	1	CD	B-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	IRF3	IRF3	NN	B-NP
O	,	,	,	O
O	thus	thus	RB	B-ADVP
O	preventing	prevent	VBG	B-VP
B-GGP	IRF3	IRF3	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	motif	motif	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	B	B	NN	I-NP
O	30	30	CD	I-NP
O	.	.	.	O
O	2	2	CD	B-NP
O	domain	domain	NN	I-NP
O	of	of	IN	B-PP
B-GGP	TRIM21	TRIM21	NN	B-NP
O	is	be	VBZ	B-VP
O	critical	critical	JJ	B-ADJP
O	for	for	IN	B-PP
O	its	its	PRP$	B-NP
O	modulation	modulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	IRF3	IRF3	NN	B-NP
O	function	function	NN	I-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	the	the	DT	B-NP
O	RING	RING	NN	I-NP
O	finger	finger	NN	I-NP
O	is	be	VBZ	B-VP
O	dispensable	dispensable	JJ	B-ADJP
O	.	.	.	O

O	Host	Host	JJ	B-NP
O	antiviral	antiviral	JJ	I-NP
O	responses	response	NNS	I-NP
O	are	be	VBP	B-VP
O	significantly	significantly	RB	I-VP
O	boosted	boost	VBN	I-VP
O	or	or	CC	I-VP
O	crippled	cripple	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	or	or	CC	I-NP
O	absence	absence	NN	I-NP
O	of	of	IN	B-PP
B-GGP	TRIM21	TRIM21	NN	B-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	results	result	NNS	I-NP
O	identify	identify	VBP	B-VP
B-GGP	TRIM21	TRIM21	NN	B-NP
O	as	as	IN	B-PP
O	an	an	DT	B-NP
O	essential	essential	JJ	I-NP
O	modulator	modulator	NN	I-NP
O	of	of	IN	B-PP
B-GGP	IRF3	IRF3	NN	B-NP
O	stability	stability	NN	I-NP
O	and	and	CC	O
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	it	it	PRP	B-NP
O	positively	positively	RB	B-ADVP
O	regulates	regulate	VBZ	B-VP
O	the	the	DT	B-NP
O	strength	strength	NN	I-NP
O	and	and	CC	I-NP
O	duration	duration	NN	I-NP
O	of	of	IN	B-PP
O	primary	primary	JJ	B-NP
O	antiviral	antiviral	JJ	I-NP
O	response	response	NN	I-NP
O	,	,	,	O
O	thus	thus	RB	O
O	further	further	RB	B-VP
O	strengthening	strengthen	VBG	I-VP
O	the	the	DT	B-NP
O	notion	notion	NN	I-NP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	TRIM	TRIM	NN	I-NP
O	family	family	NN	I-NP
O	is	be	VBZ	B-VP
O	evolutionarily	evolutionarily	RB	I-VP
O	integrated	integrate	VBN	I-VP
O	with	with	IN	B-PP
O	innate	innate	JJ	B-NP
O	immunity	immunity	NN	I-NP
O	.	.	.	O

O	Phosphorylation	Phosphorylation	NN	B-NP
O	of	of	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
B-GGP	p65	p65	NN	I-NP
O	at	at	IN	B-PP
O	Ser468	Ser468	NN	B-NP
O	controls	control	VBZ	B-VP
O	its	its	PRP$	B-NP
B-GGP	COMMD1	COMMD1	NN	I-NP
O	-	-	HYPH	I-NP
O	dependent	dependent	JJ	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	target	target	NN	I-NP
O	gene	gene	NN	I-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	proteasomal	proteasomal	JJ	I-NP
O	elimination	elimination	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	nuclear	nuclear	JJ	I-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	O
O	kappaB	kappaB	NN	B-NP
O	(	(	(	O
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	)	)	)	O
O	transcription	transcription	NN	B-NP
O	factor	factor	NN	I-NP
O	system	system	NN	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	crucial	crucial	JJ	I-NP
O	component	component	NN	I-NP
O	that	that	WDT	B-NP
O	controls	control	VBZ	B-VP
O	several	several	JJ	B-NP
O	important	important	JJ	I-NP
O	biological	biological	JJ	I-NP
O	functions	function	NNS	I-NP
O	,	,	,	O
O	thus	thus	RB	B-ADVP
O	raising	raise	VBG	B-VP
O	the	the	DT	B-NP
O	need	need	NN	I-NP
O	for	for	IN	B-PP
O	mechanisms	mechanism	NNS	B-NP
O	that	that	WDT	B-NP
O	ensure	ensure	VBP	B-VP
O	the	the	DT	B-NP
O	correct	correct	JJ	I-NP
O	termination	termination	NN	I-NP
O	of	of	IN	B-PP
O	its	its	PRP$	B-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	identify	identify	VBP	B-VP
O	a	a	DT	B-NP
O	new	new	JJ	I-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	/	/	SYM	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	switch	switch	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	NF	NF	NN	I-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	network	network	NN	I-NP
O	that	that	WDT	B-NP
O	controls	control	VBZ	B-VP
O	the	the	DT	B-NP
O	stability	stability	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	transactivating	transactivate	VBG	I-NP
B-GGP	p65	p65	NN	I-NP
O	subunit	subunit	NN	I-NP
O	.	.	.	O

B-GGP	Tumour	Tumour	NN	B-NP
I-GGP	necrosis	necrosis	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	p65	p65	NN	B-NP
O	at	at	IN	B-PP
O	Ser468	Ser468	NN	B-NP
O	allows	allow	VBZ	B-VP
O	binding	binding	NN	B-NP
O	of	of	IN	B-PP
B-GGP	COMMD1	COMMD1	NN	B-NP
O	and	and	CC	O
B-GGP	cullin	cullin	NN	B-NP
I-GGP	2	2	CD	I-NP
O	,	,	,	O
O	components	component	NNS	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	multimeric	multimeric	JJ	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	complex	complex	NN	I-NP
O	mediating	mediate	VBG	B-VP
B-GGP	p65	p65	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	.	.	.	O

O	Mutation	Mutation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	p65	p65	NN	B-NP
O	at	at	IN	B-PP
O	Ser468	Ser468	NN	B-NP
O	largely	largely	RB	B-VP
O	prevents	prevent	VBZ	I-VP
B-GGP	p65	p65	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	O
O	proteasomal	proteasomal	JJ	B-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	Inducible	Inducible	JJ	B-NP
B-GGP	p65	p65	NN	I-NP
O	elimination	elimination	NN	I-NP
O	is	be	VBZ	B-VP
O	restricted	restricted	JJ	B-ADJP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	subset	subset	NN	I-NP
O	of	of	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	target	target	NN	I-NP
O	genes	gene	NNS	I-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
B-GGP	Icam1	Icam1	NN	B-NP
O	.	.	.	O

O	Accordingly	Accordingly	RB	B-ADVP
O	,	,	,	O
O	chromatin	chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	experiments	experiment	NNS	I-NP
O	reveal	reveal	VBP	B-VP
O	the	the	DT	B-NP
O	selective	selective	JJ	I-NP
O	recruitment	recruitment	NN	I-NP
O	of	of	IN	B-PP
O	Ser468	Ser468	NN	B-NP
O	-	-	HYPH	O
O	phosphorylated	phosphorylate	VBN	B-VP
B-GGP	p65	p65	NN	B-NP
O	and	and	CC	O
B-GGP	COMMD1	COMMD1	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
B-GGP	Icam1	Icam1	NN	I-NP
O	promoter	promoter	NN	I-NP
O	.	.	.	O

O	Phosphorylation	Phosphorylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	p65	p65	NN	B-NP
O	at	at	IN	B-PP
O	Ser468	Ser468	NN	B-NP
O	leads	lead	VBZ	B-VP
O	to	to	TO	B-PP
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	/	/	SYM	B-NP
O	proteasome	proteasome	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	removal	removal	NN	I-NP
O	of	of	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	-	-	HYPH	B-NP
O	bound	bind	VBN	I-NP
B-GGP	p65	p65	NN	I-NP
O	,	,	,	O
O	thus	thus	RB	B-ADVP
O	contributing	contribute	VBG	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	selective	selective	JJ	I-NP
O	termination	termination	NN	I-NP
O	of	of	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

B-GGP	PDCD5	PDCD5	NN	B-NP
O	interacts	interact	VBZ	B-VP
O	with	with	IN	B-PP
B-GGP	Tip60	Tip60	NN	B-NP
O	and	and	CC	O
O	functions	function	VBZ	B-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	cooperator	cooperator	NN	I-NP
O	in	in	IN	B-PP
O	acetyltransferase	acetyltransferase	NN	B-NP
O	activity	activity	NN	I-NP
O	and	and	CC	O
O	DNA	DNA	NN	B-NP
O	damage	damage	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	apoptosis	apoptosis	NN	I-NP
O	.	.	.	O

B-GGP	Tip60	Tip60	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
B-GGP	histone	histone	NN	I-NP
O	acetyltransferase	acetyltransferase	NN	I-NP
O	(	(	(	O
O	HAT	HAT	NN	B-NP
O	)	)	)	O
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	acetyltransferase	acetyltransferase	NN	I-NP
O	activity	activity	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	cellular	cellular	JJ	I-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
O	DNA	DNA	NN	B-NP
O	damage	damage	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	programmed	program	VBN	B-NP
I-GGP	cell	cell	NN	I-NP
I-GGP	death	death	NN	I-NP
I-GGP	5	5	CD	I-NP
O	(	(	(	O
B-GGP	PDCD5	PDCD5	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	a	a	DT	B-NP
O	human	human	JJ	I-NP
O	apoptosis	apoptosis	NN	I-NP
O	-	-	HYPH	B-NP
O	related	relate	VBN	I-NP
O	protein	protein	NN	I-NP
O	,	,	,	O
O	binds	bind	VBZ	B-VP
O	to	to	TO	B-PP
B-GGP	Tip60	Tip60	NN	B-NP
O	and	and	CC	O
O	enhances	enhance	VBZ	B-VP
O	the	the	DT	B-NP
O	stability	stability	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Tip60	Tip60	NN	B-NP
O	protein	protein	NN	I-NP
O	in	in	IN	B-PP
O	unstressed	unstressed	JJ	B-NP
O	conditions	condition	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	binding	binding	NN	I-NP
O	amount	amount	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PDCD5	PDCD5	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Tip60	Tip60	NN	I-NP
O	is	be	VBZ	B-VP
O	significantly	significantly	RB	I-VP
O	increased	increase	VBN	I-VP
O	after	after	IN	B-PP
O	UV	UV	NN	B-NP
O	irradiation	irradiation	NN	I-NP
O	.	.	.	O

O	Further	Further	RB	B-ADVP
O	,	,	,	O
B-GGP	PDCD5	PDCD5	NN	B-NP
O	enhances	enhance	VBZ	B-VP
O	HAT	HAT	NN	B-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Tip60	Tip60	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Tip60	Tip60	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
B-GGP	histone	histone	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	in	in	IN	B-PP
O	both	both	CC	B-NP
O	basal	basal	JJ	I-NP
O	and	and	CC	I-NP
O	UV	UV	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	levels	level	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	also	also	RB	B-ADVP
O	find	find	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	PDCD5	PDCD5	NN	B-NP
O	increases	increase	VBZ	B-VP
B-GGP	Tip60	Tip60	NN	B-NP
O	-	-	HYPH	I-NP
O	dependent	dependent	JJ	I-NP
O	K120	K120	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	p53	p53	NN	B-NP
O	and	and	CC	O
O	participates	participate	VBZ	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
B-GGP	p53	p53	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	apoptosis	apoptosis	NN	B-NP
O	-	-	HYPH	B-NP
O	related	relate	VBN	I-NP
O	genes	gene	NNS	I-NP
O	,	,	,	O
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
B-GGP	Bax	Bax	NN	B-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	demonstrate	demonstrate	VBP	B-VP
O	the	the	DT	B-NP
O	biological	biological	JJ	I-NP
O	significance	significance	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	PDCD5	PDCD5	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	Tip60	Tip60	NN	I-NP
O	interaction	interaction	NN	I-NP
O	;	;	:	O
O	that	that	DT	B-NP
O	is	be	VBZ	B-VP
O	,	,	,	O
O	they	they	PRP	B-NP
O	function	function	VBP	B-VP
O	in	in	IN	B-PP
O	cooperation	cooperation	NN	B-NP
O	to	to	TO	B-VP
O	accelerate	accelerate	VB	I-VP
O	DNA	DNA	NN	B-NP
O	damage	damage	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	apoptosis	apoptosis	NN	I-NP
O	and	and	CC	I-NP
O	knockdown	knockdown	NN	I-NP
O	of	of	IN	B-PP
B-GGP	PDCD5	PDCD5	NN	B-NP
O	or	or	CC	I-NP
B-GGP	Tip60	Tip60	NN	I-NP
O	impairs	impair	VBZ	B-VP
O	their	their	PRP$	B-NP
O	apoptosis	apoptosis	NN	I-NP
O	-	-	HYPH	B-VP
O	accelerating	accelerate	VBG	B-NP
O	activity	activity	NN	I-NP
O	,	,	,	O
O	mutually	mutually	RB	B-ADVP
O	.	.	.	O

O	Consistent	Consistent	JJ	B-ADJP
O	with	with	IN	B-PP
O	this	this	DT	B-NP
O	,	,	,	O
B-GGP	PDCD5	PDCD5	NN	B-NP
O	levels	level	NNS	I-NP
O	increase	increase	VBP	B-VP
O	significantly	significantly	RB	B-ADVP
O	on	on	IN	B-PP
O	DNA	DNA	NN	B-NP
O	damage	damage	NN	I-NP
O	in	in	IN	B-PP
O	U2OS	U2OS	NN	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	as	as	IN	B-SBAR
O	does	do	VBZ	O
B-GGP	Tip60	Tip60	NN	B-NP
O	.	.	.	O

O	Together	Together	RB	B-ADVP
O	,	,	,	O
O	our	our	PRP$	B-NP
O	findings	finding	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	PDCD5	PDCD5	NN	B-NP
O	may	may	MD	B-VP
O	play	play	VB	I-VP
O	a	a	DT	B-NP
O	dual	dual	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
B-GGP	Tip60	Tip60	NN	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

O	Specifically	Specifically	RB	B-ADVP
O	,	,	,	O
O	under	under	IN	B-PP
O	normal	normal	JJ	B-NP
O	growth	growth	NN	I-NP
O	conditions	condition	NNS	I-NP
O	,	,	,	O
B-GGP	PDCD5	PDCD5	NN	B-NP
O	contributes	contribute	VBZ	B-VP
O	to	to	TO	B-PP
O	maintaining	maintain	VBG	B-VP
O	a	a	DT	B-NP
O	basal	basal	JJ	I-NP
O	pool	pool	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Tip60	Tip60	NN	B-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	HAT	HAT	NN	I-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	After	After	IN	B-PP
O	DNA	DNA	NN	B-NP
O	damage	damage	NN	I-NP
O	,	,	,	O
B-GGP	PDCD5	PDCD5	NN	B-NP
O	functions	function	VBZ	B-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
B-GGP	Tip60	Tip60	NN	I-NP
O	coactivator	coactivator	NN	I-NP
O	to	to	TO	B-VP
O	promote	promote	VB	I-VP
O	apoptosis	apoptosis	NN	B-NP
O	.	.	.	O

B-GGP	MDM2	MDM2	NN	B-NP
O	acts	act	VBZ	B-VP
O	downstream	downstream	RB	B-ADVP
O	of	of	IN	B-PP
B-GGP	p53	p53	NN	B-NP
O	as	as	IN	B-PP
O	an	an	DT	B-NP
O	E3	E3	NN	I-NP
O	ligase	ligase	NN	I-NP
O	to	to	TO	B-VP
O	promote	promote	VB	I-VP
O	FOXO	FOXO	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	Members	Member	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	FOXO	FOXO	NN	I-NP
O	(	(	(	O
O	forkhead	forkhead	NN	B-NP
O	O	O	NN	I-NP
O	)	)	)	O
O	class	class	NN	B-NP
O	of	of	IN	B-PP
O	transcription	transcription	NN	B-NP
O	factors	factor	NNS	I-NP
O	are	be	VBP	B-VP
O	tumor	tumor	NN	B-NP
O	suppressors	suppressor	NNS	I-NP
O	that	that	WDT	B-NP
O	also	also	RB	B-ADVP
O	control	control	VBP	B-VP
O	aging	age	VBG	B-NP
O	and	and	CC	I-NP
O	organismal	organismal	JJ	I-NP
O	life	life	NN	I-NP
O	span	span	NN	I-NP
O	.	.	.	O

O	Mammalian	Mammalian	JJ	B-NP
O	FOXO	FOXO	NN	I-NP
O	degradation	degradation	NN	I-NP
O	is	be	VBZ	B-VP
O	proteasome	proteasome	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-VP
O	,	,	,	O
O	although	although	IN	B-SBAR
O	the	the	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	E3	E3	NN	I-NP
O	ligase	ligase	NN	I-NP
O	for	for	IN	B-PP
O	FOXO	FOXO	NN	B-NP
O	factors	factor	NNS	I-NP
O	remains	remain	VBZ	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	defined	define	VBN	I-VP
O	.	.	.	O

O	We	We	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	MDM2	MDM2	NN	B-NP
O	binds	bind	VBZ	B-VP
O	to	to	TO	B-PP
B-GGP	FOXO1	FOXO1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	FOXO3A	FOXO3A	NN	I-NP
O	and	and	CC	O
O	promotes	promote	VBZ	B-VP
O	their	their	PRP$	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	process	process	NN	I-NP
O	apparently	apparently	RB	B-ADJP
O	dependent	dependent	JJ	I-ADJP
O	on	on	IN	B-PP
O	FOXO	FOXO	NN	B-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	at	at	IN	B-PP
B-GGP	AKT	AKT	NN	B-NP
O	sites	site	NNS	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	E3	E3	NN	I-NP
O	ligase	ligase	NN	I-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	MDM2	MDM2	NN	B-NP
O	.	.	.	O

O	Binding	Binding	NN	B-NP
O	of	of	IN	B-PP
B-GGP	MDM2	MDM2	NN	B-NP
O	to	to	TO	B-PP
O	FOXO	FOXO	NN	B-NP
O	occurs	occur	VBZ	B-VP
O	through	through	IN	B-PP
O	the	the	DT	B-NP
O	region	region	NN	I-NP
O	of	of	IN	B-PP
B-GGP	MDM2	MDM2	NN	B-NP
O	that	that	WDT	B-NP
O	directs	direct	VBZ	B-VP
O	its	its	PRP$	B-NP
O	cellular	cellular	JJ	I-NP
O	trafficking	trafficking	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	forkhead	forkhead	NN	I-NP
O	box	box	NN	I-NP
O	of	of	IN	B-PP
B-GGP	FOXO1	FOXO1	NN	B-NP
O	.	.	.	O

B-GGP	MDM2	MDM2	NN	B-NP
O	promotes	promote	VBZ	B-VP
O	the	the	DT	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	of	of	IN	B-PP
B-GGP	FOXO1	FOXO1	NN	B-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	cell	cell	NN	I-NP
O	-	-	HYPH	B-NP
O	free	free	JJ	I-NP
O	system	system	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	knockdown	knockdown	NN	I-NP
O	by	by	IN	B-PP
O	small	small	JJ	B-NP
O	interfering	interfere	VBG	I-NP
O	RNA	RNA	NN	I-NP
O	causes	cause	VBZ	B-VP
O	accumulation	accumulation	NN	B-NP
O	of	of	IN	B-PP
O	endogenous	endogenous	JJ	B-NP
B-GGP	FOXO3A	FOXO3A	NN	I-NP
O	protein	protein	NN	I-NP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	and	and	CC	O
O	enhances	enhance	VBZ	B-VP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	FOXO	FOXO	NN	B-NP
O	target	target	NN	I-NP
O	genes	gene	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	cells	cell	NNS	B-NP
O	stably	stably	RB	B-VP
O	expressing	express	VBG	I-VP
O	a	a	DT	B-NP
O	temperature	temperature	NN	I-NP
O	-	-	HYPH	B-NP
O	sensitive	sensitive	JJ	I-NP
B-GGP	p53	p53	NN	I-NP
O	mutant	mutant	NN	I-NP
O	,	,	,	O
O	activation	activation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	p53	p53	NN	B-NP
O	by	by	IN	B-PP
O	shifting	shift	VBG	B-VP
O	to	to	TO	B-PP
O	permissive	permissive	JJ	B-NP
O	temperatures	temperature	NNS	I-NP
O	leads	lead	VBZ	B-VP
O	to	to	TO	B-PP
B-GGP	MDM2	MDM2	NN	B-NP
O	induction	induction	NN	I-NP
O	and	and	CC	O
O	degradation	degradation	NN	B-NP
O	of	of	IN	B-PP
O	endogenous	endogenous	JJ	B-NP
B-GGP	FOXO3A	FOXO3A	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	MDM2	MDM2	NN	B-NP
O	acts	act	VBZ	B-VP
O	as	as	IN	B-PP
O	an	an	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	E3	E3	NN	I-NP
O	ligase	ligase	NN	I-NP
O	,	,	,	O
O	downstream	downstream	RB	B-ADVP
O	of	of	IN	B-PP
B-GGP	p53	p53	NN	B-NP
O	,	,	,	O
O	to	to	TO	B-VP
O	regulate	regulate	VB	I-VP
O	the	the	DT	B-NP
O	degradation	degradation	NN	I-NP
O	of	of	IN	B-PP
O	mammalian	mammalian	JJ	B-NP
O	FOXO	FOXO	NN	I-NP
O	factors	factor	NNS	I-NP
O	.	.	.	O

O	Properties	Property	NNS	B-NP
O	of	of	IN	B-PP
B-GGP	Nat4	Nat4	NN	B-NP
O	,	,	,	O
O	an	an	DT	B-NP
O	N	N	NN	I-NP
O	(	(	(	O
O	alpha	alpha	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	acetyltransferase	acetyltransferase	NN	I-NP
O	of	of	IN	B-PP
O	Saccharomyces	Saccharomyces	NNP	B-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	that	that	WDT	B-NP
O	modifies	modify	VBZ	B-VP
O	N	N	NN	B-NP
O	termini	terminus	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	histones	histone	NNS	B-NP
I-GGP	H2A	H2A	NN	I-NP
O	and	and	CC	I-NP
B-GGP	H4	H4	NN	I-NP
O	.	.	.	O

B-GGP	Nat4	Nat4	NN	B-NP
O	,	,	,	O
O	also	also	RB	B-VP
O	designated	designate	VBN	I-VP
B-GGP	NatD	NatD	NN	B-NP
O	,	,	,	O
O	was	be	VBD	B-VP
O	previously	previously	RB	I-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	acetylate	acetylate	VB	I-VP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	termini	terminus	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	histones	histone	NNS	B-NP
I-GGP	H2A	H2A	NN	I-NP
O	and	and	CC	I-NP
B-GGP	H4	H4	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	have	have	VBP	B-VP
O	SGGKG	SGGKG	NN	B-NP
O	and	and	CC	I-NP
O	SGRGK	SGRGK	NN	I-NP
O	N	N	NN	I-NP
O	termini	terminus	NNS	I-NP
O	(	(	(	O
O	O	O	NN	B-NP
O	.	.	.	O

O	K	K	NN	B-NP
O	.	.	.	O

O	Song	Song	RB	B-ADVP
O	,	,	,	O
O	X	X	NN	B-NP
O	.	.	.	O

O	Wang	Wang	NNP	B-NP
O	,	,	,	O
O	J	J	NNP	B-NP
O	.	.	.	I-NP
O	H	H	NNP	I-NP
O	.	.	VBD	B-VP

O	Waterborg	Waterborg	NNP	B-NP
O	,	,	,	O
O	and	and	CC	O
O	R	R	NN	B-NP
O	.	.	.	O

O	Sternglanz	Sternglanz	NNP	B-NP
O	,	,	,	O
O	J	J	NNP	B-NP
O	.	.	.	I-NP
O	Biol	Biol	NNP	I-NP
O	.	.	.	O

O	Chem	Chem	NNP	B-NP
O	.	.	.	O

O	278	278	CD	B-NP
O	:	:	:	O
O	38109	38109	CD	B-NP
O	-	-	HYPH	I-NP
O	38112	38112	CD	I-NP
O	,	,	,	I-NP
O	2003	2003	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	chimeric	chimeric	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	with	with	IN	B-PP
O	various	various	JJ	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	segments	segment	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	fused	fuse	VBN	B-VP
O	to	to	TO	B-PP
B-GGP	iso	iso	AFX	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	cytochrome	cytochrome	NN	I-NP
I-GGP	c	c	NN	I-NP
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
O	efficient	efficient	JJ	B-NP
O	acetylation	acetylation	NN	I-NP
O	by	by	IN	B-PP
B-GGP	NatD	NatD	NN	B-NP
O	required	require	VBN	B-VP
O	at	at	IN	B-NP
O	least	least	JJS	I-NP
O	30	30	CD	I-NP
O	to	to	TO	I-NP
O	50	50	CD	I-NP
O	amino	amino	NN	I-NP
O	acid	acid	NN	I-NP
O	residues	residue	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	terminus	terminus	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	requirement	requirement	NN	I-NP
O	for	for	IN	B-PP
O	an	an	DT	B-NP
O	extended	extend	VBN	I-NP
O	N	N	NN	I-NP
O	terminus	terminus	NN	I-NP
O	is	be	VBZ	B-VP
O	in	in	IN	B-PP
O	marked	marked	JJ	B-NP
O	contrast	contrast	NN	I-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	major	major	JJ	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	acetyl	acetyl	NN	I-NP
O	transferases	transferas	NNS	I-NP
O	(	(	(	O
O	NATs	NAT	NNS	B-NP
O	)	)	)	O
O	,	,	,	O
O	i	i	NN	B-NP
O	.	.	.	O
O	e	e	NN	B-NP
O	.	.	NN	I-NP
O	,	,	,	O
B-GGP	NatA	NatA	NN	B-NP
O	,	,	,	O
B-GGP	NatB	NatB	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	NatC	NatC	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	require	require	VBP	B-VP
O	as	as	RB	B-ADJP
O	few	few	JJ	I-ADJP
O	as	as	IN	B-PP
O	two	two	CD	B-NP
O	specific	specific	JJ	I-NP
O	residues	residue	NNS	I-NP
O	and	and	CC	O
O	usually	usually	RB	B-ADVP
O	no	no	DT	B-NP
O	more	more	JJR	I-NP
O	than	than	IN	I-NP
O	four	four	CD	I-NP
O	or	or	CC	I-NP
O	five	five	CD	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	similar	similar	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	other	other	JJ	I-NP
O	NATs	NAT	NNS	I-NP
O	,	,	,	O
B-GGP	NatD	NatD	NN	B-NP
O	is	be	VBZ	B-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	ribosomes	ribosome	NNS	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	nat4	nat4	NN	I-NP
O	-	-	HYPH	I-NP
O	Delta	Delta	NN	I-NP
O	strain	strain	NN	I-NP
O	showed	show	VBD	B-VP
O	several	several	JJ	B-NP
O	minor	minor	JJ	I-NP
O	phenotypes	phenotype	NNS	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	sensitivity	sensitivity	NN	B-NP
O	to	to	TO	B-PP
O	3	3	CD	B-NP
O	-	-	HYPH	I-NP
O	aminotriazole	aminotriazole	NN	I-NP
O	,	,	,	O
O	benomyl	benomyl	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	thiabendazole	thiabendazole	NN	B-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	these	these	DT	B-NP
B-GGP	nat4	nat4	NN	I-NP
O	-	-	HYPH	B-NP
O	Delta	Delta	NN	I-NP
O	phenotypes	phenotype	NNS	I-NP
O	were	be	VBD	B-VP
O	enhanced	enhance	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	strain	strain	NN	I-NP
O	containing	contain	VBG	B-VP
O	K5R	K5R	NN	B-NP
O	K8R	K8R	NN	I-NP
O	K12R	K12R	NN	I-NP
O	replacements	replacement	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	tail	tail	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	lack	lack	NN	I-NP
O	of	of	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	serine	serine	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	is	be	VBZ	B-VP
O	synergistic	synergistic	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	lack	lack	NN	I-NP
O	of	of	IN	B-PP
O	acetylation	acetylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	H4	H4	NN	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	tail	tail	NN	I-NP
O	lysines	lysine	NNS	I-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	serine	serine	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	a	a	DT	B-NP
O	part	part	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	essential	essential	JJ	I-NP
O	charge	charge	NN	I-NP
O	patch	patch	NN	I-NP
O	first	first	RB	B-VP
O	described	describe	VBN	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
B-GGP	histone	histone	NN	I-NP
I-GGP	H2A	H2A	NN	I-NP
I-GGP	.	.	.	O
I-GGP	Z	Z	NN	B-NP
O	variant	variant	NN	I-NP
O	in	in	IN	B-PP
O	Tetrahymena	Tetrahymena	NNP	B-NP
O	species	specie	NNS	I-NP
O	.	.	.	O

B-GGP	Ah	Ah	NN	B-NP
I-GGP	receptor	receptor	NN	I-NP
O	represses	repress	VBZ	B-VP
O	acute	acute	JJ	B-NP
O	-	-	HYPH	I-NP
O	phase	phase	NN	I-NP
O	response	response	NN	I-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	without	without	IN	B-PP
O	binding	bind	VBG	B-VP
O	to	to	TO	B-PP
O	its	its	PRP$	B-NP
O	cognate	cognate	JJ	I-NP
O	response	response	NN	I-NP
O	element	element	NN	I-NP
O	.	.	.	O

O	Repression	Repression	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	nuclear	nuclear	JJ	I-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	O
O	kappaB	kappaB	NN	B-NP
O	(	(	(	O
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	)	)	)	O
O	pathway	pathway	NN	B-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	extensively	extensively	RB	I-VP
O	researched	research	VBN	I-VP
O	because	because	IN	B-PP
O	of	of	IN	I-PP
O	its	its	PRP$	B-NP
O	pivotal	pivotal	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	inflammation	inflammation	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	investigated	investigate	VBD	B-VP
O	the	the	DT	B-NP
O	potential	potential	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	aryl	aryl	NN	I-NP
I-GGP	hydrocarbon	hydrocarbon	NN	I-NP
I-GGP	receptor	receptor	NN	I-NP
O	(	(	(	O
B-GGP	AHR	AHR	NN	B-NP
O	)	)	)	O
O	to	to	TO	B-VP
O	suppress	suppress	VB	I-VP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	regulated	regulate	VBN	B-VP
O	-	-	HYPH	B-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	,	,	,	O
O	especially	especially	RB	B-NP
O	acute	acute	JJ	I-NP
O	-	-	HYPH	I-NP
O	phase	phase	NN	I-NP
O	genes	gene	NNS	I-NP
O	,	,	,	O
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
B-GGP	serum	serum	NN	B-NP
I-GGP	amyloid	amyloid	NN	I-NP
I-GGP	A	A	NN	I-NP
O	(	(	(	O
B-GGP	Saa	Saa	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Using	Use	VBG	B-VP
B-GGP	AHR	AHR	NN	B-NP
O	mutants	mutant	NNS	I-NP
O	,	,	,	O
O	it	it	PRP	B-NP
O	was	be	VBD	B-VP
O	determined	determine	VBN	I-VP
O	that	that	IN	B-SBAR
O	nuclear	nuclear	JJ	B-NP
O	translocation	translocation	NN	I-NP
O	and	and	CC	I-NP
O	heterodimerization	heterodimerization	NN	I-NP
O	with	with	IN	B-PP
B-GGP	AHR	AHR	NN	B-NP
O	-	-	HYPH	B-NP
O	nuclear	nuclear	JJ	I-NP
O	translocator	translocator	NN	I-NP
O	are	be	VBP	B-VP
O	essential	essential	JJ	B-ADJP
O	,	,	,	O
O	but	but	CC	O
O	DNA	DNA	NN	B-NP
O	binding	binding	NN	I-NP
O	is	be	VBZ	B-VP
O	not	not	RB	I-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
B-GGP	AHR	AHR	NN	B-NP
O	-	-	HYPH	B-NP
O	mediated	mediate	VBN	I-NP
B-GGP	Saa	Saa	NN	I-NP
O	repression	repression	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
B-GGP	AHR	AHR	NN	B-NP
O	ligands	ligand	NNS	I-NP
O	were	be	VBD	B-VP
O	capable	capable	JJ	B-ADJP
O	of	of	IN	B-PP
O	repressing	repress	VBG	B-VP
B-GGP	Saa3	Saa3	NN	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

B-GGP	AHR	AHR	NN	B-NP
O	activation	activation	NN	I-NP
O	leads	lead	VBZ	B-VP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
B-GGP	RELA	RELA	NN	B-NP
O	and	and	CC	I-NP
B-GGP	C	C	NN	I-NP
I-GGP	/	/	SYM	B-NP
I-GGP	EBP	EBP	NN	I-NP
I-GGP	/	/	SYM	O
I-GGP	beta	beta	SYM	O
O	recruitment	recruitment	NN	B-NP
O	to	to	TO	B-PP
O	and	and	CC	O
B-GGP	histone	histone	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	at	at	IN	B-PP
B-GGP	Saa3	Saa3	NN	B-NP
O	gene	gene	NN	I-NP
O	promoter	promoter	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	battery	battery	NN	I-NP
O	of	of	IN	B-PP
O	acute	acute	JJ	B-NP
O	-	-	HYPH	I-NP
O	phase	phase	NN	I-NP
O	genes	gene	NNS	I-NP
O	(	(	(	O
O	eg	eg	NN	B-NP
B-GGP	C	C	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	reactive	reactive	JJ	I-NP
I-GGP	protein	protein	NN	I-NP
O	and	and	CC	I-NP
B-GGP	haptoglobin	haptoglobin	NN	I-NP
O	)	)	)	O
O	induced	induce	VBN	B-VP
O	by	by	IN	B-PP
O	cytokine	cytokine	NN	B-NP
O	exposure	exposure	NN	I-NP
O	was	be	VBD	B-VP
O	repressed	repress	VBN	I-VP
O	by	by	IN	B-PP
B-GGP	AHR	AHR	NN	B-NP
O	activation	activation	NN	I-NP
O	in	in	IN	B-PP
O	mouse	mouse	NN	B-NP
O	hepatocytes	hepatocyte	NNS	I-NP
O	.	.	.	O

O	Dietary	Dietary	JJ	B-NP
O	exposure	exposure	NN	I-NP
O	to	to	TO	B-PP
O	an	an	DT	B-NP
B-GGP	AHR	AHR	NN	I-NP
O	ligand	ligand	NN	I-NP
O	represses	repress	VBZ	B-VP
O	cytokine	cytokine	NN	B-NP
O	-	-	HYPH	O
O	induced	induce	VBN	B-NP
O	acute	acute	JJ	I-NP
O	-	-	HYPH	I-NP
O	phase	phase	NN	I-NP
O	response	response	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	liver	liver	NN	I-NP
O	.	.	.	O

O	Use	Use	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	human	human	JJ	I-NP
O	liver	liver	NN	I-NP
O	-	-	HYPH	B-NP
O	derived	derive	VBN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	revealed	reveal	VBD	B-VP
O	similar	similar	JJ	B-NP
O	repression	repression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Saa	Saa	NN	B-NP
O	mRNA	mRNA	NN	I-NP
O	levels	level	NNS	I-NP
O	and	and	CC	O
O	secreted	secrete	VBN	B-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	Repression	Repression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	AHR	AHR	NN	B-NP
O	expression	expression	NN	I-NP
O	also	also	RB	B-ADVP
O	enhanced	enhance	VBD	B-VP
O	Saa	Saa	JJ	B-NP
O	induction	induction	NN	I-NP
O	in	in	IN	B-PP
O	response	response	NN	I-PP
O	to	to	TO	I-PP
O	cytokines	cytokine	NNS	B-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
B-GGP	AHR	AHR	NN	B-NP
O	is	be	VBZ	B-VP
O	capable	capable	JJ	B-ADJP
O	of	of	IN	B-PP
O	constitutively	constitutively	RB	B-VP
O	repressing	repress	VBG	I-VP
B-GGP	Saa	Saa	JJ	B-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	establish	establish	VBP	B-VP
O	a	a	DT	B-NP
O	role	role	NN	I-NP
O	for	for	IN	B-PP
B-GGP	AHR	AHR	NN	B-NP
O	in	in	IN	B-PP
O	inflammatory	inflammatory	JJ	B-NP
O	signaling	signaling	NN	I-NP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	liver	liver	NN	I-NP
O	,	,	,	O
O	presenting	present	VBG	B-VP
O	a	a	DT	B-NP
O	new	new	JJ	I-NP
O	therapeutic	therapeutic	JJ	I-NP
O	opportunity	opportunity	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	signify	signify	VB	B-VP
B-GGP	AHR	AHR	NN	B-NP
O	'	'	POS	B-NP
O	s	s	NN	I-NP
O	ability	ability	NN	I-NP
O	to	to	TO	B-VP
O	function	function	VB	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	DNA	DNA	NN	I-NP
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	manner	manner	NN	I-NP
O	.	.	.	O

B-GGP	Ubiquitin	Ubiquitin	NN	B-NP
O	-	-	HYPH	I-NP
O	like	like	JJ	I-NP
O	protein	protein	NN	I-NP
O	activation	activation	NN	I-NP
O	by	by	IN	B-PP
O	E1	E1	NN	B-NP
O	enzymes	enzyme	NNS	I-NP
O	:	:	:	O
O	the	the	DT	B-NP
O	apex	apex	NN	I-NP
O	for	for	IN	B-PP
O	downstream	downstream	JJ	B-NP
O	signalling	signalling	NN	I-NP
O	pathways	pathway	NNS	I-NP
O	.	.	.	O

O	Attachment	Attachment	NN	B-NP
O	of	of	IN	B-PP
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	or	or	CC	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	(	(	(	O
O	known	know	VBN	B-VP
O	as	as	IN	B-PP
O	UBLs	UBL	NNS	B-NP
O	)	)	)	O
O	to	to	TO	B-PP
O	their	their	PRP$	B-NP
O	targets	target	NNS	I-NP
O	through	through	IN	B-PP
O	multienzyme	multienzyme	NN	B-NP
O	cascades	cascade	NNS	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	central	central	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	to	to	TO	B-VP
O	modulate	modulate	VB	I-VP
O	protein	protein	NN	B-NP
O	functions	function	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	process	process	NN	I-NP
O	is	be	VBZ	B-VP
O	initiated	initiate	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	family	family	NN	I-NP
O	of	of	IN	B-PP
O	mechanistically	mechanistically	RB	B-ADVP
O	and	and	CC	I-ADVP
O	structurally	structurally	RB	B-NP
O	related	relate	VBN	I-NP
O	E1	E1	NN	I-NP
O	(	(	(	O
O	or	or	CC	O
O	activating	activate	VBG	B-VP
O	)	)	)	O
O	enzymes	enzyme	NNS	B-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	activate	activate	VBP	B-VP
O	UBLs	UBL	NNS	B-NP
O	through	through	IN	B-PP
O	carboxy	carboxy	NN	B-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	adenylation	adenylation	NN	I-NP
O	and	and	CC	I-NP
O	thiol	thiol	NN	I-NP
O	transfer	transfer	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	coordinate	coordinate	VBP	B-VP
O	the	the	DT	B-NP
O	use	use	NN	I-NP
O	of	of	IN	B-PP
O	UBLs	UBL	NNS	B-NP
O	in	in	IN	B-PP
O	specific	specific	JJ	B-NP
O	downstream	downstream	JJ	I-NP
O	pathways	pathway	NNS	I-NP
O	by	by	IN	B-PP
O	charging	charge	VBG	B-VP
O	cognate	cognate	JJ	B-NP
O	E2	E2	NN	I-NP
O	(	(	(	O
O	or	or	CC	O
O	conjugating	conjugate	VBG	B-VP
O	)	)	)	O
O	enzymes	enzyme	NNS	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	then	then	RB	B-ADVP
O	interact	interact	VBP	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	downstream	downstream	JJ	I-NP
O	ubiquitylation	ubiquitylation	NN	I-NP
O	machinery	machinery	NN	I-NP
O	to	to	TO	B-VP
O	coordinate	coordinate	VB	I-VP
O	the	the	DT	B-NP
O	modification	modification	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	target	target	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	broad	broad	JJ	I-NP
O	understanding	understanding	NN	I-NP
O	of	of	IN	B-PP
O	how	how	WRB	B-ADVP
O	E1	E1	NN	B-NP
O	enzymes	enzyme	NNS	I-NP
O	activate	activate	VBP	B-VP
O	UBLs	UBL	NNS	B-NP
O	and	and	CC	O
O	how	how	WRB	B-ADVP
O	they	they	PRP	B-NP
O	selectively	selectively	RB	B-ADVP
O	coordinate	coordinate	VBP	B-VP
O	UBLs	UBL	NNS	B-NP
O	with	with	IN	B-PP
O	downstream	downstream	JJ	B-NP
O	function	function	NN	I-NP
O	has	have	VBZ	B-VP
O	come	come	VBN	I-VP
O	from	from	IN	B-PP
O	enzymatic	enzymatic	JJ	B-NP
O	,	,	,	I-NP
O	structural	structural	JJ	I-NP
O	and	and	CC	I-NP
O	genetic	genetic	JJ	I-NP
O	studies	study	NNS	I-NP
O	.	.	.	O

B-GGP	Histone	Histone	NN	B-NP
O	acetylations	acetylation	NNS	I-NP
O	mark	mark	VBP	B-VP
O	origins	origin	NNS	B-NP
O	of	of	IN	B-PP
O	polycistronic	polycistronic	JJ	B-NP
O	transcription	transcription	NN	I-NP
O	in	in	IN	B-PP
O	Leishmania	Leishmania	NNP	B-NP
O	major	major	JJ	I-NP
O	.	.	.	O

O	BACKGROUND	BACKGROUND	NN	B-NP
O	:	:	:	O
O	Many	Many	JJ	B-NP
O	components	component	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	RNA	RNA	NN	I-NP
O	polymerase	polymerase	NN	I-NP
O	II	II	CD	I-NP
O	transcription	transcription	NN	I-NP
O	machinery	machinery	NN	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	identified	identify	VBN	I-VP
O	in	in	IN	B-PP
O	kinetoplastid	kinetoplastid	NN	B-NP
O	protozoa	protozoa	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
O	they	they	PRP	B-NP
O	diverge	diverge	VBP	B-VP
O	substantially	substantially	RB	B-ADVP
O	from	from	IN	B-PP
O	other	other	JJ	B-NP
O	eukaryotes	eukaryote	NNS	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	protein	protein	NN	B-NP
O	-	-	HYPH	O
O	coding	cod	VBG	B-VP
O	genes	gene	NNS	B-NP
O	in	in	IN	B-PP
O	these	these	DT	B-NP
O	organisms	organism	NNS	I-NP
O	lack	lack	VBP	B-VP
O	individual	individual	JJ	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	regulation	regulation	NN	I-NP
O	,	,	,	O
O	since	since	IN	B-SBAR
O	they	they	PRP	B-NP
O	are	be	VBP	B-VP
O	transcribed	transcribe	VBN	I-VP
O	as	as	IN	B-PP
O	long	long	JJ	B-NP
O	polycistronic	polycistronic	JJ	I-NP
O	units	unit	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	transcription	transcription	NN	I-NP
O	initiation	initiation	NN	I-NP
O	sites	site	NNS	I-NP
O	are	be	VBP	B-VP
O	assumed	assume	VBN	I-VP
O	to	to	TO	I-VP
O	lie	lie	VB	I-VP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	'	'	``	I-NP
O	divergent	divergent	JJ	I-NP
O	strand	strand	NN	I-NP
O	-	-	HYPH	I-NP
O	switch	switch	NN	I-NP
O	'	'	''	I-NP
O	regions	region	NNS	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	junction	junction	NN	I-NP
O	between	between	IN	B-PP
O	opposing	oppose	VBG	B-VP
O	polycistronic	polycistronic	JJ	B-NP
O	gene	gene	NN	I-NP
O	clusters	cluster	NNS	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	by	by	IN	B-PP
O	which	which	WDT	B-NP
O	Kinetoplastidae	Kinetoplastidae	NNP	B-NP
O	initiate	initiate	VBP	B-VP
O	transcription	transcription	NN	B-NP
O	is	be	VBZ	B-VP
O	unclear	unclear	JJ	B-ADJP
O	,	,	,	O
O	and	and	CC	O
O	promoter	promoter	NN	B-NP
O	sequences	sequence	NNS	I-NP
O	are	be	VBP	B-VP
O	undefined	undefined	JJ	B-ADJP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
O	The	The	DT	B-NP
O	chromosomal	chromosomal	JJ	I-NP
O	location	location	NN	I-NP
O	of	of	IN	B-PP
O	TATA	TATA	NN	B-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	protein	protein	NN	B-NP
O	(	(	(	O
O	TBP	TBP	NN	B-NP
O	or	or	CC	O
B-GGP	TRF4	TRF4	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	Small	Small	JJ	B-NP
O	Nuclear	Nuclear	JJ	I-NP
O	Activating	Activate	VBG	I-NP
O	Protein	Protein	NN	I-NP
O	complex	complex	NN	I-NP
O	(	(	(	O
B-GGP	SNAP50	SNAP50	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
B-GGP	H3	H3	NN	B-NP
I-GGP	histones	histone	NNS	I-NP
O	were	be	VBD	B-VP
O	assessed	assess	VBN	I-VP
O	in	in	IN	B-PP
O	Leishmania	Leishmania	NNP	B-NP
O	major	major	JJ	B-NP
O	using	use	VBG	I-NP
O	microarrays	microarray	NNS	I-NP
O	hybridized	hybridize	VBN	B-VP
O	with	with	IN	B-PP
O	DNA	DNA	NN	B-NP
O	obtained	obtain	VBN	B-VP
O	through	through	IN	B-PP
O	chromatin	chromatin	NN	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	(	(	(	O
O	ChIP	ChIP	NN	B-NP
O	-	-	HYPH	B-NP
O	chip	chip	NN	I-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	TBP	TBP	NN	I-NP
O	and	and	CC	I-NP
B-GGP	SNAP50	SNAP50	NN	I-NP
O	binding	binding	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	were	be	VBD	B-VP
O	almost	almost	RB	B-NP
O	identical	identical	JJ	I-NP
O	and	and	CC	I-NP
O	high	high	JJ	I-NP
O	intensity	intensity	NN	I-NP
O	peaks	peak	NNS	I-NP
O	were	be	VBD	B-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	tRNAs	tRNA	NNS	B-NP
O	and	and	CC	I-NP
O	snRNAs	snRNA	NNS	I-NP
O	.	.	.	O

O	Only	Only	RB	B-NP
O	184	184	CD	I-NP
O	peaks	peak	NNS	I-NP
O	of	of	IN	B-PP
O	acetylated	acetylate	VBN	B-NP
B-GGP	H3	H3	NN	I-NP
I-GGP	histone	histone	NN	I-NP
O	were	be	VBD	B-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	entire	entire	JJ	I-NP
O	genome	genome	NN	I-NP
O	,	,	,	O
O	with	with	IN	B-PP
O	substantially	substantially	RB	B-NP
O	higher	high	JJR	I-NP
O	intensity	intensity	NN	I-NP
O	in	in	IN	B-PP
O	rapidly	rapidly	RB	B-NP
O	-	-	HYPH	I-NP
O	dividing	divide	VBG	B-VP
O	cells	cell	NNS	B-NP
O	than	than	IN	B-PP
O	stationary	stationary	JJ	B-NP
O	-	-	HYPH	I-NP
O	phase	phase	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	majority	majority	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	acetylated	acetylate	VBN	I-NP
B-GGP	H3	H3	NN	I-NP
O	peaks	peak	NNS	I-NP
O	were	be	VBD	B-VP
O	found	find	VBN	I-VP
O	at	at	IN	B-PP
O	divergent	divergent	JJ	B-NP
O	strand	strand	NN	I-NP
O	-	-	HYPH	B-NP
O	switch	switch	NN	I-NP
O	regions	region	NNS	I-NP
O	,	,	,	O
O	but	but	CC	O
O	some	some	DT	B-NP
O	occurred	occur	VBD	B-VP
O	at	at	IN	B-PP
O	chromosome	chromosome	NN	B-NP
O	ends	end	NNS	I-NP
O	and	and	CC	B-PP
O	within	within	IN	B-PP
O	polycistronic	polycistronic	JJ	B-NP
O	gene	gene	NN	I-NP
O	clusters	cluster	NNS	I-NP
O	.	.	.	O

O	Almost	Almost	RB	B-NP
O	all	all	PDT	I-NP
O	these	these	DT	I-NP
O	peaks	peak	NNS	I-NP
O	were	be	VBD	B-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	lower	low	JJR	B-NP
O	intensity	intensity	NN	I-NP
O	peaks	peak	NNS	I-NP
O	of	of	IN	B-PP
O	TBP	TBP	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	SNAP50	SNAP50	NN	I-NP
O	binding	bind	VBG	B-VP
O	a	a	DT	B-NP
O	few	few	JJ	I-NP
O	kilobases	kilobas	NNS	I-NP
O	upstream	upstream	RB	B-ADVP
O	,	,	,	O
O	evidence	evidence	NN	B-NP
O	that	that	IN	B-SBAR
O	they	they	PRP	B-NP
O	represent	represent	VBP	B-VP
O	transcription	transcription	NN	B-NP
O	initiation	initiation	NN	I-NP
O	sites	site	NNS	I-NP
O	.	.	.	O

O	CONCLUSION	CONCLUSION	NN	B-NP
O	:	:	:	O
O	The	The	DT	B-NP
O	first	first	JJ	I-NP
O	genome	genome	NN	I-NP
O	-	-	HYPH	B-NP
O	wide	wide	JJ	I-NP
O	maps	map	NNS	I-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-VP
O	protein	protein	NN	B-NP
O	occupancy	occupancy	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	kinetoplastid	kinetoplastid	NN	I-NP
O	organism	organism	NN	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	H3	H3	NN	B-NP
I-GGP	histones	histone	NNS	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	origins	origin	NNS	I-NP
O	of	of	IN	B-PP
O	polycistronic	polycistronic	JJ	B-NP
O	transcription	transcription	NN	I-NP
O	of	of	IN	B-PP
O	protein	protein	NN	B-NP
O	-	-	HYPH	O
O	coding	cod	VBG	B-VP
O	genes	gene	NNS	B-NP
O	are	be	VBP	B-VP
O	acetylated	acetylate	VBN	I-VP
O	.	.	.	O

O	Global	Global	JJ	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	transcription	transcription	NN	B-NP
O	initiation	initiation	NN	I-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	achieved	achieve	VBN	I-VP
O	by	by	IN	B-PP
O	modifying	modify	VBG	B-VP
O	the	the	DT	B-NP
O	acetylation	acetylation	NN	I-NP
O	state	state	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	origins	origin	NNS	I-NP
O	.	.	.	O

O	Secretion	Secretion	NN	B-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
B-GGP	epidermal	epidermal	JJ	I-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	from	from	IN	B-PP
O	Saccharomyces	Saccharomyces	NNP	B-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	using	use	VBG	B-VP
O	synthetic	synthetic	JJ	B-NP
O	leader	leader	NN	I-NP
O	sequences	sequence	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	have	have	VBP	B-VP
O	investigated	investigate	VBN	I-VP
O	different	different	JJ	B-NP
O	leader	leader	NN	I-NP
O	sequences	sequence	NNS	I-NP
O	for	for	IN	B-PP
O	their	their	PRP$	B-NP
O	ability	ability	NN	I-NP
O	to	to	TO	B-VP
O	direct	direct	VB	I-VP
O	the	the	DT	B-NP
O	efficient	efficient	JJ	I-NP
O	secretion	secretion	NN	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
B-GGP	epidermal	epidermal	JJ	I-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	(	(	(	O
B-GGP	hEGF	hEGF	NN	B-NP
O	)	)	)	O
O	from	from	IN	B-PP
O	Saccharomyces	Saccharomyces	NNP	B-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	designed	design	VBD	B-VP
O	a	a	DT	B-NP
O	consensus	consensus	NN	I-NP
O	signal	signal	NN	I-NP
O	sequence	sequence	NN	I-NP
O	which	which	WDT	B-NP
O	directs	direct	VBZ	B-VP
O	secretion	secretion	NN	B-NP
O	of	of	IN	B-PP
B-GGP	hEGF	hEGF	NN	B-NP
O	from	from	IN	B-PP
O	yeast	yeast	NN	B-NP
O	as	as	RB	B-ADVP
O	efficiently	efficiently	RB	I-ADVP
O	as	as	IN	B-PP
O	the	the	DT	B-NP
O	yeast	yeast	NN	I-NP
O	invertase	invertase	NN	I-NP
O	signal	signal	NN	I-NP
O	sequence	sequence	NN	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	secretion	secretion	NN	B-NP
O	is	be	VBZ	B-VP
O	increased	increase	VBN	I-VP
O	over	over	RB	B-ADVP
O	fivefold	fivefold	RB	I-ADVP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	introduction	introduction	NN	I-NP
O	,	,	,	O
O	after	after	IN	B-PP
O	the	the	DT	B-NP
O	signal	signal	NN	I-NP
O	sequence	sequence	NN	I-NP
O	,	,	,	O
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	synthetic	synthetic	JJ	I-NP
O	19	19	CD	I-NP
O	-	-	HYPH	I-NP
O	amino	amino	NN	I-NP
O	acid	acid	NN	I-NP
O	(	(	(	O
O	aa	aa	NN	B-NP
O	)	)	)	O
O	pro	pro	AFX	O
O	-	-	HYPH	O
O	sequence	sequence	NN	B-NP
O	containing	contain	VBG	B-VP
O	a	a	DT	B-NP
O	cleavage	cleavage	NN	I-NP
O	recognition	recognition	NN	I-NP
O	site	site	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
B-GGP	KEX2	KEX2	NN	I-NP
O	protease	protease	NN	I-NP
O	.	.	.	O

O	Even	Even	RB	B-ADVP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	absence	absence	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	Asn	Asn	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	,	,	,	O
O	secretion	secretion	NN	B-NP
O	of	of	IN	B-PP
B-GGP	hEGF	hEGF	NN	B-NP
O	using	use	VBG	B-VP
O	the	the	DT	B-NP
O	synthetic	synthetic	JJ	I-NP
O	prepro	prepro	AFX	I-NP
O	-	-	HYPH	I-NP
O	leader	leader	NN	I-NP
O	was	be	VBD	B-VP
O	as	as	RB	B-ADJP
O	efficient	efficient	JJ	I-ADJP
O	as	as	IN	B-PP
O	that	that	DT	B-NP
O	directed	direct	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	alpha	alpha	SYM	I-NP
O	-	-	HYPH	I-NP
O	factor	factor	NN	I-NP
O	leader	leader	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	KEX2	KEX2	NN	I-NP
O	protease	protease	NN	I-NP
O	cleavage	cleavage	NN	I-NP
O	site	site	NN	I-NP
O	was	be	VBD	B-VP
O	investigated	investigate	VBN	I-VP
O	by	by	IN	B-PP
O	mutation	mutation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	yeast	yeast	NN	I-NP
O	alpha	alpha	SYM	B-VP
O	-	-	HYPH	B-NP
O	factor	factor	NN	I-NP
B-GGP	KEX2	KEX2	NN	I-NP
O	site	site	NN	I-NP
O	(	(	(	O
O	cleavage	cleavage	NN	B-NP
O	after	after	IN	B-PP
O	Lys	Lys	NN	B-NP
O	-	-	HYPH	B-NP
O	Arg	Arg	NN	I-NP
O	)	)	)	O
O	.	.	.	O

O	Cleavage	Cleavage	NN	B-NP
O	was	be	VBD	B-VP
O	obtained	obtain	VBN	I-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	following	follow	VBG	I-NP
O	order	order	NN	I-NP
O	of	of	IN	B-PP
O	efficiency	efficiency	NN	B-NP
O	,	,	,	O
O	Lys	Lys	NN	B-NP
O	-	-	HYPH	I-NP
O	Arg	Arg	NN	I-NP
O	greater	great	JJR	B-ADJP
O	than	than	IN	B-PP
O	Pro	Pro	NN	B-NP
O	-	-	HYPH	O
O	Arg	Arg	NN	B-NP
O	greater	great	JJR	B-ADJP
O	than	than	IN	B-PP
O	Asp	Asp	NN	B-NP
O	-	-	HYPH	B-NP
O	Arg	Arg	NN	I-NP
O	,	,	,	O
O	although	although	IN	B-SBAR
O	the	the	DT	B-NP
O	sequence	sequence	NN	I-NP
O	context	context	NN	I-NP
O	was	be	VBD	B-VP
O	also	also	RB	I-VP
O	found	find	VBN	I-VP
O	to	to	TO	I-VP
O	affect	affect	VB	I-VP
O	efficiency	efficiency	NN	B-NP
O	.	.	.	O

B-GGP	CYLD	CYLD	NN	B-NP
O	:	:	:	O
O	a	a	DT	B-NP
O	tumor	tumor	NN	I-NP
O	suppressor	suppressor	NN	I-NP
O	deubiquitinase	deubiquitinase	NN	I-NP
O	regulating	regulate	VBG	B-VP
O	NF	NF	NN	B-NP
O	-	-	HYPH	O
O	kappaB	kappaB	NN	B-NP
O	activation	activation	NN	I-NP
O	and	and	CC	O
O	diverse	diverse	JJ	B-NP
O	biological	biological	JJ	I-NP
O	processes	process	NNS	I-NP
O	.	.	.	O

O	Protein	Protein	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	reversible	reversible	JJ	I-NP
O	reaction	reaction	NN	I-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	chains	chain	NNS	I-NP
O	are	be	VBP	B-VP
O	deconjugated	deconjugate	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	family	family	NN	I-NP
O	of	of	IN	B-PP
O	deubiquitinases	deubiquitinas	NNS	B-NP
O	(	(	(	O
O	DUBs	DUB	NNS	B-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	large	large	JJ	I-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	DUBs	DUB	NNS	B-NP
O	suggests	suggest	VBZ	B-VP
O	that	that	IN	B-SBAR
O	they	they	PRP	B-NP
O	likely	likely	RB	B-ADVP
O	possess	possess	VBP	B-VP
O	certain	certain	JJ	B-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	substrate	substrate	NN	B-NP
O	selectivity	selectivity	NN	I-NP
O	and	and	CC	O
O	functional	functional	JJ	B-NP
O	specificity	specificity	NN	I-NP
O	.	.	.	O

O	Indeed	Indeed	RB	B-ADVP
O	,	,	,	O
O	recent	recent	JJ	B-NP
O	studies	study	NNS	I-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	a	a	DT	B-NP
O	tumor	tumor	NN	I-NP
O	suppressor	suppressor	NN	I-NP
O	DUB	DUB	NN	I-NP
O	,	,	,	O
B-GGP	cylindromatosis	cylindromatosis	NN	B-NP
O	(	(	(	O
B-GGP	CYLD	CYLD	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	has	have	VBZ	B-VP
O	a	a	DT	B-NP
O	predominant	predominant	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
O	that	that	WDT	B-NP
O	promotes	promote	VBZ	B-VP
O	cell	cell	NN	B-NP
O	survival	survival	NN	I-NP
O	and	and	CC	I-NP
O	oncogenesis	oncogenesis	NN	I-NP
O	.	.	.	O

O	NF	NF	NN	B-NP
O	-	-	HYPH	I-NP
O	kappaB	kappaB	NN	I-NP
O	activation	activation	NN	I-NP
O	involves	involve	VBZ	B-VP
O	attachment	attachment	NN	B-NP
O	of	of	IN	B-PP
O	K63	K63	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	chains	chain	NNS	I-NP
O	to	to	TO	B-PP
O	its	its	PRP$	B-NP
O	upstream	upstream	JJ	I-NP
O	signaling	signaling	NN	I-NP
O	factors	factor	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	thought	think	VBN	I-VP
O	to	to	TO	I-VP
O	facilitate	facilitate	VB	I-VP
O	protein	protein	NN	B-NP
O	-	-	HYPH	B-NP
O	protein	protein	NN	I-NP
O	interactions	interaction	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	assembly	assembly	NN	I-NP
O	of	of	IN	B-PP
O	signaling	signal	VBG	B-VP
O	complexes	complex	NNS	B-NP
O	.	.	.	O

O	By	By	IN	B-PP
O	deconjugating	deconjugate	VBG	B-VP
O	these	these	DT	B-NP
O	K63	K63	NN	I-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	chains	chain	NNS	I-NP
O	,	,	,	O
B-GGP	CYLD	CYLD	NN	B-NP
O	negatively	negatively	RB	B-ADVP
O	regulates	regulate	VBZ	B-VP
O	NF	NF	NN	B-NP
O	-	-	HYPH	I-NP
O	kappaB	kappaB	NN	I-NP
O	activation	activation	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	may	may	MD	B-VP
O	contribute	contribute	VB	I-VP
O	to	to	TO	B-PP
O	its	its	PRP$	B-NP
O	tumor	tumor	NN	I-NP
O	suppressor	suppressor	NN	I-NP
O	function	function	NN	I-NP
O	.	.	.	O

B-GGP	CYLD	CYLD	NN	B-NP
O	also	also	RB	B-ADVP
O	regulates	regulate	VBZ	B-VP
O	diverse	diverse	JJ	B-NP
O	physiological	physiological	JJ	I-NP
O	processes	process	NNS	I-NP
O	,	,	,	O
O	ranging	range	VBG	B-VP
O	from	from	IN	B-PP
O	immune	immune	JJ	B-NP
O	response	response	NN	I-NP
O	and	and	CC	I-NP
O	inflammation	inflammation	NN	I-NP
O	to	to	TO	B-PP
O	cell	cell	NN	B-NP
O	cycle	cycle	NN	I-NP
O	progression	progression	NN	I-NP
O	,	,	,	O
O	spermatogenesis	spermatogenesis	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	osteoclastogenesis	osteoclastogenesis	NN	B-NP
O	.	.	.	O

O	Interestingly	Interestingly	RB	B-ADVP
O	,	,	,	O
B-GGP	CYLD	CYLD	NN	B-NP
O	itself	itself	PRP	B-NP
O	is	be	VBZ	B-VP
O	subject	subject	JJ	B-ADJP
O	to	to	TO	B-PP
O	different	different	JJ	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	of	of	IN	B-PP
O	regulation	regulation	NN	B-NP
O	.	.	.	O

B-GGP	LYRIC	LYRIC	NN	B-NP
O	/	/	SYM	I-NP
B-GGP	AEG	AEG	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	is	be	VBZ	B-VP
O	targeted	target	VBN	I-VP
O	to	to	TO	B-PP
O	different	different	JJ	B-NP
O	subcellular	subcellular	JJ	I-NP
O	compartments	compartment	NNS	I-NP
O	by	by	IN	B-PP
O	ubiquitinylation	ubiquitinylation	NN	B-NP
O	and	and	CC	O
O	intrinsic	intrinsic	JJ	B-NP
O	nuclear	nuclear	JJ	I-NP
O	localization	localization	NN	I-NP
O	signals	signal	NNS	I-NP
O	.	.	.	O

O	PURPOSE	PURPOSE	NN	B-NP
O	:	:	:	O
B-GGP	LYRIC	LYRIC	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	AEG	AEG	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	reported	report	VBN	I-VP
O	to	to	TO	I-VP
O	influence	influence	VB	I-VP
O	breast	breast	NN	B-NP
O	cancer	cancer	NN	I-NP
O	survival	survival	NN	I-NP
O	and	and	CC	I-NP
O	metastases	metastasis	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	altered	alter	VBN	I-NP
O	expression	expression	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	cancers	cancer	NNS	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	cellular	cellular	JJ	I-NP
O	function	function	NN	I-NP
O	of	of	IN	B-PP
B-GGP	LYRIC	LYRIC	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	AEG	AEG	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	has	have	VBZ	B-VP
O	previously	previously	RB	I-VP
O	been	be	VBN	I-VP
O	related	relate	VBN	I-VP
O	to	to	TO	B-PP
O	its	its	PRP$	B-NP
O	subcellular	subcellular	JJ	I-NP
O	distribution	distribution	NN	I-NP
O	in	in	IN	B-PP
O	cell	cell	NN	B-NP
O	lines	line	NNS	I-NP
O	.	.	.	O

B-GGP	LYRIC	LYRIC	NN	B-NP
O	/	/	SYM	I-NP
B-GGP	AEG	AEG	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	contains	contain	VBZ	B-VP
O	three	three	CD	B-NP
O	uncharacterized	uncharacterized	JJ	I-NP
O	nuclear	nuclear	JJ	I-NP
O	localization	localization	NN	I-NP
O	signals	signal	NNS	I-NP
O	(	(	(	O
O	NLS	NLS	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	which	which	WDT	B-NP
O	may	may	MD	B-VP
O	regulate	regulate	VB	I-VP
O	its	its	PRP$	B-NP
O	distribution	distribution	NN	I-NP
O	and	and	CC	O
O	,	,	,	O
O	ultimately	ultimately	RB	B-ADVP
O	,	,	,	O
O	function	function	NN	B-NP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	.	.	.	O

O	EXPERIMENTAL	EXPERIMENTAL	JJ	B-NP
O	DESIGN	DESIGN	NN	I-NP
O	:	:	:	O
O	Immunohistochemistry	Immunohistochemistry	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	human	human	JJ	I-NP
O	prostate	prostate	NN	I-NP
O	tissue	tissue	NN	I-NP
O	microarray	microarray	NN	I-NP
O	composed	compose	VBN	B-VP
O	of	of	IN	B-PP
O	179	179	CD	B-NP
O	prostate	prostate	NN	I-NP
O	cancer	cancer	NN	I-NP
O	and	and	CC	O
O	24	24	CD	B-NP
O	benign	benign	JJ	I-NP
O	samples	sample	NNS	I-NP
O	was	be	VBD	B-VP
O	used	use	VBN	I-VP
O	to	to	TO	B-VP
O	assess	assess	VB	I-VP
B-GGP	LYRIC	LYRIC	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	AEG	AEG	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	distribution	distribution	NN	I-NP
O	.	.	.	O

B-GGP	Green	Green	JJ	B-NP
I-GGP	fluorescent	fluorescent	JJ	I-NP
I-GGP	protein	protein	NN	I-NP
O	-	-	HYPH	B-NP
O	NLS	NLS	NN	I-NP
O	fusion	fusion	NN	I-NP
O	proteins	protein	NNS	I-NP
O	and	and	CC	O
O	deletion	deletion	NN	B-NP
O	constructs	construct	NNS	I-NP
O	were	be	VBD	B-VP
O	used	use	VBN	I-VP
O	to	to	TO	B-VP
O	show	show	VB	I-VP
O	the	the	DT	B-NP
O	ability	ability	NN	I-NP
O	of	of	IN	B-PP
B-GGP	LYRIC	LYRIC	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	AEG	AEG	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	NLS	NLS	NN	I-NP
O	to	to	TO	B-VP
O	target	target	VB	I-VP
B-GGP	green	green	JJ	B-NP
I-GGP	fluorescent	fluorescent	JJ	I-NP
I-GGP	protein	protein	NN	I-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	cytoplasm	cytoplasm	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	nucleus	nucleus	NN	I-NP
O	.	.	.	O

O	Immunoprecipitation	Immunoprecipitation	NN	B-NP
O	and	and	CC	I-NP
O	Western	Western	NN	I-NP
O	blotting	blotting	NN	I-NP
O	were	be	VBD	B-VP
O	used	use	VBN	I-VP
O	to	to	TO	B-VP
O	show	show	VB	I-VP
O	posttranslational	posttranslational	JJ	B-NP
O	modification	modification	NN	I-NP
O	of	of	IN	B-PP
B-GGP	LYRIC	LYRIC	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	AEG	AEG	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	NLS	NLS	NN	I-NP
O	regions	region	NNS	I-NP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
O	Using	Use	VBG	B-VP
O	a	a	DT	B-NP
O	prostate	prostate	NN	I-NP
O	tissue	tissue	NN	I-NP
O	microarray	microarray	NN	I-NP
O	,	,	,	O
O	significant	significant	JJ	B-NP
O	changes	change	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	distribution	distribution	NN	I-NP
O	of	of	IN	B-PP
B-GGP	LYRIC	LYRIC	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	AEG	AEG	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	were	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	in	in	IN	B-PP
O	prostate	prostate	NN	B-NP
O	cancer	cancer	NN	I-NP
O	as	as	IN	B-PP
O	an	an	DT	B-NP
O	increased	increase	VBN	I-NP
O	cytoplasmic	cytoplasmic	JJ	I-NP
O	distribution	distribution	NN	I-NP
O	in	in	IN	B-PP
O	tumors	tumor	NNS	B-NP
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	benign	benign	JJ	B-NP
O	tissue	tissue	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	differences	difference	NNS	I-NP
O	were	be	VBD	B-VP
O	most	most	RBS	B-ADJP
O	marked	marked	JJ	I-ADJP
O	in	in	IN	B-PP
O	high	high	JJ	B-NP
O	grade	grade	NN	I-NP
O	and	and	CC	O
O	aggressive	aggressive	JJ	B-NP
O	prostate	prostate	NN	I-NP
O	cancers	cancer	NNS	I-NP
O	and	and	CC	O
O	were	be	VBD	B-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	decreased	decrease	VBN	B-NP
O	survival	survival	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	COOH	COOH	NN	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	extended	extend	VBN	I-NP
O	NLS	NLS	NN	I-NP
O	-	-	HYPH	B-NP
O	3	3	CD	I-NP
O	(	(	(	O
O	amino	amino	NN	B-NP
O	acids	acid	NNS	I-NP
O	546	546	CD	B-NP
O	-	-	HYPH	B-NP
O	582	582	CD	I-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	predominant	predominant	JJ	I-NP
O	regulator	regulator	NN	I-NP
O	of	of	IN	B-PP
O	nuclear	nuclear	JJ	B-NP
O	localization	localization	NN	I-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	extended	extend	VBN	B-NP
O	NLS	NLS	NN	I-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	(	(	(	O
O	amino	amino	NN	B-NP
O	acids	acid	NNS	I-NP
O	78	78	CD	B-NP
O	-	-	HYPH	B-NP
O	130	130	CD	I-NP
O	)	)	)	O
O	regulates	regulate	VBZ	B-VP
O	its	its	PRP$	B-NP
O	nucleolar	nucleolar	JJ	I-NP
O	localization	localization	NN	I-NP
O	.	.	.	O

O	Within	Within	IN	B-PP
O	the	the	DT	B-NP
O	extended	extend	VBN	I-NP
O	NLS	NLS	NN	I-NP
O	-	-	HYPH	I-NP
O	2	2	CD	I-NP
O	region	region	NN	I-NP
O	(	(	(	O
O	amino	amino	NN	B-NP
O	acids	acid	NNS	I-NP
O	415	415	CD	B-NP
O	-	-	HYPH	B-NP
O	486	486	CD	I-NP
O	)	)	)	O
O	,	,	,	O
B-GGP	LYRIC	LYRIC	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	AEG	AEG	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	modified	modify	VBN	I-VP
O	by	by	IN	B-PP
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	almost	almost	RB	B-ADVP
O	exclusively	exclusively	RB	I-ADVP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	cytoplasm	cytoplasm	NN	I-NP
O	.	.	.	O

O	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	:	:	:	O
O	Changes	Change	NNS	B-NP
O	in	in	IN	B-PP
B-GGP	LYRIC	LYRIC	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	AEG	AEG	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	subcellular	subcellular	JJ	I-NP
O	distribution	distribution	NN	I-NP
O	can	can	MD	B-VP
O	predict	predict	VB	I-VP
O	Gleason	Gleason	NNP	B-NP
O	grade	grade	NN	I-NP
O	and	and	CC	I-NP
O	survival	survival	NN	I-NP
O	.	.	.	O

O	Two	Two	CD	B-NP
O	lysine	lysine	NN	I-NP
O	-	-	HYPH	B-NP
O	rich	rich	JJ	I-NP
O	regions	region	NNS	I-NP
O	(	(	(	O
O	NLS	NLS	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	and	and	CC	I-NP
O	NLS	NLS	NN	I-NP
O	-	-	HYPH	B-NP
O	3	3	CD	I-NP
O	)	)	)	O
O	can	can	MD	B-VP
O	target	target	VB	I-VP
B-GGP	LYRIC	LYRIC	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	AEG	AEG	NN	I-NP
I-GGP	-	-	SYM	B-NP
I-GGP	1	1	CD	I-NP
O	to	to	TO	B-PP
O	subcellular	subcellular	JJ	B-NP
O	compartments	compartment	NNS	I-NP
O	whereas	whereas	IN	B-PP
O	NLS	NLS	NN	B-NP
O	-	-	HYPH	O
O	2	2	CD	B-NP
O	is	be	VBZ	B-VP
O	modified	modify	VBN	I-VP
O	by	by	IN	B-PP
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	cytoplasm	cytoplasm	NN	I-NP
O	.	.	.	O

O	Bile	Bile	NN	B-NP
O	acid	acid	NN	I-NP
O	signaling	signaling	NN	I-NP
O	pathways	pathway	NNS	I-NP
O	increase	increase	VBP	B-VP
O	stability	stability	NN	B-NP
O	of	of	IN	B-PP
B-GGP	Small	Small	NNP	B-NP
I-GGP	Heterodimer	Heterodimer	NNP	I-NP
I-GGP	Partner	Partner	NNP	I-NP
O	(	(	(	O
B-GGP	SHP	SHP	NNP	B-NP
O	)	)	)	O
O	by	by	IN	B-PP
O	inhibiting	inhibit	VBG	B-VP
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	-	-	HYPH	B-NP
O	proteasomal	proteasomal	JJ	I-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

B-GGP	Small	Small	JJ	B-NP
I-GGP	Heterodimer	Heterodimer	NN	I-NP
I-GGP	Partner	Partner	NN	I-NP
O	(	(	(	O
B-GGP	SHP	SHP	NN	B-NP
O	)	)	)	O
O	inhibits	inhibit	VBZ	B-VP
O	activities	activity	NNS	B-NP
O	of	of	IN	B-PP
O	numerous	numerous	JJ	B-NP
O	transcription	transcription	NN	I-NP
O	factors	factor	NNS	I-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	diverse	diverse	JJ	B-NP
O	biological	biological	JJ	I-NP
O	pathways	pathway	NNS	I-NP
O	.	.	.	O

O	As	As	IN	B-PP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	metabolic	metabolic	JJ	I-NP
O	regulator	regulator	NN	I-NP
O	,	,	,	O
B-GGP	SHP	SHP	NN	B-NP
O	plays	play	VBZ	B-VP
O	a	a	DT	B-NP
O	key	key	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	maintaining	maintain	VBG	B-VP
O	cholesterol	cholesterol	NN	B-NP
O	and	and	CC	I-NP
O	bile	bile	NN	I-NP
O	acid	acid	NN	I-NP
O	homeostasis	homeostasis	NN	I-NP
O	by	by	IN	B-PP
O	inhibiting	inhibit	VBG	B-VP
O	cholesterol	cholesterol	NN	B-NP
O	conversion	conversion	NN	I-NP
O	to	to	TO	B-PP
O	bile	bile	NN	B-NP
O	acids	acid	NNS	I-NP
O	.	.	.	O

O	While	While	IN	B-SBAR
B-GGP	SHP	SHP	NN	B-NP
O	gene	gene	NN	I-NP
O	induction	induction	NN	I-NP
O	by	by	IN	B-PP
O	increased	increase	VBN	B-NP
O	bile	bile	NN	I-NP
O	acids	acid	NNS	I-NP
O	is	be	VBZ	B-VP
O	well	well	RB	I-VP
O	established	establish	VBN	I-VP
O	,	,	,	O
O	whether	whether	IN	B-SBAR
B-GGP	SHP	SHP	NN	B-NP
O	activity	activity	NN	I-NP
O	is	be	VBZ	B-VP
O	also	also	RB	I-VP
O	modulated	modulate	VBN	I-VP
O	remains	remain	VBZ	B-VP
O	unknown	unknown	JJ	B-ADJP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	report	report	VBP	B-VP
O	surprising	surprising	JJ	B-NP
O	findings	finding	NNS	I-NP
O	that	that	IN	B-SBAR
B-GGP	SHP	SHP	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	rapidly	rapidly	RB	I-NP
O	degraded	degrade	VBN	I-NP
O	protein	protein	NN	I-NP
O	via	via	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	-	-	HYPH	B-NP
O	proteasomal	proteasomal	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	bile	bile	NN	B-NP
O	acids	acid	NNS	I-NP
O	or	or	CC	O
O	bile	bile	NN	B-NP
O	acid	acid	NN	I-NP
O	-	-	HYPH	O
O	induced	induce	VBN	B-NP
O	intestinal	intestinal	JJ	I-NP
B-GGP	fibroblast	fibroblast	NN	I-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	19	19	CD	I-NP
O	(	(	(	O
B-GGP	FGF19	FGF19	NN	B-NP
O	)	)	)	O
O	increases	increase	VBZ	B-VP
O	stability	stability	NN	B-NP
O	of	of	IN	B-PP
O	hepatic	hepatic	JJ	B-NP
B-GGP	SHP	SHP	NN	I-NP
O	by	by	IN	B-PP
O	inhibiting	inhibit	VBG	B-VP
O	proteasomal	proteasomal	JJ	B-NP
O	degradation	degradation	NN	I-NP
O	in	in	IN	B-PP
O	an	an	DT	B-NP
O	extracellular	extracellular	JJ	I-NP
O	signal	signal	NN	I-NP
O	-	-	HYPH	B-NP
O	regulated	regulate	VBN	I-NP
O	kinase	kinase	NN	I-NP
O	(	(	(	O
O	ERK	ERK	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	manner	manner	NN	I-NP
O	.	.	.	O

B-GGP	SHP	SHP	NN	B-NP
O	was	be	VBD	B-VP
O	ubiquitinated	ubiquitinate	VBN	I-VP
O	at	at	IN	B-PP
O	Lys122	Lys122	NN	B-NP
O	and	and	CC	I-NP
O	Lys123	Lys123	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	mutation	mutation	NN	B-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	sites	site	NNS	I-NP
O	altered	alter	VBD	B-VP
O	its	its	PRP$	B-NP
O	stability	stability	NN	I-NP
O	and	and	CC	I-NP
O	repression	repression	NN	I-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	Tandem	Tandem	JJ	B-NP
O	mass	mass	NN	I-NP
O	spectrometry	spectrometry	NN	I-NP
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
O	upon	upon	IN	B-PP
O	bile	bile	NN	B-NP
O	acid	acid	NN	I-NP
O	treatment	treatment	NN	I-NP
O	,	,	,	O
B-GGP	SHP	SHP	NN	B-NP
O	was	be	VBD	B-VP
O	phosphorylated	phosphorylate	VBN	I-VP
O	at	at	IN	B-PP
O	Ser26	Ser26	NN	B-NP
O	,	,	,	O
O	within	within	IN	B-PP
O	an	an	DT	B-NP
O	ERK	ERK	NN	I-NP
O	motif	motif	NN	I-NP
O	in	in	IN	B-PP
B-GGP	SHP	SHP	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	mutation	mutation	NN	B-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	site	site	NN	I-NP
O	dramatically	dramatically	RB	B-ADVP
O	abolished	abolish	VBD	B-VP
B-GGP	SHP	SHP	NN	B-NP
O	stability	stability	NN	I-NP
O	.	.	.	O

O	Surprisingly	Surprisingly	RB	B-ADVP
O	,	,	,	O
B-GGP	SHP	SHP	NN	B-NP
O	stability	stability	NN	I-NP
O	was	be	VBD	B-VP
O	abnormally	abnormally	RB	I-VP
O	elevated	elevate	VBN	I-VP
O	in	in	IN	B-PP
O	ob	ob	NN	B-NP
O	/	/	SYM	B-NP
O	ob	ob	NN	I-NP
O	mice	mouse	NNS	I-NP
O	and	and	CC	I-NP
O	diet	diet	NN	I-NP
O	-	-	HYPH	O
O	induced	induce	VBN	B-NP
O	obese	obese	JJ	I-NP
O	mice	mouse	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	demonstrate	demonstrate	VBP	B-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	for	for	IN	B-PP
O	regulation	regulation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	SHP	SHP	NN	B-NP
O	stability	stability	NN	I-NP
O	in	in	IN	B-PP
O	bile	bile	NN	B-NP
O	acid	acid	NN	I-NP
O	signaling	signaling	NN	I-NP
O	in	in	IN	B-PP
O	normal	normal	JJ	B-NP
O	conditions	condition	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	abnormal	abnormal	JJ	B-NP
O	stabilization	stabilization	NN	I-NP
O	of	of	IN	B-PP
B-GGP	SHP	SHP	NN	B-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	metabolic	metabolic	JJ	B-NP
O	disorders	disorder	NNS	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	obesity	obesity	NN	B-NP
O	and	and	CC	I-NP
O	diabetes	diabetes	NN	I-NP
O	.	.	.	O

O	Rapid	Rapid	JJ	B-NP
O	proteasomal	proteasomal	JJ	I-NP
O	degradation	degradation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	transcription	transcription	NN	B-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	IIB	IIB	NN	I-NP
O	in	in	IN	B-PP
O	accordance	accordance	NN	B-NP
O	with	with	IN	B-PP
O	F9	F9	NN	B-NP
O	cell	cell	NN	I-NP
O	differentiation	differentiation	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	all	all	DT	B-NP
O	general	general	JJ	I-NP
O	transcription	transcription	NN	I-NP
O	factors	factor	NNS	I-NP
O	(	(	(	O
O	GTFs	GTF	NNS	B-NP
O	)	)	)	O
O	for	for	IN	B-PP
O	RNA	RNA	NN	B-NP
O	polymerase	polymerase	NN	I-NP
O	II	II	CD	I-NP
O	decreased	decrease	VBD	B-VP
O	in	in	IN	B-PP
O	F9	F9	NN	B-NP
O	cells	cell	NNS	I-NP
O	when	when	WRB	B-ADVP
O	the	the	DT	B-NP
O	cells	cell	NNS	I-NP
O	were	be	VBD	B-VP
O	subjected	subject	VBN	I-VP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	differentiation	differentiation	NN	I-NP
O	procedure	procedure	NN	I-NP
O	.	.	.	O

O	Different	Different	JJ	B-ADJP
O	from	from	IN	B-PP
O	other	other	JJ	B-NP
O	GTFs	GTF	NNS	I-NP
O	,	,	,	O
O	decrease	decrease	NN	B-NP
O	of	of	IN	B-PP
B-GGP	TFIIB	TFIIB	NN	B-NP
O	during	during	IN	B-PP
O	the	the	DT	B-NP
O	differentiation	differentiation	NN	I-NP
O	was	be	VBD	B-VP
O	suppressed	suppress	VBN	I-VP
O	by	by	IN	B-PP
O	addition	addition	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	proteasome	proteasome	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	,	,	,	O
O	MG132	MG132	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	half	half	NN	I-NP
O	-	-	HYPH	I-NP
O	life	life	NN	I-NP
O	of	of	IN	B-PP
B-GGP	TFIIB	TFIIB	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	differentiated	differentiate	VBN	I-NP
O	cells	cell	NNS	I-NP
O	was	be	VBD	B-VP
O	remarkably	remarkably	RB	I-VP
O	reduced	reduce	VBN	I-VP
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	that	that	DT	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	undifferentiated	undifferentiated	JJ	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	it	it	PRP	B-NP
O	was	be	VBD	B-VP
O	demonstrated	demonstrate	VBN	I-VP
O	that	that	IN	B-SBAR
B-GGP	TFIIB	TFIIB	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	poly	poly	RB	I-NP
O	-	-	HYPH	I-NP
O	ubiquitinated	ubiquitinate	VBN	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	Results	Result	NNS	B-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	components	component	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	transcription	transcription	NN	I-NP
O	machinery	machinery	NN	I-NP
O	decreased	decrease	VBD	B-VP
O	in	in	IN	B-PP
O	accordance	accordance	NN	B-NP
O	with	with	IN	B-PP
O	cell	cell	NN	B-NP
O	differentiation	differentiation	NN	I-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
B-GGP	TFIIB	TFIIB	NN	B-NP
O	is	be	VBZ	B-VP
O	specifically	specifically	RB	B-VP
O	and	and	CC	I-VP
O	rapidly	rapidly	RB	I-VP
O	degraded	degrade	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	-	-	HYPH	B-NP
O	proteasome	proteasome	NN	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

O	Acetaldehyde	Acetaldehyde	NN	B-NP
O	stimulates	stimulate	VBZ	B-VP
B-GGP	FANCD2	FANCD2	NN	B-NP
O	monoubiquitination	monoubiquitination	NN	I-NP
O	,	,	,	O
B-GGP	H2AX	H2AX	NN	B-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	BRCA1	BRCA1	NN	B-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	cells	cell	NNS	I-NP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	:	:	:	O
O	implications	implication	NNS	B-NP
O	for	for	IN	B-PP
O	alcohol	alcohol	NN	B-NP
O	-	-	HYPH	O
O	related	relate	VBN	B-NP
O	carcinogenesis	carcinogenesis	NN	I-NP
O	.	.	.	O

O	According	Accord	VBG	B-PP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	recent	recent	JJ	I-NP
O	IARC	IARC	NNP	I-NP
O	Working	Working	NNP	I-NP
O	Group	Group	NNP	I-NP
O	report	report	NN	I-NP
O	,	,	,	O
O	alcohol	alcohol	NN	B-NP
O	consumption	consumption	NN	I-NP
O	is	be	VBZ	B-VP
O	causally	causally	RB	I-VP
O	related	relate	VBN	I-VP
O	to	to	TO	B-PP
O	an	an	DT	B-NP
O	increased	increase	VBN	I-NP
O	risk	risk	NN	I-NP
O	of	of	IN	B-PP
O	cancer	cancer	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	upper	upper	JJ	I-NP
O	aerodigestive	aerodigestive	JJ	I-NP
O	tract	tract	NN	I-NP
O	,	,	,	O
O	liver	liver	NN	B-NP
O	,	,	,	O
O	colorectum	colorectum	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	female	female	JJ	B-NP
O	breast	breast	NN	I-NP
O	[	[	(	O
O	R	R	NN	B-NP
O	.	.	.	O

O	Baan	Baan	JJ	B-NP
O	,	,	,	I-NP
O	K	K	NN	I-NP
O	.	.	.	O

O	Straif	Straif	NNP	B-NP
O	,	,	,	O
O	Y	Y	NNP	B-NP
O	.	.	.	O

O	Grosse	Grosse	NNP	B-NP
O	,	,	,	O
O	B	B	NNP	B-NP
O	.	.	.	O

O	Secretan	Secretan	NNP	B-NP
O	,	,	,	O
O	F	F	NNP	B-NP
O	.	.	.	O

O	El	El	NNP	B-NP
O	Ghissassi	Ghissassi	NNP	I-NP
O	,	,	,	O
O	V	V	NNP	B-NP
O	.	.	.	O

O	Bouvard	Bouvard	NNP	B-NP
O	,	,	,	O
O	A	A	NNP	B-NP
O	.	.	.	O

O	Altieri	Altieri	NNP	B-NP
O	,	,	,	O
O	V	V	NNP	B-NP
O	.	.	.	O

O	Cogliano	Cogliano	NNP	B-NP
O	,	,	,	O
O	Carcinogenicity	Carcinogenicity	NNP	B-NP
O	of	of	IN	B-PP
O	alcoholic	alcoholic	JJ	B-NP
O	beverages	beverage	NNS	I-NP
O	,	,	,	O
O	Lancet	Lancet	NNP	B-NP
O	Oncol	Oncol	NNP	I-NP
O	.	.	.	O

O	8	8	CD	B-NP
O	(	(	(	O
O	2007	2007	CD	B-NP
O	)	)	)	O
O	292	292	CD	B-NP
O	-	-	HYPH	I-NP
O	293	293	CD	I-NP
O	]	]	)	O
O	.	.	.	O

O	Several	Several	JJ	B-NP
O	lines	line	NNS	I-NP
O	of	of	IN	B-PP
O	evidence	evidence	NN	B-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	acetaldehyde	acetaldehyde	NN	B-NP
O	(	(	(	O
O	AA	AA	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	product	product	NN	I-NP
O	of	of	IN	B-PP
O	alcohol	alcohol	NN	B-NP
O	metabolism	metabolism	NN	I-NP
O	,	,	,	O
O	plays	play	VBZ	B-VP
O	a	a	DT	B-NP
O	very	very	RB	I-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	alcohol	alcohol	NN	B-NP
O	-	-	HYPH	B-NP
O	related	relate	VBN	I-NP
O	carcinogenesis	carcinogenesis	NN	I-NP
O	,	,	,	O
O	particularly	particularly	RB	B-ADVP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	esophagus	esophagus	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	previously	previously	RB	B-ADVP
O	proposed	propose	VBD	B-VP
O	a	a	DT	B-NP
O	model	model	NN	I-NP
O	for	for	IN	B-PP
O	alcohol	alcohol	NN	B-NP
O	-	-	HYPH	O
O	related	relate	VBN	B-NP
O	carcinogenesis	carcinogenesis	NN	I-NP
O	in	in	IN	B-PP
O	which	which	WDT	B-NP
O	AA	AA	NN	B-NP
O	,	,	,	O
O	generated	generate	VBN	B-VP
O	from	from	IN	B-PP
O	alcohol	alcohol	NN	B-NP
O	metabolism	metabolism	NN	I-NP
O	,	,	,	O
O	reacts	react	VBZ	B-VP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	to	to	TO	B-VP
O	generate	generate	VB	I-VP
O	DNA	DNA	NN	B-NP
O	lesions	lesion	NNS	I-NP
O	that	that	WDT	B-NP
O	form	form	VBP	B-VP
O	interstrand	interstrand	JJ	B-NP
O	crosslinks	crosslink	NNS	I-NP
O	(	(	(	O
O	ICLs	ICL	NNS	B-NP
O	)	)	)	O
O	[	[	(	O
O	J	J	NNP	B-NP
O	.	.	.	I-NP
O	A	A	NNP	I-NP
O	.	.	.	O

O	Theruvathu	Theruvathu	NNP	B-NP
O	,	,	,	O
O	P	P	NNP	B-NP
O	.	.	.	I-NP
O	Jaruga	Jaruga	NNP	I-NP
O	,	,	,	O
O	R	R	NNP	B-NP
O	.	.	.	I-NP
O	G	G	NNP	I-NP
O	.	.	.	O

O	Nath	Nath	NNP	B-NP
O	,	,	,	O
O	M	M	NNP	B-NP
O	.	.	.	I-NP
O	Dizdaroglu	Dizdaroglu	NNP	I-NP
O	,	,	,	O
O	P	P	NNP	B-NP
O	.	.	.	I-NP
O	J	J	NNP	I-NP
O	.	.	.	O

O	Brooks	Brooks	NNP	B-NP
O	,	,	,	O
O	Polyamines	Polyamines	NNP	B-NP
O	stimulate	stimulate	VBP	B-VP
O	the	the	DT	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	mutagenic	mutagenic	JJ	B-NP
O	1	1	CD	I-NP
O	,	,	,	O
O	N2	N2	NN	B-NP
O	-	-	HYPH	I-NP
O	propanodeoxyguanosine	propanodeoxyguanosine	NN	I-NP
O	adducts	adduct	NNS	I-NP
O	from	from	IN	B-PP
O	acetaldehyde	acetaldehyde	NN	B-NP
O	,	,	,	O
O	Nucleic	Nucleic	NNP	B-NP
O	Acids	Acids	NNP	I-NP
O	Res	Res	NNP	I-NP
O	.	.	.	O

O	33	33	CD	B-NP
O	(	(	(	O
O	2005	2005	CD	B-NP
O	)	)	)	O
O	3513	3513	CD	B-NP
O	-	-	HYPH	I-NP
O	3520	3520	CD	I-NP
O	]	]	)	O
O	.	.	.	O

O	Since	Since	IN	B-SBAR
O	the	the	DT	B-NP
O	Fanconi	Fanconi	NNP	I-NP
O	anemia	anemia	NN	I-NP
O	-	-	HYPH	B-NP
O	breast	breast	NN	I-NP
O	cancer	cancer	NN	I-NP
O	associated	associate	VBN	B-VP
O	(	(	(	O
O	FANC	FANC	NN	B-NP
O	-	-	HYPH	B-NP
O	BRCA	BRCA	NN	I-NP
O	)	)	)	O
O	DNA	DNA	NN	B-NP
O	damage	damage	NN	I-NP
O	response	response	NN	I-NP
O	network	network	NN	I-NP
O	plays	play	VBZ	B-VP
O	a	a	DT	B-NP
O	crucial	crucial	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	protecting	protect	VBG	B-VP
O	cells	cell	NNS	B-NP
O	against	against	IN	B-PP
O	ICLs	ICLs	NN	B-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	work	work	NN	I-NP
O	we	we	PRP	B-NP
O	tested	test	VBD	B-VP
O	this	this	DT	B-NP
O	hypothesis	hypothesis	NN	I-NP
O	by	by	IN	B-PP
O	exposing	expose	VBG	B-VP
O	cells	cell	NNS	B-NP
O	to	to	TO	B-PP
O	AA	AA	NN	B-NP
O	and	and	CC	I-NP
O	monitoring	monitoring	NN	I-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	network	network	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
O	AA	AA	NN	B-NP
O	exposure	exposure	NN	I-NP
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	concentration	concentration	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
B-GGP	FANCD2	FANCD2	NN	B-NP
O	monoubiquitination	monoubiquitination	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	dependent	dependent	JJ	B-ADJP
O	upon	upon	IN	B-PP
O	the	the	DT	B-NP
O	FANC	FANC	NNP	I-NP
O	core	core	NN	I-NP
O	complex	complex	NN	I-NP
O	.	.	.	O

O	AA	AA	NN	B-NP
O	also	also	RB	B-ADVP
O	stimulated	stimulate	VBD	B-VP
B-GGP	BRCA1	BRCA1	NN	B-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	at	at	IN	B-PP
O	Ser1524	Ser1524	NN	B-NP
O	and	and	CC	O
O	increased	increase	VBD	B-VP
O	the	the	DT	B-NP
O	level	level	NN	I-NP
O	of	of	IN	B-PP
B-GGP	gammaH2AX	gammaH2AX	NN	B-NP
O	,	,	,	O
O	with	with	IN	B-PP
O	both	both	DT	B-NP
O	modifications	modification	NNS	I-NP
O	occurring	occur	VBG	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	dose	dose	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	manner	manner	NN	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	AA	AA	NN	B-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	detectably	detectably	RB	I-VP
O	increase	increase	VB	I-VP
O	the	the	DT	B-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	hyperphosphorylated	hyperphosphorylate	VBN	B-NP
B-GGP	RPA34	RPA34	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	marker	marker	NN	I-NP
O	of	of	IN	B-PP
O	single	single	JJ	B-NP
O	-	-	HYPH	I-NP
O	stranded	stranded	JJ	I-NP
O	DNA	DNA	NN	I-NP
O	exposure	exposure	NN	I-NP
O	at	at	IN	B-PP
O	replication	replication	NN	B-NP
O	forks	fork	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	provide	provide	VBP	B-VP
O	the	the	DT	B-NP
O	initial	initial	JJ	I-NP
O	description	description	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	AA	AA	NN	I-NP
O	-	-	HYPH	B-NP
O	DNA	DNA	NN	I-NP
O	damage	damage	NN	I-NP
O	response	response	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	qualitatively	qualitatively	RB	B-ADJP
O	similar	similar	JJ	I-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	cellular	cellular	JJ	I-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
O	mitomycin	mitomycin	NN	B-NP
O	C	C	NN	I-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	known	known	JJ	I-NP
O	DNA	DNA	NN	I-NP
O	crosslinking	crosslinking	NN	I-NP
O	agent	agent	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	discuss	discuss	VBP	B-VP
O	the	the	DT	B-NP
O	mechanistic	mechanistic	JJ	I-NP
O	implications	implication	NNS	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	results	result	NNS	I-NP
O	,	,	,	O
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	their	their	PRP$	B-NP
O	possible	possible	JJ	I-NP
O	relationship	relationship	NN	I-NP
O	to	to	TO	B-PP
O	alcohol	alcohol	NN	B-NP
O	-	-	HYPH	O
O	related	relate	VBN	B-NP
O	carcinogenesis	carcinogenesis	NN	I-NP
O	in	in	IN	B-PP
O	different	different	JJ	B-NP
O	human	human	JJ	I-NP
O	tissues	tissue	NNS	I-NP
O	.	.	.	O

B-GGP	Atg5	Atg5	NN	B-NP
O	-	-	HYPH	I-NP
O	independent	independent	JJ	I-NP
O	sequestration	sequestration	NN	I-NP
O	of	of	IN	B-PP
O	ubiquitinated	ubiquitinate	VBN	B-NP
O	mycobacteria	mycobacterium	NNS	I-NP
O	.	.	.	O

O	Like	Like	IN	B-PP
O	several	several	JJ	B-NP
O	other	other	JJ	I-NP
O	intracellular	intracellular	JJ	I-NP
O	pathogens	pathogen	NNS	I-NP
O	,	,	,	O
O	Mycobacterium	Mycobacterium	NN	B-NP
O	marinum	marinum	NN	I-NP
O	(	(	(	O
O	Mm	Mm	NN	B-NP
O	)	)	)	O
O	escapes	escape	NNS	B-NP
O	from	from	IN	B-PP
O	phagosomes	phagosome	NNS	B-NP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	host	host	NN	I-NP
O	cytosol	cytosol	NN	I-NP
O	where	where	WRB	B-ADVP
O	it	it	PRP	B-NP
O	can	can	MD	B-VP
O	polymerize	polymerize	VB	I-VP
O	actin	actin	NN	B-NP
O	,	,	,	O
O	leading	lead	VBG	B-VP
O	to	to	TO	B-PP
O	motility	motility	NN	B-NP
O	that	that	WDT	B-NP
O	promotes	promote	VBZ	B-VP
O	spread	spread	VBN	I-VP
O	to	to	TO	B-PP
O	neighboring	neighbor	VBG	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	only	only	RB	B-NP
O	approximately	approximately	RB	I-NP
O	25	25	CD	I-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	internalized	internalize	VBN	B-NP
O	Mm	Mm	NN	I-NP
O	form	form	NN	I-NP
O	actin	actin	NN	I-NP
O	tails	tail	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	fate	fate	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	remaining	remain	VBG	I-NP
O	bacteria	bacteria	NNS	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	unknown	unknown	JJ	B-ADJP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	cytosolic	cytosolic	JJ	B-NP
O	access	access	NN	I-NP
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	new	new	JJ	I-NP
O	and	and	CC	I-NP
O	intricate	intricate	JJ	I-NP
O	host	host	NN	I-NP
O	pathogen	pathogen	NN	I-NP
O	interaction	interaction	NN	I-NP
O	:	:	:	O
O	host	host	NN	B-NP
O	macrophages	macrophage	NNS	I-NP
O	ubiquitinate	ubiquitinate	VBP	B-VP
O	Mm	Mm	NN	B-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	Mm	Mm	NN	B-NP
O	shed	shed	VBD	B-VP
O	their	their	PRP$	B-NP
O	ubiquitinated	ubiquitinate	VBN	I-NP
O	cell	cell	NN	I-NP
O	walls	wall	NNS	I-NP
O	.	.	.	O

O	Phagosomal	Phagosomal	JJ	B-NP
O	escape	escape	NN	I-NP
O	and	and	CC	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	of	of	IN	B-PP
O	Mm	Mm	NN	B-NP
O	occurred	occur	VBD	B-VP
O	rapidly	rapidly	RB	B-ADVP
O	,	,	,	O
O	prior	prior	JJ	B-ADJP
O	to	to	TO	B-PP
O	3	3	CD	B-NP
O	.	.	.	O
O	5	5	CD	B-NP
O	hours	hour	NNS	I-NP
O	post	post	IN	B-PP
O	infection	infection	NN	B-NP
O	;	;	:	O
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	same	same	JJ	I-NP
O	time	time	NN	I-NP
O	,	,	,	O
O	ubiquitinated	ubiquitinate	VBD	B-VP
O	Mm	Mm	NN	B-NP
O	cell	cell	NN	I-NP
O	wall	wall	NN	I-NP
O	material	material	NN	I-NP
O	mixed	mix	VBN	B-VP
O	with	with	IN	B-PP
O	host	host	NN	B-NP
O	-	-	HYPH	O
O	derived	derive	VBN	B-NP
O	dense	dense	JJ	I-NP
O	membrane	membrane	NN	I-NP
O	networks	network	NNS	I-NP
O	appeared	appear	VBD	B-VP
O	in	in	IN	B-PP
O	close	close	JJ	B-NP
O	proximity	proximity	NN	I-NP
O	to	to	TO	B-PP
O	cytosolic	cytosolic	JJ	B-NP
O	bacteria	bacteria	NNS	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	cell	cell	NN	B-NP
O	wall	wall	NN	I-NP
O	shedding	shedding	NN	I-NP
O	and	and	CC	I-NP
O	association	association	NN	I-NP
O	with	with	IN	B-PP
O	remnants	remnant	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	lysed	lyse	VBN	I-NP
O	phagosome	phagosome	NN	I-NP
O	.	.	.	O

O	At	At	IN	B-PP
O	24	24	CD	B-NP
O	hours	hour	NNS	I-NP
O	post	post	AFX	B-NP
O	-	-	HYPH	I-NP
O	infection	infection	NN	B-NP
O	,	,	,	O
O	Mm	Mm	NN	B-NP
O	that	that	IN	B-SBAR
O	polymerized	polymerized	JJ	B-NP
O	actin	actin	NN	I-NP
O	were	be	VBD	B-VP
O	not	not	RB	I-VP
O	ubiquitinated	ubiquitinate	VBN	I-VP
O	,	,	,	O
O	whereas	whereas	IN	O
O	ubiquitinated	ubiquitinate	VBN	B-NP
O	Mm	Mm	NN	I-NP
O	were	be	VBD	B-VP
O	found	find	VBN	I-VP
O	within	within	IN	B-PP
B-GGP	LAMP	LAMP	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	-	-	HYPH	I-NP
O	positive	positive	JJ	I-NP
O	vacuoles	vacuole	NNS	I-NP
O	resembling	resemble	VBG	B-VP
O	lysosomes	lysosome	NNS	B-NP
O	.	.	.	O

O	Though	Though	IN	B-SBAR
O	double	double	JJ	B-NP
O	membranes	membrane	NNS	I-NP
O	were	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	which	which	WDT	B-NP
O	sequestered	sequester	VBD	B-VP
O	Mm	Mm	NN	B-NP
O	away	away	RB	B-ADVP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	cytosol	cytosol	NN	I-NP
O	,	,	,	O
O	targeting	target	VBG	B-VP
O	of	of	IN	B-PP
O	Mm	Mm	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
B-GGP	LAMP	LAMP	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	-	-	HYPH	I-NP
O	positive	positive	JJ	I-NP
O	vacuoles	vacuole	NNS	I-NP
O	was	be	VBD	B-VP
O	independent	independent	JJ	B-ADJP
O	of	of	IN	B-PP
O	classical	classical	JJ	B-NP
O	autophagy	autophagy	NN	I-NP
O	,	,	,	O
O	as	as	IN	B-SBAR
O	demonstrated	demonstrate	VBN	B-VP
O	by	by	IN	B-PP
O	absence	absence	NN	B-NP
O	of	of	IN	B-PP
O	LC3	LC3	NN	B-NP
O	association	association	NN	I-NP
O	and	and	CC	B-PP
O	by	by	IN	B-PP
B-GGP	Atg5	Atg5	NN	B-NP
O	-	-	HYPH	B-NP
O	independence	independence	NN	I-NP
O	of	of	IN	B-PP
O	their	their	PRP$	B-NP
O	formation	formation	NN	I-NP
O	.	.	.	O

O	Further	Further	RB	B-ADVP
O	,	,	,	O
O	ubiquitination	ubiquitination	NN	B-NP
O	and	and	CC	I-NP
B-GGP	LAMP	LAMP	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	association	association	NN	I-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	occur	occur	VB	I-VP
O	with	with	IN	B-PP
O	mutant	mutant	JJ	B-NP
O	avirulent	avirulent	JJ	I-NP
O	Mm	Mm	NN	I-NP
O	lacking	lack	VBG	B-VP
B-GGP	ESX	ESX	NNP	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
O	type	type	NN	O
O	VII	VII	CD	O
O	)	)	)	O
O	secretion	secretion	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	fail	fail	VBP	B-VP
O	to	to	TO	I-VP
O	escape	escape	VB	I-VP
O	the	the	DT	B-NP
O	primary	primary	JJ	I-NP
O	phagosome	phagosome	NN	I-NP
O	;	;	:	O
O	apart	apart	RB	B-ADVP
O	from	from	IN	B-PP
O	its	its	PRP$	B-NP
O	function	function	NN	I-NP
O	in	in	IN	B-PP
O	phagosome	phagosome	NN	B-NP
O	escape	escape	NN	I-NP
O	,	,	,	O
B-GGP	ESX	ESX	NNP	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	directly	directly	RB	I-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	Mm	Mm	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	in	in	IN	B-PP
O	macrophages	macrophage	NNS	B-NP
O	or	or	CC	O
O	in	in	FW	B-ADJP
O	vitro	vitro	FW	I-ADJP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	virulent	virulent	JJ	B-NP
O	Mm	Mm	NN	I-NP
O	follow	follow	VBP	B-VP
O	two	two	CD	B-NP
O	distinct	distinct	JJ	I-NP
O	paths	path	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	cytosol	cytosol	NN	I-NP
O	of	of	IN	B-PP
O	infected	infected	JJ	B-NP
O	host	host	NN	I-NP
O	cells	cell	NNS	I-NP
O	:	:	:	O
O	bacterial	bacterial	JJ	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	is	be	VBZ	B-VP
O	followed	follow	VBN	I-VP
O	by	by	IN	B-PP
O	sequestration	sequestration	NN	B-NP
O	into	into	IN	B-PP
O	lysosome	lysosome	NN	B-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	organelles	organelle	NNS	I-NP
O	via	via	IN	B-PP
O	an	an	DT	B-NP
O	autophagy	autophagy	NN	I-NP
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	pathway	pathway	NN	I-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	cell	cell	NN	B-NP
O	wall	wall	NN	I-NP
O	shedding	shedding	NN	I-NP
O	may	may	MD	B-VP
O	allow	allow	VB	I-VP
O	escape	escape	NN	B-NP
O	from	from	IN	B-PP
O	this	this	DT	B-NP
O	fate	fate	NN	I-NP
O	to	to	TO	B-VP
O	permit	permit	VB	I-VP
O	continued	continued	JJ	B-NP
O	residence	residence	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	cytosol	cytosol	NN	I-NP
O	and	and	CC	I-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	actin	actin	NN	B-NP
O	tails	tail	NNS	I-NP
O	.	.	.	O

B-GGP	CHIP	CHIP	NN	B-NP
O	functions	function	VBZ	B-VP
O	an	an	DT	B-NP
O	E3	E3	NN	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Runx1	Runx1	NN	B-NP
O	.	.	.	O

B-GGP	Runx1	Runx1	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	key	key	JJ	I-NP
O	factor	factor	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	generation	generation	NN	I-NP
O	and	and	CC	I-NP
O	maintenance	maintenance	NN	I-NP
O	of	of	IN	B-PP
O	hematopoietic	hematopoietic	JJ	B-NP
O	stem	stem	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Improper	Improper	JJ	B-NP
O	expression	expression	NN	I-NP
O	and	and	CC	O
O	mutations	mutation	NNS	B-NP
O	in	in	IN	B-PP
B-GGP	Runx1	Runx1	NN	B-NP
O	are	be	VBP	B-VP
O	frequently	frequently	RB	I-VP
O	implicated	implicate	VBN	I-VP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	leukemia	leukemia	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	report	report	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	CHIP	CHIP	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	carboxyl	carboxyl	NN	I-NP
O	terminus	terminus	NN	I-NP
O	of	of	IN	B-PP
O	Hsc70	Hsc70	NN	B-NP
O	-	-	HYPH	O
O	interacting	interact	VBG	B-VP
O	protein	protein	NN	B-NP
O	,	,	,	O
O	also	also	RB	B-VP
O	named	name	VBN	I-VP
B-GGP	Stub1	Stub1	NN	B-NP
O	,	,	,	O
O	physically	physically	RB	B-ADVP
O	interacts	interact	VBZ	B-VP
O	with	with	IN	B-PP
B-GGP	Runx1	Runx1	NN	B-NP
O	through	through	IN	B-PP
O	the	the	DT	B-NP
O	TPR	TPR	NN	I-NP
O	and	and	CC	O
O	Charged	Charged	JJ	B-NP
O	domains	domain	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	nucleus	nucleus	NN	I-NP
O	.	.	.	O

O	Over	Over	AFX	B-NP
O	-	-	HYPH	I-NP
O	expression	expression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	CHIP	CHIP	NN	B-NP
O	directly	directly	RB	B-ADVP
O	induced	induce	VBD	B-VP
B-GGP	Runx1	Runx1	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	through	through	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	-	-	HYPH	B-NP
O	proteasome	proteasome	NN	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

O	Interestingly	Interestingly	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	CHIP	CHIP	NN	B-NP
O	-	-	HYPH	B-VP
O	mediated	mediate	VBN	B-NP
O	degradation	degradation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Runx1	Runx1	NN	B-NP
O	is	be	VBZ	B-VP
O	independent	independent	JJ	B-ADJP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	molecular	molecular	JJ	I-NP
O	chaperone	chaperone	NN	I-NP
O	Hsp70	Hsp70	NN	I-NP
O	/	/	SYM	B-NP
O	90	90	CD	I-NP
O	.	.	.	O

O	Taken	Take	VBN	B-VP
O	together	together	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	propose	propose	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	CHIP	CHIP	NN	B-NP
O	serves	serve	VBZ	B-VP
O	as	as	IN	B-PP
O	an	an	DT	B-NP
O	E3	E3	NN	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	that	that	WDT	B-NP
O	regulates	regulate	VBZ	B-VP
B-GGP	Runx1	Runx1	NN	B-NP
O	protein	protein	NN	I-NP
O	stability	stability	NN	I-NP
O	via	via	IN	B-PP
O	an	an	DT	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	mechanism	mechanism	NN	I-NP
O	that	that	WDT	B-NP
O	is	be	VBZ	B-VP
O	independent	independent	JJ	B-ADJP
O	of	of	IN	B-PP
O	Hsp70	Hsp70	NN	B-NP
O	/	/	SYM	B-NP
O	90	90	CD	I-NP
O	.	.	.	O

B-GGP	RIG	RIG	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	I	I	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	receptors	receptor	NNS	I-NP
O	:	:	:	O
O	sensing	sense	VBG	B-VP
O	and	and	CC	I-VP
O	responding	respond	VBG	I-VP
O	to	to	TO	B-PP
O	RNA	RNA	NN	B-NP
O	virus	virus	NN	I-NP
O	infection	infection	NN	I-NP
O	.	.	.	O

O	Viral	Viral	JJ	B-NP
O	and	and	CC	I-NP
O	microbial	microbial	JJ	I-NP
O	pathogens	pathogen	NNS	I-NP
O	contain	contain	VBP	B-VP
O	specific	specific	JJ	B-NP
O	motifs	motif	NNS	I-NP
O	or	or	CC	O
O	pathogen	pathogen	NN	B-NP
O	-	-	HYPH	B-VP
O	associated	associate	VBN	B-NP
O	molecular	molecular	JJ	I-NP
O	patterns	pattern	NNS	I-NP
O	(	(	(	O
O	PAMPs	PAMP	NNS	B-NP
O	)	)	)	O
O	that	that	WDT	B-NP
O	are	be	VBP	B-VP
O	recognized	recognize	VBN	I-VP
O	by	by	IN	B-PP
O	cell	cell	NN	B-NP
O	surface	surface	NN	I-NP
O	-	-	HYPH	B-NP
O	and	and	CC	I-NP
O	endosome	endosome	NN	I-NP
O	-	-	HYPH	O
O	associated	associate	VBN	B-NP
O	Toll	Toll	NN	I-NP
O	-	-	HYPH	O
O	like	like	JJ	B-NP
O	receptors	receptor	NNS	I-NP
O	(	(	(	O
O	TLRs	TLR	NNS	B-NP
O	)	)	)	O
O	.	.	.	O

O	RNA	RNA	NN	B-NP
O	virus	virus	NN	I-NP
O	infection	infection	NN	I-NP
O	is	be	VBZ	B-VP
O	also	also	RB	I-VP
O	detected	detect	VBN	I-VP
O	through	through	IN	B-PP
O	TLR	TLR	NN	B-NP
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	mechanisms	mechanism	NNS	I-NP
O	.	.	.	O

O	Early	Early	RB	B-NP
O	viral	viral	JJ	I-NP
O	replicative	replicative	JJ	I-NP
O	intermediates	intermediate	NNS	I-NP
O	are	be	VBP	B-VP
O	detected	detect	VBN	I-VP
O	by	by	IN	B-PP
O	two	two	CD	B-NP
O	recently	recently	RB	I-NP
O	characterized	characterize	VBN	I-NP
O	cystolic	cystolic	JJ	I-NP
O	viral	viral	JJ	I-NP
O	RNA	RNA	NN	I-NP
O	receptors	receptor	NNS	I-NP
O	-	-	HYPH	B-NP
B-GGP	RIG	RIG	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	I	I	NN	I-NP
O	and	and	CC	I-NP
B-GGP	MDA	MDA	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	5	5	CD	I-NP
O	.	.	.	O

O	Both	Both	DT	B-NP
O	are	be	VBP	B-VP
O	DExDH	DExDH	NN	B-NP
O	/	/	SYM	B-VP
O	box	box	NN	B-NP
O	RNA	RNA	NN	I-NP
O	helicases	helicas	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	RIG	RIG	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	I	I	PRP	B-NP
O	specifically	specifically	RB	B-ADVP
O	recognizes	recognize	VBZ	B-VP
O	5	5	CD	B-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	triphosphate	triphosphate	NN	I-NP
O	containing	contain	VBG	B-VP
O	viral	viral	JJ	B-NP
O	RNA	RNA	NN	I-NP
O	and	and	CC	O
O	transmits	transmit	VBZ	B-VP
O	signals	signal	NNS	B-NP
O	that	that	WDT	B-NP
O	induce	induce	VBP	B-VP
O	type	type	NN	B-NP
O	I	I	CD	I-NP
O	interferon	interferon	NN	I-NP
O	-	-	HYPH	B-NP
O	mediated	mediate	VBN	I-NP
O	host	host	NN	I-NP
O	immunity	immunity	NN	I-NP
O	against	against	IN	B-PP
O	virus	virus	NN	B-NP
O	infection	infection	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	review	review	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	will	will	MD	B-VP
O	focus	focus	VB	I-VP
O	on	on	IN	B-PP
B-GGP	RIG	RIG	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	I	I	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	receptor	receptor	NN	B-NP
O	(	(	(	O
O	RLR	RLR	NN	B-NP
O	)	)	)	O
O	signal	signal	NN	B-NP
O	transduction	transduction	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	regulatory	regulatory	JJ	I-NP
O	mechanisms	mechanism	NNS	I-NP
O	-	-	HYPH	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	,	,	,	O
O	deubiquitination	deubiquitination	NN	B-NP
O	,	,	,	O
O	ISGylation	ISGylation	NN	B-NP
O	-	-	HYPH	O
O	underlying	underlie	VBG	B-VP
O	this	this	DT	B-NP
O	important	important	JJ	I-NP
O	host	host	NN	I-NP
O	response	response	NN	I-NP
O	.	.	.	O

O	Arginine	Arginine	NN	B-NP
O	methylation	methylation	NN	I-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	splicing	splicing	NN	I-NP
O	-	-	HYPH	B-VP
O	associated	associate	VBN	B-NP
O	SR	SR	NN	I-NP
O	protein	protein	NN	I-NP
B-GGP	SFRS9	SFRS9	NN	I-NP
O	/	/	SYM	B-NP
B-GGP	SRP30C	SRP30C	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	human	human	JJ	I-NP
B-GGP	SFRS9	SFRS9	NN	I-NP
O	/	/	SYM	B-NP
B-GGP	SRp30c	SRp30c	NN	I-NP
O	belongs	belong	VBZ	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	SR	SR	NN	I-NP
O	family	family	NN	I-NP
O	of	of	IN	B-PP
O	splicing	splicing	NN	B-NP
O	regulators	regulator	NNS	I-NP
O	.	.	.	O

O	Despite	Despite	IN	B-PP
O	evidence	evidence	NN	B-NP
O	that	that	IN	B-SBAR
O	members	member	NNS	B-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	protein	protein	NN	I-NP
O	family	family	NN	I-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	targeted	target	VBN	I-VP
O	by	by	IN	B-PP
O	arginine	arginine	NN	B-NP
O	methylation	methylation	NN	I-NP
O	,	,	,	O
O	this	this	DT	B-NP
O	has	have	VBZ	B-VP
O	yet	yet	RB	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	experimentally	experimentally	RB	I-VP
O	addressed	address	VBN	I-VP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	SFRS9	SFRS9	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	target	target	NN	I-NP
O	for	for	IN	B-PP
B-GGP	PRMT1	PRMT1	NN	B-NP
O	-	-	HYPH	B-NP
O	mediated	mediate	VBN	I-NP
O	arginine	arginine	NN	I-NP
O	methylation	methylation	NN	I-NP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	,	,	,	O
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	immunoprecipitated	immunoprecipitate	VBN	I-VP
O	from	from	IN	B-PP
O	HEK	HEK	NN	B-NP
O	-	-	HYPH	B-ADVP
O	293	293	CD	B-NP
O	lysates	lysate	NNS	I-NP
O	by	by	IN	B-PP
O	antibodies	antibody	NNS	B-NP
O	that	that	WDT	B-NP
O	recognize	recognize	VBP	B-VP
O	both	both	CC	O
O	mono	mono	AFX	B-NP
O	-	-	HYPH	I-NP
O	and	and	CC	I-NP
O	dimethylated	dimethylate	VBN	I-NP
O	arginines	arginine	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	further	further	RB	B-ADVP
O	observed	observe	VBD	B-VP
O	that	that	IN	B-SBAR
O	upon	upon	IN	B-PP
O	treatment	treatment	NN	B-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	methylation	methylation	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	Adox	Adox	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	fluorescent	fluorescent	JJ	I-NP
B-GGP	EGFP	EGFP	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	SFRS9	SFRS9	NN	I-NP
O	re	re	AFX	O
O	-	-	HYPH	B-NP
O	localizes	localize	VBZ	B-VP
O	to	to	TO	I-VP
O	dot	dot	VB	I-VP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	structures	structure	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	cell	cell	NN	I-NP
O	nucleus	nucleus	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	subsequent	subsequent	JJ	B-NP
O	confocal	confocal	JJ	I-NP
O	analyses	analysis	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	EGFP	EGFP	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	SFRS9	SFRS9	NN	I-NP
O	localizes	localize	VBZ	B-VP
O	to	to	TO	B-PP
O	nucleoli	nucleolus	NNS	B-NP
O	in	in	IN	B-PP
O	Adox	Adox	NN	B-NP
O	-	-	HYPH	B-NP
O	treated	treat	VBN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	findings	finding	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	the	the	DT	B-NP
O	importance	importance	NN	I-NP
O	of	of	IN	B-PP
O	arginine	arginine	NN	B-NP
O	methylation	methylation	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	subnuclear	subnuclear	JJ	I-NP
O	localization	localization	NN	I-NP
O	of	of	IN	B-PP
B-GGP	SFRS9	SFRS9	NN	B-NP
O	.	.	.	O

O	Multicenter	Multicenter	JJ	B-NP
O	evaluation	evaluation	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	investigational	investigational	JJ	I-NP
O	prostate	prostate	NN	I-NP
O	cancer	cancer	NN	I-NP
O	methylation	methylation	NN	I-NP
O	assay	assay	NN	I-NP
O	.	.	.	O

O	PURPOSE	PURPOSE	NN	B-NP
O	:	:	:	O
B-GGP	Prostate	Prostate	NN	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	antigen	antigen	NN	I-NP
O	tests	test	NNS	I-NP
O	have	have	VBP	B-VP
O	low	low	JJ	B-NP
O	specificity	specificity	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	frequently	frequently	RB	B-ADVP
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	unnecessary	unnecessary	JJ	B-NP
O	biopsy	biopsy	NN	I-NP
O	and	and	CC	O
O	typically	typically	RB	B-VP
O	limits	limit	VBZ	I-VP
O	screening	screening	NN	B-NP
O	to	to	TO	B-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
B-GGP	prostate	prostate	NN	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	antigen	antigen	NN	I-NP
O	greater	great	JJR	B-ADJP
O	than	than	IN	B-PP
O	4	4	CD	B-NP
O	.	.	.	O
O	0	0	CD	B-NP
O	ng	ng	NN	I-NP
O	/	/	SYM	B-NP
O	ml	ml	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	evaluated	evaluate	VBD	B-VP
O	an	an	DT	B-NP
O	investigational	investigational	JJ	I-NP
O	prostate	prostate	NN	I-NP
O	cancer	cancer	NN	I-NP
O	methylation	methylation	NN	I-NP
O	specific	specific	JJ	I-NP
O	polymerase	polymerase	NN	I-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	assay	assay	NN	I-NP
O	that	that	WDT	B-NP
O	detects	detect	VBZ	B-VP
O	aberrant	aberrant	JJ	B-NP
O	methylation	methylation	NN	I-NP
O	in	in	IN	B-PP
O	3	3	CD	B-NP
O	markers	marker	NNS	I-NP
O	(	(	(	O
B-GGP	GSTP1	GSTP1	NN	B-NP
O	,	,	,	I-NP
B-GGP	RARbeta2	RARbeta2	NN	I-NP
O	and	and	CC	I-NP
B-GGP	APC	APC	NN	I-NP
O	)	)	)	O
O	that	that	WDT	B-NP
O	indicate	indicate	VBP	B-VP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	prostate	prostate	NN	B-NP
O	cancer	cancer	NN	I-NP
O	.	.	.	O

O	MATERIALS	MATERIALS	NNS	B-NP
O	AND	AND	CC	I-NP
O	METHODS	METHODS	NNS	I-NP
O	:	:	:	O
O	The	The	DT	B-NP
O	assay	assay	NN	I-NP
O	was	be	VBD	B-VP
O	evaluated	evaluate	VBN	I-VP
O	in	in	IN	B-PP
O	337	337	CD	B-NP
O	post	post	AFX	B-NP
O	-	-	HYPH	I-NP
O	digital	digital	JJ	I-NP
O	rectal	rectal	JJ	I-NP
O	examination	examination	NN	I-NP
O	urine	urine	NN	I-NP
O	samples	sample	NNS	I-NP
O	(	(	(	O
O	178	178	CD	B-NP
O	cancer	cancer	NN	I-NP
O	and	and	CC	O
O	159	159	CD	B-NP
O	noncancer	noncancer	NN	I-NP
O	)	)	)	O
O	collected	collect	VBN	B-VP
O	prospectively	prospectively	RB	B-ADVP
O	at	at	IN	B-PP
O	a	a	DT	B-NP
O	total	total	NN	I-NP
O	of	of	IN	B-PP
O	9	9	CD	B-NP
O	clinical	clinical	JJ	I-NP
O	sites	site	NNS	I-NP
O	.	.	.	O

O	Samples	Sample	NNS	B-NP
O	were	be	VBD	B-VP
O	processed	process	VBN	I-VP
O	wholly	wholly	RB	B-ADVP
O	or	or	CC	O
O	after	after	IN	B-PP
O	division	division	NN	B-NP
O	into	into	IN	B-PP
O	equal	equal	JJ	B-NP
O	portions	portion	NNS	I-NP
O	.	.	.	O

O	Subject	Subject	NN	B-NP
B-GGP	prostate	prostate	NN	I-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	antigen	antigen	NN	I-NP
O	was	be	VBD	B-VP
O	2	2	CD	B-NP
O	.	.	.	O
O	0	0	CD	B-NP
O	to	to	TO	B-PP
O	10	10	CD	B-NP
O	.	.	.	O
O	0	0	CD	B-NP
O	ng	ng	NN	I-NP
O	/	/	SYM	B-NP
O	ml	ml	NN	I-NP
O	.	.	.	O

O	All	All	DT	B-NP
O	subjects	subject	NNS	I-NP
O	underwent	undergo	VBD	B-VP
O	transrectal	transrectal	JJ	B-NP
O	ultrasound	ultrasound	JJ	I-NP
O	guided	guided	JJ	I-NP
O	needle	needle	NN	I-NP
O	biopsy	biopsy	NN	I-NP
O	with	with	IN	B-PP
O	6	6	CD	B-NP
O	or	or	CC	I-NP
O	greater	great	JJR	I-NP
O	cores	core	NNS	I-NP
O	sampled	sample	VBN	B-VP
O	.	.	.	O

O	Detection	Detection	NN	B-NP
O	of	of	IN	B-PP
O	1	1	CD	B-NP
O	or	or	CC	O
O	greater	great	JJR	B-NP
O	markers	marker	NNS	I-NP
O	indicated	indicate	VBD	B-VP
O	positivity	positivity	NN	B-NP
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
O	Methylation	Methylation	NN	B-NP
O	specific	specific	JJ	I-NP
O	polymerase	polymerase	NN	I-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	assay	assay	NN	I-NP
O	performance	performance	NN	I-NP
O	was	be	VBD	B-VP
O	better	good	JJR	B-ADJP
O	in	in	IN	B-PP
O	whole	whole	JJ	B-ADJP
O	than	than	IN	B-PP
O	in	in	IN	B-PP
O	divided	divide	VBN	B-NP
O	urine	urine	NN	I-NP
O	cohorts	cohort	NNS	I-NP
O	(	(	(	O
O	p	p	NN	B-NP
O	=	=	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	035	035	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	Assay	Assay	NN	B-NP
O	AUC	AUC	NN	I-NP
O	was	be	VBD	B-VP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	72	72	CD	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	whole	whole	JJ	I-NP
O	urine	urine	NN	I-NP
O	cohort	cohort	JJ	B-ADJP
O	and	and	CC	O
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	67	67	CD	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	combined	combined	JJ	I-NP
O	population	population	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	values	value	NNS	I-NP
O	were	be	VBD	B-VP
O	higher	high	JJR	B-ADJP
O	than	than	IN	B-PP
O	those	those	DT	B-NP
O	of	of	IN	B-PP
B-GGP	prostate	prostate	NN	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	antigen	antigen	NN	I-NP
O	alone	alone	RB	B-ADVP
O	using	use	VBG	B-VP
O	4	4	CD	B-NP
O	.	.	.	O
O	0	0	CD	B-NP
O	ng	ng	NN	I-NP
O	/	/	SYM	B-NP
O	ml	ml	NN	I-NP
O	as	as	IN	B-PP
O	the	the	DT	B-NP
O	cutoff	cutoff	NN	I-NP
O	(	(	(	O
O	p	p	NN	B-NP
O	=	=	SYM	B-VP
O	0	0	CD	B-NP
O	.	.	SYM	I-NP
O	00	00	CD	I-NP
O	and	and	CC	I-NP
O	0	0	CD	I-NP
O	.	.	.	I-NP
O	01	01	CD	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	)	)	)	O
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	assay	assay	NN	I-NP
O	together	together	RB	B-ADVP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	Prostate	Prostate	NNP	I-NP
O	Cancer	Cancer	NNP	I-NP
O	Prevention	Prevention	NNP	I-NP
O	Trial	Trial	NNP	I-NP
O	risk	risk	NN	I-NP
O	calculator	calculator	NN	I-NP
O	or	or	CC	O
O	a	a	DT	B-NP
O	standard	standard	JJ	I-NP
O	nomogram	nomogram	NN	I-NP
O	significantly	significantly	RB	B-ADVP
O	improved	improve	VBD	B-VP
O	AUC	AUC	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	whole	whole	JJ	I-NP
O	urine	urine	NN	I-NP
O	cohort	cohort	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	combined	combine	VBN	I-NP
O	population	population	NN	I-NP
O	vs	vs	IN	B-PP
O	predictive	predictive	JJ	B-NP
O	algorithms	algorithm	NNS	I-NP
O	alone	alone	RB	B-ADVP
O	(	(	(	O
O	p	p	NN	B-NP
O	<	<	SYM	B-ADJP
O	0	0	CD	B-NP
O	.	.	.	I-NP
O	05	05	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	Assay	Assay	NN	B-NP
O	positive	positive	JJ	I-NP
O	predictive	predictive	JJ	I-NP
O	value	value	NN	I-NP
O	was	be	VBD	B-VP
O	54	54	CD	B-NP
O	%	%	NN	I-NP
O	in	in	IN	B-PP
O	whole	whole	JJ	B-NP
O	urine	urine	NN	I-NP
O	cohort	cohort	JJ	B-ADJP
O	with	with	IN	B-PP
B-GGP	prostate	prostate	NN	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	antigen	antigen	NN	I-NP
O	2	2	CD	I-NP
O	.	.	.	I-NP
O	0	0	CD	I-NP
O	to	to	TO	B-PP
O	4	4	CD	B-NP
O	.	.	.	O
O	0	0	CD	B-NP
O	ng	ng	NN	I-NP
O	/	/	SYM	B-NP
O	ml	ml	NN	I-NP
O	and	and	CC	O
O	negative	negative	JJ	B-NP
O	predictive	predictive	JJ	I-NP
O	value	value	NN	I-NP
O	was	be	VBD	B-VP
O	87	87	CD	B-NP
O	%	%	NN	I-NP
O	with	with	IN	B-PP
B-GGP	prostate	prostate	NN	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	antigen	antigen	NN	I-NP
O	4	4	CD	I-NP
O	.	.	.	O
O	1	1	CD	B-NP
O	to	to	TO	B-PP
O	10	10	CD	B-NP
O	.	.	.	O
O	0	0	CD	B-NP
O	ng	ng	NN	I-NP
O	/	/	SYM	B-NP
O	ml	ml	NN	I-NP
O	.	.	.	O

O	Assay	Assay	NN	B-NP
O	positive	positive	JJ	I-NP
O	predictive	predictive	JJ	I-NP
O	value	value	NN	I-NP
O	was	be	VBD	B-VP
O	higher	high	JJR	B-ADJP
O	in	in	IN	B-PP
O	subjects	subject	NNS	B-NP
O	with	with	IN	B-PP
O	all	all	DT	B-NP
O	3	3	CD	I-NP
O	methylation	methylation	NN	I-NP
O	markers	marker	NNS	I-NP
O	positive	positive	JJ	B-ADJP
O	.	.	.	O

O	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	:	:	:	O
O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	investigational	investigational	JJ	I-NP
O	assay	assay	NN	I-NP
O	used	use	VBN	B-VP
O	in	in	IN	B-PP
O	conjunction	conjunction	NN	B-NP
O	with	with	IN	B-PP
O	current	current	JJ	B-NP
O	screening	screening	NN	I-NP
O	algorithms	algorithm	NNS	I-NP
O	may	may	MD	B-VP
O	potentially	potentially	RB	I-VP
O	add	add	VB	I-VP
O	value	value	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	biopsy	biopsy	NN	I-NP
O	decision	decision	NN	I-NP
O	making	making	NN	I-NP
O	process	process	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	HECT	HECT	NN	I-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	E3	E3	NN	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
B-GGP	AIP2	AIP2	NN	I-NP
O	inhibits	inhibit	VBZ	B-VP
O	activation	activation	NN	B-NP
O	-	-	HYPH	O
O	induced	induce	VBN	B-NP
O	T	T	NN	I-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	death	death	NN	I-NP
O	by	by	IN	B-PP
O	catalyzing	catalyze	VBG	B-VP
B-GGP	EGR2	EGR2	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	.	.	.	O

O	E3	E3	NN	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligases	ligas	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	target	target	VBP	B-VP
O	specific	specific	JJ	B-NP
O	molecules	molecule	NNS	I-NP
O	for	for	IN	B-PP
O	proteolytic	proteolytic	JJ	B-NP
O	destruction	destruction	NN	I-NP
O	,	,	,	O
O	have	have	VBP	B-VP
O	emerged	emerge	VBN	I-VP
O	as	as	IN	B-PP
O	key	key	JJ	B-NP
O	regulators	regulator	NNS	I-NP
O	of	of	IN	B-PP
O	immune	immune	JJ	B-NP
O	functions	function	NNS	I-NP
O	.	.	.	O

O	Several	Several	JJ	B-NP
O	E3	E3	NN	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligases	ligas	NNS	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
B-GGP	c	c	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	Cbl	Cbl	NN	I-NP
O	,	,	,	O
B-GGP	Cbl	Cbl	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	b	b	NN	B-NP
O	,	,	,	O
B-GGP	GRAIL	GRAIL	NN	B-NP
O	,	,	,	O
B-GGP	Itch	Itch	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	Nedd4	Nedd4	NN	B-NP
O	,	,	,	O
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	negatively	negatively	RB	I-VP
O	regulate	regulate	VB	I-VP
O	T	T	NN	B-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	activation	activation	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	report	report	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	HECT	HECT	NN	I-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	E3	E3	NN	I-NP
O	ligase	ligase	NN	I-NP
B-GGP	AIP2	AIP2	NN	I-NP
O	positively	positively	RB	B-ADVP
O	regulates	regulate	VBZ	B-VP
O	T	T	NN	B-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	activation	activation	NN	I-NP
O	.	.	.	O

O	Ectopic	Ectopic	JJ	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	AIP2	AIP2	NN	B-NP
O	in	in	IN	B-PP
O	mouse	mouse	NN	B-NP
O	primary	primary	JJ	I-NP
O	T	T	NN	I-NP
O	cells	cell	NNS	I-NP
O	enhances	enhance	VBZ	B-VP
O	their	their	PRP$	B-NP
O	proliferation	proliferation	NN	I-NP
O	and	and	CC	I-NP
B-GGP	interleukin	interleukin	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	2	2	CD	B-NP
O	production	production	NN	I-NP
O	by	by	IN	B-PP
O	suppressing	suppress	VBG	B-VP
O	the	the	DT	B-NP
O	apoptosis	apoptosis	NN	I-NP
O	of	of	IN	B-PP
O	T	T	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

B-GGP	AIP2	AIP2	NN	B-NP
O	interacts	interact	VBZ	B-VP
O	with	with	IN	B-PP
O	and	and	CC	O
O	promotes	promote	VBZ	B-VP
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	degradation	degradation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	EGR2	EGR2	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	zinc	zinc	NN	I-NP
O	finger	finger	NN	I-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
O	that	that	WDT	B-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	found	find	VBN	I-VP
O	to	to	TO	I-VP
O	regulate	regulate	VB	I-VP
B-GGP	Fas	Fas	NN	B-NP
I-GGP	ligand	ligand	NN	I-NP
O	(	(	(	O
B-GGP	FasL	FasL	NN	B-NP
O	)	)	)	O
O	expression	expression	NN	B-NP
O	during	during	IN	B-PP
O	activation	activation	NN	B-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	T	T	NN	I-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	death	death	NN	I-NP
O	.	.	.	O

O	Suppression	Suppression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	AIP2	AIP2	NN	B-NP
O	expression	expression	NN	I-NP
O	by	by	IN	B-PP
O	small	small	JJ	B-NP
O	RNA	RNA	NN	I-NP
O	interference	interference	NN	I-NP
O	upregulates	upregulate	VBZ	B-VP
B-GGP	EGR2	EGR2	NN	B-NP
O	,	,	,	O
O	inhibits	inhibit	VBZ	B-VP
B-GGP	EGR2	EGR2	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	O
B-GGP	FasL	FasL	NN	B-NP
O	expression	expression	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	enhances	enhance	VBZ	B-VP
O	the	the	DT	B-NP
O	apoptosis	apoptosis	NN	I-NP
O	of	of	IN	B-PP
O	T	T	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Therefore	Therefore	RB	B-ADVP
O	,	,	,	O
B-GGP	AIP2	AIP2	NN	B-NP
O	regulates	regulate	VBZ	B-VP
O	activation	activation	NN	B-NP
O	-	-	HYPH	O
O	induced	induce	VBN	B-NP
O	T	T	NN	I-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	death	death	NN	I-NP
O	by	by	IN	B-PP
O	suppressing	suppress	VBG	B-VP
B-GGP	EGR2	EGR2	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
B-GGP	FasL	FasL	NN	I-NP
O	expression	expression	NN	I-NP
O	via	via	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

O	Linking	Link	VBG	B-VP
O	cell	cell	NN	B-NP
O	cycle	cycle	NN	I-NP
O	to	to	TO	B-PP
B-GGP	histone	histone	NN	B-NP
O	modifications	modification	NNS	I-NP
O	:	:	:	O
O	SBF	SBF	NN	B-NP
O	and	and	CC	I-NP
B-GGP	H2B	H2B	NN	I-NP
O	monoubiquitination	monoubiquitination	NN	I-NP
O	machinery	machinery	NN	I-NP
O	and	and	CC	I-NP
O	cell	cell	NN	I-NP
O	-	-	HYPH	B-NP
O	cycle	cycle	NN	I-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	H3K79	H3K79	NN	B-NP
O	dimethylation	dimethylation	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	identify	identify	VB	I-VP
O	regulators	regulator	NNS	B-NP
O	involved	involve	VBN	B-VP
O	in	in	IN	B-PP
O	determining	determine	VBG	B-VP
O	the	the	DT	B-NP
O	differential	differential	JJ	I-NP
O	pattern	pattern	NN	I-NP
O	of	of	IN	B-PP
B-GGP	H3K79	H3K79	NN	B-NP
O	methylation	methylation	NN	I-NP
O	by	by	IN	B-PP
B-GGP	Dot1	Dot1	NN	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	screened	screen	VBD	B-VP
O	the	the	DT	B-NP
O	entire	entire	JJ	I-NP
O	yeast	yeast	NN	I-NP
O	gene	gene	NN	I-NP
O	deletion	deletion	NN	I-NP
O	collection	collection	NN	I-NP
O	by	by	IN	B-PP
O	GPS	GPS	NN	B-NP
O	for	for	IN	B-PP
O	genes	gene	NNS	B-NP
O	required	require	VBN	B-VP
O	for	for	IN	B-PP
O	normal	normal	JJ	B-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	H3K79	H3K79	NN	B-NP
O	di	di	AFX	O
O	-	-	HYPH	B-NP
O	but	but	CC	B-NP
O	not	not	RB	I-NP
O	trimethylation	trimethylation	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	identified	identify	VBD	B-VP
O	the	the	DT	B-NP
O	cell	cell	NN	I-NP
O	cycle	cycle	NN	I-NP
O	-	-	HYPH	B-NP
O	regulated	regulate	VBN	I-NP
O	SBF	SBF	NN	I-NP
O	protein	protein	NN	I-NP
O	complex	complex	NN	I-NP
O	required	require	VBN	B-VP
O	for	for	IN	B-PP
B-GGP	H3K79	H3K79	NN	B-NP
O	dimethylation	dimethylation	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	also	also	RB	B-ADVP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	H3K79	H3K79	NN	B-NP
O	di	di	AFX	O
O	-	-	HYPH	O
O	and	and	CC	O
O	trimethylation	trimethylation	NN	B-NP
O	are	be	VBP	B-VP
O	mutually	mutually	RB	B-ADJP
O	exclusive	exclusive	JJ	I-ADJP
O	,	,	,	O
O	with	with	IN	B-PP
O	M	M	NN	B-NP
O	/	/	SYM	O
O	G1	G1	NN	B-NP
O	cell	cell	NN	I-NP
O	cycle	cycle	NN	I-NP
O	-	-	HYPH	B-NP
O	regulated	regulate	VBN	I-NP
O	genes	gene	NNS	I-NP
O	significantly	significantly	RB	B-VP
O	enriched	enrich	VBN	I-VP
O	for	for	IN	B-PP
B-GGP	H3K79	H3K79	NN	B-NP
O	dimethylation	dimethylation	NN	I-NP
O	.	.	.	O

O	Since	Since	IN	B-SBAR
B-GGP	H3K79	H3K79	NN	B-NP
O	trimethylation	trimethylation	NN	I-NP
O	requires	require	VBZ	B-VP
O	prior	prior	JJ	B-NP
O	monoubiquitination	monoubiquitination	NN	I-NP
O	of	of	IN	B-PP
B-GGP	H2B	H2B	NN	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	performed	perform	VBD	B-VP
O	genome	genome	NN	B-NP
O	-	-	HYPH	B-NP
O	wide	wide	JJ	I-NP
O	profiling	profiling	NN	I-NP
O	of	of	IN	B-PP
B-GGP	H2BK123	H2BK123	NN	B-NP
O	monoubiquitination	monoubiquitination	NN	I-NP
O	and	and	CC	O
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	H2BK123	H2BK123	NN	B-NP
O	monoubiquitination	monoubiquitination	NN	I-NP
O	is	be	VBZ	B-VP
O	not	not	RB	I-VP
O	detected	detect	VBN	I-VP
O	on	on	IN	B-PP
O	cell	cell	NN	B-NP
O	cycle	cycle	NN	I-NP
O	-	-	HYPH	B-NP
O	regulated	regulate	VBN	I-NP
O	genes	gene	NNS	I-NP
O	and	and	CC	I-NP
O	sites	site	NNS	I-NP
O	containing	contain	VBG	B-VP
B-GGP	H3K79me2	H3K79me2	NN	B-NP
O	,	,	,	O
O	but	but	CC	O
O	is	be	VBZ	B-VP
O	found	find	VBN	I-VP
O	on	on	IN	B-PP
B-GGP	H3K79me3	H3K79me3	NN	B-NP
O	-	-	HYPH	O
O	containing	contain	VBG	B-VP
O	regions	region	NNS	B-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	screen	screen	NN	I-NP
O	for	for	IN	B-PP
O	genes	gene	NNS	B-NP
O	responsible	responsible	JJ	B-ADJP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	establishment	establishment	NN	I-NP
O	/	/	SYM	B-NP
O	removal	removal	NN	I-NP
O	of	of	IN	B-PP
B-GGP	H3K79	H3K79	NN	B-NP
O	dimethylation	dimethylation	NN	I-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	identification	identification	NN	B-NP
O	of	of	IN	B-PP
B-GGP	NRM1	NRM1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	WHI3	WHI3	NN	I-NP
O	,	,	,	O
O	both	both	DT	B-NP
O	of	of	IN	B-PP
O	which	which	WDT	B-NP
O	impact	impact	VBP	B-VP
O	the	the	DT	B-NP
O	transcription	transcription	NN	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	SBF	SBF	NN	I-NP
O	and	and	CC	I-NP
O	MBF	MBF	NN	I-NP
O	protein	protein	NN	I-NP
O	complexes	complex	NNS	I-NP
O	,	,	,	O
O	further	further	RB	B-VP
O	linking	link	VBG	I-VP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	methylation	methylation	NN	B-NP
O	status	status	NN	I-NP
O	of	of	IN	B-PP
B-GGP	H3K79	H3K79	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	cell	cell	NN	I-NP
O	cycle	cycle	NN	I-NP
O	.	.	.	O

O	Absence	Absence	NN	B-NP
O	of	of	IN	B-PP
O	ubiquitinated	ubiquitinate	VBN	B-NP
O	inclusions	inclusion	NNS	I-NP
O	in	in	IN	B-PP
B-GGP	hypocretin	hypocretin	NN	B-NP
O	neurons	neuron	NNS	I-NP
O	of	of	IN	B-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
O	narcolepsy	narcolepsy	NN	B-NP
O	.	.	.	O

O	OBJECTIVES	OBJECTIVES	NNS	B-NP
O	:	:	:	O
O	The	The	DT	B-NP
O	cause	cause	NN	I-NP
O	of	of	IN	B-PP
B-GGP	hypocretin	hypocretin	NN	B-NP
O	cell	cell	NN	I-NP
O	loss	loss	NN	I-NP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	narcolepsy	narcolepsy	NN	I-NP
O	-	-	HYPH	O
O	cataplexy	cataplexy	NN	B-NP
O	is	be	VBZ	B-VP
O	unknown	unknown	JJ	B-ADJP
O	but	but	CC	O
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	suggested	suggest	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	neurodegenerative	neurodegenerative	JJ	B-ADJP
O	in	in	IN	B-PP
O	nature	nature	NN	B-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	test	test	VB	I-VP
O	this	this	DT	B-NP
O	hypothesis	hypothesis	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	evaluated	evaluate	VBD	B-VP
O	the	the	DT	B-NP
O	remaining	remain	VBG	I-NP
B-GGP	hypocretin	hypocretin	NN	I-NP
O	cells	cell	NNS	I-NP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	narcolepsy	narcolepsy	NN	I-NP
O	brains	brain	NNS	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	aggregated	aggregated	JJ	B-NP
O	protein	protein	NN	I-NP
O	inclusions	inclusion	NNS	I-NP
O	,	,	,	O
O	gliosis	gliosis	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	inflammation	inflammation	NN	B-NP
O	.	.	.	O

O	METHODS	METHODS	NNS	B-NP
O	:	:	:	O
O	Brains	Brain	NNS	B-NP
O	were	be	VBD	B-VP
O	examined	examine	VBN	I-VP
O	by	by	IN	B-PP
O	routine	routine	JJ	B-NP
O	histologic	histologic	JJ	I-NP
O	methods	method	NNS	I-NP
O	for	for	IN	B-PP
O	potential	potential	JJ	B-NP
O	comorbid	comorbid	JJ	I-NP
O	neurodegenerative	neurodegenerative	JJ	I-NP
O	diseases	disease	NNS	I-NP
O	and	and	CC	B-PP
O	through	through	IN	B-PP
O	immunohistochemical	immunohistochemical	JJ	B-NP
O	screening	screening	NN	I-NP
O	for	for	IN	B-PP
O	protein	protein	NN	B-NP
O	inclusions	inclusion	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	hypothalamus	hypothalamus	NN	I-NP
O	.	.	.	O

O	Hypothalamic	Hypothalamic	JJ	B-NP
O	sections	section	NNS	I-NP
O	of	of	IN	B-PP
O	4	4	CD	B-NP
O	subjects	subject	NNS	I-NP
O	with	with	IN	B-PP
O	narcolepsy	narcolepsy	NN	B-NP
O	and	and	CC	O
O	5	5	CD	B-NP
O	nonneurologic	nonneurologic	JJ	I-NP
O	controls	control	NNS	I-NP
O	were	be	VBD	B-VP
O	examined	examine	VBN	I-VP
O	immunohistochemically	immunohistochemically	RB	B-ADVP
O	with	with	IN	B-PP
O	antibodies	antibody	NNS	B-NP
O	against	against	IN	B-PP
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	(	(	(	O
O	a	a	DT	B-NP
O	marker	marker	NN	I-NP
O	of	of	IN	B-PP
O	aggregated	aggregated	JJ	B-NP
O	protein	protein	NN	I-NP
O	)	)	)	O
O	,	,	,	O
B-GGP	allograft	allograft	NN	B-NP
I-GGP	inflammatory	inflammatory	JJ	I-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
B-GGP	AIF1	AIF1	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	microglial	microglial	JJ	I-NP
O	activation	activation	NN	I-NP
O	marker	marker	NN	I-NP
O	)	)	)	O
O	,	,	,	O
B-GGP	glial	glial	JJ	B-NP
I-GGP	fibrillary	fibrillary	JJ	I-NP
I-GGP	acidic	acidic	JJ	I-NP
I-GGP	protein	protein	NN	I-NP
O	(	(	(	O
B-GGP	GFAP	GFAP	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	reactive	reactive	JJ	I-NP
O	astrocytic	astrocytic	JJ	I-NP
O	marker	marker	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
B-GGP	hypocretin	hypocretin	NN	B-NP
O	.	.	.	O

O	Hypothalami	Hypothalami	NN	B-NP
O	of	of	IN	B-PP
O	subjects	subject	NNS	B-NP
O	with	with	IN	B-PP
O	narcolepsy	narcolepsy	NN	B-NP
O	were	be	VBD	B-VP
O	additionally	additionally	RB	I-VP
O	examined	examine	VBN	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	known	known	JJ	B-NP
O	components	component	NNS	I-NP
O	of	of	IN	B-PP
O	protein	protein	NN	B-NP
O	aggregates	aggregate	NNS	I-NP
O	(	(	(	O
B-GGP	tau	tau	SYM	B-NP
O	,	,	,	O
B-GGP	alpha	alpha	SYM	O
I-GGP	-	-	HYPH	O
I-GGP	synuclein	synuclein	NN	B-NP
O	,	,	,	O
B-GGP	amyloid	amyloid	JJ	B-NP
I-GGP	beta	beta	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	TDP	TDP	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	43	43	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	RESULTS	RESULTS	NNS	B-NP
O	:	:	:	O
B-GGP	Hypocretin	Hypocretin	NN	B-NP
O	cells	cell	NNS	I-NP
O	were	be	VBD	B-VP
O	markedly	markedly	RB	I-VP
O	decreased	decrease	VBN	I-VP
O	in	in	IN	B-PP
O	all	all	DT	B-NP
O	4	4	CD	I-NP
O	subjects	subject	NNS	I-NP
O	with	with	IN	B-PP
O	narcolepsy	narcolepsy	NN	B-NP
O	.	.	.	O

O	Ubiquitinated	Ubiquitinate	VBN	B-NP
O	inclusions	inclusion	NNS	I-NP
O	were	be	VBD	B-VP
O	not	not	RB	I-VP
O	observed	observe	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	total	total	NN	I-NP
O	of	of	IN	B-PP
O	96	96	CD	B-NP
O	remaining	remain	VBG	I-NP
B-GGP	hypocretin	hypocretin	NN	I-NP
O	cells	cell	NNS	I-NP
O	in	in	IN	B-PP
O	these	these	DT	B-NP
O	subjects	subject	NNS	I-NP
O	.	.	.	O

O	Further	Further	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	noted	note	VBD	B-VP
O	that	that	IN	B-SBAR
O	even	even	RB	B-PP
O	in	in	IN	I-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
O	dementia	dementia	NN	B-NP
O	neuropathology	neuropathology	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	lateral	lateral	JJ	I-NP
O	hypothalamic	hypothalamic	JJ	I-NP
B-GGP	hypocretin	hypocretin	NN	I-NP
O	area	area	NN	I-NP
O	was	be	VBD	B-VP
O	spared	spar	VBN	I-VP
O	from	from	IN	B-PP
O	ubiquitinated	ubiquitinate	VBN	B-NP
O	inclusions	inclusion	NNS	I-NP
O	.	.	.	O

B-GGP	AIF1	AIF1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	GFAP	GFAP	NN	I-NP
O	staining	staining	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	perifornical	perifornical	JJ	I-NP
O	area	area	NN	I-NP
O	was	be	VBD	B-VP
O	unremarkable	unremarkable	JJ	B-ADJP
O	.	.	.	O

O	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	:	:	:	O
O	Our	Our	PRP$	B-NP
O	findings	finding	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	hypocretin	hypocretin	NN	B-NP
O	cell	cell	NN	I-NP
O	loss	loss	NN	I-NP
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	involve	involve	VB	I-VP
O	ubiquitinated	ubiquitinate	VBN	B-NP
O	inclusions	inclusion	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	hallmark	hallmark	NN	I-NP
O	of	of	IN	B-PP
O	most	most	JJS	B-NP
O	neurodegenerative	neurodegenerative	JJ	I-NP
O	diseases	disease	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	lack	lack	NN	I-NP
O	of	of	IN	B-PP
O	increased	increase	VBN	B-NP
O	markers	marker	NNS	I-NP
O	of	of	IN	B-PP
O	inflammation	inflammation	NN	B-NP
O	also	also	RB	B-ADVP
O	argues	argue	VBZ	B-VP
O	against	against	IN	B-PP
O	a	a	DT	B-NP
O	progressive	progressive	JJ	I-NP
O	and	and	CC	I-NP
O	continuous	continuous	JJ	I-NP
O	neurodegenerative	neurodegenerative	JJ	I-NP
O	process	process	NN	I-NP
O	.	.	.	O

O	Structural	Structural	JJ	B-NP
O	basis	basis	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	lack	lack	NN	I-NP
O	of	of	IN	B-PP
O	E2	E2	NN	B-NP
O	interaction	interaction	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	RING	RING	NN	I-NP
O	domain	domain	NN	I-NP
O	of	of	IN	B-PP
B-GGP	TRAF2	TRAF2	NN	B-NP
O	.	.	.	O

O	TRAF	TRAF	NN	B-NP
O	proteins	protein	NNS	I-NP
O	are	be	VBP	B-VP
O	intracellular	intracellular	JJ	B-NP
O	signal	signal	NN	I-NP
O	transducers	transducer	NNS	I-NP
O	for	for	IN	B-PP
O	a	a	DT	B-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	immune	immune	JJ	B-NP
O	receptor	receptor	NN	I-NP
O	superfamilies	superfamily	NNS	I-NP
O	.	.	.	O

O	Specifically	Specifically	RB	B-ADVP
O	,	,	,	O
B-GGP	TRAF2	TRAF2	NN	B-NP
O	interacts	interact	VBZ	B-VP
O	with	with	IN	B-PP
O	members	member	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	TNF	TNF	NN	I-NP
O	receptor	receptor	NN	I-NP
O	superfamily	superfamily	NN	I-NP
O	and	and	CC	O
O	connects	connect	VBZ	B-VP
O	the	the	DT	B-NP
O	receptors	receptor	NNS	I-NP
O	to	to	TO	B-PP
O	downstream	downstream	JJ	B-NP
O	signaling	signaling	NN	I-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	assumed	assume	VBN	I-VP
O	that	that	IN	B-SBAR
B-GGP	TRAF2	TRAF2	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	like	like	IN	B-PP
B-GGP	TRAF6	TRAF6	NN	B-NP
O	and	and	CC	O
O	mediates	mediate	VBZ	B-VP
O	K63	K63	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	polyubiquitination	polyubiquitination	NN	I-NP
O	of	of	IN	B-PP
B-GGP	RIP1	RIP1	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	kinase	kinase	NN	I-NP
O	pivotal	pivotal	NN	I-NP
O	in	in	IN	B-PP
B-GGP	TNFalpha	TNFalpha	NN	B-NP
O	-	-	HYPH	O
O	induced	induce	VBN	B-NP
O	NF	NF	NN	I-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	activation	activation	NN	I-NP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	we	we	PRP	B-NP
O	report	report	VBP	B-VP
O	the	the	DT	B-NP
O	crystal	crystal	JJ	I-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	RING	RING	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	zinc	zinc	NN	I-NP
O	finger	finger	NN	I-NP
O	domains	domain	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	TRAF2	TRAF2	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
B-GGP	TRAF2	TRAF2	NN	I-NP
O	RING	RING	NN	I-NP
O	structure	structure	NN	I-NP
O	is	be	VBZ	B-VP
O	very	very	RB	B-ADJP
O	different	different	JJ	I-ADJP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	known	know	VBN	I-NP
B-GGP	TRAF6	TRAF6	NN	I-NP
O	RING	RING	NN	I-NP
O	structure	structure	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	differences	difference	NNS	I-NP
O	are	be	VBP	B-VP
O	multifaceted	multifacete	VBN	I-VP
O	,	,	,	O
O	including	include	VBG	B-PP
O	amino	amino	JJ	B-NP
O	acid	acid	NN	I-NP
O	differences	difference	NNS	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	critical	critical	JJ	I-NP
B-GGP	Ubc13	Ubc13	NN	I-NP
O	-	-	HYPH	O
O	interacting	interact	VBG	B-VP
O	site	site	NN	B-NP
O	,	,	,	O
O	local	local	JJ	B-NP
O	conformational	conformational	JJ	I-NP
O	differences	difference	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	a	a	DT	B-NP
O	unique	unique	JJ	I-NP
O	nine	nine	CD	I-NP
O	-	-	HYPH	I-NP
O	residue	residue	NN	I-NP
O	insertion	insertion	NN	I-NP
O	between	between	IN	B-PP
O	the	the	DT	B-NP
O	RING	RING	NN	I-NP
O	domain	domain	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	zinc	zinc	NN	I-NP
O	finger	finger	NN	I-NP
O	in	in	IN	B-PP
B-GGP	TRAF2	TRAF2	NN	B-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	structural	structural	JJ	I-NP
O	differences	difference	NNS	I-NP
O	prevent	prevent	VBP	B-VP
B-GGP	TRAF2	TRAF2	NN	B-NP
O	from	from	IN	B-PP
O	interacting	interact	VBG	B-VP
O	with	with	IN	B-PP
B-GGP	Ubc13	Ubc13	NN	B-NP
O	and	and	CC	O
O	other	other	JJ	B-NP
O	related	related	JJ	I-NP
O	E2s	E2	NNS	I-NP
O	via	via	IN	B-PP
O	steric	steric	JJ	B-NP
O	clash	clash	NN	I-NP
O	and	and	CC	O
O	unfavorable	unfavorable	JJ	B-NP
O	interfaces	interface	NNS	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	structural	structural	JJ	I-NP
O	observation	observation	NN	I-NP
O	should	should	MD	B-VP
O	prompt	prompt	VB	I-VP
O	a	a	DT	B-NP
O	re	re	AFX	I-NP
O	-	-	HYPH	I-NP
O	evaluation	evaluation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
B-GGP	TRAF2	TRAF2	NN	B-NP
O	in	in	IN	B-PP
B-GGP	TNFalpha	TNFalpha	NN	B-NP
O	signaling	signaling	NN	I-NP
O	and	and	CC	O
O	may	may	MD	B-VP
O	indicate	indicate	VB	I-VP
O	that	that	IN	B-SBAR
B-GGP	TRAF2	TRAF2	NN	B-NP
O	-	-	HYPH	B-NP
O	associated	associate	VBN	I-NP
O	proteins	protein	NNS	I-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	cIAPs	cIAP	NNS	B-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	the	the	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligases	ligas	NNS	I-NP
O	for	for	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	I-NP
O	kappaB	kappaB	NN	I-NP
O	signaling	signaling	NN	I-NP
O	.	.	.	O

O	Changes	Change	NNS	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	allelic	allelic	JJ	I-NP
O	methylation	methylation	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	c	c	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	H	H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	ras	ras	NN	I-NP
I-GGP	-	-	SYM	I-NP
I-GGP	1	1	CD	I-NP
O	,	,	,	I-NP
B-GGP	insulin	insulin	NN	I-NP
O	and	and	CC	I-NP
B-GGP	retinoblastoma	retinoblastoma	NN	I-NP
O	genes	gene	NNS	I-NP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	development	development	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	methylation	methylation	NN	I-NP
O	status	status	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	c	c	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	H	H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	ras	ras	NN	I-NP
I-GGP	-	-	SYM	I-NP
I-GGP	1	1	CD	I-NP
O	,	,	,	I-NP
B-GGP	insulin	insulin	NN	I-NP
O	and	and	CC	I-NP
B-GGP	retinoblastoma	retinoblastoma	NN	I-NP
O	genes	gene	NNS	I-NP
O	was	be	VBD	B-VP
O	determined	determine	VBN	I-VP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	sperm	sperm	NN	I-NP
O	,	,	,	O
O	hydatidiform	hydatidiform	NN	B-NP
O	mole	mole	NN	I-NP
O	,	,	,	O
O	fetal	fetal	JJ	B-NP
O	tissues	tissue	NNS	I-NP
O	,	,	,	O
O	adult	adult	JJ	B-NP
O	lymphocytes	lymphocyte	NNS	I-NP
O	and	and	CC	O
O	adult	adult	JJ	B-NP
O	kidney	kidney	NN	I-NP
O	.	.	.	O

O	Individual	Individual	JJ	B-NP
O	alleles	allele	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	c	c	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	H	H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	ras	ras	NN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	1	1	CD	I-NP
O	and	and	CC	O
B-GGP	insulin	insulin	NN	B-NP
O	were	be	VBD	B-VP
O	distinguishable	distinguishable	JJ	B-ADJP
O	due	due	JJ	B-PP
O	to	to	TO	B-PP
O	presence	presence	NN	B-NP
O	of	of	IN	B-PP
O	endogenous	endogenous	JJ	B-NP
O	variable	variable	JJ	I-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	tandem	tandem	JJ	B-NP
O	repeat	repeat	NN	I-NP
O	(	(	(	O
O	VNTR	VNTR	NN	B-NP
O	)	)	)	O
O	polymorphisms	polymorphism	NNS	B-NP
O	.	.	.	O

O	Both	Both	DT	B-NP
O	alleles	allele	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	latter	latter	JJ	I-NP
O	two	two	CD	I-NP
O	genes	gene	NNS	I-NP
O	were	be	VBD	B-VP
O	extensively	extensively	RB	I-VP
O	methylated	methylate	VBN	I-VP
O	in	in	IN	B-PP
O	sperm	sperm	NN	B-NP
O	compared	compare	VBN	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	other	other	JJ	I-NP
O	tissues	tissue	NNS	I-NP
O	.	.	.	O

O	Several	Several	JJ	B-NP
O	sites	site	NNS	I-NP
O	within	within	IN	B-PP
O	these	these	DT	B-NP
O	genes	gene	NNS	I-NP
O	were	be	VBD	B-VP
O	less	less	RBR	B-ADJP
O	methylated	methylate	VBN	I-ADJP
O	in	in	IN	B-PP
O	fetal	fetal	JJ	B-NP
O	tissues	tissue	NNS	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	alleles	allele	NNS	I-NP
O	were	be	VBD	B-VP
O	differentially	differentially	RB	I-VP
O	methylated	methylate	VBN	I-VP
O	in	in	IN	B-PP
O	some	some	DT	B-NP
O	cases	case	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	retinoblastoma	retinoblastoma	NN	I-NP
O	gene	gene	NN	I-NP
O	was	be	VBD	B-VP
O	highly	highly	RB	I-VP
O	methylated	methylate	VBN	I-VP
O	in	in	IN	B-PP
O	all	all	DT	B-NP
O	tissues	tissue	NNS	I-NP
O	examined	examine	VBN	B-VP
O	,	,	,	O
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	exception	exception	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	single	single	JJ	I-NP
O	site	site	NN	I-NP
O	that	that	WDT	B-NP
O	was	be	VBD	B-VP
O	under	under	IN	B-PP
O	-	-	HYPH	B-NP
O	methylated	methylate	VBN	B-VP
O	in	in	IN	B-PP
O	sperm	sperm	NN	B-NP
O	only	only	RB	B-ADVP
O	.	.	.	O

O	The	The	DT	B-NP
O	sperm	sperm	NN	I-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	methylation	methylation	NN	I-NP
O	patterns	pattern	NNS	I-NP
O	in	in	IN	B-PP
O	all	all	DT	B-NP
O	three	three	CD	I-NP
O	genes	gene	NNS	I-NP
O	could	could	MD	B-VP
O	represent	represent	VB	I-VP
O	imprinting	imprinting	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	parental	parental	JJ	I-NP
O	chromosomes	chromosome	NNS	I-NP
O	.	.	.	O

O	Since	Since	IN	B-SBAR
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	methylcytosine	methylcytosine	NN	I-NP
O	is	be	VBZ	B-VP
O	inherently	inherently	RB	B-ADJP
O	mutagenic	mutagenic	JJ	I-ADJP
O	,	,	,	O
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	possible	possible	JJ	B-ADJP
O	that	that	IN	B-SBAR
O	methylation	methylation	NN	B-NP
O	imprinting	imprinting	NN	I-NP
O	could	could	MD	B-VP
O	alter	alter	VB	I-VP
O	the	the	DT	B-NP
O	susceptibilities	susceptibility	NNS	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	genes	gene	NNS	I-NP
O	to	to	TO	B-PP
O	point	point	NN	B-NP
O	mutations	mutation	NNS	I-NP
O	.	.	.	O

O	Screening	Screening	NN	B-NP
O	for	for	IN	B-PP
O	OST	OST	NN	B-NP
O	deficiencies	deficiency	NNS	I-NP
O	in	in	IN	B-PP
O	unsolved	unsolved	JJ	B-NP
O	CDG	CDG	NN	I-NP
O	-	-	HYPH	B-NP
O	I	I	NN	I-NP
O	patients	patient	NNS	I-NP
O	.	.	.	O

O	Congenital	Congenital	JJ	B-NP
O	Disorders	Disorder	NNS	I-NP
O	of	of	IN	B-PP
O	Glycosylation	Glycosylation	NN	B-NP
O	(	(	(	O
O	CDG	CDG	NN	B-NP
O	)	)	)	O
O	are	be	VBP	B-VP
O	a	a	DT	B-NP
O	group	group	NN	I-NP
O	of	of	IN	B-PP
O	inherited	inherit	VBN	B-NP
O	disorders	disorder	NNS	I-NP
O	caused	cause	VBN	B-VP
O	by	by	IN	B-PP
O	deficiencies	deficiency	NNS	B-NP
O	in	in	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	.	.	.	O

O	Since	Since	IN	B-PP
O	1980	1980	CD	B-NP
O	,	,	,	O
O	14	14	CD	B-NP
O	CDG	CDG	NN	I-NP
O	type	type	NN	I-NP
O	I	I	CD	I-NP
O	(	(	(	O
O	CDG	CDG	NN	B-NP
O	-	-	HYPH	B-NP
O	I	I	NN	I-NP
O	)	)	)	O
O	defects	defect	NNS	B-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	identified	identify	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	endoplasmic	endoplasmic	JJ	I-NP
O	reticulum	reticulum	NN	I-NP
O	,	,	,	O
O	all	all	DT	B-NP
O	affecting	affect	VBG	B-VP
O	the	the	DT	B-NP
O	assembly	assembly	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	oligosaccharide	oligosaccharide	NN	I-NP
O	precursor	precursor	NN	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	unsolved	unsolved	JJ	B-NP
O	CDG	CDG	NN	I-NP
O	-	-	HYPH	B-NP
O	I	I	NN	I-NP
O	(	(	(	O
O	CDG	CDG	NN	B-NP
O	-	-	HYPH	O
O	Ix	Ix	NN	B-NP
O	)	)	)	O
O	patients	patient	NNS	B-NP
O	displaying	display	VBG	B-VP
O	protein	protein	NN	B-NP
O	hypoglycosylation	hypoglycosylation	NN	I-NP
O	in	in	IN	B-PP
O	combination	combination	NN	B-NP
O	with	with	IN	B-PP
O	an	an	DT	B-NP
O	apparently	apparently	RB	I-NP
O	normal	normal	JJ	I-NP
O	assembly	assembly	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	oligosaccharide	oligosaccharide	NN	I-NP
O	precursor	precursor	NN	I-NP
O	is	be	VBZ	B-VP
O	currently	currently	RB	I-VP
O	expanding	expand	VBG	I-VP
O	.	.	.	O

O	We	We	PRP	B-NP
O	hypothesized	hypothesize	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	hypoglycosylation	hypoglycosylation	NN	I-NP
O	observed	observe	VBN	B-VP
O	in	in	IN	B-PP
O	some	some	DT	B-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	patients	patient	NNS	I-NP
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	caused	cause	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	deficiency	deficiency	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	transfer	transfer	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	oligosaccharide	oligosaccharide	NN	I-NP
O	precursor	precursor	NN	I-NP
O	onto	onto	IN	B-PP
O	protein	protein	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	reaction	reaction	NN	I-NP
O	catalyzed	catalyze	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	oligosaccharyltransferase	oligosaccharyltransferase	NN	I-NP
O	(	(	(	O
O	OST	OST	NN	B-NP
O	)	)	)	O
O	complex	complex	NN	B-NP
O	.	.	.	O

O	For	For	IN	B-PP
O	this	this	DT	B-NP
O	purpose	purpose	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	different	different	JJ	I-NP
O	subunits	subunit	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	OST	OST	NN	I-NP
O	complex	complex	NN	I-NP
O	were	be	VBD	B-VP
O	screened	screen	VBN	I-VP
O	in	in	IN	B-PP
O	27	27	CD	B-NP
O	CDG	CDG	NN	I-NP
O	-	-	HYPH	O
O	Ix	Ix	NN	B-NP
O	patients	patient	NNS	I-NP
O	for	for	IN	B-PP
O	whom	whom	WP	B-NP
O	structural	structural	JJ	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	lipid	lipid	NN	I-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	oligosaccharides	oligosaccharide	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	a	a	DT	B-NP
O	normal	normal	JJ	I-NP
O	level	level	NN	I-NP
O	and	and	CC	O
O	intact	intact	JJ	B-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	oligosaccharide	oligosaccharide	NN	I-NP
O	precursor	precursor	NN	I-NP
O	.	.	.	O

O	Among	Among	IN	B-PP
O	these	these	DT	B-NP
O	27	27	CD	I-NP
O	patients	patient	NNS	I-NP
O	,	,	,	O
O	one	one	CD	B-NP
O	was	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	homozygous	homozygous	JJ	I-NP
O	missense	missense	JJ	I-NP
O	mutation	mutation	NN	I-NP
O	(	(	(	O
O	c	c	NN	B-NP
O	.	.	.	O
O	1121G	1121G	NN	B-NP
O	>	>	JJ	I-NP
O	A	A	NN	I-NP
O	;	;	:	O
O	p	p	NN	B-NP
O	.	.	.	O
O	G374D	G374D	NN	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ribophorin	ribophorin	NN	I-NP
I-GGP	2	2	CD	I-NP
O	(	(	(	O
B-GGP	RPN2	RPN2	NN	B-NP
O	)	)	)	O
O	subunit	subunit	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	OST	OST	NN	I-NP
O	complex	complex	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	pathogenic	pathogenic	JJ	I-NP
O	nature	nature	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	mutation	mutation	NN	I-NP
O	remains	remain	VBZ	B-VP
O	unproven	unproven	JJ	B-ADJP
O	due	due	IN	B-PP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	complexity	complexity	NN	I-NP
O	of	of	IN	B-PP
O	tackling	tackle	VBG	B-VP
O	a	a	DT	B-NP
O	possible	possible	JJ	I-NP
O	OST	OST	NN	I-NP
O	defect	defect	NN	I-NP
O	.	.	.	O

B-GGP	MdmX	MdmX	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	substrate	substrate	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	deubiquitinating	deubiquitinate	VBG	I-NP
O	enzyme	enzyme	NN	I-NP
B-GGP	USP2a	USP2a	NN	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	has	have	VBZ	B-VP
O	previously	previously	RB	I-VP
O	been	be	VBN	I-VP
O	shown	show	VBN	I-VP
O	that	that	IN	B-SBAR
B-GGP	ubiquitin	ubiquitin	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	specific	specific	JJ	I-NP
I-GGP	protease	protease	NN	I-NP
I-GGP	2a	2a	NN	I-NP
O	(	(	(	O
B-GGP	USP2a	USP2a	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	regulator	regulator	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	Mdm2	Mdm2	NN	I-NP
O	/	/	SYM	B-NP
B-GGP	p53	p53	NN	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

B-GGP	USP2a	USP2a	NN	B-NP
O	binds	bind	VBZ	B-VP
O	to	to	TO	B-PP
B-GGP	Mdm2	Mdm2	NN	B-NP
O	and	and	CC	O
O	can	can	MD	B-VP
O	deubiquitinate	deubiquitinate	VB	I-VP
B-GGP	Mdm2	Mdm2	NN	B-NP
O	without	without	IN	B-PP
O	reversing	reverse	VBG	B-VP
B-GGP	Mdm2	Mdm2	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
B-GGP	p53	p53	NN	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	.	.	.	O

O	Overexpression	Overexpression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	USP2a	USP2a	NN	B-NP
O	causes	cause	VBZ	B-VP
O	accumulation	accumulation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	Mdm2	Mdm2	NN	B-NP
O	and	and	CC	O
O	promotes	promote	VBZ	B-VP
B-GGP	p53	p53	NN	B-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	now	now	RB	B-ADVP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	MdmX	MdmX	NN	B-NP
O	is	be	VBZ	B-VP
O	also	also	RB	B-ADVP
O	a	a	DT	B-NP
O	substrate	substrate	NN	I-NP
O	for	for	IN	B-PP
B-GGP	USP2a	USP2a	NNP	B-NP
O	.	.	.	O

O	MdmX	MdmX	NN	B-NP
O	associates	associate	VBZ	B-VP
O	with	with	IN	B-PP
B-GGP	USP2a	USP2a	NN	B-NP
O	independently	independently	RB	B-ADVP
O	of	of	IN	B-PP
B-GGP	Mdm2	Mdm2	NN	B-NP
O	.	.	.	O

O	Ectopic	Ectopic	JJ	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	wild	wild	JJ	B-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
B-GGP	USP2a	USP2a	NN	I-NP
O	but	but	CC	B-CONJP
O	not	not	RB	I-CONJP
O	a	a	DT	B-NP
O	catalytic	catalytic	JJ	I-NP
O	mutant	mutant	NN	I-NP
O	prevents	prevent	VBZ	B-VP
B-GGP	Mdm2	Mdm2	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	degradation	degradation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	MdmX	MdmX	NN	B-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	correlates	correlate	VBZ	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	ability	ability	NN	I-NP
O	of	of	IN	B-PP
O	wild	wild	JJ	B-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
B-GGP	USP2a	USP2a	NN	I-NP
O	to	to	TO	B-VP
O	deubiquitinate	deubiquitinate	VB	I-VP
B-GGP	MdmX	MdmX	NN	B-NP
O	.	.	.	B-NP
O	siRNA	siRNA	NN	I-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	knockdown	knockdown	NN	I-NP
O	of	of	IN	B-PP
B-GGP	USP2a	USP2a	NN	B-NP
O	in	in	IN	B-PP
O	NTERA	NTERA	NN	B-NP
O	-	-	HYPH	B-NP
O	2	2	CD	I-NP
O	testicular	testicular	JJ	I-NP
O	embryonal	embryonal	JJ	I-NP
O	carcinoma	carcinoma	NN	I-NP
O	cells	cell	NNS	I-NP
O	and	and	CC	O
O	MCF7	MCF7	NN	B-NP
O	breast	breast	NN	I-NP
O	cancer	cancer	NN	I-NP
O	cells	cell	NNS	I-NP
O	causes	cause	VBZ	B-VP
O	destabilization	destabilization	NN	B-NP
O	of	of	IN	B-PP
B-GGP	MdmX	MdmX	NN	B-NP
O	and	and	CC	O
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
B-GGP	MdmX	MdmX	NN	B-NP
O	protein	protein	NN	I-NP
O	levels	level	NNS	I-NP
O	,	,	,	O
O	showing	show	VBG	B-VP
O	that	that	IN	B-SBAR
O	endogenous	endogenous	JJ	B-NP
B-GGP	USP2a	USP2a	NN	I-NP
O	participates	participate	VBZ	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	MdmX	MdmX	NN	B-NP
O	stability	stability	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	therapeutic	therapeutic	JJ	I-NP
O	drug	drug	NN	I-NP
O	,	,	,	O
O	cisplatin	cisplatin	NN	B-NP
O	decreases	decrease	VBZ	B-VP
B-GGP	MdmX	MdmX	NN	B-NP
O	protein	protein	NN	I-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

B-GGP	USP2a	USP2a	NN	B-NP
O	mRNA	mRNA	NN	I-NP
O	and	and	CC	I-NP
O	protein	protein	NN	I-NP
O	levels	level	NNS	I-NP
O	were	be	VBD	B-VP
O	also	also	RB	I-VP
O	reduced	reduce	VBN	I-VP
O	after	after	IN	B-PP
O	cisplatin	cisplatin	NN	B-NP
O	exposure	exposure	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	magnitude	magnitude	NN	I-NP
O	and	and	CC	I-NP
O	time	time	NN	I-NP
O	course	course	NN	I-NP
O	of	of	IN	B-PP
B-GGP	USP2a	USP2a	NN	B-NP
O	downregulation	downregulation	NN	I-NP
O	suggests	suggest	VBZ	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	reduction	reduction	NN	I-NP
O	in	in	IN	B-PP
B-GGP	USP2a	USP2a	NN	B-NP
O	levels	level	NNS	I-NP
O	could	could	MD	B-VP
O	contribute	contribute	VB	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
B-GGP	MdmX	MdmX	NN	B-NP
O	expression	expression	NN	I-NP
O	following	follow	VBG	B-PP
O	treatment	treatment	NN	B-NP
O	with	with	IN	B-PP
O	cisplatin	cisplatin	NN	B-NP
O	.	.	.	O

O	Knockdown	Knockdown	NN	B-NP
O	of	of	IN	B-PP
B-GGP	USP2a	USP2a	NN	B-NP
O	increases	increase	VBZ	B-VP
O	the	the	DT	B-NP
O	sensitivity	sensitivity	NN	I-NP
O	of	of	IN	B-PP
O	NTERA	NTERA	NN	B-NP
O	-	-	HYPH	B-NP
O	2	2	CD	I-NP
O	cells	cell	NNS	I-NP
O	to	to	TO	B-PP
O	cisplatin	cisplatin	NN	B-NP
O	,	,	,	O
O	raising	raise	VBG	B-VP
O	the	the	DT	B-NP
O	possibility	possibility	NN	I-NP
O	that	that	IN	B-SBAR
O	suppression	suppression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	USP2a	USP2a	NN	B-NP
O	in	in	IN	B-PP
O	combination	combination	NN	B-NP
O	with	with	IN	B-PP
O	cisplatin	cisplatin	NN	B-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	an	an	DT	B-NP
O	approach	approach	NN	I-NP
O	for	for	IN	B-PP
O	cancer	cancer	NN	B-NP
O	therapy	therapy	NN	I-NP
O	.	.	.	O

B-GGP	Prolyl	Prolyl	NN	B-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	hydroxylase	hydroxylase	NN	B-NP
I-GGP	1	1	CD	I-NP
O	and	and	CC	O
B-GGP	CRTAP	CRTAP	NN	B-NP
O	are	be	VBP	B-VP
O	mutually	mutually	RB	I-VP
O	stabilizing	stabilize	VBG	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	endoplasmic	endoplasmic	JJ	I-NP
O	reticulum	reticulum	NN	I-NP
O	collagen	collagen	NN	I-NP
O	prolyl	prolyl	NN	I-NP
O	3	3	CD	I-NP
O	-	-	HYPH	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	complex	complex	NN	I-NP
O	.	.	.	O

O	Null	Null	JJ	B-NP
O	mutations	mutation	NNS	I-NP
O	in	in	IN	B-PP
B-GGP	cartilage	cartilage	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	associated	associate	VBN	I-NP
I-GGP	protein	protein	NN	I-NP
O	(	(	(	O
B-GGP	CRTAP	CRTAP	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
B-GGP	prolyl	prolyl	NN	B-NP
I-GGP	3	3	CD	I-NP
I-GGP	-	-	HYPH	O
I-GGP	hydroxylase	hydroxylase	NN	B-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
B-GGP	P3H1	P3H1	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	LEPRE1	LEPRE1	NN	I-NP
O	)	)	)	O
O	cause	cause	VBP	B-VP
O	types	type	NNS	B-NP
O	VII	VII	CD	B-NP
O	and	and	CC	I-NP
O	VIII	VIII	CD	I-NP
O	OI	OI	NN	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	,	,	,	O
O	two	two	CD	B-NP
O	novel	novel	JJ	I-NP
O	recessive	recessive	JJ	I-NP
O	forms	form	NNS	I-NP
O	of	of	IN	B-PP
O	osteogenesis	osteogenesis	NN	B-NP
O	imperfecta	imperfecta	NN	I-NP
O	(	(	(	O
O	OI	OI	NN	B-NP
O	)	)	)	O
O	with	with	IN	B-PP
O	severe	severe	JJ	B-ADJP
O	to	to	TO	B-PP
O	lethal	lethal	JJ	B-NP
O	bone	bone	NN	I-NP
O	dysplasia	dysplasia	NN	I-NP
O	and	and	CC	I-NP
O	overmodification	overmodification	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	type	type	NN	I-NP
O	I	I	CD	I-NP
O	collagen	collagen	NN	I-NP
O	helical	helical	JJ	I-NP
O	region	region	NN	I-NP
O	.	.	.	O

B-GGP	CRTAP	CRTAP	NN	B-NP
O	and	and	CC	I-NP
B-GGP	P3H1	P3H1	NN	I-NP
O	form	form	VBP	B-VP
O	a	a	DT	B-NP
O	complex	complex	NN	I-NP
O	with	with	IN	B-PP
B-GGP	cyclophilin	cyclophilin	NN	B-NP
I-GGP	B	B	NN	I-NP
O	(	(	(	O
B-GGP	CyPB	CyPB	NN	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	endoplasmic	endoplasmic	JJ	I-NP
O	reticulum	reticulum	NN	I-NP
O	(	(	(	O
O	ER	ER	NN	B-NP
O	)	)	)	O
O	which	which	WDT	B-NP
O	3	3	CD	B-NP
O	-	-	HYPH	I-NP
O	hydroxylates	hydroxylate	VBZ	B-VP
O	the	the	DT	B-NP
O	Pro986	Pro986	NN	I-NP
O	residue	residue	NN	I-NP
O	of	of	IN	B-PP
B-GGP	alpha1	alpha1	NN	B-NP
I-GGP	(	(	(	O
I-GGP	I	I	NN	B-NP
I-GGP	)	)	)	O
O	and	and	CC	O
B-GGP	alpha1	alpha1	NN	B-NP
I-GGP	(	(	(	O
I-GGP	II	II	CD	B-NP
I-GGP	)	)	)	O
I-GGP	collagen	collagen	NN	B-NP
O	chains	chain	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	investigated	investigate	VBD	B-VP
O	the	the	DT	B-NP
O	interaction	interaction	NN	I-NP
O	of	of	IN	B-PP
O	complex	complex	JJ	B-NP
O	components	component	NNS	I-NP
O	in	in	IN	B-PP
O	fibroblasts	fibroblast	NNS	B-NP
O	from	from	IN	B-PP
O	types	type	NNS	B-NP
O	VII	VII	CD	B-NP
O	and	and	CC	I-NP
O	VIII	VIII	CD	I-NP
O	OI	OI	NN	I-NP
O	patients	patient	NNS	I-NP
O	.	.	.	O

O	Both	Both	CC	O
B-GGP	CRTAP	CRTAP	NN	B-NP
O	and	and	CC	I-NP
B-GGP	P3H1	P3H1	NN	I-NP
O	are	be	VBP	B-VP
O	absent	absent	JJ	B-ADJP
O	or	or	CC	O
O	reduced	reduce	VBN	B-VP
O	on	on	IN	B-PP
O	western	western	JJ	B-NP
O	blots	blot	NNS	I-NP
O	and	and	CC	B-PP
O	by	by	IN	B-PP
O	immunofluorescence	immunofluorescence	NN	B-NP
O	microscopy	microscopy	NN	I-NP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	containing	contain	VBG	B-VP
O	null	null	JJ	B-NP
O	mutations	mutation	NNS	I-NP
O	in	in	IN	B-PP
O	either	either	DT	B-NP
O	gene	gene	NN	I-NP
O	.	.	.	O

O	Levels	Level	NNS	B-NP
O	of	of	IN	B-PP
B-GGP	LEPRE1	LEPRE1	NN	B-NP
O	or	or	CC	I-NP
B-GGP	CRTAP	CRTAP	NN	I-NP
O	transcripts	transcript	NNS	I-NP
O	,	,	,	O
O	however	however	RB	B-ADVP
O	,	,	,	O
O	are	be	VBP	B-VP
O	normal	normal	JJ	B-ADJP
O	in	in	IN	B-PP
B-GGP	CRTAP	CRTAP	NN	B-NP
O	-	-	HYPH	B-NP
O	or	or	CC	I-NP
B-GGP	LEPRE1	LEPRE1	NN	I-NP
O	-	-	HYPH	I-NP
O	null	null	JJ	I-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	Stable	Stable	JJ	B-NP
O	transfection	transfection	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
B-GGP	CRTAP	CRTAP	NN	I-NP
O	or	or	CC	I-NP
B-GGP	LEPRE1	LEPRE1	NN	I-NP
O	expression	expression	NN	I-NP
O	construct	construct	NN	I-NP
O	into	into	IN	B-PP
O	cells	cell	NNS	B-NP
O	with	with	IN	B-PP
O	null	null	JJ	B-NP
O	mutations	mutation	NNS	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	transfected	transfecte	VBN	I-NP
O	cDNA	cDNA	NN	I-NP
O	restored	restore	VBD	B-VP
O	both	both	CC	O
B-GGP	CRTAP	CRTAP	NN	B-NP
O	and	and	CC	I-NP
B-GGP	P3H1	P3H1	NN	I-NP
O	protein	protein	NN	I-NP
O	levels	level	NNS	I-NP
O	.	.	.	O

O	Normalization	Normalization	NN	B-NP
O	of	of	IN	B-PP
O	collagen	collagen	NN	B-NP
O	helical	helical	JJ	I-NP
O	modification	modification	NN	I-NP
O	in	in	IN	B-PP
O	transfected	transfecte	VBN	B-NP
B-GGP	CRTAP	CRTAP	NN	I-NP
O	-	-	HYPH	B-NP
O	null	null	JJ	I-NP
O	cells	cell	NNS	I-NP
O	demonstrated	demonstrate	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	restored	restore	VBN	I-NP
O	proteins	protein	NNS	I-NP
O	functioned	function	VBD	B-VP
O	effectively	effectively	RB	B-ADVP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	complex	complex	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	CRTAP	CRTAP	NN	B-NP
O	and	and	CC	I-NP
B-GGP	P3H1	P3H1	NN	I-NP
O	are	be	VBP	B-VP
O	mutually	mutually	RB	I-VP
O	stabilized	stabilize	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	collagen	collagen	NN	I-NP
O	prolyl	prolyl	NN	I-NP
O	3	3	CD	I-NP
O	-	-	HYPH	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	complex	complex	NN	I-NP
O	.	.	.	O

B-GGP	CyPB	CyPB	NN	B-NP
O	levels	level	NNS	I-NP
O	were	be	VBD	B-VP
O	unaffected	unaffected	JJ	B-ADJP
O	by	by	IN	B-PP
O	mutations	mutation	NNS	B-NP
O	in	in	IN	B-PP
O	either	either	CC	O
B-GGP	CRTAP	CRTAP	NN	B-NP
O	or	or	CC	I-NP
B-GGP	LEPRE1	LEPRE1	NN	I-NP
O	.	.	.	O

O	Proteasomal	Proteasomal	JJ	B-NP
O	inhibitors	inhibitor	NNS	I-NP
O	partially	partially	RB	B-ADVP
O	rescue	rescue	VBP	B-VP
B-GGP	P3H1	P3H1	NN	B-NP
O	protein	protein	NN	I-NP
O	in	in	IN	B-PP
B-GGP	CRTAP	CRTAP	NN	B-NP
O	-	-	HYPH	B-NP
O	null	null	JJ	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
B-GGP	LEPRE1	LEPRE1	NN	B-NP
O	-	-	HYPH	B-NP
O	null	null	JJ	I-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	secretion	secretion	NN	B-NP
O	of	of	IN	B-PP
B-GGP	CRTAP	CRTAP	NN	B-NP
O	is	be	VBZ	B-VP
O	increased	increase	VBN	I-VP
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	control	control	NN	B-NP
O	cells	cell	NNS	I-NP
O	and	and	CC	O
O	accounts	account	VBZ	B-VP
O	for	for	IN	B-PP
O	15	15	CD	B-NP
O	-	-	HYPH	I-NP
O	20	20	CD	I-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	decreased	decrease	VBN	I-NP
B-GGP	CRTAP	CRTAP	NN	I-NP
O	detected	detect	VBN	B-VP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
O	mutual	mutual	JJ	B-NP
O	stabilization	stabilization	NN	I-NP
O	of	of	IN	B-PP
B-GGP	P3H1	P3H1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	CRTAP	CRTAP	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	ER	ER	NN	I-NP
O	collagen	collagen	NN	I-NP
O	modification	modification	NN	I-NP
O	complex	complex	NN	I-NP
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	underlying	underlie	VBG	I-NP
O	mechanism	mechanism	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	overlapping	overlap	VBG	I-NP
O	phenotype	phenotype	NN	I-NP
O	of	of	IN	B-PP
O	types	type	NNS	B-NP
O	VII	VII	CD	B-NP
O	and	and	CC	I-NP
O	VIII	VIII	CD	I-NP
O	OI	OI	NN	I-NP
O	.	.	.	O

B-GGP	GDP	GDP	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	mannose	mannose	NN	I-NP
I-GGP	pyrophosphorylase	pyrophosphorylase	NN	I-NP
O	is	be	VBZ	B-VP
O	essential	essential	JJ	B-ADJP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	bloodstream	bloodstream	JJ	I-NP
O	form	form	NN	I-NP
O	of	of	IN	B-PP
O	Trypanosoma	Trypanosoma	NNP	B-NP
O	brucei	brucei	NNP	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	putative	putative	JJ	I-NP
B-GGP	GDP	GDP	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	Man	Man	NN	B-NP
I-GGP	PP	PP	NN	I-NP
O	(	(	(	O
B-GGP	guanidine	guanidine	NN	B-NP
I-GGP	diphosphomannose	diphosphomannose	NN	I-NP
I-GGP	pyrophosphorylase	pyrophosphorylase	NN	I-NP
O	)	)	)	O
O	gene	gene	NN	B-NP
O	from	from	IN	B-PP
O	Trypanosoma	Trypanosoma	NNP	B-NP
O	brucei	brucei	NNP	I-NP
O	(	(	(	O
B-GGP	TbGDP	TbGDP	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	Man	Man	NN	I-NP
I-GGP	PP	PP	NN	I-NP
O	)	)	)	O
O	was	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	genome	genome	NN	I-NP
O	and	and	CC	O
O	subsequently	subsequently	RB	B-VP
O	cloned	clone	VBN	I-VP
O	,	,	,	O
O	sequenced	sequence	VBN	B-VP
O	and	and	CC	O
O	recombinantly	recombinantly	RB	B-VP
O	expressed	express	VBN	I-VP
O	,	,	,	O
O	and	and	CC	O
O	shown	show	VBN	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	a	a	DT	B-NP
O	catalytically	catalytically	RB	I-NP
O	active	active	JJ	I-NP
O	dimer	dimer	NN	I-NP
O	.	.	.	O

O	Kinetic	Kinetic	JJ	B-NP
O	analysis	analysis	NN	I-NP
O	revealed	reveal	VBD	B-VP
O	a	a	DT	B-NP
O	Vmax	Vmax	NN	I-NP
O	of	of	IN	B-PP
O	0	0	CD	B-NP
O	.	.	.	O
O	34	34	CD	B-NP
O	mumol	mumol	NN	I-NP
O	/	/	SYM	B-NP
O	min	min	NN	I-NP
O	per	per	IN	B-PP
O	mg	mg	NN	B-NP
O	of	of	IN	B-PP
O	protein	protein	NN	B-NP
O	and	and	CC	I-NP
O	Km	Km	NN	I-NP
O	values	value	NNS	I-NP
O	of	of	IN	B-PP
O	67	67	CD	B-NP
O	muM	muM	NN	I-NP
O	and	and	CC	O
O	12	12	CD	B-NP
O	muM	muM	NN	I-NP
O	for	for	IN	B-PP
O	GTP	GTP	NN	B-NP
O	and	and	CC	O
O	mannose	mannose	NN	B-NP
O	1	1	CD	I-NP
O	-	-	HYPH	I-NP
O	phosphate	phosphate	NN	I-NP
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	Further	Further	JJ	B-NP
O	kinetic	kinetic	JJ	I-NP
O	studies	study	NNS	I-NP
O	showed	show	VBD	B-VP
O	GDP	GDP	NN	B-NP
O	-	-	HYPH	I-NP
O	Man	Man	NN	B-NP
O	was	be	VBD	B-VP
O	a	a	DT	B-NP
O	potent	potent	JJ	I-NP
O	product	product	NN	I-NP
O	feedback	feedback	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	.	.	.	O

O	RNAi	RNAi	NN	B-NP
O	(	(	(	O
O	RNA	RNA	NN	B-NP
O	interference	interference	NN	I-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cytosolic	cytosolic	JJ	I-NP
B-GGP	TbGDP	TbGDP	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	Man	Man	NN	I-NP
I-GGP	PP	PP	NN	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	mRNA	mRNA	NN	B-NP
O	levels	level	NNS	I-NP
O	were	be	VBD	B-VP
O	reduced	reduce	VBN	I-VP
O	to	to	TO	I-VP
O	~	~	VB	I-VP
O	20	20	CD	B-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	wild	wild	JJ	B-NP
O	-	-	HYPH	I-NP
O	type	type	NN	I-NP
O	levels	level	NNS	I-NP
O	,	,	,	O
O	causing	cause	VBG	B-VP
O	the	the	DT	B-NP
O	cells	cell	NNS	I-NP
O	to	to	TO	B-VP
O	die	die	VB	I-VP
O	after	after	IN	B-PP
O	3	3	CD	B-NP
O	-	-	HYPH	I-NP
O	4	4	CD	I-NP
O	days	day	NNS	I-NP
O	,	,	,	O
O	demonstrating	demonstrate	VBG	B-VP
O	that	that	IN	B-SBAR
B-GGP	TbGDP	TbGDP	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	Man	Man	NN	I-NP
I-GGP	PP	PP	NN	I-NP
O	is	be	VBZ	B-VP
O	essential	essential	JJ	B-ADJP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	bloodstream	bloodstream	JJ	I-NP
O	form	form	NN	I-NP
O	of	of	IN	B-PP
O	T	T	NN	B-NP
O	.	.	VBD	I-NP
O	brucei	brucei	NN	I-NP
O	and	and	CC	O
O	thus	thus	RB	O
O	a	a	DT	B-NP
O	potential	potential	JJ	I-NP
O	drug	drug	NN	I-NP
O	target	target	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	RNAi	RNAi	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	parasites	parasite	NNS	I-NP
O	have	have	VBP	B-VP
O	a	a	DT	B-NP
O	greatly	greatly	RB	I-NP
O	reduced	reduce	VBN	I-NP
O	capability	capability	NN	I-NP
O	to	to	TO	B-VP
O	form	form	VB	I-VP
O	GDP	GDP	NNP	B-NP
O	-	-	HYPH	B-NP
O	Man	Man	NNP	I-NP
O	,	,	,	O
O	leading	lead	VBG	B-VP
O	ultimately	ultimately	RB	B-ADVP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	reduction	reduction	NN	I-NP
O	in	in	IN	B-PP
O	their	their	PRP$	B-NP
O	ability	ability	NN	I-NP
O	to	to	TO	B-VP
O	synthesize	synthesize	VB	I-VP
O	their	their	PRP$	B-NP
O	essential	essential	JJ	I-NP
O	GPI	GPI	NN	I-NP
O	(	(	(	O
O	glycosylphosphatidylinositol	glycosylphosphatidylinositol	NN	B-NP
O	)	)	)	O
O	anchors	anchor	NNS	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	RNAi	RNAi	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	parasites	parasite	NNS	I-NP
O	also	also	RB	B-ADVP
O	showed	show	VBD	B-VP
O	aberrant	aberrant	JJ	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	of	of	IN	B-PP
O	their	their	PRP$	B-NP
O	major	major	JJ	I-NP
O	cell	cell	NN	I-NP
O	-	-	HYPH	B-NP
O	surface	surface	NN	I-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	,	,	,	O
O	variant	variant	JJ	B-NP
O	surface	surface	NN	I-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	,	,	,	O
O	with	with	IN	B-PP
O	loss	loss	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	high	high	JJ	I-NP
O	-	-	HYPH	I-NP
O	mannose	mannose	NN	I-NP
O	Man9GlcNAc2	Man9GlcNAc2	NN	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	at	at	IN	B-PP
O	Asn428	Asn428	NN	B-NP
O	and	and	CC	I-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	complex	complex	JJ	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	glycans	glycan	NNS	I-NP
O	at	at	IN	B-PP
O	Asn263	Asn263	NN	B-NP
O	.	.	.	O

O	Regulation	Regulation	NN	B-NP
O	of	of	IN	B-PP
O	virus	virus	NN	B-NP
O	-	-	HYPH	O
O	triggered	trigger	VBN	B-VP
O	signaling	signaling	NN	B-NP
O	by	by	IN	B-PP
B-GGP	OTUB1	OTUB1	NN	B-NP
O	-	-	HYPH	B-NP
O	and	and	CC	I-NP
B-GGP	OTUB2	OTUB2	NN	I-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	deubiquitination	deubiquitination	NN	I-NP
O	of	of	IN	B-PP
B-GGP	TRAF3	TRAF3	NN	B-NP
O	and	and	CC	I-NP
B-GGP	TRAF6	TRAF6	NN	I-NP
O	.	.	.	O

O	Ubiquitination	Ubiquitination	NN	B-NP
O	and	and	CC	I-NP
O	deubiquitination	deubiquitination	NN	I-NP
O	have	have	VBP	B-VP
O	emerged	emerge	VBN	I-VP
O	as	as	IN	B-PP
O	critical	critical	JJ	B-NP
O	post	post	AFX	I-NP
O	-	-	HYPH	I-NP
O	translational	translational	JJ	I-NP
O	regulatory	regulatory	JJ	I-NP
O	mechanisms	mechanism	NNS	I-NP
O	for	for	IN	B-PP
O	activation	activation	NN	B-NP
O	or	or	CC	I-NP
O	attenuation	attenuation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	virus	virus	NN	I-NP
O	-	-	HYPH	O
O	triggered	trigger	VBN	B-VP
O	type	type	NN	B-NP
O	I	I	CD	I-NP
O	interferon	interferon	NN	I-NP
O	(	(	(	O
O	IFN	IFN	NN	B-NP
O	)	)	)	O
O	(	(	(	B-LST
O	2	2	LS	I-LST
O	)	)	)	O
O	induction	induction	NN	B-NP
O	pathways	pathway	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	identified	identify	VBD	B-VP
O	two	two	CD	B-NP
O	deubiquitinating	deubiquitinate	VBG	I-NP
O	enzymes	enzyme	NNS	I-NP
O	,	,	,	O
B-GGP	OTUB1	OTUB1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	OTUB2	OTUB2	NN	I-NP
O	,	,	,	O
O	as	as	IN	B-SBAR
O	negative	negative	JJ	B-NP
O	regulators	regulator	NNS	I-NP
O	of	of	IN	B-PP
O	virus	virus	NN	B-NP
O	-	-	HYPH	O
O	triggered	trigger	VBN	B-VP
O	type	type	NN	B-NP
O	I	I	CD	I-NP
O	IFN	IFN	NN	I-NP
O	induction	induction	NN	I-NP
O	.	.	.	O

O	Overexpression	Overexpression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	OTUB1	OTUB1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	OTUB2	OTUB2	NN	I-NP
O	inhibited	inhibit	VBD	B-VP
O	virus	virus	NN	B-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	IRF3	IRF3	NN	B-NP
O	and	and	CC	I-NP
O	NF	NF	NN	I-NP
O	-	-	HYPH	O
O	kappaB	kappaB	NN	B-NP
O	,	,	,	O
O	transcription	transcription	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	IFNB1	IFNB1	NN	I-NP
O	gene	gene	NN	I-NP
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	cellular	cellular	JJ	B-NP
O	antiviral	antiviral	JJ	I-NP
O	response	response	NN	I-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	knockdown	knockdown	NN	B-NP
O	of	of	IN	B-PP
B-GGP	OTUB1	OTUB1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	OTUB2	OTUB2	NN	I-NP
O	had	have	VBD	B-VP
O	opposite	opposite	JJ	B-NP
O	effects	effect	NNS	I-NP
O	.	.	.	O

O	Coimmunoprecipitations	Coimmunoprecipitation	NNS	B-NP
O	indicated	indicate	VBD	B-VP
B-GGP	OTUB1	OTUB1	NN	B-NP
O	and	and	CC	O
B-GGP	-	-	SYM	B-NP
I-GGP	2	2	CD	I-NP
O	interacted	interact	VBD	B-VP
O	with	with	IN	B-PP
B-GGP	TRAF3	TRAF3	NN	B-NP
O	and	and	CC	I-NP
B-GGP	TRAF6	TRAF6	NN	I-NP
O	,	,	,	O
O	two	two	CD	B-NP
O	E3	E3	NN	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligases	ligas	NNS	I-NP
O	required	require	VBN	B-VP
O	for	for	IN	B-PP
O	virus	virus	NN	B-NP
O	-	-	HYPH	B-NP
O	triggered	trigger	VBN	I-NP
B-GGP	IRF3	IRF3	NN	I-NP
O	and	and	CC	I-NP
O	NF	NF	NN	I-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	activation	activation	NN	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	OTUB1	OTUB1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	OTUB2	OTUB2	NN	I-NP
O	mediated	mediate	VBN	I-NP
O	virus	virus	NN	I-NP
O	-	-	HYPH	O
O	triggered	trigger	VBN	B-VP
O	deubiquitination	deubiquitination	NN	B-NP
O	of	of	IN	B-PP
B-GGP	TRAF3	TRAF3	NN	B-NP
O	and	and	CC	O
B-GGP	-	-	SYM	B-NP
I-GGP	6	6	CD	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	findings	finding	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	OTUB1	OTUB1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	OTUB2	OTUB2	NN	I-NP
O	negatively	negatively	RB	B-ADVP
O	regulate	regulate	VBP	B-VP
O	virus	virus	NN	B-NP
O	-	-	HYPH	O
O	triggered	trigger	VBN	B-VP
O	type	type	NN	B-NP
O	I	I	CD	I-NP
O	IFN	IFN	NN	I-NP
O	induction	induction	NN	I-NP
O	and	and	CC	O
O	cellular	cellular	JJ	B-NP
O	antiviral	antiviral	JJ	I-NP
O	response	response	NN	I-NP
O	by	by	IN	B-PP
O	deubiquitinating	deubiquitinate	VBG	B-VP
B-GGP	TRAF3	TRAF3	NN	B-NP
O	and	and	CC	O
B-GGP	-	-	SYM	B-NP
I-GGP	6	6	CD	I-NP
O	.	.	.	O

B-GGP	Fbxo45	Fbxo45	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	,	,	,	O
O	regulates	regulate	VBZ	B-VP
O	synaptic	synaptic	JJ	B-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	Neurons	Neuron	NNS	B-NP
O	communicate	communicate	VBP	B-VP
O	with	with	IN	B-PP
O	each	each	DT	B-NP
O	other	other	JJ	I-NP
O	through	through	IN	B-PP
O	synapses	synapsis	NNS	B-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	establish	establish	VB	I-VP
O	the	the	DT	B-NP
O	precise	precise	JJ	I-NP
O	yet	yet	CC	I-NP
O	flexible	flexible	JJ	I-NP
O	connections	connection	NNS	I-NP
O	that	that	WDT	B-NP
O	make	make	VBP	B-VP
O	up	up	RP	B-PRT
O	neural	neural	JJ	B-NP
O	networks	network	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	brain	brain	NN	I-NP
O	,	,	,	O
O	continuous	continuous	JJ	B-NP
O	synaptic	synaptic	JJ	I-NP
O	modulation	modulation	NN	I-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	-	-	HYPH	I-NP
O	proteasome	proteasome	NN	I-NP
O	system	system	NN	I-NP
O	of	of	IN	B-PP
O	protein	protein	NN	B-NP
O	degradation	degradation	NN	I-NP
O	is	be	VBZ	B-VP
O	one	one	CD	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	critical	critical	JJ	I-NP
O	mechanisms	mechanism	NNS	I-NP
O	that	that	WDT	B-NP
O	underlie	underlie	VBP	B-VP
O	this	this	DT	B-NP
O	process	process	NN	I-NP
O	,	,	,	O
O	playing	play	VBG	B-VP
O	crucial	crucial	JJ	B-NP
O	roles	role	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	synaptic	synaptic	JJ	B-NP
O	structure	structure	NN	I-NP
O	and	and	CC	I-NP
O	function	function	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	identified	identify	VBD	B-VP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	,	,	,	O
B-GGP	Fbxo45	Fbxo45	NN	B-NP
O	,	,	,	O
O	that	that	WDT	B-NP
O	functions	function	VBZ	B-VP
O	at	at	IN	B-PP
O	synapses	synapsis	NNS	B-NP
O	.	.	.	O

B-GGP	Fbxo45	Fbxo45	NN	B-NP
O	is	be	VBZ	B-VP
O	evolutionarily	evolutionarily	RB	I-VP
O	conserved	conserve	VBN	I-VP
O	and	and	CC	O
O	selectively	selectively	RB	B-VP
O	expressed	express	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	nervous	nervous	JJ	I-NP
O	system	system	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	demonstrated	demonstrate	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	knockdown	knockdown	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Fbxo45	Fbxo45	NN	B-NP
O	in	in	IN	B-PP
O	primary	primary	JJ	B-NP
O	cultured	culture	VBN	I-NP
O	hippocampal	hippocampal	JJ	I-NP
O	neurons	neuron	NNS	I-NP
O	resulted	result	VBD	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	greater	great	JJR	I-NP
O	frequency	frequency	NN	I-NP
O	of	of	IN	B-PP
O	miniature	miniature	JJ	B-NP
O	excitatory	excitatory	JJ	I-NP
O	postsynaptic	postsynaptic	JJ	I-NP
O	currents	current	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	also	also	RB	B-ADVP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	Fbxo45	Fbxo45	NN	B-NP
O	induces	induce	VBZ	B-VP
O	the	the	DT	B-NP
O	degradation	degradation	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	synaptic	synaptic	JJ	I-NP
O	vesicle	vesicle	NN	I-NP
O	-	-	HYPH	B-NP
O	priming	priming	NN	I-NP
O	factor	factor	NN	I-NP
O	,	,	,	O
B-GGP	Munc13	Munc13	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	propose	propose	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	Fbxo45	Fbxo45	NN	B-NP
O	plays	play	VBZ	B-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	neurotransmission	neurotransmission	NN	B-NP
O	by	by	IN	B-PP
O	modulating	modulate	VBG	B-VP
B-GGP	Munc13	Munc13	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	synapse	synapse	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	19S	19S	NN	I-NP
O	proteasomal	proteasomal	JJ	I-NP
O	lid	lid	NN	I-NP
O	subunit	subunit	NN	I-NP
B-GGP	POH1	POH1	NN	I-NP
O	enhances	enhance	VBZ	B-VP
O	the	the	DT	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	activation	activation	NN	I-NP
O	by	by	IN	B-PP
B-GGP	Mitf	Mitf	NNP	B-NP
O	in	in	IN	B-PP
O	osteoclasts	osteoclast	NNS	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	microphthalmia	microphthalmia	NN	I-NP
I-GGP	-	-	HYPH	B-VP
I-GGP	associated	associate	VBN	B-NP
I-GGP	transcription	transcription	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	(	(	(	O
B-GGP	Mitf	Mitf	NN	B-NP
O	)	)	)	O
O	regulates	regulate	VBZ	B-VP
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	required	require	VBN	B-VP
O	for	for	IN	B-PP
O	osteoclast	osteoclast	NN	B-NP
O	differentiation	differentiation	NN	I-NP
O	.	.	.	O

O	Genes	Gene	NNS	B-NP
O	regulated	regulate	VBN	B-VP
O	by	by	IN	B-PP
B-GGP	Mitf	Mitf	NNP	B-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	previously	previously	RB	I-VP
O	identified	identify	VBN	I-VP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	proteins	protein	NNS	B-NP
O	that	that	WDT	B-NP
O	interact	interact	VBP	B-VP
O	and	and	CC	I-VP
O	regulate	regulate	VBP	I-VP
B-GGP	Mitf	Mitf	NNP	B-NP
O	'	'	POS	B-NP
O	s	s	NN	I-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	osteoclasts	osteoclast	NNS	B-NP
O	are	be	VBP	B-VP
O	not	not	RB	I-VP
O	well	well	RB	I-VP
O	known	know	VBN	I-VP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	report	report	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	POH1	POH1	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	subunit	subunit	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	19S	19S	NN	I-NP
O	proteasome	proteasome	NN	I-NP
O	lid	lid	NN	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	regulator	regulator	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Mitf	Mitf	NNP	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	POH1	POH1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Mitf	Mitf	NN	I-NP
O	interact	interact	VBP	B-VP
O	in	in	IN	B-PP
O	osteoclasts	osteoclast	NNS	B-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	interaction	interaction	NN	I-NP
O	is	be	VBZ	B-VP
O	dependent	dependent	JJ	B-ADJP
O	on	on	IN	B-PP
B-GGP	RANKL	RANKL	NN	B-NP
O	signaling	signaling	NN	I-NP
O	.	.	.	O

O	Overexpression	Overexpression	NN	B-NP
O	of	of	IN	B-PP
B-GGP	POH1	POH1	NN	B-NP
O	increased	increase	VBD	B-VP
B-GGP	Mitf	Mitf	NNP	B-NP
O	'	'	POS	B-NP
O	s	s	JJ	I-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
O	5XGal4	5XGal4	NN	B-NP
O	-	-	HYPH	B-NP
O	TK	TK	NN	I-NP
O	and	and	CC	I-NP
B-GGP	Acp5	Acp5	NN	I-NP
O	promoters	promoter	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	amino	amino	JJ	I-NP
O	terminus	terminus	NN	I-NP
O	of	of	IN	B-PP
B-GGP	POH1	POH1	NN	B-NP
O	mediates	mediate	VBZ	B-VP
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	to	to	TO	B-PP
B-GGP	Mitf	Mitf	NN	B-NP
O	and	and	CC	O
O	is	be	VBZ	B-VP
O	sufficient	sufficient	JJ	B-ADJP
O	to	to	TO	B-VP
O	increase	increase	VB	I-VP
B-GGP	Mitf	Mitf	NNP	B-NP
O	'	'	POS	B-NP
O	s	s	JJ	I-NP
O	transcriptional	transcriptional	JJ	I-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	Finally	Finally	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	mutations	mutation	NNS	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	JAMM	JAMM	NN	I-NP
O	motif	motif	NN	I-NP
O	of	of	IN	B-PP
B-GGP	POH1	POH1	NN	B-NP
O	reduced	reduce	VBD	B-VP
B-GGP	Mitf	Mitf	NNP	B-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
O	promoters	promoter	NNS	B-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	summary	summary	NN	B-NP
O	,	,	,	O
O	our	our	PRP$	B-NP
O	results	result	NNS	I-NP
O	identify	identify	VBP	B-VP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Mitf	Mitf	NNP	B-NP
O	regulation	regulation	NN	I-NP
O	in	in	IN	B-PP
O	osteoclasts	osteoclast	NNS	B-NP
O	by	by	IN	B-PP
B-GGP	POH1	POH1	NN	B-NP
O	.	.	.	O

O	Mutations	Mutation	NNS	B-NP
O	in	in	IN	B-PP
B-GGP	Cullin	Cullin	NN	B-NP
I-GGP	4B	4B	NN	I-NP
O	result	result	VBP	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	human	human	JJ	I-NP
O	syndrome	syndrome	NN	I-NP
O	associated	associate	VBN	B-VP
O	with	with	IN	B-PP
O	increased	increase	VBN	B-NP
O	camptothecin	camptothecin	NN	I-NP
O	-	-	HYPH	O
O	induced	induce	VBN	B-VP
B-GGP	topoisomerase	topoisomerase	NN	B-NP
I-GGP	I	I	CD	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	DNA	DNA	NN	I-NP
O	breaks	break	NNS	I-NP
O	.	.	.	O

B-GGP	CUL4A	CUL4A	NN	B-NP
O	and	and	CC	I-NP
B-GGP	B	B	NN	I-NP
O	encode	encode	VBP	B-VP
O	subunits	subunit	NNS	B-NP
O	of	of	IN	B-PP
O	E3	E3	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligases	ligas	NNS	I-NP
O	implicated	implicate	VBN	B-VP
O	in	in	IN	B-PP
O	diverse	diverse	JJ	B-NP
O	processes	process	NNS	I-NP
O	including	include	VBG	B-PP
O	nucleotide	nucleotide	NN	B-NP
O	excision	excision	NN	I-NP
O	repair	repair	NN	I-NP
O	,	,	,	O
O	regulating	regulate	VBG	B-VP
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	and	and	CC	O
O	controlling	control	VBG	B-VP
O	DNA	DNA	NN	B-NP
O	replication	replication	NN	I-NP
O	fork	fork	NN	I-NP
O	licensing	licensing	NN	I-NP
O	.	.	.	O

O	But	But	CC	O
O	,	,	,	O
O	the	the	DT	B-NP
O	functional	functional	JJ	I-NP
O	distinction	distinction	NN	I-NP
O	between	between	IN	B-PP
B-GGP	CUL4A	CUL4A	NN	B-NP
O	and	and	CC	I-NP
B-GGP	CUL4B	CUL4B	NN	I-NP
O	,	,	,	O
O	if	if	IN	B-SBAR
O	any	any	DT	B-NP
O	,	,	,	O
O	is	be	VBZ	B-VP
O	unclear	unclear	JJ	B-ADJP
O	.	.	.	O

O	Recently	Recently	RB	B-ADVP
O	,	,	,	O
O	mutations	mutation	NNS	B-NP
O	in	in	IN	B-PP
B-GGP	CUL4B	CUL4B	NN	B-NP
O	were	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	in	in	IN	B-PP
O	humans	human	NNS	B-NP
O	associated	associate	VBN	B-VP
O	with	with	IN	B-PP
O	mental	mental	JJ	B-NP
O	retardation	retardation	NN	I-NP
O	,	,	,	O
O	relative	relative	JJ	B-ADJP
O	macrocephaly	macrocephaly	RB	B-ADVP
O	,	,	,	O
O	tremor	tremor	NN	B-NP
O	and	and	CC	O
O	a	a	DT	B-NP
O	peripheral	peripheral	JJ	I-NP
O	neuropathy	neuropathy	NN	I-NP
O	.	.	.	O

O	Cells	Cell	NNS	B-NP
O	from	from	IN	B-PP
O	these	these	DT	B-NP
O	patients	patient	NNS	I-NP
O	offer	offer	VBP	B-VP
O	a	a	DT	B-NP
O	unique	unique	JJ	I-NP
O	system	system	NN	I-NP
O	to	to	TO	B-VP
O	help	help	VB	I-VP
O	define	define	VB	I-VP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	molecular	molecular	JJ	I-NP
O	level	level	NN	I-NP
O	the	the	DT	B-NP
O	consequences	consequence	NNS	I-NP
O	of	of	IN	B-PP
O	defective	defective	JJ	B-NP
B-GGP	CUL4B	CUL4B	NN	I-NP
O	specifically	specifically	RB	B-ADVP
O	.	.	.	O

O	We	We	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	these	these	DT	B-NP
O	patient	patient	NN	I-NP
O	-	-	HYPH	O
O	derived	derive	VBN	B-NP
O	cells	cell	NNS	I-NP
O	exhibit	exhibit	VBP	B-VP
O	sensitivity	sensitivity	NN	B-NP
O	to	to	TO	B-PP
O	camptothecin	camptothecin	NN	B-NP
O	(	(	(	O
O	CPT	CPT	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	impaired	impaired	JJ	B-NP
O	CPT	CPT	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
B-GGP	topoisomerase	topoisomerase	NN	I-NP
I-GGP	I	I	CD	I-NP
O	(	(	(	O
B-GGP	Topo	Topo	NN	O
I-GGP	I	I	CD	O
O	)	)	)	O
O	degradation	degradation	NN	B-NP
O	and	and	CC	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	,	,	,	O
O	thereby	thereby	RB	B-VP
O	suggesting	suggest	VBG	I-VP
B-GGP	Topo	Topo	IN	B-SBAR
I-GGP	I	I	PRP	B-NP
O	to	to	TO	B-VP
O	be	be	VB	I-VP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	Cul4	Cul4	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	substrate	substrate	NN	I-NP
O	.	.	.	O

O	Consistent	Consistent	JJ	B-ADJP
O	with	with	IN	B-PP
O	this	this	DT	B-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	also	also	RB	B-ADVP
O	find	find	VBP	B-VP
O	that	that	IN	B-SBAR
O	these	these	DT	B-NP
O	cells	cell	NNS	I-NP
O	exhibit	exhibit	VBP	B-VP
O	increased	increase	VBN	B-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	CPT	CPT	NN	B-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	DNA	DNA	NN	I-NP
O	breaks	break	NNS	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	over	over	AFX	B-NP
O	-	-	HYPH	I-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	known	know	VBN	B-NP
O	CUL4	CUL4	NN	I-NP
O	-	-	HYPH	O
O	dependent	dependent	JJ	B-NP
O	substrates	substrate	NNS	I-NP
O	including	include	VBG	B-PP
B-GGP	Cdt1	Cdt1	NN	B-NP
O	and	and	CC	I-NP
B-GGP	p21	p21	NN	I-NP
O	appear	appear	VBP	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	a	a	DT	B-NP
O	feature	feature	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	patient	patient	NN	I-NP
O	-	-	HYPH	B-NP
O	derived	derive	VBN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Collectively	Collectively	RB	B-ADVP
O	,	,	,	O
O	our	our	PRP$	B-NP
O	findings	finding	NNS	I-NP
O	highlight	highlight	VBP	B-VP
O	the	the	DT	B-NP
O	interplay	interplay	NN	I-NP
O	between	between	IN	B-PP
B-GGP	CUL4A	CUL4A	NN	B-NP
O	and	and	CC	I-NP
B-GGP	CUL4B	CUL4B	NN	I-NP
O	and	and	CC	O
O	provide	provide	VBP	B-VP
O	insight	insight	NN	B-NP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	pathogenesis	pathogenesis	NN	I-NP
O	of	of	IN	B-PP
B-GGP	CUL4B	CUL4B	NN	B-NP
O	-	-	HYPH	B-NP
O	deficiency	deficiency	NN	I-NP
O	in	in	IN	B-PP
O	humans	human	NNS	B-NP
O	.	.	.	O

O	Normal	Normal	JJ	B-NP
O	shear	shear	NN	I-NP
O	stress	stress	NN	I-NP
O	and	and	CC	O
O	vascular	vascular	JJ	B-NP
O	smooth	smooth	JJ	I-NP
O	muscle	muscle	NN	I-NP
O	cells	cell	NNS	I-NP
O	modulate	modulate	VBP	B-VP
O	migration	migration	NN	B-NP
O	of	of	IN	B-PP
O	endothelial	endothelial	JJ	B-NP
O	cells	cell	NNS	I-NP
O	through	through	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	deacetylase	deacetylase	NN	I-NP
I-GGP	6	6	CD	I-NP
O	activation	activation	NN	B-NP
O	and	and	CC	O
O	tubulin	tubulin	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	.	.	.	O

O	Endothelial	Endothelial	JJ	B-NP
O	cells	cell	NNS	I-NP
O	(	(	(	O
O	ECs	EC	NNS	B-NP
O	)	)	)	O
O	line	line	VBP	B-VP
O	the	the	DT	B-NP
O	innermost	innermost	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	blood	blood	NN	I-NP
O	vessel	vessel	NN	I-NP
O	wall	wall	NN	I-NP
O	and	and	CC	O
O	are	be	VBP	B-VP
O	constantly	constantly	RB	I-VP
O	subjected	subject	VBN	I-VP
O	to	to	TO	I-VP
O	shear	shear	VB	I-VP
O	stress	stress	NN	B-NP
O	imposed	impose	VBN	B-VP
O	by	by	IN	B-PP
O	blood	blood	NN	B-NP
O	flow	flow	NN	I-NP
O	.	.	.	O

O	ECs	EC	NNS	B-NP
O	were	be	VBD	B-VP
O	also	also	RB	I-VP
O	influenced	influence	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	neighboring	neighbor	VBG	I-NP
O	vascular	vascular	JJ	I-NP
O	smooth	smooth	JJ	I-NP
O	muscle	muscle	NN	I-NP
O	cells	cell	NNS	I-NP
O	(	(	(	O
O	VSMCs	VSMC	NNS	B-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	bidirectional	bidirectional	JJ	I-NP
O	communication	communication	NN	I-NP
O	between	between	IN	B-PP
O	ECs	EC	NNS	B-NP
O	and	and	CC	I-NP
O	VSMCs	VSMC	NNS	I-NP
O	modulates	modulate	VBZ	B-VP
O	vascular	vascular	JJ	B-NP
O	homeostasis	homeostasis	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	involvement	involvement	NN	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	deacetylase	deacetylase	NN	I-NP
I-GGP	6	6	CD	I-NP
O	(	(	(	O
B-GGP	HDAC6	HDAC6	NN	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	modulating	modulate	VBG	B-VP
O	migration	migration	NN	B-NP
O	of	of	IN	B-PP
O	ECs	EC	NNS	B-NP
O	co	co	AFX	O
O	-	-	HYPH	O
O	cultured	culture	VBN	B-VP
O	with	with	IN	B-PP
O	VSMCs	VSMC	NNS	B-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	normal	normal	JJ	I-NP
O	level	level	NN	I-NP
O	of	of	IN	B-PP
O	laminar	laminar	JJ	B-NP
O	shear	shear	NN	I-NP
O	stress	stress	NN	I-NP
O	(	(	(	O
O	NSS	NSS	NN	B-NP
O	)	)	)	O
O	was	be	VBD	B-VP
O	investigated	investigate	VBN	I-VP
O	.	.	.	O

O	ECs	EC	NNS	B-NP
O	was	be	VBD	B-VP
O	either	either	CC	I-VP
O	cultured	culture	VBN	I-VP
O	alone	alone	RB	B-ADVP
O	or	or	CC	O
O	co	co	AFX	O
O	-	-	HYPH	O
O	cultured	culture	VBN	B-VP
O	with	with	IN	B-PP
O	VSMCs	VSMC	NNS	B-NP
O	under	under	IN	B-PP
O	static	static	JJ	B-NP
O	conditions	condition	NNS	I-NP
O	or	or	CC	O
O	subjected	subject	VBN	B-VP
O	to	to	TO	B-PP
O	NSS	NSS	NN	B-NP
O	of	of	IN	B-PP
O	15	15	CD	B-NP
O	dyne	dyne	NN	I-NP
O	/	/	SYM	O
O	cm2	cm2	NN	B-NP
O	by	by	IN	B-PP
O	using	use	VBG	B-VP
O	a	a	DT	B-NP
O	parallel	parallel	JJ	I-NP
O	-	-	HYPH	I-NP
O	plate	plate	NN	I-NP
O	co	co	AFX	O
O	-	-	HYPH	B-NP
O	culture	culture	NN	I-NP
O	flow	flow	NN	I-NP
O	chamber	chamber	NN	I-NP
O	system	system	NN	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	was	be	VBD	B-VP
O	demonstrated	demonstrate	VBN	I-VP
O	that	that	IN	B-SBAR
O	both	both	CC	O
O	NSS	NSS	NNS	B-NP
O	and	and	CC	I-NP
O	VSMCs	VSMC	NNS	I-NP
O	could	could	MD	B-VP
O	increase	increase	VB	I-VP
O	EC	EC	NNP	B-NP
O	migration	migration	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	migration	migration	NN	I-NP
O	level	level	NN	I-NP
O	of	of	IN	B-PP
O	ECs	EC	NNS	B-NP
O	co	co	AFX	O
O	-	-	HYPH	O
O	cultured	culture	VBN	B-VP
O	with	with	IN	B-PP
O	VSMCs	VSMC	NNS	B-NP
O	under	under	IN	B-PP
O	NSS	NSS	NN	B-NP
O	was	be	VBD	B-VP
O	not	not	RB	O
O	higher	high	JJR	B-ADJP
O	than	than	IN	B-PP
O	that	that	DT	B-NP
O	under	under	IN	B-PP
O	the	the	DT	B-NP
O	static	static	JJ	I-NP
O	condition	condition	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	process	process	NN	I-NP
O	of	of	IN	B-PP
O	EC	EC	NN	B-NP
O	migration	migration	NN	I-NP
O	regulated	regulate	VBN	B-VP
O	by	by	IN	B-PP
O	VSMCs	VSMC	NNS	B-NP
O	and	and	CC	O
O	NSS	NSS	NN	B-NP
O	was	be	VBD	B-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	increased	increase	VBN	I-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	HDAC6	HDAC6	NN	B-NP
O	and	and	CC	I-NP
O	low	low	JJ	I-NP
O	level	level	NN	I-NP
O	of	of	IN	B-PP
O	acetylated	acetylate	VBN	B-NP
O	tubulin	tubulin	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
B-GGP	HDAC6	HDAC6	NN	B-NP
O	expression	expression	NN	I-NP
O	was	be	VBD	B-VP
O	accompanied	accompany	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	time	time	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	acetylation	acetylation	NN	I-NP
O	of	of	IN	B-PP
O	tubulin	tubulin	NN	B-NP
O	in	in	IN	B-PP
O	ECs	EC	NNS	B-NP
O	co	co	AFX	O
O	-	-	HYPH	O
O	cultured	culture	VBN	B-VP
O	with	with	IN	B-PP
O	VSMCs	VSMC	NNS	B-NP
O	.	.	.	O

O	Inhibition	Inhibition	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	HDAC6	HDAC6	NN	I-NP
O	by	by	IN	B-PP
O	siRNA	siRNA	NN	B-NP
O	or	or	CC	I-NP
O	tributyrin	tributyrin	NN	I-NP
O	,	,	,	O
O	an	an	DT	B-NP
O	inhibitor	inhibitor	NN	I-NP
O	of	of	IN	B-PP
O	HDACs	HDAC	NNS	B-NP
O	,	,	,	O
O	induced	induce	VBD	B-VP
O	a	a	DT	B-NP
O	parallel	parallel	JJ	I-NP
O	alteration	alteration	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	migration	migration	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	acetylated	acetylate	VBN	I-NP
O	tubulin	tubulin	NN	I-NP
O	of	of	IN	B-PP
O	ECs	EC	NNS	B-NP
O	co	co	AFX	O
O	-	-	HYPH	O
O	cultured	culture	VBN	B-VP
O	with	with	IN	B-PP
O	VSMCs	VSMC	NNS	B-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	was	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	by	by	IN	B-PP
O	immunofluorescence	immunofluorescence	NN	B-NP
O	staining	staining	NN	I-NP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	acetylated	acetylate	VBN	I-NP
O	tubulin	tubulin	NN	I-NP
O	was	be	VBD	B-VP
O	distributed	distribute	VBN	I-VP
O	mostly	mostly	RB	B-ADVP
O	around	around	IN	B-PP
O	the	the	DT	B-NP
O	cell	cell	NN	I-NP
O	nucleus	nucleus	NN	I-NP
O	in	in	IN	B-PP
O	ECs	EC	NNS	B-NP
O	co	co	AFX	O
O	-	-	HYPH	O
O	cultured	culture	VBN	B-VP
O	with	with	IN	B-PP
O	VSMCs	VSMC	NNS	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	NSS	NSS	NN	I-NP
O	may	may	MD	B-VP
O	display	display	VB	I-VP
O	a	a	DT	B-NP
O	protective	protective	JJ	I-NP
O	function	function	NN	I-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	vascular	vascular	JJ	I-NP
O	homeostasis	homeostasis	NN	I-NP
O	by	by	IN	B-PP
O	modulating	modulate	VBG	B-VP
O	EC	EC	NNP	B-NP
O	migration	migration	NN	I-NP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	normal	normal	JJ	I-NP
O	level	level	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	VSMC	VSMC	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	manner	manner	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	modulation	modulation	NN	I-NP
O	process	process	NN	I-NP
O	involves	involve	VBZ	B-VP
O	the	the	DT	B-NP
O	down	down	RB	B-ADVP
O	-	-	HYPH	O
O	regulation	regulation	NN	B-NP
O	of	of	IN	B-PP
O	acetylated	acetylate	VBN	B-NP
O	tubulin	tubulin	NN	I-NP
O	which	which	WDT	B-NP
O	results	result	VBZ	B-VP
O	from	from	IN	B-PP
O	increased	increase	VBN	B-NP
B-GGP	HDAC6	HDAC6	NN	I-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	ECs	EC	NNS	B-NP
O	.	.	.	O

O	Tonic	Tonic	JJ	B-NP
O	ubiquitylation	ubiquitylation	NN	I-NP
O	controls	control	VBZ	B-VP
O	T	T	NN	B-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	receptor	receptor	NN	I-NP
O	:	:	:	O
O	CD3	CD3	NN	B-NP
O	complex	complex	NN	I-NP
O	expression	expression	NN	I-NP
O	during	during	IN	B-PP
O	T	T	NN	B-NP
O	-	-	HYPH	B-NP
O	cell	cell	NN	I-NP
O	development	development	NN	I-NP
O	.	.	.	O

O	Expression	Expression	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	T	T	NN	I-NP
O	-	-	HYPH	B-NP
O	cell	cell	NN	I-NP
O	receptor	receptor	NN	I-NP
O	(	(	(	O
O	TCR	TCR	NN	B-NP
O	)	)	)	O
O	:	:	:	O
O	CD3	CD3	NN	B-NP
O	complex	complex	NN	I-NP
O	is	be	VBZ	B-VP
O	tightly	tightly	RB	I-VP
O	regulated	regulate	VBN	I-VP
O	during	during	IN	B-PP
O	T	T	NN	B-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	development	development	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	and	and	CC	I-NP
O	physiological	physiological	JJ	I-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	regulation	regulation	NN	I-NP
O	are	be	VBP	B-VP
O	unclear	unclear	JJ	B-ADJP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	TCR	TCR	NN	I-NP
O	:	:	:	O
O	CD3	CD3	NN	B-NP
O	complex	complex	NN	I-NP
O	is	be	VBZ	B-VP
O	constitutively	constitutively	RB	I-VP
O	ubiquitylated	ubiquitylate	VBN	I-VP
O	in	in	IN	B-PP
O	immature	immature	JJ	B-NP
O	double	double	JJ	I-NP
O	positive	positive	JJ	I-NP
O	(	(	(	O
O	DP	DP	NN	B-NP
O	)	)	)	O
O	thymocytes	thymocyte	NNS	B-NP
O	,	,	,	O
O	but	but	CC	O
O	not	not	RB	O
O	mature	mature	JJ	B-NP
O	single	single	JJ	I-NP
O	positive	positive	JJ	I-NP
O	(	(	(	O
O	SP	SP	NN	B-NP
O	)	)	)	O
O	thymocytes	thymocyte	NNS	B-NP
O	or	or	CC	O
O	splenic	splenic	JJ	B-NP
O	T	T	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	steady	steady	JJ	I-NP
O	state	state	NN	I-NP
O	,	,	,	O
O	tonic	tonic	JJ	B-NP
O	CD3	CD3	NN	I-NP
O	monoubiquitylation	monoubiquitylation	NN	I-NP
O	is	be	VBZ	B-VP
O	mediated	mediate	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	CD3varepsilon	CD3varepsilon	NN	I-NP
O	proline	proline	NN	I-NP
O	-	-	HYPH	B-NP
O	rich	rich	JJ	I-NP
O	sequence	sequence	NN	I-NP
O	,	,	,	O
B-GGP	Lck	Lck	NN	B-NP
O	,	,	,	O
B-GGP	c	c	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	Cbl	Cbl	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	SLAP	SLAP	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	collectively	collectively	RB	B-ADVP
O	trigger	trigger	VBP	B-VP
O	the	the	DT	B-NP
O	dynamin	dynamin	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	downmodulation	downmodulation	NN	I-NP
O	,	,	,	O
O	lysosomal	lysosomal	JJ	B-NP
O	sequestration	sequestration	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	of	of	IN	B-PP
O	surface	surface	NN	B-NP
O	TCR	TCR	NN	I-NP
O	:	:	:	O
O	CD3	CD3	NN	B-NP
O	complexes	complex	NNS	I-NP
O	.	.	.	O

O	Blocking	Block	VBG	B-VP
O	this	this	DT	B-NP
O	tonic	tonic	JJ	I-NP
O	ubiquitylation	ubiquitylation	NN	I-NP
O	by	by	IN	B-PP
O	mutating	mutate	VBG	B-VP
O	all	all	PDT	B-NP
O	the	the	DT	I-NP
O	lysines	lysine	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	CD3	CD3	NN	I-NP
O	cytoplasmic	cytoplasmic	JJ	I-NP
O	tails	tail	NNS	I-NP
O	significantly	significantly	RB	B-ADVP
O	upregulates	upregulate	VBZ	B-VP
O	TCR	TCR	NN	B-NP
O	levels	level	NNS	I-NP
O	on	on	IN	B-PP
O	DP	DP	NN	B-NP
O	thymocytes	thymocyte	NNS	I-NP
O	.	.	.	O

O	Mimicking	Mimic	VBG	B-VP
O	monoubiquitylation	monoubiquitylation	NN	B-NP
O	by	by	IN	B-PP
O	expression	expression	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
B-GGP	CD3zeta	CD3zeta	NN	I-NP
O	-	-	HYPH	O
B-GGP	monoubiquitin	monoubiquitin	NN	B-NP
O	(	(	(	O
B-GGP	monoUb	monoUb	NN	B-NP
O	)	)	)	O
O	fusion	fusion	NN	B-NP
O	molecule	molecule	NN	I-NP
O	significantly	significantly	RB	B-ADVP
O	reduces	reduce	VBZ	B-VP
O	TCR	TCR	NN	B-NP
O	levels	level	NNS	I-NP
O	on	on	IN	B-PP
O	immature	immature	JJ	B-NP
O	thymocytes	thymocyte	NNS	I-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	modulating	modulate	VBG	B-VP
O	CD3	CD3	NN	B-NP
O	ubiquitylation	ubiquitylation	NN	I-NP
O	alters	alter	VBZ	B-VP
O	immunological	immunological	JJ	B-NP
O	synapse	synapse	NN	I-NP
O	(	(	(	O
O	IS	IS	NN	B-NP
O	)	)	)	O
O	formation	formation	NN	B-NP
O	and	and	CC	I-NP
O	Erk	Erk	NN	I-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	,	,	,	O
O	thereby	thereby	RB	B-VP
O	shifting	shift	VBG	I-VP
O	the	the	DT	B-NP
O	signalling	signalling	NN	I-NP
O	threshold	threshold	NN	I-NP
O	for	for	IN	B-PP
O	positive	positive	JJ	B-NP
O	and	and	CC	I-NP
O	negative	negative	JJ	I-NP
O	selection	selection	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	regulatory	regulatory	JJ	B-NP
O	T	T	NN	I-NP
O	-	-	HYPH	B-NP
O	cell	cell	NN	I-NP
O	development	development	NN	I-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
O	tonic	tonic	JJ	B-NP
O	TCR	TCR	NN	I-NP
O	:	:	:	O
O	CD3	CD3	NN	B-NP
O	ubiquitylation	ubiquitylation	NN	I-NP
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	precise	precise	JJ	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	TCR	TCR	NN	B-NP
O	expression	expression	NN	I-NP
O	on	on	IN	B-PP
O	immature	immature	JJ	B-NP
O	T	T	NN	I-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	to	to	TO	I-VP
O	maintain	maintain	VB	I-VP
O	the	the	DT	B-NP
O	fidelity	fidelity	NN	I-NP
O	of	of	IN	B-PP
O	T	T	NN	B-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	development	development	NN	I-NP
O	.	.	.	O

B-GGP	RNF8	RNF8	NN	B-NP
O	-	-	HYPH	I-NP
O	dependent	dependent	JJ	I-NP
B-GGP	histone	histone	NN	I-NP
O	modifications	modification	NNS	I-NP
O	regulate	regulate	VBP	B-VP
O	nucleosome	nucleosome	NN	B-NP
O	removal	removal	NN	I-NP
O	during	during	IN	B-PP
O	spermatogenesis	spermatogenesis	NN	B-NP
O	.	.	.	O

O	During	During	IN	B-PP
O	spermatogenesis	spermatogenesis	NN	B-NP
O	,	,	,	O
O	global	global	JJ	B-NP
O	nucleosome	nucleosome	NN	I-NP
O	removal	removal	NN	I-NP
O	occurs	occur	VBZ	B-VP
O	where	where	WRB	B-ADVP
B-GGP	histones	histone	NNS	B-NP
O	are	be	VBP	B-VP
O	initially	initially	RB	I-VP
O	replaced	replace	VBN	I-VP
O	by	by	IN	B-PP
O	transition	transition	NN	B-NP
O	proteins	protein	NNS	I-NP
O	and	and	CC	O
O	subsequently	subsequently	RB	B-ADVP
O	by	by	IN	B-PP
O	protamines	protamine	NNS	B-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	chromatin	chromatin	NN	I-NP
O	reorganization	reorganization	NN	I-NP
O	is	be	VBZ	B-VP
O	thought	think	VBN	I-VP
O	to	to	TO	I-VP
O	facilitate	facilitate	VB	I-VP
O	the	the	DT	B-NP
O	compaction	compaction	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	paternal	paternal	JJ	I-NP
O	genome	genome	NN	I-NP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	sperm	sperm	NN	I-NP
O	head	head	NN	I-NP
O	and	and	CC	O
O	to	to	TO	B-VP
O	protect	protect	VB	I-VP
O	the	the	DT	B-NP
O	DNA	DNA	NN	I-NP
O	from	from	IN	B-PP
O	damaging	damage	VBG	B-NP
O	agents	agent	NNS	I-NP
O	.	.	.	O

B-GGP	Histone	Histone	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	suggested	suggest	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	important	important	JJ	B-ADJP
O	for	for	IN	B-PP
O	sex	sex	NN	B-NP
O	chromosome	chromosome	NN	I-NP
O	inactivation	inactivation	NN	I-NP
O	during	during	IN	B-PP
O	meiotic	meiotic	JJ	B-NP
O	prophase	prophase	NN	I-NP
O	and	and	CC	I-NP
O	nucleosome	nucleosome	NN	I-NP
O	removal	removal	NN	I-NP
O	at	at	IN	B-PP
O	postmeiotic	postmeiotic	JJ	B-NP
O	stages	stage	NNS	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	regulating	regulate	VBG	B-VP
O	these	these	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	-	-	HYPH	B-NP
O	mediated	mediate	VBN	I-NP
O	processes	process	NNS	I-NP
O	are	be	VBP	B-VP
O	unknown	unknown	JJ	B-ADJP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	investigate	investigate	VBP	B-VP
O	the	the	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
B-GGP	RNF8	RNF8	NN	I-NP
O	during	during	IN	B-PP
O	spermatogenesis	spermatogenesis	NN	B-NP
O	and	and	CC	O
O	find	find	VB	B-VP
O	that	that	IN	B-SBAR
B-GGP	RNF8	RNF8	NN	B-NP
O	-	-	HYPH	B-NP
O	deficient	deficient	JJ	I-NP
O	mice	mouse	NNS	I-NP
O	are	be	VBP	B-VP
O	proficient	proficient	JJ	B-ADJP
O	in	in	IN	B-PP
O	meiotic	meiotic	JJ	B-NP
O	sex	sex	NN	I-NP
O	chromosome	chromosome	NN	I-NP
O	inactivation	inactivation	NN	I-NP
O	(	(	(	O
O	MSCI	MSCI	NN	B-NP
O	)	)	)	O
O	but	but	CC	O
O	deficient	deficient	JJ	B-ADJP
O	in	in	IN	B-PP
O	global	global	JJ	B-NP
O	nucleosome	nucleosome	NN	I-NP
O	removal	removal	NN	I-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	RNF8	RNF8	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
B-GGP	histone	histone	NN	I-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	induces	induce	VBZ	B-VP
B-GGP	H4K16	H4K16	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	an	an	DT	B-NP
O	initial	initial	JJ	I-NP
O	step	step	NN	I-NP
O	in	in	IN	B-PP
O	nucleosome	nucleosome	NN	B-NP
O	removal	removal	NN	I-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
O	our	our	PRP$	B-NP
O	results	result	NNS	I-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	RNF8	RNF8	NN	B-NP
O	plays	play	VBZ	B-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	role	role	NN	I-NP
O	during	during	IN	B-PP
O	spermatogenesis	spermatogenesis	NN	B-NP
O	through	through	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	,	,	,	O
O	resulting	result	VBG	B-VP
O	in	in	IN	B-PP
O	trans	trans	AFX	B-NP
O	-	-	HYPH	I-NP
B-GGP	histone	histone	NN	I-NP
O	acetylation	acetylation	NN	I-NP
O	and	and	CC	O
O	global	global	JJ	B-NP
O	nucleosome	nucleosome	NN	I-NP
O	removal	removal	NN	I-NP
O	.	.	.	O

O	Predicted	Predict	VBN	B-NP
O	functions	function	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	MdmX	MdmX	NN	B-NP
O	in	in	IN	B-PP
O	fine	fine	NN	B-NP
O	-	-	HYPH	O
O	tuning	tune	VBG	B-VP
O	the	the	DT	B-NP
O	response	response	NN	I-NP
O	of	of	IN	B-PP
B-GGP	p53	p53	NN	B-NP
O	to	to	TO	B-PP
O	DNA	DNA	NN	B-NP
O	damage	damage	NN	I-NP
O	.	.	.	O

O	Tumor	Tumor	NN	B-NP
O	suppressor	suppressor	NN	I-NP
O	protein	protein	NN	I-NP
B-GGP	p53	p53	NN	I-NP
O	is	be	VBZ	B-VP
O	regulated	regulate	VBN	I-VP
O	by	by	IN	B-PP
O	two	two	CD	B-NP
O	structurally	structurally	RB	I-NP
O	homologous	homologous	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	,	,	,	O
B-GGP	Mdm2	Mdm2	NN	B-NP
O	and	and	CC	I-NP
B-GGP	MdmX	MdmX	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	contrast	contrast	NN	B-NP
O	to	to	TO	B-PP
B-GGP	Mdm2	Mdm2	NN	B-NP
O	,	,	,	O
B-GGP	MdmX	MdmX	NN	B-NP
O	lacks	lack	VBZ	B-VP
B-GGP	ubiquitin	ubiquitin	NN	B-NP
O	ligase	ligase	NN	I-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	Although	Although	IN	B-SBAR
O	the	the	DT	B-NP
O	essential	essential	JJ	I-NP
O	interactions	interaction	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	MdmX	MdmX	NN	B-NP
O	are	be	VBP	B-VP
O	known	know	VBN	I-VP
O	,	,	,	O
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	not	not	RB	O
O	clear	clear	JJ	B-ADJP
O	how	how	WRB	B-ADVP
O	they	they	PRP	B-NP
O	function	function	VBP	B-VP
O	to	to	TO	I-VP
O	regulate	regulate	VB	I-VP
B-GGP	p53	p53	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	tumor	tumor	NN	B-NP
O	suppressor	suppressor	NN	I-NP
B-GGP	p53	p53	NN	I-NP
O	by	by	IN	B-PP
B-GGP	Mdm2	Mdm2	NN	B-NP
O	and	and	CC	I-NP
B-GGP	MdmX	MdmX	NN	I-NP
O	in	in	IN	B-PP
O	response	response	NN	I-PP
O	to	to	TO	I-PP
O	DNA	DNA	NN	B-NP
O	damage	damage	NN	I-NP
O	was	be	VBD	B-VP
O	investigated	investigate	VBN	I-VP
O	by	by	IN	B-PP
O	mathematical	mathematical	JJ	B-NP
O	modeling	modeling	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	simplified	simplified	JJ	I-NP
O	network	network	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	simplified	simplified	JJ	I-NP
O	network	network	NN	I-NP
O	model	model	NN	I-NP
O	was	be	VBD	B-VP
O	derived	derive	VBN	I-VP
O	from	from	IN	B-PP
O	a	a	DT	B-NP
O	detailed	detailed	JJ	I-NP
O	molecular	molecular	JJ	I-NP
O	interaction	interaction	NN	I-NP
O	map	map	NN	I-NP
O	(	(	(	O
O	MIM	MIM	NN	B-NP
O	)	)	)	O
O	that	that	WDT	B-NP
O	exhibited	exhibit	VBD	B-VP
O	four	four	CD	B-NP
O	coherent	coherent	JJ	I-NP
O	DNA	DNA	NN	I-NP
O	damage	damage	NN	I-NP
O	response	response	NN	I-NP
O	pathways	pathway	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	MdmX	MdmX	NN	B-NP
O	may	may	MD	B-VP
O	amplify	amplify	VB	I-VP
O	or	or	CC	I-VP
O	stabilize	stabilize	VB	I-VP
O	DNA	DNA	NN	B-NP
O	damage	damage	NN	I-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
B-GGP	p53	p53	NN	I-NP
O	responses	response	NNS	I-NP
O	via	via	IN	B-PP
O	non	non	AFX	B-NP
O	-	-	HYPH	I-NP
O	enzymatic	enzymatic	JJ	I-NP
O	interactions	interaction	NNS	I-NP
O	.	.	.	O

O	Transient	Transient	JJ	B-NP
O	effects	effect	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	MdmX	MdmX	NN	B-NP
O	are	be	VBP	B-VP
O	mediated	mediate	VBN	I-VP
O	by	by	IN	B-PP
O	reservoirs	reservoir	NNS	B-NP
O	of	of	IN	B-PP
B-GGP	p53ratioMdmX	p53ratioMdmX	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Mdm2ratioMdmX	Mdm2ratioMdmX	NN	I-NP
O	heterodimers	heterodimer	NNS	I-NP
O	,	,	,	O
O	with	with	IN	B-PP
B-GGP	MdmX	MdmX	NN	B-NP
O	buffering	buffer	VBG	B-VP
O	the	the	DT	B-NP
O	concentrations	concentration	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	p53	p53	NN	B-NP
O	and	and	CC	O
O	/	/	SYM	B-NP
O	or	or	CC	O
B-GGP	Mdm2	Mdm2	NN	B-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	survey	survey	NN	I-NP
O	of	of	IN	B-PP
O	kinetic	kinetic	JJ	B-NP
O	parameter	parameter	NN	I-NP
O	space	space	NN	I-NP
O	disclosed	disclose	VBD	B-VP
O	regions	region	NNS	B-NP
O	of	of	IN	B-PP
O	switch	switch	NN	B-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	behavior	behavior	NN	I-NP
O	stemming	stem	VBG	B-VP
O	from	from	IN	B-PP
O	such	such	JJ	B-NP
O	reservoir	reservoir	NN	I-NP
O	-	-	HYPH	B-NP
O	based	base	VBN	I-NP
O	transients	transient	NNS	I-NP
O	.	.	.	O

O	During	During	IN	B-PP
O	an	an	DT	B-NP
O	early	early	JJ	I-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
O	DNA	DNA	NN	B-NP
O	damage	damage	NN	I-NP
O	,	,	,	O
B-GGP	MdmX	MdmX	NN	B-NP
O	positively	positively	RB	B-VP
O	or	or	CC	I-VP
O	negatively	negatively	RB	B-NP
O	regulated	regulate	VBN	I-NP
B-GGP	p53	p53	NN	I-NP
O	activity	activity	NN	I-NP
O	,	,	,	O
O	depending	depend	VBG	B-PP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	level	level	NN	I-NP
O	of	of	IN	B-PP
B-GGP	Mdm2	Mdm2	NN	B-NP
O	;	;	:	O
O	this	this	DT	B-NP
O	led	lead	VBD	B-VP
O	to	to	TO	B-PP
O	amplification	amplification	NN	B-NP
O	of	of	IN	B-PP
B-GGP	p53	p53	NN	B-NP
O	activity	activity	NN	I-NP
O	and	and	CC	I-NP
O	switch	switch	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	response	response	NN	I-NP
O	.	.	.	O

O	During	During	IN	B-PP
O	a	a	DT	B-NP
O	late	late	JJ	I-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
O	DNA	DNA	NN	B-NP
O	damage	damage	NN	I-NP
O	,	,	,	O
B-GGP	MdmX	MdmX	NN	B-NP
O	could	could	MD	B-VP
O	dampen	dampen	VB	I-VP
O	oscillations	oscillation	NNS	B-NP
O	of	of	IN	B-PP
B-GGP	p53	p53	NN	B-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	possible	possible	JJ	I-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
B-GGP	MdmX	MdmX	NN	B-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	to	to	TO	B-VP
O	dampen	dampen	VB	I-VP
O	such	such	JJ	B-NP
O	oscillations	oscillation	NNS	I-NP
O	that	that	WDT	B-NP
O	otherwise	otherwise	RB	B-ADVP
O	could	could	MD	B-VP
O	produce	produce	VB	I-VP
O	erratic	erratic	JJ	B-NP
O	cell	cell	NN	I-NP
O	behavior	behavior	NN	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	study	study	NN	I-NP
O	suggests	suggest	VBZ	B-VP
O	how	how	WRB	B-ADVP
B-GGP	MdmX	MdmX	NN	B-NP
O	may	may	MD	B-VP
O	participate	participate	VB	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	response	response	NN	I-NP
O	of	of	IN	B-PP
B-GGP	p53	p53	NN	B-NP
O	to	to	TO	B-PP
O	DNA	DNA	NN	B-NP
O	damage	damage	NN	I-NP
O	either	either	CC	B-PP
O	by	by	IN	B-PP
O	increasing	increase	VBG	B-VP
O	dependency	dependency	NN	B-NP
O	of	of	IN	B-PP
B-GGP	p53	p53	NN	B-NP
O	on	on	IN	B-PP
B-GGP	Mdm2	Mdm2	NN	B-NP
O	or	or	CC	B-PP
O	by	by	IN	B-PP
O	dampening	dampen	VBG	B-VP
O	oscillations	oscillation	NNS	B-NP
O	of	of	IN	B-PP
B-GGP	p53	p53	NN	B-NP
O	activity	activity	NN	I-NP
O	and	and	CC	O
O	presents	present	VBZ	B-VP
O	a	a	DT	B-NP
O	model	model	NN	I-NP
O	for	for	IN	B-PP
O	experimental	experimental	JJ	B-NP
O	investigation	investigation	NN	I-NP
O	.	.	.	O

B-GGP	Glioma	Glioma	NN	B-NP
I-GGP	pathogenesis	pathogenesis	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	related	relate	VBN	B-NP
I-GGP	1	1	CD	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	like	like	JJ	I-NP
I-GGP	1	1	CD	I-NP
O	is	be	VBZ	B-VP
O	testis	testis	NN	B-NP
O	enriched	enrich	VBN	B-VP
O	,	,	,	O
O	dynamically	dynamically	RB	B-VP
O	modified	modify	VBN	I-VP
O	,	,	,	O
O	and	and	CC	O
O	redistributed	redistribute	VBN	B-VP
O	during	during	IN	B-PP
O	male	male	JJ	B-NP
O	germ	germ	NN	I-NP
O	cell	cell	NN	I-NP
O	maturation	maturation	NN	I-NP
O	and	and	CC	O
O	has	have	VBZ	B-VP
O	a	a	DT	B-NP
O	potential	potential	JJ	I-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	sperm	sperm	NN	B-NP
O	-	-	HYPH	B-NP
O	oocyte	oocyte	NN	I-NP
O	binding	binding	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	glioma	glioma	NN	I-NP
I-GGP	pathogenesis	pathogenesis	NN	I-NP
I-GGP	-	-	HYPH	O
I-GGP	related	relate	VBN	B-NP
I-GGP	1	1	CD	I-NP
O	(	(	(	O
B-GGP	GLIPR1	GLIPR1	NN	B-NP
O	)	)	)	O
O	family	family	NN	B-NP
O	consists	consist	VBZ	B-VP
O	of	of	IN	B-PP
O	three	three	CD	B-NP
O	genes	gene	NNS	I-NP
O	[	[	(	O
B-GGP	GLIPR1	GLIPR1	NN	B-NP
O	,	,	,	O
B-GGP	GLIPR1	GLIPR1	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	like	like	JJ	O
I-GGP	1	1	CD	B-NP
O	(	(	(	O
B-GGP	GLIPR1L1	GLIPR1L1	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
B-GGP	GLIPR1	GLIPR1	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	like	like	JJ	I-NP
I-GGP	2	2	CD	I-NP
O	(	(	NN	I-NP
B-GGP	GLIPR1L2	GLIPR1L2	NN	I-NP
O	)	)	)	O
O	]	]	)	O
O	and	and	CC	O
O	forms	form	VBZ	B-VP
O	a	a	DT	B-NP
O	distinct	distinct	JJ	I-NP
O	subgroup	subgroup	NN	I-NP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	cysteine	cysteine	NN	I-NP
O	-	-	HYPH	B-NP
O	rich	rich	JJ	I-NP
O	secretory	secretory	JJ	I-NP
O	protein	protein	NN	I-NP
O	(	(	(	O
O	CRISP	CRISP	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	antigen	antigen	NN	B-NP
O	5	5	CD	I-NP
O	,	,	,	O
O	and	and	CC	O
O	pathogenesis	pathogenesis	NN	B-NP
O	-	-	HYPH	O
O	related	relate	VBN	B-NP
O	1	1	CD	I-NP
O	(	(	(	O
O	CAP	CAP	NN	B-NP
O	)	)	)	O
O	superfamily	superfamily	NN	B-NP
O	.	.	.	O

O	CAP	CAP	NN	B-NP
O	superfamily	superfamily	NN	I-NP
O	proteins	protein	NNS	I-NP
O	are	be	VBP	B-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	phyla	phyla	NN	B-NP
O	ranging	range	VBG	B-VP
O	from	from	IN	B-PP
O	plants	plant	NNS	B-NP
O	to	to	TO	B-PP
O	humans	human	NNS	B-NP
O	and	and	CC	O
O	,	,	,	O
O	based	base	VBN	B-VP
O	largely	largely	RB	B-ADVP
O	on	on	IN	B-PP
O	expression	expression	NN	B-NP
O	and	and	CC	O
O	limited	limited	JJ	B-NP
O	functional	functional	JJ	I-NP
O	studies	study	NNS	I-NP
O	,	,	,	O
O	are	be	VBP	B-VP
O	hypothesized	hypothesize	VBN	I-VP
O	to	to	TO	I-VP
O	have	have	VB	I-VP
O	roles	role	NNS	B-NP
O	in	in	IN	B-PP
O	carcinogenesis	carcinogenesis	NN	B-NP
O	,	,	,	O
O	immunity	immunity	NN	B-NP
O	,	,	,	O
O	cell	cell	NN	B-NP
O	adhesion	adhesion	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	male	male	JJ	B-NP
O	fertility	fertility	NN	I-NP
O	.	.	.	O

O	Specifically	Specifically	RB	B-NP
O	data	datum	NNS	I-NP
O	from	from	IN	B-PP
O	a	a	DT	B-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	systems	system	NNS	B-NP
O	suggests	suggest	VBZ	B-VP
O	that	that	IN	B-SBAR
O	sequences	sequence	NNS	B-NP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	C	C	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	CAP	CAP	NN	I-NP
O	domain	domain	NN	I-NP
O	of	of	IN	B-PP
O	CAP	CAP	NN	B-NP
O	proteins	protein	NNS	I-NP
O	have	have	VBP	B-VP
O	the	the	DT	B-NP
O	ability	ability	NN	I-NP
O	to	to	TO	B-VP
O	promote	promote	VB	I-VP
O	cell	cell	NN	B-NP
O	-	-	HYPH	I-NP
O	cell	cell	NN	I-NP
O	adhesion	adhesion	NN	I-NP
O	.	.	.	O

O	Herein	Herein	RB	B-ADVP
O	we	we	PRP	B-NP
O	cloned	clone	VBD	B-VP
O	mouse	mouse	NN	B-NP
B-GGP	Glipr1l1	Glipr1l1	NN	I-NP
O	and	and	CC	O
O	have	have	VBP	B-VP
O	shown	show	VBN	I-VP
O	it	it	PRP	B-NP
O	has	have	VBZ	B-VP
O	a	a	DT	B-NP
O	testis	testis	NN	I-NP
O	-	-	HYPH	O
O	enriched	enrich	VBN	B-NP
O	expression	expression	NN	I-NP
O	profile	profile	NN	I-NP
O	.	.	.	O

B-GGP	GLIPR1L1	GLIPR1L1	NN	B-NP
O	is	be	VBZ	B-VP
O	posttranslationally	posttranslationally	RB	I-VP
O	modified	modify	VBN	I-VP
O	by	by	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	during	during	IN	B-PP
O	spermatogenesis	spermatogenesis	NN	B-NP
O	and	and	CC	O
O	ultimately	ultimately	RB	B-VP
O	becomes	become	VBZ	I-VP
O	localized	localized	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	connecting	connect	VBG	I-NP
O	piece	piece	NN	I-NP
O	of	of	IN	B-PP
O	elongated	elongate	VBN	B-NP
O	spermatids	spermatid	NNS	I-NP
O	and	and	CC	I-NP
O	sperm	sperm	NN	I-NP
O	.	.	.	O

O	After	After	IN	B-PP
O	sperm	sperm	NN	B-NP
O	capacitation	capacitation	NN	I-NP
O	,	,	,	O
O	however	however	RB	B-ADVP
O	,	,	,	O
B-GGP	GLIPR1L1	GLIPR1L1	NN	B-NP
O	is	be	VBZ	B-VP
O	also	also	RB	B-ADVP
O	localized	localized	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	anterior	anterior	JJ	I-NP
O	regions	region	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	sperm	sperm	NN	I-NP
O	head	head	NN	I-NP
O	.	.	.	O

O	Zona	Zona	NN	B-NP
O	pellucida	pellucida	NN	I-NP
O	binding	binding	NN	I-NP
O	assays	assay	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	GLIPR1L1	GLIPR1L1	NN	B-NP
O	has	have	VBZ	B-VP
O	a	a	DT	B-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
O	sperm	sperm	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	zona	zona	NN	I-NP
O	pellucida	pellucida	NN	I-NP
O	surrounding	surround	VBG	B-VP
O	the	the	DT	B-NP
O	oocyte	oocyte	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	,	,	,	O
O	along	along	IN	B-PP
O	with	with	IN	B-PP
O	other	other	JJ	B-NP
O	members	member	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	CAP	CAP	NN	I-NP
O	superfamily	superfamily	NN	I-NP
O	and	and	CC	O
O	several	several	JJ	B-NP
O	other	other	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	,	,	,	O
B-GGP	GLIPR1L1	GLIPR1L1	NN	B-NP
O	is	be	VBZ	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
O	sperm	sperm	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	oocyte	oocyte	NN	I-NP
O	complex	complex	NN	I-NP
O	.	.	.	O

O	Collectively	Collectively	RB	B-ADVP
O	these	these	DT	B-NP
O	data	datum	NNS	I-NP
O	further	further	RBR	B-ADVP
O	strengthen	strengthen	VBP	B-VP
O	the	the	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	CAP	CAP	NN	B-NP
O	domain	domain	NN	I-NP
O	-	-	HYPH	O
O	containing	contain	VBG	B-VP
O	proteins	protein	NNS	B-NP
O	in	in	IN	B-PP
O	cellular	cellular	JJ	B-NP
O	adhesion	adhesion	NN	I-NP
O	and	and	CC	O
O	propose	propose	VBP	B-VP
O	a	a	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	whereby	whereby	WRB	B-ADVP
O	CAP	CAP	NN	B-NP
O	proteins	protein	NNS	I-NP
O	show	show	VBP	B-VP
O	overlapping	overlap	VBG	I-VP
O	functional	functional	JJ	B-NP
O	significance	significance	NN	I-NP
O	during	during	IN	B-PP
O	fertilization	fertilization	NN	B-NP
O	.	.	.	O

B-GGP	UTX	UTX	NN	B-NP
O	mediates	mediate	VBZ	B-VP
O	demethylation	demethylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	H3K27me3	H3K27me3	NN	B-NP
O	at	at	IN	B-PP
O	muscle	muscle	NN	B-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	genes	gene	NNS	I-NP
O	during	during	IN	B-PP
O	myogenesis	myogenesis	NN	B-NP
O	.	.	.	O

O	Polycomb	Polycomb	NN	B-NP
O	(	(	(	O
O	PcG	PcG	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	Trithorax	Trithorax	NN	B-NP
O	(	(	(	O
O	TrxG	TrxG	NN	B-NP
O	)	)	)	O
O	group	group	NN	B-NP
O	proteins	protein	NNS	I-NP
O	act	act	VBP	B-VP
O	antagonistically	antagonistically	RB	B-ADVP
O	to	to	TO	B-VP
O	establish	establish	VB	I-VP
O	tissue	tissue	NN	B-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	patterns	pattern	NNS	I-NP
O	of	of	IN	B-PP
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	PcG	PcG	NN	I-NP
O	protein	protein	NN	I-NP
B-GGP	Ezh2	Ezh2	NN	I-NP
O	facilitates	facilitate	VBZ	B-VP
O	repression	repression	NN	B-NP
O	by	by	IN	B-PP
O	catalysing	catalyse	VBG	B-VP
B-GGP	histone	histone	NN	B-NP
I-GGP	H3	H3	NN	I-NP
O	-	-	HYPH	B-NP
O	Lys27	Lys27	NN	I-NP
O	trimethylation	trimethylation	NN	I-NP
O	(	(	(	O
B-GGP	H3K27me3	H3K27me3	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	For	For	IN	B-PP
O	expression	expression	NN	B-NP
O	,	,	,	O
B-GGP	H3K27me3	H3K27me3	NN	B-NP
O	marks	mark	NNS	I-NP
O	are	be	VBP	B-VP
O	removed	remove	VBN	I-VP
O	and	and	CC	I-VP
O	replaced	replace	VBN	I-VP
O	by	by	IN	B-PP
O	TrxG	TrxG	NN	B-NP
O	protein	protein	NN	I-NP
O	catalysed	catalyse	VBD	B-VP
O	histone	histone	NN	B-NP
B-GGP	H3	H3	NN	I-NP
O	-	-	HYPH	B-NP
O	Lys4	Lys4	NN	I-NP
O	trimethylation	trimethylation	NN	I-NP
O	(	(	(	O
B-GGP	H3K4me3	H3K4me3	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Although	Although	IN	B-SBAR
B-GGP	H3K27	H3K27	NN	B-NP
O	demethylases	demethylas	NNS	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	identified	identify	VBN	I-VP
O	,	,	,	O
O	the	the	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	by	by	IN	B-PP
O	which	which	WDT	B-NP
O	these	these	DT	B-NP
O	enzymes	enzyme	NNS	I-NP
O	are	be	VBP	B-VP
O	targeted	target	VBN	I-VP
O	to	to	TO	B-PP
O	specific	specific	JJ	B-NP
O	genomic	genomic	JJ	I-NP
O	regions	region	NNS	I-NP
O	to	to	TO	B-VP
O	remove	remove	VB	I-VP
B-GGP	H3K27me3	H3K27me3	NN	B-NP
O	marks	mark	NNS	I-NP
O	has	have	VBZ	B-VP
O	not	not	RB	I-VP
O	been	be	VBN	I-VP
O	established	establish	VBN	I-VP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	demonstrate	demonstrate	VBP	B-VP
O	a	a	DT	B-NP
O	two	two	CD	I-NP
O	-	-	HYPH	I-NP
O	step	step	NN	I-NP
O	mechanism	mechanism	NN	I-NP
O	for	for	IN	B-PP
B-GGP	UTX	UTX	NN	B-NP
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	demethylation	demethylation	NN	I-NP
O	at	at	IN	B-PP
O	muscle	muscle	NN	B-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	genes	gene	NNS	I-NP
O	during	during	IN	B-PP
O	myogenesis	myogenesis	NN	B-NP
O	.	.	.	O

O	Although	Although	IN	B-SBAR
O	the	the	DT	B-NP
O	transactivator	transactivator	NN	I-NP
B-GGP	Six4	Six4	CD	I-NP
O	initially	initially	RB	B-ADVP
O	recruits	recruit	VBZ	B-VP
B-GGP	UTX	UTX	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	regulatory	regulatory	JJ	I-NP
O	region	region	NN	I-NP
O	of	of	IN	B-PP
O	muscle	muscle	NN	B-NP
O	genes	gene	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	resulting	result	VBG	I-NP
O	loss	loss	NN	I-NP
O	of	of	IN	B-PP
B-GGP	H3K27me3	H3K27me3	NN	B-NP
O	marks	mark	NNS	I-NP
O	is	be	VBZ	B-VP
O	limited	limit	VBN	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	region	region	NN	I-NP
O	upstream	upstream	JJ	B-ADJP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	start	start	NN	I-NP
O	site	site	NN	I-NP
O	.	.	.	O

O	Removal	Removal	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	repressive	repressive	JJ	I-NP
B-GGP	H3K27me3	H3K27me3	NN	I-NP
O	mark	mark	NN	I-NP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	coding	cod	VBG	I-NP
O	region	region	NN	I-NP
O	then	then	RB	B-ADVP
O	requires	require	VBZ	B-VP
O	RNA	RNA	NN	B-NP
O	Polymerase	Polymerase	NN	I-NP
O	II	II	CD	I-NP
O	(	(	(	O
O	Pol	Pol	NN	O
O	II	II	CD	O
O	)	)	)	O
O	elongation	elongation	NN	B-NP
O	.	.	.	O

O	Interestingly	Interestingly	RB	B-ADVP
O	,	,	,	O
O	blocking	block	VBG	B-VP
O	Pol	Pol	NN	B-NP
O	II	II	CD	I-NP
O	elongation	elongation	NN	I-NP
O	on	on	IN	B-PP
O	transcribed	transcribe	VBN	B-NP
O	genes	gene	NNS	I-NP
O	leads	lead	VBZ	B-VP
O	to	to	TO	B-PP
O	increased	increase	VBN	B-NP
B-GGP	H3K27me3	H3K27me3	NN	I-NP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	coding	cod	VBG	I-NP
O	region	region	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	formation	formation	NN	B-NP
O	of	of	IN	B-PP
O	bivalent	bivalent	JJ	B-NP
O	(	(	(	O
B-GGP	H3K27me3	H3K27me3	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	H3K4me3	H3K4me3	NN	I-NP
O	)	)	)	O
O	chromatin	chromatin	NN	B-NP
O	domains	domain	NNS	I-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
O	removal	removal	NN	B-NP
O	of	of	IN	B-PP
O	repressive	repressive	JJ	B-NP
B-GGP	H3K27me3	H3K27me3	NN	I-NP
O	marks	mark	NNS	I-NP
O	by	by	IN	B-PP
B-GGP	UTX	UTX	NN	B-NP
O	occurs	occur	VBZ	B-VP
O	through	through	IN	B-PP
O	targeted	target	VBN	B-NP
O	recruitment	recruitment	NN	I-NP
O	followed	follow	VBN	B-VP
O	by	by	IN	B-PP
O	spreading	spread	VBG	B-VP
O	across	across	IN	B-PP
O	the	the	DT	B-NP
O	gene	gene	NN	I-NP
O	.	.	.	O

O	Protein	Protein	NN	B-NP
O	-	-	HYPH	I-NP
O	protein	protein	NN	I-NP
O	interactions	interaction	NNS	I-NP
O	involving	involve	VBG	B-VP
B-GGP	IKKgamma	IKKgamma	NN	B-NP
O	(	(	(	O
B-GGP	NEMO	NEMO	NN	B-NP
O	)	)	)	O
O	that	that	WDT	B-NP
O	promote	promote	VBP	B-VP
O	the	the	DT	B-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	.	.	.	O

B-GGP	Inhibitor	Inhibitor	NN	B-NP
I-GGP	of	of	IN	B-PP
I-GGP	kappaB	kappaB	NN	B-NP
I-GGP	kinase	kinase	NN	I-NP
I-GGP	(	(	(	O
I-GGP	IKK	IKK	NN	B-NP
I-GGP	)	)	)	O
I-GGP	gamma	gamma	NN	B-NP
O	(	(	(	O
B-GGP	IKKgamma	IKKgamma	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	also	also	RB	B-VP
O	referred	refer	VBN	I-VP
O	to	to	TO	B-PP
O	as	as	IN	B-PP
B-GGP	nuclear	nuclear	JJ	B-NP
I-GGP	factor	factor	NN	I-NP
I-GGP	kappaB	kappaB	NN	I-NP
I-GGP	(	(	(	O
I-GGP	NF	NF	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	kappaB	kappaB	NN	I-NP
I-GGP	)	)	)	I-NP
I-GGP	essential	essential	JJ	I-NP
I-GGP	modulator	modulator	NN	I-NP
O	(	(	(	O
B-GGP	NEMO	NEMO	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	is	be	VBZ	B-VP
O	an	an	DT	B-NP
O	important	important	JJ	I-NP
O	regulatory	regulatory	JJ	I-NP
O	component	component	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	IKK	IKK	NN	I-NP
O	complex	complex	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	IKK	IKK	NN	I-NP
O	complex	complex	NN	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	signalosome	signalosome	NN	I-NP
O	that	that	WDT	B-NP
O	catalyzes	catalyze	VBZ	B-VP
O	the	the	DT	B-NP
O	inducible	inducible	JJ	I-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	of	of	IN	B-PP
O	IkappaB	IkappaB	NN	B-NP
O	proteins	protein	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	key	key	JJ	I-NP
O	step	step	NN	I-NP
O	that	that	WDT	B-NP
O	leads	lead	VBZ	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	exact	exact	JJ	I-NP
O	functions	function	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	IKKgamma	IKKgamma	NN	B-NP
O	(	(	(	O
B-GGP	NEMO	NEMO	NN	B-NP
O	)	)	)	O
O	as	as	IN	B-PP
O	part	part	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	IKK	IKK	NN	I-NP
O	complex	complex	NN	I-NP
O	have	have	VBP	B-VP
O	not	not	RB	I-VP
O	yet	yet	RB	I-VP
O	been	be	VBN	I-VP
O	fully	fully	RB	B-ADJP
O	elucidated	elucidate	VBN	I-ADJP
O	.	.	.	O

O	This	This	DT	B-NP
O	mini	mini	AFX	I-NP
O	-	-	HYPH	I-NP
O	review	review	NN	I-NP
O	covers	cover	VBZ	B-VP
O	16	16	CD	B-NP
O	proteins	protein	NNS	I-NP
O	that	that	WDT	B-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	reported	report	VBN	I-VP
O	to	to	TO	I-VP
O	bind	bind	VB	I-VP
O	to	to	TO	B-PP
B-GGP	IKKgamma	IKKgamma	NN	B-NP
O	and	and	CC	O
O	lead	lead	VBP	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	enhancement	enhancement	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	activities	activity	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	IKK	IKK	NN	I-NP
O	complex	complex	NN	I-NP
O	,	,	,	O
O	thus	thus	RB	B-ADVP
O	resulting	result	VBG	B-VP
O	in	in	IN	B-PP
O	NF	NF	NN	B-NP
O	-	-	HYPH	B-NP
O	kappaB	kappaB	NN	I-NP
O	activation	activation	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	major	major	JJ	I-NP
O	mechanisms	mechanism	NNS	I-NP
O	by	by	IN	B-PP
O	which	which	WDT	B-NP
O	these	these	DT	B-NP
O	interactions	interaction	NNS	I-NP
O	are	be	VBP	B-VP
O	mediated	mediate	VBN	I-VP
O	involve	involve	VBP	B-VP
O	the	the	DT	B-NP
O	recognition	recognition	NN	I-NP
O	of	of	IN	B-PP
O	ubiquitinated	ubiquitinated	JJ	B-NP
O	upstream	upstream	JJ	I-NP
O	signaling	signaling	NN	I-NP
O	components	component	NNS	I-NP
O	by	by	IN	B-PP
B-GGP	IKKgamma	IKKgamma	NN	B-NP
O	or	or	CC	O
O	the	the	DT	B-NP
O	modification	modification	NN	I-NP
O	of	of	IN	B-PP
B-GGP	IKKgamma	IKKgamma	NN	B-NP
O	itself	itself	PRP	B-NP
O	by	by	IN	B-PP
O	ubiquitination	ubiquitination	NN	B-NP
O	.	.	.	O

O	Additional	Additional	JJ	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	include	include	VBP	B-VP
O	the	the	DT	B-NP
O	sumoylation	sumoylation	NN	I-NP
O	or	or	CC	I-NP
O	phosphorylation	phosphorylation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	IKKgamma	IKKgamma	NN	B-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	modification	modification	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	tertiary	tertiary	JJ	I-NP
O	or	or	CC	I-NP
O	quaternary	quaternary	JJ	I-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
B-GGP	IKKgamma	IKKgamma	NN	B-NP
O	.	.	.	O

O	Extended	Extend	VBN	B-NP
O	ischemia	ischemia	NN	I-NP
O	prevents	prevent	VBZ	B-VP
B-GGP	HIF1alpha	HIF1alpha	NN	B-NP
O	degradation	degradation	NN	I-NP
O	at	at	IN	B-PP
O	reoxygenation	reoxygenation	NN	B-NP
O	by	by	IN	B-PP
O	impairing	impair	VBG	B-VP
O	prolyl	prolyl	NN	B-NP
O	-	-	HYPH	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	:	:	:	O
O	role	role	NN	B-NP
O	of	of	IN	B-PP
O	Krebs	Krebs	NNP	B-NP
O	cycle	cycle	NN	I-NP
O	metabolites	metabolite	NNS	I-NP
O	.	.	.	O

O	Hypoxia	Hypoxia	NN	B-NP
O	-	-	HYPH	B-NP
O	inducible	inducible	JJ	I-NP
O	factor	factor	NN	I-NP
O	(	(	(	O
O	HIF	HIF	NN	B-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	heterodimeric	heterodimeric	JJ	I-NP
O	transcription	transcription	NN	I-NP
O	factor	factor	NN	I-NP
O	that	that	WDT	B-NP
O	activates	activate	VBZ	B-VP
O	the	the	DT	B-NP
O	cellular	cellular	JJ	I-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
O	hypoxia	hypoxia	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	HIF1alpha	HIF1alpha	NN	I-NP
O	subunit	subunit	NN	I-NP
O	is	be	VBZ	B-VP
O	constantly	constantly	RB	I-VP
O	synthesized	synthesize	VBN	I-VP
O	and	and	CC	I-VP
O	degraded	degrade	VBN	I-VP
O	under	under	IN	B-PP
O	normoxia	normoxia	NN	B-NP
O	,	,	,	O
O	but	but	CC	O
O	degradation	degradation	NN	B-NP
O	is	be	VBZ	B-VP
O	rapidly	rapidly	RB	I-VP
O	inhibited	inhibit	VBN	I-VP
O	when	when	WRB	B-ADVP
O	oxygen	oxygen	NN	B-NP
O	levels	level	NNS	I-NP
O	drop	drop	VBP	B-VP
O	.	.	.	O

O	Oxygen	Oxygen	NN	B-NP
O	-	-	HYPH	I-NP
O	dependent	dependent	JJ	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	by	by	IN	B-PP
O	prolyl	prolyl	NN	B-NP
O	-	-	HYPH	B-NP
O	4	4	CD	I-NP
O	-	-	HYPH	I-NP
O	hydroxylases	hydroxylas	NNS	I-NP
O	(	(	(	O
O	PHD	PHD	NN	B-NP
O	)	)	)	O
O	mediates	mediate	VBZ	B-VP
B-GGP	HIF1alpha	HIF1alpha	NN	B-NP
O	proteasome	proteasome	NN	I-NP
O	degradation	degradation	NN	I-NP
O	.	.	.	O

O	Brain	Brain	NN	B-NP
O	ischemia	ischemia	NN	I-NP
O	limits	limit	VBZ	B-VP
O	the	the	DT	B-NP
O	availability	availability	NN	I-NP
O	not	not	RB	B-CONJP
O	only	only	RB	I-CONJP
O	of	of	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	but	but	CC	B-CONJP
O	also	also	RB	I-CONJP
O	of	of	IN	B-PP
O	glucose	glucose	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	hypothesized	hypothesize	VBD	B-VP
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	circumstance	circumstance	NN	I-NP
O	could	could	MD	B-VP
O	have	have	VB	I-VP
O	a	a	DT	B-NP
O	modulating	modulating	JJ	I-NP
O	effect	effect	NN	I-NP
O	on	on	IN	B-PP
O	HIF	HIF	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	assessed	assess	VBD	B-VP
O	the	the	DT	B-NP
O	separate	separate	JJ	I-NP
O	involvement	involvement	NN	I-NP
O	of	of	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	and	and	CC	I-NP
O	glucose	glucose	NN	I-NP
O	in	in	IN	B-PP
B-GGP	HIF1alpha	HIF1alpha	NN	B-NP
O	regulation	regulation	NN	I-NP
O	in	in	IN	B-PP
O	differentiated	differentiate	VBN	B-NP
O	neuroblastoma	neuroblastoma	NN	I-NP
O	cells	cell	NNS	I-NP
O	subjected	subject	VBN	B-VP
O	to	to	TO	B-PP
O	ischemia	ischemia	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	report	report	VBP	B-VP
O	higher	high	JJR	B-NP
O	transcriptional	transcriptional	JJ	I-NP
O	activity	activity	NN	I-NP
O	and	and	CC	I-NP
B-GGP	HIF1alpha	HIF1alpha	NN	I-NP
O	expression	expression	NN	I-NP
O	under	under	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	deprivation	deprivation	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	glucose	glucose	NN	B-NP
O	(	(	(	O
O	OD	OD	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	than	than	IN	B-PP
O	in	in	IN	B-PP
O	its	its	PRP$	B-NP
O	absence	absence	NN	I-NP
O	(	(	(	O
O	oxygen	oxygen	NN	B-NP
O	and	and	CC	O
O	glucose	glucose	NN	B-NP
O	deprivation	deprivation	NN	I-NP
O	,	,	,	O
O	OGD	OGD	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Unexpectedly	Unexpectedly	RB	B-ADVP
O	,	,	,	O
B-GGP	HIF1alpha	HIF1alpha	NN	B-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	degraded	degrade	VBN	I-VP
O	at	at	IN	B-PP
O	reoxygenation	reoxygenation	NN	B-NP
O	after	after	IN	B-PP
O	an	an	DT	B-NP
O	episode	episode	NN	I-NP
O	of	of	IN	B-PP
O	OGD	OGD	NN	B-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	was	be	VBD	B-VP
O	not	not	RB	O
O	due	due	JJ	B-ADJP
O	to	to	TO	B-PP
O	impairment	impairment	NN	B-NP
O	of	of	IN	B-PP
O	proteasome	proteasome	NN	B-NP
O	function	function	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
O	was	be	VBD	B-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	lower	low	JJR	B-NP
B-GGP	HIF1alpha	HIF1alpha	NN	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	.	.	.	O

O	Krebs	Kreb	NNS	B-NP
O	cycle	cycle	NN	I-NP
O	metabolites	metabolite	NNS	I-NP
O	fumarate	fumarate	NN	I-NP
O	and	and	CC	I-NP
O	succinate	succinate	NN	I-NP
O	are	be	VBP	B-VP
O	known	know	VBN	I-VP
O	inhibitors	inhibitor	NNS	B-NP
O	of	of	IN	B-PP
O	PHD	PHD	NN	B-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	alpha	alpha	SYM	O
O	-	-	HYPH	O
O	ketoglutarate	ketoglutarate	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	co	co	AFX	I-NP
O	-	-	HYPH	I-NP
O	substrate	substrate	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	reaction	reaction	NN	I-NP
O	.	.	.	O

O	Lack	Lack	NN	B-NP
O	of	of	IN	B-PP
B-GGP	HIF1alpha	HIF1alpha	NN	B-NP
O	degradation	degradation	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	was	be	VBD	B-VP
O	accompanied	accompany	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	very	very	RB	I-NP
O	low	low	JJ	I-NP
O	alpha	alpha	SYM	I-NP
O	-	-	HYPH	I-NP
O	ketoglutarate	ketoglutarate	NN	I-NP
O	/	/	SYM	I-NP
O	fumarate	fumarate	NN	I-NP
O	ratio	ratio	NN	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	treatment	treatment	NN	B-NP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	fumarate	fumarate	JJ	I-NP
O	analogue	analogue	NN	I-NP
O	prevented	prevent	VBD	B-VP
O	HIF1alpha	HIF1alpha	NN	B-NP
O	degradation	degradation	NN	I-NP
O	under	under	IN	B-PP
O	normoxia	normoxia	NN	B-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	all	all	DT	B-NP
O	,	,	,	O
O	our	our	PRP$	B-NP
O	data	datum	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	postischemic	postischemic	JJ	B-NP
O	metabolic	metabolic	JJ	I-NP
O	alterations	alteration	NNS	I-NP
O	in	in	IN	B-PP
O	Krebs	Krebs	NNP	B-NP
O	cycle	cycle	NN	I-NP
O	metabolites	metabolite	NNS	I-NP
O	impair	impair	VBP	B-VP
O	HIF1alpha	HIF1alpha	NN	B-NP
O	degradation	degradation	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	by	by	IN	B-PP
O	decreasing	decrease	VBG	B-VP
O	its	its	PRP$	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	highlight	highlight	VBP	B-VP
O	the	the	DT	B-NP
O	involvement	involvement	NN	I-NP
O	of	of	IN	B-PP
O	metabolic	metabolic	JJ	B-NP
O	pathways	pathway	NNS	I-NP
O	in	in	IN	B-PP
B-GGP	HIF1alpha	HIF1alpha	NN	B-NP
O	regulation	regulation	NN	I-NP
O	besides	besides	IN	B-PP
O	the	the	DT	B-NP
O	well	well	RB	I-NP
O	known	know	VBN	I-NP
O	effects	effect	NNS	I-NP
O	of	of	IN	B-PP
O	oxygen	oxygen	NN	B-NP
O	.	.	.	O

O	Regulated	Regulate	VBN	B-NP
O	degradation	degradation	NN	I-NP
O	of	of	IN	B-PP
O	spindle	spindle	NN	B-NP
O	assembly	assembly	NN	I-NP
O	factors	factor	NNS	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	anaphase	anaphase	NN	I-NP
O	-	-	HYPH	O
O	promoting	promote	VBG	B-VP
O	complex	complex	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	ubiquitin	ubiquitin	NN	I-NP
O	ligase	ligase	NN	I-NP
O	anaphase	anaphase	NN	I-NP
O	-	-	HYPH	O
O	promoting	promote	VBG	B-VP
O	complex	complex	NN	B-NP
O	(	(	(	O
O	APC	APC	NN	B-NP
O	/	/	SYM	B-NP
O	C	C	NN	I-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	essential	essential	JJ	B-ADJP
O	for	for	IN	B-PP
O	cell	cell	NN	B-NP
O	division	division	NN	I-NP
O	in	in	IN	B-PP
O	all	all	DT	B-NP
O	eukaryotes	eukaryote	NNS	I-NP
O	.	.	.	O

O	Loss	Loss	NN	B-NP
O	of	of	IN	B-PP
O	APC	APC	NN	B-NP
O	/	/	SYM	I-NP
O	C	C	NN	I-NP
O	activity	activity	NN	I-NP
O	arrests	arrest	VBZ	B-VP
O	cells	cell	NNS	B-NP
O	at	at	IN	B-PP
O	metaphase	metaphase	NN	B-NP
O	and	and	CC	O
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	severe	severe	JJ	B-NP
O	aberrations	aberration	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mitotic	mitotic	JJ	I-NP
O	spindle	spindle	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
O	how	how	WRB	B-ADVP
O	the	the	DT	B-NP
O	APC	APC	NN	I-NP
O	/	/	SYM	B-NP
O	C	C	NN	I-NP
O	regulates	regulate	VBZ	B-VP
O	spindle	spindle	NN	B-NP
O	formation	formation	NN	I-NP
O	is	be	VBZ	B-VP
O	not	not	RB	I-VP
O	understood	understand	VBN	I-VP
O	.	.	.	O

O	Here	Here	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	report	report	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	APC	APC	NN	I-NP
O	/	/	SYM	B-NP
O	C	C	NN	I-NP
O	promotes	promote	VBZ	B-VP
O	the	the	DT	B-NP
O	ubiquitination	ubiquitination	NN	I-NP
O	and	and	CC	I-NP
O	degradation	degradation	NN	I-NP
O	of	of	IN	B-PP
O	four	four	CD	B-NP
O	proteins	protein	NNS	I-NP
O	required	require	VBN	B-VP
O	for	for	IN	B-PP
B-GGP	Ran	Ran	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	spindle	spindle	NN	I-NP
O	assembly	assembly	NN	I-NP
O	:	:	:	O
B-GGP	Bard1	Bard1	NN	B-NP
O	,	,	,	O
B-GGP	Hmmr	Hmmr	NN	B-NP
O	,	,	,	O
B-GGP	HURP	HURP	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	NuSAP	NuSAP	NN	B-NP
O	.	.	.	O

O	Among	Among	IN	B-PP
O	these	these	DT	B-NP
O	substrates	substrate	NNS	I-NP
O	,	,	,	O
B-GGP	HURP	HURP	NN	B-NP
O	and	and	CC	I-NP
B-GGP	NuSAP	NuSAP	NN	I-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	degraded	degrade	VBN	I-VP
O	during	during	IN	B-PP
O	spindle	spindle	NN	B-NP
O	formation	formation	NN	I-NP
O	when	when	WRB	B-ADVP
O	the	the	DT	B-NP
O	spindle	spindle	NN	I-NP
O	checkpoint	checkpoint	NN	I-NP
O	is	be	VBZ	B-VP
O	active	active	JJ	B-ADJP
O	.	.	.	O

O	Their	Their	PRP$	B-NP
O	degradation	degradation	NN	I-NP
O	requires	require	VBZ	B-VP
O	additional	additional	JJ	B-NP
O	layers	layer	NNS	I-NP
O	of	of	IN	B-PP
O	regulation	regulation	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	both	both	DT	B-NP
O	SAFs	SAF	NNS	I-NP
O	are	be	VBP	B-VP
O	only	only	RB	I-VP
O	degraded	degrade	VBN	I-VP
O	after	after	IN	B-PP
O	being	be	VBG	B-VP
O	released	release	VBN	I-VP
O	from	from	IN	B-PP
O	their	their	PRP$	B-NP
O	inhibitor	inhibitor	NN	I-NP
O	importin	importin	NN	I-NP
O	beta	beta	NN	I-NP
O	by	by	IN	B-PP
B-GGP	Ran	Ran	NN	B-NP
O	(	(	(	O
O	GTP	GTP	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	findings	finding	NNS	I-NP
O	reveal	reveal	VBP	B-VP
O	a	a	DT	B-NP
O	tightly	tightly	RB	I-NP
O	regulated	regulate	VBN	I-NP
O	mechanism	mechanism	NN	I-NP
O	by	by	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
O	APC	APC	NN	I-NP
O	/	/	SYM	B-NP
O	C	C	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	GTPase	GTPase	NN	I-NP
B-GGP	Ran	Ran	NN	I-NP
O	control	control	VBP	B-VP
O	the	the	DT	B-NP
O	abundance	abundance	NN	I-NP
O	of	of	IN	B-PP
O	active	active	JJ	B-NP
O	spindle	spindle	NN	I-NP
O	assembly	assembly	NN	I-NP
O	factors	factor	NNS	I-NP
O	to	to	TO	B-VP
O	achieve	achieve	VB	I-VP
O	the	the	DT	B-NP
O	accurate	accurate	JJ	I-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mitotic	mitotic	JJ	I-NP
O	spindle	spindle	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	novel	novel	JJ	I-NP
O	antioxidant	antioxidant	JJ	I-NP
O	role	role	NN	I-NP
O	for	for	IN	B-PP
O	hemoglobin	hemoglobin	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	comproportionation	comproportionation	NN	I-NP
O	of	of	IN	B-PP
O	ferrylhemoglobin	ferrylhemoglobin	NN	B-NP
O	with	with	IN	B-PP
O	oxyhemoglobin	oxyhemoglobin	NN	B-NP
O	.	.	.	O

O	Ferrylhemoglobin	Ferrylhemoglobin	NN	B-NP
O	(	(	(	O
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	I-NP
O	OH	OH	NN	I-NP
O	,	,	,	O
O	where	where	WRB	B-ADVP
O	X	X	NN	B-NP
O	denotes	denote	VBZ	B-VP
O	an	an	DT	B-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	residue	residue	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	globin	globin	NN	I-NP
O	moiety	moiety	NN	I-NP
O	)	)	)	O
O	has	have	VBZ	B-VP
O	long	long	RB	I-VP
O	been	be	VBN	I-VP
O	suspected	suspect	VBN	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	cytotoxic	cytotoxic	JJ	I-NP
O	agent	agent	NN	I-NP
O	produced	produce	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	interaction	interaction	NN	I-NP
O	of	of	IN	B-PP
O	oxyhemoglobin	oxyhemoglobin	NN	B-NP
O	(	(	(	O
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIIO2	FeIIO2	NN	I-NP
O	)	)	)	O
O	or	or	CC	O
O	methemoglobin	methemoglobin	NN	B-NP
O	(	(	(	O
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIII	FeIII	NN	I-NP
O	)	)	)	O
O	with	with	IN	B-PP
O	H2O2	H2O2	NN	B-NP
O	in	in	IN	B-PP
O	red	red	JJ	B-NP
O	blood	blood	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	To	To	TO	B-PP
O	date	date	NN	B-NP
O	,	,	,	O
O	however	however	RB	B-ADVP
O	,	,	,	O
O	technical	technical	JJ	B-NP
O	difficulties	difficulty	NNS	I-NP
O	have	have	VBP	B-VP
O	prevented	prevent	VBN	I-VP
O	the	the	DT	B-NP
O	identification	identification	NN	I-NP
O	and	and	CC	I-NP
O	quantification	quantification	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	B-NP
O	OH	OH	NN	I-NP
O	.	.	.	O

O	Oxyhemoglobin	Oxyhemoglobin	NN	B-NP
O	exposed	expose	VBN	B-VP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	continuous	continuous	JJ	I-NP
O	flux	flux	NN	I-NP
O	of	of	IN	B-PP
O	H2O2	H2O2	NN	B-NP
O	(	(	(	O
O	generated	generate	VBN	B-VP
O	at	at	IN	B-PP
O	a	a	DT	B-NP
O	rate	rate	NN	I-NP
O	of	of	IN	B-PP
O	120	120	CD	B-NP
O	microM	microM	NN	I-NP
O	/	/	SYM	B-NP
O	min	min	NN	I-NP
O	during	during	IN	B-PP
O	the	the	DT	B-NP
B-GGP	glucose	glucose	NN	I-NP
I-GGP	oxidase	oxidase	NN	I-NP
O	-	-	HYPH	B-VP
O	catalyzed	catalyze	VBN	B-NP
O	oxidation	oxidation	NN	I-NP
O	of	of	IN	B-PP
O	glucose	glucose	NN	B-NP
O	)	)	)	O
O	was	be	VBD	B-VP
O	oxidized	oxidize	VBN	I-VP
O	to	to	TO	B-PP
O	(	(	(	O
O	a	a	DT	O
O	)	)	)	O
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	B-NP
O	OH	OH	NN	I-NP
O	when	when	WRB	B-ADVP
O	[	[	(	B-NP
O	X	X	NN	I-NP
O	-	-	HYPH	I-NP
O	FeIIO2	FeIIO2	NN	I-NP
O	]	]	)	O
O	less	less	JJR	B-NP
O	than	than	IN	I-NP
O	75	75	CD	I-NP
O	microM	microM	NN	I-NP
O	and	and	CC	O
O	(	(	(	B-LST
O	b	b	LS	I-LST
O	)	)	)	O
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIII	FeIII	NN	I-NP
O	when	when	WRB	B-ADVP
O	[	[	(	B-NP
O	X	X	NN	I-NP
O	-	-	HYPH	I-NP
O	FeIIO2	FeIIO2	NN	I-NP
O	]	]	)	O
O	greater	great	JJR	B-NP
O	than	than	IN	I-NP
O	75	75	CD	I-NP
O	microM	microM	NN	I-NP
O	(	(	(	O
O	the	the	DT	B-NP
O	production	production	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIII	FeIII	NN	I-NP
O	proceeded	proceed	VBD	B-VP
O	with	with	IN	B-PP
O	intermediate	intermediate	JJ	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	B-NP
O	OH	OH	NN	I-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	reduction	reduction	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	X	X	NN	I-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	I-NP
O	OH	OH	NN	I-NP
O	to	to	TO	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	O
O	FeIII	FeIII	NN	B-NP
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	explained	explain	VBN	I-VP
O	by	by	IN	B-PP
O	either	either	DT	B-NP
O	of	of	IN	B-PP
O	two	two	CD	B-NP
O	alternative	alternative	JJ	I-NP
O	mechanisms	mechanism	NNS	I-NP
O	:	:	:	O
O	a	a	DT	B-NP
O	O2	O2	NN	I-NP
O	(	(	(	O
O	-	-	SYM	B-NP
O	)	)	)	O
O	-	-	HYPH	O
O	mediated	mediate	VBN	B-NP
O	X	X	NN	I-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	B-NP
O	OH	OH	NN	I-NP
O	-	-	HYPH	O
O	-	-	SYM	O
O	-	-	HYPH	O
O	X	X	SYM	O
O	-	-	HYPH	O
O	FeIII	FeIII	NN	B-NP
O	transition	transition	NN	I-NP
O	or	or	CC	O
O	a	a	DT	B-NP
O	comproportionation	comproportionation	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	B-NP
O	OH	OH	NN	I-NP
O	and	and	CC	I-NP
O	X	X	NN	I-NP
O	-	-	HYPH	B-NP
O	FeIIO2	FeIIO2	NN	I-NP
O	to	to	TO	B-VP
O	yield	yield	VB	I-VP
O	X	X	NN	B-NP
O	-	-	HYPH	I-NP
O	FeIII	FeIII	NN	I-NP
O	(	(	(	O
O	a	a	DT	B-NP
O	process	process	NN	I-NP
O	mediated	mediate	VBN	B-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	tyrosine	tyrosine	NN	I-NP
O	moiety	moiety	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	hemoprotein	hemoprotein	NN	I-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	low	low	JJ	I-NP
O	rate	rate	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIIO2	FeIIO2	NN	I-NP
O	autoxidation	autoxidation	NN	I-NP
O	plus	plus	CC	O
O	the	the	DT	B-NP
O	negligible	negligible	JJ	I-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	rate	rate	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIII	FeIII	NN	I-NP
O	formation	formation	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	I-PP
O	presence	presence	NN	I-PP
O	of	of	IN	I-PP
O	either	either	CC	O
O	native	native	JJ	B-NP
O	or	or	CC	O
O	heat	heat	NN	B-NP
O	-	-	HYPH	O
O	denatured	denature	VBN	B-NP
O	superoxide	superoxide	NN	I-NP
O	dismutase	dismutase	NN	I-NP
O	or	or	CC	O
O	apoenzyme	apoenzyme	NN	B-NP
O	(	(	(	O
O	1	1	CD	B-NP
O	microM	microM	NN	I-NP
O	)	)	)	O
O	suggested	suggest	VBD	B-VP
O	that	that	IN	B-SBAR
O	O2	O2	NN	B-NP
O	-	-	HYPH	B-NP
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	contribute	contribute	VB	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	reduction	reduction	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	B-NP
O	OH	OH	NN	I-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	dependence	dependence	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIII	FeIII	NN	I-NP
O	formation	formation	NN	I-NP
O	on	on	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	I-NP
O	FeIIO2	FeIIO2	NN	I-NP
O	concentration	concentration	NN	I-NP
O	,	,	,	O
O	together	together	RB	B-ADVP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	results	result	NNS	I-NP
O	of	of	IN	B-PP
O	O2	O2	NN	B-NP
O	uptake	uptake	NN	I-NP
O	and	and	CC	O
O	H2O2	H2O2	NN	B-NP
O	consumption	consumption	NN	I-NP
O	measurements	measurement	NNS	I-NP
O	,	,	,	O
O	provide	provide	VBP	B-VP
O	experimental	experimental	JJ	B-NP
O	evidence	evidence	NN	I-NP
O	to	to	TO	B-VP
O	support	support	VB	I-VP
O	the	the	DT	B-NP
O	comproportionation	comproportionation	NN	I-NP
O	reaction	reaction	NN	I-NP
O	.	.	.	O

O	Comproportionation	Comproportionation	NN	B-NP
O	is	be	VBZ	B-VP
O	apparently	apparently	RB	I-VP
O	catalyzed	catalyze	VBN	I-VP
O	by	by	IN	B-PP
O	intermolecular	intermolecular	JJ	B-NP
O	electron	electron	NN	I-NP
O	transfer	transfer	NN	I-NP
O	between	between	IN	B-PP
O	tyrosine	tyrosine	NN	B-NP
O	residues	residue	NNS	I-NP
O	,	,	,	O
O	since	since	IN	B-SBAR
O	the	the	DT	B-NP
O	reaction	reaction	NN	I-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	occur	occur	VB	I-VP
O	when	when	WRB	B-ADVP
O	tyrosine	tyrosine	NN	B-NP
O	residues	residue	NNS	I-NP
O	were	be	VBD	B-VP
O	blocked	block	VBN	I-VP
O	by	by	IN	B-PP
O	acetylation	acetylation	NN	B-NP
O	.	.	.	O

O	Intact	Intact	JJ	B-NP
O	red	red	JJ	I-NP
O	blood	blood	NN	I-NP
O	cells	cell	NNS	I-NP
O	exposed	expose	VBN	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	same	same	JJ	I-NP
O	flow	flow	NN	I-NP
O	rate	rate	NN	I-NP
O	of	of	IN	B-PP
O	H2O2	H2O2	NN	B-NP
O	presented	present	VBD	B-VP
O	a	a	DT	B-NP
O	spectral	spectral	JJ	I-NP
O	profile	profile	NN	I-NP
O	which	which	WDT	B-NP
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	explained	explain	VBN	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	transition	transition	NN	I-NP
O	from	from	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIIO2	FeIIO2	NN	I-NP
O	to	to	TO	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIII	FeIII	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	intermediate	intermediate	JJ	I-NP
O	production	production	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	I-NP
O	OH	OH	NN	I-NP
O	was	be	VBD	B-VP
O	detected	detect	VBN	I-VP
O	by	by	IN	B-PP
O	adding	add	VBG	B-VP
O	Na2S	Na2S	NN	B-NP
O	(	(	(	O
O	2	2	CD	B-NP
O	mM	mM	NN	I-NP
O	)	)	)	O
O	,	,	,	O
O	which	which	WDT	B-NP
O	revealed	reveal	VBD	B-VP
O	a	a	DT	B-NP
O	spectral	spectral	JJ	I-NP
O	profile	profile	NN	I-NP
O	identical	identical	JJ	B-ADJP
O	with	with	IN	B-PP
O	that	that	DT	B-NP
O	obtained	obtain	VBN	B-VP
O	with	with	IN	B-PP
O	purified	purify	VBN	B-NP
O	X	X	NN	I-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	B-NP
O	OH	OH	NN	I-NP
O	.	.	.	O

O	Measurements	Measurement	NNS	B-NP
O	of	of	IN	B-PP
O	concentrations	concentration	NNS	B-NP
O	and	and	CC	O
O	relative	relative	JJ	B-NP
O	rate	rate	NN	I-NP
O	constants	constant	NNS	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	reaction	reaction	NN	I-NP
O	of	of	IN	B-PP
O	various	various	JJ	B-NP
O	intracellular	intracellular	JJ	I-NP
O	reductants	reductant	NNS	I-NP
O	(	(	(	O
O	glutathione	glutathione	NN	B-NP
O	,	,	,	O
O	NAD	NAD	NN	B-NP
O	(	(	(	O
O	P	P	NN	B-NP
O	)	)	)	O
O	H	H	NN	B-NP
O	,	,	,	O
O	uric	uric	JJ	B-NP
O	acid	acid	NN	I-NP
O	,	,	,	O
O	ascorbic	ascorbic	JJ	B-NP
O	acid	acid	NN	I-NP
O	)	)	)	O
O	with	with	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	I-NP
O	OH	OH	NN	I-NP
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
O	comproportionation	comproportionation	NN	B-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	B-NP
O	OH	OH	NN	I-NP
O	with	with	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIIO2	FeIIO2	NN	I-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	favored	favored	JJ	I-NP
O	reaction	reaction	NN	I-NP
O	.	.	.	O

O	Our	Our	PRP$	B-NP
O	results	result	NNS	I-NP
O	provide	provide	VBP	B-VP
O	(	(	(	O
O	to	to	TO	B-PP
O	our	our	PRP$	B-NP
O	knowledge	knowledge	NN	I-NP
O	)	)	)	O
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	definitive	definitive	JJ	I-NP
O	evidence	evidence	NN	I-NP
O	for	for	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	B-NP
O	OH	OH	NN	I-NP
O	in	in	IN	B-PP
O	intact	intact	JJ	B-NP
O	red	red	JJ	I-NP
O	blood	blood	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	rapid	rapid	JJ	I-NP
O	comproportionation	comproportionation	NN	I-NP
O	reaction	reaction	NN	I-NP
O	between	between	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	B-NP
O	OH	OH	NN	I-NP
O	and	and	CC	I-NP
O	X	X	NN	I-NP
O	-	-	HYPH	B-NP
O	FeIIO2	FeIIO2	NN	I-NP
O	(	(	(	O
O	to	to	TO	B-VP
O	produce	produce	VB	I-VP
O	X	X	NN	B-NP
O	-	-	HYPH	I-NP
O	FeIII	FeIII	NN	I-NP
O	)	)	)	O
O	explains	explain	VBZ	B-VP
O	why	why	WRB	B-ADVP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	FeIV	FeIV	NN	I-NP
O	-	-	HYPH	I-NP
O	OH	OH	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	elusive	elusive	JJ	B-ADJP
O	to	to	TO	B-PP
O	date	date	NN	B-NP
O	.	.	.	O
O	(	(	(	O
O	ABSTRACT	ABSTRACT	NN	B-NP
O	TRUNCATED	TRUNCATED	VBN	B-VP
O	AT	AT	IN	B-PP
O	400	400	CD	B-NP
O	WORDS	WORDS	NNS	I-NP
O	)	)	)	O

O	Expression	Expression	NN	B-NP
O	and	and	CC	I-NP
O	characterization	characterization	NN	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
B-GGP	factor	factor	NN	I-NP
I-GGP	IX	IX	CD	I-NP
O	and	and	CC	O
B-GGP	factor	factor	NN	B-NP
I-GGP	IX	IX	CD	I-NP
O	-	-	HYPH	I-NP
B-GGP	factor	factor	NN	I-NP
I-GGP	X	X	NN	I-NP
O	chimeras	chimera	NNS	I-NP
O	in	in	IN	B-PP
O	mouse	mouse	NN	B-NP
O	C127	C127	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Human	Human	JJ	B-NP
O	blood	blood	NN	I-NP
O	clotting	clotting	NN	I-NP
B-GGP	factor	factor	NN	I-NP
I-GGP	IX	IX	CD	I-NP
O	,	,	,	O
O	and	and	CC	O
O	two	two	CD	B-NP
O	chimeric	chimeric	JJ	I-NP
O	molecules	molecule	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	factor	factor	NN	B-NP
I-GGP	IX	IX	CD	I-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	epidermal	epidermal	JJ	I-NP
O	growth	growth	NN	I-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	domain	domain	NN	I-NP
O	or	or	CC	O
O	both	both	CC	O
O	epidermal	epidermal	JJ	B-NP
O	growth	growth	NN	I-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	domains	domain	NNS	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	replaced	replace	VBN	I-VP
O	by	by	IN	B-PP
O	that	that	DT	B-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
B-GGP	factor	factor	NN	I-NP
I-GGP	X	X	NN	I-NP
O	,	,	,	O
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	expressed	express	VBN	I-VP
O	in	in	IN	B-PP
O	mouse	mouse	NN	B-NP
O	C127	C127	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	recombinants	recombinant	NNS	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	purified	purify	VBN	I-VP
O	using	use	VBG	B-VP
O	a	a	DT	B-NP
O	metal	metal	NN	I-NP
O	ion	ion	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	monoclonal	monoclonal	JJ	I-NP
O	antibody	antibody	NN	I-NP
O	specific	specific	JJ	B-ADJP
O	for	for	IN	B-PP
O	residues	residue	NNS	B-NP
O	1	1	CD	I-NP
O	-	-	HYPH	I-NP
O	42	42	CD	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
B-GGP	factor	factor	NN	I-NP
I-GGP	IX	IX	CD	I-NP
O	.	.	.	O

O	All	All	DT	B-NP
O	recombinant	recombinant	JJ	I-NP
O	molecules	molecule	NNS	I-NP
O	are	be	VBP	B-VP
O	activated	activate	VBN	I-VP
O	normally	normally	RB	B-ADVP
O	by	by	IN	B-PP
O	human	human	JJ	B-NP
B-GGP	factor	factor	NN	I-NP
I-GGP	XIa	XIa	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	calcium	calcium	NN	B-NP
O	ion	ion	NN	I-NP
O	.	.	.	O

O	Activation	Activation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	factor	factor	NN	I-NP
I-GGP	IX	IX	CD	B-NP
O	recombinants	recombinant	NNS	I-NP
O	by	by	IN	B-PP
B-GGP	factor	factor	NN	B-NP
I-GGP	VIIa	VIIa	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	tissue	tissue	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	appears	appear	VBZ	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	normal	normal	JJ	B-ADJP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	epidermal	epidermal	JJ	I-NP
O	growth	growth	NN	I-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	O
O	1	1	CD	B-NP
O	exchange	exchange	NN	I-NP
O	but	but	CC	O
O	considerably	considerably	RB	B-VP
O	reduced	reduce	VBN	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	construction	construction	NN	I-NP
O	containing	contain	VBG	B-VP
O	both	both	CC	O
O	epidermal	epidermal	JJ	B-NP
O	growth	growth	NN	I-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	domains	domain	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	factor	factor	NN	B-NP
I-GGP	X	X	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	gamma	gamma	SYM	B-NP
O	-	-	HYPH	O
O	carboxyglutamic	carboxyglutamic	JJ	B-NP
O	acid	acid	NN	I-NP
O	residues	residue	NNS	I-NP
O	reveals	reveal	VBZ	B-VP
O	that	that	IN	B-SBAR
O	all	all	DT	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	purified	purify	VBN	I-NP
O	recombinants	recombinant	NNS	I-NP
O	are	be	VBP	B-VP
O	almost	almost	RB	I-VP
O	fully	fully	RB	I-VP
O	carboxylated	carboxylate	VBN	I-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	extent	extent	NN	I-NP
O	of	of	IN	B-PP
O	aspartic	aspartic	JJ	B-NP
O	acid	acid	NN	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	at	at	IN	B-PP
O	residue	residue	NN	B-NP
O	64	64	CD	I-NP
O	is	be	VBZ	B-VP
O	60	60	CD	B-NP
O	%	%	NN	I-NP
O	for	for	IN	B-PP
O	all	all	DT	B-NP
O	recombinants	recombinant	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	chimeric	chimeric	JJ	I-NP
O	molecule	molecule	NN	I-NP
O	with	with	IN	B-PP
O	both	both	CC	B-NP
O	epidermal	epidermal	JJ	I-NP
O	growth	growth	NN	I-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	domains	domain	NNS	I-NP
O	from	from	IN	B-PP
B-GGP	factor	factor	NN	B-NP
I-GGP	X	X	NN	I-NP
O	has	have	VBZ	B-VP
O	about	about	RB	B-NP
O	4	4	CD	I-NP
O	%	%	NN	I-NP
O	normal	normal	JJ	I-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	activated	activate	VBN	I-NP
O	partial	partial	JJ	I-NP
B-GGP	thromboplastin	thromboplastin	NN	I-NP
O	time	time	NN	I-NP
O	assay	assay	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	contrast	contrast	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	construct	construct	NN	I-NP
O	containing	contain	VBG	B-VP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	epidermal	epidermal	JJ	I-NP
O	growth	growth	NN	I-NP
O	factor	factor	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	domain	domain	NN	I-NP
O	of	of	IN	B-PP
B-GGP	factor	factor	NN	B-NP
I-GGP	X	X	NN	I-NP
O	shows	show	VBZ	B-VP
O	essentially	essentially	RB	B-NP
O	normal	normal	JJ	I-NP
O	clotting	clotting	NN	I-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	unlikely	unlikely	JJ	B-ADJP
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	domain	domain	NN	I-NP
O	is	be	VBZ	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	unique	unique	JJ	I-NP
O	interaction	interaction	NN	I-NP
O	with	with	IN	B-PP
B-GGP	factor	factor	NN	B-NP
I-GGP	VIII	VIII	CD	I-NP
O	.	.	.	O

O	Release	Release	NN	B-NP
O	of	of	IN	B-PP
O	[	[	(	O
O	hydroxyproline3	hydroxyproline3	NN	B-NP
O	]	]	)	O
O	-	-	HYPH	B-NP
B-GGP	kinins	kinin	NNS	I-NP
O	by	by	IN	B-PP
O	tissue	tissue	NN	B-NP
O	kallikreins	kallikrein	NNS	I-NP
O	of	of	IN	B-PP
O	pig	pig	NN	B-NP
O	,	,	,	I-NP
O	rat	rat	NN	I-NP
O	and	and	CC	I-NP
O	man	man	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	determine	determine	VB	I-VP
O	the	the	DT	B-NP
O	susceptibility	susceptibility	NN	I-NP
O	of	of	IN	B-PP
B-GGP	kininogens	kininogen	NNS	B-NP
O	containing	contain	VBG	B-VP
O	the	the	DT	B-NP
O	recently	recently	RB	I-NP
O	described	describe	VBN	I-NP
O	[	[	(	I-NP
O	Hyp3	Hyp3	NN	I-NP
O	]	]	)	O
O	-	-	HYPH	B-NP
B-GGP	bradykinin	bradykinin	NN	I-NP
O	moiety	moiety	NN	I-NP
O	to	to	TO	B-PP
O	cleavage	cleavage	NN	B-NP
O	by	by	IN	B-PP
O	tissue	tissue	NN	B-NP
O	kallikreins	kallikrein	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	have	have	VBP	B-VP
O	studied	study	VBN	I-VP
O	the	the	DT	B-NP
O	release	release	NN	I-NP
O	of	of	IN	B-PP
O	[	[	(	O
O	Hyp3	Hyp3	NN	B-NP
O	]	]	)	O
O	-	-	HYPH	B-NP
B-GGP	kinins	kinin	NNS	I-NP
O	from	from	IN	B-PP
O	heat	heat	NN	B-NP
O	inactivated	inactivate	VBD	B-VP
O	human	human	JJ	B-NP
O	plasma	plasma	NN	I-NP
O	by	by	IN	B-PP
O	purified	purify	VBN	B-NP
O	tissue	tissue	NN	I-NP
O	kallikreins	kallikrein	NNS	I-NP
O	.	.	.	O

O	Kallikreins	Kallikrein	NNS	B-NP
O	from	from	IN	B-PP
O	man	man	NN	B-NP
O	and	and	CC	I-NP
O	pig	pig	NN	I-NP
O	were	be	VBD	B-VP
O	employed	employ	VBN	I-VP
O	and	and	CC	O
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	purified	purify	VBN	B-NP
O	rat	rat	NN	I-NP
O	urinary	urinary	JJ	I-NP
O	kallikrein	kallikrein	NN	I-NP
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	known	know	VBN	I-VP
O	to	to	TO	I-VP
O	have	have	VB	I-VP
O	a	a	DT	B-NP
O	different	different	JJ	I-NP
O	cleavage	cleavage	NN	I-NP
O	specificity	specificity	NN	I-NP
O	.	.	.	O

O	Kinins	Kinin	NNS	B-NP
O	released	release	VBN	B-VP
O	were	be	VBD	B-VP
O	separated	separate	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	modified	modify	VBN	I-NP
O	reversed	reverse	VBD	B-VP
O	phase	phase	NN	B-NP
O	HPLC	HPLC	NN	I-NP
O	method	method	NN	I-NP
O	and	and	CC	O
O	quantitated	quantitate	VBN	B-VP
O	by	by	IN	B-PP
O	bioassay	bioassay	NN	B-NP
O	and	and	CC	I-NP
O	radioimmunoassay	radioimmunoassay	NN	I-NP
O	.	.	.	O

O	Human	Human	JJ	B-NP
O	urinary	urinary	JJ	I-NP
O	kallikrein	kallikrein	NN	I-NP
O	and	and	CC	I-NP
O	hog	hog	NN	I-NP
O	tissue	tissue	NN	I-NP
O	kallikreins	kallikrein	NNS	I-NP
O	released	release	VBD	B-VP
O	85	85	CD	B-NP
O	-	-	HYPH	I-NP
O	90	90	CD	I-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	total	total	JJ	I-NP
B-GGP	kinins	kinin	NNS	I-NP
O	as	as	IN	B-PP
O	Lys	Lys	NN	B-NP
O	-	-	HYPH	B-NP
B-GGP	bradykinin	bradykinin	NN	I-NP
O	and	and	CC	O
O	10	10	CD	B-NP
O	-	-	HYPH	I-NP
O	15	15	CD	I-NP
O	%	%	NN	I-NP
O	as	as	IN	B-SBAR
O	[	[	(	O
O	Hyp3	Hyp3	NN	B-NP
O	]	]	)	O
O	-	-	HYPH	B-NP
O	Lys	Lys	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	bradykinin	bradykinin	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	contrast	contrast	NN	B-NP
O	,	,	,	O
O	rat	rat	NN	B-NP
O	urinary	urinary	JJ	I-NP
O	kallikrein	kallikrein	NN	I-NP
O	released	release	VBN	B-VP
O	77	77	CD	B-NP
O	%	%	NN	I-NP
O	as	as	IN	B-PP
B-GGP	bradykinin	bradykinin	NN	B-NP
O	,	,	,	O
O	22	22	CD	B-NP
O	%	%	NN	I-NP
O	as	as	IN	B-SBAR
O	[	[	(	O
O	Hyp3	Hyp3	NN	B-NP
O	]	]	)	O
O	-	-	HYPH	B-NP
B-GGP	bradykinin	bradykinin	NN	I-NP
O	and	and	CC	O
O	negligible	negligible	JJ	B-NP
O	amounts	amount	NNS	I-NP
O	of	of	IN	B-PP
O	[	[	(	O
O	Hyp3	Hyp3	NN	B-NP
O	]	]	)	O
O	-	-	HYPH	B-NP
O	Lys	Lys	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	bradykinin	bradykinin	NN	I-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	identical	identical	JJ	I-NP
O	substrate	substrate	NN	I-NP
O	source	source	NN	I-NP
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
O	rat	rat	NN	B-NP
O	tissue	tissue	NN	I-NP
O	kallikreins	kallikrein	NNS	I-NP
O	prefer	prefer	VBP	B-VP
O	the	the	DT	B-NP
O	Lys	Ly	NNPS	I-NP
O	-	-	HYPH	I-NP
O	Arg	Arg	NN	I-NP
O	-	-	HYPH	O
O	bond	bond	NN	B-NP
O	within	within	IN	B-PP
O	both	both	CC	B-NP
O	unhydroxylated	unhydroxylate	VBN	I-NP
O	and	and	CC	I-NP
O	hydroxylated	hydroxylate	VBN	I-NP
B-GGP	kininogens	kininogen	NNS	I-NP
O	.	.	.	O

O	Therefore	Therefore	RB	B-ADVP
O	,	,	,	O
O	hydroxylation	hydroxylation	NN	B-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
B-GGP	kininogens	kininogen	NNS	I-NP
O	apparently	apparently	RB	B-ADVP
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	affect	affect	VB	I-VP
O	their	their	PRP$	B-NP
O	ability	ability	NN	I-NP
O	to	to	TO	B-VP
O	serve	serve	VB	I-VP
O	as	as	IN	B-PP
O	substrates	substrate	NNS	B-NP
O	for	for	IN	B-PP
O	tissue	tissue	NN	B-NP
O	kallikreins	kallikrein	NNS	I-NP
O	with	with	IN	B-PP
O	different	different	JJ	B-NP
O	cleavage	cleavage	NN	I-NP
O	specificities	specificity	NNS	I-NP
O	.	.	.	O

O	Processing	Processing	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	gp55	gp55	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	116	116	CD	I-NP
O	envelope	envelope	NN	I-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	complex	complex	NN	I-NP
O	(	(	(	O
B-GGP	gB	gB	NN	B-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	cytomegalovirus	cytomegalovirus	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	processing	processing	NN	I-NP
O	pathway	pathway	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	major	major	JJ	I-NP
O	envelope	envelope	NN	I-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	complex	complex	NN	I-NP
O	,	,	,	O
B-GGP	gp55	gp55	NN	B-NP
O	-	-	HYPH	O
B-GGP	116	116	CD	B-NP
O	(	(	(	O
B-GGP	gB	gB	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	cytomegalovirus	cytomegalovirus	NN	I-NP
O	was	be	VBD	B-VP
O	studied	study	VBN	I-VP
O	using	use	VBG	B-VP
O	inhibitors	inhibitor	NNS	B-NP
O	of	of	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	and	and	CC	I-NP
O	endoglycosidases	endoglycosidas	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	studies	study	NNS	I-NP
O	indicated	indicate	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	mature	mature	JJ	I-NP
B-GGP	gp55	gp55	NN	I-NP
O	-	-	HYPH	O
B-GGP	116	116	CD	B-NP
O	is	be	VBZ	B-VP
O	synthesized	synthesize	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	addition	addition	NN	I-NP
O	of	of	IN	B-PP
O	both	both	CC	B-NP
O	simple	simple	JJ	I-NP
O	and	and	CC	I-NP
O	complex	complex	JJ	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	sugars	sugar	NNS	I-NP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	nonglycosylated	nonglycosylated	JJ	I-NP
O	precursor	precursor	NN	I-NP
O	of	of	IN	B-PP
O	estimated	estimate	VBN	B-NP
O	Mr	Mr	NN	I-NP
O	105	105	CD	I-NP
O	,	,	,	I-NP
O	000	000	CD	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	a	a	DT	B-NP
O	rapid	rapid	JJ	I-NP
O	processing	processing	NN	I-NP
O	step	step	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	Mr	Mr	NN	I-NP
O	105	105	CD	I-NP
O	,	,	,	I-NP
O	000	000	CD	I-NP
O	precursor	precursor	NN	I-NP
O	is	be	VBZ	B-VP
O	glycosylated	glycosylate	VBN	I-VP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	protein	protein	NN	I-NP
O	of	of	IN	B-PP
O	Mr	Mr	NN	B-NP
O	150	150	CD	I-NP
O	,	,	,	I-NP
O	000	000	CD	I-NP
O	(	(	(	O
B-GGP	gp150	gp150	NN	B-NP
O	)	)	)	O
O	which	which	WDT	B-NP
O	contains	contain	VBZ	B-VP
O	only	only	RB	B-NP
B-GGP	endoglycosidase	endoglycosidase	NN	I-NP
I-GGP	H	H	NN	I-NP
O	-	-	HYPH	B-NP
O	sensitive	sensitive	JJ	I-NP
O	sugar	sugar	NN	I-NP
O	linkages	linkage	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	gp150	gp150	NN	I-NP
O	is	be	VBZ	B-VP
O	then	then	RB	I-VP
O	processed	process	VBN	I-VP
O	relatively	relatively	RB	B-ADVP
O	slowly	slowly	RB	I-ADVP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	Mr	Mr	NN	I-NP
O	165	165	CD	I-NP
O	,	,	,	I-NP
O	000	000	CD	I-NP
O	to	to	TO	I-ADVP
O	170	170	CD	I-ADVP
O	,	,	,	O
O	000	000	CD	B-NP
O	species	specie	NNS	I-NP
O	(	(	(	O
B-GGP	gp165	gp165	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	170	170	CD	I-NP
O	)	)	)	O
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	then	then	RB	I-VP
O	cleaved	cleave	VBN	I-VP
O	to	to	TO	B-VP
O	yield	yield	VB	I-VP
O	the	the	DT	B-NP
O	mature	mature	JJ	I-NP
B-GGP	gp55	gp55	NN	I-NP
O	-	-	HYPH	B-NP
B-GGP	116	116	CD	I-NP
O	.	.	.	O

O	Monensin	Monensin	NN	B-NP
O	prevented	prevent	VBD	B-VP
O	the	the	DT	B-NP
O	final	final	JJ	I-NP
O	processing	processing	NN	I-NP
O	steps	step	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	gp150	gp150	NN	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	cleavage	cleavage	NN	B-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	transport	transport	NN	B-NP
O	through	through	IN	B-PP
O	the	the	DT	B-NP
O	Golgi	Golgi	NNP	I-NP
O	apparatus	apparatus	NN	I-NP
O	is	be	VBZ	B-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	complete	complete	JJ	B-NP
O	processing	processing	NN	I-NP
O	.	.	.	O

O	Digestion	Digestion	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	intracellular	intracellular	JJ	I-NP
O	forms	form	NNS	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	complex	complex	NN	I-NP
O	as	as	RB	B-CONJP
O	well	well	RB	I-CONJP
O	as	as	IN	I-CONJP
O	the	the	DT	B-NP
O	virion	virion	NN	I-NP
O	forms	form	NNS	I-NP
O	confirmed	confirm	VBD	B-VP
O	the	the	DT	B-NP
O	above	above	JJ	I-NP
O	findings	finding	NNS	I-NP
O	and	and	CC	O
O	indicated	indicate	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	mature	mature	JJ	I-NP
O	virion	virion	NN	I-NP
O	form	form	NN	I-NP
O	of	of	IN	B-PP
B-GGP	gp55	gp55	NN	B-NP
O	contains	contain	VBZ	B-VP
O	8	8	CD	B-NP
O	,	,	,	I-NP
O	000	000	CD	I-NP
O	daltons	dalton	NNS	I-NP
O	of	of	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	sugars	sugar	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	virion	virion	NN	I-NP
B-GGP	gp116	gp116	NN	I-NP
O	contains	contain	VBZ	B-VP
O	some	some	DT	B-NP
O	52	52	CD	I-NP
O	,	,	,	I-NP
O	000	000	CD	I-NP
O	to	to	TO	B-PP
O	57	57	CD	B-NP
O	,	,	,	O
O	000	000	CD	B-NP
O	daltons	dalton	NNS	I-NP
O	of	of	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	carbohydrates	carbohydrate	NNS	I-NP
O	and	and	CC	O
O	approximately	approximately	RB	B-NP
O	5	5	CD	I-NP
O	,	,	,	I-NP
O	000	000	CD	I-NP
O	daltons	dalton	NNS	I-NP
O	of	of	IN	B-PP
O	O	O	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	sugars	sugar	NNS	I-NP
O	.	.	.	O

B-GGP	Microthrombomodulin	Microthrombomodulin	NNP	B-NP
O	.	.	.	I-NP
O	Residues	Residues	NNP	I-NP
O	310	310	CD	I-NP
O	-	-	HYPH	B-NP
O	486	486	CD	I-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
B-GGP	epidermal	epidermal	JJ	I-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	precursor	precursor	NN	I-NP
O	homology	homology	NN	I-NP
O	domain	domain	NN	I-NP
O	of	of	IN	B-PP
B-GGP	thrombomodulin	thrombomodulin	NN	B-NP
O	will	will	MD	B-VP
O	accelerate	accelerate	VB	I-VP
O	protein	protein	NN	B-NP
O	C	C	NN	I-NP
O	activation	activation	NN	I-NP
O	.	.	.	O

B-GGP	Thrombomodulin	Thrombomodulin	NN	B-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	endothelial	endothelial	JJ	I-NP
O	cell	cell	NN	I-NP
O	cofactor	cofactor	NN	I-NP
O	for	for	IN	B-PP
O	thrombin	thrombin	NN	B-NP
O	-	-	HYPH	O
O	catalyzed	catalyze	VBN	B-VP
O	activation	activation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	protein	protein	NN	B-NP
I-GGP	C	C	NN	I-NP
O	.	.	.	O

O	Recently	Recently	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	isolated	isolate	VBD	B-VP
O	a	a	DT	B-NP
O	10	10	CD	I-NP
O	-	-	HYPH	I-NP
O	kDa	kDa	NN	I-NP
B-GGP	thrombin	thrombin	NN	I-NP
O	binding	binding	NN	I-NP
O	fragment	fragment	NN	I-NP
O	,	,	,	O
O	CB3	CB3	NN	B-NP
O	,	,	,	O
O	from	from	IN	B-PP
O	the	the	DT	B-NP
B-GGP	epidermal	epidermal	JJ	I-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	precursor	precursor	NN	I-NP
O	homology	homology	NN	I-NP
O	domain	domain	NN	I-NP
O	(	(	(	O
B-GGP	epidermal	epidermal	JJ	B-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	(	(	(	O
B-GGP	EGF	EGF	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	regions	region	NNS	I-NP
O	)	)	)	O
O	of	of	IN	B-PP
B-GGP	thrombomodulin	thrombomodulin	NN	B-NP
O	(	(	(	O
O	Kurasawa	Kurasawa	NNP	B-NP
O	,	,	,	O
O	S	S	NNP	B-NP
O	.	.	.	O
O	,	,	,	O
O	Stearns	Stearns	NNP	B-NP
O	,	,	,	O
O	D	D	NNP	B-NP
O	.	.	.	O

O	J	J	NNP	B-NP
O	.	.	NN	I-NP
O	,	,	,	O
O	Jackson	Jackson	NNP	B-NP
O	,	,	,	O
O	K	K	NNP	B-NP
O	.	.	NNP	I-NP
O	W	W	NNP	I-NP
O	.	.	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	Esmon	Esmon	NNP	B-NP
O	,	,	,	O
O	C	C	NNP	B-NP
O	.	.	.	I-NP
O	T	T	NNP	I-NP
O	.	.	VBD	B-VP

O	(	(	(	O
O	1988	1988	CD	B-NP
O	)	)	)	O
O	J	J	NNP	B-NP
O	.	.	.	O

O	Biol	Biol	NN	B-NP
O	.	.	.	O

O	Chem	Chem	NNP	B-NP
O	.	.	.	O

O	263	263	CD	B-NP
O	,	,	,	I-NP
O	5993	5993	CD	I-NP
O	-	-	HYPH	I-NP
O	5996	5996	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	CB3	CB3	NN	I-NP
O	fragment	fragment	NN	I-NP
O	did	do	VBD	B-VP
O	not	not	RB	O
O	,	,	,	O
O	however	however	RB	B-ADVP
O	,	,	,	O
O	support	support	NN	B-NP
B-GGP	protein	protein	NN	I-NP
I-GGP	C	C	NN	I-NP
O	activation	activation	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	29	29	CD	I-NP
O	-	-	HYPH	I-NP
O	kDa	kDa	NN	I-NP
O	fragment	fragment	NN	I-NP
O	,	,	,	O
O	called	call	VBN	B-VP
O	CB23	CB23	NN	B-NP
O	,	,	,	O
O	has	have	VBZ	B-VP
O	now	now	RB	I-VP
O	been	be	VBN	I-VP
O	isolated	isolate	VBN	I-VP
O	and	and	CC	O
O	corresponds	correspond	VBZ	B-VP
O	to	to	TO	B-PP
O	residues	residue	NNS	B-NP
O	310	310	CD	B-NP
O	-	-	HYPH	I-NP
O	486	486	CD	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
B-GGP	EGF	EGF	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	region	region	NN	I-NP
O	of	of	IN	B-PP
B-GGP	thrombomodulin	thrombomodulin	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	CB23	CB23	NN	I-NP
O	fragment	fragment	NN	I-NP
O	bound	bind	VBD	B-VP
B-GGP	thrombin	thrombin	NN	B-NP
O	and	and	CC	O
O	accelerated	accelerate	VBD	B-VP
B-GGP	thrombin	thrombin	NN	B-NP
O	-	-	HYPH	O
O	catalyzed	catalyze	VBN	B-NP
B-GGP	protein	protein	NN	I-NP
I-GGP	C	C	NN	I-NP
O	activation	activation	NN	I-NP
O	.	.	.	O

O	With	With	IN	B-PP
O	two	two	CD	B-NP
O	separate	separate	JJ	I-NP
O	preparations	preparation	NNS	I-NP
O	of	of	IN	B-PP
O	CB23	CB23	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	Km	Km	NN	I-NP
O	for	for	IN	B-PP
B-GGP	protein	protein	NN	B-NP
I-GGP	C	C	NN	I-NP
O	was	be	VBD	B-VP
O	1	1	CD	B-NP
O	.	.	.	O
O	6	6	CD	B-NP
O	and	and	CC	I-NP
O	1	1	CD	I-NP
O	.	.	.	I-NP
O	9	9	CD	I-NP
O	microM	microM	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	Kd	Kd	NN	I-NP
O	for	for	IN	B-PP
B-GGP	thrombin	thrombin	NN	B-NP
O	was	be	VBD	B-VP
O	8	8	CD	B-NP
O	.	.	.	O
O	9	9	CD	B-NP
O	and	and	CC	I-NP
O	13	13	CD	I-NP
O	.	.	.	O
O	2	2	CD	B-NP
O	nM	nM	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	carboxyl	carboxyl	NN	I-NP
O	terminus	terminus	NN	I-NP
O	of	of	IN	B-PP
O	CB23	CB23	NN	B-NP
O	and	and	CC	I-NP
O	CB3	CB3	NN	I-NP
O	was	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	by	by	IN	B-PP
O	isolation	isolation	NN	B-NP
O	and	and	CC	I-NP
O	sequence	sequence	NN	I-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	tryptic	tryptic	JJ	I-NP
O	peptide	peptide	NN	I-NP
O	from	from	IN	B-PP
O	CB3	CB3	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	sequence	sequence	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	peptide	peptide	NN	I-NP
O	corresponded	correspond	VBD	B-VP
O	to	to	TO	B-PP
O	Asn457	Asn457	NN	B-NP
O	-	-	HYPH	B-NP
O	Ser486	Ser486	NN	I-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	carboxyl	carboxyl	NN	I-NP
O	terminus	terminus	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	fragments	fragment	NNS	I-NP
O	is	be	VBZ	B-VP
O	6	6	CD	B-NP
O	residues	residue	NNS	I-NP
O	beyond	beyond	IN	B-PP
O	the	the	DT	B-NP
O	sixth	sixth	JJ	I-NP
B-GGP	EGF	EGF	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	region	region	NN	I-NP
O	of	of	IN	B-PP
B-GGP	thrombomodulin	thrombomodulin	NN	B-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	,	,	,	O
O	although	although	IN	B-SBAR
O	CB3	CB3	NN	B-NP
O	cannot	cannot	MD	B-VP
O	accelerate	accelerate	VB	I-VP
B-GGP	protein	protein	NN	B-NP
I-GGP	C	C	NN	I-NP
O	activation	activation	NN	I-NP
O	,	,	,	O
O	CB3	CB3	NN	B-NP
O	did	do	VBD	B-VP
O	inhibit	inhibit	VB	I-VP
O	the	the	DT	B-NP
O	rate	rate	NN	I-NP
O	of	of	IN	B-PP
B-GGP	thrombin	thrombin	NN	B-NP
O	-	-	HYPH	B-NP
O	catalyzed	catalyze	VBN	I-NP
O	fibrinopeptide	fibrinopeptide	NN	I-NP
O	release	release	NN	I-NP
O	from	from	IN	B-PP
O	fibrinogen	fibrinogen	NN	B-NP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	,	,	,	O
O	like	like	IN	B-PP
O	native	native	JJ	B-NP
B-GGP	thrombomodulin	thrombomodulin	NN	I-NP
O	,	,	,	O
O	CB3	CB3	NN	B-NP
O	will	will	MD	B-VP
O	alter	alter	VB	I-VP
B-GGP	thrombin	thrombin	NN	B-NP
O	'	'	POS	B-NP
O	s	s	NN	I-NP
O	substrate	substrate	NN	I-NP
O	specificity	specificity	NN	I-NP
O	,	,	,	O
O	but	but	CC	O
B-GGP	protein	protein	NN	B-NP
I-GGP	C	C	NN	I-NP
O	activation	activation	NN	I-NP
O	requires	require	VBZ	B-VP
O	additional	additional	JJ	B-NP
O	information	information	NN	I-NP
O	all	all	DT	B-NP
O	of	of	IN	B-PP
O	which	which	WDT	B-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	provided	provide	VBN	I-VP
O	by	by	IN	B-PP
O	other	other	JJ	B-NP
O	regions	region	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	EGF	EGF	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	domain	domain	NN	I-NP
O	.	.	.	O

O	Clonal	Clonal	JJ	B-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	of	of	IN	B-PP
O	immunoglobulin	immunoglobulin	NN	B-NP
O	G	G	NN	I-NP
O	secreted	secrete	VBN	B-VP
O	by	by	IN	B-PP
O	murine	murine	JJ	B-NP
O	hybridomas	hybridoma	NNS	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	panel	panel	NN	I-NP
O	of	of	IN	B-PP
O	10	10	CD	B-NP
O	hybridomas	hybridoma	NNS	I-NP
O	was	be	VBD	B-VP
O	assembled	assemble	VBN	I-VP
O	to	to	TO	I-VP
O	assess	assess	VB	I-VP
O	the	the	DT	B-NP
O	influence	influence	NN	I-NP
O	of	of	IN	B-PP
O	various	various	JJ	B-NP
O	genetic	genetic	JJ	I-NP
O	and	and	CC	I-NP
O	biological	biological	JJ	I-NP
O	factors	factor	NNS	I-NP
O	upon	upon	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	of	of	IN	B-PP
O	secreted	secrete	VBN	B-NP
O	monoclonal	monoclonal	JJ	I-NP
O	IgG	IgG	NN	I-NP
O	.	.	.	O

O	After	After	IN	B-PP
O	exhaustive	exhaustive	JJ	B-NP
O	Pronase	Pronase	NN	I-NP
O	digestion	digestion	NN	I-NP
O	of	of	IN	B-PP
O	IgG	IgG	NN	B-NP
O	,	,	,	O
O	glycopeptides	glycopeptide	NNS	B-NP
O	were	be	VBD	B-VP
O	characterized	characterize	VBN	I-VP
O	chromatographically	chromatographically	RB	B-ADVP
O	by	by	IN	B-PP
O	apparent	apparent	JJ	B-NP
O	size	size	NN	I-NP
O	,	,	,	O
O	charge	charge	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	concanavalin	concanavalin	NN	B-NP
I-GGP	A	A	NN	I-NP
O	(	(	(	O
B-GGP	Con	Con	NN	B-NP
I-GGP	A	A	NN	I-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	Sepharose	Sepharose	NN	I-NP
O	and	and	CC	O
O	Lens	Lens	NNP	B-NP
O	culinaris	culinaris	NN	I-NP
O	(	(	(	O
O	LcH	LcH	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	agarose	agarose	NN	I-NP
O	affinity	affinity	NN	I-NP
O	.	.	.	O

O	Six	Six	CD	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	phenotypes	phenotype	NNS	I-NP
O	were	be	VBD	B-VP
O	found	find	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	common	common	JJ	B-ADJP
O	among	among	IN	B-PP
O	all	all	DT	B-NP
O	clones	clone	NNS	I-NP
O	studied	study	VBN	B-VP
O	.	.	.	O

O	Despite	Despite	IN	B-PP
O	this	this	DT	B-NP
O	phenotypic	phenotypic	JJ	I-NP
O	heterogeneity	heterogeneity	NN	I-NP
O	in	in	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	of	of	IN	B-PP
O	IgG	IgG	NN	B-NP
O	,	,	,	O
O	considerable	considerable	JJ	B-NP
O	similarity	similarity	NN	I-NP
O	exists	exist	VBZ	B-VP
O	between	between	IN	B-PP
O	different	different	JJ	B-NP
O	clones	clone	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	particular	particular	JJ	B-NP
O	,	,	,	O
O	virtually	virtually	RB	B-NP
O	all	all	DT	I-NP
O	IgG	IgG	NN	I-NP
O	glycopeptides	glycopeptide	NNS	I-NP
O	bear	bear	VBP	B-VP
O	a	a	DT	B-NP
O	core	core	NN	I-NP
O	fucose	fucose	NN	I-NP
O	residue	residue	NN	I-NP
O	.	.	.	O

O	Second	Second	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	majority	majority	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	repertoire	repertoire	NN	I-NP
O	is	be	VBZ	B-VP
O	comprised	comprise	VBN	I-VP
O	of	of	IN	B-PP
O	two	two	CD	B-NP
O	phenotypes	phenotype	NNS	I-NP
O	,	,	,	O
O	characterized	characterize	VBN	B-VP
O	by	by	IN	B-PP
O	glycopeptides	glycopeptide	NNS	B-NP
O	which	which	WDT	B-NP
O	differ	differ	VBP	B-VP
O	in	in	IN	B-PP
O	affinity	affinity	NN	B-NP
O	for	for	IN	B-PP
B-GGP	Con	Con	NN	B-NP
I-GGP	A	A	NN	I-NP
O	-	-	HYPH	I-NP
O	Sepharose	Sepharose	NN	I-NP
O	.	.	.	O

O	Of	Of	IN	B-PP
O	these	these	DT	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	predominantly	predominantly	RB	I-NP
O	expressed	express	VBN	I-NP
O	phenotype	phenotype	NN	I-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	same	same	JJ	I-NP
O	for	for	IN	B-PP
O	all	all	DT	B-NP
O	clones	clone	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	carbohydrate	carbohydrate	NN	I-NP
O	structure	structure	NN	I-NP
O	derived	derive	VBN	B-VP
O	from	from	IN	B-PP
O	this	this	DT	B-NP
O	phenotype	phenotype	NN	I-NP
O	,	,	,	O
O	elucidated	elucidate	VBN	B-VP
O	by	by	IN	B-PP
O	500	500	CD	B-NP
O	-	-	HYPH	I-NP
O	MHz	MHz	NN	I-NP
O	1H	1H	NN	I-NP
O	NMR	NMR	NN	I-NP
O	spectroscopy	spectroscopy	NN	I-NP
O	,	,	,	O
O	is	be	VBZ	B-VP
O	(	(	(	O
O	Formula	Formula	NNP	B-NP
O	:	:	:	O
O	see	see	VB	B-VP
O	text	text	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Significant	Significant	JJ	B-NP
O	variability	variability	NN	I-NP
O	between	between	IN	B-PP
O	different	different	JJ	B-NP
O	hybridomas	hybridoma	NNS	I-NP
O	exists	exist	VBZ	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	relative	relative	JJ	I-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	major	major	JJ	I-NP
O	phenotypes	phenotype	NNS	I-NP
O	.	.	.	O

O	Other	Other	JJ	B-NP
O	differences	difference	NNS	I-NP
O	between	between	IN	B-PP
O	clones	clone	NNS	B-NP
O	may	may	MD	B-VP
O	reflect	reflect	VB	I-VP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	additional	additional	JJ	I-NP
O	site	site	NN	I-NP
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	glycosylated	glycosylate	VBN	I-VP
O	differently	differently	RB	B-ADVP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	there	there	EX	B-NP
O	is	be	VBZ	B-VP
O	no	no	DT	B-NP
O	apparent	apparent	JJ	I-NP
O	correlation	correlation	NN	I-NP
O	of	of	IN	B-PP
O	phenotype	phenotype	NN	B-NP
O	with	with	IN	B-PP
O	either	either	CC	O
O	the	the	DT	B-NP
O	hybridoma	hybridoma	NN	I-NP
O	'	'	POS	B-NP
O	s	s	NNS	I-NP
O	parentage	parentage	NN	I-NP
O	or	or	CC	O
O	the	the	DT	B-NP
O	serologically	serologically	RB	I-NP
O	defined	define	VBN	I-NP
O	polypeptide	polypeptide	NN	I-NP
O	structure	structure	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	IgG	IgG	NN	I-NP
O	which	which	WDT	B-NP
O	it	it	PRP	B-NP
O	secretes	secrete	VBZ	B-VP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	to	to	TO	B-PP
O	clonal	clonal	JJ	B-NP
O	variability	variability	NN	I-NP
O	,	,	,	O
O	other	other	JJ	B-NP
O	sources	source	NNS	I-NP
O	of	of	IN	B-PP
O	variability	variability	NN	B-NP
O	in	in	IN	B-PP
O	phenotypic	phenotypic	JJ	B-NP
O	expression	expression	NN	I-NP
O	were	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	.	.	.	O

O	A	A	DT	B-NP
O	generational	generational	JJ	I-NP
O	variability	variability	NN	I-NP
O	is	be	VBZ	B-VP
O	apparent	apparent	JJ	B-ADJP
O	upon	upon	IN	B-PP
O	continuous	continuous	JJ	B-NP
O	culturing	culturing	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	same	same	JJ	I-NP
O	hybridoma	hybridoma	NN	I-NP
O	.	.	.	O

O	Also	Also	RB	B-ADVP
O	,	,	,	O
O	differences	difference	NNS	B-NP
O	in	in	IN	B-PP
O	culture	culture	NN	B-NP
O	medium	medium	NN	I-NP
O	pH	pH	NN	I-NP
O	or	or	CC	O
O	proliferative	proliferative	JJ	B-NP
O	state	state	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cells	cell	NNS	I-NP
O	may	may	MD	B-VP
O	have	have	VB	I-VP
O	a	a	DT	B-NP
O	modest	modest	JJ	I-NP
O	influence	influence	NN	I-NP
O	upon	upon	IN	B-PP
O	the	the	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	phenotype	phenotype	NN	I-NP
O	.	.	.	O

O	Specific	Specific	JJ	B-NP
O	immune	immune	JJ	I-NP
O	responses	response	NNS	I-NP
O	restored	restore	VBN	B-VP
O	by	by	IN	B-PP
O	alteration	alteration	NN	B-NP
O	in	in	IN	B-PP
O	carbohydrate	carbohydrate	NN	B-NP
O	chains	chain	NNS	I-NP
O	of	of	IN	B-PP
O	surface	surface	NN	B-NP
O	molecules	molecule	NNS	I-NP
O	on	on	IN	B-PP
O	antigen	antigen	NN	B-NP
O	-	-	HYPH	O
O	presenting	present	VBG	B-VP
O	cells	cell	NNS	B-NP
O	.	.	.	O

O	Two	Two	CD	B-NP
O	class	class	NN	I-NP
O	I	I	CD	I-NP
O	major	major	JJ	I-NP
O	histocompatibility	histocompatibility	NN	I-NP
O	(	(	(	O
O	MHC	MHC	NN	B-NP
O	)	)	)	O
O	mutant	mutant	JJ	B-NP
O	mouse	mouse	NN	I-NP
O	strains	strain	NNS	I-NP
O	,	,	,	O
O	H	H	NN	B-NP
O	-	-	HYPH	B-NP
O	2bm14	2bm14	CD	I-NP
O	and	and	CC	I-NP
O	H	H	NN	I-NP
O	-	-	HYPH	O
O	2bm6	2bm6	CD	B-NP
O	,	,	,	O
O	differ	differ	VBP	B-VP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	strain	strain	NN	I-NP
O	of	of	IN	B-PP
O	origin	origin	NN	B-NP
O	C57BL	C57BL	NN	I-NP
O	/	/	SYM	O
O	6	6	CD	B-NP
O	(	(	(	O
O	B6	B6	NN	B-NP
O	,	,	,	O
O	H	H	NN	B-NP
O	-	-	HYPH	B-NP
O	2b	2b	NN	I-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	one	one	CD	B-NP
O	and	and	CC	I-NP
O	two	two	CD	I-NP
O	amino	amino	JJ	I-NP
O	acids	acid	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	H	H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	2Db	2Db	NN	I-NP
O	and	and	CC	I-NP
B-GGP	H	H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	2Kb	2Kb	NN	I-NP
O	molecule	molecule	NN	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	The	The	DT	B-NP
O	bm14	bm14	NN	I-NP
O	Db	Db	NN	I-NP
O	mutation	mutation	NN	I-NP
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	specific	specific	JJ	B-NP
O	failure	failure	NN	I-NP
O	of	of	IN	B-PP
O	female	female	JJ	B-NP
O	bm14	bm14	NN	I-NP
O	mice	mouse	NNS	I-NP
O	to	to	TO	B-VP
O	generate	generate	VB	I-VP
O	a	a	DT	B-NP
O	cytotoxic	cytotoxic	JJ	I-NP
O	T	T	NN	I-NP
O	lymphocyte	lymphocyte	NN	I-NP
O	(	(	(	O
O	Tc	Tc	NN	B-NP
O	)	)	)	O
O	response	response	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	male	male	NN	I-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	antigen	antigen	NN	I-NP
B-GGP	H	H	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	Y	Y	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	allospecific	allospecific	JJ	I-NP
O	Tc	Tc	NN	I-NP
O	response	response	NN	I-NP
O	of	of	IN	B-PP
B-GGP	CD8	CD8	NN	B-NP
O	+	+	SYM	I-NP
O	B6T	B6T	NN	I-NP
O	cells	cell	NNS	I-NP
O	against	against	IN	B-PP
O	bm6	bm6	NN	B-NP
O	Kb	Kb	NN	I-NP
O	mutant	mutant	JJ	I-NP
O	spleen	spleen	NN	I-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	contrast	contrast	NN	B-NP
O	to	to	TO	B-PP
O	that	that	DT	B-NP
O	against	against	IN	B-PP
O	other	other	JJ	B-NP
O	Kb	Kb	NN	I-NP
O	mutants	mutant	NNS	I-NP
O	,	,	,	O
O	is	be	VBZ	B-VP
O	absolutely	absolutely	RB	B-ADVP
B-GGP	CD4	CD4	NN	B-NP
O	+	+	CC	I-NP
O	T	T	NN	I-NP
O	helper	helper	NN	I-NP
O	cell	cell	NN	I-NP
O	dependent	dependent	JJ	B-ADJP
O	.	.	.	O

O	Purified	Purify	VBN	B-NP
B-GGP	CD8	CD8	NN	I-NP
O	+	+	SYM	I-NP
O	T	T	NN	I-NP
O	cells	cell	NNS	I-NP
O	completely	completely	RB	B-ADVP
O	fail	fail	VBP	B-VP
O	to	to	TO	I-VP
O	respond	respond	VB	I-VP
O	.	.	.	O

O	We	We	PRP	B-NP
O	now	now	RB	B-ADVP
O	report	report	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	inability	inability	NN	I-NP
O	to	to	TO	B-VP
O	mount	mount	VB	I-VP
O	these	these	DT	B-NP
O	specific	specific	JJ	I-NP
O	immune	immune	JJ	I-NP
O	responses	response	NNS	I-NP
O	is	be	VBZ	B-VP
O	restored	restore	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	use	use	NN	I-NP
O	of	of	IN	B-PP
O	dendritic	dendritic	JJ	B-NP
O	cells	cell	NNS	I-NP
O	(	(	(	O
O	DC	DC	NN	B-NP
O	)	)	)	O
O	as	as	IN	B-PP
O	antigen	antigen	NN	B-NP
O	-	-	HYPH	I-NP
O	presenting	present	VBG	B-VP
O	cells	cell	NNS	B-NP
O	(	(	(	O
O	APC	APC	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Comparison	Comparison	NN	B-NP
O	of	of	IN	B-PP
O	MHC	MHC	NN	B-NP
O	expression	expression	NN	I-NP
O	on	on	IN	B-PP
O	various	various	JJ	B-NP
O	types	type	NNS	I-NP
O	of	of	IN	B-PP
O	APC	APC	NN	B-NP
O	by	by	IN	B-PP
O	cytofluorimetry	cytofluorimetry	NN	B-NP
O	and	and	CC	O
O	quantitative	quantitative	JJ	B-NP
O	immunoprecipitation	immunoprecipitation	NN	I-NP
O	showed	show	VBD	B-VP
O	very	very	RB	B-NP
O	high	high	JJ	I-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	class	class	NN	B-NP
O	I	I	CD	I-NP
O	and	and	CC	O
O	class	class	NN	B-NP
O	II	II	CD	I-NP
O	MHC	MHC	NN	I-NP
O	molecules	molecule	NNS	I-NP
O	on	on	IN	B-PP
O	DC	DC	NN	B-NP
O	.	.	.	O

O	Strikingly	Strikingly	RB	B-ADVP
O	,	,	,	O
O	examination	examination	NN	B-NP
O	of	of	IN	B-PP
O	class	class	NN	B-NP
O	I	I	CD	I-NP
O	and	and	CC	O
O	class	class	NN	B-NP
O	II	II	CD	B-NP
O	molecules	molecule	NNS	I-NP
O	by	by	IN	B-PP
O	isoelectric	isoelectric	JJ	B-NP
O	focusing	focusing	NN	I-NP
O	revealed	reveal	VBD	B-VP
O	qualitative	qualitative	JJ	B-NP
O	differences	difference	NNS	I-NP
O	as	as	RB	B-ADVP
O	well	well	RB	I-ADVP
O	.	.	.	O

O	We	We	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	surface	surface	NN	I-NP
O	MHC	MHC	NN	I-NP
O	class	class	NN	I-NP
O	I	I	CD	B-NP
O	molecules	molecule	NNS	I-NP
O	of	of	IN	B-PP
O	DC	DC	NN	B-NP
O	are	be	VBP	B-VP
O	present	present	JJ	B-ADJP
O	in	in	IN	B-PP
O	greater	great	JJR	B-NP
O	quantity	quantity	NN	I-NP
O	and	and	CC	I-NP
O	carry	carry	NN	I-NP
O	on	on	IN	B-PP
O	average	average	JJ	B-NP
O	fewer	few	JJR	I-NP
O	sialic	sialic	JJ	I-NP
O	acids	acid	NNS	I-NP
O	than	than	IN	B-PP
O	the	the	DT	B-NP
O	same	same	JJ	I-NP
O	molecules	molecule	NNS	I-NP
O	isolated	isolate	VBN	B-VP
O	from	from	IN	B-PP
O	other	other	JJ	B-NP
O	APC	APC	NN	I-NP
O	types	type	NNS	I-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	spleen	spleen	NN	B-NP
O	cells	cell	NNS	I-NP
O	,	,	,	O
O	lipopolysaccharide	lipopolysaccharide	NN	B-NP
O	blasts	blast	NNS	I-NP
O	or	or	CC	O
B-GGP	concanavalin	concanavalin	NN	B-NP
I-GGP	A	A	NN	I-NP
O	blasts	blast	NNS	I-NP
O	.	.	.	O

O	That	That	DT	B-NP
O	sialic	sialic	JJ	I-NP
O	acids	acid	NNS	I-NP
O	on	on	IN	B-PP
O	cell	cell	NN	B-NP
O	surface	surface	NN	I-NP
O	molecules	molecule	NNS	I-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	MHC	MHC	NN	B-NP
O	,	,	,	O
O	may	may	MD	B-VP
O	play	play	VB	I-VP
O	a	a	DT	B-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	antigen	antigen	NN	B-NP
O	presentation	presentation	NN	I-NP
O	is	be	VBZ	B-VP
O	suggested	suggest	VBN	I-VP
O	by	by	IN	B-PP
O	our	our	PRP$	B-NP
O	finding	finding	NN	I-NP
O	that	that	IN	B-SBAR
O	removal	removal	NN	B-NP
O	of	of	IN	B-PP
O	sialic	sialic	JJ	B-NP
O	acids	acid	NNS	I-NP
O	,	,	,	O
O	by	by	IN	B-PP
O	neuraminidase	neuraminidase	NN	B-NP
O	,	,	,	O
O	can	can	MD	B-VP
O	restore	restore	VB	I-VP
O	specific	specific	JJ	B-NP
O	responses	response	NNS	I-NP
O	to	to	TO	B-VP
O	nonresponder	nonresponder	VB	I-VP
O	APC	APC	NN	B-NP
O	as	as	RB	B-ADVP
O	well	well	RB	I-ADVP
O	.	.	.	O

O	Effects	Effect	NNS	B-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
O	acetylation	acetylation	NN	I-NP
O	on	on	IN	B-PP
O	nucleosome	nucleosome	NN	B-NP
O	properties	property	NNS	I-NP
O	as	as	IN	B-SBAR
O	evaluated	evaluate	VBN	B-VP
O	by	by	IN	B-PP
O	polyacrylamide	polyacrylamide	NN	B-NP
O	gel	gel	NN	I-NP
O	electrophoresis	electrophoresis	NN	I-NP
O	and	and	CC	O
O	hydroxylapatite	hydroxylapatite	NN	B-NP
O	dissociation	dissociation	NN	I-NP
O	chromatography	chromatography	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	release	release	NN	I-NP
O	of	of	IN	B-PP
O	acetylated	acetylate	VBN	B-NP
B-GGP	histones	histone	NNS	I-NP
O	from	from	IN	B-PP
O	chick	chick	NN	B-NP
O	oviduct	oviduct	NN	I-NP
O	chromatin	chromatin	NN	I-NP
O	was	be	VBD	B-VP
O	analyzed	analyze	VBN	I-VP
O	by	by	IN	B-PP
O	hydroxylapatite	hydroxylapatite	NN	B-NP
O	column	column	NN	I-NP
O	chromatography	chromatography	NN	I-NP
O	.	.	.	O

O	By	By	IN	B-PP
O	raising	raise	VBG	B-VP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	NaCl	NaCl	NN	I-NP
O	concentration	concentration	NN	I-NP
O	,	,	,	O
O	acetylated	acetylate	VBN	B-NP
B-GGP	histones	histone	NNS	I-NP
O	were	be	VBD	B-VP
O	eluted	elute	VBN	I-VP
O	from	from	IN	B-PP
O	hydroxylapatite	hydroxylapatite	NN	B-NP
O	-	-	HYPH	B-PP
O	bound	bind	VBN	B-NP
O	chromatin	chromatin	NN	I-NP
O	depending	depend	VBG	B-PP
O	on	on	IN	B-PP
O	their	their	PRP$	B-NP
O	release	release	NN	I-NP
O	from	from	IN	B-PP
O	nucleosomal	nucleosomal	JJ	B-NP
O	DNA	DNA	NN	I-NP
O	.	.	.	O

O	Electrophoresis	Electrophoresis	NN	B-NP
O	on	on	IN	B-PP
O	acid	acid	NN	B-NP
O	-	-	HYPH	B-NP
O	urea	urea	NN	I-NP
O	gel	gel	NN	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	hyperacetylated	hyperacetylate	VBN	B-NP
O	forms	form	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	histone	histone	NN	B-NP
I-GGP	H4	H4	NN	I-NP
O	were	be	VBD	B-VP
O	eluted	elute	VBN	I-VP
O	at	at	IN	B-PP
O	a	a	DT	B-NP
O	lower	low	JJR	I-NP
O	NaCl	NaCl	NN	I-NP
O	concentration	concentration	NN	I-NP
O	than	than	IN	B-PP
O	non	non	AFX	B-NP
O	-	-	HYPH	I-NP
O	acetylated	acetylate	VBN	B-VP
O	or	or	CC	I-VP
O	hypoacetylated	hypoacetylate	VBN	I-VP
B-GGP	H4	H4	NN	B-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	hyperacetylated	hyperacetylate	VBN	B-NP
B-GGP	H4	H4	NN	I-NP
O	has	have	VBZ	B-VP
O	decreased	decrease	VBN	I-VP
O	stability	stability	NN	B-NP
O	in	in	IN	B-PP
O	nucleosomes	nucleosome	NNS	B-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	under	under	IN	B-PP
O	milder	mild	JJR	B-NP
O	ionic	ionic	JJ	I-NP
O	conditions	condition	NNS	I-NP
O	which	which	WDT	B-NP
O	do	do	VBP	B-VP
O	not	not	RB	I-VP
O	induce	induce	VB	I-VP
O	dissociation	dissociation	NN	B-NP
O	between	between	IN	B-PP
B-GGP	histones	histone	NNS	B-NP
O	and	and	CC	O
O	DNA	DNA	NN	B-NP
O	,	,	,	O
O	polyacrylamide	polyacrylamide	NN	B-NP
O	gel	gel	NN	I-NP
O	electrophoresis	electrophoresis	NN	I-NP
O	of	of	IN	B-PP
O	purified	purify	VBN	B-NP
O	nucleosome	nucleosome	NN	I-NP
O	cores	core	NNS	I-NP
O	showed	show	VBD	B-VP
O	no	no	DT	B-NP
O	evidence	evidence	NN	I-NP
O	for	for	IN	B-PP
O	their	their	PRP$	B-NP
O	unfolding	unfolding	NN	I-NP
O	or	or	CC	B-PP
O	for	for	IN	B-PP
O	increased	increase	VBN	B-NP
O	accessibility	accessibility	NN	I-NP
O	by	by	IN	B-PP
B-GGP	high	high	JJ	B-NP
I-GGP	mobility	mobility	NN	I-NP
I-GGP	group	group	NN	I-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	17	17	CD	I-NP
O	.	.	.	O

O	beta	beta	SYM	B-NP
O	-	-	:	O
O	Hydroxyasparagine	Hydroxyasparagine	NN	B-NP
O	in	in	IN	B-PP
O	domains	domain	NNS	B-NP
O	homologous	homologous	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
B-GGP	epidermal	epidermal	JJ	I-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	precursor	precursor	NN	I-NP
O	in	in	IN	B-PP
B-GGP	vitamin	vitamin	NN	B-NP
I-GGP	K	K	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	dependent	dependent	JJ	I-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	S	S	NN	I-NP
O	.	.	.	O

B-GGP	Vitamin	Vitamin	NN	B-NP
I-GGP	K	K	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	dependent	dependent	JJ	I-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	S	S	NN	I-NP
O	is	be	VBZ	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	blood	blood	NN	B-NP
O	coagulation	coagulation	NN	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	75	75	CD	I-NP
O	-	-	HYPH	I-NP
O	kDa	kDa	NN	I-NP
O	single	single	JJ	I-NP
O	chain	chain	NN	I-NP
O	protein	protein	NN	I-NP
O	with	with	IN	B-PP
O	an	an	DT	B-NP
O	NH2	NH2	NN	I-NP
O	-	-	HYPH	O
O	terminal	terminal	JJ	B-NP
O	gamma	gamma	SYM	I-NP
O	-	-	HYPH	I-NP
O	carboxyglutamic	carboxyglutamic	JJ	B-NP
O	acid	acid	NN	I-NP
O	-	-	HYPH	O
O	containing	contain	VBG	B-VP
O	domain	domain	NN	B-NP
O	followed	follow	VBN	B-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
B-GGP	thrombin	thrombin	NN	I-NP
O	-	-	HYPH	B-NP
O	sensitive	sensitive	JJ	I-NP
O	region	region	NN	I-NP
O	and	and	CC	O
O	four	four	CD	B-NP
O	domains	domain	NNS	I-NP
O	arranged	arrange	VBN	B-VP
O	in	in	IN	B-PP
O	tandem	tandem	NN	B-NP
O	,	,	,	O
O	each	each	DT	B-NP
O	of	of	IN	B-PP
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	homologous	homologous	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
B-GGP	epidermal	epidermal	JJ	I-NP
I-GGP	growth	growth	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	(	(	(	O
B-GGP	EGF	EGF	NN	B-NP
O	)	)	)	O
O	precursor	precursor	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	NH2	NH2	NN	I-NP
O	-	-	HYPH	O
O	terminal	terminal	JJ	B-NP
O	EGF	EGF	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	domain	domain	NN	I-NP
O	contains	contain	VBZ	B-VP
O	beta	beta	SYM	B-NP
O	-	-	HYPH	O
O	hydroxyaspartic	hydroxyaspartic	JJ	B-NP
O	acid	acid	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	identified	identify	VBN	I-VP
O	in	in	IN	B-PP
O	vitamin	vitamin	NN	B-NP
O	K	K	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	following	follow	VBG	I-NP
O	EGF	EGF	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	repeat	repeat	NN	I-NP
O	has	have	VBZ	B-VP
O	a	a	DT	B-NP
O	very	very	RB	I-NP
O	pronounced	pronounced	JJ	I-NP
O	sequence	sequence	NN	I-NP
O	homology	homology	NN	I-NP
O	(	(	(	O
O	10	10	CD	B-NP
O	consecutive	consecutive	JJ	I-NP
O	residues	residue	NNS	I-NP
O	identical	identical	JJ	B-ADJP
O	)	)	)	O
O	to	to	TO	B-PP
O	one	one	CD	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	EGF	EGF	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	units	unit	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
B-GGP	EGF	EGF	NN	I-NP
O	precursor	precursor	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	now	now	RB	B-ADVP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	,	,	,	O
O	in	in	IN	B-PP
B-GGP	protein	protein	NN	B-NP
I-GGP	S	S	NN	I-NP
O	,	,	,	O
O	this	this	DT	B-NP
O	EGF	EGF	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	repeat	repeat	NN	I-NP
O	has	have	VBZ	B-VP
O	one	one	CD	B-NP
O	beta	beta	SYM	I-NP
O	-	-	HYPH	I-NP
O	hydroxyasparagine	hydroxyasparagine	NN	I-NP
O	residue	residue	NN	I-NP
O	formed	form	VBN	B-VP
O	by	by	IN	B-PP
O	hydroxylation	hydroxylation	NN	B-NP
O	of	of	IN	B-PP
O	asparagine	asparagine	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	two	two	CD	I-NP
O	COOH	COOH	NN	I-NP
O	-	-	HYPH	O
O	terminal	terminal	JJ	B-NP
O	EGF	EGF	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	repeats	repeat	NNS	B-NP
O	also	also	RB	B-ADVP
O	contain	contain	VBP	B-VP
O	beta	beta	SYM	B-NP
O	-	-	HYPH	B-NP
O	hydroxyasparagine	hydroxyasparagine	NN	I-NP
O	,	,	,	O
O	an	an	DT	B-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	not	not	RB	O
O	previously	previously	RB	B-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	proteins	protein	NNS	B-NP
O	.	.	.	O

O	Sequence	Sequence	NN	B-NP
O	comparisons	comparison	NNS	I-NP
O	have	have	VBP	B-VP
O	enabled	enable	VBN	I-VP
O	us	us	PRP	B-NP
O	to	to	TO	B-VP
O	identify	identify	VB	I-VP
O	a	a	DT	B-NP
O	consensus	consensus	NN	I-NP
O	sequence	sequence	NN	I-NP
O	that	that	WDT	B-NP
O	seems	seem	VBZ	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	required	require	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	hydroxylase	hydroxylase	NN	I-NP
O	(	(	(	I-NP
O	s	s	NNS	I-NP
O	)	)	)	O
O	.	.	.	O

O	Comparison	Comparison	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	immune	immune	JJ	I-NP
O	response	response	NN	I-NP
O	to	to	TO	B-PP
O	variant	variant	JJ	B-NP
O	influenza	influenza	NN	I-NP
O	type	type	NN	I-NP
O	B	B	NN	I-NP
B-GGP	hemagglutinins	hemagglutinin	NNS	I-NP
O	expressed	express	VBN	B-VP
O	in	in	IN	B-PP
O	vaccinia	vaccinia	NN	B-NP
O	virus	virus	NN	I-NP
O	.	.	.	O

O	To	To	TO	B-VP
O	compare	compare	VB	I-VP
O	the	the	DT	B-NP
O	immune	immune	JJ	I-NP
O	response	response	NN	I-NP
O	induced	induce	VBN	B-VP
O	by	by	IN	B-PP
O	influenza	influenza	NN	B-NP
B-GGP	hemagglutinin	hemagglutinin	NN	I-NP
O	(	(	(	O
B-GGP	HA	HA	NN	B-NP
O	)	)	)	O
O	variants	variant	NNS	B-NP
O	differing	differ	VBG	B-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	single	single	JJ	I-NP
O	amino	amino	NN	I-NP
O	acid	acid	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	genes	gene	NNS	I-NP
O	for	for	IN	B-PP
O	each	each	DT	B-NP
B-GGP	HA	HA	NN	I-NP
O	variant	variant	NN	I-NP
O	were	be	VBD	B-VP
O	cloned	clone	VBN	I-VP
O	and	and	CC	O
O	expressed	express	VBN	B-VP
O	in	in	IN	B-PP
O	vaccinia	vaccinia	NN	B-NP
O	virus	virus	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	variant	variant	JJ	I-NP
B-GGP	HA	HA	NN	I-NP
O	genes	gene	NNS	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	previously	previously	RB	I-VP
O	described	describe	VBN	I-VP
O	as	as	IN	B-PP
O	being	be	VBG	B-VP
O	present	present	JJ	B-ADJP
O	exclusively	exclusively	RB	B-ADVP
O	in	in	IN	B-PP
O	either	either	CC	O
O	egg	egg	NN	B-NP
O	-	-	HYPH	B-NP
O	derived	derive	VBN	B-VP
O	or	or	CC	O
O	MDCK	MDCK	NN	B-NP
O	cell	cell	NN	I-NP
O	-	-	HYPH	B-NP
O	derived	derive	VBN	I-NP
O	subpopulations	subpopulation	NNS	I-NP
O	of	of	IN	B-PP
O	influenza	influenza	NN	B-NP
O	B	B	NN	I-NP
O	/	/	SYM	B-NP
O	England	England	NN	I-NP
O	/	/	SYM	B-NP
O	222	222	CD	B-NP
O	/	/	SYM	I-NP
O	82	82	CD	I-NP
O	virus	virus	NN	I-NP
O	.	.	.	O

O	By	By	IN	B-PP
O	using	use	VBG	B-VP
O	this	this	DT	B-NP
O	approach	approach	NN	I-NP
O	we	we	PRP	B-NP
O	were	be	VBD	B-VP
O	able	able	JJ	B-ADJP
O	to	to	TO	B-VP
O	vaccinate	vaccinate	VB	I-VP
O	animals	animal	NNS	B-NP
O	with	with	IN	B-PP
O	homogeneous	homogeneous	JJ	B-NP
O	preparations	preparation	NNS	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	viral	viral	JJ	I-NP
O	antigens	antigen	NNS	I-NP
O	and	and	CC	O
O	thus	thus	RB	B-ADVP
O	circumvent	circumvent	VB	B-VP
O	the	the	DT	B-NP
O	problem	problem	NN	I-NP
O	of	of	IN	B-PP
O	heterogeneity	heterogeneity	NN	B-NP
O	within	within	IN	B-PP
O	RNA	RNA	NN	B-NP
O	virus	virus	NN	I-NP
O	stocks	stock	NNS	I-NP
O	.	.	.	O

O	Immunization	Immunization	NN	B-NP
O	and	and	CC	I-NP
O	challenge	challenge	NN	I-NP
O	experiments	experiment	NNS	I-NP
O	in	in	IN	B-PP
O	mice	mouse	NNS	B-NP
O	indicated	indicate	VBD	B-VP
O	that	that	IN	B-SBAR
O	even	even	RB	B-SBAR
O	though	though	IN	I-SBAR
O	vaccination	vaccination	NN	B-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	recombinant	recombinant	JJ	I-NP
O	vaccinia	vaccinia	NN	I-NP
O	viruses	virus	NNS	I-NP
O	induced	induce	VBD	B-VP
O	different	different	JJ	B-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	cross	cross	AFX	B-NP
O	-	-	HYPH	I-NP
O	reactive	reactive	JJ	B-NP
O	neutralizing	neutralize	VBG	I-NP
O	antibodies	antibody	NNS	I-NP
O	,	,	,	O
O	mice	mouse	NNS	B-NP
O	vaccinated	vaccinate	VBN	B-VP
O	with	with	IN	B-PP
O	either	either	CC	B-NP
O	recombinant	recombinant	JJ	I-NP
O	vaccinia	vaccinia	NN	I-NP
O	virus	virus	NN	I-NP
O	were	be	VBD	B-VP
O	protected	protect	VBN	I-VP
O	from	from	IN	B-PP
O	infection	infection	NN	B-NP
O	with	with	IN	B-PP
O	either	either	CC	O
O	subpopulation	subpopulation	NN	B-NP
O	of	of	IN	B-PP
O	influenza	influenza	NN	B-NP
O	virus	virus	NN	I-NP
O	.	.	.	O

O	Results	Result	NNS	B-NP
O	with	with	IN	B-PP
O	this	this	DT	B-NP
O	model	model	NN	I-NP
O	system	system	NN	I-NP
O	support	support	VBP	B-VP
O	the	the	DT	B-NP
O	view	view	NN	I-NP
O	that	that	IN	B-SBAR
O	influenza	influenza	NN	B-NP
O	vaccines	vaccine	NNS	I-NP
O	prepared	prepare	VBN	B-VP
O	with	with	IN	B-PP
O	egg	egg	NN	B-NP
O	-	-	HYPH	O
O	derived	derive	VBN	B-NP
O	virus	virus	NN	I-NP
O	should	should	MD	B-VP
O	be	be	VB	I-VP
O	protective	protective	JJ	B-ADJP
O	against	against	IN	B-PP
O	microvariants	microvariant	NNS	B-NP
O	of	of	IN	B-PP
O	virus	virus	NN	B-NP
O	that	that	WDT	B-NP
O	grow	grow	VBP	B-VP
O	preferentially	preferentially	RB	B-ADVP
O	in	in	IN	B-PP
O	MDCK	MDCK	NN	B-NP
O	and	and	CC	O
O	possibly	possibly	RB	B-NP
O	other	other	JJ	I-NP
O	mammalian	mammalian	JJ	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Biosynthesis	Biosynthesis	NN	B-NP
O	of	of	IN	B-PP
O	type	type	NN	B-NP
O	I	I	CD	I-NP
O	procollagen	procollagen	NN	I-NP
O	.	.	.	O

O	Characterization	Characterization	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	distribution	distribution	NN	I-NP
O	of	of	IN	B-PP
O	chain	chain	NN	B-NP
O	sizes	size	NNS	I-NP
O	and	and	CC	O
O	extent	extent	NN	B-NP
O	of	of	IN	B-PP
O	hydroxylation	hydroxylation	NN	B-NP
O	of	of	IN	B-PP
O	polysome	polysome	NN	B-NP
O	-	-	HYPH	O
O	associated	associate	VBN	B-VP
O	pro	pro	AFX	O
O	-	-	HYPH	O
O	alpha	alpha	SYM	O
O	-	-	HYPH	O
O	chains	chain	NNS	B-NP
O	.	.	.	O

O	[	[	(	O
O	3H	3H	NN	B-NP
O	]	]	)	I-NP
O	Proline	Proline	NN	I-NP
O	-	-	HYPH	O
O	labeled	label	VBN	B-VP
O	nascent	nascent	JJ	B-NP
O	procollagen	procollagen	NN	I-NP
O	chains	chain	NNS	I-NP
O	were	be	VBD	B-VP
O	isolated	isolate	VBN	I-VP
O	from	from	IN	B-PP
O	chick	chick	NN	B-NP
O	tendon	tendon	NN	I-NP
O	polysome	polysome	NN	I-NP
O	preparations	preparation	NNS	I-NP
O	as	as	IN	B-PP
O	peptidyl	peptidyl	NN	B-NP
O	-	-	HYPH	B-NP
O	tRNA	tRNA	NN	I-NP
O	complexes	complex	NNS	I-NP
O	by	by	IN	B-PP
O	ion	ion	NN	B-NP
O	exchange	exchange	NN	I-NP
O	chromatography	chromatography	NN	I-NP
O	.	.	.	O

O	Proline	Proline	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	nascent	nascent	JJ	I-NP
O	chains	chain	NNS	I-NP
O	was	be	VBD	B-VP
O	at	at	IN	B-NP
O	least	least	JJS	I-NP
O	40	40	CD	I-NP
O	%	%	NN	I-NP
O	complete	complete	JJ	B-ADJP
O	,	,	,	O
O	based	base	VBN	B-PP
O	on	on	IN	B-PP
O	radioactive	radioactive	JJ	B-NP
O	hydroxyproline	hydroxyproline	NN	I-NP
O	/	/	SYM	B-VP
O	proline	proline	NN	B-NP
O	ratios	ratio	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	provide	provide	VBP	B-VP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	direct	direct	JJ	I-NP
O	evidence	evidence	NN	I-NP
O	that	that	IN	B-SBAR
O	hydroxylation	hydroxylation	NN	B-NP
O	of	of	IN	B-PP
O	procollagen	procollagen	NN	B-NP
O	proline	proline	NN	I-NP
O	residues	residue	NNS	I-NP
O	does	do	VBZ	B-VP
O	occur	occur	VB	I-VP
O	on	on	IN	B-PP
O	nascent	nascent	JJ	B-NP
O	chains	chain	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	electrophoretic	electrophoretic	JJ	I-NP
O	profiles	profile	NNS	I-NP
O	of	of	IN	B-PP
O	[	[	(	B-NP
O	3H	3H	NN	I-NP
O	]	]	)	I-NP
O	proline	proline	NN	I-NP
O	-	-	HYPH	O
O	labeled	label	VBN	B-VP
O	nascent	nascent	JJ	B-NP
O	chains	chain	NNS	I-NP
O	and	and	CC	B-PP
O	of	of	IN	B-PP
O	unlabeled	unlabeled	JJ	B-NP
O	nascent	nascent	JJ	I-NP
O	chains	chain	NNS	I-NP
O	visualized	visualize	VBN	B-VP
O	by	by	IN	B-PP
O	Western	Western	JJ	B-NP
O	blotting	blotting	NN	I-NP
O	with	with	IN	B-PP
O	35S	35S	NN	B-NP
O	-	-	HYPH	O
O	labeled	label	VBN	B-VP
O	monoclonal	monoclonal	JJ	B-NP
O	antibodies	antibody	NNS	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
B-GGP	alpha	alpha	SYM	I-NP
I-GGP	1	1	CD	I-NP
I-GGP	(	(	(	O
I-GGP	I	I	NN	B-NP
I-GGP	)	)	)	O
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	propeptide	propeptide	NN	I-NP
O	or	or	CC	O
O	the	the	DT	B-NP
O	C	C	NN	I-NP
O	-	-	HYPH	B-NP
O	propeptides	propeptide	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	there	there	EX	B-NP
O	are	be	VBP	B-VP
O	pauses	pause	NNS	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	translation	translation	NN	I-NP
O	of	of	IN	B-PP
O	procollagen	procollagen	NN	B-NP
O	alpha	alpha	SYM	B-NP
O	-	-	HYPH	B-VP
O	chains	chain	NNS	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	intact	intact	JJ	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Approximately	Approximately	RB	B-NP
O	25	25	CD	I-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	radioactivity	radioactivity	NN	I-NP
O	associated	associate	VBN	B-VP
O	with	with	IN	B-PP
O	[	[	(	B-NP
O	3H	3H	NN	I-NP
O	]	]	)	I-NP
O	proline	proline	NN	I-NP
O	-	-	HYPH	B-NP
O	labeled	label	VBN	I-NP
O	polysomes	polysome	NNS	I-NP
O	was	be	VBD	B-VP
O	in	in	IN	B-PP
O	fully	fully	RB	B-VP
O	elongated	elongate	VBN	I-VP
O	but	but	CC	O
O	underhydroxylated	underhydroxylate	VBN	B-VP
O	(	(	(	O
O	relative	relative	JJ	B-ADVP
O	to	to	TO	B-PP
O	secreted	secrete	VBN	B-NP
O	procollagen	procollagen	NN	I-NP
O	)	)	)	O
O	pro	pro	AFX	O
O	-	-	HYPH	O
O	alpha	alpha	SYM	O
O	-	-	HYPH	O
O	chains	chain	NNS	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	association	association	NN	I-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	completely	completely	RB	I-NP
O	elongated	elongate	VBN	I-NP
O	but	but	CC	O
O	only	only	RB	B-VP
O	partially	partially	RB	I-VP
O	modified	modify	VBN	I-VP
O	procollagen	procollagen	NN	B-NP
O	chains	chain	NNS	I-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	polysome	polysome	JJ	I-NP
O	complex	complex	NN	I-NP
O	may	may	MD	B-VP
O	facilitate	facilitate	VB	I-VP
O	the	the	DT	B-NP
O	carboxyl	carboxyl	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	interactions	interaction	NNS	I-NP
O	which	which	WDT	B-NP
O	lead	lead	VBP	B-VP
O	to	to	TO	I-VP
O	triple	triple	VB	I-VP
O	helix	helix	NN	B-NP
O	formation	formation	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	comparison	comparison	NN	I-NP
O	of	of	IN	B-PP
O	accessibility	accessibility	NN	B-NP
O	of	of	IN	B-PP
O	ribosomal	ribosomal	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	on	on	IN	B-PP
O	free	free	JJ	B-NP
O	and	and	CC	I-NP
O	membrane	membrane	NN	I-NP
O	-	-	HYPH	B-NP
O	bound	bind	VBN	I-NP
O	ribosomes	ribosome	NNS	I-NP
O	:	:	:	O
O	the	the	DT	B-NP
O	ribosomal	ribosomal	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	potentially	potentially	RB	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	ribosome	ribosome	NN	B-NP
O	-	-	HYPH	B-NP
O	membrane	membrane	NN	I-NP
O	binding	binding	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	relative	relative	JJ	I-NP
O	accessibility	accessibility	NN	I-NP
O	of	of	IN	B-PP
O	rat	rat	NN	B-NP
O	liver	liver	NN	I-NP
O	ribosomal	ribosomal	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	to	to	TO	B-PP
O	reductive	reductive	JJ	B-NP
O	methylation	methylation	NN	I-NP
O	was	be	VBD	B-VP
O	examined	examine	VBN	I-VP
O	using	use	VBG	B-VP
O	membrane	membrane	NN	B-NP
O	-	-	HYPH	B-ADJP
O	bound	bind	VBN	I-ADJP
O	and	and	CC	O
O	free	free	JJ	B-NP
O	ribosomes	ribosome	NNS	I-NP
O	.	.	.	O

O	Comparisons	Comparison	NNS	B-NP
O	indicated	indicate	VBD	B-VP
O	that	that	IN	B-SBAR
O	12	12	CD	B-NP
O	-	-	HYPH	I-NP
O	13	13	CD	I-NP
O	large	large	JJ	I-NP
O	ribosomal	ribosomal	JJ	I-NP
O	proteins	protein	NNS	I-NP
O	are	be	VBP	B-VP
O	masked	mask	VBN	I-VP
O	by	by	IN	B-PP
O	ribosomal	ribosomal	JJ	B-NP
O	association	association	NN	I-NP
O	with	with	IN	B-PP
O	membranes	membrane	NNS	B-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	consisted	consist	VBD	B-VP
O	of	of	IN	B-PP
B-GGP	L8	L8	NN	B-NP
O	,	,	,	O
B-GGP	L10	L10	NN	B-NP
O	,	,	,	O
B-GGP	L17	L17	NN	B-NP
O	,	,	,	O
B-GGP	L26	L26	NN	B-NP
O	-	-	HYPH	I-NP
B-GGP	28	28	CD	I-NP
O	,	,	,	I-NP
B-GGP	L31	L31	NN	I-NP
O	and	and	CC	I-NP
B-GGP	L36	L36	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	probably	probably	RB	B-ADVP
O	also	also	RB	B-ADVP
O	include	include	VBP	B-VP
B-GGP	L4	L4	NN	B-NP
O	,	,	,	I-NP
B-GGP	L5	L5	NN	I-NP
O	,	,	,	I-NP
B-GGP	L7	L7	NN	I-NP
O	and	and	CC	I-NP
B-GGP	L29	L29	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	proteins	protein	NNS	I-NP
O	seem	seem	VBP	B-VP
O	to	to	TO	I-VP
O	surround	surround	VB	I-VP
O	a	a	DT	B-NP
O	region	region	NN	I-NP
O	centered	centered	JJ	B-ADJP
O	about	about	IN	B-PP
B-GGP	L3	L3	NN	B-NP
O	and	and	CC	O
O	may	may	MD	B-VP
O	partly	partly	RB	I-VP
O	define	define	VB	I-VP
O	a	a	DT	B-NP
O	ribosomal	ribosomal	JJ	I-NP
O	channel	channel	NN	I-NP
O	through	through	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
O	nascent	nascent	JJ	I-NP
O	peptide	peptide	NN	I-NP
O	emerges	emerge	NNS	I-NP
O	.	.	.	O

O	Approx	Approx	NNP	B-NP
O	.	.	.	O

O	10	10	CD	B-NP
O	-	-	HYPH	I-NP
O	20	20	CD	I-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	large	large	JJ	I-NP
O	ribosomal	ribosomal	JJ	I-NP
O	subunit	subunit	NN	I-NP
O	surface	surface	NN	I-NP
O	area	area	NN	I-NP
O	is	be	VBZ	B-VP
O	shielded	shield	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	membrane	membrane	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	prolonged	prolonged	JJ	I-NP
O	stimulatory	stimulatory	JJ	I-NP
O	effect	effect	NN	I-NP
O	of	of	IN	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	on	on	IN	B-PP
O	11	11	CD	B-NP
O	beta	beta	SYM	I-NP
O	-	-	HYPH	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	contribution	contribution	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	steroidogenic	steroidogenic	JJ	I-NP
O	potency	potency	NN	I-NP
O	of	of	IN	B-PP
O	adrenocortical	adrenocortical	JJ	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	mechanism	mechanism	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	prolonged	prolonged	JJ	I-NP
O	stimulatory	stimulatory	JJ	I-NP
O	influence	influence	NN	I-NP
O	of	of	IN	B-PP
B-GGP	corticotropin	corticotropin	NN	B-NP
O	(	(	(	O
B-GGP	ACTH	ACTH	NN	B-NP
O	)	)	)	O
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	capacity	capacity	NN	I-NP
O	of	of	IN	B-PP
O	adrenocortical	adrenocortical	JJ	B-NP
O	cells	cell	NNS	I-NP
O	to	to	TO	B-VP
O	produce	produce	VB	I-VP
O	cortisol	cortisol	NN	B-NP
O	in	in	IN	B-PP
O	response	response	NN	B-NP
O	to	to	TO	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	and	and	CC	O
O	more	more	RBR	B-ADVP
O	specifically	specifically	RB	I-ADVP
O	the	the	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	11	11	CD	B-NP
O	beta	beta	SYM	O
O	-	-	HYPH	O
O	hydroxylation	hydroxylation	NN	B-NP
O	,	,	,	O
O	was	be	VBD	B-VP
O	studied	study	VBN	I-VP
O	on	on	IN	B-PP
O	guinea	guinea	NN	B-NP
O	-	-	HYPH	I-NP
O	pig	pig	NN	I-NP
O	adrenocortical	adrenocortical	JJ	I-NP
O	cells	cell	NNS	I-NP
O	dispersed	disperse	VBN	B-VP
O	from	from	IN	B-PP
O	control	control	NN	B-NP
O	and	and	CC	I-NP
B-GGP	ACTH	ACTH	NN	I-NP
O	-	-	HYPH	B-NP
O	treated	treat	VBN	I-NP
O	animals	animal	NNS	I-NP
O	.	.	.	O

O	As	As	IN	B-PP
O	a	a	DT	B-NP
O	result	result	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	previous	previous	JJ	I-NP
O	in	in	FW	I-NP
O	vivo	vivo	FW	I-NP
O	exposure	exposure	NN	I-NP
O	to	to	TO	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	net	net	JJ	I-NP
O	maximal	maximal	JJ	I-NP
O	production	production	NN	I-NP
O	of	of	IN	B-PP
O	glucocorticoids	glucocorticoid	NNS	B-NP
O	in	in	IN	B-PP
O	response	response	NN	B-NP
O	to	to	TO	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	(	(	(	O
O	by	by	IN	B-PP
O	10	10	CD	B-NP
O	(	(	(	O
O	5	5	CD	B-NP
O	)	)	)	I-NP
O	cells	cell	NNS	I-NP
O	and	and	CC	O
O	2	2	CD	B-NP
O	h	h	NN	I-NP
O	incubation	incubation	NN	I-NP
O	)	)	)	O
O	increased	increase	VBD	B-VP
O	from	from	IN	B-PP
O	660	660	CD	B-NP
O	+	+	SYM	B-ADJP
O	/	/	SYM	O
O	-	-	SYM	B-NP
O	33	33	CD	B-NP
O	.	.	SYM	I-NP
O	9	9	CD	I-NP
O	ng	ng	NN	I-NP
O	(	(	(	O
O	control	control	NN	B-NP
O	group	group	NN	I-NP
O	)	)	)	O
O	to	to	TO	B-PP
O	1105	1105	CD	B-NP
O	+	+	SYM	O
O	/	/	SYM	O
O	-	-	SYM	B-NP
O	117	117	CD	B-NP
O	.	.	SYM	I-NP
O	9	9	CD	I-NP
O	ng	ng	NN	I-NP
O	for	for	IN	B-PP
O	cells	cell	NNS	B-NP
O	from	from	IN	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	-	-	HYPH	B-NP
O	treated	treat	VBN	I-NP
O	animals	animal	NNS	I-NP
O	(	(	(	O
O	P	P	NN	B-NP
O	less	less	JJR	B-NP
O	than	than	IN	I-NP
O	0	0	CD	I-NP
O	.	.	.	I-NP
O	001	001	CD	I-NP
O	)	)	)	O
O	,	,	,	O
O	whereas	whereas	IN	O
O	the	the	DT	B-NP
O	apparent	apparent	JJ	I-NP
O	affinity	affinity	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	steroidogenic	steroidogenic	JJ	I-NP
O	response	response	NN	I-NP
O	remained	remain	VBD	B-VP
O	unchanged	unchanged	JJ	B-ADJP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	there	there	EX	B-NP
O	occurred	occur	VBD	B-VP
O	an	an	DT	B-NP
O	increased	increase	VBN	I-NP
O	conversion	conversion	NN	I-NP
O	of	of	IN	B-PP
O	exogenous	exogenous	JJ	B-NP
O	pregnenolone	pregnenolone	NN	I-NP
O	into	into	IN	B-PP
O	cortisol	cortisol	NN	B-NP
O	by	by	IN	B-PP
O	cells	cell	NNS	B-NP
O	from	from	IN	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	-	-	HYPH	B-NP
O	treated	treat	VBN	I-NP
O	animals	animal	NNS	I-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	a	a	DT	B-NP
O	prolonged	prolonged	JJ	I-NP
O	stimulatory	stimulatory	JJ	I-NP
O	influence	influence	NN	I-NP
O	of	of	IN	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	post	post	AFX	I-NP
O	-	-	HYPH	I-NP
O	pregnenolone	pregnenolone	NN	I-NP
O	pathway	pathway	NN	I-NP
O	of	of	IN	B-PP
O	cortisol	cortisol	NN	B-NP
O	biosynthesis	biosynthesis	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
O	11	11	CD	B-NP
O	beta	beta	SYM	B-NP
O	-	-	HYPH	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	step	step	NN	I-NP
O	was	be	VBD	B-VP
O	therefore	therefore	RB	I-VP
O	examined	examine	VBN	I-VP
O	by	by	IN	B-PP
O	incubating	incubate	VBG	B-VP
O	the	the	DT	B-NP
O	adrenocortical	adrenocortical	JJ	I-NP
O	cells	cell	NNS	I-NP
O	from	from	IN	B-PP
O	control	control	NN	B-NP
O	and	and	CC	I-NP
B-GGP	ACTH	ACTH	NN	I-NP
O	-	-	HYPH	B-NP
O	treated	treat	VBN	I-NP
O	animals	animal	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	increasing	increase	VBG	B-NP
O	amounts	amount	NNS	I-NP
O	of	of	IN	B-PP
O	11	11	CD	B-NP
O	-	-	HYPH	I-NP
O	deoxycortisol	deoxycortisol	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	maximal	maximal	JJ	I-NP
O	capacity	capacity	NN	I-NP
O	of	of	IN	B-PP
O	11	11	CD	B-NP
O	-	-	HYPH	I-NP
O	deoxycortisol	deoxycortisol	NN	I-NP
O	conversion	conversion	NN	I-NP
O	into	into	IN	B-PP
O	cortisol	cortisol	NN	B-NP
O	was	be	VBD	B-VP
O	increased	increase	VBN	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	result	result	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	in	in	FW	I-NP
O	vivo	vivo	FW	I-NP
O	exposure	exposure	NN	I-NP
O	to	to	TO	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	,	,	,	O
O	averaging	average	VBG	B-VP
O	3423	3423	CD	B-NP
O	+	+	SYM	O
O	/	/	SYM	O
O	-	-	SYM	O
O	211	211	CD	B-NP
O	ng	ng	NN	I-NP
O	cortisol	cortisol	NN	I-NP
O	formed	form	VBN	B-VP
O	from	from	IN	B-PP
O	5	5	CD	B-NP
O	micrograms	microgram	NNS	I-NP
O	11	11	CD	B-NP
O	-	-	HYPH	I-NP
O	deoxycortisol	deoxycortisol	NN	I-NP
O	by	by	IN	B-PP
O	10	10	CD	B-NP
O	(	(	(	O
O	5	5	CD	B-NP
O	)	)	)	O
O	cells	cell	NNS	B-NP
O	from	from	IN	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	-	-	HYPH	B-NP
O	treated	treat	VBN	I-NP
O	animals	animal	NNS	I-NP
O	vs	vs	IN	B-PP
O	2074	2074	CD	B-NP
O	+	+	SYM	O
O	/	/	SYM	O
O	-	-	SYM	O
O	185	185	CD	B-NP
O	ng	ng	NN	I-NP
O	for	for	IN	B-PP
O	cells	cell	NNS	B-NP
O	from	from	IN	B-PP
O	control	control	NN	B-NP
O	guinea	guinea	NN	I-NP
O	-	-	HYPH	O
O	pigs	pig	NNS	B-NP
O	(	(	(	O
O	P	P	NN	B-NP
O	less	less	JJR	B-NP
O	than	than	IN	I-NP
O	0	0	CD	I-NP
O	.	.	.	I-NP
O	001	001	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	conversion	conversion	NN	I-NP
O	of	of	IN	B-PP
O	lower	low	JJR	B-NP
O	amounts	amount	NNS	I-NP
O	of	of	IN	B-PP
O	11	11	CD	B-NP
O	-	-	HYPH	I-NP
O	deoxycortisol	deoxycortisol	NN	I-NP
O	into	into	IN	B-PP
O	cortisol	cortisol	NN	B-NP
O	,	,	,	O
O	reproducing	reproduce	VBG	B-VP
O	quantitatively	quantitatively	RB	B-ADVP
O	the	the	DT	B-NP
O	maximal	maximal	JJ	I-NP
O	effect	effect	NN	I-NP
O	of	of	IN	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	on	on	IN	B-PP
O	cortisol	cortisol	NN	B-NP
O	biosynthesis	biosynthesis	NN	I-NP
O	,	,	,	O
O	was	be	VBD	B-VP
O	only	only	RB	I-VP
O	barely	barely	RB	I-VP
O	increased	increase	VBN	I-VP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	from	from	IN	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	-	-	HYPH	B-NP
O	treated	treat	VBN	I-NP
O	animals	animal	NNS	I-NP
O	(	(	(	O
O	P	P	NN	B-NP
O	greater	great	JJR	B-ADJP
O	than	than	IN	B-PP
O	0	0	CD	B-NP
O	.	.	.	O
O	05	05	CD	B-NP
O	)	)	)	O
O	.	.	.	O

O	Therefore	Therefore	RB	B-ADVP
O	it	it	PRP	B-NP
O	was	be	VBD	B-VP
O	concluded	conclude	VBN	I-VP
O	that	that	IN	B-SBAR
B-GGP	ACTH	ACTH	NN	B-NP
O	increases	increase	NNS	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	lasting	lasting	JJ	I-NP
O	way	way	NN	I-NP
O	not	not	RB	B-CONJP
O	only	only	RB	I-CONJP
O	the	the	DT	B-NP
O	overall	overall	JJ	I-NP
O	steroidogenic	steroidogenic	JJ	I-NP
O	capacity	capacity	NN	I-NP
O	of	of	IN	B-PP
O	adrenocortical	adrenocortical	JJ	B-NP
O	cells	cell	NNS	I-NP
O	but	but	CC	B-CONJP
O	also	also	RB	I-CONJP
O	the	the	DT	B-NP
O	maximal	maximal	JJ	I-NP
O	efficiency	efficiency	NN	I-NP
O	of	of	IN	B-PP
O	11	11	CD	B-NP
O	beta	beta	SYM	I-NP
O	-	-	HYPH	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	.	.	.	O

O	Since	Since	IN	B-SBAR
O	the	the	DT	B-NP
O	latter	latter	JJ	I-NP
O	effect	effect	NN	I-NP
O	cannot	cannot	MD	B-VP
O	account	account	VB	I-VP
O	quantitatively	quantitatively	RB	B-ADVP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	magnitude	magnitude	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	lasting	lasting	JJ	I-NP
O	effect	effect	NN	I-NP
O	of	of	IN	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	maximal	maximal	JJ	I-NP
O	capacity	capacity	NN	I-NP
O	of	of	IN	B-PP
O	adrenocortical	adrenocortical	JJ	B-NP
O	cells	cell	NNS	I-NP
O	to	to	TO	B-VP
O	produce	produce	VB	I-VP
O	cortisol	cortisol	NN	B-NP
O	in	in	IN	B-PP
O	response	response	NN	B-NP
O	to	to	TO	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	,	,	,	O
O	it	it	PRP	B-NP
O	appears	appear	VBZ	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	prolonged	prolonged	JJ	I-NP
O	influence	influence	NN	I-NP
O	of	of	IN	B-PP
B-GGP	ACTH	ACTH	NN	B-NP
O	on	on	IN	B-PP
O	cortisol	cortisol	NN	B-NP
O	biosynthesis	biosynthesis	NN	I-NP
O	should	should	MD	B-VP
O	also	also	RB	I-VP
O	involve	involve	VB	I-VP
O	a	a	DT	B-NP
O	stimulatory	stimulatory	JJ	I-NP
O	influence	influence	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	peptide	peptide	NN	I-NP
O	on	on	IN	B-PP
O	earlier	early	JJR	B-NP
O	step	step	NN	I-NP
O	(	(	(	I-NP
O	s	s	NNS	I-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	steroidogenesis	steroidogenesis	NN	B-NP
O	.	.	.	O

O	Pyridine	Pyridine	NN	B-NP
O	borane	borane	NN	I-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	reducing	reduce	VBG	I-NP
O	agent	agent	NN	I-NP
O	for	for	IN	B-PP
O	proteins	protein	NNS	B-NP
O	.	.	.	O

O	Pyridine	Pyridine	NN	B-NP
O	borane	borane	NN	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	reported	report	VBN	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	superior	superior	JJ	I-NP
O	reagent	reagent	NN	I-NP
O	over	over	IN	B-PP
O	a	a	DT	B-NP
O	wide	wide	JJ	I-NP
O	pH	pH	NN	I-NP
O	range	range	NN	I-NP
O	,	,	,	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	9	9	CD	I-NP
O	,	,	,	O
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	reductive	reductive	JJ	I-NP
O	methylation	methylation	NN	I-NP
O	of	of	IN	B-PP
O	amino	amino	JJ	B-NP
O	groups	group	NNS	I-NP
O	of	of	IN	B-PP
O	proteins	protein	NNS	B-NP
O	with	with	IN	B-PP
O	formaldehyde	formaldehyde	NN	B-NP
O	[	[	(	O
O	J	J	NN	B-NP
O	.	.	.	O

O	C	C	NN	B-NP
O	.	.	.	O

O	Cabacungan	Cabacungan	NNP	B-NP
O	,	,	,	O
O	A	A	NNP	B-NP
O	.	.	.	O

O	I	I	PRP	B-NP
O	.	.	.	O

O	Ahmed	Ahmed	NNP	B-NP
O	,	,	,	O
O	and	and	CC	O
O	R	R	NN	B-NP
O	.	.	.	O

O	E	E	NN	B-NP
O	.	.	.	O

O	Feeney	Feeney	NN	B-NP
O	(	(	(	O
O	1982	1982	CD	B-NP
O	)	)	)	O
O	Anal	Anal	NNP	B-NP
O	.	.	.	O

O	Biochem	Biochem	NNP	B-NP
O	.	.	.	O

O	124	124	CD	B-NP
O	,	,	,	I-NP
O	272	272	CD	I-NP
O	-	-	HYPH	I-NP
O	278	278	CD	I-NP
O	]	]	)	O
O	.	.	.	O

O	It	It	PRP	B-NP
O	has	have	VBZ	B-VP
O	also	also	RB	I-VP
O	been	be	VBN	I-VP
O	reported	report	VBN	I-VP
O	to	to	TO	B-VP
O	reduce	reduce	VB	I-VP
O	tryptophan	tryptophan	NN	B-NP
O	to	to	TO	B-PP
O	dihydrotryptophan	dihydrotryptophan	NN	B-NP
O	and	and	CC	O
O	to	to	TO	B-VP
O	inactivate	inactivate	VB	I-VP
B-GGP	lysozyme	lysozyme	NN	B-NP
O	in	in	IN	B-PP
O	trifluoroacetic	trifluoroacetic	JJ	B-NP
O	acid	acid	NN	I-NP
O	[	[	(	O
O	M	M	NN	B-NP
O	.	.	.	O

O	Kurata	Kurata	NNP	B-NP
O	,	,	,	O
O	Y	Y	NNP	B-NP
O	.	.	.	O

O	Kikugawa	Kikugawa	NN	B-NP
O	,	,	,	O
O	T	T	NN	B-NP
O	.	.	.	O

O	Kuwae	Kuwae	NNP	B-ADVP
O	,	,	,	O
O	I	I	NNP	B-NP
O	.	.	.	O

O	Koyama	Koyama	NNP	B-NP
O	,	,	,	O
O	and	and	CC	O
O	T	T	NN	B-NP
O	.	.	.	O

O	Takagi	Takagi	NN	B-NP
O	(	(	(	O
O	1980	1980	CD	B-NP
O	)	)	)	O
O	Chem	Chem	NNP	B-NP
O	.	.	.	O

O	Pharm	Pharm	NNP	B-NP
O	.	.	.	I-NP
O	Bull	Bull	NNP	I-NP
O	28	28	CD	I-NP
O	,	,	,	I-NP
O	2274	2274	CD	I-NP
O	-	-	HYPH	I-NP
O	2275	2275	CD	I-NP
O	]	]	)	O
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	study	study	NN	I-NP
O	the	the	DT	B-NP
O	specificity	specificity	NN	I-NP
O	of	of	IN	B-PP
O	pyridine	pyridine	NN	B-NP
O	borane	borane	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	different	different	JJ	I-NP
O	modifications	modification	NNS	I-NP
O	under	under	IN	B-PP
O	different	different	JJ	B-NP
O	reaction	reaction	NN	I-NP
O	conditions	condition	NNS	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	demonstrated	demonstrate	VBN	I-VP
O	,	,	,	O
O	and	and	CC	O
O	extended	extend	VBD	B-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	application	application	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	synthesis	synthesis	NN	I-NP
O	of	of	IN	B-PP
O	protein	protein	NN	B-NP
O	containing	contain	VBG	B-VP
O	reductively	reductively	RB	B-NP
O	attached	attach	VBN	I-NP
O	carbohydrates	carbohydrate	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	acid	acid	NN	I-NP
O	reduction	reduction	NN	I-NP
O	,	,	,	O
O	pyridine	pyridine	NN	B-NP
O	borane	borane	NN	I-NP
O	selectively	selectively	RB	B-ADVP
O	reduced	reduce	VBD	B-VP
O	all	all	DT	B-NP
O	six	six	CD	I-NP
O	tryptophans	tryptophan	NNS	I-NP
O	in	in	IN	B-PP
B-GGP	lysozyme	lysozyme	NN	B-NP
O	to	to	TO	B-PP
O	dihydrotryptophan	dihydrotryptophan	NN	B-NP
O	while	while	IN	B-SBAR
O	all	all	DT	B-NP
O	other	other	JJ	I-NP
O	amino	amino	JJ	I-NP
O	acids	acid	NNS	I-NP
O	remained	remain	VBD	B-VP
O	intact	intact	JJ	B-ADJP
O	.	.	.	O

O	On	On	IN	B-PP
O	similar	similar	JJ	B-NP
O	treatment	treatment	NN	I-NP
O	no	no	DT	B-NP
O	cleavage	cleavage	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	carbohydrate	carbohydrate	NN	I-NP
O	moiety	moiety	NN	I-NP
O	from	from	IN	B-PP
O	chicken	chicken	NN	B-NP
B-GGP	ovomucoid	ovomucoid	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	no	no	DT	B-NP
O	losses	loss	NNS	I-NP
O	of	of	IN	B-PP
O	activity	activity	NN	B-NP
O	of	of	IN	B-PP
B-GGP	ovomucoid	ovomucoid	NN	B-NP
O	or	or	CC	I-NP
O	ribonuclease	ribonuclease	NN	I-NP
O	,	,	,	O
O	two	two	CD	B-NP
O	proteins	protein	NNS	I-NP
O	devoid	devoid	JJ	B-ADJP
O	of	of	IN	B-PP
O	tryptophan	tryptophan	NN	B-NP
O	,	,	,	O
O	were	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	.	.	.	O

O	Nearly	Nearly	RB	B-NP
O	complete	complete	JJ	I-NP
O	methylation	methylation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	lysines	lysine	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	lysozyme	lysozyme	NN	B-NP
O	,	,	,	O
O	chicken	chicken	NN	B-NP
B-GGP	ovomucoid	ovomucoid	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	ribonuclease	ribonuclease	NN	B-NP
O	was	be	VBD	B-VP
O	achieved	achieve	VBN	I-VP
O	with	with	IN	B-PP
O	formaldehyde	formaldehyde	NN	B-NP
O	at	at	IN	B-PP
O	pH	pH	NN	B-NP
O	7	7	CD	I-NP
O	.	.	.	O
O	0	0	CD	B-NP
O	after	after	IN	B-SBAR
O	2	2	CD	B-NP
O	h	h	NN	I-NP
O	at	at	IN	B-PP
O	room	room	NN	B-NP
O	temperature	temperature	NN	I-NP
O	,	,	,	O
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	retention	retention	NN	I-NP
O	of	of	IN	B-PP
O	full	full	JJ	B-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	without	without	IN	B-PP
O	any	any	DT	B-NP
O	destruction	destruction	NN	I-NP
O	of	of	IN	B-PP
O	tryptophan	tryptophan	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	same	same	JJ	I-NP
O	chemistry	chemistry	NN	I-NP
O	was	be	VBD	B-VP
O	applied	apply	VBN	I-VP
O	to	to	TO	B-VP
O	covalently	covalently	RB	I-VP
O	attach	attach	VB	I-VP
O	glucose	glucose	NN	B-NP
O	and	and	CC	I-NP
O	lactose	lactose	NN	I-NP
O	to	to	TO	B-PP
O	bovine	bovine	JJ	B-NP
B-GGP	serum	serum	NN	I-NP
I-GGP	albumin	albumin	NN	I-NP
O	.	.	.	O

O	Parameters	Parameter	NNS	B-NP
O	,	,	,	O
O	including	include	VBG	B-PP
O	pH	pH	NN	B-NP
O	,	,	,	O
O	temperature	temperature	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	methanol	methanol	NN	B-NP
O	,	,	,	O
O	that	that	WDT	B-NP
O	affect	affect	VBP	B-VP
O	the	the	DT	B-NP
O	reactions	reaction	NNS	I-NP
O	were	be	VBD	B-VP
O	investigated	investigate	VBN	I-VP
O	.	.	.	O

O	Incremental	Incremental	JJ	B-NP
O	additions	addition	NNS	I-NP
O	of	of	IN	B-PP
O	pyridine	pyridine	NN	B-NP
O	borane	borane	NN	I-NP
O	during	during	IN	B-PP
O	the	the	DT	B-NP
O	course	course	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	reactions	reaction	NNS	I-NP
O	increased	increase	VBD	B-VP
O	the	the	DT	B-NP
O	rate	rate	NN	I-NP
O	of	of	IN	B-PP
O	modification	modification	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	covalent	covalent	JJ	I-NP
O	attachment	attachment	NN	I-NP
O	of	of	IN	B-PP
O	sugar	sugar	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	epsilon	epsilon	NN	I-NP
O	-	-	HYPH	I-NP
O	amino	amino	NN	I-NP
O	group	group	NN	I-NP
O	of	of	IN	B-PP
O	lysine	lysine	NN	B-NP
O	was	be	VBD	B-VP
O	demonstrated	demonstrate	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	synthesis	synthesis	NN	I-NP
O	of	of	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	alpha	alpha	SYM	I-NP
O	-	-	HYPH	I-NP
O	acetylglucitollysine	acetylglucitollysine	NN	I-NP
O	and	and	CC	I-NP
O	comparison	comparison	NN	I-NP
O	with	with	IN	B-PP
O	acid	acid	NN	B-NP
O	hydrolysates	hydrolysate	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	bovine	bovine	JJ	I-NP
B-GGP	serum	serum	NN	I-NP
I-GGP	albumin	albumin	NN	I-NP
O	-	-	HYPH	B-NP
O	sugar	sugar	NN	I-NP
O	derivatives	derivative	NNS	I-NP
O	.	.	.	O

O	Arylamine	Arylamine	NN	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetyltransferase	acetyltransferase	NN	I-NP
O	and	and	CC	I-NP
B-GGP	arylalkylamine	arylalkylamine	NN	I-NP
I-GGP	N	N	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	acetyltransferase	acetyltransferase	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	mammalian	mammalian	JJ	I-NP
O	pineal	pineal	JJ	I-NP
O	gland	gland	NN	I-NP
O	.	.	.	O

O	Amine	Amine	NN	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetylation	acetylation	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	pineal	pineal	JJ	I-NP
O	gland	gland	NN	I-NP
O	is	be	VBZ	B-VP
O	of	of	IN	B-PP
O	special	special	JJ	B-NP
O	importance	importance	NN	I-NP
O	because	because	IN	B-SBAR
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	first	first	JJ	I-NP
O	step	step	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	synthesis	synthesis	NN	I-NP
O	of	of	IN	B-PP
O	melatonin	melatonin	NN	B-NP
O	from	from	IN	B-PP
O	serotonin	serotonin	NN	B-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	the	the	DT	B-NP
O	present	present	JJ	I-NP
O	study	study	NN	I-NP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetylation	acetylation	NN	I-NP
O	of	of	IN	B-PP
O	arylamines	arylamine	NNS	B-NP
O	and	and	CC	I-NP
O	arylalkylamines	arylalkylamine	NNS	I-NP
O	by	by	IN	B-PP
O	homogenates	homogenate	NNS	B-NP
O	of	of	IN	B-PP
O	rat	rat	NN	B-NP
O	and	and	CC	O
O	sheep	sheep	VB	B-VP
O	pineal	pineal	JJ	B-NP
O	glands	gland	NNS	I-NP
O	was	be	VBD	B-VP
O	investigated	investigate	VBN	I-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	arylamines	arylamine	NNS	I-NP
O	studied	study	VBN	B-VP
O	were	be	VBD	B-VP
O	p	p	NN	B-NP
O	-	-	HYPH	B-NP
O	phenetidine	phenetidine	NN	I-NP
O	and	and	CC	I-NP
O	aniline	aniline	NN	I-NP
O	;	;	:	O
O	the	the	DT	B-NP
O	arylalkylamines	arylalkylamine	NNS	I-NP
O	studied	study	VBN	B-VP
O	were	be	VBD	B-VP
O	tryptamine	tryptamine	NN	B-NP
O	,	,	,	O
O	serotonin	serotonin	NN	B-NP
O	,	,	,	O
O	5	5	CD	B-NP
O	-	-	HYPH	I-NP
O	methoxytryptamine	methoxytryptamine	NN	I-NP
O	,	,	,	O
O	6	6	CD	B-NP
O	-	-	HYPH	I-NP
O	fluorotryptamine	fluorotryptamine	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	phenylethylamine	phenylethylamine	NN	B-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	amines	amine	NNS	I-NP
O	were	be	VBD	B-VP
O	acetylated	acetylate	VBN	I-VP
O	by	by	IN	B-PP
O	pineal	pineal	JJ	B-NP
O	homogenates	homogenate	NNS	I-NP
O	of	of	IN	B-PP
O	both	both	DT	B-NP
O	species	specie	NNS	I-NP
O	,	,	,	O
O	although	although	IN	B-SBAR
O	marked	marked	JJ	B-NP
O	interspecies	interspecies	JJ	I-NP
O	differences	difference	NNS	I-NP
O	in	in	IN	B-PP
O	apparent	apparent	JJ	B-NP
O	Km	Km	NN	I-NP
O	and	and	CC	I-NP
O	Vmax	Vmax	NN	I-NP
O	values	value	NNS	I-NP
O	were	be	VBD	B-VP
O	found	find	VBN	I-VP
O	.	.	.	O

O	A	A	DT	B-NP
O	series	series	NN	I-NP
O	of	of	IN	B-PP
O	observations	observation	NNS	B-NP
O	in	in	IN	B-PP
O	both	both	DT	B-NP
O	species	specie	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	aromatic	aromatic	JJ	B-NP
O	amine	amine	NN	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetylation	acetylation	NN	I-NP
O	is	be	VBZ	B-VP
O	catalyzed	catalyze	VBN	I-VP
O	by	by	IN	B-PP
O	two	two	CD	B-NP
O	distinct	distinct	JJ	I-NP
O	enzymes	enzyme	NNS	I-NP
O	;	;	:	O
O	one	one	CD	B-NP
O	preferentially	preferentially	RB	B-ADVP
O	acetylates	acetylate	VBZ	B-VP
O	arylamines	arylamine	NNS	B-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	other	other	JJ	I-NP
O	preferentially	preferentially	RB	B-ADVP
O	acetylates	acetylate	VBZ	B-VP
O	arylalkylamines	arylalkylamine	NNS	B-NP
O	.	.	.	O

O	First	First	RB	B-ADVP
O	,	,	,	O
O	isoproterenol	isoproterenol	NN	B-NP
O	treatment	treatment	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	rat	rat	NN	I-NP
O	increased	increase	VBD	B-VP
O	arylalkylamine	arylalkylamine	NN	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	O
O	acetylation	acetylation	NN	B-NP
O	100	100	CD	I-NP
O	-	-	HYPH	B-VP
O	fold	fold	RB	B-ADVP
O	without	without	IN	B-PP
O	increasing	increase	VBG	B-VP
O	arylamine	arylamine	NN	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetylation	acetylation	NN	I-NP
O	.	.	.	O

O	Second	Second	RB	B-ADVP
O	,	,	,	O
O	cycloheximide	cycloheximide	NN	B-NP
O	treatment	treatment	NN	I-NP
O	in	in	IN	B-PP
O	sheep	sheep	NN	B-NP
O	reduced	reduce	VBD	B-VP
O	arylalkylamine	arylalkylamine	NN	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetylation	acetylation	NN	I-NP
O	at	at	IN	B-PP
O	night	night	NN	B-NP
O	to	to	TO	B-PP
O	one	one	CD	B-NP
O	-	-	HYPH	I-NP
O	tenth	tenth	NN	I-NP
O	control	control	NN	I-NP
O	values	value	NNS	I-NP
O	,	,	,	O
O	without	without	IN	B-PP
O	altering	alter	VBG	B-VP
O	arylamine	arylamine	NN	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetylation	acetylation	NN	I-NP
O	.	.	.	O

O	Third	Third	RB	B-ADVP
O	,	,	,	O
O	arylamine	arylamine	NN	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetyltransferase	acetyltransferase	NN	I-NP
O	and	and	CC	I-NP
B-GGP	arylalkylamine	arylalkylamine	NN	I-NP
I-GGP	N	N	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	acetyltransferase	acetyltransferase	NN	I-NP
O	inactivated	inactivate	VBN	B-VP
O	at	at	IN	B-PP
O	different	different	JJ	B-NP
O	rates	rate	NNS	I-NP
O	at	at	IN	B-PP
O	4	4	CD	B-NP
O	degrees	degree	NNS	I-NP
O	C	C	JJ	B-ADJP
O	.	.	.	O

O	Fourth	Fourth	NNP	B-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	enzymes	enzyme	NNS	I-NP
O	were	be	VBD	B-VP
O	resolved	resolve	VBN	I-VP
O	by	by	IN	B-PP
O	size	size	NN	B-NP
O	exclusion	exclusion	NN	I-NP
O	chromatography	chromatography	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	clearly	clearly	RB	B-VP
O	establish	establish	VBP	I-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	pineal	pineal	JJ	I-NP
O	gland	gland	NN	I-NP
O	contains	contain	VBZ	B-VP
O	an	an	DT	B-NP
O	arylamine	arylamine	NN	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetyltransferase	acetyltransferase	NN	I-NP
O	and	and	CC	O
O	a	a	DT	B-NP
O	second	second	JJ	I-NP
O	,	,	,	O
O	independently	independently	RB	B-VP
O	regulated	regulate	VBN	I-VP
B-GGP	arylalkylamine	arylalkylamine	NN	B-NP
I-GGP	N	N	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	acetyltransferase	acetyltransferase	NN	I-NP
O	which	which	WDT	B-NP
O	appears	appear	VBZ	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	primarily	primarily	RB	B-ADJP
O	responsible	responsible	JJ	I-ADJP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	physiological	physiological	JJ	I-NP
O	conversion	conversion	NN	I-NP
O	of	of	IN	B-PP
O	serotonin	serotonin	NN	B-NP
O	to	to	TO	B-PP
O	melatonin	melatonin	NN	B-NP
O	via	via	IN	B-PP
O	the	the	DT	B-NP
O	intermediate	intermediate	JJ	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetylserotonin	acetylserotonin	NN	I-NP
O	.	.	.	O

O	Undermethylation	Undermethylation	NN	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	5	5	CD	I-NP
O	'	'	SYM	I-NP
O	end	end	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	albumin	albumin	NN	I-NP
O	gene	gene	NN	I-NP
O	is	be	VBZ	B-VP
O	necessary	necessary	JJ	B-ADJP
O	but	but	CC	O
O	not	not	RB	B-ADJP
O	sufficient	sufficient	JJ	I-ADJP
O	for	for	IN	B-PP
B-GGP	albumin	albumin	NN	B-NP
O	production	production	NN	I-NP
O	by	by	IN	B-PP
O	rat	rat	NN	B-NP
O	hepatoma	hepatoma	NN	I-NP
O	cells	cell	NNS	I-NP
O	in	in	IN	B-PP
O	culture	culture	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	have	have	VBP	B-VP
O	measured	measure	VBN	I-VP
O	methylation	methylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	albumin	albumin	NN	I-NP
O	gene	gene	NN	I-NP
O	in	in	IN	B-PP
O	clones	clone	NNS	B-NP
O	of	of	IN	B-PP
O	rat	rat	NN	B-NP
O	hepatoma	hepatoma	NN	I-NP
O	cells	cell	NNS	I-NP
O	that	that	WDT	B-NP
O	vary	vary	VBP	B-VP
O	quantitatively	quantitatively	RB	B-ADVP
O	in	in	IN	B-PP
O	their	their	PRP$	B-NP
O	rates	rate	NNS	I-NP
O	of	of	IN	B-PP
O	synthesis	synthesis	NN	B-NP
O	of	of	IN	B-PP
B-GGP	albumin	albumin	NN	B-NP
O	and	and	CC	B-PP
O	in	in	IN	B-PP
O	variant	variant	JJ	B-NP
O	and	and	CC	I-NP
O	hybrid	hybrid	JJ	I-NP
O	cells	cell	NNS	I-NP
O	that	that	WDT	B-NP
O	produce	produce	VBP	B-VP
O	no	no	DT	B-NP
B-GGP	albumin	albumin	NN	I-NP
O	.	.	.	O

O	Although	Although	IN	B-SBAR
O	the	the	DT	B-NP
B-GGP	albumin	albumin	NN	I-NP
O	gene	gene	NN	I-NP
O	is	be	VBZ	B-VP
O	undermethylated	undermethylate	VBN	I-VP
O	for	for	IN	B-PP
O	its	its	PRP$	B-NP
O	entire	entire	JJ	I-NP
O	length	length	NN	I-NP
O	in	in	IN	B-PP
O	rat	rat	NN	B-NP
O	liver	liver	NN	I-NP
O	,	,	,	O
O	only	only	RB	B-NP
O	the	the	DT	I-NP
O	5	5	CD	I-NP
O	'	'	SYM	I-NP
O	end	end	NN	I-NP
O	is	be	VBZ	B-VP
O	ever	ever	RB	I-VP
O	undermethylated	undermethylate	VBN	I-VP
O	in	in	IN	B-PP
O	hepatoma	hepatoma	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	undermethylation	undermethylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	5	5	CD	I-NP
O	'	'	SYM	I-NP
O	end	end	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	gene	gene	NN	I-NP
O	appears	appear	VBZ	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	necessary	necessary	JJ	B-ADJP
O	for	for	IN	B-PP
O	stable	stable	JJ	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	albumin	albumin	NN	I-NP
O	gene	gene	NN	I-NP
O	in	in	IN	B-PP
O	hepatoma	hepatoma	NN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Since	Since	IN	B-PP
O	undermethylation	undermethylation	NN	B-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	region	region	NN	I-NP
O	is	be	VBZ	B-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	some	some	DT	B-NP
O	variant	variant	JJ	I-NP
O	cells	cell	NNS	I-NP
O	that	that	WDT	B-NP
O	fail	fail	VBP	B-VP
O	to	to	TO	I-VP
O	produce	produce	VB	I-VP
B-GGP	albumin	albumin	NN	B-NP
O	,	,	,	O
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	not	not	RB	O
O	a	a	DT	B-NP
O	sufficient	sufficient	JJ	I-NP
O	condition	condition	NN	I-NP
O	for	for	IN	B-PP
B-GGP	albumin	albumin	NN	B-NP
O	gene	gene	NN	I-NP
O	expression	expression	NN	I-NP
O	.	.	.	O

O	Despite	Despite	IN	B-PP
O	the	the	DT	B-NP
O	excellent	excellent	JJ	I-NP
O	correlation	correlation	NN	I-NP
O	between	between	IN	B-PP
O	undermethylation	undermethylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	5	5	CD	I-NP
O	'	'	SYM	I-NP
O	end	end	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	albumin	albumin	NN	I-NP
O	gene	gene	NN	I-NP
O	and	and	CC	O
O	its	its	PRP$	B-NP
O	stable	stable	JJ	I-NP
O	expression	expression	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	results	result	NNS	I-NP
O	argue	argue	VBP	B-VP
O	against	against	IN	B-PP
O	the	the	DT	B-NP
O	possibility	possibility	NN	I-NP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	methylated	methylate	VBN	I-NP
O	state	state	NN	I-NP
O	of	of	IN	B-PP
O	such	such	JJ	B-NP
O	genes	gene	NNS	I-NP
O	during	during	IN	B-PP
O	development	development	NN	B-NP
O	determines	determine	NNS	I-NP
O	whether	whether	IN	B-SBAR
O	they	they	PRP	B-NP
O	will	will	MD	B-VP
O	or	or	CC	O
O	will	will	MD	B-VP
O	not	not	RB	I-VP
O	be	be	VB	I-VP
O	expressed	express	VBN	I-VP
O	.	.	.	O

O	Hydroxylated	Hydroxylate	VBN	B-NP
O	aromatic	aromatic	JJ	I-NP
O	inhibitors	inhibitor	NNS	I-NP
O	of	of	IN	B-PP
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
B-GGP	integrase	integrase	NN	I-NP
O	.	.	.	O

O	Efficient	Efficient	JJ	B-NP
O	replication	replication	NN	I-NP
O	of	of	IN	B-PP
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	requires	require	VBZ	B-VP
O	integration	integration	NN	B-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	DNA	DNA	NN	I-NP
O	copy	copy	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	viral	viral	JJ	I-NP
O	genome	genome	NN	I-NP
O	into	into	IN	B-PP
O	a	a	DT	B-NP
O	chromosome	chromosome	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	host	host	NN	I-NP
O	cell	cell	NN	I-NP
O	.	.	.	O

O	Integration	Integration	NN	B-NP
O	is	be	VBZ	B-VP
O	catalyzed	catalyze	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	viral	viral	JJ	I-NP
B-GGP	integrase	integrase	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	we	we	PRP	B-NP
O	have	have	VBP	B-VP
O	previously	previously	RB	I-VP
O	reported	report	VBN	I-VP
O	that	that	IN	B-SBAR
O	phenolic	phenolic	JJ	B-NP
O	moieties	moiety	NNS	I-NP
O	in	in	IN	B-PP
O	compounds	compound	NNS	B-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	flavones	flavone	NNS	B-NP
O	,	,	,	O
O	caffeic	caffeic	JJ	B-NP
O	acid	acid	NN	I-NP
O	phenethyl	phenethyl	NN	I-NP
O	ester	ester	NN	I-NP
O	(	(	(	O
O	CAPE	CAPE	NN	B-NP
O	,	,	,	O
O	2	2	CD	B-NP
O	)	)	)	O
O	,	,	,	O
O	and	and	CC	O
O	curcumin	curcumin	NN	B-NP
O	confer	confer	VBP	B-VP
O	inhibitory	inhibitory	JJ	B-NP
O	activity	activity	NN	I-NP
O	against	against	IN	B-PP
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
B-GGP	integrase	integrase	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	now	now	RB	B-ADVP
O	extend	extend	VBP	B-VP
O	these	these	DT	B-NP
O	findings	finding	NNS	I-NP
O	by	by	IN	B-PP
O	performing	perform	VBG	B-VP
O	a	a	DT	B-NP
O	comprehensive	comprehensive	JJ	I-NP
O	structure	structure	NN	I-NP
O	-	-	HYPH	B-NP
O	activity	activity	NN	I-NP
O	relationship	relationship	NN	I-NP
O	using	use	VBG	B-VP
O	CAPE	CAPE	NN	B-NP
O	analogues	analogue	NNS	I-NP
O	.	.	.	O

O	Approximately	Approximately	RB	B-NP
O	30	30	CD	I-NP
O	compounds	compound	NNS	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	prepared	prepare	VBN	I-VP
O	as	as	IN	B-PP
O	HIV	HIV	NN	B-NP
B-GGP	integrase	integrase	NN	I-NP
O	inhibitors	inhibitor	NNS	I-NP
O	based	base	VBN	B-PP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	structural	structural	JJ	I-NP
O	lead	lead	NN	I-NP
O	provided	provide	VBN	B-VP
O	by	by	IN	B-PP
O	CAPE	CAPE	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	has	have	VBZ	B-VP
O	previously	previously	RB	I-VP
O	been	be	VBN	I-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	exhibit	exhibit	VB	I-VP
O	an	an	DT	B-NP
O	IC50	IC50	NN	I-NP
O	value	value	NN	I-NP
O	of	of	IN	B-PP
O	7	7	CD	B-NP
O	microM	microM	NN	I-NP
O	in	in	IN	B-PP
O	our	our	PRP$	B-NP
O	integration	integration	NN	I-NP
O	assay	assay	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	analogues	analogue	NNS	I-NP
O	were	be	VBD	B-VP
O	designed	design	VBN	I-VP
O	to	to	TO	B-VP
O	examine	examine	VB	I-VP
O	specific	specific	JJ	B-NP
O	features	feature	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	parent	parent	NN	I-NP
O	CAPE	CAPE	NN	I-NP
O	structure	structure	NN	I-NP
O	which	which	WDT	B-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	important	important	JJ	B-ADJP
O	for	for	IN	B-PP
O	activity	activity	NN	B-NP
O	.	.	.	O

O	Among	Among	IN	B-PP
O	the	the	DT	B-NP
O	features	feature	NNS	I-NP
O	examined	examine	VBN	B-VP
O	for	for	IN	B-PP
O	their	their	PRP$	B-NP
O	effects	effect	NNS	I-NP
O	on	on	IN	B-PP
O	inhibitory	inhibitory	JJ	B-NP
O	potency	potency	NN	I-NP
O	were	be	VBD	B-VP
O	ring	ring	NN	B-NP
O	substitution	substitution	NN	I-NP
O	,	,	,	O
O	side	side	NN	B-NP
O	chain	chain	NN	I-NP
O	length	length	NN	I-NP
O	and	and	CC	I-NP
O	composition	composition	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	phenyl	phenyl	NN	B-NP
O	ring	ring	NN	I-NP
O	conformational	conformational	JJ	I-NP
O	orientation	orientation	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	an	an	DT	B-NP
O	assay	assay	NN	I-NP
O	which	which	WDT	B-NP
O	measured	measure	VBD	B-VP
O	the	the	DT	B-NP
O	combined	combined	JJ	I-NP
O	effect	effect	NN	I-NP
O	of	of	IN	B-PP
O	two	two	CD	B-NP
O	sequential	sequential	JJ	I-NP
O	steps	step	NNS	I-NP
O	,	,	,	O
O	dinucleotide	dinucleotide	NN	B-NP
O	cleavage	cleavage	NN	I-NP
O	and	and	CC	O
O	strand	strand	NN	B-NP
O	transfer	transfer	NN	I-NP
O	,	,	,	O
O	several	several	JJ	B-NP
O	analogues	analogue	NNS	I-NP
O	have	have	VBP	B-VP
O	IC50	IC50	NN	B-NP
O	values	value	NNS	I-NP
O	for	for	IN	B-PP
O	3	3	CD	B-NP
O	'	'	SYM	I-NP
O	-	-	HYPH	I-NP
O	processing	processing	NN	I-NP
O	and	and	CC	I-NP
O	strand	strand	NN	I-NP
O	transfer	transfer	NN	I-NP
O	lower	low	JJR	B-ADJP
O	than	than	IN	B-PP
O	those	those	DT	B-NP
O	of	of	IN	B-PP
O	CAPE	CAPE	NN	B-NP
O	.	.	.	O

O	Inhibition	Inhibition	NN	B-NP
O	of	of	IN	B-PP
O	strand	strand	NN	B-NP
O	transfer	transfer	NN	I-NP
O	was	be	VBD	B-VP
O	assayed	assay	VBN	I-VP
O	using	use	VBG	I-VP
O	both	both	CC	O
O	blunt	blunt	NN	B-NP
O	-	-	HYPH	B-NP
O	ended	end	VBN	B-VP
O	and	and	CC	O
O	"	"	``	B-NP
O	precleaved	precleaved	JJ	I-NP
O	"	"	''	I-NP
O	DNA	DNA	NN	I-NP
O	substrates	substrate	NNS	I-NP
O	.	.	.	O

O	Disintegration	Disintegration	NN	B-NP
O	using	use	VBG	B-VP
O	an	an	DT	B-NP
B-GGP	integrase	integrase	NN	I-NP
O	mutant	mutant	NN	I-NP
O	lacking	lack	VBG	B-VP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	zinc	zinc	NN	I-NP
O	finger	finger	NN	I-NP
O	and	and	CC	I-NP
O	C	C	NN	I-NP
O	-	-	HYPH	O
O	terminal	terminal	JJ	B-NP
O	DNA	DNA	NN	I-NP
O	-	-	HYPH	B-VP
O	binding	bind	VBG	B-NP
O	domains	domain	NNS	I-NP
O	was	be	VBD	B-VP
O	also	also	RB	I-VP
O	inhibited	inhibit	VBN	I-VP
O	by	by	IN	B-PP
O	these	these	DT	B-NP
O	analogues	analogue	NNS	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	binding	bind	VBG	I-NP
O	site	site	NN	I-NP
O	for	for	IN	B-PP
O	these	these	DT	B-NP
O	compounds	compound	NNS	I-NP
O	resides	reside	VBZ	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	central	central	JJ	I-NP
O	catalytic	catalytic	JJ	I-NP
O	core	core	NN	I-NP
O	.	.	.	O

O	Several	Several	JJ	B-NP
O	CAPE	CAPE	NN	I-NP
O	analogues	analogue	NNS	I-NP
O	were	be	VBD	B-VP
O	also	also	RB	I-VP
O	tested	test	VBN	I-VP
O	for	for	IN	B-PP
O	selective	selective	JJ	B-NP
O	activity	activity	NN	I-NP
O	against	against	IN	B-PP
O	transformed	transform	VBN	B-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Taken	Take	VBN	B-VP
O	together	together	RB	B-ADVP
O	,	,	,	O
O	these	these	DT	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	development	development	NN	I-NP
O	of	of	IN	B-PP
O	novel	novel	JJ	B-NP
O	antiviral	antiviral	JJ	I-NP
O	agents	agent	NNS	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	treatment	treatment	NN	I-NP
O	of	of	IN	B-PP
O	acquired	acquire	VBN	B-NP
O	immune	immune	JJ	I-NP
O	deficiency	deficiency	NN	I-NP
O	syndrome	syndrome	NN	I-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	based	base	VBN	I-VP
O	upon	upon	IN	B-PP
O	inhibition	inhibition	NN	B-NP
O	of	of	IN	B-PP
O	HIV	HIV	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
B-GGP	integrase	integrase	NN	I-NP
O	.	.	.	O

O	Effect	Effect	NN	B-NP
O	of	of	IN	B-PP
O	modification	modification	NN	B-NP
O	of	of	IN	B-PP
O	carbohydrate	carbohydrate	NN	B-NP
O	side	side	NN	I-NP
O	chains	chain	NNS	I-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	reactivity	reactivity	NN	I-NP
O	of	of	IN	B-PP
O	antibodies	antibody	NNS	B-NP
O	with	with	IN	B-PP
O	core	core	NN	B-NP
O	-	-	HYPH	B-NP
O	protein	protein	NN	I-NP
O	epitopes	epitope	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	MUC1	MUC1	NN	I-NP
O	gene	gene	NN	I-NP
O	product	product	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	product	product	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	MUC1	MUC1	NN	I-NP
O	gene	gene	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
B-GGP	polymorphic	polymorphic	JJ	I-NP
I-GGP	epithelial	epithelial	JJ	I-NP
I-GGP	mucin	mucin	NN	I-NP
O	(	(	(	O
B-GGP	PEM	PEM	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	contains	contain	VBZ	B-VP
O	a	a	DT	B-NP
O	large	large	JJ	I-NP
O	domain	domain	NN	I-NP
O	consisting	consist	VBG	B-VP
O	of	of	IN	B-PP
O	tandem	tandem	JJ	B-NP
O	repeats	repeat	NNS	I-NP
O	of	of	IN	B-PP
O	20	20	CD	B-NP
O	amino	amino	NN	I-NP
O	acids	acid	NNS	I-NP
O	.	.	.	O

O	Each	Each	DT	B-NP
O	repeat	repeat	NN	I-NP
O	contains	contain	VBZ	B-VP
O	five	five	CD	B-NP
O	potential	potential	JJ	I-NP
O	sites	site	NNS	I-NP
O	for	for	IN	B-PP
O	O	O	NN	B-NP
O	-	-	HYPH	O
O	glycosylation	glycosylation	NN	B-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	region	region	NN	I-NP
O	forms	form	VBZ	B-VP
O	a	a	DT	B-NP
O	scaffold	scaffold	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	attachment	attachment	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	O	O	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	carbohydrate	carbohydrate	NN	I-NP
O	which	which	WDT	B-NP
O	makes	make	VBZ	B-VP
O	up	up	RB	B-ADVP
O	more	more	JJR	B-NP
O	than	than	IN	I-NP
O	50	50	CD	I-NP
O	%	%	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	molecule	molecule	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	number	number	NN	I-NP
O	of	of	IN	B-PP
O	monoclonal	monoclonal	JJ	B-NP
O	antibodies	antibody	NNS	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	recognize	recognize	VB	I-VP
O	core	core	NN	B-NP
O	-	-	HYPH	B-NP
O	protein	protein	NN	I-NP
O	epitopes	epitope	NNS	I-NP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	tandem	tandem	JJ	I-NP
O	repeat	repeat	NN	I-NP
O	domain	domain	NN	I-NP
O	.	.	.	O

O	One	One	CD	B-NP
O	such	such	JJ	I-NP
O	antibody	antibody	NN	I-NP
O	,	,	,	O
O	SM3	SM3	NN	B-NP
O	,	,	,	O
O	reacts	react	VBZ	B-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	mucin	mucin	NN	I-NP
O	expressed	express	VBN	B-VP
O	by	by	IN	B-PP
O	breast	breast	NN	B-NP
O	carcinomas	carcinoma	NNS	I-NP
O	but	but	CC	O
O	shows	show	VBZ	B-VP
O	little	little	JJ	B-NP
O	or	or	CC	I-NP
O	no	no	DT	I-NP
O	reaction	reaction	NN	I-NP
O	with	with	IN	B-PP
O	normal	normal	JJ	B-NP
O	resting	rest	VBG	I-NP
O	or	or	CC	I-NP
O	lactating	lactate	VBG	I-NP
O	breast	breast	NN	I-NP
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	primary	primary	JJ	B-NP
O	mammary	mammary	JJ	I-NP
O	epithelial	epithelial	JJ	I-NP
O	cells	cell	NNS	I-NP
O	(	(	(	O
O	HuME	HuME	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	an	an	DT	B-NP
O	immortalized	immortalize	VBN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	derived	derive	VBN	B-VP
O	from	from	IN	B-PP
O	HuME	HuME	NN	B-NP
O	(	(	(	O
O	MTSV1	MTSV1	NN	B-NP
O	-	-	HYPH	B-NP
O	7	7	CD	I-NP
O	)	)	)	O
O	and	and	CC	O
O	a	a	DT	B-NP
O	breast	breast	NN	I-NP
O	carcinoma	carcinoma	NN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	(	(	(	O
O	BT20	BT20	NN	B-NP
O	)	)	)	O
O	the	the	DT	B-NP
O	influence	influence	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	carbohydrate	carbohydrate	NN	I-NP
O	side	side	NN	I-NP
O	chains	chain	NNS	I-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
O	antibodies	antibody	NNS	B-NP
O	to	to	TO	B-PP
O	core	core	NN	B-NP
O	-	-	HYPH	I-NP
O	protein	protein	NN	I-NP
O	epitopes	epitope	NNS	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	investigated	investigate	VBN	I-VP
O	.	.	.	O

O	We	We	PRP	B-NP
O	unequivocally	unequivocally	RB	B-ADVP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	masking	masking	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	SM3	SM3	NN	I-NP
O	epitopes	epitope	NNS	I-NP
O	in	in	IN	B-PP
O	normal	normal	JJ	B-NP
O	breast	breast	NN	I-NP
O	epithelial	epithelial	JJ	I-NP
O	cells	cell	NNS	I-NP
O	is	be	VBZ	B-VP
O	due	due	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	carbohydrate	carbohydrate	NN	I-NP
O	side	side	NN	I-NP
O	chains	chain	NNS	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	addition	addition	NN	B-NP
O	we	we	PRP	B-NP
O	demonstrate	demonstrate	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
O	two	two	CD	B-NP
O	other	other	JJ	I-NP
O	antibodies	antibody	NNS	I-NP
O	(	(	(	O
O	HMFG1	HMFG1	NN	B-NP
O	,	,	,	O
O	HMFG2	HMFG2	NN	B-NP
O	)	)	)	O
O	to	to	TO	B-PP
O	core	core	NN	B-NP
O	-	-	HYPH	B-NP
O	protein	protein	NN	I-NP
O	epitopes	epitope	NNS	I-NP
O	is	be	VBZ	B-VP
O	influenced	influence	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	carbohydrate	carbohydrate	NN	I-NP
O	side	side	NN	I-NP
O	chains	chain	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
O	HMFG	HMFG	NN	B-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	is	be	VBZ	B-VP
O	particularly	particularly	RB	I-VP
O	affected	affect	VBN	I-VP
O	by	by	IN	B-PP
O	sialic	sialic	JJ	B-NP
O	acid	acid	NN	I-NP
O	whereas	whereas	IN	B-PP
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
O	HMFG2	HMFG2	NN	B-NP
O	is	be	VBZ	B-VP
O	influenced	influence	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	length	length	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	oligosaccharide	oligosaccharide	NN	I-NP
O	side	side	NN	I-NP
O	chains	chain	NNS	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	inhibited	inhibit	VBD	B-VP
O	elongation	elongation	NN	B-NP
O	of	of	IN	B-PP
O	O	O	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	carbohydrate	carbohydrate	NN	I-NP
O	side	side	NN	I-NP
O	chains	chain	NNS	I-NP
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	seem	seem	VB	I-VP
O	to	to	TO	I-VP
O	interfere	interfere	VB	I-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	cell	cell	NN	I-NP
O	trafficking	trafficking	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mucin	mucin	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	cell	cell	NN	I-NP
O	surface	surface	NN	I-NP
O	.	.	.	O

O	Fusing	Fuse	VBG	B-VP
O	the	the	DT	B-NP
O	carboxy	carboxy	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	peptide	peptide	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	chorionic	chorionic	JJ	I-NP
I-GGP	gonadotropin	gonadotropin	NN	I-NP
I-GGP	(	(	(	O
I-GGP	CG	CG	NN	B-NP
I-GGP	)	)	)	O
I-GGP	beta	beta	SYM	O
I-GGP	-	-	HYPH	O
I-GGP	subunit	subunit	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	common	common	JJ	I-NP
O	alpha	alpha	NN	I-NP
O	-	-	HYPH	O
O	subunit	subunit	NN	B-NP
O	:	:	:	O
O	retention	retention	NN	B-NP
O	of	of	IN	B-PP
O	O	O	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	and	and	CC	O
O	enhanced	enhance	VBN	B-VP
O	in	in	FW	B-NP
O	vivo	vivo	FW	I-NP
O	bioactivity	bioactivity	NN	I-NP
O	of	of	IN	B-PP
O	chimeric	chimeric	JJ	B-NP
O	human	human	JJ	I-NP
O	CG	CG	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	hCG	hCG	NN	I-NP
I-GGP	beta	beta	SYM	O
I-GGP	-	-	HYPH	O
I-GGP	subunit	subunit	NN	B-NP
O	contains	contain	VBZ	B-VP
O	a	a	DT	B-NP
O	carboxy	carboxy	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	extension	extension	NN	I-NP
O	bearing	bear	VBG	B-VP
O	four	four	CD	B-NP
O	serine	serine	NN	I-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	oligosaccharides	oligosaccharide	NNS	I-NP
O	[	[	(	O
O	carboxy	carboxy	NN	B-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	peptide	peptide	NN	I-NP
O	(	(	(	O
O	CTP	CTP	NN	B-NP
O	)	)	)	O
O	]	]	)	O
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	important	important	JJ	B-ADJP
O	for	for	IN	B-PP
O	maintaining	maintain	VBG	B-VP
O	its	its	PRP$	B-NP
O	longer	long	JJR	I-NP
O	half	half	JJ	I-NP
O	-	-	HYPH	I-NP
O	life	life	NN	I-NP
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	other	other	JJ	I-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	hormones	hormone	NNS	I-NP
O	.	.	.	O

O	Previously	Previously	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	enhanced	enhance	VBD	B-VP
O	the	the	DT	B-NP
O	in	in	FW	I-NP
O	vivo	vivo	FW	I-NP
O	half	half	NN	I-NP
O	-	-	HYPH	I-NP
O	life	life	NN	I-NP
O	of	of	IN	B-PP
O	FSH	FSH	NN	B-NP
O	by	by	IN	B-PP
O	fusing	fuse	VBG	B-VP
O	the	the	DT	B-NP
O	CTP	CTP	NN	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	carboxy	carboxy	NN	I-NP
O	end	end	NN	I-NP
O	of	of	IN	B-PP
B-GGP	FSH	FSH	NN	B-NP
I-GGP	beta	beta	SYM	B-NP
O	coding	cod	VBG	B-VP
O	sequence	sequence	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	alpha	alpha	SYM	I-NP
O	-	-	HYPH	I-NP
O	subunit	subunit	NN	I-NP
O	is	be	VBZ	B-VP
O	common	common	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	family	family	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	constructed	construct	VBD	B-VP
O	alpha	alpha	SYM	B-NP
O	-	-	HYPH	B-NP
O	subunit	subunit	NN	I-NP
O	CTP	CTP	NN	I-NP
O	chimeras	chimera	NNS	I-NP
O	,	,	,	O
O	since	since	IN	B-SBAR
O	such	such	JJ	B-NP
O	analogs	analog	NNS	I-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	appropriate	appropriate	JJ	I-NP
O	O	O	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	and	and	CC	I-NP
O	conformation	conformation	NN	I-NP
O	would	would	MD	B-VP
O	increase	increase	VB	I-VP
O	the	the	DT	B-NP
O	in	in	FW	I-NP
O	vivo	vivo	FW	I-NP
O	stability	stability	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	entire	entire	JJ	I-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	hormone	hormone	NN	I-NP
O	family	family	NN	I-NP
O	.	.	.	O

O	Two	Two	CD	B-NP
O	chimeras	chimera	NNS	I-NP
O	were	be	VBD	B-VP
O	constructed	construct	VBN	I-VP
O	using	use	VBG	B-VP
O	overlapping	overlap	VBG	B-VP
O	polymerase	polymerase	NN	B-NP
O	chain	chain	NN	I-NP
O	reaction	reaction	NN	I-NP
O	mutagenesis	mutagenesis	NN	I-NP
O	:	:	:	O
O	a	a	DT	B-NP
O	variant	variant	NN	I-NP
O	with	with	IN	B-PP
O	CTP	CTP	NN	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	carboxy	carboxy	NN	I-NP
O	end	end	NN	I-NP
O	and	and	CC	O
O	another	another	DT	B-NP
O	analog	analog	NN	I-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	CTP	CTP	NN	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	region	region	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	subunit	subunit	NN	I-NP
O	,	,	,	O
O	between	between	IN	B-PP
O	amino	amino	NN	B-NP
O	acids	acid	NNS	I-NP
O	3	3	CD	B-NP
O	and	and	CC	I-NP
O	4	4	CD	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	latter	latter	JJ	I-NP
O	design	design	NN	I-NP
O	was	be	VBD	B-VP
O	based	base	VBN	I-VP
O	on	on	IN	B-PP
O	models	model	NNS	B-NP
O	showing	show	VBG	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	region	region	NN	I-NP
O	of	of	IN	B-PP
O	alpha	alpha	NN	B-NP
O	is	be	VBZ	B-VP
O	not	not	RB	I-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	assembly	assembly	NN	B-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	beta	beta	SYM	I-NP
O	-	-	HYPH	I-NP
O	subunit	subunit	NN	I-NP
O	,	,	,	O
O	nor	nor	CC	O
O	is	be	VBZ	O
O	it	it	PRP	B-NP
O	essential	essential	JJ	B-ADJP
O	for	for	IN	B-PP
O	receptor	receptor	NN	B-NP
O	binding	binding	NN	I-NP
O	and	and	CC	O
O	signal	signal	NN	B-NP
O	transduction	transduction	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	chimeras	chimera	NNS	I-NP
O	were	be	VBD	B-VP
O	cotransfected	cotransfecte	VBN	I-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
B-GGP	hCG	hCG	NN	I-NP
I-GGP	beta	beta	NN	I-NP
O	gene	gene	NN	I-NP
O	into	into	IN	B-PP
O	Chinese	Chinese	JJ	B-NP
O	hamster	hamster	NN	I-NP
O	ovary	ovary	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	chimeras	chimera	NNS	I-NP
O	were	be	VBD	B-VP
O	secreted	secrete	VBN	I-VP
O	and	and	CC	O
O	combined	combine	VBN	B-VP
O	efficiently	efficiently	RB	B-ADVP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
B-GGP	CG	CG	NN	I-NP
I-GGP	beta	beta	SYM	O
I-GGP	-	-	HYPH	O
I-GGP	subunit	subunit	NN	B-NP
O	,	,	,	O
O	comparable	comparable	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	wild	wild	JJ	I-NP
O	type	type	NN	I-NP
O	alpha	alpha	SYM	B-VP
O	-	-	HYPH	O
O	subunit	subunit	NN	B-NP
O	.	.	.	O

O	CG	CG	NN	B-NP
O	dimers	dimer	NNS	I-NP
O	containing	contain	VBG	B-VP
O	the	the	DT	B-NP
O	alpha	alpha	SYM	I-NP
O	-	-	HYPH	I-NP
O	subunit	subunit	NN	I-NP
O	chimera	chimera	NN	I-NP
O	with	with	IN	B-PP
O	CTP	CTP	NN	B-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	carboxy	carboxy	NN	I-NP
O	end	end	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	subunit	subunit	NN	I-NP
O	had	have	VBD	B-VP
O	a	a	DT	B-NP
O	much	much	RB	I-NP
O	lower	low	JJR	I-NP
O	binding	binding	NN	I-NP
O	affinity	affinity	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
B-GGP	hLH	hLH	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	hCG	hCG	NN	I-NP
I-GGP	receptor	receptor	NN	I-NP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	,	,	,	O
O	whereas	whereas	IN	O
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	dimer	dimer	NN	I-NP
O	containing	contain	VBG	B-VP
O	the	the	DT	B-NP
O	CTP	CTP	NN	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	end	end	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	subunit	subunit	NN	I-NP
O	was	be	VBD	B-VP
O	similar	similar	JJ	B-ADJP
O	to	to	TO	B-PP
O	wild	wild	JJ	B-NP
O	type	type	NN	I-NP
O	hCG	hCG	NN	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	in	in	FW	I-NP
O	vivo	vivo	FW	I-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	analog	analog	NN	I-NP
O	was	be	VBD	B-VP
O	enhanced	enhance	VBN	I-VP
O	significantly	significantly	RB	B-ADVP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	regardless	regardless	RB	B-ADVP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	insertion	insertion	NN	I-NP
O	points	point	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	alpha	alpha	SYM	I-NP
O	-	-	HYPH	I-NP
O	subunit	subunit	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	CTP	CTP	NN	I-NP
O	sequence	sequence	NN	I-NP
O	was	be	VBD	B-VP
O	O	O	NN	B-NP
O	-	-	HYPH	O
O	glycosylated	glycosylate	VBN	B-VP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	entire	entire	JJ	I-NP
O	signal	signal	NN	I-NP
O	for	for	IN	B-PP
O	O	O	NN	B-NP
O	-	-	HYPH	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	is	be	VBZ	B-VP
O	primarily	primarily	RB	I-VP
O	contained	contain	VBN	I-VP
O	within	within	IN	B-PP
O	the	the	DT	B-NP
O	CTP	CTP	NN	I-NP
O	sequence	sequence	NN	I-NP
O	and	and	CC	O
O	is	be	VBZ	B-VP
O	not	not	RB	O
O	dependent	dependent	JJ	B-ADJP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	flanking	flanking	NN	I-NP
O	regions	region	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	recipient	recipient	JJ	I-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	transfer	transfer	NN	I-NP
O	of	of	IN	B-PP
O	CTP	CTP	NN	B-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	alpha	alpha	SYM	I-NP
O	-	-	HYPH	I-NP
O	subunit	subunit	NN	I-NP
O	of	of	IN	B-PP
O	hCG	hCG	NN	B-NP
O	results	result	VBZ	B-VP
O	in	in	IN	B-PP
O	an	an	DT	B-NP
O	agonist	agonist	NN	I-NP
O	with	with	IN	B-PP
O	prolonged	prolonged	JJ	B-NP
O	biological	biological	JJ	I-NP
O	action	action	NN	I-NP
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	further	further	RBR	B-ADVP
O	support	support	VBP	B-VP
O	the	the	DT	B-NP
O	rationale	rationale	NN	I-NP
O	for	for	IN	B-PP
O	using	use	VBG	B-VP
O	the	the	DT	B-NP
O	CTP	CTP	NN	I-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	general	general	JJ	I-NP
O	target	target	NN	I-NP
O	to	to	TO	B-VP
O	increase	increase	VB	I-VP
O	the	the	DT	B-NP
O	potency	potency	NN	I-NP
O	of	of	IN	B-PP
O	bioactive	bioactive	JJ	B-NP
O	glycoproteins	glycoprotein	NNS	I-NP
O	.	.	.	O

O	Glycosylation	Glycosylation	NN	B-NP
O	of	of	IN	B-PP
O	IgG	IgG	NN	B-NP
O	during	during	IN	B-PP
O	potentially	potentially	RB	B-NP
O	arthritogenic	arthritogenic	JJ	I-NP
O	lentiviral	lentiviral	JJ	I-NP
O	infections	infection	NNS	I-NP
O	.	.	.	O

O	Agalactosyl	Agalactosyl	NN	B-NP
O	IgG	IgG	NN	I-NP
O	[	[	(	O
O	Gal	Gal	NN	B-NP
O	(	(	(	O
O	0	0	CD	B-NP
O	)	)	)	O
O	]	]	)	O
O	was	be	VBD	B-VP
O	first	first	RB	I-VP
O	discovered	discover	VBN	I-VP
O	in	in	IN	B-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
O	rheumatoid	rheumatoid	JJ	B-NP
O	arthritis	arthritis	NN	I-NP
O	(	(	(	O
O	RA	RA	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	proportion	proportion	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	glycoform	glycoform	NN	I-NP
O	is	be	VBZ	B-VP
O	also	also	RB	I-VP
O	raised	raise	VBN	I-VP
O	in	in	IN	B-PP
O	tuberculosis	tuberculosis	NN	B-NP
O	and	and	CC	I-NP
O	leprosy	leprosy	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	has	have	VBZ	B-VP
O	helped	help	VBN	I-VP
O	reinforce	reinforce	VB	I-VP
O	the	the	DT	B-NP
O	suggestion	suggestion	NN	I-NP
O	that	that	IN	B-SBAR
O	RA	RA	NN	B-NP
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	triggered	trigger	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	mycobacterium	mycobacterium	NN	I-NP
O	-	-	HYPH	B-NP
O	like	like	JJ	I-NP
O	slow	slow	JJ	I-NP
O	bacterial	bacterial	JJ	I-NP
O	infection	infection	NN	I-NP
O	.	.	.	O

O	On	On	IN	B-PP
O	the	the	DT	B-NP
O	other	other	JJ	I-NP
O	hand	hand	NN	I-NP
O	,	,	,	O
O	arthritis	arthritis	NN	B-NP
O	can	can	MD	B-VP
O	occur	occur	VB	I-VP
O	in	in	IN	B-PP
O	mycobacterial	mycobacterial	JJ	B-NP
O	diseases	disease	NNS	I-NP
O	,	,	,	O
O	so	so	RB	O
O	raised	raised	JJ	B-NP
O	Gal	Gal	NNP	I-NP
O	(	(	(	O
O	0	0	CD	B-NP
O	)	)	)	O
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	associated	associate	VBN	I-VP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	tendency	tendency	NN	I-NP
O	to	to	TO	B-PP
O	arthritis	arthritis	NN	B-NP
O	,	,	,	O
O	rather	rather	RB	B-PP
O	than	than	IN	I-PP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	particular	particular	JJ	I-NP
O	type	type	NN	I-NP
O	of	of	IN	B-PP
O	infection	infection	NN	B-NP
O	.	.	.	O

O	Therefore	Therefore	RB	B-ADVP
O	,	,	,	O
O	we	we	PRP	B-NP
O	wished	wish	VBD	B-VP
O	to	to	TO	I-VP
O	find	find	VB	I-VP
O	out	out	RP	B-PRT
O	whether	whether	IN	B-SBAR
O	the	the	DT	B-NP
O	percentage	percentage	NN	I-NP
O	of	of	IN	B-PP
O	Gal	Gal	NNP	B-NP
O	(	(	(	O
O	0	0	CD	B-NP
O	)	)	)	O
O	[	[	(	B-NP
O	%	%	NN	I-NP
O	Gal	Gal	NN	I-NP
O	(	(	(	O
O	0	0	CD	B-NP
O	)	)	)	O
O	]	]	)	O
O	is	be	VBZ	B-VP
O	increased	increase	VBN	I-VP
O	in	in	IN	B-PP
O	sheep	sheep	NNS	B-NP
O	and	and	CC	I-NP
O	goats	goat	NNS	I-NP
O	following	follow	VBG	B-PP
O	infection	infection	NN	B-NP
O	with	with	IN	B-PP
O	maedi	maedi	NN	B-NP
O	visna	visna	NN	I-NP
O	virus	virus	NN	I-NP
O	or	or	CC	O
O	caprine	caprine	NN	B-NP
O	arthritis	arthritis	NN	I-NP
O	encephalitis	encephalitis	NN	I-NP
O	virus	virus	NN	I-NP
O	(	(	(	O
O	CAEV	CAEV	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	both	both	DT	B-NP
O	of	of	IN	B-PP
O	which	which	WDT	B-NP
O	can	can	MD	B-VP
O	lead	lead	VB	I-VP
O	to	to	TO	B-PP
O	inflammatory	inflammatory	JJ	B-NP
O	synovitis	synovitis	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	found	find	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	normal	normal	JJ	I-NP
O	level	level	NN	I-NP
O	of	of	IN	B-PP
O	Gal	Gal	NNP	B-NP
O	(	(	(	O
O	0	0	CD	B-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	these	these	DT	B-NP
O	species	specie	NNS	I-NP
O	is	be	VBZ	B-VP
O	much	much	RB	B-ADJP
O	lower	low	JJR	I-ADJP
O	than	than	IN	B-PP
O	in	in	IN	B-PP
O	humans	human	NNS	B-NP
O	.	.	.	O

O	Goats	Goat	NNS	B-NP
O	infected	infect	VBN	B-VP
O	with	with	IN	B-PP
O	CAEV	CAEV	NN	B-NP
O	or	or	CC	O
O	Mycobacterium	Mycobacterium	NN	B-NP
O	paratuberculosis	paratuberculosis	NN	I-NP
O	(	(	(	O
O	used	use	VBN	B-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	control	control	NN	I-NP
O	mycobacterial	mycobacterial	JJ	I-NP
O	infection	infection	NN	I-NP
O	)	)	)	O
O	had	have	VBD	B-VP
O	a	a	DT	B-NP
O	significant	significant	JJ	I-NP
O	increase	increase	NN	I-NP
O	in	in	IN	B-PP
O	%	%	NN	B-NP
O	Gal	Gal	NN	I-NP
O	(	(	(	O
O	0	0	CD	B-NP
O	)	)	)	O
O	,	,	,	O
O	though	though	IN	B-SBAR
O	it	it	PRP	B-NP
O	was	be	VBD	B-VP
O	still	still	RB	B-ADVP
O	below	below	IN	B-PP
O	the	the	DT	B-NP
O	level	level	NN	I-NP
O	seen	see	VBN	B-VP
O	in	in	IN	B-PP
O	normal	normal	JJ	B-NP
O	humans	human	NNS	I-NP
O	.	.	.	O

O	Studies	Study	NNS	B-NP
O	by	by	IN	B-PP
O	Western	Western	JJ	B-NP
O	blot	blot	NN	I-NP
O	confirmed	confirm	VBD	B-VP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	terminal	terminal	JJ	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	acetylglucosamine	acetylglucosamine	NN	I-NP
O	on	on	IN	B-PP
O	heavy	heavy	JJ	B-NP
O	chains	chain	NNS	I-NP
O	,	,	,	O
O	and	and	CC	O
O	percentages	percentage	NNS	B-NP
O	of	of	IN	B-PP
O	Gal	Gal	NNP	B-NP
O	(	(	(	O
O	0	0	CD	B-NP
O	)	)	)	O
O	comparable	comparable	JJ	B-ADJP
O	to	to	TO	B-PP
O	those	those	DT	B-NP
O	seen	see	VBN	B-VP
O	in	in	IN	B-PP
O	human	human	JJ	B-NP
O	RA	RA	NN	I-NP
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	generated	generate	VBN	I-VP
O	by	by	IN	B-PP
O	exposing	expose	VBG	B-VP
O	goat	goat	NN	B-NP
O	IgG	IgG	NN	I-NP
O	to	to	TO	B-PP
O	streptococcal	streptococcal	JJ	B-NP
B-GGP	beta	beta	SYM	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	galactosidase	galactosidase	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	rise	rise	NN	I-NP
O	in	in	IN	B-PP
O	%	%	NN	B-NP
O	Gal	Gal	NN	I-NP
O	(	(	(	O
O	0	0	CD	B-NP
O	)	)	)	O
O	was	be	VBD	B-VP
O	greatest	great	JJS	B-ADJP
O	in	in	IN	B-PP
O	members	member	NNS	B-NP
O	of	of	IN	B-PP
O	infected	infected	JJ	B-NP
O	herds	herd	NNS	I-NP
O	that	that	WDT	B-NP
O	were	be	VBD	B-VP
O	just	just	RB	I-VP
O	starting	start	VBG	I-VP
O	to	to	TO	I-VP
O	manifest	manifest	VB	I-VP
O	arthritis	arthritis	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	tended	tend	VBD	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	lower	low	JJR	B-ADJP
O	in	in	IN	B-PP
O	those	those	DT	B-NP
O	in	in	IN	B-PP
O	which	which	WDT	B-NP
O	severe	severe	JJ	B-NP
O	carpitis	carpitis	NN	I-NP
O	had	have	VBD	B-VP
O	developed	develop	VBN	I-VP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	time	time	NN	I-NP
O	of	of	IN	B-PP
O	bleeding	bleed	VBG	B-NP
O	,	,	,	O
O	implying	imply	VBG	B-VP
O	the	the	DT	B-NP
O	possibility	possibility	NN	I-NP
O	that	that	IN	B-SBAR
O	raise	raise	NN	B-NP
O	%	%	NN	I-NP
O	Gal	Gal	NN	I-NP
O	(	(	(	O
O	0	0	CD	B-NP
O	)	)	)	O
O	may	may	MD	B-VP
O	be	be	VB	I-VP
O	an	an	DT	B-NP
O	early	early	JJ	I-NP
O	or	or	CC	I-NP
O	predisposing	predispose	VBG	I-NP
O	event	event	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	development	development	NN	I-NP
O	of	of	IN	B-PP
O	arthritis	arthritis	NN	B-NP
O	.	.	.	O
O	(	(	(	O
O	ABSTRACT	ABSTRACT	NN	B-NP
O	TRUNCATED	TRUNCATED	VBN	B-VP
O	AT	AT	IN	B-PP
O	250	250	CD	B-NP
O	WORDS	WORDS	NNS	I-NP
O	)	)	)	O

O	The	The	DT	B-NP
O	effects	effect	NNS	I-NP
O	of	of	IN	B-PP
O	variable	variable	JJ	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	functional	functional	JJ	I-NP
O	activities	activity	NNS	I-NP
O	of	of	IN	B-PP
O	ribonuclease	ribonuclease	NN	B-NP
O	,	,	,	I-NP
B-GGP	plasminogen	plasminogen	NN	I-NP
O	and	and	CC	I-NP
B-GGP	tissue	tissue	NN	I-NP
I-GGP	plasminogen	plasminogen	NN	I-NP
I-GGP	activator	activator	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	relatively	relatively	RB	I-NP
O	large	large	JJ	I-NP
O	size	size	NN	I-NP
O	and	and	CC	I-NP
O	dynamics	dynamic	NNS	I-NP
O	of	of	IN	B-PP
O	oligosaccharides	oligosaccharide	NNS	B-NP
O	can	can	MD	B-VP
O	result	result	VB	I-VP
O	in	in	IN	B-PP
O	substantial	substantial	JJ	B-NP
O	shielding	shielding	NN	I-NP
O	of	of	IN	B-PP
O	functionally	functionally	RB	B-NP
O	important	important	JJ	I-NP
O	areas	area	NNS	I-NP
O	of	of	IN	B-PP
O	proteins	protein	NNS	B-NP
O	to	to	TO	B-PP
O	which	which	WDT	B-NP
O	they	they	PRP	B-NP
O	are	be	VBP	B-VP
O	attached	attach	VBN	I-VP
O	,	,	,	O
O	modulate	modulate	VBP	B-VP
O	the	the	DT	B-NP
O	interactions	interaction	NNS	I-NP
O	of	of	IN	B-PP
O	glycoconjugates	glycoconjugate	NNS	B-NP
O	with	with	IN	B-PP
O	other	other	JJ	B-NP
O	molecules	molecule	NNS	I-NP
O	and	and	CC	O
O	affect	affect	VB	B-VP
O	the	the	DT	B-NP
O	rate	rate	NN	I-NP
O	of	of	IN	B-PP
O	processes	process	NNS	B-NP
O	which	which	WDT	B-NP
O	involve	involve	VBP	B-VP
O	conformational	conformational	JJ	B-NP
O	changes	change	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	review	review	NN	I-NP
O	focuses	focus	VBZ	B-VP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	occupancy	occupancy	NN	I-NP
O	of	of	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	sites	site	NNS	I-NP
O	on	on	IN	B-PP
O	three	three	CD	B-NP
O	enzymes	enzyme	NNS	I-NP
O	,	,	,	O
O	ribonuclease	ribonuclease	NN	B-NP
O	,	,	,	O
B-GGP	plasminogen	plasminogen	NN	B-NP
O	and	and	CC	O
B-GGP	tissue	tissue	NN	B-NP
I-GGP	plasminogen	plasminogen	NN	I-NP
I-GGP	activator	activator	NN	I-NP
O	.	.	.	O

O	Each	Each	DT	B-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	proteins	protein	NNS	I-NP
O	occurs	occur	VBZ	B-VP
O	naturally	naturally	RB	B-ADVP
O	as	as	IN	B-PP
O	two	two	CD	B-NP
O	populations	population	NNS	I-NP
O	of	of	IN	B-PP
O	molecules	molecule	NNS	B-NP
O	,	,	,	O
O	distinguished	distinguish	VBN	B-VP
O	from	from	IN	B-PP
O	each	each	DT	B-NP
O	other	other	JJ	I-NP
O	only	only	RB	B-ADVP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	or	or	CC	I-NP
O	absence	absence	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	oligosaccharide	oligosaccharide	NN	I-NP
O	at	at	IN	B-PP
O	one	one	CD	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	oligomannose	oligomannose	NN	I-NP
O	sugar	sugar	NN	I-NP
O	on	on	IN	B-PP
O	ribonuclease	ribonuclease	NN	B-NP
O	(	(	(	O
O	at	at	IN	B-PP
O	Asn	Asn	NN	B-NP
O	-	-	HYPH	B-NP
O	34	34	CD	I-NP
O	)	)	)	O
O	alters	alter	VBZ	B-VP
O	its	its	PRP$	B-NP
O	overall	overall	JJ	I-NP
O	dynamics	dynamic	NNS	I-NP
O	,	,	,	O
O	increases	increase	VBZ	B-VP
O	its	its	PRP$	B-NP
O	stability	stability	NN	I-NP
O	towards	towards	IN	B-PP
O	proteinases	proteinas	NNS	B-NP
O	and	and	CC	O
O	decreases	decrease	VBZ	B-VP
O	its	its	PRP$	B-NP
O	functional	functional	JJ	I-NP
O	activity	activity	NN	I-NP
O	towards	towards	IN	B-PP
O	double	double	JJ	B-NP
O	-	-	HYPH	I-NP
O	stranded	stranded	JJ	I-NP
O	RNA	RNA	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	sugar	sugar	NN	I-NP
O	on	on	IN	B-PP
B-GGP	plasminogen	plasminogen	NN	B-NP
O	(	(	(	O
O	at	at	IN	B-PP
O	Asn	Asn	NN	B-NP
O	-	-	HYPH	B-NP
O	288	288	CD	I-NP
O	)	)	)	O
O	within	within	IN	B-PP
O	kringle	kringle	NN	B-NP
O	3	3	CD	I-NP
O	reduces	reduce	VBZ	B-VP
O	the	the	DT	B-NP
O	rate	rate	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	beta	beta	SYM	I-NP
O	-	-	HYPH	I-NP
O	to	to	TO	B-PP
O	alpha	alpha	SYM	B-NP
O	-	-	HYPH	B-NP
O	conformational	conformational	JJ	I-NP
O	change	change	NN	I-NP
O	,	,	,	O
O	modulates	modulate	VBZ	B-VP
O	the	the	DT	B-NP
O	transport	transport	NN	I-NP
O	of	of	IN	B-PP
B-GGP	plasminogen	plasminogen	NN	B-NP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	extravascular	extravascular	JJ	I-NP
O	compartment	compartment	NN	I-NP
O	,	,	,	O
O	decreases	decrease	VBZ	B-VP
B-GGP	plasminogen	plasminogen	NN	B-NP
O	binding	binding	NN	I-NP
O	to	to	TO	B-PP
O	U937	U937	NN	B-NP
O	cells	cell	NNS	I-NP
O	and	and	CC	O
O	downregulates	downregulate	VBZ	B-VP
O	the	the	DT	B-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	plasminogen	plasminogen	NN	B-NP
O	by	by	IN	B-PP
O	both	both	CC	O
B-GGP	urokinase	urokinase	NN	B-NP
O	and	and	CC	O
B-GGP	tissue	tissue	NN	B-NP
I-GGP	plasminogen	plasminogen	NN	I-NP
I-GGP	activator	activator	NN	I-NP
O	.	.	.	O

O	Additionally	Additionally	RB	B-ADVP
O	,	,	,	O
O	in	in	IN	B-PP
O	fibrinolysis	fibrinolysis	NN	B-NP
O	,	,	,	O
O	within	within	IN	B-PP
O	a	a	DT	B-NP
O	ternary	ternary	JJ	I-NP
O	complex	complex	NN	I-NP
O	of	of	IN	B-PP
O	fibrin	fibrin	NN	B-NP
O	,	,	,	O
B-GGP	plasminogen	plasminogen	NN	B-NP
O	and	and	CC	O
B-GGP	tissue	tissue	NN	B-NP
I-GGP	plasminogen	plasminogen	NN	I-NP
I-GGP	activator	activator	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	sugar	sugar	NN	I-NP
O	of	of	IN	B-PP
B-GGP	plasminogen	plasminogen	NN	B-NP
O	hinders	hinder	VBZ	B-VP
O	the	the	DT	B-NP
O	initial	initial	JJ	I-NP
O	interaction	interaction	NN	I-NP
O	with	with	IN	B-PP
B-GGP	tissue	tissue	NN	B-NP
I-GGP	plasminogen	plasminogen	NN	I-NP
I-GGP	activator	activator	NN	I-NP
O	(	(	(	O
O	i	i	NN	B-NP
O	.	.	.	I-NP
O	e	e	NN	I-NP
O	.	.	.	O
O	,	,	,	O
O	it	it	PRP	B-NP
O	alters	alter	VBZ	B-VP
O	Km	Km	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	The	The	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	glycan	glycan	NN	I-NP
O	(	(	(	O
O	at	at	IN	B-PP
O	Asn	Asn	NN	B-NP
O	-	-	HYPH	B-NP
O	184	184	CD	I-NP
O	)	)	)	O
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	kringle	kringle	JJ	I-NP
O	2	2	CD	I-NP
O	domain	domain	NN	I-NP
O	of	of	IN	B-PP
B-GGP	tissue	tissue	NN	B-NP
I-GGP	plasminogen	plasminogen	NN	I-NP
I-GGP	activator	activator	NN	I-NP
O	hinders	hinder	VBZ	B-VP
O	the	the	DT	B-NP
O	rearrangement	rearrangement	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	ternary	ternary	JJ	I-NP
O	complex	complex	NN	I-NP
O	,	,	,	O
O	decreasing	decrease	VBG	B-VP
O	the	the	DT	B-NP
O	turnover	turnover	NN	I-NP
O	rate	rate	NN	I-NP
O	(	(	(	O
O	Kcat	Kcat	NN	B-NP
O	)	)	)	O
O	.	.	.	O

O	Production	Production	NN	B-NP
O	of	of	IN	B-PP
O	vampire	vampire	NN	B-NP
O	bat	bat	NN	I-NP
B-GGP	plasminogen	plasminogen	NN	I-NP
O	activator	activator	NN	I-NP
B-GGP	DSPA	DSPA	NN	I-NP
I-GGP	alpha	alpha	NN	I-NP
I-GGP	1	1	CD	I-NP
O	in	in	IN	B-PP
O	CHO	CHO	NN	B-NP
O	and	and	CC	I-NP
O	insect	insect	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Salivary	Salivary	JJ	B-NP
B-GGP	plasminogen	plasminogen	NN	I-NP
O	activator	activator	NN	I-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	vampire	vampire	NN	I-NP
O	bat	bat	NN	I-NP
O	Desmodus	Desmodus	NN	I-NP
O	rotundus	rotundus	NN	I-NP
O	(	(	(	O
B-GGP	DSPA	DSPA	NN	B-NP
I-GGP	alpha	alpha	SYM	B-NP
I-GGP	1	1	CD	I-NP
O	)	)	)	O
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	promising	promising	JJ	I-NP
O	new	new	JJ	I-NP
O	thrombolytic	thrombolytic	JJ	I-NP
O	agent	agent	NN	I-NP
O	.	.	.	O

O	Continuous	Continuous	JJ	B-NP
O	growth	growth	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	stably	stably	RB	I-NP
O	transfected	transfecte	VBN	I-NP
O	,	,	,	I-NP
O	methotrexate	methotrexate	NN	I-NP
O	amplified	amplify	VBN	B-VP
O	,	,	,	O
O	dhfr	dhfr	NN	B-NP
O	-	-	HYPH	I-NP
O	CHO	CHO	NN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	yields	yield	VBZ	B-VP
O	up	up	IN	B-NP
O	to	to	TO	I-NP
O	60	60	CD	I-NP
O	mg	mg	NN	I-NP
O	l	l	NN	I-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	of	of	IN	B-PP
B-GGP	DSPA	DSPA	NN	B-NP
I-GGP	alpha	alpha	NN	I-NP
I-GGP	1	1	CD	I-NP
O	.	.	.	O

O	Utilizing	Utilize	VBG	B-VP
O	an	an	DT	B-NP
O	engineered	engineer	VBN	I-NP
O	baculovirus	baculovirus	NN	I-NP
O	10	10	CD	I-NP
O	mg	mg	NN	I-NP
O	l	l	NN	I-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	were	be	VBD	B-VP
O	produced	produce	VBN	I-VP
O	in	in	IN	B-PP
O	batches	batch	NNS	B-NP
O	of	of	IN	B-PP
O	Sf9	Sf9	NN	B-NP
O	insect	insect	NN	I-NP
O	cells	cell	NNS	I-NP
O	.	.	.	O

O	Recombinant	Recombinant	JJ	B-NP
B-GGP	DSPA	DSPA	NN	I-NP
I-GGP	alpha	alpha	NN	I-NP
I-GGP	1	1	CD	I-NP
O	is	be	VBZ	B-VP
O	purified	purify	VBN	I-VP
O	from	from	IN	B-PP
O	both	both	DT	B-NP
O	sources	source	NNS	I-NP
O	using	use	VBG	B-VP
O	a	a	DT	B-NP
O	one	one	CD	I-NP
O	-	-	HYPH	I-NP
O	step	step	NN	I-NP
O	purification	purification	NN	I-NP
O	protocol	protocol	NN	I-NP
O	.	.	.	O

O	Although	Although	IN	B-SBAR
O	differences	difference	NNS	B-NP
O	in	in	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	were	be	VBD	B-VP
O	detected	detect	VBN	I-VP
O	,	,	,	O
O	enzymatic	enzymatic	JJ	B-NP
O	activity	activity	NN	I-NP
O	and	and	CC	O
O	fibrin	fibrin	NN	B-NP
O	cofactor	cofactor	NN	I-NP
O	dependency	dependency	NN	I-NP
O	are	be	VBP	B-VP
O	unaffected	unaffected	JJ	B-ADJP
O	when	when	WRB	B-ADVP
B-GGP	DSPA	DSPA	NN	B-NP
I-GGP	alpha	alpha	NN	I-NP
I-GGP	1	1	CD	I-NP
O	derived	derive	VBN	B-VP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	expression	expression	NN	I-NP
O	systems	system	NNS	I-NP
O	is	be	VBZ	B-VP
O	compared	compare	VBN	I-VP
O	.	.	.	O

O	Glycosylation	Glycosylation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	CD4	CD4	NN	B-NP
O	and	and	CC	I-NP
B-GGP	Thy	Thy	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	site	site	NN	I-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	of	of	IN	B-PP
O	soluble	soluble	JJ	B-NP
O	recombinant	recombinant	JJ	I-NP
O	variants	variant	NNS	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
O	and	and	CC	I-NP
O	rat	rat	NN	I-NP
B-GGP	CD4	CD4	NN	I-NP
O	(	(	(	O
B-GGP	sCD4	sCD4	NN	B-NP
O	)	)	)	O
O	expressed	express	VBN	B-VP
O	in	in	IN	B-PP
O	Chinese	Chinese	JJ	B-NP
O	hamster	hamster	NN	I-NP
O	ovary	ovary	NN	I-NP
O	(	(	(	I-NP
O	CHO	CHO	NN	I-NP
O	)	)	)	I-NP
O	cells	cell	NNS	I-NP
O	has	have	VBZ	B-VP
O	been	be	VBN	I-VP
O	characterized	characterize	VBN	I-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	identical	identical	JJ	B-NP
O	oligosaccharides	oligosaccharide	NNS	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	conserved	conserve	VBN	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	in	in	IN	B-PP
O	domain	domain	NN	B-NP
O	3	3	CD	I-NP
O	of	of	IN	B-PP
O	rat	rat	NN	B-NP
O	and	and	CC	O
O	human	human	JJ	B-NP
B-GGP	sCD4	sCD4	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	greater	great	JJR	I-NP
O	abundance	abundance	NN	I-NP
O	of	of	IN	B-PP
O	oligomannose	oligomannose	NN	B-NP
O	and	and	CC	I-NP
O	hybrid	hybrid	NN	I-NP
O	type	type	NN	I-NP
O	glycans	glycan	NNS	I-NP
O	at	at	IN	B-PP
O	the	the	DT	B-NP
O	non	non	AFX	I-NP
O	-	-	HYPH	I-NP
O	conserved	conserve	VBN	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	of	of	IN	B-PP
O	rat	rat	NN	B-NP
B-GGP	sCD4	sCD4	NN	I-NP
O	clearly	clearly	RB	B-ADVP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	structure	structure	NN	I-NP
O	influences	influence	VBZ	B-VP
O	oligosaccharide	oligosaccharide	NN	B-NP
O	processing	processing	NN	I-NP
O	.	.	.	O

O	Comparisons	Comparison	NNS	B-NP
O	of	of	IN	B-PP
O	rat	rat	NN	B-NP
B-GGP	sCD4	sCD4	NN	I-NP
O	glycopeptides	glycopeptide	NNS	I-NP
O	with	with	IN	B-PP
O	mutant	mutant	JJ	B-NP
O	molecules	molecule	NNS	I-NP
O	with	with	IN	B-PP
O	only	only	RB	B-NP
O	single	single	JJ	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	sites	site	NNS	I-NP
O	and	and	CC	B-PP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	truncated	truncate	VBN	I-NP
O	form	form	NN	I-NP
O	containing	contain	VBG	B-VP
O	only	only	RB	B-ADVP
O	the	the	DT	B-NP
O	two	two	CD	I-NP
O	NH2	NH2	NN	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	domains	domain	NNS	I-NP
O	,	,	,	O
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	independent	independent	JJ	B-NP
O	processing	processing	NN	I-NP
O	occurs	occur	VBZ	B-VP
O	at	at	IN	B-PP
O	each	each	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	site	site	NN	I-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	domain	domain	NN	B-NP
O	interactions	interaction	NNS	I-NP
O	can	can	MD	B-VP
O	also	also	RB	I-VP
O	affect	affect	VB	I-VP
O	oligosaccharide	oligosaccharide	NN	B-NP
O	processing	processing	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	and	and	CC	I-NP
O	other	other	JJ	I-NP
O	analyses	analysis	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	sCD2	sCD2	NN	B-NP
O	expressed	express	VBN	B-VP
O	in	in	IN	B-PP
O	CHO	CHO	NN	B-NP
O	cells	cell	NNS	I-NP
O	and	and	CC	O
B-GGP	Thy	Thy	NNP	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	purified	purify	VBN	B-VP
O	from	from	IN	B-PP
O	various	various	JJ	B-NP
O	tissues	tissue	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	diversity	diversity	NN	I-NP
O	of	of	IN	B-PP
O	oligosaccharide	oligosaccharide	NN	B-NP
O	structures	structure	NNS	I-NP
O	on	on	IN	B-PP
O	a	a	DT	B-NP
O	protein	protein	NN	I-NP
O	is	be	VBZ	B-VP
O	regulated	regulate	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	location	location	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	sites	site	NNS	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	nature	nature	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	target	target	NN	I-NP
O	protein	protein	NN	I-NP
O	,	,	,	O
O	cell	cell	NN	B-NP
O	and	and	CC	I-NP
O	tissue	tissue	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	functional	functional	JJ	I-NP
O	significance	significance	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	control	control	NN	I-NP
O	remains	remain	VBZ	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	determined	determine	VBN	I-VP
O	.	.	.	O

O	Protein	Protein	NN	B-NP
O	carboxyl	carboxyl	NN	I-NP
O	methylation	methylation	NN	I-NP
O	in	in	IN	B-PP
O	Saccharomyces	Saccharomyces	NNP	B-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	:	:	:	O
O	evidence	evidence	NN	B-NP
O	for	for	IN	B-PP
B-GGP	STE14	STE14	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	and	and	CC	I-NP
B-GGP	STE14	STE14	NN	I-NP
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	pathways	pathway	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	incubated	incubate	VBD	B-VP
O	yeast	yeast	NN	B-NP
O	cells	cell	NNS	I-NP
O	(	(	(	O
O	Saccharomyces	Saccharomyce	NNS	B-NP
O	cerevisiae	cerevisiae	VBP	B-VP
O	)	)	)	O
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	methyl	methyl	NN	I-NP
O	donor	donor	NN	I-NP
O	S	S	NN	I-NP
O	-	-	HYPH	B-NP
O	adenosyl	adenosyl	NN	I-NP
O	-	-	HYPH	B-NP
O	L	L	NN	I-NP
O	-	-	HYPH	B-NP
O	[	[	(	B-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	I-NP
O	3H	3H	NN	I-NP
O	]	]	)	I-NP
O	methionine	methionine	NN	I-NP
O	and	and	CC	O
O	then	then	RB	B-VP
O	fractionated	fractionate	VBD	I-VP
O	their	their	PRP$	B-NP
O	cellular	cellular	JJ	I-NP
O	components	component	NNS	I-NP
O	by	by	IN	B-PP
O	gel	gel	NN	B-NP
O	electrophoresis	electrophoresis	NN	I-NP
O	in	in	IN	B-PP
O	sodium	sodium	NN	B-NP
O	dodecyl	dodecyl	NN	I-NP
O	sulfate	sulfate	NN	I-NP
O	.	.	.	O

O	By	By	IN	B-PP
O	analyzing	analyze	VBG	B-VP
O	gel	gel	NN	B-NP
O	slices	slice	NNS	I-NP
O	for	for	IN	B-PP
O	[	[	(	O
O	3H	3H	NN	B-NP
O	]	]	)	O
O	methyl	methyl	NN	B-NP
O	esters	ester	NNS	I-NP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
O	vapor	vapor	NN	I-NP
O	-	-	HYPH	I-NP
O	phase	phase	NN	I-NP
O	diffusion	diffusion	NN	I-NP
O	assay	assay	NN	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	detect	detect	VBP	B-VP
O	major	major	JJ	B-NP
O	methyl	methyl	NN	I-NP
O	-	-	HYPH	B-NP
O	esterified	esterify	VBN	I-NP
O	species	specie	NNS	I-NP
O	that	that	WDT	B-NP
O	migrate	migrate	VBP	B-VP
O	at	at	IN	B-PP
O	apparent	apparent	JJ	B-NP
O	polypeptide	polypeptide	NN	I-NP
O	sizes	size	NNS	I-NP
O	of	of	IN	B-PP
O	24	24	CD	B-NP
O	and	and	CC	I-NP
O	22	22	CD	I-NP
O	kDa	kDa	NN	I-NP
O	and	and	CC	O
O	minor	minor	JJ	B-NP
O	species	specie	NNS	I-NP
O	of	of	IN	B-PP
O	49	49	CD	B-NP
O	,	,	,	I-NP
O	38	38	CD	I-NP
O	,	,	,	I-NP
O	35	35	CD	I-NP
O	,	,	,	I-NP
O	33	33	CD	I-NP
O	,	,	,	I-NP
O	31	31	CD	I-NP
O	,	,	,	O
O	and	and	CC	O
O	26	26	CD	B-NP
O	kDa	kDa	NN	I-NP
O	.	.	.	O

O	Incubation	Incubation	NN	B-NP
O	of	of	IN	B-PP
O	extracts	extract	NNS	B-NP
O	from	from	IN	B-PP
O	labeled	label	VBN	B-NP
O	cells	cell	NNS	I-NP
O	with	with	IN	B-PP
B-GGP	ribonuclease	ribonuclease	NN	B-NP
I-GGP	A	A	NN	I-NP
O	or	or	CC	I-NP
B-GGP	proteinase	proteinase	NN	I-NP
I-GGP	K	K	NN	I-NP
O	revealed	reveal	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	24	24	CD	I-NP
O	-	-	HYPH	I-NP
O	and	and	CC	I-NP
O	22	22	CD	I-NP
O	-	-	HYPH	I-NP
O	kDa	kDa	NN	I-NP
O	species	specie	NNS	I-NP
O	represent	represent	VBP	B-VP
O	methyl	methyl	NN	B-NP
O	-	-	HYPH	B-NP
O	esterified	esterify	VBN	I-NP
O	RNAs	RNA	NNS	I-NP
O	,	,	,	O
O	whereas	whereas	IN	O
O	the	the	DT	B-NP
O	other	other	JJ	I-NP
O	species	specie	NNS	I-NP
O	are	be	VBP	B-VP
O	methyl	methyl	NN	B-NP
O	-	-	HYPH	B-NP
O	esterified	esterify	VBN	I-NP
O	polypeptides	polypeptide	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	38	38	CD	I-NP
O	-	-	HYPH	I-NP
O	,	,	,	O
O	33	33	CD	B-NP
O	-	-	HYPH	B-ADVP
O	,	,	,	O
O	31	31	CD	B-NP
O	-	-	HYPH	B-ADJP
O	,	,	,	O
O	and	and	CC	O
O	26	26	CD	B-NP
O	-	-	HYPH	I-NP
O	kDa	kDa	NN	I-NP
O	polypeptides	polypeptide	NNS	I-NP
O	were	be	VBD	B-VP
O	not	not	RB	O
O	methyl	methyl	NN	B-NP
O	-	-	HYPH	O
O	esterified	esterify	VBN	B-VP
O	in	in	IN	B-PP
O	an	an	DT	B-NP
O	isogenic	isogenic	JJ	I-NP
O	yeast	yeast	NN	I-NP
O	strain	strain	NN	I-NP
O	lacking	lack	VBG	B-VP
O	the	the	DT	B-NP
B-GGP	STE14	STE14	NN	I-NP
O	gene	gene	NN	I-NP
O	encoding	encode	VBG	B-VP
O	a	a	DT	B-NP
O	C	C	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	isoprenylcysteine	isoprenylcysteine	NN	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-SBAR
O	they	they	PRP	B-NP
O	are	be	VBP	B-VP
O	substrates	substrate	NNS	B-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
B-GGP	STE14	STE14	NN	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	.	.	.	O

O	On	On	IN	B-PP
O	the	the	DT	B-NP
O	other	other	JJ	I-NP
O	hand	hand	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	amount	amount	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	methylated	methylate	VBN	I-NP
O	49	49	CD	I-NP
O	-	-	HYPH	I-NP
O	kDa	kDa	NN	I-NP
O	polypeptide	polypeptide	NN	I-NP
O	is	be	VBZ	B-VP
O	reduced	reduce	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
B-GGP	ste14	ste14	NN	I-NP
O	mutant	mutant	NN	I-NP
O	,	,	,	O
O	indicating	indicate	VBG	B-VP
O	that	that	IN	B-SBAR
O	at	at	IN	B-NP
O	least	least	JJS	I-NP
O	two	two	CD	I-NP
O	methylated	methylate	VBN	I-NP
O	polypeptides	polypeptide	NNS	I-NP
O	are	be	VBP	B-VP
O	present	present	JJ	B-ADJP
O	-	-	HYPH	B-NP
O	-	-	SYM	I-NP
O	one	one	CD	I-NP
O	a	a	DT	B-NP
O	substrate	substrate	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	STE14	STE14	NN	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	and	and	CC	O
O	one	one	CD	B-NP
O	a	a	DT	B-NP
O	substrate	substrate	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
B-GGP	STE14	STE14	NN	I-NP
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	35	35	CD	I-NP
O	-	-	HYPH	I-NP
O	kDa	kDa	NN	I-NP
O	polypeptide	polypeptide	NN	I-NP
O	also	also	RB	B-ADVP
O	appears	appear	VBZ	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	methylated	methylate	VBN	I-VP
O	by	by	IN	B-PP
O	a	a	DT	B-NP
B-GGP	STE14	STE14	NN	I-NP
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	methyltransferase	methyltransferase	NN	I-NP
O	.	.	.	O

O	When	When	WRB	B-ADVP
O	cells	cell	NNS	B-NP
O	were	be	VBD	B-VP
O	incubated	incubate	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	synthesis	synthesis	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	cycloheximide	cycloheximide	NN	I-NP
O	,	,	,	O
O	little	little	JJ	B-NP
O	or	or	CC	I-NP
O	no	no	DT	I-NP
O	methylation	methylation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	STE14	STE14	NN	I-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	species	specie	NNS	I-NP
O	was	be	VBD	B-VP
O	detected	detect	VBN	I-VP
O	while	while	IN	B-SBAR
O	the	the	DT	B-NP
O	methylation	methylation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	STE14	STE14	NN	I-NP
O	-	-	HYPH	B-NP
O	independent	independent	JJ	I-NP
O	substrates	substrate	NNS	I-NP
O	was	be	VBD	B-VP
O	unaffected	unaffected	JJ	B-ADJP
O	.	.	.	O

O	Pulse	Pulse	NN	B-NP
O	-	-	HYPH	I-NP
O	chase	chase	NN	I-NP
O	studies	study	NNS	I-NP
O	revealed	reveal	VBD	B-VP
O	significant	significant	JJ	B-NP
O	turnover	turnover	NN	I-NP
O	of	of	IN	B-PP
O	all	all	DT	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	methylated	methylate	VBN	I-NP
O	species	specie	NNS	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	4	4	CD	I-NP
O	-	-	HYPH	I-NP
O	h	h	NN	I-NP
O	period	period	NN	I-NP
O	,	,	,	O
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	exception	exception	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	38	38	CD	I-NP
O	-	-	HYPH	I-NP
O	kDa	kDa	NN	I-NP
O	polypeptide	polypeptide	NN	I-NP
O	.	.	.	O
O	(	(	(	O
O	ABSTRACT	ABSTRACT	NN	B-NP
O	TRUNCATED	TRUNCATED	VBN	B-VP
O	AT	AT	IN	B-PP
O	250	250	CD	B-NP
O	WORDS	WORDS	NNS	I-NP
O	)	)	)	O

O	Reconstitution	Reconstitution	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	folding	folding	NN	I-NP
O	pathway	pathway	NN	I-NP
O	of	of	IN	B-PP
O	collagen	collagen	NN	B-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	cell	cell	NN	I-NP
O	-	-	HYPH	B-NP
O	free	free	JJ	I-NP
O	system	system	NN	I-NP
O	:	:	:	O
O	formation	formation	NN	B-NP
O	of	of	IN	B-PP
O	correctly	correctly	RB	B-NP
O	aligned	align	VBN	I-NP
O	and	and	CC	I-NP
O	hydroxylated	hydroxylate	VBN	I-NP
O	triple	triple	JJ	I-NP
O	helices	helix	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	describe	describe	VBP	B-VP
O	here	here	RB	B-ADVP
O	a	a	DT	B-NP
O	cell	cell	NN	I-NP
O	-	-	HYPH	B-NP
O	free	free	JJ	I-NP
O	system	system	NN	I-NP
O	which	which	WDT	B-NP
O	will	will	MD	B-VP
O	carry	carry	VB	I-VP
O	out	out	RP	B-PRT
O	the	the	DT	B-NP
O	initial	initial	JJ	I-NP
O	stages	stage	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	synthesis	synthesis	NN	I-NP
O	,	,	,	O
O	post	post	AFX	O
O	-	-	HYPH	B-NP
O	translational	translational	JJ	I-NP
O	modification	modification	NN	I-NP
O	and	and	CC	I-NP
O	assembly	assembly	NN	I-NP
O	of	of	IN	B-PP
B-GGP	type	type	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	X	X	NN	I-NP
I-GGP	collagen	collagen	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	mRNA	mRNA	NN	I-NP
O	coding	coding	NN	I-NP
O	for	for	IN	B-PP
O	bovine	bovine	JJ	B-NP
B-GGP	type	type	NN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	X	X	NN	I-NP
I-GGP	collagen	collagen	NN	I-NP
O	was	be	VBD	B-VP
O	synthesized	synthesize	VBN	I-VP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	and	and	CC	O
O	translated	translate	VBN	B-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	rabbit	rabbit	NN	I-NP
O	reticulocyte	reticulocyte	NN	I-NP
O	lysate	lysate	NN	I-NP
O	to	to	TO	B-VP
O	yield	yield	VB	I-VP
O	a	a	DT	B-NP
O	protein	protein	NN	I-NP
O	that	that	WDT	B-NP
O	was	be	VBD	B-VP
O	collagenase	collagenase	NN	B-NP
O	sensitive	sensitive	JJ	B-ADJP
O	and	and	CC	O
O	could	could	MD	B-VP
O	be	be	VB	I-VP
O	immunoprecipitated	immunoprecipitate	VBN	I-VP
O	with	with	IN	B-PP
O	antibodies	antibody	NNS	B-NP
O	raised	raise	VBN	B-VP
O	to	to	TO	B-PP
O	purified	purify	VBN	B-NP
O	avian	avian	JJ	I-NP
B-GGP	type	type	NN	I-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	X	X	NN	I-NP
I-GGP	collagen	collagen	NN	I-NP
O	.	.	.	O

O	When	When	WRB	B-ADVP
B-GGP	type	type	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	X	X	NN	I-NP
I-GGP	collagen	collagen	NN	I-NP
O	was	be	VBD	B-VP
O	synthesized	synthesize	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	absence	absence	NN	I-NP
O	of	of	IN	B-PP
O	added	add	VBN	B-NP
O	microsomes	microsome	NNS	I-NP
O	or	or	CC	B-PP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	canine	canine	JJ	B-NP
O	pancreas	pancreas	NN	I-NP
O	microsomes	microsome	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	translation	translation	NN	I-NP
O	products	product	NNS	I-NP
O	showed	show	VBD	B-VP
O	partial	partial	JJ	B-NP
O	resistance	resistance	NN	I-NP
O	to	to	TO	B-PP
O	digestion	digestion	NN	B-NP
O	with	with	IN	B-PP
O	pepsin	pepsin	NN	B-NP
O	but	but	CC	O
O	were	be	VBD	B-VP
O	completely	completely	RB	I-VP
O	degraded	degrade	VBN	I-VP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
O	mixture	mixture	NN	I-NP
O	of	of	IN	B-PP
O	chymotrypsin	chymotrypsin	NN	B-NP
O	and	and	CC	I-NP
O	trypsin	trypsin	NN	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	that	that	IN	B-NP
O	only	only	RB	B-VP
O	incorrectly	incorrectly	RB	I-VP
O	aligned	align	VBN	I-VP
O	non	non	AFX	O
O	-	-	HYPH	O
O	native	native	JJ	B-NP
O	collagen	collagen	NN	I-NP
O	molecules	molecule	NNS	I-NP
O	were	be	VBD	B-VP
O	synthesized	synthesize	VBN	I-VP
O	under	under	IN	B-PP
O	these	these	DT	B-NP
O	conditions	condition	NNS	I-NP
O	.	.	.	O

O	When	When	WRB	B-ADVP
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	was	be	VBD	B-VP
O	synthesized	synthesize	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	microsomes	microsome	NNS	B-NP
O	derived	derive	VBN	B-VP
O	from	from	IN	B-PP
O	avian	avian	JJ	B-NP
O	fibroblasts	fibroblast	NNS	I-NP
O	or	or	CC	O
O	a	a	DT	B-NP
O	human	human	JJ	I-NP
O	fibrosarcoma	fibrosarcoma	NN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	translocated	translocate	VBN	I-NP
O	product	product	NN	I-NP
O	migrated	migrate	VBD	B-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	diffuse	diffuse	JJ	I-NP
O	band	band	NN	I-NP
O	characteristic	characteristic	JJ	B-ADJP
O	of	of	IN	B-PP
O	hydroxylated	hydroxylate	VBN	B-NP
O	collagen	collagen	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	synthesized	synthesize	VBN	I-NP
O	polypeptides	polypeptide	NNS	I-NP
O	were	be	VBD	B-VP
O	also	also	RB	B-ADVP
O	resistant	resistant	JJ	B-ADJP
O	to	to	TO	B-PP
O	both	both	CC	O
O	pepsin	pepsin	NN	B-NP
O	and	and	CC	I-NP
O	trypsin	trypsin	NN	I-NP
O	/	/	SYM	I-NP
O	chymotrypsin	chymotrypsin	NN	I-NP
O	digestion	digestion	NN	I-NP
O	,	,	,	O
O	demonstrating	demonstrate	VBG	B-VP
O	the	the	DT	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	correctly	correctly	RB	B-NP
O	aligned	align	VBN	I-NP
O	native	native	JJ	I-NP
O	collagen	collagen	NN	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	collagen	collagen	NN	I-NP
O	polypeptides	polypeptide	NNS	I-NP
O	assembled	assemble	VBD	B-VP
O	into	into	IN	B-PP
O	higher	high	JJR	B-NP
O	-	-	HYPH	I-NP
O	order	order	NN	I-NP
O	structures	structure	NNS	I-NP
O	,	,	,	O
O	possibly	possibly	RB	B-NP
O	trimers	trimer	NNS	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	were	be	VBD	B-VP
O	stabilized	stabilize	VBN	I-VP
O	by	by	IN	B-PP
O	interchain	interchain	NN	B-NP
O	disulphide	disulphide	NN	I-NP
O	bonds	bond	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	collagen	collagen	NN	I-NP
O	helix	helix	NN	I-NP
O	synthesized	synthesize	VBN	B-VP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	had	have	VBD	B-VP
O	a	a	DT	B-NP
O	melting	melting	NN	I-NP
O	temperature	temperature	NN	I-NP
O	of	of	IN	B-PP
O	41	41	CD	B-NP
O	degrees	degree	NNS	I-NP
O	C	C	NN	I-NP
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	comparable	comparable	JJ	B-ADJP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	synthesized	synthesize	VBN	B-VP
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	,	,	,	O
O	further	further	RB	B-ADVP
O	demonstrating	demonstrate	VBG	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	polypeptides	polypeptide	NNS	I-NP
O	were	be	VBD	B-VP
O	hydroxylated	hydroxylate	VBN	I-VP
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	triple	triple	JJ	I-NP
O	helix	helix	NN	I-NP
O	formed	form	VBN	B-VP
O	was	be	VBD	B-VP
O	correctly	correctly	RB	I-VP
O	aligned	align	VBN	I-VP
O	.	.	.	O

O	Structural	Structural	JJ	B-NP
O	requirements	requirement	NNS	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	binding	binding	NN	I-NP
O	of	of	IN	B-PP
O	modified	modified	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	scavenger	scavenger	NN	I-NP
O	receptor	receptor	NN	I-NP
O	of	of	IN	B-PP
O	macrophages	macrophage	NNS	B-NP
O	.	.	.	O

O	Oxidized	Oxidize	VBN	B-NP
O	low	low	JJ	I-NP
O	density	density	NN	I-NP
O	lipoprotein	lipoprotein	NN	I-NP
O	(	(	(	O
O	LDL	LDL	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	certain	certain	JJ	B-NP
O	chemically	chemically	RB	I-NP
O	modified	modify	VBN	I-NP
O	LDL	LDL	NN	I-NP
O	are	be	VBP	B-VP
O	recognized	recognize	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	scavenger	scavenger	NN	I-NP
O	receptor	receptor	NN	I-NP
O	of	of	IN	B-PP
O	macrophages	macrophage	NNS	B-NP
O	.	.	.	O

O	All	All	DT	B-NP
O	of	of	IN	B-PP
O	these	these	DT	B-NP
O	modifications	modification	NNS	I-NP
O	involve	involve	VBP	B-VP
O	charge	charge	NN	B-NP
O	-	-	HYPH	O
O	neutralizing	neutralize	VBG	B-VP
O	derivatization	derivatization	NN	B-NP
O	of	of	IN	B-PP
O	lysine	lysine	NN	B-NP
O	amino	amino	JJ	I-NP
O	groups	group	NNS	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	it	it	PRP	B-NP
O	remains	remain	VBZ	B-VP
O	controversial	controversial	JJ	B-ADJP
O	whether	whether	IN	B-SBAR
O	recognition	recognition	NN	B-NP
O	of	of	IN	B-PP
O	modified	modify	VBN	B-NP
O	LDL	LDL	NN	I-NP
O	by	by	IN	B-PP
O	this	this	DT	B-NP
O	receptor	receptor	NN	I-NP
O	is	be	VBZ	B-VP
O	due	due	IN	B-PP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	modification	modification	NN	I-NP
O	per	per	FW	B-ADVP
O	se	se	FW	I-ADVP
O	,	,	,	O
O	or	or	CC	B-PP
O	to	to	TO	B-PP
O	other	other	JJ	B-NP
O	factors	factor	NNS	I-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	a	a	DT	B-NP
O	conformational	conformational	JJ	I-NP
O	change	change	NN	I-NP
O	of	of	IN	B-PP
B-GGP	apoB	apoB	NN	B-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	,	,	,	O
O	LDL	LDL	NN	B-NP
O	and	and	CC	O
O	other	other	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	including	include	VBG	B-PP
O	bovine	bovine	JJ	B-NP
B-GGP	serum	serum	NN	I-NP
I-GGP	albumin	albumin	NN	I-NP
O	,	,	,	O
O	human	human	JJ	B-NP
O	high	high	JJ	I-NP
O	density	density	NN	I-NP
O	lipoprotein	lipoprotein	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	murine	murine	JJ	B-NP
O	IgG	IgG	NN	I-NP
O	were	be	VBD	B-VP
O	derivatized	derivatize	VBN	I-VP
O	with	with	IN	B-PP
O	oxidation	oxidation	NN	B-NP
O	products	product	NNS	I-NP
O	generated	generate	VBN	B-VP
O	from	from	IN	B-PP
O	arachidonic	arachidonic	JJ	B-NP
O	acid	acid	NN	I-NP
O	by	by	IN	B-PP
O	thermal	thermal	JJ	B-NP
O	autoxidation	autoxidation	NN	I-NP
O	.	.	.	O

O	Modified	Modify	VBN	B-NP
O	proteins	protein	NNS	I-NP
O	had	have	VBD	B-VP
O	increased	increase	VBN	I-VP
O	negative	negative	JJ	B-NP
O	charge	charge	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	showed	show	VBD	B-VP
O	a	a	DT	B-NP
O	more	more	JJR	I-NP
O	than	than	IN	I-NP
O	10	10	CD	I-NP
O	-	-	HYPH	I-NP
O	fold	fold	JJ	I-NP
O	enhancement	enhancement	NN	I-NP
O	of	of	IN	B-PP
O	degradation	degradation	NN	B-NP
O	by	by	IN	B-PP
O	mouse	mouse	NN	B-NP
O	peritoneal	peritoneal	JJ	B-NP
O	macrophages	macrophage	NNS	I-NP
O	via	via	IN	B-PP
O	the	the	DT	B-NP
O	scavenger	scavenger	NN	I-NP
O	receptor	receptor	NN	I-NP
O	pathway	pathway	NN	I-NP
O	.	.	.	O

O	Modification	Modification	NN	B-NP
O	was	be	VBD	B-VP
O	prevented	prevent	VBN	I-VP
O	by	by	IN	B-PP
O	blocking	block	VBG	B-VP
O	lysine	lysine	NN	B-NP
O	residues	residue	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	proteins	protein	NNS	I-NP
O	by	by	IN	B-PP
O	prior	prior	JJ	B-NP
O	reductive	reductive	JJ	I-NP
O	methylation	methylation	NN	I-NP
O	.	.	.	O

O	Amino	Amino	NN	B-NP
O	acid	acid	NN	I-NP
O	analysis	analysis	NN	I-NP
O	revealed	reveal	VBD	B-VP
O	dose	dose	NN	B-NP
O	-	-	HYPH	B-NP
O	dependent	dependent	JJ	I-NP
O	modification	modification	NN	I-NP
O	of	of	IN	B-PP
O	lysine	lysine	NN	B-NP
O	residues	residue	NNS	I-NP
O	with	with	IN	B-PP
O	no	no	DT	B-NP
O	significant	significant	JJ	I-NP
O	effects	effect	NNS	I-NP
O	on	on	IN	B-PP
O	any	any	DT	B-NP
O	other	other	JJ	I-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	.	.	.	O

O	Fab	Fab	NN	B-NP
O	fragments	fragment	NNS	I-NP
O	of	of	IN	B-PP
O	monoclonal	monoclonal	JJ	B-NP
O	antibodies	antibody	NNS	I-NP
O	specific	specific	JJ	B-ADJP
O	for	for	IN	B-PP
O	adducts	adduct	NNS	B-NP
O	of	of	IN	B-PP
O	oxidation	oxidation	NN	B-NP
O	products	product	NNS	I-NP
O	with	with	IN	B-PP
O	lysine	lysine	NN	B-NP
O	prevented	prevent	VBD	B-VP
O	the	the	DT	B-NP
O	uptake	uptake	NN	I-NP
O	of	of	IN	B-PP
O	oxidation	oxidation	NN	B-NP
O	product	product	NN	I-NP
O	-	-	HYPH	B-VP
O	modified	modify	VBN	B-NP
O	LDL	LDL	NN	I-NP
O	and	and	CC	O
O	oxidized	oxidize	VBN	B-NP
O	LDL	LDL	NN	I-NP
O	by	by	IN	B-PP
O	macrophages	macrophage	NNS	B-NP
O	.	.	.	O

O	Chromatography	Chromatography	NN	B-NP
O	of	of	IN	B-PP
O	oxidation	oxidation	NN	B-NP
O	product	product	NN	I-NP
O	-	-	HYPH	B-VP
O	modified	modify	VBN	B-NP
O	LDL	LDL	NN	I-NP
O	over	over	IN	B-PP
O	Sepharose	Sepharose	NN	B-NP
O	CL	CL	NN	I-NP
O	-	-	HYPH	B-NP
O	4B	4B	NN	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	uptake	uptake	NN	B-NP
O	by	by	IN	B-PP
O	macrophages	macrophage	NNS	B-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	require	require	VB	I-VP
O	LDL	LDL	NN	B-NP
O	aggregation	aggregation	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	a	a	DT	B-NP
O	relatively	relatively	RB	I-NP
O	simple	simple	JJ	I-NP
O	domain	domain	NN	I-NP
O	consisting	consist	VBG	B-VP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	cluster	cluster	NN	I-NP
O	of	of	IN	B-PP
O	suitably	suitably	RB	B-NP
O	derivatized	derivatize	VBN	I-NP
O	lysine	lysine	NN	I-NP
O	residues	residue	NNS	I-NP
O	is	be	VBZ	B-VP
O	sufficient	sufficient	JJ	B-ADJP
O	for	for	IN	B-PP
O	recognition	recognition	NN	B-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	scavenger	scavenger	NN	I-NP
O	receptor	receptor	NN	I-NP
O	of	of	IN	B-PP
O	macrophages	macrophage	NNS	B-NP
O	.	.	.	O

O	Adenosine	Adenosine	NN	B-NP
O	stimulation	stimulation	NN	I-NP
O	of	of	IN	B-PP
O	AMP	AMP	NN	B-NP
O	deaminase	deaminase	NN	I-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	adult	adult	JJ	B-NP
O	rat	rat	NN	I-NP
O	cardiac	cardiac	JJ	I-NP
O	myocytes	myocyte	NNS	I-NP
O	.	.	.	O

O	Using	Use	VBG	B-VP
O	an	an	DT	B-NP
O	in	in	FW	I-NP
O	situ	situ	FW	I-NP
O	assay	assay	NN	I-NP
O	for	for	IN	B-PP
O	analyzing	analyze	VBG	B-VP
O	AMP	AMP	NN	B-NP
O	deaminase	deaminase	NN	I-NP
O	activity	activity	NN	I-NP
O	in	in	IN	B-PP
O	isolated	isolate	VBN	B-NP
O	adult	adult	JJ	I-NP
O	rat	rat	NN	I-NP
O	ventricular	ventricular	JJ	I-NP
O	myocytes	myocyte	NNS	I-NP
O	,	,	,	O
O	we	we	PRP	B-NP
O	have	have	VBP	B-VP
O	shown	show	VBN	I-VP
O	that	that	IN	B-SBAR
O	IMP	IMP	NN	B-NP
O	production	production	NN	I-NP
O	is	be	VBZ	B-VP
O	stimulated	stimulate	VBN	I-VP
O	approximately	approximately	RB	B-ADVP
O	twofold	twofold	RB	I-ADVP
O	in	in	IN	B-PP
O	cardiac	cardiac	JJ	B-NP
O	cells	cell	NNS	I-NP
O	incubated	incubate	VBN	B-VP
O	with	with	IN	B-PP
O	10	10	CD	B-NP
O	microM	microM	NN	I-NP
O	adenosine	adenosine	NN	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	effect	effect	NN	I-NP
O	of	of	IN	B-PP
O	adenosine	adenosine	NN	B-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	blocked	block	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
B-GGP	adenosine	adenosine	NN	I-NP
I-GGP	A1	A1	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	receptor	receptor	NN	I-NP
O	antagonist	antagonist	NN	I-NP
O	8	8	CD	I-NP
O	-	-	HYPH	I-NP
O	cyclophenyl	cyclophenyl	NN	I-NP
O	-	-	HYPH	I-NP
O	1	1	CD	I-NP
O	,	,	,	I-NP
O	3	3	CD	I-NP
O	-	-	HYPH	I-NP
O	dipropylaxanthine	dipropylaxanthine	NN	I-NP
O	(	(	(	O
O	0	0	CD	B-NP
O	.	.	.	O
O	01	01	CD	B-NP
O	-	-	HYPH	I-NP
O	1	1	CD	I-NP
O	microM	microM	NN	I-NP
O	)	)	)	O
O	except	except	IN	B-PP
O	at	at	IN	B-PP
O	a	a	DT	B-NP
O	concentration	concentration	NN	I-NP
O	(	(	(	O
O	100	100	CD	B-NP
O	microM	microM	NN	I-NP
O	)	)	)	O
O	that	that	WDT	B-NP
O	may	may	MD	B-VP
O	inhibit	inhibit	VB	I-VP
O	adenosine	adenosine	NN	B-NP
O	transport	transport	NN	I-NP
O	.	.	.	O

O	Similarly	Similarly	RB	B-ADVP
O	,	,	,	O
O	in	in	FW	B-NP
O	situ	situ	FW	I-NP
O	AMP	AMP	NN	I-NP
O	deaminase	deaminase	NN	I-NP
O	activity	activity	NN	I-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	enhanced	enhance	VBN	I-VP
O	by	by	IN	B-PP
O	treatment	treatment	NN	B-NP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	specific	specific	JJ	I-NP
B-GGP	adenosine	adenosine	NN	I-NP
I-GGP	A1	A1	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	receptor	receptor	NN	I-NP
O	agonists	agonist	NNS	I-NP
O	N6	N6	NN	I-NP
O	-	-	HYPH	B-NP
O	phenylisopropyl	phenylisopropyl	NN	I-NP
O	adenosine	adenosine	NN	I-NP
O	or	or	CC	I-NP
O	cyclopentyladenosine	cyclopentyladenosine	NN	I-NP
O	,	,	,	O
O	nor	nor	CC	O
O	was	be	VBD	O
O	it	it	PRP	B-NP
O	sensitive	sensitive	JJ	B-ADJP
O	to	to	TO	B-PP
O	prior	prior	JJ	B-NP
O	treatment	treatment	NN	I-NP
O	of	of	IN	B-PP
O	cells	cell	NNS	B-NP
O	with	with	IN	B-PP
O	pertussis	pertussis	NN	B-NP
O	toxin	toxin	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	nucleoside	nucleoside	NN	I-NP
O	transport	transport	NN	I-NP
O	blockers	blocker	NNS	I-NP
O	S	S	NN	I-NP
O	-	-	HYPH	B-NP
O	4	4	CD	I-NP
O	-	-	HYPH	I-NP
O	nitrobenzyl	nitrobenzyl	NN	I-NP
O	-	-	HYPH	B-NP
O	6	6	CD	I-NP
O	-	-	HYPH	I-NP
O	thioinosine	thioinosine	NN	I-NP
O	,	,	,	O
O	dipyridamole	dipyridamole	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	papaverine	papaverine	NN	B-NP
O	inhibited	inhibit	VBD	B-VP
O	adenosine	adenosine	NN	B-NP
O	-	-	HYPH	B-NP
O	induced	induce	VBN	I-NP
O	increases	increase	NNS	I-NP
O	in	in	IN	B-PP
O	IMP	IMP	NN	B-NP
O	production	production	NN	I-NP
O	by	by	IN	B-PP
O	75	75	CD	B-NP
O	-	-	HYPH	I-NP
O	85	85	CD	I-NP
O	%	%	NN	I-NP
O	,	,	,	O
O	suggesting	suggest	VBG	B-VP
O	an	an	DT	B-NP
O	intracellular	intracellular	JJ	I-NP
O	site	site	NN	I-NP
O	of	of	IN	B-PP
O	action	action	NN	B-NP
O	.	.	.	O

O	Modulation	Modulation	NN	B-NP
O	of	of	IN	B-PP
O	enzyme	enzyme	NN	B-NP
O	activity	activity	NN	I-NP
O	via	via	IN	B-PP
O	the	the	DT	B-NP
O	transmethylation	transmethylation	NN	I-NP
O	pathway	pathway	NN	I-NP
O	could	could	MD	B-VP
O	not	not	RB	I-VP
O	be	be	VB	I-VP
O	implicated	implicate	VBN	I-VP
O	since	since	IN	B-PP
O	incubation	incubation	NN	B-NP
O	of	of	IN	B-PP
O	cardiac	cardiac	JJ	B-NP
O	cells	cell	NNS	I-NP
O	under	under	IN	B-PP
O	conditions	condition	NNS	B-NP
O	known	know	VBN	B-VP
O	to	to	TO	B-VP
O	elevate	elevate	VB	I-VP
O	intracellular	intracellular	JJ	B-NP
O	S	S	NN	I-NP
O	-	-	HYPH	B-NP
O	adenosyl	adenosyl	NN	I-NP
O	-	-	HYPH	B-NP
O	L	L	NN	I-NP
O	-	-	HYPH	O
O	homocysteine	homocysteine	NN	B-NP
O	had	have	VBD	B-VP
O	no	no	DT	B-NP
O	demonstrable	demonstrable	JJ	I-NP
O	effect	effect	NN	I-NP
O	on	on	IN	B-PP
O	AMP	AMP	NN	B-NP
O	deaminase	deaminase	NN	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
O	a	a	DT	B-NP
O	direct	direct	JJ	I-NP
O	allosteric	allosteric	JJ	I-NP
O	effect	effect	NN	I-NP
O	of	of	IN	B-PP
O	adenosine	adenosine	NN	B-NP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	partially	partially	RB	I-NP
O	purified	purify	VBN	I-NP
O	rat	rat	NN	I-NP
O	cardiac	cardiac	JJ	I-NP
O	enzyme	enzyme	NN	I-NP
O	was	be	VBD	B-VP
O	not	not	RB	I-VP
O	observed	observe	VBN	I-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	results	result	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	intracellular	intracellular	JJ	B-NP
O	adenosine	adenosine	NN	I-NP
O	modulates	modulate	VBZ	B-VP
O	rat	rat	NN	B-NP
O	cardiac	cardiac	JJ	I-NP
O	AMP	AMP	NN	I-NP
O	deaminase	deaminase	NN	I-NP
O	by	by	IN	B-PP
O	an	an	DT	B-NP
O	unknown	unknown	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	.	.	.	O

O	Purification	Purification	NN	B-NP
O	and	and	CC	I-NP
O	characterization	characterization	NN	I-NP
O	of	of	IN	B-PP
O	Saccharomyces	Saccharomyces	NNP	B-NP
O	cerevisiae	cerevisiae	NNP	I-NP
B-GGP	DNA	DNA	NN	I-NP
I-GGP	damage	damage	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	responsive	responsive	JJ	I-NP
I-GGP	protein	protein	NN	I-NP
I-GGP	48	48	CD	I-NP
O	(	(	(	O
B-GGP	DDRP	DDRP	NN	B-NP
I-GGP	48	48	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	A	A	DT	B-NP
O	yeast	yeast	NN	I-NP
O	protein	protein	NN	I-NP
O	was	be	VBD	B-VP
O	purified	purify	VBN	I-VP
O	from	from	IN	B-PP
O	wild	wild	JJ	B-NP
O	type	type	NN	I-NP
O	Saccharomyces	Saccharomyces	NNP	I-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	(	(	(	O
O	S	S	NNP	B-NP
O	.	.	.	I-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	)	)	)	O
O	to	to	TO	B-PP
O	near	near	JJ	B-NP
O	homogeneity	homogeneity	NN	I-NP
O	using	use	VBG	B-VP
O	an	an	DT	B-NP
O	ethanolamine	ethanolamine	NN	I-NP
O	affinity	affinity	NN	I-NP
O	chromatography	chromatography	NN	I-NP
O	procedure	procedure	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	O
O	terminal	terminal	JJ	B-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	sequencing	sequencing	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	composition	composition	NN	I-NP
O	analyses	analysis	NNS	I-NP
O	identified	identify	VBD	B-VP
O	this	this	DT	B-NP
O	protein	protein	NN	I-NP
O	as	as	IN	B-PP
O	the	the	DT	B-NP
O	product	product	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	second	second	JJ	I-NP
O	open	open	JJ	I-NP
O	reading	reading	NN	I-NP
O	frame	frame	NN	I-NP
O	of	of	IN	B-PP
O	S	S	NN	B-NP
O	.	.	.	O
O	cerevisiae	cerevisiae	FW	B-NP
B-GGP	DNA	DNA	NN	I-NP
I-GGP	Damage	Damage	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	responsive	responsive	JJ	I-NP
I-GGP	gene	gene	NN	I-NP
I-GGP	48	48	CD	I-NP
O	(	(	(	O
B-GGP	DDR48	DDR48	NN	B-NP
O	)	)	)	O
O	(	(	(	O
O	Treger	Treger	NNP	B-NP
O	,	,	,	O
O	J	J	NNP	B-NP
O	.	.	.	I-NP
O	M	M	NNP	I-NP
O	.	.	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	McEntee	McEntee	NNP	B-NP
O	,	,	,	O
O	K	K	NNP	B-NP
O	.	.	.	O

O	(	(	(	O
O	1990	1990	CD	B-NP
O	)	)	)	O
O	Mol	Mol	NNP	B-NP
O	.	.	.	O

O	Cell	Cell	NN	B-NP
O	.	.	.	O

O	Biol	Biol	NN	B-NP
O	.	.	.	O

O	10	10	CD	B-NP
O	,	,	,	I-NP
O	3174	3174	CD	I-NP
O	-	-	HYPH	I-NP
O	3184	3184	CD	I-NP
O	)	)	)	O
O	The	The	DT	B-NP
O	first	first	JJ	I-NP
O	methionine	methionine	NN	I-NP
O	residue	residue	NN	I-NP
O	encoded	encode	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	translation	translation	NN	I-NP
O	starting	starting	NN	I-NP
O	codon	codon	NN	I-NP
O	was	be	VBD	B-VP
O	not	not	RB	O
O	present	present	JJ	B-ADJP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	mature	mature	JJ	I-NP
O	protein	protein	NN	I-NP
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	designated	designate	VBN	I-VP
O	as	as	IN	B-PP
B-GGP	DDRP	DDRP	NN	B-NP
I-GGP	48	48	CD	I-NP
O	.	.	.	O

B-GGP	DDRP	DDRP	NN	B-NP
I-GGP	48	48	CD	I-NP
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	a	a	DT	B-NP
O	negatively	negatively	RB	I-NP
O	charged	charge	VBN	I-NP
O	and	and	CC	I-NP
O	highly	highly	RB	I-NP
O	hydrophilic	hydrophilic	JJ	I-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	glycosidase	glycosidase	NN	I-NP
O	cleavage	cleavage	NN	I-NP
O	analyses	analysis	NNS	I-NP
O	suggested	suggest	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	DDRP	DDRP	NN	B-NP
I-GGP	48	48	CD	I-NP
O	was	be	VBD	B-VP
O	mainly	mainly	RB	B-ADVP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	link	link	NN	I-NP
O	-	-	HYPH	B-NP
O	glycosylated	glycosylate	VBN	B-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	apparent	apparent	JJ	I-NP
O	molecular	molecular	JJ	I-NP
O	mass	mass	NN	I-NP
O	of	of	IN	B-PP
B-GGP	DDRP	DDRP	NN	B-NP
I-GGP	48	48	CD	I-NP
O	was	be	VBD	B-VP
O	estimated	estimate	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	approximately	approximately	RB	B-NP
O	65	65	CD	I-NP
O	kilodaltons	kilodalton	NNS	I-NP
O	.	.	.	O

B-GGP	DDRP	DDRP	NN	B-NP
I-GGP	48	48	CD	I-NP
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	able	able	JJ	B-ADJP
O	to	to	TO	B-VP
O	hydrolyze	hydrolyze	VB	I-VP
O	ATP	ATP	NN	B-NP
O	and	and	CC	I-NP
O	GTP	GTP	NN	I-NP
O	yielding	yield	VBG	B-VP
O	PPi	PPi	NNP	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	Km	Km	NN	I-NP
O	values	value	NNS	I-NP
O	for	for	IN	B-PP
O	ATP	ATP	NN	B-NP
O	and	and	CC	I-NP
O	GTP	GTP	NN	I-NP
O	are	be	VBP	B-VP
O	0	0	CD	B-NP
O	.	.	.	O
O	29	29	CD	B-NP
O	mM	mM	NN	I-NP
O	and	and	CC	O
O	0	0	CD	B-NP
O	.	.	.	O
O	58	58	CD	B-NP
O	mM	mM	NN	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	The	The	DT	B-NP
O	Western	Western	JJ	I-NP
O	blot	blot	NN	I-NP
O	analysis	analysis	NN	I-NP
O	demonstrated	demonstrate	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	DDRP	DDRP	NN	B-NP
I-GGP	48	48	CD	I-NP
O	was	be	VBD	B-VP
O	expressed	express	VBN	I-VP
O	to	to	TO	B-PP
O	various	various	JJ	B-NP
O	concentrations	concentration	NNS	I-NP
O	in	in	IN	B-PP
O	different	different	JJ	B-NP
O	S	S	NN	I-NP
O	.	.	.	O
O	cerevisiae	cerevisiae	JJ	B-NP
O	strains	strain	NNS	I-NP
O	.	.	.	O

O	Increased	Increase	VBN	B-NP
B-GGP	DDRP	DDRP	NN	I-NP
O	48	48	CD	I-NP
O	abundance	abundance	NN	I-NP
O	was	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	after	after	IN	B-PP
O	yeast	yeast	NN	B-NP
O	cells	cell	NNS	I-NP
O	carrying	carry	VBG	B-VP
O	the	the	DT	B-NP
B-GGP	wild	wild	JJ	I-NP
I-GGP	type	type	NN	I-NP
I-GGP	RAD	RAD	NN	I-NP
I-GGP	52	52	CD	I-NP
I-GGP	gene	gene	NN	I-NP
O	were	be	VBD	B-VP
O	exposed	expose	VBN	I-VP
O	to	to	TO	B-PP
O	either	either	CC	O
O	ethylmethane	ethylmethane	NN	B-NP
O	sulfonate	sulfonate	NN	I-NP
O	or	or	CC	O
O	heat	heat	NN	B-NP
O	shock	shock	NN	I-NP
O	treatments	treatment	NNS	I-NP
O	.	.	.	O

O	After	After	IN	B-PP
O	similar	similar	JJ	B-NP
O	DNA	DNA	NN	I-NP
O	-	-	HYPH	B-NP
O	damaging	damage	VBG	I-NP
O	treatments	treatment	NNS	I-NP
O	,	,	,	O
O	however	however	RB	B-ADVP
O	,	,	,	O
O	no	no	DT	B-NP
O	significant	significant	JJ	I-NP
O	inductions	induction	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	DDRP	DDRP	NN	B-NP
I-GGP	48	48	CD	I-NP
O	were	be	VBD	B-VP
O	found	find	VBN	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	rad	rad	NN	I-NP
O	52	52	CD	I-NP
O	mutant	mutant	JJ	I-NP
O	strain	strain	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	observations	observation	NNS	I-NP
O	are	be	VBP	B-VP
O	consistent	consistent	JJ	B-ADJP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	predictions	prediction	NNS	I-NP
O	resulting	result	VBG	B-VP
O	from	from	IN	B-PP
O	previous	previous	JJ	B-NP
O	studies	study	NNS	I-NP
O	on	on	IN	B-PP
O	transcriptional	transcriptional	JJ	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
B-GGP	DDR	DDR	NN	I-NP
I-GGP	48	48	CD	I-NP
O	gene	gene	NN	I-NP
O	(	(	(	O
O	Maga	Maga	NNP	B-NP
O	,	,	,	O
O	J	J	NNP	B-NP
O	.	.	.	I-NP
O	A	A	NNP	I-NP
O	.	.	.	O
O	,	,	,	O
O	McClanahan	McClanahan	NNP	B-NP
O	,	,	,	O
O	T	T	NN	B-NP
O	.	.	VBD	B-VP
O	A	A	NNP	B-NP
O	.	.	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	McEntee	McEntee	NNP	B-NP
O	,	,	,	O
O	K	K	NNP	B-NP
O	.	.	.	O

O	(	(	(	O
O	1986	1986	CD	B-NP
O	)	)	)	O
O	Mol	Mol	NNP	B-NP
O	.	.	.	O

O	&	&	CC	B-NP
O	Gen	Gen	NNP	I-NP
O	.	.	.	O

O	Genet	Genet	NNP	B-NP
O	.	.	.	O

O	205	205	CD	B-NP
O	,	,	,	I-NP
O	276	276	CD	I-NP
O	-	-	HYPH	B-NP
O	284	284	CD	I-NP
O	;	;	:	O
O	McClanahan	McClanahan	NNP	B-NP
O	,	,	,	O
O	T	T	NN	B-NP
O	.	.	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	McEntee	McEntee	NNP	B-NP
O	,	,	,	O
O	K	K	NNP	B-NP
O	.	.	.	O

O	(	(	(	O
O	1986	1986	CD	B-NP
O	)	)	)	O
O	Mol	Mol	NNP	B-NP
O	.	.	.	O

O	Cell	Cell	NN	B-NP
O	.	.	.	O

O	Biol	Biol	NN	B-NP
O	.	.	.	O

O	6	6	CD	B-NP
O	,	,	,	I-NP
O	90	90	CD	I-NP
O	-	-	HYPH	I-NP
O	96	96	CD	I-NP
O	)	)	)	O
O	.	.	.	O

O	Control	Control	NN	B-NP
O	of	of	IN	B-PP
O	IgG	IgG	NN	B-NP
O	/	/	SYM	B-NP
B-GGP	Fc	Fc	NN	I-NP
O	glycosylation	glycosylation	NN	I-NP
O	:	:	:	O
O	a	a	DT	B-NP
O	comparison	comparison	NN	I-NP
O	of	of	IN	B-PP
O	oligosaccharides	oligosaccharide	NNS	B-NP
O	from	from	IN	B-PP
O	chimeric	chimeric	JJ	B-NP
O	human	human	JJ	I-NP
O	/	/	SYM	I-NP
O	mouse	mouse	NN	B-NP
O	and	and	CC	O
O	mouse	mouse	NN	B-NP
O	subclass	subclass	NN	I-NP
O	immunoglobulin	immunoglobulin	NN	I-NP
O	Gs	Gs	NN	I-NP
O	.	.	.	O

O	Oligosaccharide	Oligosaccharide	NN	B-NP
O	profiles	profile	NNS	I-NP
O	were	be	VBD	B-VP
O	obtained	obtain	VBN	I-VP
O	for	for	IN	B-PP
O	chimeric	chimeric	JJ	B-NP
O	mouse	mouse	NN	I-NP
O	-	-	HYPH	B-NP
O	human	human	JJ	I-NP
O	antibodies	antibody	NNS	I-NP
O	corresponding	correspond	VBG	B-VP
O	to	to	TO	B-PP
O	each	each	DT	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	human	human	JJ	I-NP
O	IgG	IgG	NN	I-NP
O	subclasses	subclass	NNS	I-NP
O	1	1	CD	I-NP
O	-	-	HYPH	I-NP
O	4	4	CD	I-NP
O	,	,	,	O
O	and	and	CC	O
O	mouse	mouse	NN	B-NP
O	IgG2b	IgG2b	NN	I-NP
O	antibodies	antibody	NNS	I-NP
O	each	each	DT	B-NP
O	expressed	express	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	mouse	mouse	NN	I-NP
O	J558L	J558L	NN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	antibodies	antibody	NNS	I-NP
O	have	have	VBP	B-VP
O	specificity	specificity	NN	B-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	NIP	NIP	NN	I-NP
O	hapten	hapten	VB	B-VP
O	and	and	CC	I-VP
O	form	form	VB	I-VP
O	a	a	DT	B-NP
O	matched	matched	JJ	I-NP
O	set	set	NN	I-NP
O	of	of	IN	B-PP
O	IgGs	IgG	NNS	B-NP
O	.	.	.	O

O	An	An	DT	B-NP
O	IgG4	IgG4	NN	I-NP
O	chimeric	chimeric	JJ	I-NP
O	antibody	antibody	NN	I-NP
O	(	(	(	O
O	B72	B72	NN	B-NP
O	.	.	.	I-NP
O	3	3	CD	I-NP
O	)	)	)	O
O	produced	produce	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	chinese	chinese	JJ	I-NP
O	hamster	hamster	NN	I-NP
O	ovary	ovary	NN	I-NP
O	(	(	(	O
O	CHO	CHO	NN	B-NP
O	-	-	HYPH	B-NP
O	K1	K1	NN	I-NP
O	)	)	)	O
O	cell	cell	NN	B-NP
O	line	line	NN	I-NP
O	was	be	VBD	B-VP
O	also	also	RB	I-VP
O	analysed	analyse	VBN	I-VP
O	for	for	IN	B-PP
O	carbohydrate	carbohydrate	NN	B-NP
O	.	.	.	O

O	Additionally	Additionally	RB	B-NP
O	aglycosylated	aglycosylate	VBN	I-NP
O	mutants	mutant	NNS	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	IgG4	IgG4	NN	I-NP
O	(	(	(	O
O	B72	B72	NN	B-NP
O	.	.	.	I-NP
O	3	3	CD	I-NP
O	)	)	)	O
O	and	and	CC	O
O	anti	anti	AFX	B-NP
O	-	-	HYPH	I-NP
O	NIP	NIP	NN	I-NP
O	mouse	mouse	NN	I-NP
O	IgG2b	IgG2b	NN	I-NP
O	were	be	VBD	B-VP
O	analysed	analyse	VBN	I-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	total	total	JJ	I-NP
O	lack	lack	NN	I-NP
O	of	of	IN	B-PP
O	carbohydrate	carbohydrate	NN	B-NP
O	found	find	VBN	B-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	aglycosylated	aglycosylate	VBN	I-NP
O	site	site	NN	I-NP
O	-	-	HYPH	B-NP
O	directed	direct	VBN	I-NP
O	mutants	mutant	NNS	I-NP
O	human	human	JJ	I-NP
O	chimeric	chimeric	JJ	I-NP
O	IgG4	IgG4	NN	I-NP
O	B72	B72	NN	I-NP
O	.	.	.	O
O	3	3	CD	B-NP
O	(	(	(	O
O	Asn	Asn	NN	B-NP
O	297	297	CD	I-NP
O	-	-	HYPH	B-NP
O	-	-	HYPH	I-NP
O	>	>	SYM	I-NP
O	Gln	Gln	NN	I-NP
O	)	)	)	O
O	and	and	CC	O
O	mouse	mouse	NN	B-NP
O	IgG2b	IgG2b	NN	I-NP
O	(	(	(	O
O	Asn	Asn	NN	B-NP
O	297	297	CD	I-NP
O	-	-	HYPH	B-NP
O	-	-	HYPH	I-NP
O	>	>	SYM	I-NP
O	Ala	Ala	NN	I-NP
O	)	)	)	O
O	demonstrates	demonstrate	VBZ	B-VP
O	that	that	IN	B-SBAR
O	there	there	EX	B-NP
O	are	be	VBP	B-VP
O	no	no	DT	B-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	sites	site	NNS	I-NP
O	other	other	JJ	B-ADJP
O	than	than	IN	B-PP
O	Asn	Asn	NN	B-NP
O	297	297	CD	I-NP
O	.	.	.	O

O	Therefore	Therefore	RB	B-ADVP
O	glycosylation	glycosylation	NN	B-NP
O	profiles	profile	NNS	I-NP
O	for	for	IN	B-PP
O	all	all	PDT	B-NP
O	the	the	DT	I-NP
O	IgGs	IgG	NNS	I-NP
O	analysed	analyse	VBN	B-VP
O	reflect	reflect	VBP	B-VP
O	carbohydrate	carbohydrate	NN	B-NP
O	attached	attach	VBN	B-VP
O	to	to	TO	B-PP
O	this	this	DT	B-NP
O	site	site	NN	I-NP
O	.	.	.	O

O	Factors	Factor	NNS	B-NP
O	such	such	JJ	B-PP
O	as	as	IN	I-PP
O	cell	cell	NN	B-NP
O	type	type	NN	I-NP
O	(	(	(	O
O	A	A	NN	B-NP
O	)	)	)	O
O	,	,	,	O
O	template	template	JJ	B-NP
O	direction	direction	NN	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	IgG	IgG	NN	I-NP
O	heavy	heavy	JJ	I-NP
O	chains	chain	NNS	I-NP
O	(	(	(	O
O	B	B	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	culture	culture	NN	B-NP
O	conditions	condition	NNS	I-NP
O	(	(	(	O
O	C	C	NN	B-NP
O	)	)	)	O
O	are	be	VBP	B-VP
O	shown	show	VBN	I-VP
O	to	to	TO	I-VP
O	influence	influence	VB	I-VP
O	IgG	IgG	NN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	profiles	profile	NNS	I-NP
O	.	.	.	O

O	(	(	(	O
O	A	A	DT	B-NP
O	)	)	)	O
O	The	The	DT	B-NP
O	anti	anti	AFX	I-NP
O	-	-	HYPH	I-NP
O	NIP	NIP	NN	I-NP
O	IgG	IgG	NN	I-NP
O	antibodies	antibody	NNS	I-NP
O	expressed	express	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	J558L	J558L	NN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	may	may	MD	B-VP
O	have	have	VB	I-VP
O	one	one	CD	B-NP
O	or	or	CC	I-NP
O	two	two	CD	I-NP
O	Gal	Gal	JJ	I-NP
O	(	(	(	O
O	alpha	alpha	SYM	B-NP
O	1	1	CD	I-NP
O	-	-	SYM	O
O	-	-	HYPH	O
O	>	>	SYM	B-NP
O	3	3	CD	I-NP
O	)	)	)	O
O	Gal	Gal	JJ	B-NP
O	residues	residue	NNS	I-NP
O	per	per	IN	B-PP
O	oligosaccharide	oligosaccharide	NN	B-NP
O	unit	unit	NN	I-NP
O	,	,	,	O
O	indicative	indicative	JJ	B-ADJP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	(	(	(	O
O	alpha	alpha	SYM	O
O	1	1	CD	O
O	-	-	SYM	O
O	-	-	HYPH	O
O	>	>	SYM	O
O	3	3	CD	O
O	)	)	)	O
O	galactosyl	galactosyl	NN	B-NP
O	transferase	transferase	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	J558L	J558L	NN	I-NP
O	mouse	mouse	NN	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	.	.	.	O

O	(	(	(	O
O	B	B	NN	B-NP
O	)	)	)	O
O	The	The	DT	B-NP
O	galactosylation	galactosylation	NN	I-NP
O	profiles	profile	NNS	I-NP
O	obtained	obtain	VBN	B-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	IgG	IgG	NN	I-NP
O	heavy	heavy	JJ	I-NP
O	chains	chain	NNS	I-NP
O	,	,	,	O
O	in	in	IN	B-PP
O	particular	particular	JJ	B-ADJP
O	the	the	DT	B-NP
O	preference	preference	NN	I-NP
O	for	for	IN	B-PP
O	galactosylation	galactosylation	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Man	Man	NN	I-NP
O	(	(	(	O
O	alpha	alpha	SYM	B-NP
O	1	1	CD	I-NP
O	-	-	SYM	O
O	-	-	HYPH	O
O	>	>	SYM	O
O	6	6	CD	O
O	)	)	)	O
O	arm	arm	NN	B-NP
O	rather	rather	RB	B-CONJP
O	than	than	IN	I-CONJP
O	the	the	DT	B-NP
O	Man	Man	NN	I-NP
O	(	(	(	O
O	alpha	alpha	SYM	B-NP
O	1	1	CD	I-NP
O	-	-	SYM	O
O	-	-	HYPH	O
O	>	>	SYM	O
O	3	3	CD	O
O	)	)	)	O
O	arm	arm	NN	B-NP
O	,	,	,	O
O	contrary	contrary	JJ	B-ADJP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	beta	beta	SYM	I-NP
O	-	-	HYPH	I-NP
O	galactosyltransferase	galactosyltransferase	NN	I-NP
O	specificity	specificity	NN	I-NP
O	,	,	,	O
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	polypeptide	polypeptide	NN	I-NP
O	chain	chain	NN	I-NP
O	may	may	MD	B-VP
O	act	act	VB	I-VP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	template	template	NN	I-NP
O	to	to	TO	B-VP
O	influence	influence	VB	I-VP
O	the	the	DT	B-NP
O	extent	extent	NN	I-NP
O	of	of	IN	B-PP
O	galactosylation	galactosylation	NN	B-NP
O	and	and	CC	O
O	hence	hence	RB	B-ADVP
O	the	the	DT	B-NP
O	proportions	proportion	NNS	I-NP
O	of	of	IN	B-PP
O	each	each	DT	B-NP
O	oligosaccharide	oligosaccharide	NN	I-NP
O	incorporated	incorporate	VBN	B-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	IgG2	IgG2	NN	I-NP
O	antibody	antibody	NN	I-NP
O	does	do	VBZ	B-VP
O	not	not	RB	I-VP
O	display	display	VB	I-VP
O	this	this	DT	B-NP
O	galactosylation	galactosylation	NN	I-NP
O	preference	preference	NN	I-NP
O	.	.	.	O

O	(	(	(	O
O	C	C	NN	B-NP
O	)	)	)	O
O	The	The	DT	B-NP
O	extent	extent	NN	I-NP
O	of	of	IN	B-PP
O	galactosylation	galactosylation	NN	B-NP
O	appears	appear	VBZ	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	influenced	influence	VBN	I-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	growth	growth	NN	I-NP
O	conditions	condition	NNS	I-NP
O	,	,	,	O
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	highest	high	JJS	I-NP
O	levels	level	NNS	I-NP
O	of	of	IN	B-PP
O	galactosylation	galactosylation	NN	B-NP
O	being	be	VBG	B-VP
O	found	find	VBN	I-VP
O	for	for	IN	B-PP
O	IgG	IgG	NN	B-NP
O	produced	produce	VBN	B-VP
O	by	by	IN	B-PP
O	cells	cell	NNS	B-NP
O	grown	grow	VBN	B-VP
O	in	in	IN	B-PP
O	still	still	RB	B-NP
O	cultures	culture	NNS	I-NP
O	,	,	,	O
O	rather	rather	RB	B-CONJP
O	than	than	IN	I-CONJP
O	cells	cell	NNS	B-NP
O	grown	grow	VBN	B-VP
O	as	as	IN	B-PP
O	ascites	ascite	NNS	B-NP
O	or	or	CC	B-PP
O	in	in	IN	B-PP
O	hollow	hollow	JJ	B-NP
O	fibre	fibre	NN	I-NP
O	bioreactors	bioreactor	NNS	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	is	be	VBZ	B-VP
O	concluded	conclude	VBN	I-VP
O	that	that	IN	B-SBAR
O	though	though	IN	B-SBAR
O	the	the	DT	B-NP
O	profile	profile	NN	I-NP
O	of	of	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	is	be	VBZ	B-VP
O	controlled	control	VBN	I-VP
O	predominantly	predominantly	RB	B-ADVP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cell	cell	NN	I-NP
O	in	in	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
O	IgG	IgG	NN	I-NP
O	is	be	VBZ	B-VP
O	expressed	express	VBN	I-VP
O	,	,	,	O
O	differences	difference	NNS	B-NP
O	between	between	IN	B-PP
O	the	the	DT	B-NP
O	IgG	IgG	NN	I-NP
O	heavy	heavy	JJ	I-NP
O	chain	chain	NN	I-NP
O	templates	template	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	various	various	JJ	I-NP
O	subclasses	subclass	NNS	I-NP
O	and	and	CC	I-NP
O	culture	culture	NN	I-NP
O	conditions	condition	NNS	I-NP
O	can	can	MD	B-VP
O	also	also	RB	I-VP
O	influence	influence	VB	I-VP
O	glycosylation	glycosylation	NN	B-NP
O	.	.	.	O

O	Regulation	Regulation	NN	B-NP
O	of	of	IN	B-PP
B-GGP	CD44	CD44	NN	B-NP
O	binding	binding	NN	I-NP
O	to	to	TO	B-PP
O	hyaluronan	hyaluronan	NN	B-NP
O	by	by	IN	B-PP
O	glycosylation	glycosylation	NN	B-NP
O	of	of	IN	B-PP
O	variably	variably	RB	B-NP
O	spliced	splice	VBN	I-NP
O	exons	exon	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	hyaluronan	hyaluronan	NN	I-NP
O	(	(	(	O
O	HA	HA	NN	B-NP
O	)	)	)	O
O	-	-	HYPH	B-NP
O	binding	bind	VBG	B-VP
O	function	function	NN	B-NP
O	(	(	(	O
O	lectin	lectin	NN	B-NP
O	function	function	NN	I-NP
O	)	)	)	O
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	leukocyte	leukocyte	NN	I-NP
O	homing	home	VBG	B-VP
O	receptor	receptor	NN	B-NP
O	,	,	,	O
B-GGP	CD44	CD44	NN	B-NP
O	,	,	,	O
O	is	be	VBZ	B-VP
O	tightly	tightly	RB	I-VP
O	regulated	regulate	VBN	I-VP
O	.	.	.	O

O	Herein	Herein	RB	B-ADVP
O	we	we	PRP	B-NP
O	address	address	VBP	B-VP
O	possible	possible	JJ	B-NP
O	mechanisms	mechanism	NNS	I-NP
O	that	that	WDT	B-NP
O	regulate	regulate	VBP	B-VP
B-GGP	CD44	CD44	NN	B-NP
O	isoform	isoform	NN	I-NP
O	-	-	HYPH	B-NP
O	specific	specific	JJ	I-NP
O	HA	HA	NN	I-NP
O	binding	binding	NN	I-NP
O	.	.	.	O

O	Binding	Binding	NN	B-NP
O	studies	study	NNS	I-NP
O	with	with	IN	B-PP
O	melanoma	melanoma	NN	B-NP
O	transfectants	transfectant	NNS	I-NP
O	expressing	express	VBG	B-VP
B-GGP	CD44H	CD44H	NN	B-NP
O	,	,	,	O
B-GGP	CD44E	CD44E	NN	B-NP
O	,	,	,	O
O	or	or	CC	O
O	with	with	IN	B-PP
O	soluble	soluble	JJ	B-NP
O	immunoglobulin	immunoglobulin	NN	I-NP
O	fusions	fusion	NNS	I-NP
O	of	of	IN	B-PP
B-GGP	CD44H	CD44H	NN	B-NP
O	and	and	CC	I-NP
B-GGP	CD44E	CD44E	NN	I-NP
O	(	(	(	O
B-GGP	CD44H	CD44H	NN	B-NP
O	-	-	HYPH	B-NP
O	Rg	Rg	NN	I-NP
O	,	,	,	O
B-GGP	CD44E	CD44E	NN	B-NP
O	-	-	HYPH	I-NP
O	Rg	Rg	NN	I-NP
O	)	)	)	O
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	although	although	IN	B-SBAR
O	both	both	DT	B-NP
B-GGP	CD44	CD44	NN	I-NP
O	isoforms	isoform	NNS	I-NP
O	can	can	MD	B-VP
O	bind	bind	VB	I-VP
O	HA	HA	NN	B-NP
O	,	,	,	O
B-GGP	CD44H	CD44H	NN	B-NP
O	binds	bind	VBZ	B-VP
O	HA	HA	NN	B-NP
O	more	more	RBR	B-ADVP
O	efficiently	efficiently	RB	I-ADVP
O	than	than	IN	B-PP
B-GGP	CD44E	CD44E	NN	B-NP
O	.	.	.	O

O	Using	Use	VBG	B-VP
B-GGP	CD44	CD44	NN	B-NP
O	-	-	HYPH	I-NP
O	Rg	Rg	NN	I-NP
O	fusion	fusion	NN	I-NP
O	proteins	protein	NNS	I-NP
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	variably	variably	RB	I-NP
O	spliced	splice	VBN	I-NP
O	exons	exon	NNS	I-NP
O	in	in	IN	B-PP
B-GGP	CD44E	CD44E	NN	B-NP
O	,	,	,	O
O	V8	V8	NN	B-NP
O	-	-	HYPH	B-NP
O	V10	V10	NN	I-NP
O	,	,	,	O
O	specifically	specifically	RB	B-VP
O	reduce	reduce	VB	I-VP
O	the	the	DT	B-NP
O	lectin	lectin	NN	I-NP
O	function	function	NN	I-NP
O	of	of	IN	B-PP
B-GGP	CD44	CD44	NN	B-NP
O	,	,	,	O
O	while	while	IN	B-SBAR
O	replacement	replacement	NN	B-NP
O	of	of	IN	B-PP
O	V8	V8	NN	B-NP
O	-	-	HYPH	O
O	V10	V10	NN	B-NP
O	by	by	IN	B-PP
O	an	an	DT	B-NP
B-GGP	ICAM	ICAM	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	immunoglobulin	immunoglobulin	NN	I-NP
O	domain	domain	NN	I-NP
O	restores	restore	VBZ	B-VP
O	binding	bind	VBG	I-VP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	level	level	NN	I-NP
O	comparable	comparable	JJ	B-ADJP
O	to	to	TO	B-PP
O	that	that	DT	B-NP
O	of	of	IN	B-PP
B-GGP	CD44H	CD44H	NN	B-NP
O	.	.	.	O

O	Conversely	Conversely	RB	B-ADVP
O	,	,	,	O
B-GGP	CD44	CD44	NN	B-NP
O	bound	bind	VBD	B-VP
O	HA	HA	NN	B-NP
O	very	very	RB	B-ADVP
O	weakly	weakly	RB	I-ADVP
O	when	when	WRB	B-ADVP
O	exons	exon	NNS	B-NP
O	V8	V8	NN	I-NP
O	-	-	HYPH	B-NP
O	V10	V10	NN	I-NP
O	were	be	VBD	B-VP
O	replaced	replace	VBN	I-VP
O	with	with	IN	B-PP
O	a	a	DT	B-NP
B-GGP	CD34	CD34	NN	I-NP
O	mucin	mucin	NN	I-NP
O	domain	domain	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	is	be	VBZ	B-VP
O	heavily	heavily	RB	I-VP
O	modified	modify	VBN	I-VP
O	by	by	IN	B-PP
O	O	O	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	glycans	glycan	NNS	I-NP
O	.	.	.	O

O	Production	Production	NN	B-NP
O	of	of	IN	B-PP
B-GGP	CD44E	CD44E	NN	B-NP
O	-	-	HYPH	B-NP
O	Rg	Rg	NN	I-NP
O	or	or	CC	I-NP
O	incubation	incubation	NN	I-NP
O	of	of	IN	B-PP
B-GGP	CD44E	CD44E	NN	B-NP
O	-	-	HYPH	O
O	expressing	express	VBG	B-VP
O	transfectants	transfectant	NNS	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	an	an	DT	B-NP
O	O	O	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	inhibitor	inhibitor	NN	I-NP
O	restored	restore	VBD	B-VP
O	HA	HA	NN	B-NP
O	binding	binding	NN	I-NP
O	to	to	TO	B-PP
B-GGP	CD44H	CD44H	NN	B-NP
O	-	-	HYPH	O
O	Rg	Rg	NN	B-NP
O	and	and	CC	B-PP
O	to	to	TO	B-PP
O	cell	cell	NN	B-NP
O	surface	surface	NN	I-NP
O	CD44H	CD44H	NN	I-NP
O	levels	level	NNS	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	.	.	.	O

O	We	We	PRP	B-NP
O	conclude	conclude	VBP	B-VP
O	that	that	IN	B-SBAR
O	differential	differential	JJ	B-NP
O	splicing	splicing	NN	I-NP
O	provides	provide	VBZ	B-VP
O	a	a	DT	B-NP
O	regulatory	regulatory	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	for	for	IN	B-PP
B-GGP	CD44	CD44	NN	B-NP
O	lectin	lectin	NN	I-NP
O	function	function	NN	I-NP
O	and	and	CC	O
O	that	that	IN	B-SBAR
O	this	this	DT	B-NP
O	effect	effect	NN	I-NP
O	is	be	VBZ	B-VP
O	due	due	JJ	B-ADJP
O	in	in	IN	B-PP
O	part	part	NN	B-NP
O	to	to	TO	B-PP
O	O	O	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-NP
O	carbohydrate	carbohydrate	NN	I-NP
O	moieties	moiety	NNS	I-NP
O	which	which	WDT	B-NP
O	are	be	VBP	B-VP
O	added	add	VBN	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	Ser	Ser	NN	I-NP
O	/	/	SYM	B-NP
O	Thr	Thr	NN	I-NP
O	rich	rich	JJ	I-NP
O	regions	region	NNS	I-NP
O	encoded	encode	VBN	B-VP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	variably	variably	RB	I-NP
O	spliced	splice	VBN	I-NP
B-GGP	CD44	CD44	NN	I-NP
O	exons	exon	NNS	I-NP
O	.	.	.	O

O	Alternative	Alternative	JJ	B-NP
O	splicing	splicing	NN	I-NP
O	resulting	result	VBG	B-VP
O	in	in	IN	B-PP
O	changes	change	NNS	B-NP
O	in	in	IN	B-PP
O	protein	protein	NN	B-NP
O	glycosylation	glycosylation	NN	I-NP
O	provide	provide	VBP	B-VP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	mechanism	mechanism	NN	I-NP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	regulation	regulation	NN	I-NP
O	of	of	IN	B-PP
O	lectin	lectin	NN	B-NP
O	activity	activity	NN	I-NP
O	.	.	.	O

O	Recombinant	Recombinant	JJ	B-NP
O	fish	fish	NN	I-NP
B-GGP	neurotrophin	neurotrophin	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	6	6	CD	I-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	heparin	heparin	NN	I-NP
O	-	-	HYPH	O
O	binding	bind	VBG	B-NP
O	glycoprotein	glycoprotein	NN	I-NP
O	:	:	:	O
O	implications	implication	NNS	B-NP
O	for	for	IN	B-PP
O	a	a	DT	B-NP
O	role	role	NN	I-NP
O	in	in	IN	B-PP
O	axonal	axonal	JJ	B-NP
O	guidance	guidance	NN	I-NP
O	.	.	.	O

B-GGP	Neurotrophin	Neurotrophin	NN	B-NP
I-GGP	-	-	HYPH	I-NP
I-GGP	6	6	CD	I-NP
O	(	(	(	O
B-GGP	NT	NT	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	6	6	CD	I-NP
O	)	)	)	O
O	was	be	VBD	B-VP
O	identified	identify	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	teleost	teleost	NN	I-NP
O	fish	fish	NN	I-NP
O	Xiphophorus	Xiphophorus	NN	I-NP
O	as	as	IN	B-PP
O	a	a	DT	B-NP
O	new	new	JJ	I-NP
O	member	member	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	neurotrophin	neurotrophin	NN	I-NP
O	gene	gene	NN	I-NP
O	family	family	NN	I-NP
O	.	.	.	O

B-GGP	NT	NT	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	6	6	CD	B-NP
O	binds	bind	VBZ	B-VP
O	specifically	specifically	RB	B-ADVP
O	the	the	DT	B-NP
O	glycosaminoglycan	glycosaminoglycan	NN	I-NP
O	heparin	heparin	NN	I-NP
O	.	.	.	O

O	In	In	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
B-GGP	NT	NT	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	6	6	CD	I-NP
O	was	be	VBD	B-VP
O	expressed	express	VBN	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	stably	stably	RB	I-NP
O	transfected	transfecte	VBN	I-NP
O	mammalian	mammalian	JJ	I-NP
O	cell	cell	NN	I-NP
O	line	line	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
O	in	in	IN	B-PP
O	insect	insect	NN	B-NP
O	cells	cell	NNS	I-NP
O	via	via	IN	B-PP
O	a	a	DT	B-NP
O	recombinant	recombinant	JJ	I-NP
O	baculovirus	baculovirus	NN	I-NP
O	.	.	.	O

O	It	It	PRP	B-NP
O	was	be	VBD	B-VP
O	purified	purify	VBN	I-VP
O	to	to	TO	B-PP
O	homogeneity	homogeneity	NN	B-NP
O	and	and	CC	O
O	characterized	characterize	VBN	B-VP
O	by	by	IN	B-PP
O	MS	MS	NN	B-NP
O	and	and	CC	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	sequencing	sequencing	NN	I-NP
O	.	.	.	O

B-GGP	NT	NT	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	6	6	CD	B-NP
O	from	from	IN	B-PP
O	both	both	DT	B-NP
O	expression	expression	NN	I-NP
O	systems	system	NNS	I-NP
O	was	be	VBD	B-VP
O	proteolytically	proteolytically	RB	I-VP
O	processed	process	VBN	I-VP
O	at	at	IN	B-PP
O	one	one	CD	B-NP
O	of	of	IN	B-PP
O	two	two	CD	B-NP
O	protease	protease	NN	I-NP
O	cleavage	cleavage	NN	I-NP
O	motifs	motif	NNS	I-NP
O	and	and	CC	O
O	was	be	VBD	B-VP
O	found	find	VBN	I-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	glycosylated	glycosylate	VBN	I-VP
O	.	.	.	O

O	It	It	PRP	B-NP
O	supported	support	VBD	B-VP
O	the	the	DT	B-NP
O	survival	survival	NN	I-NP
O	of	of	IN	B-PP
O	embryonic	embryonic	JJ	B-NP
O	chick	chick	NN	I-NP
O	sensory	sensory	JJ	I-NP
O	neurons	neuron	NNS	I-NP
O	;	;	:	O
O	half	half	RB	B-NP
O	-	-	HYPH	I-NP
O	maximal	maximal	JJ	I-NP
O	survival	survival	NN	I-NP
O	was	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	at	at	IN	B-PP
O	100	100	CD	B-NP
O	ng	ng	NN	I-NP
O	/	/	SYM	B-NP
O	ml	ml	NN	I-NP
O	.	.	.	O

O	Furthermore	Furthermore	RB	B-ADVP
O	,	,	,	O
B-GGP	NT	NT	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	6	6	CD	B-NP
O	elicited	elicit	VBD	B-VP
O	neurite	neurite	NN	B-NP
O	outgrowth	outgrowth	NN	I-NP
O	in	in	IN	B-PP
O	explanted	explante	VBN	B-NP
O	embryonic	embryonic	JJ	I-NP
O	dorsal	dorsal	JJ	I-NP
O	root	root	NN	I-NP
O	ganglia	ganglia	NNS	I-NP
O	.	.	.	O

O	Addition	Addition	NN	B-NP
O	of	of	IN	B-PP
O	heparin	heparin	NN	B-NP
O	into	into	IN	B-PP
O	the	the	DT	B-NP
O	medium	medium	NN	I-NP
O	did	do	VBD	B-VP
O	not	not	RB	I-VP
O	potentiate	potentiate	VB	I-VP
O	the	the	DT	B-NP
O	activity	activity	NN	I-NP
O	of	of	IN	B-PP
B-GGP	NT	NT	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	6	6	CD	I-NP
O	in	in	IN	B-PP
O	survival	survival	NN	B-NP
O	assays	assay	NNS	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	when	when	WRB	B-ADVP
O	a	a	DT	B-NP
O	sensory	sensory	JJ	I-NP
O	ganglion	ganglion	NN	I-NP
O	explant	explant	NN	I-NP
O	was	be	VBD	B-VP
O	cultured	culture	VBN	I-VP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	collagen	collagen	NN	I-NP
O	gel	gel	NN	I-NP
O	matrix	matrix	NN	I-NP
O	assay	assay	NN	I-NP
O	adjacent	adjacent	JJ	B-ADJP
O	to	to	TO	B-PP
O	a	a	DT	B-NP
O	heparin	heparin	NN	I-NP
O	bead	bead	NN	I-NP
O	coated	coat	VBN	B-VP
O	with	with	IN	B-PP
B-GGP	NT	NT	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	6	6	CD	B-NP
O	,	,	,	O
O	neurite	neurite	NN	B-NP
O	outgrowth	outgrowth	NN	I-NP
O	directed	direct	VBN	B-VP
O	towards	towards	IN	B-PP
O	the	the	DT	B-NP
O	bead	bead	NN	I-NP
O	was	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	.	.	.	O

O	This	This	DT	B-NP
O	indicated	indicate	VBD	B-VP
O	that	that	IN	B-SBAR
B-GGP	NT	NT	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	6	6	CD	I-NP
O	was	be	VBD	B-VP
O	slowly	slowly	RB	I-VP
O	released	release	VBN	I-VP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	heparin	heparin	NN	I-NP
O	bead	bead	NN	I-NP
O	generating	generate	VBG	B-VP
O	a	a	DT	B-NP
O	concentration	concentration	NN	I-NP
O	gradient	gradient	NN	I-NP
O	of	of	IN	B-PP
B-GGP	NT	NT	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	6	6	CD	I-NP
O	instrumental	instrumental	JJ	I-NP
O	for	for	IN	B-PP
O	axonal	axonal	JJ	B-NP
O	guidance	guidance	NN	I-NP
O	in	in	FW	B-ADVP
O	vitro	vitro	FW	I-ADVP
O	.	.	.	O

O	Thus	Thus	RB	B-ADVP
O	the	the	DT	B-NP
O	interaction	interaction	NN	I-NP
O	of	of	IN	B-PP
B-GGP	NT	NT	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	6	6	CD	B-NP
O	with	with	IN	B-PP
O	heparin	heparin	NN	B-NP
O	might	might	MD	B-VP
O	not	not	RB	I-VP
O	be	be	VB	I-VP
O	required	require	VBN	I-VP
O	for	for	IN	B-PP
O	the	the	DT	B-NP
O	activation	activation	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	cellular	cellular	JJ	I-NP
O	receptor	receptor	NN	I-NP
O	for	for	IN	B-PP
B-GGP	NT	NT	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	6	6	CD	I-NP
O	on	on	IN	B-PP
O	responsive	responsive	JJ	B-NP
O	cells	cell	NNS	I-NP
O	but	but	CC	O
O	rather	rather	RB	B-VP
O	may	may	MD	I-VP
O	serve	serve	VB	I-VP
O	to	to	TO	B-PP
O	control	control	NN	B-NP
O	,	,	,	O
O	in	in	FW	B-ADVP
O	vivo	vivo	FW	I-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	distribution	distribution	NN	I-NP
O	of	of	IN	B-PP
B-GGP	NT	NT	NN	B-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	6	6	CD	I-NP
O	.	.	.	O

O	Study	Study	NN	B-NP
O	of	of	IN	B-PP
O	biochemical	biochemical	JJ	B-NP
O	substrate	substrate	NN	I-NP
O	and	and	CC	I-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	metalloproteinases	metalloproteinas	NNS	B-NP
O	in	in	IN	B-PP
O	fascia	fascia	NN	B-NP
O	transversalis	transversalis	NN	I-NP
O	from	from	IN	B-PP
O	hernial	hernial	JJ	B-NP
O	processes	process	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	aim	aim	NN	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	study	study	NN	I-NP
O	was	be	VBD	B-VP
O	to	to	TO	B-VP
O	examine	examine	VB	I-VP
O	the	the	DT	B-NP
O	fascia	fascia	NN	I-NP
O	transversalis	transversalis	NN	I-NP
O	(	(	(	O
O	FT	FT	NN	B-NP
O	)	)	)	O
O	from	from	IN	B-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
O	direct	direct	JJ	B-NP
O	and	and	CC	I-NP
O	indirect	indirect	JJ	I-NP
O	hernia	hernia	NN	I-NP
O	in	in	IN	B-PP
O	an	an	DT	B-NP
O	attempt	attempt	NN	I-NP
O	to	to	TO	B-VP
O	identify	identify	VB	I-VP
O	possible	possible	JJ	B-NP
O	differences	difference	NNS	I-NP
O	between	between	IN	B-PP
O	each	each	DT	B-NP
O	type	type	NN	I-NP
O	of	of	IN	B-PP
O	hernia	hernia	NN	B-NP
O	.	.	.	O

O	FT	FT	NN	B-NP
O	samples	sample	NNS	I-NP
O	were	be	VBD	B-VP
O	obtained	obtain	VBN	I-VP
O	from	from	IN	B-PP
O	36	36	CD	B-NP
O	patients	patient	NNS	I-NP
O	presenting	present	VBG	B-VP
O	inguinal	inguinal	JJ	B-NP
O	hernia	hernia	NN	I-NP
O	(	(	(	O
O	23	23	CD	B-NP
O	indirect	indirect	JJ	I-NP
O	hernia	hernia	NN	I-NP
O	and	and	CC	O
O	13	13	CD	B-NP
O	direct	direct	JJ	I-NP
O	hernia	hernia	NN	I-NP
O	)	)	)	O
O	who	who	WP	B-NP
O	underwent	undergo	VBD	B-VP
O	surgery	surgery	NN	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	have	have	VBP	B-VP
O	analysed	analyse	VBN	I-VP
O	the	the	DT	B-NP
O	ultrastructure	ultrastructure	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	fascia	fascia	NN	I-NP
O	surrounding	surround	VBG	B-VP
O	the	the	DT	B-NP
O	hernial	hernial	JJ	I-NP
O	lesions	lesion	NNS	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	proline	proline	NN	I-NP
O	and	and	CC	I-NP
O	lysine	lysine	NN	I-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	tissue	tissue	NN	I-NP
O	,	,	,	O
O	the	the	DT	B-NP
O	type	type	NN	I-NP
O	I	I	CD	I-NP
O	-	-	:	O
B-GGP	type	type	NN	B-NP
I-GGP	III	III	CD	I-NP
I-GGP	collagen	collagen	NN	I-NP
O	ratio	ratio	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	metalloproteinases	metalloproteinas	NNS	B-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	have	have	VBP	B-VP
O	not	not	RB	I-VP
O	detected	detect	VBN	I-VP
O	ultrastructural	ultrastructural	JJ	B-NP
O	differences	difference	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	collagen	collagen	NN	I-NP
O	fibrils	fibril	NNS	I-NP
O	from	from	IN	B-PP
O	FT	FT	NN	B-NP
O	in	in	IN	B-PP
O	direct	direct	JJ	B-NP
O	and	and	CC	I-NP
O	indirect	indirect	JJ	I-NP
O	hernias	hernia	NNS	I-NP
O	.	.	.	O

O	However	However	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
O	interfibrillar	interfibrillar	JJ	I-NP
O	matrix	matrix	NN	I-NP
O	was	be	VBD	B-VP
O	more	more	RBR	B-ADJP
O	abundant	abundant	JJ	I-ADJP
O	in	in	IN	B-PP
O	direct	direct	JJ	B-NP
O	hernias	hernia	NNS	I-NP
O	,	,	,	O
O	showing	show	VBG	B-VP
O	abundant	abundant	JJ	B-NP
O	electron	electron	NN	I-NP
O	-	-	HYPH	B-NP
O	dense	dense	JJ	I-NP
O	particles	particle	NNS	I-NP
O	.	.	.	O

O	No	No	DT	B-NP
O	differences	difference	NNS	I-NP
O	in	in	IN	B-PP
O	proline	proline	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	were	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	between	between	IN	B-PP
O	each	each	DT	B-NP
O	type	type	NN	I-NP
O	of	of	IN	B-PP
O	hernia	hernia	NN	B-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	small	small	JJ	I-NP
O	decrease	decrease	NN	I-NP
O	in	in	IN	B-PP
O	lysine	lysine	NN	B-NP
O	hydroxylation	hydroxylation	NN	I-NP
O	was	be	VBD	B-VP
O	detected	detect	VBN	I-VP
O	in	in	IN	B-PP
O	patients	patient	NNS	B-NP
O	with	with	IN	B-PP
O	direct	direct	JJ	B-NP
O	hernia	hernia	NN	I-NP
O	.	.	.	O

O	Enzyme	Enzyme	NN	B-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	immunosorbent	immunosorbent	JJ	I-NP
O	assays	assay	NNS	I-NP
O	(	(	(	O
O	ELISAs	ELISA	NNS	B-NP
O	)	)	)	O
O	showed	show	VBD	B-VP
O	no	no	DT	B-NP
O	statistically	statistically	RB	I-NP
O	significant	significant	JJ	I-NP
O	differences	difference	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	type	type	NN	I-NP
O	I	I	CD	I-NP
O	-	-	:	O
B-GGP	type	type	NN	B-NP
I-GGP	III	III	CD	I-NP
I-GGP	collagen	collagen	NN	I-NP
O	absorbance	absorbance	NN	I-NP
O	ratios	ratio	NNS	I-NP
O	.	.	.	O

O	Immunohistochemistry	Immunohistochemistry	NN	B-NP
O	revealed	reveal	VBD	B-VP
O	no	no	DT	B-NP
O	differences	difference	NNS	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	expression	expression	NN	I-NP
O	of	of	IN	B-PP
B-GGP	matrix	matrix	NN	B-NP
I-GGP	metalloproteinase	metalloproteinase	NN	I-NP
I-GGP	-	-	HYPH	B-NP
I-GGP	1	1	CD	I-NP
O	.	.	.	O

O	FT	FT	NN	B-NP
O	from	from	IN	B-PP
O	patients	patient	NNS	B-NP
O	presenting	present	VBG	B-VP
O	direct	direct	JJ	B-NP
O	hernia	hernia	NN	I-NP
O	showed	show	VBD	B-VP
O	a	a	DT	B-NP
O	very	very	RB	I-NP
O	strong	strong	JJ	I-NP
O	staining	staining	NN	I-NP
O	vs	v	NNS	I-NP
O	.	.	.	O
B-GGP	metalloproteinase	metalloproteinase	NN	B-NP
I-GGP	-	-	HYPH	O
I-GGP	2	2	CD	B-NP
O	when	when	WRB	B-ADVP
O	compared	compare	VBN	B-PP
O	with	with	IN	B-PP
O	that	that	DT	B-NP
O	observed	observe	VBN	B-VP
O	in	in	IN	B-PP
O	indirect	indirect	JJ	B-NP
O	hernia	hernia	NN	I-NP
O	.	.	.	O

O	Porcine	Porcine	JJ	B-NP
B-GGP	submaxillary	submaxillary	JJ	I-NP
I-GGP	mucin	mucin	NN	I-NP
O	forms	form	VBZ	B-VP
O	disulfide	disulfide	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-VP
O	multimers	multimer	NNS	B-NP
O	through	through	IN	B-PP
O	its	its	PRP$	B-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	D	D	NN	I-NP
O	-	-	HYPH	B-VP
O	domains	domain	NNS	B-NP
O	.	.	.	O

O	COS	COS	NN	B-NP
O	-	-	HYPH	I-NP
O	7	7	CD	I-NP
O	cells	cell	NNS	I-NP
O	expressing	express	VBG	B-VP
O	1	1	CD	B-NP
O	,	,	,	O
O	360	360	CD	B-NP
O	residues	residue	NNS	I-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	terminus	terminus	NN	I-NP
O	of	of	IN	B-PP
O	porcine	porcine	JJ	B-NP
B-GGP	submaxillary	submaxillary	JJ	I-NP
I-GGP	mucin	mucin	NN	I-NP
O	were	be	VBD	B-VP
O	used	use	VBN	I-VP
O	to	to	TO	B-VP
O	determine	determine	VB	I-VP
O	whether	whether	IN	B-SBAR
O	this	this	DT	B-NP
O	region	region	NN	I-NP
O	,	,	,	O
O	containing	contain	VBG	B-VP
O	the	the	DT	B-NP
O	D1	D1	NN	I-NP
O	,	,	,	O
O	D2	D2	NN	B-NP
O	,	,	,	O
O	and	and	CC	O
O	D3	D3	NN	B-NP
O	domains	domain	NNS	I-NP
O	,	,	,	O
O	is	be	VBZ	B-VP
O	involved	involve	VBN	I-VP
O	in	in	IN	B-PP
O	forming	form	VBG	B-VP
O	mucin	mucin	NN	B-NP
O	multimers	multimer	NNS	I-NP
O	.	.	.	O

O	Analysis	Analysis	NN	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	proteins	protein	NNS	I-NP
O	immunoprecipitated	immunoprecipitate	VBN	B-VP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	medium	medium	NN	I-NP
O	of	of	IN	B-PP
O	transfected	transfecte	VBN	B-NP
O	cells	cell	NNS	I-NP
O	by	by	IN	B-PP
O	reducing	reduce	VBG	B-VP
O	SDS	SDS	NN	B-NP
O	-	-	HYPH	B-NP
O	gel	gel	NN	I-NP
O	electrophoresis	electrophoresis	NN	I-NP
O	showed	show	VBD	B-VP
O	a	a	DT	B-NP
O	single	single	JJ	I-NP
O	N	N	NN	I-NP
O	-	-	HYPH	B-VP
O	glycosylated	glycosylate	VBN	B-NP
O	protein	protein	NN	I-NP
O	with	with	IN	B-PP
O	no	no	DT	B-NP
O	indication	indication	NN	I-NP
O	of	of	IN	B-PP
O	proteolytically	proteolytically	RB	B-NP
O	processed	process	VBN	I-NP
O	forms	form	NNS	I-NP
O	.	.	.	O

O	Without	Without	IN	B-PP
O	prior	prior	JJ	B-NP
O	reduction	reduction	NN	I-NP
O	,	,	,	O
O	only	only	RB	B-NP
O	two	two	CD	I-NP
O	proteins	protein	NNS	I-NP
O	,	,	,	O
O	corresponding	correspond	VBG	B-VP
O	to	to	TO	B-PP
O	monomeric	monomeric	JJ	B-NP
O	and	and	CC	I-NP
O	disulfide	disulfide	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	trimeric	trimeric	JJ	I-NP
O	species	specie	NNS	I-NP
O	,	,	,	O
O	were	be	VBD	B-VP
O	observed	observe	VBN	I-VP
O	.	.	.	O

O	The	The	DT	B-NP
O	expressed	express	VBN	I-NP
O	protein	protein	NN	I-NP
O	devoid	devoid	JJ	B-ADJP
O	of	of	IN	B-PP
O	N	N	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	oligosaccharides	oligosaccharide	NNS	I-NP
O	also	also	RB	B-ADVP
O	formed	form	VBD	B-VP
O	trimers	trimer	NNS	B-NP
O	,	,	,	O
O	but	but	CC	O
O	was	be	VBD	B-VP
O	secreted	secrete	VBN	I-VP
O	from	from	IN	B-PP
O	cells	cell	NNS	B-NP
O	in	in	IN	B-PP
O	significantly	significantly	RB	B-NP
O	less	less	JJR	I-NP
O	amounts	amount	NNS	I-NP
O	than	than	IN	B-PP
O	glycosylated	glycosylate	VBN	B-NP
O	trimers	trimer	NNS	I-NP
O	.	.	.	O

O	Pulse	Pulse	NN	B-NP
O	-	-	HYPH	I-NP
O	chase	chase	NN	I-NP
O	studies	study	NNS	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	disulfide	disulfide	NN	I-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	trimers	trimer	NNS	I-NP
O	were	be	VBD	B-VP
O	assembled	assemble	VBN	I-VP
O	inside	inside	IN	B-PP
O	the	the	DT	B-NP
O	cells	cell	NNS	I-NP
O	no	no	RB	B-ADVP
O	earlier	earlier	RBR	I-ADVP
O	than	than	IN	B-NP
O	30	30	CD	I-NP
O	min	min	NN	I-NP
O	after	after	IN	B-PP
O	protein	protein	NN	B-NP
O	synthesis	synthesis	NN	I-NP
O	commenced	commence	VBD	B-VP
O	and	and	CC	O
O	after	after	IN	B-PP
O	the	the	DT	B-NP
O	intracellular	intracellular	JJ	I-NP
O	precursors	precursor	NNS	I-NP
O	were	be	VBD	B-VP
O	N	N	NN	B-NP
O	-	-	HYPH	O
O	glycosylated	glycosylate	VBN	B-VP
O	.	.	.	O

O	Trimer	Trimer	NN	B-NP
O	formation	formation	NN	I-NP
O	was	be	VBD	B-VP
O	inhibited	inhibit	VBN	I-VP
O	in	in	IN	B-PP
O	cells	cell	NNS	B-NP
O	treated	treat	VBN	B-VP
O	with	with	IN	B-PP
O	brefeldin	brefeldin	NN	B-NP
O	A	A	NN	I-NP
O	,	,	,	O
O	monensin	monensin	NN	B-NP
O	,	,	,	O
O	chloroquine	chloroquine	NN	B-NP
O	,	,	,	O
O	or	or	CC	O
O	bafilomycin	bafilomycin	NN	B-NP
O	A1	A1	NN	I-NP
O	,	,	,	O
O	although	although	IN	B-SBAR
O	only	only	RB	B-NP
O	brefeldin	brefeldin	NN	I-NP
O	A	A	NN	I-NP
O	prevented	prevent	VBD	B-VP
O	the	the	DT	B-NP
O	secretion	secretion	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	results	result	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	trimerization	trimerization	NN	B-NP
O	takes	take	VBZ	B-VP
O	place	place	NN	B-NP
O	in	in	IN	B-PP
O	compartments	compartment	NNS	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	Golgi	Golgi	NNP	I-NP
O	complex	complex	NN	I-NP
O	in	in	IN	B-PP
O	which	which	WDT	B-NP
O	the	the	DT	B-NP
O	vacuolar	vacuolar	JJ	I-NP
O	H	H	NN	I-NP
O	+	+	SYM	O
O	-	-	HYPH	O
O	ATPase	ATPase	NN	B-NP
O	maintains	maintain	VBZ	B-VP
O	an	an	DT	B-NP
O	acidic	acidic	JJ	I-NP
O	pH	pH	NN	I-NP
O	.	.	.	O

O	Coexpression	Coexpression	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	same	same	JJ	I-NP
O	cells	cell	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	region	region	NN	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	disulfide	disulfide	NN	I-NP
O	-	-	HYPH	O
O	rich	rich	JJ	B-NP
O	carboxyl	carboxyl	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	domain	domain	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mucin	mucin	NN	I-NP
O	showed	show	VBD	B-VP
O	that	that	IN	B-SBAR
O	these	these	DT	B-NP
O	structures	structure	NNS	I-NP
O	were	be	VBD	B-VP
O	not	not	RB	O
O	disulfide	disulfide	NN	B-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-VP
O	with	with	IN	B-PP
O	one	one	CD	B-NP
O	another	another	DT	I-NP
O	.	.	.	O

O	Cells	Cell	NNS	B-NP
O	expressing	express	VBG	B-VP
O	a	a	DT	B-NP
O	DNA	DNA	NN	I-NP
O	construct	construct	NN	I-NP
O	encoding	encode	VBG	B-VP
O	a	a	DT	B-NP
O	fusion	fusion	NN	I-NP
O	protein	protein	NN	I-NP
O	between	between	IN	B-PP
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	and	and	CC	I-NP
O	carboxyl	carboxyl	NN	I-NP
O	-	-	HYPH	B-NP
O	terminal	terminal	JJ	I-NP
O	regions	region	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	mucin	mucin	NN	I-NP
O	secreted	secrete	VBD	B-VP
O	disulfide	disulfide	NN	B-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	dimeric	dimeric	JJ	I-NP
O	and	and	CC	I-NP
O	high	high	JJ	I-NP
O	molecular	molecular	JJ	I-NP
O	weight	weight	NN	I-NP
O	multimeric	multimeric	JJ	I-NP
O	species	specie	NNS	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	recombinant	recombinant	JJ	I-NP
O	mucin	mucin	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	presence	presence	NN	I-NP
O	of	of	IN	B-PP
O	monensin	monensin	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	medium	medium	NN	I-NP
O	was	be	VBD	B-VP
O	without	without	IN	B-PP
O	effect	effect	NN	B-NP
O	on	on	IN	B-PP
O	dimerization	dimerization	NN	B-NP
O	,	,	,	O
O	but	but	CC	O
O	inhibited	inhibit	VBD	B-VP
O	the	the	DT	B-NP
O	formation	formation	NN	I-NP
O	of	of	IN	B-PP
O	disulfide	disulfide	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	multimers	multimer	NNS	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	studies	study	NNS	I-NP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	disulfide	disulfide	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	dimers	dimer	NNS	I-NP
O	of	of	IN	B-PP
O	mucin	mucin	NN	B-NP
O	are	be	VBP	B-VP
O	subsequently	subsequently	RB	I-VP
O	assembled	assemble	VBN	I-VP
O	into	into	IN	B-PP
O	disulfide	disulfide	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	multimers	multimer	NNS	I-NP
O	by	by	IN	B-PP
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	regions	region	NNS	I-NP
O	.	.	.	O

O	They	They	PRP	B-NP
O	also	also	RB	B-ADVP
O	suggest	suggest	VBP	B-VP
O	that	that	IN	B-SBAR
O	the	the	DT	B-NP
O	porcine	porcine	JJ	I-NP
O	mucin	mucin	NN	I-NP
O	forms	form	NNS	I-NP
O	branched	branch	VBD	B-VP
O	disulfide	disulfide	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	multimers	multimer	NNS	I-NP
O	.	.	.	O

O	This	This	DT	B-NP
O	ability	ability	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	region	region	NN	I-NP
O	of	of	IN	B-PP
O	mucin	mucin	NN	B-NP
O	to	to	TO	B-VP
O	aid	aid	VB	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	assembly	assembly	NN	I-NP
O	of	of	IN	B-PP
O	multimers	multimer	NNS	B-NP
O	is	be	VBZ	B-VP
O	consistent	consistent	JJ	B-ADJP
O	with	with	IN	B-PP
O	its	its	PRP$	B-NP
O	amino	amino	JJ	I-NP
O	acid	acid	NN	I-NP
O	identities	identity	NNS	I-NP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	amino	amino	JJ	I-NP
O	-	-	HYPH	I-NP
O	terminal	terminal	JJ	I-NP
O	region	region	NN	I-NP
O	of	of	IN	B-PP
O	human	human	JJ	B-NP
B-GGP	von	von	NN	I-NP
I-GGP	Willebrand	Willebrand	NN	I-NP
I-GGP	factor	factor	NN	I-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	also	also	RB	B-ADVP
O	serves	serve	VBZ	B-VP
O	to	to	TO	I-VP
O	form	form	VB	I-VP
O	disulfide	disulfide	NN	B-NP
O	-	-	HYPH	B-NP
O	linked	link	VBN	I-NP
O	multimers	multimer	NNS	I-NP
O	of	of	IN	B-PP
O	this	this	DT	B-NP
O	protein	protein	NN	I-NP
O	.	.	.	O

O	A	A	DT	B-NP
O	link	link	NN	I-NP
O	between	between	IN	B-PP
O	secretion	secretion	NN	B-NP
O	and	and	CC	O
O	pre	pre	AFX	B-NP
O	-	-	HYPH	I-NP
O	mRNA	mRNA	NN	I-NP
O	processing	processing	NN	I-NP
O	defects	defect	NNS	I-NP
O	in	in	IN	B-PP
O	Saccharomyces	Saccharomyces	NNP	B-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	identification	identification	NN	I-NP
O	of	of	IN	B-PP
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	splicing	splicing	NN	I-NP
O	gene	gene	NN	I-NP
O	,	,	,	O
B-GGP	RSE1	RSE1	NN	B-NP
O	.	.	.	O

O	Secretory	Secretory	JJ	B-NP
O	proteins	protein	NNS	I-NP
O	in	in	IN	B-PP
O	eukaryotic	eukaryotic	JJ	B-NP
O	cells	cell	NNS	I-NP
O	are	be	VBP	B-VP
O	transported	transport	VBN	I-VP
O	to	to	TO	B-PP
O	the	the	DT	B-NP
O	cell	cell	NN	I-NP
O	surface	surface	NN	I-NP
O	via	via	IN	B-PP
O	the	the	DT	B-NP
O	endoplasmic	endoplasmic	JJ	I-NP
O	reticulum	reticulum	NN	I-NP
O	(	(	(	O
O	ER	ER	NN	B-NP
O	)	)	)	O
O	and	and	CC	O
O	the	the	DT	B-NP
O	Golgi	Golgi	NNP	I-NP
O	apparatus	apparatus	NN	I-NP
O	by	by	IN	B-PP
O	membrane	membrane	NN	B-NP
O	-	-	HYPH	B-NP
O	bounded	bound	VBN	I-NP
O	vesicles	vesicle	NNS	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	screened	screen	VBD	B-VP
O	a	a	DT	B-NP
O	collection	collection	NN	I-NP
O	of	of	IN	B-PP
O	temperature	temperature	NN	B-NP
O	-	-	HYPH	B-NP
O	sensitive	sensitive	JJ	I-NP
O	mutants	mutant	NNS	I-NP
O	of	of	IN	B-PP
O	Saccharomyces	Saccharomyces	NNP	B-NP
O	cerevisiae	cerevisiae	NNP	I-NP
O	for	for	IN	B-PP
O	defects	defect	NNS	B-NP
O	in	in	IN	B-PP
O	ER	ER	NN	B-NP
O	-	-	HYPH	B-ADVP
O	to	to	TO	B-PP
O	-	-	HYPH	B-NP
O	Golgi	Golgi	NNP	I-NP
O	transport	transport	NN	I-NP
O	.	.	.	O

O	Two	Two	CD	B-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	genes	gene	NNS	I-NP
O	identified	identify	VBN	B-VP
O	in	in	IN	B-PP
O	this	this	DT	B-NP
O	screen	screen	NN	I-NP
O	were	be	VBD	B-VP
B-GGP	PRP2	PRP2	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	encodes	encode	VBZ	B-VP
O	a	a	DT	B-NP
O	known	known	JJ	I-NP
O	pre	pre	AFX	I-NP
O	-	-	HYPH	I-NP
O	mRNA	mRNA	NN	I-NP
O	splicing	splicing	NN	I-NP
O	factor	factor	NN	I-NP
O	,	,	,	O
O	and	and	CC	O
B-GGP	RSE1	RSE1	NN	B-NP
O	,	,	,	O
O	a	a	DT	B-NP
O	novel	novel	JJ	I-NP
O	gene	gene	NN	I-NP
O	that	that	IN	B-NP
O	we	we	PRP	B-NP
O	show	show	VBP	B-VP
O	to	to	TO	I-VP
O	be	be	VB	I-VP
O	important	important	JJ	B-ADJP
O	for	for	IN	B-PP
O	pre	pre	AFX	B-NP
O	-	-	HYPH	I-NP
O	mRNA	mRNA	NN	I-NP
O	splicing	splicing	NN	I-NP
O	.	.	.	O

O	Both	Both	CC	O
B-GGP	prp2	prp2	NN	B-NP
O	-	-	HYPH	B-NP
O	13	13	CD	I-NP
O	and	and	CC	I-NP
B-GGP	rse1	rse1	NN	I-NP
O	-	-	HYPH	O
O	1	1	CD	B-NP
O	mutants	mutant	NNS	I-NP
O	accumulate	accumulate	VBP	B-VP
O	the	the	DT	B-NP
O	ER	ER	NN	I-NP
O	forms	form	NNS	I-NP
O	of	of	IN	B-PP
O	invertase	invertase	NN	B-NP
O	and	and	CC	O
O	the	the	DT	B-NP
O	vacuolar	vacuolar	JJ	I-NP
O	protease	protease	NN	I-NP
B-GGP	CPY	CPY	NN	I-NP
O	at	at	IN	B-PP
O	restrictive	restrictive	JJ	B-NP
O	temperature	temperature	NN	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
O	secretion	secretion	NN	I-NP
O	defect	defect	NN	I-NP
O	in	in	IN	B-PP
O	each	each	DT	B-NP
O	mutant	mutant	NN	I-NP
O	can	can	MD	B-VP
O	be	be	VB	I-VP
O	suppressed	suppress	VBN	I-VP
O	by	by	IN	B-PP
O	increasing	increase	VBG	B-VP
O	the	the	DT	B-NP
O	amount	amount	NN	I-NP
O	of	of	IN	B-PP
B-GGP	SAR1	SAR1	NN	B-NP
O	,	,	,	O
O	which	which	WDT	B-NP
O	encodes	encode	VBZ	B-VP
O	a	a	DT	B-NP
O	small	small	JJ	I-NP
O	GTPase	GTPase	NN	I-NP
O	essential	essential	JJ	B-ADJP
O	for	for	IN	B-PP
O	COPII	COPII	NN	B-NP
O	vesicle	vesicle	NN	I-NP
O	formation	formation	NN	I-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	ER	ER	NN	I-NP
O	,	,	,	O
O	or	or	CC	O
O	by	by	IN	B-PP
O	deleting	delete	VBG	B-VP
O	the	the	DT	B-NP
O	intron	intron	NN	I-NP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
B-GGP	SAR1	SAR1	NN	I-NP
O	gene	gene	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	data	datum	NNS	I-NP
O	indicate	indicate	VBP	B-VP
O	that	that	IN	B-SBAR
O	a	a	DT	B-NP
O	failure	failure	NN	I-NP
O	to	to	TO	B-VP
O	splice	splice	VB	I-VP
B-GGP	SAR1	SAR1	NN	B-NP
O	pre	pre	AFX	O
O	-	-	HYPH	O
O	mRNA	mRNA	NN	B-NP
O	is	be	VBZ	B-VP
O	the	the	DT	B-NP
O	specific	specific	JJ	I-NP
O	cause	cause	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	secretion	secretion	NN	I-NP
O	defects	defect	NNS	I-NP
O	in	in	IN	B-PP
B-GGP	prp2	prp2	NN	B-NP
O	-	-	HYPH	B-NP
O	13	13	CD	I-NP
O	and	and	CC	I-NP
B-GGP	rse1	rse1	NN	I-NP
O	-	-	HYPH	B-NP
O	1	1	CD	I-NP
O	.	.	.	O

O	Moreover	Moreover	RB	B-ADVP
O	,	,	,	O
O	these	these	DT	B-NP
O	data	datum	NNS	I-NP
O	imply	imply	VBP	B-VP
O	that	that	IN	B-SBAR
B-GGP	Sar1p	Sar1p	NN	B-NP
O	is	be	VBZ	B-VP
O	a	a	DT	B-NP
O	limiting	limit	VBG	I-NP
O	component	component	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	ER	ER	NN	I-NP
O	-	-	HYPH	B-ADJP
O	to	to	TO	B-PP
O	-	-	HYPH	B-NP
O	Golgi	Golgi	NNP	I-NP
O	transport	transport	NN	I-NP
O	machinery	machinery	NN	I-NP
O	and	and	CC	O
O	suggest	suggest	VBP	B-VP
O	a	a	DT	B-NP
O	way	way	NN	I-NP
O	that	that	IN	B-SBAR
O	secretory	secretory	JJ	B-NP
O	pathway	pathway	NN	I-NP
O	function	function	NN	I-NP
O	might	might	MD	B-VP
O	be	be	VB	I-VP
O	coordinated	coordinate	VBN	I-VP
O	with	with	IN	B-PP
O	the	the	DT	B-NP
O	amount	amount	NN	I-NP
O	of	of	IN	B-PP
O	gene	gene	NN	B-NP
O	expression	expression	NN	I-NP
O	in	in	IN	B-PP
O	a	a	DT	B-NP
O	cell	cell	NN	I-NP
O	.	.	.	O

O	Comparative	Comparative	JJ	B-NP
O	methylation	methylation	NN	I-NP
O	analysis	analysis	NN	I-NP
O	of	of	IN	B-PP
O	murine	murine	JJ	B-NP
O	transgenes	transgene	NNS	I-NP
O	that	that	WDT	B-NP
O	undergo	undergo	VBP	B-VP
O	or	or	CC	I-VP
O	escape	escape	VBP	I-VP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	chromosome	chromosome	NN	I-NP
O	inactivation	inactivation	NN	I-NP
O	.	.	.	O

O	We	We	PRP	B-NP
O	analyzed	analyze	VBD	B-VP
O	an	an	DT	B-NP
O	X	X	NN	I-NP
O	-	-	HYPH	B-VP
O	linked	link	VBN	B-NP
O	metallothionein	metallothionein	NN	I-NP
O	-	-	HYPH	O
B-GGP	vasopressin	vasopressin	NN	B-NP
O	(	(	(	O
B-GGP	MTVP	MTVP	NN	B-NP
O	)	)	)	O
O	fusion	fusion	NN	B-NP
O	transgene	transgene	NN	I-NP
O	that	that	WDT	B-NP
O	undergoes	undergo	VBZ	B-VP
O	X	X	NN	B-NP
O	-	-	HYPH	O
O	chromosome	chromosome	NN	B-NP
O	inactivation	inactivation	NN	I-NP
O	(	(	(	O
O	X	X	NN	B-NP
O	inactivation	inactivation	NN	I-NP
O	)	)	)	O
O	and	and	CC	O
O	an	an	DT	B-NP
O	X	X	NN	I-NP
O	-	-	HYPH	O
O	linked	link	VBN	B-VP
B-GGP	transferrin	transferrin	NN	B-NP
O	(	(	(	O
B-GGP	TFN	TFN	NN	B-NP
O	)	)	)	O
O	transgene	transgene	NN	B-NP
O	that	that	WDT	B-NP
O	escapes	escape	VBZ	B-VP
O	X	X	NN	B-NP
O	inactivation	inactivation	NN	I-NP
O	with	with	IN	B-PP
O	respect	respect	NN	B-NP
O	to	to	TO	B-PP
O	methylation	methylation	NN	B-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	5	5	CD	I-NP
O	'	'	SYM	I-NP
O	regulatory	regulatory	JJ	I-NP
O	regions	region	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	MTVP	MTVP	NN	I-NP
O	transgene	transgene	NN	I-NP
O	promoter	promoter	NN	I-NP
O	region	region	NN	I-NP
O	is	be	VBZ	B-VP
O	unmethylated	unmethylate	VBN	I-VP
O	when	when	WRB	B-ADVP
O	the	the	DT	B-NP
O	transgene	transgene	NN	I-NP
O	is	be	VBZ	B-VP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	active	active	JJ	I-NP
O	X	X	NN	I-NP
O	chromosome	chromosome	NN	I-NP
O	and	and	CC	O
O	methylated	methylate	VBN	B-VP
O	when	when	WRB	B-ADVP
O	on	on	IN	B-PP
O	the	the	DT	B-NP
O	inactive	inactive	JJ	I-NP
O	X	X	NN	I-NP
O	chromosome	chromosome	NN	I-NP
O	.	.	.	O

O	Interestingly	Interestingly	RB	B-ADVP
O	,	,	,	O
O	the	the	DT	B-NP
B-GGP	MTVP	MTVP	NN	I-NP
O	transgene	transgene	NN	I-NP
O	is	be	VBZ	B-VP
O	not	not	RB	I-VP
O	detectably	detectably	RB	I-VP
O	transcribed	transcribe	VBN	I-VP
O	from	from	IN	B-PP
O	the	the	DT	B-NP
O	male	male	JJ	I-NP
O	X	X	NN	I-NP
O	chromosome	chromosome	NN	I-NP
O	,	,	,	O
O	although	although	IN	B-SBAR
O	it	it	PRP	B-NP
O	is	be	VBZ	B-VP
O	unmethylated	unmethylated	JJ	B-ADJP
O	,	,	,	O
O	consistent	consistent	JJ	B-ADJP
O	with	with	IN	B-PP
O	its	its	PRP$	B-NP
O	availability	availability	NN	I-NP
O	for	for	IN	B-PP
O	transcription	transcription	NN	B-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	TFN	TFN	NN	I-NP
O	transgene	transgene	NN	I-NP
O	promoter	promoter	NN	I-NP
O	region	region	NN	I-NP
O	is	be	VBZ	B-VP
O	hypomethylated	hypomethylate	VBN	I-VP
O	on	on	IN	B-PP
O	both	both	CC	O
O	the	the	DT	B-NP
O	active	active	JJ	I-NP
O	and	and	CC	I-NP
O	inactive	inactive	JJ	I-NP
O	X	X	NN	I-NP
O	chromosomes	chromosome	NNS	I-NP
O	,	,	,	O
O	consistent	consistent	JJ	B-ADJP
O	with	with	IN	B-PP
O	its	its	PRP$	B-NP
O	expression	expression	NN	I-NP
O	from	from	IN	B-PP
O	both	both	DT	B-NP
O	chromosomes	chromosome	NNS	I-NP
O	.	.	.	O

O	The	The	DT	B-NP
B-GGP	TFN	TFN	NN	I-NP
O	and	and	CC	I-NP
B-GGP	MTVP	MTVP	NN	I-NP
O	transgenes	transgene	NNS	I-NP
O	have	have	VBP	B-VP
O	been	be	VBN	I-VP
O	mapped	map	VBN	I-VP
O	to	to	TO	B-PP
O	chromosomal	chromosomal	JJ	B-NP
O	regions	region	NNS	I-NP
O	D	D	NN	I-NP
O	and	and	CC	I-NP
O	C	C	NN	I-NP
O	,	,	,	O
O	respectively	respectively	RB	B-ADVP
O	,	,	,	O
O	by	by	IN	B-PP
O	fluorescence	fluorescence	NN	B-NP
O	in	in	FW	B-NP
O	situ	situ	FW	I-NP
O	hybridization	hybridization	NN	I-NP
O	.	.	.	O

O	These	These	DT	B-NP
O	observations	observation	NNS	I-NP
O	are	be	VBP	B-VP
O	discussed	discuss	VBN	I-VP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	context	context	NN	I-NP
O	of	of	IN	B-PP
O	our	our	PRP$	B-NP
O	understanding	understanding	NN	I-NP
O	of	of	IN	B-PP
O	the	the	DT	B-NP
O	role	role	NN	I-NP
O	of	of	IN	B-PP
O	DNA	DNA	NN	B-NP
O	methylation	methylation	NN	I-NP
O	in	in	IN	B-PP
O	the	the	DT	B-NP
O	spread	spread	NN	I-NP
O	and	and	CC	I-NP
O	maintenance	maintenance	NN	I-NP
O	of	of	IN	B-PP
O	X	X	NN	B-NP
O	-	-	HYPH	B-NP
O	chromosome	chromosome	NN	I-NP
O	inactivation	inactivation	NN	I-NP
O	.	.	.	O

